note_id
stringlengths
13
15
subject_id
int64
10M
20M
hadm_id
int64
20M
30M
note_type
stringclasses
1 value
note_seq
int64
2
133
charttime
stringlengths
19
19
storetime
stringlengths
19
19
text
stringlengths
1.56k
52.7k
19797687-DS-18
19,797,687
25,776,542
DS
18
2162-11-26 00:00:00
2162-11-26 21:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Mustard / Levaquin / Ceftriaxone / Benadryl / cefepime Attending: ___. Chief Complaint: cc: dyspnea Major ___ or Invasive Procedure: None History of Present Illness: ___ yo F with MM, asthma/copd, GERD who presents with subacute dyspnea and wheezing not resolving despite multiple steroid bursts over the past month. Pt with multiple myeloma, recently started on pomalidomide until she developed a flare of COPD. Pt with transient improvement on steroids but persistent symptoms that have led to at least 3 steroid tapers over the past month. Pt hospitalized on ___ and has had multiple visits with her oncologist and pulmonologist for this issue. Initially attributed to side effect of her pomalidomide which has been held, but pt not improving. Alternate diagnoses pursued with multiple negative d-dimers, normal TTE, and normal BNP. No advanced imaging of chest done yet. Pt reports dry cough which is unusual for her asthma/copd. No fevers or chills. No sick contacts. No change to housing. On bactrim and acyclovir ppx. Dyspnea is significant with short ambulation whereas she can ususually tolerate significant exertion (works as ___). Pt seen in ___ clinic today and sent in for inpatient workup. In the ED, pt given multiple rounds of nebulizer treatments for diffuse wheezing as well as 125 of solumedrol and admitted for furhter care. ROS: negative except as above Past Medical History: PAST ONCOLOGIC HISTORY: - ___: began developing pain in distal medial right leg. Did not go away as would with typical MSK pain from dancing. - ___: Xray which showed a 2.3 cm R tibial lesion - ___: CT guided bone biopsy significant for plasmacytoma. After this diagnosis she was seen by Dr. ___ and referred to us. - ___: Bone marrow biopsy with 30% monoclonal plasma cells - ___ - ___: Radiation 35 Gy in 14 fractions to right distal tibia. - ___: Dexamethasone 20mg with rapid taper over 7 days. - On DF/___ ___ Elotuzumab + 4 cycles of Revlimid and Decadron. - ___ Revlimid/Dex therapy. Revlimid discontinued on ___ and Dexamethasone discontinued on ___. - ___: started therapy on clinical trial Protocol ___: A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of Pomalidomide (POM), Bortezomib (BTZ) and Low-Dose Dexamethasone (LD-DEX) versus Bortezomib and Low-Dose Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma (MM). - patient was randomized to the Velcade/Dex arm - ___: Cycle 1 Velcade/Dex - ___: Cycle 2 Velcade/Dex PAST MEDICAL HISTORY: - asthma - dx'ed ___ - COPD - dx'ed in ___ - GERD - ___ - HLD - ___ - anemia - dx'ed ___, resolved ___ - right rotator cuff tear -___ - chronic low back pain - ___ - s/p R meniscus repair - ___ - s/p L meniscus repair - ___ - L forearm abrasion ___ tx'ed with Clindamycin x 7 days - Arthritis x ___ years Social History: ___ Family History: siblings: brother with mental health problems children: 1 son, healthy No family history of malignancy or blood disorders besides a cousin with breast cancer. Physical Exam: Vitals: 97.7 98 110/54 23 97%3L Gen: NAD, able to speak in complete sentences HEENT: no cervical lad, no thrush CV: rrr, no r/m/g Pulm: poor air movement, diffuse wheeze Abd: soft, nt/nd, +bs Ext: no edema Neuro: alert and oriented x 3 Exam on discharge: 97.8 130/55 93 20 95%RA Sitting in bed in NAD, Able to speak in full sentences HEENT: MMM, no lesions LUNGS: Clear B/L at bases, +expiratory wheeze on forced expiration ___: RRR S1 S2 present ABD: Soft, slightly distended, non-tender Ext: No edema, chronic skin changes on anterior shins NEURO: AAOx3, pleasant and cooperative Pertinent Results: ___ 06:48PM WBC-12.4*# RBC-3.55* HGB-12.5 HCT-37.4 MCV-105* MCH-35.1* MCHC-33.3 RDW-15.9* ___ 06:48PM PLT COUNT-315# ___ 06:48PM ___ PTT-28.8 ___ ___ 06:48PM GLUCOSE-84 UREA N-21* CREAT-0.9 SODIUM-137 POTASSIUM-4.6 CHLORIDE-99 TOTAL CO2-29 ANION GAP-14 ___ 06:48PM proBNP-180 ___ 06:48PM cTropnT-<0.01 CXR: 1. Hyperinflated lungs compatible with chronic obstructive pulmonary disease, but no focal consolidation. 2. Persistent left upper lobe opacity may represent a parenchymal nodule and further evaluation via non-urgent Chest CT may be indicated. CT chest: IMPRESSION: 1. No acute aortic pathology or pulmonary embolism. 2. 5 mm right upper lobe nodule, not clearly seen on prior studies. Followup with dedicated chest CT is recommended in 6 months. Additional pulmonary nodules are stable since at least ___. 3. Small focal right lower lobe aspiration. No consolidation. 4. Panlobular emphysema with lower lobe predominance, typically seen in alpha 1 antitrypsin deficiency, but per the medical record, there is no history of this. 5. Moderate to severe stenosis at the origin of the celiac axis. Brief Hospital Course: ___ yo F with asthma/copd, multiple myeloma here with subacute dyspnea and wheezing not responding to increasing doses of steroids as outpatient. # Asthma/COPD - #Pneumonia, bacterial The patient presented with significant dyspnea on exertion in addition to increased cough with sputum production concerning for COPD exacerbation. She was seen by her pulmonologist, Dr. ___ recommended high dose steroids. She also underwent a CT chest which ruled out PE but raised concern for a RLL infiltrate. Additionally, the pulmonary team suggested checking ANCA and IgE which were negative. Aspergillus specific antibodies is pending on discharge. Given failure to improve on steroids, the patent was started on Meropenem with some improvement in her symptoms. Given her immunocompromised state, significant underlying lung disease the decision was made to continue IV Ertapenem for a total of 7 days. The patent was discharged on a steroid taper (80mg decrease by 10mg every 4 days) with close follow up with both her oncologist and pulmonologist. As an outpatient can consider allergic work up and work up for tracheobronchomalacia. The patent was continued on her home Spiriva, Advair and nebulizers on discharge. #Multiple Myeloma Currently off treatment given COPD exacerbations. Continued Bactrim and acyclovir ppx #Pulmonary nodule Not seen on previous images- repeat CT in 6months, patient aware, letter sent to PCP ___ issues: - Continue Ertapenem until ___ - repeat CT in 6months to asses pumonary nodule Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO BID 2. Albuterol 0.083% Neb Soln 1 NEB IH Q8H:PRN dyspnea 3. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheeze 4. Azithromycin 250 mg PO Q24H 5. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 6. Lorazepam 0.5 mg PO QHS:PRN insomnia 7. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 8. Tiotropium Bromide 1 CAP IH DAILY 9. Aspirin 81 mg PO DAILY 10. Ascorbic Acid ___ mg PO DAILY Discharge Medications: 1. Acyclovir 400 mg PO BID 2. Albuterol 0.083% Neb Soln 1 NEB IH Q8H:PRN dyspnea 3. Aspirin 81 mg PO DAILY 4. Azithromycin 250 mg PO Q24H 5. Docusate Sodium 100 mg PO DAILY 6. Lorazepam 0.5 mg PO QHS:PRN insomnia 7. PredniSONE 80 mg PO DAILY Duration: 1 Dose Start: Tomorrow - ___, First Dose: First Routine Administration Time RX *prednisone 10 mg 8 tablet(s) by mouth daily Disp #*104 Tablet Refills:*0 8. PredniSONE 70 mg PO DAILY Duration: 4 Doses Start: After 80 mg DAILY tapered dose 9. PredniSONE 60 mg PO DAILY Duration: 4 Doses Start: After 70 mg DAILY tapered dose 10. PredniSONE 50 mg PO DAILY Duration: 4 Doses Start: After 60 mg DAILY tapered dose 11. PredniSONE 40 mg PO DAILY Duration: 4 Doses Start: After 50 mg DAILY tapered dose 12. PredniSONE 30 mg PO DAILY Duration: 4 Doses Start: After 40 mg DAILY tapered dose 13. PredniSONE 20 mg PO DAILY Duration: 4 Doses Start: After 30 mg DAILY tapered dose 14. PredniSONE 10 mg PO DAILY Duration: 4 Doses Start: After 20 mg DAILY tapered dose 15. Psyllium 1 PKT PO DAILY 16. Ranitidine 150 mg PO QAM 17. Ranitidine 75 mg PO QHS 18. Senna 8.6 mg PO DAILY:PRN constipation 19. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 20. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheeze 21. Artificial Tears ___ DROP BOTH EYES QAM 22. Ascorbic Acid ___ mg PO DAILY 23. Benefiber (guar gum) (guar gum) 0 . ORAL DAILY 24. Flovent HFA (fluticasone) 220 mcg/actuation inhalation Other 25. Glucosamine Sulf-Chondroitin (glucosamine ___ 2KCl-chondroit) 500-400 mg oral DAILY 26. Guaifenesin ___ mL PO Q4H:PRN cough 27. Guaifenesin-Dextromethorphan 5 mL PO Q4H:PRN cough 28. Multivitamins 1 TAB PO DAILY 29. Tiotropium Bromide 1 CAP IH DAILY 30. Vitamin B Complex 1 CAP PO DAILY 31. carboxymethylcellulose 0 . MISCELLANEOUS QHS 32. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 33. Ertapenem Sodium 1 g IV DAILY Duration: 5 Doses RX *ertapenem [Invanz] 1 gram 1 gm IV daily Disp #*5 Vial Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: COPD exacerbation Pneumonia Multiple myeloma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: It was a pleasure taking care of you during your recent admission to ___. You were admitted with difficulty breathing. You had a CT of your chest which showed a possible infection. With the help of your pulmonologist, a decision was made to start you on antibiotics for pneumonia. You had a PICC line placed and you will continue on Ertapenem to complete a 7 day course. You were also given high dose steriods. You will be discharged on 80mg daily and you should reduce your dose by 10mg every four days. Please follow up with your oncologist and with your pulmonologist as scheduled. Followup Instructions: ___
19797687-DS-21
19,797,687
28,866,675
DS
21
2164-04-26 00:00:00
2164-04-26 18:23:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Mustard / Levaquin / Ceftriaxone / Benadryl / cefepime Attending: ___. Chief Complaint: Shortness of breath, confusion, fever Major Surgical or Invasive Procedure: None History of Present Illness: ___ yoF followed by Dr. ___ with hx of multiple myeloma (___) tx with radiation to right distal tibia, Elotuzumab + 4 cycles of Revlimid and Decadron, ___ Revlimid/Dex therapy. ___: started therapy on clinical trial Protocol ___: patient was randomized to the Velcade/Dex arm, completed 2 cycles of velcade/dex. Course has been complicated by mixed asthma, copd, multiple admissions for exacerbations I/s/o infection and chemotherapy induced dyspnea often requiring prolonged steroid tapers. Pt has been on azithromycin since ___. Most recently pt was admitted in ___ with pan sensitive pseudomonas PNA and possibly aspergillus ___ (oropharyngeal contamination invalidated results). She was treated with 14d meropenem. Multiple myeloma tx was held at this time I/s/o infection and decreased stability. After pt was started on Carfilzomib which was interrupted by SOB. ECHO which did not show evidence of HF. There was some concern that that she could be having some immune inf response for Carfilomib so tx was held. Ninlaro 4mg 3 weeks + dexamethasone 20mg once weekly was started on ___. Last night she p/w fever, hypotension, tachycardia, AMS and CXR showing Multifocal pneumonia with a small left pleural effusion. The patient was found at her home by her son to be very confused so he brought her to the ED. She is alert and oriented on admission but is unsure of some details over the last few days. The son thinks she has probably been ill for about 3 days. She has chronic shortness of breath and cough and is unsure if this has worsened at all. She is not aware of any fevers at home. She has not been eating or drinking much for the last few days or taking care of herself. Her son noted diarrhea near her when he found her. She thinks this may have been going on for two days. She denies any nausea or dysuria. In the ED she was noted to be hypotensive to 89/66, febrile to 102.6 tachycardic to 107 and hypoxic. She was also noted to have a leukocytosis and ___. A CXR showed a pneumonia and she was given vanc and meropenum. Past Medical History: (per chart, confirmed with pt and updated): PAST ONCOLOGIC HISTORY: - ___: began developing pain in distal medial right leg. Did not go away as would with typical MSK pain from dancing. - ___: Xray which showed a 2.3 cm R tibial lesion - ___: CT guided bone biopsy significant for plasmacytoma. After this diagnosis she was seen by Dr. ___ and referred to us. - ___: Bone marrow biopsy with 30% monoclonal plasma cells - ___ - ___: Radiation 35 Gy in 14 fractions to right distal tibia. - ___: Dexamethasone 20mg with rapid taper over 7 days. - On DF/HCC ___ Elotuzumab + 4 cycles of Revlimid and Decadron. - ___ Revlimid/Dex therapy. Revlimid discontinued on ___ and Dexamethasone discontinued on ___. - ___: started therapy on clinical trial Protocol ___: A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of Pomalidomide (POM), Bortezomib (BTZ) and Low-Dose Dexamethasone (LD-DEX) versus Bortezomib and Low-Dose Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma (MM). - patient was randomized to the Velcade/Dex arm - ___: Cycle 1 Velcade/Dex - ___: Cycle 2 Velcade/Dex - currently on carfilzomib PAST MEDICAL HISTORY: - asthma - dx'ed ___ - COPD - dx'ed in ___, no smoking hx, thought to be due to second hand smoke as husband was smoker - GERD - ___ - HLD - ___, not on treatment - anemia - dx'ed ___, resolved ___ - right rotator cuff tear -___ - chronic low back pain - ___ - s/p R meniscus repair - ___ - s/p L meniscus repair - ___ - Arthritis x ___ years Social History: ___ Family History: siblings: brother with mental health problems children: 1 son, healthy Father with chronic bronchitis Physical Exam: PHYSICAL EXAM ON ADMISSION ========================== General: NAD VITAL SIGNS: 98.3 PO 90 / 52 94 20 93 2.0LNC --> 100/50 HEENT: MMM, no OP lesions CV: RR, NL S1S2 PULM: Decreased breath at lower bases with inspiratory and expiratory wheezing, +rhonchi with shifts when cough ABD: Soft, ND, no masses or hepatosplenomegaly, mild tenderness in LUQ LIMBS: No edema, clubbing, tremors, or asterixis. + for bruising around ankles and darkened skin on anterior leg. Significant bruise left ankle NEURO: Alert and oriented x3. Unable to lift arms past elbow joint, cannot elevate elbow. Proximal upper extremity ___ Distal upper extremity ___ Proximal lower extremity ___ distal lower extremity ___ PHYSICAL EXAM ON DISCHARGE ============================= VITAL SIGNS: ___ 98.4 PO 114 / 62 72 18 98 3L 1136 98.3 PO 102 / 64 75 18 98 3L NC General: NAD, sleeping comfortably in bed with sleep mask over eyes and shawl around shoulders HEENT: MMM, no OP lesions CV: RRR, NL S1S2 PULM: Decreased breath at lower bases bilaterally (R worse than L), poor inspiratory effort; seems unchanged from prior ABDOMEN: soft NT ND; small area of ecchymosis LLQ from injections. LIMBS: 1+ edema ___ bilaterally, trace edema LUE forearm persists Skin: large band of ecchymosis L abdomen/pannus, stretching from hip toward pubis continues to improve. NEURO: Alert and responding to questions appropriately; moving all extremities. EOMI grossly, full ROM in upper extremities bilaterally; ___ ___ bilaterally. Speech fluent. Lines: R arm midline placed, no bleeding or surrounding erythema noted after procedure. Pertinent Results: Admission ___ 11:37PM BLOOD WBC-12.4*# RBC-3.75* Hgb-12.6 Hct-40.7 MCV-109* MCH-33.6* MCHC-31.0* RDW-14.3 RDWSD-57.5* Plt ___ ___ 11:37PM BLOOD Neuts-62 Bands-33* ___ Monos-3* Eos-0 Baso-0 ___ Metas-1* Myelos-1* NRBC-1* AbsNeut-11.78* AbsLymp-0.00* AbsMono-0.37 AbsEos-0.00* AbsBaso-0.00* ___ 11:37PM BLOOD Hypochr-NORMAL Anisocy-NORMAL Poiklo-OCCASIONAL Macrocy-3+ Microcy-NORMAL Polychr-NORMAL Ovalocy-OCCASIONAL ___ 11:37PM BLOOD ___ PTT-35.2 ___ ___ 09:30AM BLOOD ___ ___ 11:37PM BLOOD Glucose-193* UreaN-38* Creat-1.6* Na-136 K-4.3 Cl-97 HCO3-20* AnGap-23* ___ 11:37PM BLOOD ALT-31 AST-53* AlkPhos-80 TotBili-0.4 DirBili-<0.2 IndBili-0.4 ___ 11:37PM BLOOD cTropnT-<0.01 ___ 11:37PM BLOOD Albumin-3.0* Calcium-8.5 Mg-2.1 ___ 09:30AM BLOOD Free T4-1.2 ___ 09:30AM BLOOD PEP-PND FreeKap-PND FreeLam-PND b2micro-4.4* IgG-1187 IgA-<5* IgM-<5* ___ 11:37PM BLOOD ___ 11:50PM BLOOD Lactate-2.2* RELEVANT IMAGING ================= Modified Barium Swallow ___ IMPRESSION: 1. No significant spontaneous gastroesophageal reflux was seen during this examination will while the patient was in supine position or turning either towards the right or towards the left. 2. No gross aspiration is seen during this examination. 3. There is notable dysmotility, with incomplete emptying of the esophagus and residua seen within the esophagus after each swallow, despite attempts to clear using subsequent dry swallows. CXR ___ IMPRESSION: Multifocal pneumonia with a small left pleural effusion. CT Chest w/o Contrast ___ IMPRESSION: Borderline sized mediastinal lymph nodes. New multifocal pneumonia. Subsequent areas of consolidations and opacities in the middle lobe, the lingular and the left and right lower lobe. Accompanying moderate pleural effusions. Moderate coronary and aortic wall calcifications. U/S UE ___ IMPRESSION: No evidence of deep vein thrombosis in the left upper extremity. U/S ___ ___ IMPRESSION: 1. No evidence of deep venous thrombosis in the right or left lower extremity veins. 2. Left ___ cyst, stable from ___. U/S UE ___ IMPRESSION: No evidence of deep vein thrombosis in the left upper extremity. RELEVANT MICROBIOLOGY ===================== Legionella Urinary Antigen (Final ___: NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. (Reference Range-Negative). Respiratory Viral Culture (Final ___: No respiratory viruses isolated. Culture screened for Adenovirus, Influenza A & B, Parainfluenza type 1,2 & 3, and Respiratory Syncytial Virus.. Detection of viruses other than those listed above will only be performed on specific request. Please call Virology at ___ within 1 week if additional testing is needed. Respiratory Viral Antigen Screen (Final ___: Negative for Respiratory Viral Antigen. Specimen screened for: Adeno, Parainfluenza 1, 2, 3, Influenza A, B, and RSV by immunofluorescence. Refer to respiratory viral culture and/or Influenza PCR (results listed under "OTHER" tab) for further information. C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). ___ 12:00 pm SPUTUM Source: Expectorated. GRAM STAIN (Final ___: >25 PMNs and <10 epithelial cells/100X field. NO MICROORGANISMS SEEN. RESPIRATORY CULTURE (Final ___: Commensal Respiratory Flora Absent. YEAST. RARE GROWTH. PSEUDOMONAS AERUGINOSA. RARE GROWTH. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | CEFEPIME-------------- 8 S CEFTAZIDIME----------- 4 S CIPROFLOXACIN--------- 1 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- 8 S TOBRAMYCIN------------ <=1 S LEGIONELLA CULTURE (Final ___: NO LEGIONELLA ISOLATED. FUNGAL CULTURE (Preliminary): YEAST. MRSA SCREEN (Final ___: No MRSA isolated. PERTINENT LABS AND LABS ON DISCHARGE ======================================= ___ 06:35AM BLOOD WBC-5.7 RBC-2.97* Hgb-9.9* Hct-31.0* MCV-104* MCH-33.3* MCHC-31.9* RDW-14.2 RDWSD-54.0* Plt ___ ___ 06:20AM BLOOD WBC-5.1 RBC-2.89* Hgb-9.9* Hct-30.5* MCV-106* MCH-34.3* MCHC-32.5 RDW-14.4 RDWSD-56.2* Plt ___ ___ 07:50AM BLOOD WBC-7.0 RBC-3.02* Hgb-10.2* Hct-32.1* MCV-106* MCH-33.8* MCHC-31.8* RDW-14.5 RDWSD-56.8* Plt ___ ___ 05:32AM BLOOD WBC-7.0 RBC-3.00* Hgb-10.0* Hct-31.7* MCV-106* MCH-33.3* MCHC-31.5* RDW-14.4 RDWSD-56.1* Plt ___ ___ 06:10AM BLOOD WBC-8.7 RBC-3.19* Hgb-10.6* Hct-34.3 MCV-108* MCH-33.2* MCHC-30.9* RDW-14.4 RDWSD-56.9* Plt ___ ___ 06:05AM BLOOD WBC-6.9 RBC-2.96* Hgb-9.7* Hct-31.5* MCV-106* MCH-32.8* MCHC-30.8* RDW-14.6 RDWSD-56.2* Plt ___ ___ 06:05AM BLOOD WBC-6.1 RBC-2.78* Hgb-9.3* Hct-30.1* MCV-108* MCH-33.5* MCHC-30.9* RDW-14.5 RDWSD-57.6* Plt ___ ___ 06:15AM BLOOD WBC-7.3 RBC-2.91* Hgb-9.6* Hct-31.5* MCV-108* MCH-33.0* MCHC-30.5* RDW-14.3 RDWSD-57.1* Plt ___ ___ 07:50AM BLOOD Neuts-80* Bands-3 Lymphs-7* Monos-10 Eos-0 Baso-0 ___ Myelos-0 AbsNeut-5.81 AbsLymp-0.49* AbsMono-0.70 AbsEos-0.00* AbsBaso-0.00* ___ 05:32AM BLOOD Neuts-88* Bands-2 Lymphs-3* Monos-3* Eos-0 Baso-0 ___ Metas-4* Myelos-0 AbsNeut-6.30* AbsLymp-0.21* AbsMono-0.21 AbsEos-0.00* AbsBaso-0.00* ___ 06:10AM BLOOD Neuts-72* Bands-3 Lymphs-12* Monos-3* Eos-3 Baso-0 ___ Metas-5* Myelos-2* AbsNeut-6.53* AbsLymp-1.04* AbsMono-0.26 AbsEos-0.26 AbsBaso-0.00* ___ 06:05AM BLOOD Neuts-87* Bands-0 Lymphs-4* Monos-7 Eos-1 Baso-0 ___ Myelos-1* AbsNeut-6.00 AbsLymp-0.28* AbsMono-0.48 AbsEos-0.07 AbsBaso-0.00* ___ 06:05AM BLOOD Neuts-86* Bands-0 Lymphs-10* Monos-3* Eos-1 Baso-0 ___ Myelos-0 AbsNeut-5.25 AbsLymp-0.61* AbsMono-0.18* AbsEos-0.06 AbsBaso-0.00* ___ 06:15AM BLOOD Neuts-79.4* Lymphs-8.5* Monos-9.0 Eos-1.2 Baso-0.1 Im ___ AbsNeut-5.76 AbsLymp-0.62* AbsMono-0.65 AbsEos-0.09 AbsBaso-0.01 ___ 06:05AM BLOOD ___ PTT-30.0 ___ ___ 06:05AM BLOOD ___ PTT-30.0 ___ ___ 06:15AM BLOOD ___ PTT-31.0 ___ ___ 06:20AM BLOOD ___ ___ 06:35AM BLOOD ___ ___ 06:05AM BLOOD ___ ___ 06:15AM BLOOD ___ 06:20AM BLOOD Glucose-153* UreaN-28* Creat-1.0 Na-144 K-3.5 Cl-108 HCO3-29 AnGap-11 ___ 07:50AM BLOOD Glucose-156* UreaN-28* Creat-0.9 Na-145 K-3.8 Cl-108 HCO3-30 AnGap-11 ___ 05:32AM BLOOD Glucose-87 UreaN-25* Creat-0.9 Na-141 K-3.5 Cl-104 HCO3-29 AnGap-12 ___ 06:10AM BLOOD Glucose-93 UreaN-25* Creat-0.9 Na-142 K-4.4 Cl-101 HCO3-33* AnGap-12 ___ 06:05AM BLOOD Glucose-88 UreaN-23* Creat-1.0 Na-142 K-4.2 Cl-101 HCO3-36* AnGap-9 ___ 06:05AM BLOOD Glucose-85 UreaN-22* Creat-1.0 Na-141 K-4.2 Cl-100 HCO3-38* AnGap-7* ___ 06:15AM BLOOD Glucose-83 UreaN-19 Creat-0.9 Na-142 K-4.2 Cl-101 HCO3-36* AnGap-9 ___ 07:50AM BLOOD Albumin-2.3* Calcium-8.4 Phos-3.6 Mg-2.0 ___ 05:32AM BLOOD Albumin-2.2* Calcium-8.6 Phos-3.4 Mg-1.8 ___ 06:10AM BLOOD Albumin-2.4* Calcium-8.8 Phos-3.7 Mg-1.9 ___ 06:05AM BLOOD Calcium-8.5 Phos-3.0 ___ 06:05AM BLOOD Albumin-2.2* Calcium-8.5 Phos-3.1 Mg-2.2 ___ 06:15AM BLOOD Albumin-2.6* Calcium-8.6 Phos-2.8 Mg-2.3 ___ 09:30AM BLOOD PEP-ABNORMAL B b2micro-4.4* IgG-1187 IgA-<5* IgM-<5* ___ 11:37PM BLOOD ___ FreeLam-2.7* Fr K/L-5.59* Brief Hospital Course: ___ w/ IgG kappa MM recently started on ninlaro/dex ___, has finished 2 cycles, ___ cycle ___, w/ hx chronic obstructive asthma and COPD (never smoker; FEV1 51%; supposed to be on home O2 but does not use), multiple prior pulmonary infections p/w confusion, hypotension, bandemia, and found to have multifocal PNA. #PNA: Multiple prior PNAs, most recently ___ w/ Pseudomonas and Aspergillus ___ on sputum sample ___ of unclear significance at the time (galactomannan negative, ultimately not treated). Psuedomonas tx in the past with 14d meropenem. On admission, pt was AOx3 with diffuse weakness, cough. Physical exam notable for rhonchi and mild inspiratory and expiratory wheezing with a wet weak cough with O2 requirement of 2LNC. Pt was started on meropenem and had a total of 2 doses of vanc and immediately improved with all her symptoms. CT scan on ___ notable for borderline sized mediastinal lymph nodes. New multifocal pneumonia. Subsequent areas of consolidations and opacities in the middle lobe, the lingular and the left and right lower lobe. Accompanying moderate pleural effusions. Vancomycin was discontinued as its levels were found to be sub-theraputic with significant improvement overnight. Pulmonary consulted and recommended no bronchoscopy. ID consulted and agreed with keeping her on meropenem for three weeks, end date ___. Work up for fungal infection/ sputumm cultures, viral cultures pertinent for pseudomonas growth with pan susceptibility. Azithromycin continued as prescribed in outpatient. On day of discharge, patient's respiratory status remained stable; still requiring 3L NC with sats in high ___. Per ___ evaluation, Shows signs of improving mobility as pt is able to ambulate 350' with S and SC and steady gait; however, pt continuous to require O2 at rest, increased with mobility secondary to desaturation. Pt is functionally appropriate for d/c to home with A and home ___ services when pt is medically stable. Recommend continued physical therapy and conditioning at rehab facility to prevent further deconditioning as outpatient. #Diarrhea Pt was found unkept in her home with diarrhea. Patient states she has never had diarrhea. BM normal during hospital course with some constipation. W/u with C. difficile DNA amplification assay; Cryptosporidium/Giardia (DFA); Cyclospora; Stool culture; Microsporidium; Stool culture - E.coli 0157:H7; Stool culture - Yersinia; Ova and Parasites; Viral culture all negative. Please see full results section. #MM: Recently started ixazomib/dex after rise in M protein on carfilzomib/dex. Last BMBx ___ cycle of ninlaro and dex due for ___ which was held. Pt was changed from 7.5mg prednisone to Hydrocortisone Na Succ. 50 mg IV Q6H for stress dosing and was tapered off and back to her home dose on ___. Now on prednisone 7.5 mg daily. PPX were continued with Acyclovir 400 mg PO/NG Q12H, Aspirin 81 mg PO/NG DAILY. # Cough ___ to infection or GERD, chronic since ___, worse at night when laying at 45 degree angle to sleep. Added mucomyst and omeprazole, d/c zantac on ___. Will follow with pulm/Id as outpatient to consider IH tobra therapy. #Macrocytic anemia No B12 or folate deficiency. #Coagulopathy; elevated INR ___ on 1.7; Vit K 5mg PO x3 days (___). Now stable. #Diffuse weakness, decreased strength ___ to infection or medication induced with ninlaro/dex. Ft4 normal. Strength improved with treatment of pneumonia. Patient still with deconditioning during hospitalization ___ ___ to poor PO intake in setting of confusion from infection. Resolved after fluids. # Asthma/COPD Continued home advair, Spiriva, azithromycin, albuterol, and combivent. # GERD: Home zantac changed to omeprazole as per above. BOWEL REGIMEN: -Held home senna, magnesium, Metamucil, Colace, and benefiber given diarrhea initially. Continued when constipated. ==================== Transitional issues ___ with GI for possible promotility agent to prevent aspiration ___ with repeat CXR prior to ID visit ___ with Dr. ___ third cycle of ninlaro and dex ___ with ID as outpatient for possible inhaled tobramycin therapy 5. Per discussion with ID no need for lab draw for monitoring from their perspective; further evaluation per Heme/Onc recommendations. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q12H 2. Ascorbic Acid ___ mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Azithromycin 250 mg PO Q24H 5. Magnesium Oxide 250 mg PO DAILY 6. PredniSONE 7.5 mg PO DAILY 7. Psyllium Powder 1 PKT PO DAILY 8. Senna 8.6 mg PO DAILY:PRN constipation 9. Vitamin B Complex 1 CAP PO DAILY 10. ipratropium-albuterol ___ mcg/actuation inhalation Q6H:PRN dyspnea/wheeze 11. Multivitamins 1 TAB PO DAILY 12. GenTeal Mild to Moderate (artificial tears(hypromellose)) 0.3 % ophthalmic ___ gtt QAM 13. Dexamethasone 20 mg PO 1X/WEEK (TH) 14. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 15. Ninlaro (ixazomib) 4 mg oral DAILY 16. Benefiber Clear SF (dextrin) (wheat dextrin) Dose is Unknown oral DAILY 17. Lactobacillus acidophilus Dose is Unknown oral DAILY 18. Ranitidine 150 mg PO DAILY 19. Albuterol Inhaler 2 PUFF IH Q4H:PRN Wheezing 20. LORazepam 0.5 mg PO QHS:PRN Anxiety 21. Docusate Sodium 100 mg PO DAILY:PRN Constipation 22. Tiotropium Bromide 1 CAP IH DAILY 23. GuaiFENesin ER 600 mg PO Q12H:PRN Cough 24. Sulfameth/Trimethoprim SS 1 TAB PO DAILY Discharge Medications: 1. Benzonatate 100 mg PO TID cough You may stop taking this medication when your cough gets better. 2. Calcium Carbonate 500 mg PO QID:PRN upset stomach 3. Caphosol 30 mL ORAL QID:PRN dry mouth 4. Enoxaparin Sodium 30 mg SC DAILY Start: Today - ___, First Dose: Next Routine Administration Time 5. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line flush 6. Meropenem 500 mg IV Q8H Please continue this medication until ___. 7. Milk of Magnesia 30 mL PO Q8H:PRN constipation 8. Omeprazole 40 mg PO DAILY 9. Acyclovir 400 mg PO Q12H 10. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN SOB, wheezing 11. Albuterol Inhaler 2 PUFF IH Q4H:PRN Wheezing 12. Ascorbic Acid ___ mg PO DAILY 13. Aspirin 81 mg PO DAILY 14. Azithromycin 250 mg PO Q24H 15. Benefiber Clear SF (dextrin) (wheat dextrin) Dose is Unknown ORAL DAILY 16. Docusate Sodium 100 mg PO DAILY:PRN Constipation 17. Flovent HFA (fluticasone) 220 mcg/actuation inhalation BID 18. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 19. GenTeal Mild to Moderate (artificial tears(hypromellose)) 0.3 % ophthalmic ___ gtt QAM 20. GuaiFENesin ER 600 mg PO Q12H:PRN Cough 21. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB 22. ipratropium-albuterol ___ mcg/actuation inhalation Q6H:PRN dyspnea/wheeze 23. Lactobacillus acidophilus Dose is Unknown ORAL DAILY 24. LORazepam 0.5 mg PO QHS:PRN Anxiety 25. Multivitamins 1 TAB PO DAILY 26. PredniSONE 7.5 mg PO DAILY 27. Psyllium Powder 1 PKT PO DAILY 28. Senna 8.6 mg PO DAILY:PRN constipation 29. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 30. Tiotropium Bromide 1 CAP IH DAILY 31. Vitamin B Complex 1 CAP PO DAILY Discharge Disposition: Extended Care Discharge Diagnosis: Multifocal pneumonia Discharge Condition: Stable Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you at ___. You came in with shortness of breath, confusion and fever. An image of your lungs showed you had pneumonia and you were treated on antibiotics. Your shortness of breath improved as well as your confusion. Please continue taking the antibiotics through the ___ line at the rehab facility (they will end on ___ You will have close follow up with Dr. ___ continuation of your multiple myeloma meds, as well as our Infectious Disease doctors (___) and your pulmonolgist (Dr. ___ for repeat imaging of your lungs. We are wishing you all the best and good luck on your next performance! Sincerely, Your ___ team Followup Instructions: ___
19797687-DS-23
19,797,687
27,682,568
DS
23
2164-06-14 00:00:00
2164-06-14 22:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Mustard / Levaquin / Ceftriaxone / Benadryl / cefepime Attending: ___. Chief Complaint: Difficulty with antibiotic infusions at home Major Surgical or Invasive Procedure: None History of Present Illness: ___ woman with a history of COPD and multiple myeloma, recently treated at ___ for a pulmonary abscess with MDR pseudomonas, discharged on ceftazidime/avibactam who is admitted due to logistical issues with PICC and infusion company which resulted ___ 3 missed antibiotic doses as an outpatient. Patient was recently hospitalized from ___ for a complicated hospital course most notably for a pulmonary abscess. Given the complexity of her situation, she was eventually discharged home to complete 4 weeks of ceftazidime/avibactam therapy with ___ administration at 1200 and patient self administrating at 2400. Over the past few days, Mrs ___ has had increasing difficulty getting her PICC line to flush with medication. She contacted her PCP for help, although there were significant issues with communication between Pt/PCP and infusion company/PNA. This resulted ___ patient missing 3 doses total. Given the difficulty managing her as an outpatient, her difficult infection, and logistical challenges, she was referred ___ to the hospital for admission ___ order to get missed medication doses and set up secure home services. Per patient, she had no problem with the PICC line, but rather with the regulator of the antibiotic infuser. ___ regards to her infection, Mrs ___ has been doing well. Her pulmonary symptoms have been improving. Although she still requires oxygen, her cough may have somewhat improved. No fevers or chills. REVIEW OF SYSTEMS: Positive as per HPI. Past Medical History: PAST ONCOLOGIC HISTORY: - ___: began developing pain ___ distal medial right leg. Did not go away as would with typical MSK pain from dancing. - ___: Xray which showed a 2.3 cm R tibial lesion - ___: CT guided bone biopsy significant for plasmacytoma. After this diagnosis she was seen by Dr. ___ and referred to ___. - ___: Bone marrow biopsy with 30% monoclonal plasma cells - ___ - ___: Radiation 35 Gy ___ 14 fractions to right distal tibia. - ___: Dexamethasone 20mg with rapid taper over 7 days. - On DF/HCC ___ Elotuzumab + 4 cycles of Revlimid and Decadron. - ___ Revlimid/Dex therapy. Revlimid discontinued on ___ and Dexamethasone discontinued on ___. - ___: started therapy on clinical trial Protocol ___: A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of Pomalidomide (POM), Bortezomib (BTZ) and Low-Dose Dexamethasone (LD-DEX) versus Bortezomib and Low-Dose Dexamethasone ___ Subjects with Relapsed or Refractory Multiple Myeloma (MM). - patient was randomized to the Velcade/Dex arm - ___: Cycle 1 Velcade/Dex - ___: Cycle 2 Velcade/Dex - currently on carfilzomib - Started ninlaro and dexamethasone on ___. PAST MEDICAL HISTORY - asthma - dx'ed ___ - COPD - dx'ed ___ ___, no smoking hx, thought to be due to second hand smoke as husband was smoker - GERD - ___ - HLD - ___, not on treatment - anemia - dx'ed ___, resolved ___ - right rotator cuff tear -___ - chronic low back pain - ___ - s/p R meniscus repair - ___ - s/p L meniscus repair - ___ - Arthritis x ___ years Social History: ___ Family History: Siblings: brother with mental health problems Children: 1 son, healthy Father with chronic bronchitis Physical Exam: PHYSICAL EXAM ON ADMISSION: =========================== VITALS: 98.2 110 / 52 100 18 98 1.5L GEN: Thin woman lying ___ bed with nasal cannula on, not ___ apparent respiratory distress, appears comfortable. HEENT: Oropharynx without erythema, exudate, or erosion, mucus membranes appear moist. Sclera anicteric. Neck supple. CV: RRR, normal S1S2 without audible murmurs CHEST: Exam limited secondary to coughing; poor air entry ___ the lower fields, marked diffuse rhonchi ABD: Soft, non-tender, non-distended LIMBS: No edema, clubbing, tremors, or asterixis. Purple ecchymoses on the upper and lower extremities. Chronic venous stasis changes ___ the lower extremities bilaterally. SKIN: No rashes, bruises and venous stasis changes as noted above NEURO: Alert and oriented, no focal deficits. PHYSICAL EXAM ON DISCHARGE: =========================== GEN: Thin woman lying ___ bed with nasal cannula on at 1.5 L and eye mask, not ___ apparent respiratory distress, appears comfortable. HEENT: Oropharynx without erythema, exudate, or erosion, mucus membranes appear moist. Sclera anicteric. Neck supple. CV: RRR, normal S1S2 without audible murmurs CHEST: Poor air entry ___ the lower fields, marked diffuse rhonchi ABD: Soft, non-tender, non-distended LIMBS: No edema, clubbing, tremors, or asterixis. Purple ecchymoses on the upper and lower extremities. Chronic venous stasis changes ___ the lower extremities bilaterally. L 1.5 cm tibial wound on anterior aspect of leg, no purulent drainage or erythema. SKIN: No rashes, bruises and venous stasis changes as noted above NEURO: Alert and oriented, no focal deficits. Pertinent Results: LAB RESULTS ON ADMISSION: ========================= ___ 12:40PM BLOOD WBC-7.8 RBC-2.50* Hgb-8.5* Hct-27.0* MCV-108* MCH-34.0* MCHC-31.5* RDW-13.9 RDWSD-55.3* Plt ___ ___ 12:40PM BLOOD Neuts-85.3* Lymphs-4.0* Monos-7.5 Eos-2.0 Baso-0.4 Im ___ AbsNeut-6.68* AbsLymp-0.31* AbsMono-0.59 AbsEos-0.16 AbsBaso-0.03 ___ 05:04PM BLOOD ___ PTT-35.3 ___ ___ 12:40PM BLOOD Glucose-103* UreaN-21* Creat-1.4* Na-135 K-4.1 Cl-97 HCO3-28 AnGap-14 ___ 05:04PM BLOOD ALT-27 AST-33 LD(LDH)-228 AlkPhos-60 TotBili-<0.2 ___ 12:40PM BLOOD Calcium-9.0 Mg-2.0 PERTINENT INTERVAL LABS: ======================== ___ 07:00AM BLOOD IgG-3174* IgA-22* IgM-9* ___ 12:40PM BLOOD ___ Fr K/L-2.1* LAB RESULTS ON DISCHARGE: ========================= ___ 07:00AM BLOOD WBC-4.1 RBC-2.35* Hgb-7.9* Hct-25.3* MCV-108* MCH-33.6* MCHC-31.2* RDW-13.8 RDWSD-54.2* Plt ___ ___ 07:00AM BLOOD Neuts-63.4 Lymphs-12.0* Monos-18.8* Eos-5.1 Baso-0.2 Im ___ AbsNeut-2.59 AbsLymp-0.49* AbsMono-0.77 AbsEos-0.21 AbsBaso-0.01 ___ 07:00AM BLOOD ___ PTT-32.0 ___ ___ 07:00AM BLOOD Glucose-88 UreaN-22* Creat-1.2* Na-142 K-4.2 Cl-106 HCO3-29 AnGap-11 ___ 07:00AM BLOOD ALT-21 AST-18 LD(LDH)-202 AlkPhos-46 TotBili-<0.2 ___ 07:00AM BLOOD Albumin-3.2* Calcium-8.7 Phos-3.4 Mg-2.1 MICROBIOLOGY: ============= ___ 12:17 pm SPUTUM Source: Expectorated. ACID-FAST SMEAR & CULTURE ADDED ON ___ PER FAX. GRAM STAIN (Final ___: >25 PMNs and <10 epithelial cells/100X field. 3+ ___ per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS AND CHAINS. 1+ (<1 per 1000X FIELD): GRAM NEGATIVE ROD(S). 1+ (<1 per 1000X FIELD): GRAM POSITIVE ROD(S). RESPIRATORY CULTURE (Final ___: SPARSE GROWTH Commensal Respiratory Flora. PSEUDOMONAS AERUGINOSA. SPARSE GROWTH. WORK-UP REQUEST BY ___ ___ ___ . Piperacillin/Tazobactam sensitivity testing performed by ___ ___. ZERBAXA AND CEFTAZIDIME/AVIBACTAM Sensitivity testing per ___ ___ ___. CEFTAZIDIME /AVIBACTAM = ___ MCG/ML = SUSCEPTIBLE. CEFTAZIDIME /AVIBACTAM SUSCEPTIBILITY PERFORMED BY THE ALLERGAN REFERENCE LAB. PLEASE REFER TO ___ FOR CEFTOLOZANE/TAZOBACTAM SUSCEPTIBILITY. SENSITIVITIES: MIC expressed ___ MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | CEFEPIME-------------- 32 R CEFTAZIDIME----------- 16 I CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S MEROPENEM------------- 8 R PIPERACILLIN/TAZO----- I TOBRAMYCIN------------ <=1 S LEGIONELLA CULTURE (Final ___: NO LEGIONELLA ISOLATED. ACID FAST SMEAR (Final ___: NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. ACID FAST CULTURE (Pending): Time Taken Not Noted ___ Date/Time: ___ 4:54 pm TRACHEAL ASPIRATE Site: TRACHEA TRACHEAL ASPIRATE, SPECIMEN TYPE CONFIRMED PER ___ ___ 19:25. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. RESPIRATORY CULTURE (Final ___: Commensal Respiratory Flora Absent. PSEUDOMONAS AERUGINOSA. SPARSE GROWTH. PSEUDOMONAS AERUGINOSA. SPARSE GROWTH. SECOND TYPE. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. CEFTOLOZANE/TAZOBACTAM Sensitivity testing per ___ ___ ___. SENT FOR CEFTOLOZANE/ TAZOBACTAM TESTING AT LAB ___, ___ ___. CEFTOLOZANE/ TAZOBACTAM MIC OF ___ MCG/ML = RESISTANT. SENSITIVITIES: MIC expressed ___ MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | PSEUDOMONAS AERUGINOSA | | CEFEPIME-------------- 16 I 32 R CEFTAZIDIME----------- 16 I 8 S CIPROFLOXACIN--------- 1 S =>4 R GENTAMICIN------------ <=1 S <=1 S MEROPENEM------------- 1 S 8 R PIPERACILLIN/TAZO----- 8 S R TOBRAMYCIN------------ <=1 S <=1 S ANAEROBIC CULTURE (Final ___: NO ANAEROBES ISOLATED. ACID FAST SMEAR (Final ___: NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. FUNGAL CULTURE (Final ___: NO FUNGUS ISOLATED. ACID FAST CULTURE (Preliminary): NO MYCOBACTERIA ISOLATED. IMAGING: ======== CXR ___ Persistent right basilar opacity although improved since ___. This is likely due to known underlying pulmonary abscess/consolidation. Suspected residual small effusion on the right as well as left lower lobe atelectasis. Left PICC tip projects over the upper right atrium. RENAL ULTRASOUND ___ 1. Unremarkable renal ultrasound. 2. Patient reports voiding 15 min before the exam, but bladder appears moderately distended. Finding is suggestive of moderate-large postvoid residual bladder volume. Brief Hospital Course: Mrs ___ is an ___ woman with a history of COPD and multiple myeloma, recently on Ninlaro therapy and recently hospitalized with a MDR pseudomonas pulmonary abscess who was re-admitted with difficulties with her infusion pump at home, resulting ___ multiple missed antibiotic doses. # Pulmonary abscess: From a clinical standpoint, patient did not have any worse respiratory or infectious symptoms. No fevers. O2 requirements remained stable. Pulmonary imaging without significant interval change. Patient expressed difficulty with working the infusion pump. After discussion with case management, it was decided that patient would return home with daily ___ services for her 1200 dose. Mrs. ___ agreed to pay for private nursing to come ___ the evening and run her infusion for the first several scheduled 2400 doses. Her son would accompany her and both would receive daily teaching regarding use of the infuser. Thereafter, patient's son would help with her 2400 doses until antibiotic course completion. If she had any difficulty with infusion, they could call ___ hour on-call infusion nurse, available at ___ for infusion-related difficulties. She will resume her regularly scheduled OPAT follow-up. # Multiple Myeloma: Ninlaro currently on hold secondary to recurrent lung infections. Acyclovir, Bactrim, Ativan, and vitamin B were continued. # Acute kidney injury: Admission Cr 1.4 from recent baseline of 1.1. She has had documented exposure to tobramycin for 10 days which could theoretically lead to direct tubular damage and interstitial nephritis though the latter is less likely as she doesn't have a perhiperhal eosinophilia or WBC ___ the urine. Renal ultrasound had question of elevated PVR, but when actually measuring PVR was < 50, hence obstructive cause unlikely. We note that she has Albumin/Creatinine radio of 144.4. Free K/L was 2.1. ___ had initially improved with increased PO fluid intake back to recent baseline of 1.1, however increased slightly to 1.2 on day of discharge, and she will require close follow up of renal function. # COPD/Asthma: Albuterol, adviar, guafenesin, prednisone, tiotropium, bensonatate, and ipratropium were continued. Azithromycin was discontinued at the recommendation of infectious diseases consult during prior hospitalization. # L shin wound: Patient has very fragile, thin skin from chronic steroid use. Wound care nurse was concerned about L shin wound appearance and thought it may require debridement. Per vascular surgery, wound appears to be consistent with skin hematoma that is healing and beginning to detach from wound base. Does not appear infected. Does not appear to require debridement. Wound care as follows: cover with xeroform then gauze; wrap with kling and secure with medipore tape; change daily. TRANSITIONAL ISSUES ==================== PULMONARY ABSCESS: # Patient will require Q12H dosed at 1200 and 2400 x 4 weeks. 1200 dose to be performed by ___ services, while 2400 dose to be administered by patient ___ conjunction with her son and a private-pay nurse. # OPAT Labs: WEEKLY: CBC/DIFF, BUN, Cr, AST, ALT, ALK PHOS, TBILI # OPAT CONTACT: **ATTN: ___ CLINIC - FAX: ___ # Infectious Disease Dept. will contact pt as needed for any follow-up appointments # Pt to be seen with pulmonary follow-up (Dr ___ # Pt to wear 1.5L supplemental O2 at all times with portable O2 concentrator # Pt to have follow up CT at ___ ___ # Please draw CMP at next PCP appointment, follow creatinine # A 24 hour on-call infusion nurse is available at ___ should patient have difficulty with her infusion pump. ___ # Discharge Cr 1.2; she requires close follow up of renal function # Patient will require labs to be drawn ___ and faxed to ___ ATTN: ___. Labs: CBC/DIFF BUN, Cr, AST, ALT, ALK PHOS, TBILI. MULTIPLE MYELOMA # Patient's myeloma treatments were placed on hold during this hospitalization given her frequent lung infections. # Patient to follow-up with Dr ___ as listed above for ongoing treatment. # Prophylactic mediations were continued. COPD: # Continue outpatient pred taper as dictated by pulmonary and heme/onc. # Contact: ___ (Son/HCP) ___ # Code: Full Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Avycaz (ceftazidime-avibactam) 2.5 gram injection Q12H 2. Acyclovir 400 mg PO Q12H 3. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN SOB, wheezing 4. Albuterol Inhaler 2 PUFF IH Q4H:PRN Wheezing 5. Ascorbic Acid ___ mg PO DAILY 6. Aspirin 81 mg PO DAILY 7. Benzonatate 100 mg PO TID cough 8. Calcium Carbonate 500 mg PO QID:PRN upset stomach 9. Caphosol 30 mL ORAL QID:PRN dry mouth 10. Docusate Sodium 100 mg PO DAILY:PRN Constipation 11. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 12. GuaiFENesin ER 600 mg PO Q12H:PRN Cough 13. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB 14. LORazepam 0.5 mg PO QHS:PRN Anxiety 15. Milk of Magnesia 30 mL PO Q8H:PRN constipation 16. Multivitamins 1 TAB PO DAILY 17. Omeprazole 40 mg PO DAILY 18. PredniSONE 7.5 mg PO DAILY 19. Psyllium Powder 1 PKT PO DAILY 20. Senna 8.6 mg PO DAILY:PRN constipation 21. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 22. Tiotropium Bromide 1 CAP IH DAILY 23. Vitamin B Complex 1 CAP PO DAILY 24. GenTeal Mild to Moderate (artificial tears(hypromellose)) 0.3 % ophthalmic ___ gtt QAM Discharge Medications: 1. Acyclovir 400 mg PO Q12H 2. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN SOB, wheezing 3. Albuterol Inhaler 2 PUFF IH Q4H:PRN Wheezing 4. Ascorbic Acid ___ mg PO DAILY 5. Aspirin 81 mg PO DAILY 6. Avycaz (ceftazidime-avibactam) 2.5 gram injection Q12H RX *ceftazidime-avibactam [Avycaz] 2.5 gram 2.5 G IV every twelve (12) hours Disp #*32 Vial Refills:*0 7. Benzonatate 100 mg PO TID cough 8. Calcium Carbonate 500 mg PO QID:PRN upset stomach 9. Caphosol 30 mL ORAL QID:PRN dry mouth 10. Docusate Sodium 100 mg PO DAILY:PRN Constipation 11. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 12. GenTeal Mild to Moderate (artificial tears(hypromellose)) 0.3 % ophthalmic ___ gtt QAM 13. GuaiFENesin ER 600 mg PO Q12H:PRN Cough 14. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB 15. LORazepam 0.5 mg PO QHS:PRN Anxiety 16. Milk of Magnesia 30 mL PO Q8H:PRN constipation 17. Multivitamins 1 TAB PO DAILY 18. Omeprazole 40 mg PO DAILY 19. PredniSONE 7.5 mg PO DAILY 20. Psyllium Powder 1 PKT PO DAILY 21. Senna 8.6 mg PO DAILY:PRN constipation 22. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 23. Tiotropium Bromide 1 CAP IH DAILY 24. Vitamin B Complex 1 CAP PO DAILY 25.Outpatient Lab Work Draw on ___ Labs: CBC/DIFF BUN, Cr, AST, ALT, ALK PHOS, TBILI ICD 10: ___ FAX RESULTS TO: ___ ATTN: ___ CLINIC 26.Outpatient Lab Work Draw on ___ Labs: CBC/DIFF BUN, Cr, AST, ALT, ALK PHOS, TBILI ICD 10: ___ FAX RESULTS TO: ___ ATTN: ___ CLINIC 27.Outpatient Lab Work Draw on ___ Labs: CBC/DIFF BUN, Cr, AST, ALT, ALK PHOS, TBILI ICD 10: ___ FAX RESULTS TO: ___ ATTN: ___ Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis: Pulmonary Abscess Multiple Myeloma Acute Kidney Injury Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, ___ were admitted to the hospital because ___ were having difficulty with your infusion pump at home and ___ had missed some antibiotic dosing. While ___ were hospitalized, ***** Should ___ have any difficulty with the infusion pump while at home, a 24 hour on-call infusion nurse is available at ___. Please call at any time with any questions. ***** Please take all medications as prescribed and keep all scheduled appointments. It was a pleasure taking care of ___! Your ___ Care Team Followup Instructions: ___
19797687-DS-33
19,797,687
24,221,054
DS
33
2167-01-09 00:00:00
2167-01-09 13:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: Penicillins / Mustard / Levaquin / Ceftriaxone / cefepime Attending: ___. Chief Complaint: right intertrochanteric hip fracture Major Surgical or Invasive Procedure: right long TFN History of Present Illness: ___ female with a history of MM (dx ___, not eligible for auto-HSCT, most recently on Pomalidomide/Carfilzomib/Dex therapy), chronic obstructive asthma, osteoporosis on monthly zoledronic acid, recurrent pneumonias on monthly IVIG, severe persistent asthma, and COPD with eosinophilia (s/p treatment with mepolizumab) on home O2 2L, who presents with right intertrochanteric/basicervical FNF after trip and fall. She reports that she was walking this morning and tripped over her oxygen tubing. She fell around 11 AM. Her son ended up finding her this evening around 9 ___. She reports that although she was on the ground for that extended period of time she was able to scoot around on her behind and was not in any one position too long. Any time she felt uncomfortable she was able to move around. However she does report that she is in excruciating pain and that the morphine that they have given her does seem to help somewhat. She denies any numbness or tingling, head strike, loss of consciousness, chest pain, any new or worsening dyspnea other than her baseline need for oxygen, fevers, sweats, or chills. Of note she does have some baseline bilateral shoulder and arm pain. She does also have bilateral anterior tibia pain, as well as "sensitive skin". She is not on any anticoagulation. Past Medical History: PAST ONCOLOGIC HISTORY ========================================= -___: began developing pain in distal medial right leg. Did not go away as would with typical MSK pain from dancing. -___: Xray which showed a 2.3 cm R tibial lesion -___: CT guided bone biopsy significant for plasmacytoma. After this diagnosis she was seen by Dr. ___ and referred to ___. -___: Bone marrow biopsy with 30% monoclonal plasma cells -___ - ___: Radiation 35 Gy in 14 fractions to right distal tibia. -___: Dexamethasone 20mg with rapid taper over 7 days. -On DF/___ ___ Elotuzumab + 4 cycles of Revlimid and Decadron. -___ Revlimid/Dex therapy. Revlimid discontinued on ___ and Dexamethasone discontinued on ___. -___: started therapy on clinical trial Protocol ___: A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of Pomalidomide (POM), Bortezomib (BTZ) and Low-Dose Dexamethasone (LD-DEX) versus Bortezomib and Low-Dose Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma (MM). -patient was randomized to the Velcade/Dex arm -___: Cycle 1 Velcade/Dex -___: Cycle 2 Velcade/Dex -currently on carfilzomib -Started ninlaro and dexamethasone on ___. -___: Initiated Pom + ___ (cycle 1 50% dose reduction)\ -___: Daratumumab (full dose) Plus Pomalyst 2mg daily ___ days ___- Present: Increase Pomalyst to 3mg,continue Daratumumab DARATUMUMAB TREATMENT HISOTRY ========================================= ___ Dose 1: 50% dose reduction + Pom 2mg ___ days ___: Dose 2: Full dose - delay due to infection + Pom ___: Dose 3: Full dose given + Pom 3mg daily ___ days ___: Dose 4: Full dose given + Pom 3mg daily ___ days ___: Dose 5: Full dose given - Delay due to COPD + Pom 3mg ___: Dose 6: Full dose given + Pom 3mg daily ___ days ___: Dose 7: Full dose given + Pom 3mg daily ___ days ___: Dose 8: Full dose given + Pom 3mg daily ___ days ___: Dose 9: Full dose given + Pom 3mg daily ___ days ___: Dose 10: Full dose given + Pom 3mg daily ___ days ___: Dose 11: Full dose given + Pom 3mg daily ___ days ___: Dose 12: Full dose given + Pom 3mg daily ___ days ___: Dose 13: Full dose given + Pom 3mg daily ___ days ___: Dose 14: Full dose given + Pom 3mg daily ___ days ___: Dose 15: Full dose given + Pom 3mg daily ___ days ___: Dose 16: Full dose given + Pom 3mg daily ___ days ___: Dose 17: Full dose given + Pom 3mg daily ___ days ___: Dose 18: Full dose given + Pom 3mg daily ___ days ___- Dose 19 Full Dose given + Pom 2mg. ___- Dose 20 Full Dose given + Pom 2mg. ___- Dose 21 Full Dose given + Pom 2mg. ___- Dose 22 Full Dose ___, Pom 2mg daily ___ days ___ Dose 23 Full Dose ___, Pom 2mg daily for ___ days ___ Dose 24 Full Dose ___, Pom 2mg daily for ___ days ___ Dose 25 Full Dose ___, Pom 2mg daily for ___ days ___: Admit for new sternal fractures, pain control and radiation therapy. ___: Dose 26. Full dose ___ Hold Pom after recent completion of RT. ___: ___, ___ - Restart POM ___: Daratumumab every other week/Pom 2mg daily ___ days. Monthly IVIG. Monthly Zometa ___: Daratumumab monthly/Pom 2mg daily ___ days. Monthly IVIG, Monthly Zometa ___: Continue Daratumumab maintenance. Pomalyst placed on hold given ongoing functional decline in the setting of disease stability. PAST MEDICAL HISTORY ================================ -asthma - dx'ed ___ -COPD - dx'ed in ___, no smoking hx, thought to be due to second hand smoke as husband was smoker -GERD - ___ -HLD - ___, not on treatment -anemia - dx'ed ___, resolved ___ -right rotator cuff tear -___ -chronic low back pain - ___ -s/p R meniscus repair - ___ -s/p L meniscus repair - ___ -Arthritis x ___ years Social History: ___ Family History: Siblings: brother with mental health problems Children: 1 son, healthy Father with chronic bronchitis Physical Exam: right lower extremity -dressings intact -fires ___ -silt s/s/sp/dp/t nerve distributions -foot wwp Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a right intertrochanteric hip fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for a right long TFN, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is ___ partial weight bearing in the right lower extremity, and will be discharged on lovenox for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q12H 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN dyspnea 3. Aspirin 81 mg PO DAILY 4. Azithromycin 250 mg PO Q24H 5. Bisacodyl 5 mg PO DAILY:PRN Constipation - Third Line 6. Fentanyl Patch 75 mcg/h TD Q72H 7. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 8. Furosemide 20 mg PO DAILY:PRN edema 9. GuaiFENesin ER 600 mg PO Q12H 10. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN shortness of breath 11. LORazepam 0.5 mg PO QHS:PRN insomnia 12. Morphine Sulfate ___ 15 mg PO Q4H:PRN Pain - Moderate 13. Omeprazole 40 mg PO DAILY 14. Polyethylene Glycol 17 g PO DAILY 15. PredniSONE 5 mg PO DAILY 16. Psyllium Powder 1 PKT PO DAILY 17. Senna 8.6 mg PO BID:PRN Constipation - Third Line 18. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 19. Nucala (mepolizumab) 100 mg subcutaneous ASDIR 20. Magnesium Oxide 400 mg PO DAILY 21. Klor-Con 10 (potassium chloride) 10 mEq oral DAILY 22. guar gum 1 packet oral DAILY 23. Tiotropium Bromide 2 CAP IH DAILY 24. Ondansetron 8 mg PO Q8H:PRN Nausea/Vomiting - First Line 25. Pomalyst (pomalidomide) 2 mg oral DAILY 26. Dexamethasone 12 mg PO 1X/WEEK (FR) ASDIR 27. Docusate Sodium 200-300 mg PO DAILY Discharge Medications: 1. Atorvastatin 20 mg PO QPM 2. Enoxaparin Sodium 30 mg SC QHS RX *enoxaparin 30 mg/0.3 mL ___t bedtime Disp #*28 Syringe Refills:*0 3. Acyclovir 400 mg PO Q12H 4. Albuterol Inhaler 2 PUFF IH Q6H:PRN dyspnea 5. Aspirin 81 mg PO DAILY 6. Azithromycin 250 mg PO Q24H 7. Bisacodyl 5 mg PO DAILY:PRN Constipation - Third Line 8. Dexamethasone 12 mg PO 1X/WEEK (FR) ASDIR 9. Docusate Sodium 200-300 mg PO DAILY 10. Fentanyl Patch 75 mcg/h TD Q72H 11. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 12. Furosemide 20 mg PO DAILY:PRN edema 13. GuaiFENesin ER 600 mg PO Q12H 14. guar gum 1 packet oral DAILY 15. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN shortness of breath 16. Klor-Con 10 (potassium chloride) 10 mEq oral DAILY 17. LORazepam 0.5 mg PO QHS:PRN insomnia 18. Magnesium Oxide 400 mg PO DAILY 19. Morphine Sulfate ___ 15 mg PO Q4H:PRN Pain - Moderate 20. Nucala (mepolizumab) 100 mg subcutaneous ASDIR 21. Omeprazole 40 mg PO DAILY 22. Ondansetron 8 mg PO Q8H:PRN Nausea/Vomiting - First Line 23. Polyethylene Glycol 17 g PO DAILY 24. Pomalyst (pomalidomide) 2 mg oral DAILY 25. PredniSONE 5 mg PO DAILY 26. Psyllium Powder 1 PKT PO DAILY 27. Senna 8.6 mg PO BID:PRN Constipation - Third Line 28. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 29. Tiotropium Bromide 2 CAP IH DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: right hip fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - 50% partial weight bearing right lower extremity MEDICATIONS: 1) Take Tylenol ___ every 6 hours around the clock. This is an over the counter medication. 2) Add *** as needed for increased pain. Aim to wean off this medication in 1 week or sooner. This is an example on how to wean down: Take 1 tablet every 3 hours as needed x 1 day, then 1 tablet every 4 hours as needed x 1 day, then 1 tablet every 6 hours as needed x 1 day, then 1 tablet every 8 hours as needed x 2 days, then 1 tablet every 12 hours as needed x 1 day, then 1 tablet every before bedtime as needed x 1 day. Then continue with Tylenol for pain. 3) Do not stop the Tylenol until you are off of the narcotic medication. 4) Per state regulations, we are limited in the amount of narcotics we can prescribe. If you require more, you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5) Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds (senna, colace, miralax) are over the counter and may be obtained at any pharmacy. 6) Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. 7) Please take all medications as prescribed by your physicians at discharge. 8) Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: - Please take lovenox daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. - If you have a splint in place, splint must be left on until follow up appointment unless otherwise instructed. Do NOT get splint wet. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns THIS PATIENT IS EXPECTED TO REQUIRE <30 DAYS OF REHAB FOLLOW UP: Please follow up with your Orthopaedic Surgeon, Dr. ___. You will have follow up with ___, NP in the Orthopaedic Trauma Clinic 14 days post-operation for evaluation. Call ___ to schedule appointment upon discharge. Please follow up with your primary care doctor regarding this admission within ___ weeks and for any new medications/refills. Physical Therapy: see last ___ note Treatments Frequency: staples to be removed at two week postop appointment Followup Instructions: ___
19797689-DS-24
19,797,689
22,027,509
DS
24
2187-07-06 00:00:00
2187-07-06 16:18:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) / Ace Inhibitors Attending: ___. Chief Complaint: s/p fall Major Surgical or Invasive Procedure: none History of Present Illness: ___ F dCHF, afib (on coumadin) presents after fall from toilet to carpeted floor. She does not recall events immediately surrounding the fall, however denies any head strike or loss of consciousness. Believes it happened as she was getting up from commode and not during any straining for urination. Fell backwards and developed large left gluteal hematoma. Heard calling for help immediately after event by sister and brought to ED. In ___ had a fall forward with head strike. At that time had bruising of face. Pt lives in assisted living facility and is quite independent at baseline. Since previous fall has had 24 hour supervision. Uses walker and has good mobility at baseline with it. Sister lives in ___ but has been with pt for for last 3 months. Has chronic lower back pain with unclear diagnosis but has been getting LESI ___ years or so with the most recent being 2 weeks ago. Per pt back pain did not contribute to fall. Of note patient has recurrent UTIs. Was on Cefuroxime in late ___ for UTI which was discontinued due to diarrhea. No diarrhea currently. In mid ___ she also had a left ankle cellulitis with ulceration that was successfully treated with Keflex. Went to PCP yesterday and was prescribed Cipro 500mg BID for treatment of symptomatic UTI (dysuria and frequency). Pt is on torsemide 40mg BID and spironolactone 12.5mg BID but has not had these medications adjusted in some time. In the ED, initial vital signs were 97.3 100 90/59 18 100%. Patient was given 1L NS. Found to have INR 1.9 (on coumadin) and creatinine 2.8 and BUN 128 over baseline ranging from 2.1 to 2.5 and ___, respectively. No pelvic, vertebral or femoral fracture on Xray. Past Medical History: - Hypertension - dCHF - Atrial fibrillation on warfarin - Chronic kidney disease (baseline creatinine 2.5 mg/dL) - Hypothyroidism - Gout - Osteoarthritis Social History: ___ Family History: Two brothers died in their ___ of heart failure. Also notable for HTN, esophageal cancer. No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION Vitals- 97.4 ___ 18 97RA General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP at clavicle, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Soft heart sounds, Irregular rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, 6cm diameter left gluteal hematoma with smaller 2cm diameter hematoma superiorly. Non-tender. Mildly indurated. Neuro- CNs2-12 intact, motor function grossly normal DISCHARGE Vitals- 98.4 102/70 95 18 97RA General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP at clavicle, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Soft heart sounds, Irregular rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, 6cm diameter left gluteal hematoma with smaller 2cm diameter hematoma superiorly. Non-tender. Mildly indurated. Neuro- CNs2-12 intact, motor function grossly normal Pertinent Results: ADMISSION ___ 05:21AM BLOOD WBC-12.6*# RBC-4.78 Hgb-14.7 Hct-46.1 MCV-96 MCH-30.7 MCHC-31.8 RDW-16.7* Plt ___ ___ 05:21AM BLOOD ___ PTT-33.7 ___ ___ 05:21AM BLOOD Glucose-211* UreaN-128* Creat-2.8* Na-137 K-4.3 Cl-96 HCO3-28 AnGap-17 IMAGING ___ Xray Lumbosacral spine: No fracture Xray Pelvis/Femur: No fracture. DISCHARGE ___ 06:20AM BLOOD WBC-10.3 RBC-4.09* Hgb-12.5 Hct-39.4 MCV-96 MCH-30.6 MCHC-31.7 RDW-16.7* Plt ___ ___ 06:20AM BLOOD ___ PTT-30.8 ___ ___ 06:20AM BLOOD Glucose-147* UreaN-89* Creat-2.0* Na-145 K-3.9 Cl-106 HCO3-27 AnGap-16 ___ 06:20AM BLOOD Calcium-8.5 Phos-3.9 Mg-2.8* Brief Hospital Course: BRIEF HOSPITAL COURSE ___ F dCHF, afib (on coumadin) presents after fall from toilet to carpeted floor. On admission found to be 5lbs under baseline weight of 170 and with florid orthostatic hypotension. Home torsemide/spironolactone held and pt given 2L fluid. Home metoprolol transiently dose reduced to 50mg BID from 75mgBID. Orthostasis improved. ___ evaluated and recommended rehab but patient adamantly refused--has 24 hour home supervision with ___ and sister is always present. When pt fell she stuck buttocks and developed L gluteal hematoma. Hct dropped 6 points on day of admission but this was likely due to volume expansion. Stable thereafter. Hematoma did not markedly increase in size. Should be assessed for stability by PCP shortly after discharge. Warfarin was continued for Afib. While patient was here was continued on Cipro for treatment of symptomatic UTI to finish a ___CTIVE ISSUES # FALL: Differential includes vagal event due to setting, arrhythmia, orthostatic hypotension (baseline BP ___ with standing in context of diuresis. Positive orthostatics. Bolused 2L total over course of stay. Monitored on tele which just showed baseline Afib. ___ evaluated and recommended rehab but patient adamantly refused--has 24 hour home supervision with ___ and sister is always present. # HEMATOMA: INR subtherapeutic on admission to 1.9. Also given renal failure with significant uremia may have element of platelet dysfunction. Initial fall in Hct from 46 to 40 attributed to volume expansion. Subsequently Hct stabilized around 40. Hematoma did not markedly increase in size. Should be assessed for stability by PCP shortly after discharge. Warfarin was continued for Afib given low suspicion of active bleeding. # UTI: Pt had been placed on Cipro 500mg BID day prior to admission for symptoms of dysuria and urgency. Leukocytosis on admission to 12.6 resolved. Pt told to continue to finish a 3 day course of treatment. # AOCKD: Likely hypertensive and diabetic nephropathy as baseline chronic CKD. More recently may be overdiuresed on torsemide and spironolactone. Creatinine improved with 2L fluids. Diuretics continued to be held on discharge. Has followup with PCP ___. # AFIB: CHADS2= 3 (heart failure, age, HTN). INR subtherapeutic on admission but with hematoma. Currently no signs of continued bleeding into the hematoma. INR currently subtherapeutic at 1.9. Although pt has had 2 falls recently, with a CHADs this high, still worthwhile to anticoagulate. Metoprolol transiently reduced to 50mg BID given fall, but then home dose restarted on day of discharge. Warfarin continued as above. # dCHF: Last stress echo showed LVEF 43% in ___. Currently does not appear volume overloaded. If anything appears somewhat dry. On an aggressive home diuretic regimen of spironolactone 12.5mg and torsemide 40mg BID. Diuresis was held as above. INACTIVE ISSUES # IMPAIRED OGT: Historically had DM but per discussion with PCP has had better control recently with most recent A1c down to 6.5%. Possible this number has gone up again and poor control is contributing to her frequent recent infections. Not on any current pharmacologic therapy. # HoThyroidism: stable. Continued levothyroxine 50mcg # Gout: Crystal-proven gout. Colchicine had been discontinued in ___. Per rheum notes she has been doing well with only one possible attack since then. Continued allopurinol ___ daily TRANSITIONAL ISSUES # Assess volume status, consider restarting diuretics. Discharge wt 75.2kg. # Assess L gluteal hematoma and stability of hematocrit given that patient is anticoagulated # Anticoagulation for Afib # consider outpatient rehab for deconditioning Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Ciprofloxacin HCl 500 mg PO Q12H Day 1 = ___ 3. Levothyroxine Sodium 50 mcg PO DAILY 4. Metoprolol Tartrate 75 mg PO BID HOld for SBP < 100 or HR < 60 5. Simvastatin 20 mg PO DAILY 6. Spironolactone 12.5 mg PO DAILY 7. Torsemide 40 mg PO BID 8. Warfarin 2 mg PO DAILY16 9. Aspirin 81 mg PO DAILY 10. Cyanocobalamin 50 mcg PO DAILY 11. Vitamin D 1000 UNIT PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Cyanocobalamin 50 mcg PO DAILY 4. Levothyroxine Sodium 50 mcg PO DAILY 5. Metoprolol Tartrate 75 mg PO BID 6. Simvastatin 20 mg PO DAILY 7. Vitamin D 1000 UNIT PO DAILY 8. Warfarin 2 mg PO DAILY16 9. Ciprofloxacin HCl 500 mg PO Q12H Please continue this through ___ to complete 3 day treatment for UTI. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Orthostatic Hypotension likely from overdiuresis Left gluteal hematoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, Thank you for choosing us for your care. You were admitted after a fall that we think was related to you being dehydrated. Your labs showed some worsening of your kidney function. We held you diuretic medicines and gave you some fluids and your blood pressures and kidney function recovered. Please discuss with Dr. ___ when to start these diuretic medicines (torsemide and spironolactone) again. When you fell, you developed a large hematoma on your left buttocks. We monitored this for any signs of active bleeding. You blood counts remained stable. You were evaluated by our physical therapists who thought that you would benefit from a stay at a rehabilitation facility to help get you stronger. However, you clearly stated that you did not want to go. At discharge, you weigh 75.2kg or 166 lbs. (Weigh yourself every morning, call MD if weight goes up more than 3 lbs) We have made the following changes to your medications: Followup Instructions: ___
19797689-DS-26
19,797,689
26,541,624
DS
26
2188-01-10 00:00:00
2188-01-22 21:38:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) / Ace Inhibitors Attending: ___. Chief Complaint: SOB, abdominal pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ year old woman with a history of CHF, HTN, afib on warfarin and CKD, presents with SOB and abdominal pain since yesterday. The patient states that for the past 2 days, she has felt malaise. Yesterday, she began to experience shortness of breath. She denies associated cough, fevers, chills. She also had mild abdominal pain and decreased appetite. Last night, she experienced loose stool and a "large" amount of BRBPR (unable to quantify, enough to scare her). Following this, she experienced pain in her rectum. She has subsequently had 1 bloody bowel movement today. No back pain. No nausea, vomiting. In the ED, initial VS: 92 BP 96/66 99%RA RR 15. The patient underwent EKG that showed no ischemic change. Exam was notable for diffusely tender abdomen to palpation, guiac positive with light red stool. Labs were notable for Cr. 2.0, Hct 40.1, BNP 8895. CXR with mild effusions bilaterally. The patient was written for 40 mg IV lasix. She was admitted for diuresis, serial Hct for GI bleed. VS prior to transfer: 98.0 92 ___ 95% RA. On the floor, the patient endorses ongoing rectal pain and dyspnea. Review of Systems: (+) HPI (-) fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, nausea, vomiting, constipation, dysuria, hematuria. Past Medical History: Hypertension - ___ - Atrial fibrillation on warfarin - Chronic kidney disease (baseline creatinine 2.5 mg/dL) - Hypothyroidism - Gout - Osteoarthritis - Recurrent UTIs Social History: ___ Family History: Two brothers died in their ___ of heart failure. Also notable for HTN, esophageal cancer. No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION: Vitals- 97.9 ___ 22 98%RA General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP elevated angle of jaw, no LAD Lungs- bibasilar crackles, no wheezes or rhonchi CV- Irregularly irregular S1, S2, no murmurs, rubs, gallops Abdomen- soft, mildly tender in lower quadrants bilaterally, non-distended, bowel sounds present; patient refused repeat rectal exam GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, motor function grossly normal DISCHARGE: Vitals- T97.4 BP 100/70 HR 94 18 97% RA General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP elevated bilaterally Lungs- soft crackles, but good air movement CV- Irregular rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- obese, (+) BS, soft, mild diffuse tenderness, non-distended, bowel sounds present, no rebound tenderness or guarding, aly Rectal- small external hemorrhoids, no fluctance around the perianal area, Tenderness on exam no masses felt, no BRBPR, no melena GU- no foley Ext- warm, well perfused, 2+ pulses, Neuro- , motor function grossly normal Pertinent Results: ADMISSION: ___ 05:30PM NEUTS-64.9 ___ MONOS-5.3 EOS-3.0 BASOS-0.6 ___ 05:30PM WBC-7.8 RBC-4.41 HGB-12.9 HCT-40.1 MCV-91 MCH-29.2 MCHC-32.1 RDW-17.8* ___ 05:30PM ALBUMIN-3.9 CALCIUM-8.8 PHOSPHATE-4.0 MAGNESIUM-2.6 ___ 05:30PM proBNP-8895* ___ 05:30PM cTropnT-0.03* ___ 05:30PM LIPASE-108* ___ 05:30PM ALT(SGPT)-22 AST(SGOT)-27 ALK PHOS-105 TOT BILI-0.4 ___ 05:30PM GLUCOSE-162* UREA N-76* CREAT-2.0* SODIUM-142 POTASSIUM-4.5 CHLORIDE-106 TOTAL CO2-24 ANION GAP-17 ___ 06:25PM LACTATE-1.8 DISCHARGE: ___ 06:00AM BLOOD WBC-8.7 RBC-4.05* Hgb-11.7* Hct-37.0 MCV-91 MCH-28.9 MCHC-31.6 RDW-17.7* Plt ___ ___ 04:05PM BLOOD Hct-36.0 ___ 11:34PM BLOOD Hct-37.6 ___ 11:34PM BLOOD ___ ___ 06:00AM BLOOD Glucose-115* UreaN-73* Creat-2.0* Na-143 K-3.9 Cl-107 HCO3-29 AnGap-11 ___ 06:00AM BLOOD CK-MB-3 cTropnT-0.03* ___ 05:30PM BLOOD cTropnT-0.03* Brief Hospital Course: ___ year old woman with a history of CHF, HTN, afib on warfarin and CKD, presents with SOB and bright red blood per rectum. # Acute on Chronic Diastolic Heart Failure: Patient presented with several day history of SOB, orthopnea, and Dyspnea on exertion. Symptoms were attributed to ___ axacerbation given mild elevation in JVD and bibasilar crackles/effusions on CXR with a BNP elevated to 8800. She was diuresed with lasix and symptomatically improved. # Anal Fissures: Patient had 1 episode of rectal bleeding that was described as bright red blood on toilet paper after a bowel movement. Patient also described rectal pain. Rectal exam showed good rectal tone with no evidence of hemorrhoids or gross blood. The exam was painful supporting the diagnosis of anal fissures. Her hematocrit was stable during the admission. She declined lidocaine jelly or steroid suppository for symptomatic treatment. #Dysuria- Patient intermittently complained of burning with urination, and increased frequency. Unfortunately Ms ___ declined giving a urine sample. # Atrial fibrillation: Rate controlled on metoprolol and anticoagulated on coumadin. Admission INR was supratherapeutic so coumadin was initially held in the context of the possible bleed. she was restarted on her home dose on discharge. CHRONIC ISSUES: # Gout: Chronic. - continued allopurinol and colchicine # Hypothyroidism: Chronic. - continued levothyroxine # Hypercholesterolemia: Chronic. - continued simvastatin # CAD: Chronic. - continued plavix, atorvastatin, metorprolol ****Transitional issues*** Patient briefly complained of dysuria, but would not give urine sample. Please reasses. If her rectal pain does not improve, consider anoscopy for further workup. Please re-assess the dosage of her diuretic Please recheck her inr and assess the appropriateness of the current dose Her allopurinol may need to be renally dosed given her CKD Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Colchicine 0.6 mg PO DAILY 3. Levothyroxine Sodium 50 mcg PO DAILY 4. Metoprolol Tartrate 75 mg PO BID 5. Simvastatin 20 mg PO DAILY 6. Spironolactone 12.5 mg PO DAILY 7. Torsemide 40 mg PO DAILY 8. Warfarin 2 mg PO DAILY16 9. Aspirin 81 mg PO DAILY 10. Clopidogrel 75 mg PO DAILY 11. Acetaminophen 650 mg PO Q6H:PRN pain 12. Docusate Sodium 100 mg PO BID Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Clopidogrel 75 mg PO DAILY 3. Colchicine 0.6 mg PO DAILY 4. Levothyroxine Sodium 50 mcg PO DAILY 5. Docusate Sodium 100 mg PO BID 6. Simvastatin 20 mg PO DAILY 7. Torsemide 40 mg PO DAILY 8. Acetaminophen 650 mg PO Q6H:PRN pain 9. Allopurinol ___ mg PO DAILY 10. Metoprolol Tartrate 75 mg PO BID 11. Spironolactone 12.5 mg PO DAILY 12. Warfarin 2 mg PO DAILY16 13. Senna 1 TAB PO BID Stop if you are having diarrhea. RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*20 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS: Acute on chronic diastolic heart failure, Anal Fissure SECONDARY DIAGNOSIS: Atrial fibrillation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, You came to the hospital due to increasing shortness of breath and were found to have an exacerbation of your diastolic heart failure. We gave you extra medicine to diurese you (make you urinate out extra fluid) and your breathing improved. You should weigh yourself every morning, and call your cardiologist if your weight goes up more than 3 lbs. You also came after you found red blood on the toilet paper after a bowel movement. This was likely due to a anal fissure. Your blood level was stable during your stay and you had no more episodes of the bleeding. We held your coumadin during your stay because it was above the goal level. We gave you some medicine to help with the pain. You can take ___ baths at home to help with the pain (Please see attached handout.) We also recommend you take medicine to help keep your stools soft. You should follow up with your primary care doctor and your cardiologist at the appointments below. Followup Instructions: ___
19797689-DS-27
19,797,689
28,992,963
DS
27
2188-02-24 00:00:00
2188-02-26 11:50:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) / Ace Inhibitors Attending: ___. Chief Complaint: shortness of breath Major Surgical or Invasive Procedure: none History of Present Illness: ___ with history of ___, CKD, A.Fib on coumadin presenting with SOB since this morning and questionable right sided, constant, sharp, nonradiating chest pain since last night. History limited by patient's mental status (gives inconsistent answers, AO X 1). Pt initially stated that she is not having any chest pain and 2 minutes later said that she has had constant chest pain for the past day that has not gone away. History partially provided by pt's health aide and sister. Per health aide, pt had SOB this AM, worse with exertion. Health aide states pt was not complaining of chest pain, just SOB. ___ home RN noticed rales on pulmonary exam on ___ and her torsemide dose was increased from 40mg to 80mg daily. Pt also complaining of dysuria since ___, was evaluated by PCP who started her on Abx for presumed UTI. Health aide denies fevers, chills, cough, nausea, vomiting, ___ swelling, orthopnea, hematuria, diarrhea. Took torsemide 80mg ~10AM. Did not take her clopidogrel today. Took aspirin 81 and warfarin. In the ED initial vital signs were: 98.7 96 119/93 20 95% ra. Labs were significant for Na 141, K 5, Cl 98, HCO3 27, BUN 62, Cr 2.0, glucose 172, Ca 9.1, Mg 2.5, P 3.6, WBC 10.1 (N:86.5 L:7.3 M:3.7 E:2.1 Bas:0.4), H/H 12.8/42.2, plt 213, ___ 24.9, PTT 33.9, INR 2.3, proBNP 7731, CK 76, MB 2 and Trop-T 0.02. UA was largely unremarkable. CXR showed vascular congestion and b/l pleural effusions. She recevied furosemide 80 mg IV and albuterol/ipratropium nebs. Transfer vital signs were: 98.2 98 116/83 17 95% RA. On arrival to the floor pt, complains of suprapubic discomfort, denies chest pain, denies SOB. Pt intermittently tearful, but states she is not sure why. Past Medical History: Hypertension - ___ - Atrial fibrillation on warfarin - Chronic kidney disease (baseline creatinine 2.5 mg/dL) - Hypothyroidism - Gout - Osteoarthritis - Recurrent UTIs Social History: ___ Family History: Two brothers died in their ___ of heart failure. Also notable for HTN, esophageal cancer. No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION: VS: 98.4 122/84 100 22 92% RA GENERAL: Frail, NAD. Alternates between smiling and being tearful. HEENT: NCAT. PERRL. NECK: Supple with JVP to tragus. CARDIAC: Tachycardic. Irregular rhythm. Nl S1, S2. No m/r/g LUNGS: Rales halfway up posterior lung fields. ABDOMEN: Soft, NTND. Nl BS. No rebound or guarding. EXTREMITIES: 1+ pitting edema bilateral ___ to mid calf. wwp. NEURO: AO to self and to BI. Does not know city or year. Unable to say days of week backwards (could not go back one day). SKIN: Erythematous, warm patch posteromedial LLE just above the ankle w/o fluctuance or induration. Hyperpigmentation of bilateral ___ (venous stasis). . DISCHARGE: O: VS Temp 98.5 BP 81-92/59-69 HR 98-108 RR 20 O2 sat 98% on RA AM I/O: incontinent 24 hr I/O: incontinent Wgt: 75.2 kg (74.9 on ___ General: frail, NAD HEENT: sclera anicteric, conjunctiva clear, MMM Neck: supple, JVP 1 cm above clavicle with patient sitting at 45 degrees Cardiac: irregularly irregular, normal S1 and S2, no murmurs, rubs, or gallops Lungs: mild bibasilar crackles(L>R) Abdomen: NABS, soft, nontender, nondistended Extremities: 1+ b/l ___ edema to mid-shin level Skin: bilateral hyperpigmentation of lower extremities Pertinent Results: ADMISSION LABS: ___ 01:20PM BLOOD WBC-10.1 RBC-4.72 Hgb-12.8 Hct-42.2 MCV-89 MCH-27.0 MCHC-30.2* RDW-17.5* Plt ___ ___ 01:20PM BLOOD Neuts-86.5* Lymphs-7.3* Monos-3.7 Eos-2.1 Baso-0.4 ___ 01:20PM BLOOD ___ PTT-33.9 ___ ___ 01:20PM BLOOD Glucose-173* UreaN-62* Creat-2.0* Na-141 K-5.0 Cl-98 HCO3-27 AnGap-21* ___ 01:20PM BLOOD CK(CPK)-76 ___ 01:20PM BLOOD CK-MB-2 cTropnT-0.02* proBNP-7731* ___ 01:20PM BLOOD Calcium-9.1 Phos-3.6 Mg-2.5 ___ 01:38PM BLOOD Lactate-2.7* ___ U/A NEGATIVE . IMAGING: CXR ___: 1. Left retrocardiac opacity could represent atelectasis, infection or aspiration. 2. The left costophrenic angle is blunted. A small left pleural effusion is not excluded. . ECHO ___: Suboptimal image quality. Within the technical limitations of the exam, overall LV function appears moderately depressed, with estimated LVEF 35-40% with beat-to-beat variability. Mildly dilated RV with mildly depressed function. Biatrial enlargement. Moderate tricuspid regurgitation. Mild pulmonary artery systolic hypertension. Image quality on the current exam limits comparison with the prior study (images reviewed) of ___. Overall LV ventricular function appears worse. . DISCHARGE LABS: ___ 05:40AM BLOOD WBC-8.4 RBC-4.63 Hgb-12.7 Hct-41.6 MCV-90 MCH-27.4 MCHC-30.5* RDW-18.2* Plt ___ ___ 05:40AM BLOOD ___ ___ 05:40AM BLOOD Glucose-100 UreaN-100* Creat-2.3* Na-138 K-3.6 Cl-92* HCO3-33* AnGap-17 ___ 05:40AM BLOOD Calcium-9.1 Phos-4.9* Mg-2.7* Brief Hospital Course: ___ y/o F with PMHx of dCHF, afib on coumadin, presents with progressive SOB X 3 days c/w CHF exacerbation, as well as dysuria with negative U/A. . # Acute on chronic diastolic and systolic CHF: Last ECHO ___ with LVEF 55%. Dry weight unknown. Echo performed on ___ revealed decreased systolic function (LVEF 35-40%) and biatrial enlargement concerning for infarction. The decision was made with Ms. ___ HCP, PCP, and outpatient cardiologist to defer cardiac cath and continue medical management. Started lasix 80mg IV BID ___. Began furosemide drip ___ at 12/hr with goal net negative 1.5L per day. Administered metolazone 2.5mg X 1 on ___. Discontinued lasix gtt ___ ___uvolemic with dry weight 74.6 kg. Held home spironolactone and torsemide in setting of lasix diuresis. Started torsemide 60mg daily on ___. . # Atrial fibrillation: CHADS2= 3 (heart failure, age, HTN). On coumadin with INR 2.3 on admission. Pt with HR to ___. Changed home metoprolol 75 mg BID to 50 mg Q6 hr for better control of HR/optimization of cardiac output with resulting decrease in HR to ___. . # Coronary artery disease: Last cath in ___ showing multivessel disease in D1, LCx, and RCA. No history of PCI. Ms ___ was confused and oriented x1 during this hospitalization and gave inconsistent reports of chest pain. EKGs negative for ischemic changes, and troponins showed no uptrending. Echo performed on ___ revealed decreased systolic function (LVEF 35-40%) and biatrial enlargement concerning for infarction. The decision was made with Ms. ___ HCP, PCP, and outpatient cardiologist to defer cardiac cath and continue medical management. Continued home ASA, simvastatin. Adjusted metoprolol as above. . # HTN: Held home spironolactone and torsemide in setting of lasix diuresis and adjusted home metoprolol as above. Restarted torsemide 60mg daily on ___. . # LLE cellulitis: Pt received cefazolin 1g q12h X 3 days, then keflex ___ q8h X 4 days. Completed abx course ___ with complete resolution of cellulitis. . # suprapubic pain/dysuria: No ttp on exam. U/A negative. Etiology of pain unclear. Pt AO X 1 and gives inconsistent reporting of symptoms. . # Gout: No evidence of acute flare. Decreased home colchicine from 0.6mg to 0.3mg daily on ___ in setting of CKD. Continued home allopurinol. . # CKD with baseline Cr 2: Creatinine increased to 2.6 this admission and trended down to 2.3, which likely represents new baseline in setting of systolic CHF with EF 35-40% . # Hypothyroidism: Continued home levothyroxine . ## transitional issues: --changed metoprolol from 75 mg BID --> metoprolol succinate 50mg daily --changed torsemide from 40 mg BID --> to 40mg daily --changed colchicine from 0.6 mg daily --> 0.3 mg daily, given poor renal function --Cr 2.3 on ___, please re-check on ___ --INR 2.5, please re-check on ___ --would consider adding ACE-I to ___ regimen once blood pressure and renal function stabalize Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Colchicine 0.6 mg PO DAILY 3. Levothyroxine Sodium 50 mcg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Simvastatin 20 mg PO DAILY 6. Torsemide 40 mg PO BID 7. Acetaminophen 650 mg PO Q6H:PRN pain 8. Allopurinol ___ mg PO DAILY 9. Metoprolol Tartrate 75 mg PO BID 10. Spironolactone 12.5 mg PO DAILY 11. Warfarin 2 mg PO DAILY16 12. Senna 1 TAB PO BID Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. Allopurinol ___ mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Colchicine 0.3 mg PO DAILY RX *colchicine [Colcrys] 0.6 mg 0.5 (One half) tablet(s) by mouth once daily Disp #*15 Tablet Refills:*1 5. Docusate Sodium 100 mg PO BID 6. Levothyroxine Sodium 50 mcg PO DAILY 7. Senna 1 TAB PO BID 8. Simvastatin 20 mg PO DAILY 9. Torsemide 40 mg PO DAILY 10. Warfarin 2 mg PO DAILY16 11. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet extended release 24 hr(s) by mouth daily Disp #*30 Tablet Refills:*3 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: acute on chronic congestive heart failure, cellulitis Secondary: atrial fibrillation, hypertension, gout, chronic kidney disease, hypothyroidism Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ was a pleasure to take care of you at ___. You were admitted for evaluation of shortness of breath and were found to have an exacerbation of your congestive heart failure. We gave you medication to help remove the excess fluid from your lungs and your breathing improved. Please weigh yourself every morning, and call your PCP if weight goes up more than 3 lbs. You were also found to have an infection of the skin on your left lower leg. You were treated successfully with a course of antibiotics. You had some pain with urination when you came to the hospital. We did some tests on your urine and did not find any signs of infection. Followup Instructions: ___
19797689-DS-29
19,797,689
24,527,421
DS
29
2189-02-26 00:00:00
2189-02-26 14:43:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) / Ace Inhibitors Attending: ___. Chief Complaint: Urinary Tract Infection / Hematuria Major Surgical or Invasive Procedure: None History of Present Illness: Mrs ___ is an ___ year old woman with a past medical history of afib on warfarin, CKD, dsCHF, and recurrent UTIs who presents with questionable vaginal bleeding in the setting of acute kidney injury. Mrs ___ was in her normal state of health until the evening of ___ when she noticed that there was a large amount of blood with her in the toilet after she urinated. This was also associated with suprapubic pain. Endorses urinary urgency and frequency, but not dysuria. Describes her abdominal pain as "like her old periods." Has a history of vaginal bleeding by pessary that was left unattended for years. Most recent pessary was placed by OBGYN (___ some months ago and has not been problematic. After continuing to have abdominal pain and hematuria, she called her PCP who directed her to go to the ED. No fevers, chills, nausea, vomiting, changes in bowel habits, CP, SOB. Baseline walks minimally before becoming short of breath. In the ED, initial vital signs were: 5 97.2 58 115/63 18 95% Exam notable for absence of blood seen on speculum exam Labs were notable for 10.3 > 11.5 / 36.6 < 203 N: 67 L: 24 Band: 0 Eo: ___ M: 4 136 / 103 / 84 ---------------< 138 ___: 21.6 PTT: 30.2 INR: 2.0 5.5 / ___ / 3.6 Lactate 3.5 to 2.0 on repeat UA: pink/cloudy 1.101 ph 6.0 large leuk, lerge blood, trace protein RBC > 182 WBC > 182 Epi <1 Blood and Urine Cultures taken Patient was given 1g ceftriaxone Past Medical History: - Systolic + diastolic CHF (EF 40%) - CAD - Atrial fibrillation on warfarin - Chronic kidney disease (baseline creatinine 2.5 mg/dL) - Hypothyroidism - Gout - Osteoarthritis - Recurrent UTIs Social History: ___ Family History: Two brothers died in their ___ of heart failure. Also notable for HTN, esophageal cancer. No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: 97.9 114/83 56 18 99/RA Wt 183.6 General: awake, alert, NAD HEENT: PERRL EOMI MMM grossly normal oropharynx Lymph: no lymphadenopathy cervical or CV: RRR S1+S2 no g/r/m peripheral pulses intact. Lungs: bibasilar rales with fair movement b/l GU: foley draining light pink urine Abdomen: obese, soft, ? large ventral hernia normoactive BS, no organomegally felt Ext: 1+ peripheral edema to shin, dry, WWP Neuro: orianted to self and place, not time. no focal defects Skin: no rashes, lesions, excoriations DISCHARGE PHYSICAL EXAM: Vitals: 98.1 126/63 63 18 95/RA General: awake, alert, NAD HEENT: EMOI MMM grossly normal oropharynx CV: RRR S1+S2 no g/r/m peripheral pulses intact. Lungs: bibasilar rales with fair movement b/l Abdomen: obese, soft, nt/nd no r/g Ext: 1+ peripheral edema to shin, dry, WWP. No CVA tenderness Neuro: orianted to self and place, not time. no focal defects Skin: no rashes, lesions, excoriations Pertinent Results: ADMISSION LABS: ___ 10:40AM BLOOD WBC-10.3 RBC-3.91* Hgb-11.5* Hct-36.6 MCV-94 MCH-29.4# MCHC-31.4 RDW-15.3 Plt ___ ___ 10:40AM BLOOD Neuts-67 Bands-0 ___ Monos-4 Eos-2 Baso-1 ___ Myelos-2* ___ 10:40AM BLOOD ___ PTT-30.2 ___ ___ 10:40AM BLOOD Glucose-138* UreaN-84* Creat-3.6*# Na-136 K-5.5* Cl-103 HCO3-19* AnGap-20 ___ 06:55AM BLOOD Calcium-8.8 Phos-4.5 Mg-2.3 ___ 02:13PM BLOOD Lactate-3.5* ___ 02:33PM BLOOD Lactate-2.0 ___ 05:27AM URINE Color-DKAMB Appear-Cloudy Sp ___ ___ 01:00PM URINE Color-Pink Appear-Cloudy Sp ___ ___ 05:27AM URINE Blood-LG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-LG ___ 01:00PM URINE Blood-LG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG ___ 01:00PM URINE RBC->182* WBC->182* Bacteri-MOD Yeast-NONE Epi-<1 ___ 01:00PM URINE AmorphX-FEW ___ 01:00PM URINE WBC Clm-FEW ___ 01:00PM URINE Hours-RANDOM UreaN-237 Creat-21 Na-111 K-16 Cl-113 NOTABLE LABS: ___ 07:13AM BLOOD Plt ___ ___ 07:13AM BLOOD ___ PTT-32.0 ___ ___ 05:15PM BLOOD Plt ___ ___ 06:35AM BLOOD Plt ___ ___ 06:35AM BLOOD ___ PTT-29.3 ___ ___ 06:55AM BLOOD ___ PTT-29.7 ___ ___ 10:40AM BLOOD Plt Smr-NORMAL Plt ___ ___ 10:40AM BLOOD ___ PTT-30.2 ___ MICROBIOLOGY: URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML.. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- 32 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S IMAGING: RENAL U.S. ___ COMPARISON: CT abdomen and pelvis ___. Renal ultrasound ___ FINDINGS: The right kidney measures 8.7 cm. The left kidney measures 9.6 cm. There is no hydronephrosis, stones, or masses bilaterally. In the lower pole of the right kidney a simple cyst measures 1.7 x 1.7 cm. In the interpolar region of the right kidney a lesion that is isoechoic to renal cortex measures 1.2 x 1.4 cm and likely corresponds to the prior hemorrhagic cyst seen on the CT abdomen of ___. Normal cortical echogenicity and corticomedullary differentiation are seen bilaterally. The bladder is decompressed by a Foley catheter. IMPRESSION: No hydronephrosis. In comparison to the prior CT findings, the lesion in the interpolar region of the right kidney most likely represents a hemorrhagic cyst that is stable in size since ___. DISCHARGE LABS: ___ 07:13AM BLOOD WBC-8.8 RBC-3.50* Hgb-10.1* Hct-33.3* MCV-95 MCH-28.9 MCHC-30.4* RDW-14.9 Plt ___ ___ 07:13AM BLOOD Plt ___ ___ 07:13AM BLOOD ___ PTT-32.0 ___ ___ 07:13AM BLOOD Glucose-131* UreaN-78* Creat-3.0* Na-139 K-5.4* Cl-106 HCO3-24 AnGap-14 ___ 07:13AM BLOOD Calcium-8.5 Phos-4.8* Mg-2.5 Brief Hospital Course: PATIENT: Mrs ___ is an ___ year old woman with a past medical history of afib on warfarin, CKD, dsCHF, and recurrent UTIs who presented with a hemorrhagic UTI and ___ on CKD. ACUTE ISSUES: # Urinary Tract Infection/Acute cystitis: Patient originally presented to the ED with concern of vaginal bleeding. Speculum exam was without blood and later Foley samples confirmed presence of hematuria and a urinary tract infection once admitted to the hospital floor. Blood and urine cultures drawn and started empirically on ceftriaxone (given she had previous UTIs with resistance to ciprofloxacin and ampicillin.) There were no systemic signs to Microscopic urinalysis revealed isomorphic RBCs and WBCs without casts or acanthocytes. Urine culture eventually speciated as pan-sensitive E. coli. Patient switched to cefpodoxime and completed a total 5 day course of antibiotics. At time of discharge, patient had no more dysuria or suprapubic pain, however, she continued to have pink-tinged hematuria. # Gross Hematuria: No signs of clots or obstruction. Likely related to her acute cystitis in the setting of warfarin therapy. Foley was placed which subsequently was discontinued by patient. She did not want it replaced. Her renal function improved with IVF and holding her diuretics. Her hematuria improved slightly in house, though continued at discharge. We felt it reasonable to continue to monitor. Urology referral is recommended given possibility of other underlying processes. # ___ on CKD: Patient with unclear baseline creatinine which appeared to be between around 2.3, but PCP communicated that her creatinine was 2.9 in ___ and more recently. Admitted value was 3.6. Patient appeared clinically volume overloaded on admission and a trial of diuresis resulted in a creatinine bump. She was subsequently volume replete and her creatinine corrected to near baseline. Medications were renally dosed as needed. CHRONIC ISSUES: # Atrial fibrillation: Patient's warfarin was continued while inpatient given minor nature of bleed, hemodynamic stability, and stable hematocrit, and high risk of embolic stroke given CHAD2S2-Vasc. INR initially at 1.9, downtrended to 1.6 before rebounding. Rate control with metoprolol and amiodarone were continued. Please monitor INR closely # Chronic Systolic & Diastolic CHF: Patient appeared clinically volume overloaded, but responded to fluid repletion. Torsemide and spironolactone where held as detailed above. # CAD: History of multivessel disease in D1, LCx, and RCA. There does not appear to be active ischemia or angina on admission # Hypothyroidism: Home levothyroxine was coninuted # Gout: Home allopurinol was held at admission and restarted at discharge. TRANSITIONAL ISSUES: - Patient continues to have red-tinged hematuria at time of discharge. If patient stops producig urine, suspicion for clotting and bring to emergency room. If passing large clots, consider holding warfarin for ___ days. - Torsemide held during hospitalization and at time of discharge (replaced with Lasix 20mg PO daily). It appeared that patient's ___ was a result of hypovolemia from overdiuresis. - Spironolactone held during hospitalization and at time of discharge for hyperkalemia - Please address patient's need for diuretic use in the future. - Please obtain UA at next PCP ___, and if there is persistent hematuria please consider a referral to urology - Warfarin continued through hospitalization and at time of discharge given minor bleed, and stable vitals/hematocrit. Please assess the risk/benefit of ongoing anticoagulation. - Please consider placing patient on a high-intensity statin given her history of CAD INSTRUCTIONS FOR HOME CARE TEAM - PLEASE OBTAIN ___ Q ___ Instructions and please fax results to Dr. ___ at ___ - PLEASE OBTAIN ___ and fax results to Dr. ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Metoprolol Tartrate 50 mg PO BID 3. Torsemide 20 mg PO DAILY 4. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN Chest Pain 5. Dexamethasone Ophthalmic Soln 0.1% 1 DROP BOTH EYES HS 6. Levothyroxine Sodium 50 mcg PO DAILY 7. Vitamin D 1000 UNIT PO DAILY 8. Warfarin 2 mg PO DAILY16 9. Spironolactone 12.5 mg PO DAILY 10. Allopurinol ___ mg PO DAILY 11. Docusate Sodium 100 mg PO TID 12. Colcrys (colchicine) 0.3 mg oral DAILY 13. Omeprazole 20 mg PO DAILY 14. Simvastatin 20 mg PO DAILY 15. Cyanocobalamin 1000 mcg PO DAILY 16. Amiodarone 200 mg PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Amiodarone 200 mg PO DAILY 3. Cyanocobalamin 1000 mcg PO DAILY 4. Dexamethasone Ophthalmic Soln 0.1% 1 DROP BOTH EYES HS 5. Docusate Sodium 100 mg PO TID 6. Levothyroxine Sodium 50 mcg PO DAILY 7. Metoprolol Tartrate 50 mg PO BID 8. Warfarin 2 mg PO DAILY16 9. Vitamin D 1000 UNIT PO DAILY 10. Simvastatin 20 mg PO DAILY 11. Omeprazole 20 mg PO DAILY 12. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN Chest Pain 13. Cefpodoxime Proxetil 100 mg PO Q24H RX *cefpodoxime 100 mg 1 tablet(s) by mouth ONCE Disp #*1 Tablet Refills:*0 14. Colcrys (colchicine) 0.3 mg ORAL DAILY 15. Aspirin 81 mg PO DAILY 16. Furosemide 20 mg PO DAILY RX *furosemide 20 mg 1 tablet(s) by mouth DAILY Disp #*30 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis: Urinary Tract Infection Secondary Diagnoses: Hematuria Hypovolemia Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ were seen in the emergency department for bleeding in your urine. ___ were admitted to the hospital where ___ were diagnosed with a urinary tract infection (UTI). ___ were treated with antibiotics. ___ were also found to have an injury to your kidneys. An ultrasound of your kidneys demonstrated no structural damage. ___ were given intravneous fluids and your kidney function improved. Because we thought your diuretics had caused ___ too lose too much water, swe stopped those medications, and changed to a less potent diuretic at discharge. Your symptoms improved and ___ will be discharged home. Please weigh yourself every morning, and call MD if weight goes up more than 3 lbs. Please take all medications as prescribed and keep all scheduled appointments. It was a pleasure taking care of ___! Your ___ Care Team Followup Instructions: ___
19797807-DS-11
19,797,807
25,184,584
DS
11
2164-06-24 00:00:00
2164-07-05 16:47:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / codeine / amitriptyline Attending: ___. Chief Complaint: Fall, R flank hematoma. Major Surgical or Invasive Procedure: None History of Present Illness: ___ resident of assisted living home w/ PMH of HTN, NIDDM2, PMR, history of falls presents after awakening with right flank pain during the course of last night (___). She experienced a novel sharp pain in her right flank, non pleuiritc, or radiating in nature and was immobilized by the severity for a few minutes. Upon attempt to reach the emergency cord/button near her bed, she fell backwards from the bed to the floor landing on her buttocks. She did not strike her head or loose consciousness. She was down no more than 5 minutes. Shortly after signaling the alarm help and subsequently EMS arrived and brought her to ___. She was hypotensive to SBP ___ then ___ but maintained her mental status and her BP was responsive to fluid resuscitation (approximately 2.5L given at OSH). Her Hct was 31 which is on par with our previous recorded baseline. Otherwise, she had an elevated lactate of 4.0. Her troponin was negative and an EKG showed T wave inversions (previous EKGs with similar tracings). NCHCT and CT spine were negative for acute injuries. A CT Torso showed a large left sub muscular hematoma in the setting of old rib fractures with no associated hemo or pneumothorax. On evaluation in the ED, the patient is alert and oriented and provides a detailed recent history. She has experienced recent lightheadedness with ambulation, particularly when not using her walker. She has had a recent admission to ___ ___ with resultant right sided rib fractures and R clavicular fracture. Previous left wrist fracture braced. However, the tenderness and soft enlarged thoracic/flank mass is new and developed after today's fall. She is intermittently in SVT to 120s but otherwise normal HR in 60-70 during evaluation with normotension. Repeat HCT is 27 despite 1u PRBC. Lactate down to 1.8. On exam, she is comfortable, noting pain in the right flank/thoracic back without overlying ecchymosis. No respiratory distress. She does not know her full medications but endorses aspirin use. She states that her daughter prepares her medications for her. Past Medical History: HTN DM2 HLD atrial flutter persistent orthostatic hypotension h/o falls GERD (oesophageal ulcer) Polymyalgia rheumatica lumbar radiculopathy thalamic hemorrhage, likely traumatic PSH: spine surgery appendectomy early in life bowel obstruction s/p ex-lap Social History: ___ Family History: Not relevant to current admission Physical Exam: ADMISSION PHYSICAL EXAM: VS: ___ 68 143/69 16 96% RA Gen: awake, AAOx3, affable and conversant HEENT: no hemotympanum, no evidence of trauma to head or face, trachea midline, no facial tenderness, no cervical ttp, neck full range of motion w/o pain Neuro: AAOx3, CN ___ intact, EOMI, PERRL, equal strength b/l UE and ___, sensate, no pronator drift CV: sinus regular, no murmur or gallops Pulm: CTAB, diminished on posterior due to mass Thorax: no spinal tenderness except for paraspinal ttp near large flank mass which is tender to exam, no overlying ecchymosis or skin changes, no CVA tenderness Abd: midline scar well healed no fascial defect, no ttp on exam no guarding no rebound DRE: good tone, no gross blood GU: Foley in place, no perineal injury ___: warm well perfused, left wrist braced, removed w/p evidence of underlying skin changes, distal pulses palable UE and ___ radial, ___, pop and femoral b/l, ___ no evidence of injury, nttp = = = = = = = = = = ================================================================ DISCHARGE PHYSICAL EXAM: Vital Signs: T98, BP ___, orthostatic BP negative, HR ___, RR 98% RA. General: AAOx3, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: RRR, normal S1 + S2, no murmurs, rubs, gallops Lungs: CTAB, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding R Flank hematoma measuring 12 inches x 8 inches, stable, mildly tender. GU: No foley ___: L radial wrist with echymosis. Healing fracture. Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred. Pertinent Results: Labs on Admission: ___ 05:09AM BLOOD WBC-9.9# RBC-2.74* Hgb-8.4* Hct-27.2* MCV-99*# MCH-30.7 MCHC-30.9* RDW-13.9 RDWSD-50.7* Plt ___ ___ 05:09AM BLOOD Neuts-73.4* ___ Monos-6.0 Eos-0.6* Baso-0.3 Im ___ AbsNeut-7.28*# AbsLymp-1.89 AbsMono-0.59 AbsEos-0.06 AbsBaso-0.03 ___ 05:09AM BLOOD ___ PTT-26.1 ___ ___ 05:09AM BLOOD Plt ___ ___ 11:30AM BLOOD Plt ___ ___ 05:09AM BLOOD Glucose-135* UreaN-17 Creat-0.6 Na-139 K-3.9 Cl-106 HCO3-24 AnGap-13 ___ 05:32AM BLOOD Lactate-1.8 = = = = = = = ================================================================ Labs on Discharge: ___ 04:10AM BLOOD WBC-7.2 RBC-2.42* Hgb-7.6* Hct-24.3* MCV-100* MCH-31.4 MCHC-31.3* RDW-14.6 RDWSD-52.5* Plt ___ ___ 04:10AM BLOOD Plt ___ ___ 04:10AM BLOOD Glucose-105* UreaN-14 Creat-0.6 Na-140 K-3.9 Cl-106 HCO3-25 AnGap-13 ___ 04:10AM BLOOD Calcium-8.9 Phos-3.7 Mg-1.9 ___ 09:00AM BLOOD Cortsol-15.0 ___ 04:10AM BLOOD Cortsol-1.1* = = = = = = = ================================================================ Studies/Radiographic Imaging: ___: L Wrist Xray IMPRESSION: Comparison to ___. Status post fracture of the left radius. The transverse fracture is still visible extending into the articular surface but the margins of the fracture show calus formation. A new lucent line, not extending into the articular surface, is visualized along the radial component of the distal bone, perpendicular to the old fracture. This hyperlucent line, not visualized on the previous image, could represent an new fracture. A pre-existing fracture of the styloid is no longer clearly visualized. ___: R clavicle Xray IMPRESSION: Comparison to ___. The known rib fractures on the right as well as the complete an dislocated right clavicular fracture are not substantially changed. The degree of displacement and dislocation is stable as compared to the previous image. ___: CXR IMPRESSION: Moderate cardiomegaly is a stable. The aorta is tortuous. There is no evident pneumothorax. Right rib fractures are again noted. There are bibasilar atelectasis increasing from prior study . ___: CTA Abd/Pelvis IMPRESSION: 1. No evidence of IV contrast extravasation. No significant interval change in the extent of the right posterolateral chest wall hematoma measuring up to 24 cm in craniocaudal dimension. 2. Extensive diverticulosis. 3. Multiple fractures of varying ages, as described in detail above. 4. Increased distraction of the right clavicular fracture, compared to the prior exam, concerning for an acute on subacute component and underlying ligamentous injury. ___: CT CSpine IMPRESSION: 1. There is no evidence of acute cervical spine fracture or traumatic malalignment. 2. Degenerative changes of the cervical spine, as above. ___: CT Head IMPRESSION: 1. Interval evolution/resolution of the previously described small left posterior inferior thalamic hemorrhage. No new acute intracranial hemorrhage. 2. Previously described fractures of the right zygomatic process and right superolateral orbital wall are again seen. No new fracture detected. Brief Hospital Course: ___ y/o female with a past medical history of Aflutter, orthostatic hypotension currently on midodrine, h/o falls, DMII, PMR on prednisone who presented s/p fall and was found to have a right flank hematoma, transferred for medicine for management of fall, orthostatic hypotension and acute blood loss anemia. #Fall, orthostatic hypotension: Patient has a history of orthostatic hypotension, numerous falls, and suffered a fall on ___ at her living facility. She described losing her step upon getting out of bed, and had symptoms of lightheadedness at the time. She denied any loss of consciousness. For her orthostatic hypotension, patient at baseline is on midodrine. It is possible that ___ midodrine in combination with her beta blocker and lisinopril is contributing to her orthostatic hypotension. Patient is on chronic pred 5mg for PMR and there was initially a concern for possible adrenal insufficiency but this was ruled out (see below for more information). Patient also has peripheral neuropathy, and poor ambulatory function at baseline, both of which causes her gait to be unsteady as well. Patient denied any prior history of sudden LOC to suggest cardiac etiology. She also denied any palpitations or chest symptoms. She was monitored on tele without any notable cardiac events. Patient has a history of AF but remained in SR while she was hospitalized. There was no physical exam findings to suggest aortic stenosis. Hence, overall there is a low suspicion for structural heart disease. She denied any prior seizure history and was not post-ictal after her fall. ___ BP was in 120s-140s/60s-70s prior to discharge and she was not orthostatic. All together, we believe patient suffered a fall in the setting of being on midodrine, and antihypertensives (lisinopril, metoprolol), in combination with poor balance/peripheral neuropathy at baseline. Patient was continued on home midodrine on discharge, and after a discussion with her PCP, ___ lisinopril was discontinued and metoprolol decreased to 25mg XL daily. Patient will follow-up with PCP to determine whether she should have any other adjustments to her medication doses. #R/o adrenal insufficiency: Patient is on chronic pred 5mg for PMR, and in the process of working up for her fall, an AM cortisol returned at 1.1. This was likely artifact. We obtained a repeat cortisol, which returned as 15 and is more consistent with prior cortisol levels in our system. This repeat cortisol level was also drawn at a more appropriate time of the day. Given that patient did not have any orthostasis, without sodium or glucose abnormalities, and absence of other adrenal insufficiency symptoms, this level is likely a laboratory error. Patient was able to ambulate without any dizziness or other symptoms. This questionable cortisol result was communicated with outpatient PCP via phone call, who agreed that it is likely a non-issue. We continued patient back on home prednisone for her PMR upon discharge. #Acute blood loss anemia: Patient developed acute blood loss anemia in the setting of her fall and developing a large R flank hematoma. Hgb on discharge was 7.6 (baseline ___. She did not have any active evidence of bleeding on discharge, and her CT did not show any active extravasation. Patient will follow-up with her PCP, and should have her CBC repeated as an outpatient. #R flank/extrathoracic hematoma: Patient suffered a fall and developed a large R flank hematoma. A CT scan showed the flank/extrathoracic hematoma was 18 x 12 x 4.3cm without any evidence of active extravasation. This was progressively resolving and improved at the time discharge. #L radial fracture, R midshaft clavicle fracture: Patient with fractures from prior fall in ___ and is s/p by ortho. Per ortho, ___ fractures are healing well and is best managed non-operatively. Per ortho, patient can be WBAT for LUE and RUE. She will follow-up in outpatient orthopedics clinic. #PMR: ___ PMR was stable during this inpatient hospitalization. We continued ___ home prednisone on discharge. #DMII: Patient was treated with ISS while inpatient with sugar levels remaining largely at goal. She was resumed on her outpatient DM regimen upon discharge. #GERD: We continued patient on home omeprazole. =============================================================== Transitional Issues: 1. Please follow-up on ___ orthostatic hypotension. After discussing with her primary care physician, ___ discontinued her lisinopril, decreased her metoprolol to 25mg XL daily and continued her home midodrine. 2. Please follow-up on her acute blood loss anemia and repeat CBC during primary care appointment. Hgb on discharge was 7.6. 3. Please follow-up regarding her ACTH level (pending on discharge). Note that this was sent due to low cortisol (1.1), but the 1.1 was likely a lab error as the repeat cortisol level was 15. 4. Please follow-up regarding the healing of her L radial and R clavicle fractures. # CODE: Full Code # CONTACT: Daughter, ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. PredniSONE 5 mg PO DAILY 2. Midodrine 5 mg PO TID 3. Lisinopril 20 mg PO DAILY 4. Metoprolol Tartrate 12.5 mg PO Q6H 5. MetFORMIN (Glucophage) 500 mg PO DAILY 6. Alendronate Sodium 70 mg PO QMON 7. Atorvastatin 10 mg PO QPM 8. Omeprazole 20 mg PO DAILY 9. Calcium Carbonate 500 mg PO DAILY 10. Aspirin 81 mg PO DAILY 11. Citalopram 20 mg PO DAILY 12. Thiamine 100 mg PO DAILY Discharge Medications: 1. Citalopram 20 mg PO DAILY 2. Midodrine 5 mg PO TID 3. Omeprazole 20 mg PO DAILY 4. Thiamine 100 mg PO DAILY 5. Alendronate Sodium 70 mg PO QMON 6. Aspirin 81 mg PO DAILY 7. Atorvastatin 10 mg PO QPM 8. Calcium Carbonate 500 mg PO DAILY 9. MetFORMIN (Glucophage) 500 mg PO DAILY 10. PredniSONE 5 mg PO DAILY 11. Metoprolol Succinate XL 25 mg PO DAILY hold for BP<100/50, HR<60 RX *metoprolol succinate 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ ___: Primary Diagnoses: 1. Fall 2. Right flank hematoma 3. Orthostatic hypotension 4. Acute blood loss anemia Secondary Diagnoses: 1. L radial fracture 2. R clavicle fracture 3. PMR 4. DMII 5. AFib 6. GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, You were admitted to the hospital after you suffered a fall at home. We evaluated you in the hospital and found that you had a big bruise on your right side. We believe this was likely due to your blood pressure being too low when you stand up. We stopped your lisinopril to help keep your blood pressure up, and it was in a good range while you were here. We also decreased your metoprolol from 50mg to 25 mg. We also called your primary care physician, ___ to let him know about these changes, and ___ agreed that it was a good plan. You were able to work with the physical therapists who recommended that you receive more physical therapy sessions at home. You should follow-up with your primary care physician and the orthopedic doctors in the outpatient setting. Please take all your medications as instructed. It was a pleasure to care for you during this hospitalization. We wish you the best. Sincerely, Your ___ Care Team Followup Instructions: ___
19797807-DS-9
19,797,807
25,158,847
DS
9
2164-03-13 00:00:00
2164-03-14 09:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Penicillins / codeine / amitriptyline Attending: ___ Chief Complaint: Trauma: fall: lat/ant walls R maxillary sinus fracture right zygomatic arch fracture sphenoid right orbital fracture right rib fractures ___ displaced Right clavicle fracture right scapula fracture sternal fracture Compression def T12,indeterminate age left distal radius fracture Major Surgical or Invasive Procedure: none History of Present Illness: ___ year old female, s/p fall down 5 steps with head strike and unclear LOC for unknown amount of time. Unable to recall why she fell. Per report, she woke up in a pool of congealed blood at the bottom of her steps and activated her Life Alert. She was brought to ___ where she was GCS ___, had a CT head revealing a SAH/IPH, CT max/face demonstrated multiple facial fractures: nondisplaced R inferior orbital and maxillary sinus fx w/o evidence of entrapment or intraorbital hemorrhage. She was given clindamycin and keppra at ___ and transferred to ___ for further evaluation Past Medical History: Lumbar Radiculopathy, NIDDM2, GERD, Polymyalgia rheumatica Social History: ___ Family History: non-contributory Physical Exam: Physical Exam: ___: upon admission Vitals: 98.2 102 ST 145/41 19 98%RA GEN: A&O, NAD, GCS 15 HEENT: No scleral icterus, mucus membranes moist, bilateral periorbital ecchymosis, no head lacerations, PERRL, EOMI, small R subconjunctival hemorrhage CV: rhythm sounds somewhat irregular ? frequent PACs vs. PVCs, no rubs, normal S1/S2 PULM: Clear to auscultation b/l, No W/R/R, tenderness to palpation over right chest wall and clavicle, no skin tenting, ecchymosis over right chest wall ABD: Soft, nondistended, nontender, no rebound or guarding, normoactive bowel sounds, no palpable masses, mini laparotomy scar BACK: Nontender on exam, no stepoff deformities, however, while examining back, patient was distracted by her right flank pain Ext: UE: ecchymosis and pain with palpation of right elbow, edema and ecchymosis L wrist, with notable reluctance to give thumbs up with L thumb ___ to pain. ___ atraumatic, no significant edema, warm and well perfused CV: 2+ palpable radial and pedal pulses bilaterally Physical examination upon discharge: ___ vital signs: 98.1, 140/62, 72, 18, o2 sat 99% General: ___ ecchymosis bil CV: irreg, ns1, s2 LUNGS: crackles bases bil ABDOMEN: soft, non-tender EXT: no calf tenderness bil., + radial right, splint left NEURO: Scleral injection right eye, pupils pinpoint, alert and oriented x 3, speech clear SKIN; Ecchymosis left fore-arm, right shoulder/clavicle Pertinent Results: ___ 03:48AM BLOOD WBC-9.8 RBC-3.08* Hgb-10.7* Hct-31.4* MCV-102* MCH-34.7* MCHC-34.1 RDW-12.9 RDWSD-47.9* Plt ___ ___ 04:15PM BLOOD Neuts-75.2* Lymphs-12.3* Monos-11.7 Eos-0.0* Baso-0.2 Im ___ AbsNeut-7.17* AbsLymp-1.17* AbsMono-1.12* AbsEos-0.00* AbsBaso-0.02 ___ 03:48AM BLOOD ___ PTT-25.3 ___ ___ 09:10AM BLOOD Glucose-169* UreaN-9 Creat-0.5 Na-136 K-4.1 Cl-104 HCO3-23 AnGap-13 ___ 03:48AM BLOOD Glucose-158* UreaN-10 Creat-0.5 Na-136 K-4.1 Cl-99 HCO3-21* AnGap-20 ___ 03:48AM BLOOD CK(CPK)-645* ___ 03:48AM BLOOD CK-MB-5 cTropnT-<0.01 ___ 11:47PM BLOOD CK-MB-6 cTropnT-<0.01 ___ 09:10AM BLOOD Calcium-8.3* Phos-2.1* Mg-2.3 ___: right shoulder: There is a displaced fracture of the mid right clavicle with 1 shaft width of inferior displacement of the distal portion and with bony overriding of approximately 4.3 cm. There also be appears irregularity with concern for fracture at the base of the acromion, seen on the external rotation view, but not substantiated on the other views. The right acromio-clavicular joint is not widened. Multiple right-sided rib fractures are seen, including at least the posterior lateral right third, lateral fourth, fifth and likely sixth ribs. ___: CTA head/neck: 1. Unchanged posterior-lateral left thalamic parenchymal hemorrhage without evidence of underlying vascular malformation. 2. Small amount of new right sylvian fissure subarachnoid and layering occipital horn left lateral ventricular hemorrhage. 3. Patent intracranial and neck vasculature without occlusion or dissection. 4. 4 mm superiorly projecting thrombosed and calcified left supra clinoid segment internal carotid artery aneurysm. 5. 60-70% stenosis of the left carotid bulb by NASCET criteria. 6. Fracture of the right orbit with intracranial extension and small foci of pneumo-cephalus, as described. Additional fracture of the right zygoma and right maxillary sinus walls. The facial fractures are better characterized on dedicated CT of the face. 7. Enlarging right scalp hematoma. 8. Fractures involving the right mid clavicle, and the right lateral third, fourth, and fifth ribs, better characterized on dedicated CT of the chest. 9. Partially visualized large right gleno-humeral joint effusion extending into sub-acromial space with internal heterogeneous hyper-density and scattered calcifications. Findings may be related to chronic degeneration versus an acute process. Recommend clinical correlation. ___: ct of chest, abd. pelvis: 1. Acute fractures of the third, fourth, fifth, and sixth right ribs posteriorly and laterally. Fractures of the right clavicle and right scapula. 2. Compression fracture of T12 vertebral body, of indeterminate age. Overall appears subacute, but cannot exclude an acute component. 3. No evidence of large hemorrhage. 4. Bladder is very distended, correlate with ability to voluntarily urinate. ___: right elbow x-ray: Degenerative changes without definite acute fracture. ___: left hand x-ray: . Oblique nondisplaced distal radial fracture with intra-articular extension is likely acute/subacute in age. Clinical correlation for focal tenderness. 2. Mild soft tissue swelling of wrist. 3. Moderate to severe osteoarthritis involving the DIP joints, first CMC and triscaphe joint. 4. Diffuse osteopenia. ___: left wrist x-ray : Unchanged alignment of a left distal radius fracture. ___: MR cervical spine: . Multilevel degenerative changes of the lumbar spine, as described, without MR evidence of ligamentous or soft tissue injury. Please refer to dedicated CT of the cervical spine for the evaluation of osseous fractures. 2. Multilevel neural foraminal stenosis greatest at left C3-C4, left C4-C5, and bilateral C5-C6, where there is severe neural foraminal stenosis. 3. No evidence of cord compression or contusion. ___: MRI head: 1. Parenchymal hemorrhage at the posterior inferior left thalamus without evidence of underlying enhancing mass. Small amount of blood layering in the bilateral occipital horns and within the fourth ventricle. Small amount of right convexity subdural blood. Small right convexity subdural hematoma. These findings are relatively unchanged. 2. Punctate focus of slow diffusion at the mid superior left thalamus without corresponding blood products which may represent an acute infarct. 3. Background sequela chronic microangiopathy and small right frontal remote microbleeds. 4. Facial fractures are not well seen on MRI and are better characterized on prior dedicated CT. Brief Hospital Course: ___ year old female who sustained a fall down 5 steps with head strike and unclear LOC for unknown amount of time. She was unable to recall why she fell. She activated her Life alert. She was brought to an OSH where she was GCS ___. She underwent a CT of the head which revealed a SAH/IPH. Cat scan imaging of the maxillary/face demonstrated multiple facial fractures: non-displaced right inferior orbital and maxillary sinus fracture without evidence of entrapment or intraorbital hemorrhage. She was given clindamycin and keppra at ___ and transferred to ___ for further evaluation. Upon arrival to the hospital, the patient was admitted to the Trauma Intensive care unit for monitoring. She was alert and oriented x 3. She was having ectopy with multiple runs of NSVT which improved with electrolytes repletion. Troponins were sent to rule out a cardiac contusion. She was given additional intravenous fluids for a decreased urine output. On review of the imaging the patient was reported to have right sided ___ rib fractures, a right displaced clavicle fracture, a right scapula fracture and a sternal fracture. Her pain was controlled with oral analgesia. The patient was encouraged to use the incentive spirometer. The patient was transferred to the surgical floor on ___. Because of her multiple injuries, the Orthopedic, Neurosurgery, and Plastic surgery service were consulted. No surgical intervention was indicated. The patient was placed on sinus precautions for the facial fractures and a sling was applied to support the right clavicle and scapular fracture. Because of her orbital and maxillary sinus fracture, the Ophthalmology service was consulted. Outpatient follow-up was recommended. During the remainder of the ___ hospital course, her vital signs remained stable and she was afebrile. She was started on a regular diet. Her foley catheter was removed on ___ and she was voiding without difficulty. Her hematocrit was stable at 31 with a normal white blood cell count. In preparation for discharge, the patient was evaluated by physical and occupational therapy. Recommendations were made for discharge to a rehabilitation facility to help the patient regain her strength and mobility. The patient was discharged on ___ in stable condition. Appointments for follow-up were made with the multiple services who were consulted in her care. Her aspirin is on hold until ___ *****An incindental finding of a thrombosed left paraclinoid ICA aneurysm was identified on head CT.**** *****Punctate focus of slow diffusion at the mid superior left thalamus without corresponding blood products which may represent an acute infarct Medications on Admission: The Preadmission Medication list is accurate and complete. 1. PredniSONE 5 mg PO DAILY 2. Lisinopril 20 mg PO DAILY 3. Atenolol 37.5 mg PO DAILY 4. Atorvastatin 10 mg PO QPM 5. Citalopram 20 mg PO DAILY 6. Omeprazole 20 mg PO DAILY 7. Thiamine 100 mg PO DAILY 8. Aspirin 81 mg PO DAILY 9. MetFORMIN (Glucophage) 500 mg PO DAILY Discharge Medications: 1. Atorvastatin 10 mg PO QPM 2. Citalopram 20 mg PO DAILY 3. Omeprazole 20 mg PO DAILY 4. PredniSONE 5 mg PO DAILY 5. Thiamine 100 mg PO DAILY 6. Acetaminophen 1000 mg PO Q6H:PRN Pain 7. HydrALAzine 25 mg PO Q6H:PRN SBP > 140 8. Hydrochlorothiazide 25 mg PO DAILY 9. Insulin SC Sliding Scale Fingerstick Q6h Insulin SC Sliding Scale using REG Insulin 10. Aspirin 81 mg PO ON HOLD ON HOLD, MAY RESUME ON ___. Metoprolol Tartrate 12.5 mg PO Q6H 12. Atenolol 37.5 mg PO DAILY 13. Lisinopril 20 mg PO DAILY 14. MetFORMIN (Glucophage) 500 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: Trauma: lateral/ant walls R maxillary sinus fracture right zygomatic arch fracture sphenoid right orbital fracture right rib fractures ___ displaced Right clavicle fracture right scapula fracture sternal fracture Compression def T12,indeterminate age left distal radius fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: You were admitted to the hospital after a fall in which you sustained injuries to your face, ribs, scapula, clavicle, sternum, left radius fracture, and T12 compression deformity. You did not require any surgical intervention. You were seen by physical therapy and recommendations were made for discharge to a rehabilitation facility to help you regain your strength and mobility. You are being discharged with the following instructions: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Followup Instructions: ___
19797896-DS-13
19,797,896
29,486,556
DS
13
2174-09-04 00:00:00
2174-09-04 13:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Penicillins / Sudafed Attending: ___. Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: ___: Replacement of right tube thoracostomy. History of Present Illness: ___ with history of moderate dementia, on Lovenox for recent right hip surgery (___), now 2 weeks status post fall with right-sided rib fractures, who presents with acutely worsening shortness of breath for the two days. Patient was seen over at ___ prior to arrival where she had a CT of her chest which demonstrated large right pleural effusion with consolidation of the lower lobe, no mediastinal shift, lungs aerated and clear, no left pleural effusion along with multiple right-sided rib fractures. Patient denies any abdominal pain or black or bloody stools or nausea or vomiting. No dysuria. Patient at baseline mental status per family at bedside. Patient describes shortness of breath with chest pain and has difficulty speaking in full sentences. She is pleasant but confused and accompanied by her daughter (HCP) who states that her pain and shortness of breath acutely worsened over the past few days, prompting the ED presentation. Past Medical History: PMH: Type 2 diabetes, cerebral palsy, mild mitral stenosis, tricuspid regurgitation, hypertension, uterine cancer, pulmonary hypertension, history of CVA, chronic back pain, spinal stenosis, osteoporosis, depression, anxiety and GERD. PSH: ORIF for right trochanteric fracture (___), hysterectomy ___ years prior) Social History: ___ Family History: Non-contributory Physical Exam: Admission Physical Exam: Vitals: T98.7, HR100, BP 162/60, RR32 95%2LNC GEN: A&Ox1, uncomfortable, tachypneic, not speaking in full sentences HEENT: No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation on left, decreased breath sounds on right, tenderness to right lateral chest wall ABD: Soft, nondistended, nontender, no rebound or guarding, normoactive bowel sounds, no palpable masses Ext: No ___ edema, ___ warm and well perfused Discharge Physical Exam: Pertinent Results: ___ 06:50AM BLOOD WBC-6.7 RBC-3.18* Hgb-9.2* Hct-29.1* MCV-92 MCH-28.9 MCHC-31.6* RDW-13.4 RDWSD-45.5 Plt ___ ___ 06:35AM BLOOD WBC-5.5 RBC-3.06* Hgb-8.9* Hct-28.2* MCV-92 MCH-29.1 MCHC-31.6* RDW-13.5 RDWSD-45.8 Plt ___ ___ 06:45AM BLOOD WBC-6.6 RBC-3.02* Hgb-8.8* Hct-28.0* MCV-93 MCH-29.1 MCHC-31.4* RDW-13.6 RDWSD-45.9 Plt ___ ___ 02:15AM BLOOD WBC-8.2 RBC-3.37* Hgb-9.8* Hct-30.8* MCV-91 MCH-29.1 MCHC-31.8* RDW-13.5 RDWSD-45.5 Plt ___ ___ 03:00PM BLOOD WBC-8.3 RBC-3.82* Hgb-11.1* Hct-35.2 MCV-92 MCH-29.1 MCHC-31.5* RDW-13.7 RDWSD-46.4* Plt ___ ___ 03:00PM BLOOD ___ PTT-32.3 ___ ___ 06:50AM BLOOD Glucose-126* UreaN-8 Creat-0.4 Na-137 K-4.3 Cl-100 HCO3-29 AnGap-12 ___ 06:35AM BLOOD Glucose-111* UreaN-7 Creat-0.4 Na-141 K-4.1 Cl-102 HCO3-30 AnGap-13 ___ 06:45AM BLOOD Glucose-125* UreaN-8 Creat-0.4 Na-137 K-3.9 Cl-101 HCO3-29 AnGap-11 ___ 02:15AM BLOOD Glucose-155* UreaN-12 Creat-0.4 Na-139 K-4.4 Cl-104 HCO3-24 AnGap-15 ___ 03:00PM BLOOD Glucose-114* UreaN-12 Creat-0.5 Na-139 K-4.9 Cl-102 HCO3-25 AnGap-17 ___ 03:00PM BLOOD ALT-75* AST-63* AlkPhos-134* TotBili-0.4 ___ 03:00PM BLOOD proBNP-___* ___ 06:50AM BLOOD Calcium-8.5 Phos-3.3 Mg-2.1 ___ 06:35AM BLOOD Calcium-8.6 Phos-3.7 Mg-1.9 ___ 06:45AM BLOOD Calcium-8.5 Phos-3.5 Mg-1.7 ___ 02:15AM BLOOD Calcium-8.7 Phos-4.5 Mg-1.8 ___ 03:19PM BLOOD Lactate-1.4 ___ 3:00 pm BLOOD CULTURE Blood Culture, Routine (Preliminary): STAPHYLOCOCCUS, COAGULASE NEGATIVE. Isolated from only one set in the previous five days. SENSITIVITIES PERFORMED ON REQUEST.. Aerobic Bottle Gram Stain (Final ___: GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS. Reported to and read back by ___, ___, ON ___ AT 20:00 ___. ___ 8:50 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: Culture workup discontinued. Further incubation showed contamination with mixed skin/genital flora. Clinical significance of isolate(s) uncertain. Interpret with caution. KLEBSIELLA PNEUMONIAE. >100,000 CFU/mL. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. STAPHYLOCOCCUS, COAGULASE NEGATIVE. 10,000-100,000 CFU/mL. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ KLEBSIELLA PNEUMONIAE | AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- 64 I PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S ___ 08:50PM URINE Color-Yellow Appear-Hazy* Sp ___ ___ 08:50PM URINE Blood-SM* Nitrite-POS* Protein-TR* Glucose-NEG Ketone-TR* Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG ___ 08:50PM URINE RBC-7* WBC-16* Bacteri-MOD* Yeast-NONE Epi-16 TransE-1 ___ CXR: In comparison with the study of ___, the right chest tube is now within the thoracic cavity with the tip just above the medial aspect of the clavicle. No evidence of post procedure pneumothorax. There has been apparent removal of a substantial amount of pleural fluid with residual atelectatic changes or possible re-expansion edema at the base. Cardiomediastinal silhouette is stable and there again is some elevation of pulmonary venous pressure. ___ CXR: Interval increase in small right pleural effusion. Increased opacification of the right lower lobe of unclear etiology. Follow-up imaging is recommended. ___ CXR: Compared to the prior study, I doubt significant interval change. Again seen is a right-sided chest tube overlying the right lung, mild undulation as it enters chest walls noted, unchanged. No pneumothorax. Small right greater left pleural effusion. Fluid in the minor fissure and opacity in the right lung zone as well as atelectasis at the left lung base again noted. Probable CHF, unchanged. ___ CT Chest: 1. Right posterior chest tube in place. Significant decrease in now small right pleural effusion with a few small areas of loculated fluid, particularly in the fissures and at the right lung base. A discrete locule measuring 2.6 x 1.8 cm along the right major fissure contains several of locule of internal gas and me be related to placement of the initial chest tube. 2. Consolidative opacity at the right lung base, concerning for pneumonia. 3. Small left pleural effusion, increased from prior CT. 4. Re-demonstrated multiple right-sided rib fractures, detailed above. 5. Enlarged mediastinal lymph nodes, increased from prior chest CT, likely reactive. ___ CXR: FINDINGS: The right chest tube is been removed. No pneumothorax is identified. There are small bilateral pleural effusions. Unchanged right basilar opacity. The right rib fractures were better assessed on the CT scan performed yesterday. The left lung is grossly clear. The size of the cardiac silhouette is within normal limits. There are degenerative changes of the right acromioclavicular joint. IMPRESSION: Interval removal of the right chest tube. No pneumothorax is identified. Brief Hospital Course: Ms. ___ is a ___ yo F with moderate dementia, on lovenox for recent right hip surgery (___), who presented to outside hospital on ___ with increased shortness of breath after fall with right sided rib fractures 2 weeks prior. She was transferred to ___ for further management. Right chest tube was placed in emergency department but found to be in the subcutaneous tissues and the pleural space had not been entered. Because of pain during initial insertion, she was taken to the operating room and had chest tube inserted under MAC anesthesia. Upon chest tube insertion, approximately 1200 cc of blood was evacuated. The patient was extubated and taken to the trauma ICU for continued monitoring and management. Neuro: The patient was alert and oriented x1 throughout hospitalization; pain was initially managed with a IV tyleonol and IV dilaudid for breakthrough and then transitioned to oral Tylenol and tramadol once tolerating a diet. Home gabapentin regimen continued. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Intially home lisinopril was held for kidney protection and amlodipine for hypotension. The patient remained stable and therefore home medications were restarted at previous dosing. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. Daily chest xrays were obtained while chest tube was in place. Chest tube was removed on ___ and repeat chest xray showed no pneumothorax. Supplemental oxygen was titrated to maintain O2 sat >93% GI/GU/FEN: The patient was initially kept NPO with a ___ tube in place for decompression. On ____, the NGT was removed_____, therefore, the diet was advanced sequentially to a Regular diet, which was well tolerated. Patient's intake and output were closely monitored ID: The patient's fever curves were closely watched for signs of infection, of which there were none. HEME: The patient's blood counts were closely watched for signs of bleeding, of which there were none. Prophylaxis: The patient received subcutaneous heparin and ___ dyne boots were used during this stay and was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. The patient was tolerating a diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. CARDIOVASCULAR: History of hypertension, mild mitral stenosis, tricuspid regurgitation, pulmonary hypertension #hypertension -IV Lopressor 5mg q6hr -currently hemodynamically stable -holding home lisinopril and amlodipine PULMONARY: hemothorax s/p chest tube placement in OR -chest tube to suction per ACS -daily CXR while CT in place -titrate supplemental oxygen to >93% GI/ABDOMEN: no history of GI disease, benign abdomen on exam -currently NPO per ACS -holding home lactulose FEN: # Fluids: LR @ 75 # Electrolytes: replete lytes PRN # Enteral/Parenteral nutrition: NPO except meds RENAL: Baseline renal function unknown -No foley in place, monitor UOP HEMATOLOGY: Anemia: Hct 35.2 -> 30.8 -trend Hct q12hr in setting of hemothorax -monitor chest tube output q2hr, character and output volume -transfuse if Hct <21 DVT prophylaxis: SCDs, holding SQH in setting of bleed TYPE AND SCREEN OUTDATES: MSK: ___ consult when appropriate ENDOCRINE: #history of diabetes Glycemic control: RISS for Goal FSBS <180, avoid hypoglycemia. Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: Right rib fractures and right traumatic hemothorax. Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Lethargic but arousable. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: * Your injury caused right-sided rib fractures which can cause severe pain and subsequently cause you to take shallow breaths because of the pain. * You should take your pain medication as directed to stay ahead of the pain otherwise you won't be able to take deep breaths. If the pain medication is too sedating take half the dose and notify your physician. * Pneumonia is a complication of rib fractures. In order to decrease your risk you must use your incentive spirometer 4 times every hour while awake. This will help expand the small airways in your lungs and assist in coughing up secretions that pool in the lungs. * You will be more comfortable if you use a cough pillow to hold against your chest and guard your rib cage while coughing and deep breathing. * Symptomatic relief with ice packs or heating pads for short periods may ease the pain. * Narcotic pain medication can cause constipation therefore you should take a stool softener twice daily and increase your fluid and fiber intake if possible. * Do NOT smoke * If your doctor allows, non-steroidal ___ drugs are very effective in controlling pain ( ie, Ibuprofen, Motrin, Advil, Aleve, Naprosyn) but they have their own set of side effects so make sure your doctor approves. * Return to the Emergency Room right away for any acute shortness of breath, increased pain or crackling sensation around your ribs (crepitus). Followup Instructions: ___
19798000-DS-10
19,798,000
26,225,415
DS
10
2146-03-10 00:00:00
2146-03-10 21:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Aspirin / Compazine / Morphine Attending: ___. Chief Complaint: R Flank Pain Major Surgical or Invasive Procedure: EGD ___ History of Present Illness: This is a ___ w/ h/o thalassemia trait, chronic anemia, kidney stones, lap band ___ presenting w/ flank pain radiating to right shoulder, ___ AM she developed sharp right flank pain, radiating to right shoulder starting ___, waxes and wanes in intensity, worse with deep breath and moving. Over the same time has had substernal pain with swallowing, without food sticking sensation. No pelvic pain. Has been passing nonbloody urine. She has had subjective chills but no documented fevers. No dysuria, doesnt remind her of prior nephrolithiasis. Has had bloody spotting of the toilet paper with wiping with stool, but her stool has been brown and nonbloody. Able to eat. Ibuprofen hasnt helped. Notes that she has ongoing heavy periods, typically lasting 2 weeks at a time, no intermenstrual bleeding. Has not been taking her iron for at least the last month. In the ED, initial vitals: 98.7 90 135/68 18 100% RA. She was consistently afebrile, with normal renal function and no leukocytosis. She had a neg abd US, no hydro. KUB w/ ?lap band migration but UGI/barium reassuring. Cleared by bariatric surgery. Initial plan to get CTU but barium in the bowel would interfere so admitted to medicine to allow the barium to pass. Meds given: HYDROmorphone (Dilaudid) .5 mg ___ 00:21 IVF 1000 mL LR ___ 03:31 IVF 1000 mL LR ___ 03:32 IV HYDROmorphone 1mg ___ 04:48 IV Ketorolac 15 mg ___ 09:52 IVF 1000 mL LR ___ 12:43 IV HYDROmorphone 1mg Vitals prior to transfer: 98.3 67 121/51 16 100% RA Currently, the pt symptoms are stable as described above. ROS: As above. Otherwise negative in detail. Past Medical History: ANEMIA, chronic, thalassemia trait, iron deficiency LEFT ANKLE FRACTURE ASTHMA CHRONIC BACK PAIN DEPRESSION (hx of SI) HEALTH MAINTENANCE MENORRHAGIA OBESITY s/p Gastric Banding H/O KIDNEY STONES CERVICAL METAPLASIA Reported celiac disease by biopsy, antibody reportedly negative Social History: ___ Family History: Mom, with anemia. No history of blood clots. Several cousins with cancers at early ages, including breast and colon in ___. Physical Exam: ADMISSION: Vitals- 98.3 135/62 73 18 100% RA General- Alert, oriented, no acute distress HEENT- Sclerae anicteric, pale conjuctivae and complexion, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- CTAB no wheezes, rales, rhonchi CV- RRR, Nl S1, S2, No MRG Abdomen- soft, NT, no hepatosplenomegaly. On palpation of RUQ, "pressure" behind right shoulder appreciated. No pain on palpation of right chest wall. No CVAT Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. Right shoulder ROM intact, no impingement signs of e/o bursitis/tendonitis clinically Neuro- CNs2-12 intact, motor function grossly normal Rectal: No visible blood seen externally, external hemorrhoids visualized DISCHARGE: Vitals- 98.5 120/65 66 18 100% RA General- Alert, oriented, no acute distress HEENT- Sclerae anicteric, pale conjuctivae and complexion, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- CTAB no wheezes, rales, rhonchi CV- RRR, Nl S1, S2, No MRG Abdomen- soft, NT, no hepatosplenomegaly. No abd ttp Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. Neuro- CNs2-12 intact, sensiromotor function grossly normal Pertinent Results: ADMISSION LABS: ___ 09:09PM PLT COUNT-249 ___ 09:09PM WBC-6.4# RBC-4.33 HGB-7.0* HCT-25.9* MCV-60* MCH-16.2* MCHC-27.1* RDW-19.2* ___ 09:09PM WBC-6.4# RBC-4.33 HGB-7.0* HCT-25.9* MCV-60* MCH-16.2* MCHC-27.1* RDW-19.2* ___ 09:09PM TSH-1.6 ___ 09:09PM calTIBC-482* VIT B12-290 FERRITIN-3.0* TRF-371* ___ 09:09PM ALBUMIN-4.1 IRON-13* ___ 09:09PM cTropnT-<0.01 ___ 09:09PM LIPASE-32 ___ 09:09PM ALT(SGPT)-10 ALK PHOS-62 TOT BILI-0.2 ___ 09:09PM estGFR-Using this ___ 09:09PM GLUCOSE-94 UREA N-11 CREAT-0.9 SODIUM-138 POTASSIUM-3.8 CHLORIDE-102 TOTAL CO2-25 ANION GAP-15 ___ 12:47AM LACTATE-0.8 ___ 12:47AM ___ COMMENTS-GREEN TOP ___ 03:20AM URINE MUCOUS-FEW ___ 03:20AM URINE RBC-2 WBC-1 BACTERIA-NONE YEAST-NONE EPI-2 ___ 03:20AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-2* PH-6.5 LEUK-TR ___ 03:20AM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 03:20AM URINE UHOLD-HOLD ___ 03:20AM URINE UHOLD-HOLD ___ 03:20AM URINE UCG-NEGATIVE ___ 03:20AM URINE HOURS-RANDOM ___ 03:20AM URINE HOURS-RANDOM ___ 06:53AM cTropnT-<0.01 DISCHARGE: ___ 07:35AM BLOOD WBC-4.6 RBC-4.07* Hgb-6.8* Hct-24.6* MCV-60* MCH-16.6* MCHC-27.5* RDW-19.2* Plt ___ ___ 07:35AM BLOOD Glucose-85 UreaN-9 Creat-0.5 Na-136 K-4.2 Cl-102 HCO3-22 AnGap-16 ___ 07:35AM BLOOD ALT-9 AST-13 LD(LDH)-153 AlkPhos-56 TotBili-0.3 ___ 07:35AM BLOOD Calcium-8.7 Phos-3.1 Mg-2.0 ___ 04:52PM BLOOD HIV Ab-NEGATIVE IMAGING: EGD ___ Impression: Normal mucosa in the esophagus (biopsy) Normal mucosa in the stomach Normal mucosa in the duodenum (biopsy) Otherwise normal EGD to third part of the duodenum RUQ US ___: 1. No evidence of acute cholecystitis. 2. Echogenic liver consistent with hepatic steatosis. 3. 2.3 cm nonvascular echogenic lesion in the left lobe of the liver, not fully characterized on this study. While may represent a hemangioma, a nonemergent MR can be obtained for further evaluation. KUB ___: No evidence of bowel obstruction. Laparoscopic band at a more vertical angle compared to prior studies (___), raising the concern for band slippage. Barium swallow/UGI ___: IMPRESSION: Unchanged position of the laparoscopic band, no evidence of obstruction. CXR ___ Since the prior study the impression is at the cardiac silhouette has enlarged but that may be attributed to portable nature of the study. Mediastinum is unremarkable and the lungs are clear. Repeated radiograph with PA and lateral views might be suggested for pre size assessment of the cardiac silhouette. Renal US ___ IMPRESSION: Normal renal ultrasound with no evidence of renal calculi, no hydronephrosis. Brief Hospital Course: This is a ___ w/ h/o thalassemia trait, chronic anemia, kidney stones, lap band ___ presenting w/ flank pain. # Flank pain: Reassuring exam, vital signs, labs. Pt noted that the pain has been present on/off for months. On history and exam felt to most likely be musculoskeletal lower back pain. No stigmata of nephrolithiasis (no hydro or hematuria), and it was felt that there was no current indication for abdominal imaging. Used APAP, oxycodone for pain control. Recommended outpt ___, contiuing attempts at weight loss, lidocaine patch. Consider dedicated back imaging as outpt if pain persists or worsens. # Odynophagia: Started after admission. EGD wnl, lap band was functioning normally and now deflated prior to discharge. Ddx includes motility disorder, unlikely to be celiac-related. Tolerated POs. Received a PPI and will f/u with GI. # Anemia: Chronic, hct slightly lower than baseline. Microcytic. Probably combination of known thalassemia and severe iron deficiency in the setting of menorrhagia and nonadherence with PO iron regimen. That during this admission 2.5%. Received IV iron and restarted on PO iron. B12 was borderline and started on supplementation. Suggest GYN eval as outpt given persistent anemia in the setting of heavy menstruation. Rectal bleeding as belows # Hematochezia: Pattern c/w hemorrhoidal source and these were seen on exam. Does have a FH of early onset colon cancer. Last ___ ___, wnl. Outpt repeat colonoscopy can be considered, will f/u with GI. # Liver lesion: Likely hemangioma but radiology recommending outpt liver MRI # Asthma: Albuterol prn # EKG findings: Baseline LAD and T wave inversions, all non-specific. Consider outpt TTE to exclude HOCM, especially given ?cardiomegaly seen on CXR Transitional issues: - Followup with GI regarding odynophagia, hematochezia (hemorrhoids noted on exam), possible celiac disease - Followup with bariatric surgery re. lap band - Recommend GYN evaluation for menorrhagia leading to severe anemia - MRI of the liver for lesion seen in left lobe, likely hemangioma - Referred to ___ for lower back pain - TTE for baseline EKG changes, ?cardiomegaly on exam, to exclude HOCM. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing 2. Cyanocobalamin 1000 mcg PO DAILY RX *cyanocobalamin (vitamin B-12) 1,000 mcg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills:*0 3. Docusate Sodium 100 mg PO BID Do not take if stools are loose RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 4. Lidocaine 5% Patch 1 PTCH TD QAM RX *lidocaine [Lidoderm] 5 % (700 mg/patch) 1 patch to painful site on lower back daily Disp #*30 Patch Refills:*0 5. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain Do not operate motor vehicles or drink alcohol when taking this medication RX *oxycodone 5 mg 1 tablet(s) by mouth q6 Disp #*12 Tablet Refills:*0 6. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth q12 hours Disp #*60 Tablet Refills:*0 7. Ferrous Sulfate 325 mg PO DAILY RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills:*0 8. Acetaminophen 650 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: Lower back pain Odynophagia Iron deficiency anemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you at ___. You were admitted with back pain and pain with swallowing. We recommend physical therapy for your lower back pain. You had an endoscopy which was normal. You should followup with gastroenterology, bariatric surgery, and your primary care doctor. We have started you on iron and vitamin B12 supplements for your anemia. If the iron pills make your swallowing worse, please discuss with your PCP regarding IV iron infusions. We do recommend that you be evaluated by Ob/Gyn regarding your heavy periods and anemia. Your PCP can help you with this referral. You may require a colonoscopy because of the rectal bleeding you noticed this past month - this can be discussed with your gastroenterologist at followup. You will require an MRI to evaluate a small, benign-appearing spot on your liver. This likely represents an enlarged blood vessel. Best wishes, Your ___ Team Followup Instructions: ___
19798000-DS-12
19,798,000
23,051,141
DS
12
2150-04-03 00:00:00
2150-04-03 19:10:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Aspirin / Compazine / Morphine Attending: ___ Chief Complaint: Abdominal pain and food intolerance Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ PMH thalassemia trait, morbid obesity s/p lap band ___, presenting with 2 days of RUQ & epigastric pain. She states that the pain began 2 days ago, and she cannot associate the start of the symptoms with any specific inciting factor, such as a fatty meal. She states that the pain has increased, especially in her lower chest, to the point where she cannot take a deep breath due to pain. She denies fever, chills, nausea, vomiting, dysuria, or changes in bowel movements. She denies sick contacts or previous episodes of similar pain. A CT performed in the ED was concerning for possible early appendicitis, and ___ surgery was consulted for further management. Past Medical History: ANEMIA, chronic, thalassemia trait, iron deficiency LEFT ANKLE FRACTURE ASTHMA CHRONIC BACK PAIN DEPRESSION (hx of SI) HEALTH MAINTENANCE MENORRHAGIA OBESITY s/p Gastric Banding H/O KIDNEY STONES CERVICAL METAPLASIA Reported celiac disease by biopsy, antibody reportedly negative Social History: ___ Family History: Mom, with anemia. No history of blood clots. Several cousins with cancers at early ages, including breast and colon in ___. Physical Exam: GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR PULM: No respiratory distress ABD: Obese, soft, non-tender RLQ, mildly tender RUQ, negative ___ sign, mildly tender epigastric. Ext: No ___ edema, ___ warm and well perfused Pertinent Results: ___ 12:00AM BLOOD WBC-7.3 RBC-4.50 Hgb-10.8* Hct-36.7 MCV-82 MCH-24.0* MCHC-29.4* RDW-18.5* RDWSD-54.5* Plt ___ ___ 12:00AM BLOOD Neuts-59.9 ___ Monos-7.2 Eos-3.8 Baso-0.5 Im ___ AbsNeut-4.38 AbsLymp-2.06 AbsMono-0.53 AbsEos-0.28 AbsBaso-0.04 ___ 12:00AM BLOOD Plt ___ ___ 12:00AM BLOOD ___ PTT-27.0 ___ ___ 12:00AM BLOOD D-Dimer-272 ___ 04:48PM BLOOD K-4.2 ___ 12:00AM BLOOD Glucose-87 UreaN-9 Creat-0.6 Na-137 K-6.6* Cl-100 HCO3-25 AnGap-12 ___ 12:00AM BLOOD ALT-15 AST-56* AlkPhos-55 TotBili-0.3 ___ 12:00AM BLOOD Lipase-21 ___ 12:00AM BLOOD cTropnT-<0.01 ___ 12:00AM BLOOD Albumin-3.9 Calcium-9.3 Phos-4.1 Mg-1.8 ___ 12:17AM BLOOD Lactate-1.6 K-3.7 Brief Hospital Course: Ms. ___ was admitted early on ___ with abdominal pain, chest pain, and the inability to keep food down for 2 days. A CT in the ED was concerning for early appendicitis. Due to this and concern for a slipped gastric lap band, she was admitted for observation. The CT read came back negative for acute appendicitis and the upper GI study came back negative for a slipped band. The patient quickly expressed her desire for discharge and left against medical advice before the paperwork could be finalized. She received a few doses of Tylenol and one dose of oxycodone. She was otherwise medically cleared for discharge. Medications on Admission: Medications - Prescription ALBUTEROL - albuterol 90 mcg/actuation aerosol inhaler. 2 puffs inhale four times a day as needed for asthma OXYCODONE - oxycodone 5 mg tablet. 1 tablet(s) by mouth every 6 hours as needed for pain Medications - OTC DOCUSATE SODIUM [COLACE] - Colace 100 mg capsule. 1 (One) capsule(s) by mouth twice a day FERROUS SULFATE - ferrous sulfate 325 mg (65 mg iron) tablet. 1 (One) tablet(s) by mouth twice a day PRENATAL VIT-IRON FUM-FOLIC AC - prenatal vitamin-ferrous fumarate 28 mg iron-folic acid ___ mcg tablet. 1 tablet(s) by mouth daily Discharge Medications: Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever Medications - Prescription ALBUTEROL - albuterol 90 mcg/actuation aerosol inhaler. 2 puffs inhale four times a day as needed for asthma OXYCODONE - oxycodone 5 mg tablet. 1 tablet(s) by mouth every 6 hours as needed for pain Medications - OTC DOCUSATE SODIUM [COLACE] - Colace 100 mg capsule. 1 (One) capsule(s) by mouth twice a day FERROUS SULFATE - ferrous sulfate 325 mg (65 mg iron) tablet. 1 (One) tablet(s) by mouth twice a day PRENATAL VIT-IRON FUM-FOLIC AC - prenatal vitamin-ferrous fumarate 28 mg iron-folic acid ___ mcg tablet. 1 tablet(s) by mouth daily Discharge Disposition: Home Discharge Diagnosis: Abdominal pain, food intolerance Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you here at ___ ___. You were admitted to our hospital for observation due to concern over appendicitis and a possible slipped laparoscopic band. You were found to not have either of these issues. You have recovered and are now ready to be discharged to home. Please follow the recommendations below to ensure a speedy and uneventful recovery. ACTIVITY: - Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. - You may climb stairs. - You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. - You may start some light exercise when you feel comfortable. - Heavy exercise may be started after 6 weeks, but use common sense and go slowly at first. - You may resume sexual activity unless your doctor has told you otherwise. HOW YOU MAY FEEL: - You may feel weak or "washed out" for 6 weeks. You might want to nap often. Simple tasks may exhaust you. - You may have a sore throat because of a tube that was in your throat during the endoscopy. YOUR BOWELS: - Constipation is a common side effect of medicine such as Percocet or codeine. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. - If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. - After some operations, diarrhea can occur. If you get diarrhea, don't take anti-diarrhea medicines. Drink plenty of fluids and see if it goes away. If it does not go away, or is severe and you feel ill, please call your surgeon. PAIN MANAGEMENT: - Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: - Take all the medicines you were on before the operation just as you did before, unless you have been told differently. - If you have any questions about what medicine to take or not to take, please call your surgeon. Thank you for letting us care for you! Followup Instructions: ___
19798000-DS-9
19,798,000
27,868,654
DS
9
2144-10-27 00:00:00
2144-10-27 20:43:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Aspirin / Compazine / Morphine Attending: ___. Chief Complaint: Intolerance to PO, solids and liquids Major Surgical or Invasive Procedure: None History of Present Illness: ___ y/o F s/p adjustable gastric band in ___, p/w PO intolerance X 4 days. She describes eating a piece of chicken on ___ that seemed to not advance past the band. Following this she experienced epigastric fullness to solid food that progressed to both solid and liquid food over the past 4 days. These symptoms are a/w N, vomiting X >10, diarrhea X 5, NB/NB. She has had decreased PO intake over this time. She experiences epigastric pain while vomiting, that resolves after. She denies ab. pain, BRBPR, melena, fever, chills. Past Medical History: Asthma, anemia, obesity Social History: ___ Family History: Mom, with anemia. No history of gastrointestinal illnesses Physical Exam: Discharge Exam: V: 98.6, 98.2, 58, 102/59, 18, 99% RA Gen: NAD, comfortable, A and O X3 CV: RRR, no murmurs Pulm: CTAB, no wheezes Ab.: Soft, NT/ND, BS+, no rebound/guarding Ext: WWP, no calf tenderness, no lower extremity swelling Pertinent Results: ___ 03:30PM WBC-4.3 RBC-4.58 HGB-8.9* HCT-30.3* MCV-66*# MCH-19.4*# MCHC-29.3* RDW-16.8* Brief Hospital Course: The patient was evaluated in the Emergency Department by the Bariatrics Team for intolerance to solid and liquid PO. Her gastric band was unfilled and the patient felt better upon drinking water after. It was decided to admit her to advance diet slowly, for IV hydration and for an upper GI to evaluate for band prolapse. She received IV fluids throughout her hospitalization and after her upper GI on HD#1, which was unchanged from previous, she was advanced sequentially from Bariatrics Stage I through Bariatrics Stage III diets. She tolerated all without complaint, N/V. Upon discharge, her vitals were stable, she was taking adequate PO intake, she was voiding her bowels and bladder appropriately. She will follow up with Dr. ___ in 2 weeks. Medications on Admission: Albuterol PRN Ferrous sulfate MVI Discharge Medications: 1. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 2. Multivitamins 1 TAB PO DAILY Discharge Disposition: Home Discharge Diagnosis: Band obstruction Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital for monitoring after intolerance to oral food, likely due to some food stuck at your gastric band. Your band was unfilled in the Emergency Department and you were admitted overnight. All of your blood work was normal and the upper GI swallow study showed that the band was in good position. Medication: Please continue all pre-admission medications as you were before this hospital stay. Diet: Please remain on a Bariatric Stage III diet until your post-operative visit with Dr. ___ ___: As tolerated. Followup Instructions: ___
19798578-DS-33
19,798,578
20,033,975
DS
33
2141-07-29 00:00:00
2141-08-04 22:25:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Nitrate Analogues / Vancomycin Attending: ___ ___ Complaint: dyspnea on exertion Major Surgical or Invasive Procedure: none History of Present Illness: Mr. ___ is a ___ man with a history of recently-diagnosed Burkitt's lymphoma, a PTLD status post renal transplant in ___ who prsented to clinic on ___ for day #14 of his first cycle of EPOCH and was found to have bandemia and dyspnea on exertion. History is obtained from the patient as well as oncology note in ___. He reports an episode of night sweats the night before admission which soaked his sheets but denies fever or chills. He felt well until he walked down the stairs in the morning and then felt short of breath. This was not associated with any chest pain, chest tightness, associated naisea, diaphoresis, lightheadedness, or dizziness. He does endorse bilateral clavicular pain which he says is common with neupogen. He denies orthopnea, weight gain, ankle swelling, or PND. He notes a slight cough the morning of admission with some white sputum. His daughter has a sore throat, but he does not feel a sore throat, sinus pain, or rinorrhea. He has missed 2 doses of Lovenox because he was waiting to have his platelet count checked. In clinic his vitals were as follows: BP: 123/55. Heart Rate: 70. Weight: 233.4. Height: 71.5.BMI: 32.1. Temperature: 98.3. Resp. Rate: 20. Pain Score: 0. O2 Saturation%: 99. He was taken to the ER where he received Cefepime 2g IV and was transferred to the floor for further management. On arrival to the floor, he states he is feeling well. REVIEW OF SYSTEMS: Complete 10 point review of systems was preformed. All were negative except where noted above. Past Medical History: PAST MEDICAL HISTORY: 1. Coronary artery disease status post CABG in ___ and DES placed a vein graft in ___. 2. Hyperlipidemia. 3. Diabetes type 2, complicated by retinopathy and neuropathy 4. End-stage renal disease status post renal transplant in ___ 5. History of nephrolithiasis 6. DVT, ___ presumed to have PE due to symptoms of shortness of breath but no CTA was done due to his renal function. 7. Peptic ulcer disease. PAST ONCOLOGIC HISTORY: ___: Admitted to ___ due to dehydration and abdominal mass felt on physical exam. CT scan showed a large 16 cm abdominal mass involving the cecum and terminal ilium as well as extensive omental implants. - ___: colonoscopy with biopsy, which showed atypical lymphoid cells - ___: Admitted for laparoscopic omental biopsy. Pathology from this biopsy was consistent with a high-grade B-cell lymphoma consistent with Bu___'s lymphoma. Immunohistochemistry showed the tumor was CD20 positive, CD10 positive, CD21 positive and BCL6 positive. The MIB-1 proliferation index was 100%, BCL2 was negative. c-MYC fusion probe for t(8;14) was negative. The patient was transferred to the ___ service. He was treated with rasburicase for uric acid level of 15. ___: received EPOCH chemotherapy cycle #1. Social History: ___ Family History: father had CAD, stroke and Renal failure on dialysis Physical Exam: T 96.8 bp 120/70 HR 65 RR 17 SaO2 99 RA GENERAL: Alert, oriented, NAD, joking HEENT: Anicteric, mucous membranes moist; CV: Regular rate and rhythm, nl S1/S2, no murmurs, rubs or gallops PULM: Clear to auscultation bilaterally, normal effort ABD: Obese, normoactive bowel sounds, soft, non-tender, non-distended, no masses or hepatosplenomegaly LIMBS: Trace edema of the lower extremities bilaterally. Right lower extremity swelling greater than right. SKIN: No rashes or skin breakdown NEURO: no focal deficits, attention normal PSYCH: cooperative, appropriate Pertinent Results: ___ 11:24PM cTropnT-<0.01 ___ 01:55PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 01:55PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG ___ 12:49PM LACTATE-1.8 ___ 12:40PM GLUCOSE-525* UREA N-18 CREAT-1.0 SODIUM-136 POTASSIUM-4.0 CHLORIDE-107 TOTAL CO2-21* ANION GAP-12 ___ 12:40PM cTropnT-<0.01 ___ 12:40PM WBC-7.7# RBC-3.73* HGB-10.0* HCT-33.7* MCV-90 MCH-26.8* MCHC-29.7* RDW-14.8 ___ 12:40PM NEUTS-47* BANDS-17* LYMPHS-16* MONOS-12* EOS-0 BASOS-0 ___ METAS-5* MYELOS-3* ___ 12:40PM HYPOCHROM-2+ ANISOCYT-NORMAL POIKILOCY-NORMAL MACROCYT-1+ MICROCYT-NORMAL POLYCHROM-NORMAL ___ 12:40PM PLT SMR-LOW PLT COUNT-70* ___ 12:40PM ___ PTT-34.5 ___ ___ 11:30AM UREA N-20 CREAT-1.4* SODIUM-139 POTASSIUM-4.6 CHLORIDE-103 TOTAL CO2-25 ANION GAP-16 ___ 11:30AM tacroFK-6.8 ___ 11:30AM WBC-2.1* RBC-4.45* HGB-12.7* HCT-38.7* MCV-87 MCH-28.6 MCHC-32.9 RDW-13.6 ___ 11:30AM NEUTS-26* BANDS-3 LYMPHS-52* MONOS-5 EOS-3 BASOS-0 ___ MYELOS-0 OTHER-11* ___ 11:30AM PLT SMR-VERY LOW PLT COUNT-79* ___ 11:30AM ___ ___ Echo ___ The left atrium is elongated. No atrial septal defect is seen by 2D or color Doppler. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. There is mild regional left ventricular systolic dysfunction with basal inferior hypokinesis. No masses or thrombi are seen in the left ventricle. There is no ventricular septal defect. The aortic root is mildly dilated at the sinus level. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. The tricuspid valve leaflets are mildly thickened. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. . Compared with the prior study (images reviewed) of ___, no change . CXR ___: IMPRESSION: 1. No evidence of pneumonia. 2. Small left pleural effusion. EKG: normal sinus rhythm, no significant change from previous tracing . . ___ 06:15AM BLOOD WBC-12.9* RBC-4.26* Hgb-12.1* Hct-37.3* MCV-88 MCH-28.4 MCHC-32.4 RDW-14.5 Plt Ct-97* ___ 06:15AM BLOOD Hypochr-1+ Anisocy-NORMAL Poiklo-NORMAL Macrocy-OCCASIONAL Microcy-NORMAL Polychr-OCCASIONAL ___ 06:15AM BLOOD Glucose-115* UreaN-16 Creat-1.0 Na-138 K-4.5 Cl-106 HCO3-27 AnGap-10 ___ 06:15AM BLOOD ALT-22 AST-26 LD(LDH)-305* AlkPhos-109 TotBili-0.2 ___ 06:15AM BLOOD Calcium-9.0 Phos-3.7 Mg-1.8 UricAcd-8.3* . ___ Radiology LUNG SCAN IMPRESSION: Normal V-Q scan. Normal lung scan rules out recent pulmonary embolism. . ___ URINE URINE CULTURE-FINAL- no growth. . ___ BLOOD CULTURE x 2 - no growth to date. Brief Hospital Course: Mr. ___ is a ___ man with a history of renal transplant in ___ and newly diagnosed burkitt's lymphoma who presented on cycle 1, day 14 of EPOCH chemotherapy with an episode of mild cough and dyspnea on exertion. . #Dyspnea on exertion: Pt has atyical mild chest "pressure" w/ walking down the stairs, which he says was different from his prior episodes of stable angina. Significantly, he has a history of clincally diagnosed PE/DVT ___ (no CTA was done given his baseline renal insufficiency and renal transplant) and has been on treatment with enoxaparin. There is no significant historical or physical change to suggest that his cardiac function has changed from Echo preformed about 2 weeks prior to admission. MI was ruled out with unchanged ECG relative to baseline and negative troponins. Pt was started empirically on levofloxacin for atypical PNA or tracheobronchitis given normal appearance of chest film w/ only small L pleural effusion. Although he had leukocytosis this was most likely due to his use of filgrastim just prior to admission for neutropenia. He remained afrebrile throughout his stay. He had a V/Q scan done, which showed no evidence at all of a pulmonary embolism. By the evening of admission, Pt stated that he felt completely well and had no symptoms whatsoever. His ambulatory O2 saturation was 97% on room air. His is unlikely to have any a true pneumonia or bronchitis, and his antibiotics were discontinued on discharge. . # Leukocytosis - most likely due to Pt's use of filgrastim just prior to admission for neutropenia. This was discontinued given current WBC counts. . # Coronary artery disease status post CABG in ___ and DES; vein graft in ___. Pt was ruled out for MI (see above). Pt was continued on his home beta blocker and statin w/out issue. # Diabetes type 2, complicated by retinopathy and neuropathy. 70/30 insulin BID and sliding scale as per home med. #End-stage renal disease status post renal transplant in ___. Continued home tacrolimus, level appropriate at 5.9, avoid nephrotoxins. Continued home ACE-I and prophylactic bactrim w/out issue. # Peptic ulcer disease - continued home PPI Medications on Admission: ALLOPURINOL - 100 mg Tablet - 1 Tablet(s) by mouth once a day ENALAPRIL MALEATE - 5 mg Tablet - 1 Tablet(s) by mouth once a day ENOXAPARIN - 80 mg/0.8 mL Syringe - 1 Syringe(s) every twelve (12) hours INSULIN ASP PRT-INSULIN ASPART [NOVOLOG MIX 70-30] - (Prescribed by Other Provider) - 100 unit/mL (70-30) Solution - 50 units twice daily ___ [FIRST-MOUTHWASH BLM] - 400 mg-400 mg-40 mg-25 mg-200 mg/30 mL Mouthwash - 1 teaspoon four times per day as needed for mouth pain swish and spit METOCLOPRAMIDE - 10 mg Tablet - 1 Tablet(s) by mouth four times per day as needed for nausea METOPROLOL SUCCINATE - 50 mg Tablet Extended Release 24 hr - one Tablet(s) by mouth daily PRAVASTATIN - 40 mg Tablet - 1 (One) Tablet(s) by mouth once a day SULFAMETHOXAZOLE-TRIMETHOPRIM [BACTRIM DS] - 800 mg-160 mg Tablet - 1 Tablet(s) by mouth three times a week TACROLIMUS - (Dose adjustment - no new Rx) - 1 mg Capsule - 3 Capsule(s) by mouth twice a day Medications - OTC SALIVA STIMULANT AGENTS COMB.2 [BIOTENE ORALBALANCE] - Liquid - use as directed four times per day SENNOSIDES [SENNA] - 8.6 mg Tablet - 1 Tablet(s) by mouth twice a day as needed for constipation Discharge Medications: 1. allopurinol ___ mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. enalapril maleate 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. enoxaparin 80 mg/0.8 mL Syringe Sig: One (1) 80mg Subcutaneous Q12H (every 12 hours). 4. insulin asp prt-insulin aspart 100 unit/mL (70-30) Solution Sig: One (1) 50 units Subcutaneous twice a day. 5. FIRST-Mouthwash BLM 200-25-400-40 mg/30 mL Mouthwash Sig: One (1) teaspoon Mucous membrane four times a day as needed for mouth pain: swish and spit. 6. metoclopramide 10 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for nausea. 7. metoprolol succinate 50 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day. 8. sulfamethoxazole-trimethoprim 800-160 mg Tablet Sig: One (1) Tablet PO DAYS (___). 9. pravastatin 40 mg Tablet Sig: One (1) Tablet PO once a day. 10. tacrolimus 1 mg Capsule Sig: Three (3) Capsule PO Q12H (every 12 hours). 11. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation. 12. Biotene Oralbalance Liquid Sig: One (1) Mucous membrane four times a day. Discharge Disposition: Home Discharge Diagnosis: atypical chest pain Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, you were admitted to the hospital because you had shortness of breath and chest pressure. You also had some night sweats. You had a workup in the hospital, which showed that you did not have a heart attack. You also had no signs of pneumonia or other infections. You were briefly treated with antibiotics, which were not continued on discharge. You had a scan of your lungs, which showed no significant blood clot. We have not made any changes to your medications. Please continue to take them as previously prescribed. Followup Instructions: ___
19798578-DS-40
19,798,578
28,174,049
DS
40
2141-11-15 00:00:00
2141-11-15 22:59:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Nitrate Analogues / Vancomycin Attending: ___ Chief Complaint: fever, nausea, vomiting, diarrhea Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ year old male with Burkitt's lymphoma who presented to the ED on D12 of IVAC regimen with chills, dizziness and diarrhea. Mr. ___ was discharged from the hospital on ___ after an admission for his last cycle of chemotherapy (R-IVAC). Since his discharge, he has felt unwell with fatigue, nausea, and poor po intake. He has been seen frequently in the outpatient clinic for IV hydration and blood product transfusions. He presented for a scheduled visit to the ___ outpatient clinic the day prior to admission and reported profound fatigue, dyspnea on any exertion, poor po intake, nausea, and 6 watery stools the previous night with use of a diaper due to incontinence. Admission was recommended but refused. He received 1 liter IV fluid, 2 units prbc and 1 bag of platelets and went home. . The morning of admission, Mr. ___ called with a report of ongoing diarrhea, chills and dizziness. He has been on cipro during his nadir for prophylaxis. He was referred to the ED. Vitals in the ED were: 99.5 80 147/65 18 100%. He was hydrated, cultures were obtained, he was given cefepime and admitted. . On the floor on admission day, he was feeling unwell. He was chilled and wrapped in blankets. His last po intake was ___ night. He had ~12 bowel movements in the last 24 hours. There is no cramping or bleeding. The bowel movements are watery. He associates them with his recent platelet transfusions. He began Cipro on ___ for neutropenic prophylaxis. He has also experienced a cough for the last ___ days, nonproductive. He has no sick contacts. He has been taking his medication and he reports normal blood sugars. He did not have any fever or chills until the day of admission. . Past Medical History: Past Oncologic History: ___: Admitted to ___ due to dehydration and abdominal mass felt on physical exam. CT scan showed a large 16 cm abdominal mass involving the cecum and terminal ilium as well as extensive omental implants. - ___: colonoscopy with biopsy, which showed atypical lymphoid cells. - ___: Admitted for laparoscopic omental biopsy. Pathology from this biopsy was consistent with a high-grade B-cell lymphoma consistent with Burkitt's lymphoma. Immunohistochemistry showed the tumor was CD20 positive, CD10 positive, CD21 positive and BCL6 positive. The MIB-1 proliferation index was 100%, BCL2 was negative. c-MYC fusion probe for t(8;14) was negative. - ___: received EPOCH chemotherapy cycle #1. - ___: EPOCH cycle 2, rituximab given ___. - ___: EPOCH cycle 3. - ___: EPOCH cycle 4. - ___: due to disease profression chemotherapy changed to R-IVAC cycle 1 - ___: R-IVAC cycle 2 . Past Medical History: 1. Coronary artery disease status post CABG in ___ and DES placed a vein graft in ___. 2. Hyperlipidemia. 3. Diabetes type 2, complicated by retinopathy and neuropathy 4. End-stage renal disease status post renal transplant in ___ 5. History of nephrolithiasis. 6. DVT, ___ presumed to have PE due to symptoms of shortness of breath but no CTA was done due to his renal function. 7. Peptic ulcer disease. Social History: ___ Family History: Mother with colon cancer in her ___. Father with heart disease. One sister who is healthy. No family history of leukemia or lymphoma. Physical Exam: Admission physical exam: VS: 100.2 130/80 20 99% RA Gen: wrapped in blankets, well appearing HEENT: no conjuctival pallor, sclera anicterus, dry mucus membranes Neck: Supple, no LAD Chest: CTA b/l, no wheeze rale or rhonchi ___: S1S2 rrr, no rubs, soft systolic murmur Abd: Obese, soft, non-tender, bruise, no guarding or rigidity, NABS present Ext: trace pitting pedal edema, pulses +1 b/l, right amputated toe. Open wound on dorsal surface of right ___ toe. Peeling skin on feet. . Discharge physical exam: VS: Tc 98.1 Tmax 98.4 122/64 (120'-140'/60'-70') 64 (60-70') 16 100% RA Gen: NAD, sitting on chair, not dizzy HEENT: no conjuctival pallor, sclera anicterus, moist mucus membranes Neck: Supple, no LAD Chest: CTA b/l, no wheeze rale or rhonchi ___: S1S2 rrr, no rubs, soft systolic murmur Abd: Obese, soft, non-tender, no guarding or rigidity, bowel sounds present Ext: no pitting edema, pulses +1 b/l, right amputated toe. Wound on dorsal surface of right ___ toe. Peeling skin on feet. Pertinent Results: Admission labs: =============== ___ 11:35AM BLOOD WBC-0.1* RBC-2.35* Hgb-7.3* Hct-20.8* MCV-89 MCH-31.2 MCHC-35.2* RDW-15.8* Plt Ct-25* ___ 11:50AM BLOOD Neuts-1* Bands-0 Lymphs-17* Monos-67* Eos-0 Baso-1 Atyps-14* ___ Myelos-0 ___ 11:50AM BLOOD ___ PTT-30.3 ___ ___ 11:35AM BLOOD ___ Ct-20* ___ 11:50AM BLOOD Glucose-139* UreaN-12 Creat-0.8 Na-142 K-3.5 Cl-108 HCO3-21* AnGap-17 ___ 11:50AM BLOOD ALT-13 AST-17 AlkPhos-111 TotBili-1.0 ___ 11:50AM BLOOD Albumin-4.0 Calcium-9.3 Phos-2.4* Mg-1.3* ___ 11:52AM BLOOD Lactate-1.3 ___ CMV viral load not detected . Stool studies: ============== - Norovirus negative - C. difficile DNA amplification assay negative - STOOL FECAL CULTURE (Final ___: NO SALMONELLA OR SHIGELLA FOUND. NO ENTERIC GRAM NEGATIVE RODS FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. OVA + PARASITES (Final ___: NO OVA AND PARASITES SEEN. This test does not reliably detect Cryptosporidium, Cyclospora or Microsporidium. While most cases of Giardia are detected by routine O+P, the Giardia antigen test may enhance detection when organisms are rare. FECAL CULTURE - R/O VIBRIO (Final ___: NO VIBRIO FOUND. FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA FOUND. FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: NO E.COLI 0157:H7 FOUND. . Discharge labs: =============== ___ 12:10AM BLOOD WBC-7.2# RBC-2.61* Hgb-7.9* Hct-22.6* MCV-87 MCH-30.4 MCHC-35.1* RDW-15.3 Plt Ct-23* ___ 12:10AM BLOOD Neuts-82* Bands-0 Lymphs-4* Monos-14* Eos-0 Baso-0 ___ Myelos-0 ___ 12:01AM BLOOD ___ ___ ___ 12:10AM BLOOD Glucose-141* UreaN-8 Creat-0.6 Na-137 K-3.5 Cl-106 HCO3-24 AnGap-11 ___ 12:01AM BLOOD ALT-11 AST-12 LD(LDH)-151 AlkPhos-87 TotBili-0.4 ___ 12:10AM BLOOD Calcium-8.6 Phos-2.2* Mg-1.2* . Tacro trough level: =================== ___ 09:10AM BLOOD tacroFK-4.6* ___ 10:30AM BLOOD tacroFK-6.7 ___ 09:54AM BLOOD tacroFK-7.1 . Microbiology: ============= Blood cultures - pending, no growth to date Urine culture - no significant growth . Imaging: ======== ___ CXR PA and LAT FINDINGS: No focal consolidation to suggest pneumonia is seen. There may be trace pleural effusions. No pneumothorax is identified. The heart size is normal. A right-sided central venous line is unchanged with tip in mid-to-low SVC. The patient is status post median sternotomy. Brief Hospital Course: ___ year old male with PTLD/Burkitt Lymphoma, presenting with diarrhea, poor po intake and chills during a neutropenic period. His symptoms improved after his WBC count recovered and he was discharged home in stable condition. Had PET-CT scan on his discharge day and he ___ follow with Dr ___. . 1.Diarrhea: C. difficle and norovirus was negative. He required IVF's and immodium along with anti-emetic agents to help control the symptoms. He did not have abdominal pain or further fever while in the hospital. These symptoms improved and he did not require any further anti-emetic or anti-diarrheal agents. He gradually tolerated oral intake and started to eat regular meals. CMV viral load was negative. . 2.Fever/Neutropenia: only low grade fever was on admission, none afterwards. He was initially treated with cefepime and daptomycin until his counts recovered. Urine culture didn't show significant growth. Blood cultures were negative. Stool C diff and Norovirus negative. CXR didn't reveal pneumonia. . 3. Burkitt's lymphoma: was due for PET/CT and the day of admission, however given his significant diarrhea the PET-CT was postponed until his symptoms resolved. This was done just prior to his discharge. Bactrim prophylaxis was continued as inpatient. Neupogen was discontued after his ___ recovered. Acyclovir 400 mg three times a day was initiated on discharge. He ___ see Dr ___ tomorrow in the clinic. . 4. s/p Kidney transplant: tacro trough on admission was 4.6 and was up to 7.1 on discharge day. Renal team was following with us during his stay. After discussing with them, it was agreed to reduce his tacrolimus to 4 mg twice daily with repeat tacro trough level on ___ 30 min prior to his morning dose. Mr ___ understands the instructions. This can be done at outside clinic with results being faxed to Dr ___. . 5. CAD: We continued metoprolol and enalapril as inpatient. . 6. History of UE DVT: He was on Lovenox prophylaxis which is currently being held due to thrombocytopenia. . 7. Diabetes: He was on insulin sliding scale only given limited oral intake. He ___ resume his home regimen once he goes home since he is able to eat regular meals. During his stay, blood sugar ranged 150's-200's. . . ================================= Transitional issues: - Please follow up final report of PET-CT - Please follow up ___ tacro level which ___ be faxed to Dr ___ - ___ have repeat labs on ___ - Received 2nd unit of PRBC just prior to discharge - Please follow up final report of blood cultures - COnsider restarting lovenox when plt count recovers Medications on Admission: Ciprofloxacin 500 mg bid Enalapril 5 mg daily Novolog 70-30: 50 units bid Metoprolol 50 mg bid Compazine prn Bactrim DS ___ Tacrolimus 5 mg bid Neupogen Discharge Medications: 1. enalapril maleate 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Novolog Mix 70-30 100 unit/mL (70-30) Solution Sig: Fifty (50) unit Subcutaneous twice a day. 3. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 4. prochlorperazine maleate 10 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for nausea. 5. sulfamethoxazole-trimethoprim 800-160 mg Tablet Sig: One (1) Tablet PO MWF (___). 6. tacrolimus 1 mg Capsule Sig: Four (4) Capsule PO Q12H (every 12 hours). 7. acyclovir 400 mg Tablet Sig: One (1) Tablet PO three times a day. Disp:*90 Tablet(s)* Refills:*2* 8. Outpatient Lab Work please check your tacrolimus level 30 min prior to your morning dose on ___ and fax results to ___. Thanks. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary diagnoses: PTLD/burkitt's lymphoma Acute Gastroenteritis Diabetes type 2 History of upper extremity DVT Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr ___, It was a great pleasure taking care of you again at ___. As you know you were admitted because of fever, chills, nausea, vomiting and frequent loose stools. We think this was a viral process that resolved in a few days while we provided you support through IV fluids, anti-vomiting and anti-diarrheal medications. Your C diff and CMV were negative. Initially you were given broad spectrum antibiotics however given no source identified and no more fever except one on admission, these were stopped. You remained without fever for 24 hour after discontinuing the antibiotics. During your stay, you tolerated oral intake without nausea and vomiting. You required only 1 tablets of immodium to help you control your bowel movements. You did not have further watery stools. You received 2 bags of red cells and 1 bag of platelet during your stay. The 2nd bag of red cells was just before leaving the floor. You had PET-CT scan prior to discharge. It was initially postponed due to your acute illness from which you recovered. We made the following changes in your medication list: - Please STOP neupogen injections since your ANC greatly improved - Please STOP lovenox injections since your platelet count is low - Please STOP ciprofloxacin - Please REDUCE Tacrolimus to from 5 mg twice daily to 4 mg twice daily - Please START acyclovir 400 mg three times daily Please continue the rest of your medications the way you were taking them at home prior to admission. Please check your tacro trough level 30 min prior to your morning dose on ___ with the prescription provided to you and have the lab fax the results to Dr ___ office at ___. Please follow with your appointments as illustrated below. Followup Instructions: ___
19798835-DS-17
19,798,835
28,689,781
DS
17
2159-12-19 00:00:00
2159-12-22 07:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: lisinopril / Influenza Virus Vaccines Attending: ___. Chief Complaint: episodes of facial twitching Major Surgical or Invasive Procedure: EEG History of Present Illness: ___ yr with HTN who presented to the ED with 5 episodes of 10 sec left ___ twitching with associated difficulty speaking while twitching. Neurology was consulted for concerns about TIA. Patient is a poor historian despite her 2 daughters translating and an interpreter. She describes episodes of a feeling that her whole left lower face is deviating or getting pulled to the right side with difficulty speaking during the event. these episodes occur only during sleep. last episode occurred today during afternoon nap for which her son brought her in. She could not give a duration of frequency but said they happen every time she goes to sleep. She denies associated pain, numbness in her face. No drooling , no associated vision loss, numbness or weakness anywhere and no twitching or jerky movements in any of her extremities. . She is awake and aware during these episodes and denies post-event confusion. No recent illnesses or falls. Past Medical History: DIABETES TYPE II HYPERLIPIDEMIA HYPERTENSION OSTEOPOROSIS KNEE PAIN GASTROESOPHAGEAL REFLUX CONSTIPATION TRICUSPID REGURGITATION H/O HELICOBACTER PYLORI H/O PPD POSITIVE H/O RENAL CYST H/O HEPATIC CYST Social History: Country of Origin: ___ Marital status: Widowed Children: Yes: 3 sons, 2 dtrs Lives with: Children Lives in: House Work: ___ Multiple partners: ___ ___ activity: Past Sexual orientation: Male Sexual Abuse: Denies Domestic violence: Denies Tobacco use: Never smoker Alcohol use: Denies Recreational drugs Denies (marijuana, heroin, crack pills or other): Family History: Relative Status Age Problem Comments Mother ___ ___ ASTHMA Father ___ ___ HEALTHY Aunt Deceased DIABETES MELLITUS maternal Uncle Deceased DIABETES MELLITUS maternal Physical Exam: ADMISSION PHYSICAL EXAMINATION: Physical Exam: Vitals: temp 97.8, HR 67, BP 165/84, RR 18, 98% RA. General: awake, cooperative, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: supple, no nuchal rigidity Pulmonary: breathing comfortably on room air Cardiac: RRR, nl Abdomen: soft, NT/ND Extremities: warm, well perfused Skin: no rashes or lesions noted Neurologic: -Mental Status: Alert, oriented x 3. limited given language barrier. poor historian . Attentive, able to name ___ backward without difficulty. Language is fluent per daughters. Pt was able to name both high and low frequency objects. Speech was not dysarthric. Able to follow both midline and appendicular commands. There was no evidence of neglect. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2mm and brisk. EOMI without nystagmus. Normal saccades. VFF to confrontation. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 5 5 5 5 5 5 5 R 5 ___ ___ 5 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense, proprioception throughout. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 1 R 2 2 2 2 1 Plantar response was flexor bilaterally. -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF or HKS bilaterally. -Gait: deferred DISCHARGE PHYSICAL EXAMINATION: Stable, unchanged, stable gait Pertinent Results: Hematology COMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW RDWSD Plt Ct ___ 05:40AM 8.0 4.27 12.9 38.6 90 30.2 33.4 14.4 47.1* 220 Import Result ___ 05:15AM 8.1 4.37 12.7 39.5 90 29.1 32.2 14.2 46.4* 208 Import Result ___ 05:45AM 6.9 4.08 12.2 37.3 91 29.9 32.7 14.4 47.8* 215 Import Result ___ 05:57PM 9.7 4.13 12.4 37.7 91 30.0 32.9 14.2 47.1* 222 Import Result DIFFERENTIAL Neuts Bands Lymphs Monos Eos Baso Atyps Metas Im ___ AbsLymp AbsMono AbsEos AbsBaso ___ 05:57PM 38.8 50.2 8.1 2.0 0.5 0.4 3.76 4.86* 0.78 0.19 0.05 Import Result RED CELL MORPHOLOGY Hypochr Anisocy Poiklo Macrocy Microcy Polychr ___ 05:57PM NORMAL OCCASIONAL NORMAL OCCASIONAL NORMAL OCCASIONAL Import Result BASIC COAGULATION ___, PTT, PLT, INR) ___ PTT Plt Smr Plt Ct ___ ___ 05:40AM 220 Import Result ___ 05:40AM 12.0 37.3* 1.1 Import Result ___ 05:15AM 208 Import Result ___ 05:45AM 215 Import Result ___ 05:57PM NORMAL 222 Import Result Chemistry RENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap ___ 05:40AM 113* 21* 0.9 138 3.5 100 25 17 Import Result ___ 05:15AM 113* 20 0.8 139 3.9 ___ Import Result ___ 05:45AM 110* 21* 0.8 139 3.7 ___ Import Result ___ 05:57PM 96 17 1.1 136 5.1 100 26 15 Import Result ESTIMATED GFR (MDRD CALCULATION) estGFR ___ 05:57PM Using this Import Result ENZYMES & BILIRUBIN ALT AST LD(LDH) CK(CPK) AlkPhos Amylase TotBili DirBili ___ 05:57PM 57* 71 0.4 Import Result OTHER ENZYMES & BILIRUBINS Lipase ___ 05:57PM 34 Import Result CHEMISTRY TotProt Albumin Globuln Calcium Phos Mg UricAcd Iron ___ 05:40AM 10.0 3.7 1.9 Import Result ___ 05:15AM 9.7 3.7 2.0 Import Result ___ 05:45AM 9.8 3.5 2.0 Import Result ___ 05:57PM 4.0 9.6 3.5 1.9 Import Result DIABETES MONITORING %HbA1c eAG ___ 06:39PM 6.1* 128* Import Result PITUITARY TSH ___ 05:57PM 1.6 Import Result LAB USE ONLY GreenHd ___ 05:57PM HOLD Import Result IMAGING: MRI BRAIN: 1. No evidence of infarction, hemorrhage, mass, or abnormal enhancement. 2. Mild diffuse parenchymal volume loss with mild probable chronic small vessel ischemic disease. 3. Question of vascular ectasia versus aneurysm or vascular infundibulum of the right carotid terminus, as described above. Recommend CTA or MRA to further assess. Brief Hospital Course: Ms. ___ is a healthy ___ woman with a past medical history of htn, hyperlipidemia who presented with complaints of paroxysmal head turning to the left only while sleeping. These events have been going on for a few months and have been occurring a few times per week. Otherwise, the patient as feeling well. Seizure was at the top of the differential, and her neurologic examination was unremarkable. The patient was connected to EEG where one of these events was captured on video EEG. No eeg correlate to suggest epileptiform activity, however on video it seemed to look like a focal motor seizure which may be too deep down to have been picked up on eeg. Next, MRI brain with and without contrast was done to evaluate for any enhancement, strokes, or structural lesions to explain her symptoms, however the MRI only showed small vessel disease and some mild atrophy, but no other significant findings. An LP was also done which was bland, however viral studies and autoimmune/paraneoplastic studies were sent. A trial of keppra 750 mg BID was started to see if this would help stop her symptoms at night. The patient tolerated this medication well. An MRA of the head and neck was lastly conducted to rule out any aneurysms or vessel abnormalities and was read ?of aneurysm of ICA at the level of the clinoid. We arranged for neurosurgical/vascular follow up with Dr. ___ ___ to review this and monitor the small aneurysm (incidental finding) The patient's exam remained stable and she was discharged home on keppra 750mg BID and an appointment to follow up with Neurology in ___. Transitions of care issues: 1. Please take all of your home medications as prescribed 2. Please take your new anti seizure medication called Keppra at 750mg twice a day 3. Please follow up with us in Neurology on ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY Discharge Medications: 1. LevETIRAcetam 750 mg PO Q12H 2. Atorvastatin 40 mg PO QPM 3. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY Discharge Disposition: Home Discharge Diagnosis: Focal motor seizure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the Neurology service as you were having these strange episodes of face and head pulling to the left while you are sleeping. You were connected to EEG and one of these episodes were captured on EEG (measures brainwaves), but no clear abnormalities were seen with this test. You next underwent MRI brain which also did not show any structural lesions to cause these symptoms. Lastly, you had a lumbar puncture which tests your spinal fluid for any signs of inflammation or infection to cause this, which thankfully was normal. We feel that you are having focal motor seizures that cause you to be pulled to the left. We started you on a new medication called Keppra at 750mg twice daily. Please continue to take this medication. You will follow with us in Neurology. You were discharged safely to home. We wish you the best! Sincerely, Your ___ Neurology Team Followup Instructions: ___
19799379-DS-18
19,799,379
22,177,074
DS
18
2130-05-13 00:00:00
2130-05-13 11:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Syncope and lightheadedness Major Surgical or Invasive Procedure: left cephalic dual chamber pacemaker placement, ___ Scientific History of Present Illness: This is a ___ year old male patient who had a syncopal episode in the past week. He did not incur any injury, flew home from ___ and had several episodes of lightheadedness thereafter. He was seen in urgent care following weakness and unsteadiness in the grocery store and found to have changes in his ECG. He has a noted right bundle branch block, left anterior hemiblock and prolonged AV block. He was admitted through the ED for further workup and insertion of pacemaker. Past Medical History: Alcoholism, HTN, Depression, Hyperlipidemia, elevated LFTs in past, L MCA punctate infarcts in L MCA territory. Social History: ___ Family History: Father - stroke. mother - pacemaker. Physical Exam: On the day of discharge, physical exam is as follows: SUBJECTIVE: This is a ___ year old male with a history of RBBB and LAFB with recent syncopal episode now s/p pacemaker insertion. Tolerating PO diet and voiding without difficulty. Neuro workup was negative, head CT unremarkable. OBJECTIVE: VS: T 98.1 HR 81 RR 18 BP 126/76 97% RA Tele: HR 80's, occ. rare PVC General: Age appropriate, NAD Neck/JVD: no JVD, no carotid bruit CV: RRR, no M/R/G LUNGS: CTAB ABD: soft, non-tender, +BS Extr: feet warm, no edema Anterior chest ___ insertion site gauze, Tegaderm c/d/I, no erythema, excess warmth, drainage or hematoma noted, FROM wrist, hand, elbow digits, elevates to shoulder height, understands restrictions Neuro: Grossly N/V/I moves all extremities well CXR: Reviewed by Fellow, leads in good placement, no acute process CAROTID U/S: Read pending LABS: Na2+ 136; K+ 3.8; Cl- 97; HCO3 28; BUN 15; Cr 1.0 Assessment/Plan: This is a ___ year old male with recent PMH for syncope, RBBB and LAFB now s/p insertion of pacemaker, doing well. # Syncope, RBBB, LAFB s/p Pacemaker insertion - ABX x 3 Days escripted to his pharmacy - f/u device one week - f/u Dr ___ ___ weeks # HTN - clinically stable - cont dyazide # History of stroke - clinically stable - Carotid U/S imaging updated - read pending - Continue ASA, good BP control Dispo: Full Code DC Home Today Pertinent Results: ___ 10:22AM GLUCOSE-96 UREA N-12 CREAT-0.8 SODIUM-137 POTASSIUM-3.8 CHLORIDE-99 TOTAL CO2-23 ANION GAP-19 ___ 10:22AM cTropnT-<0.01 ___ 10:22AM WBC-5.3 RBC-4.77 HGB-14.5 HCT-43.0 MCV-90 MCH-30.4 MCHC-33.7 RDW-12.8 RDWSD-42.4 ___ 10:22AM NEUTS-62.7 ___ MONOS-7.4 EOS-2.5 BASOS-0.6 IM ___ AbsNeut-3.33 AbsLymp-1.40 AbsMono-0.39 AbsEos-0.13 AbsBaso-0.03 ___ 10:22AM PLT COUNT-268 ___ 05:01PM GLUCOSE-105* UREA N-14 CREAT-1.1 SODIUM-134 POTASSIUM-3.5 CHLORIDE-97 TOTAL CO2-26 ANION GAP-15 ___ 05:01PM estGFR-Using this ___ 05:01PM cTropnT-<0.01 ___ 05:01PM WBC-6.5 RBC-4.56* HGB-14.3 HCT-40.7 MCV-89 MCH-31.4 MCHC-35.1 RDW-12.7 RDWSD-41.5 ___ 05:01PM NEUTS-61 BANDS-0 ___ MONOS-2* EOS-5 BASOS-0 ___ MYELOS-0 AbsNeut-3.97 AbsLymp-2.08 AbsMono-0.13* AbsEos-0.33 AbsBaso-0.00* ___ 05:01PM HYPOCHROM-OCCASIONAL ANISOCYT-OCCASIONAL POIKILOCY-NORMAL MACROCYT-NORMAL MICROCYT-OCCASIONAL POLYCHROM-NORMAL ___ 05:01PM PLT SMR-NORMAL PLT COUNT-246 ___ 05:01PM ___ PTT-37.0* ___ Brief Hospital Course: The patient was assessed in the ED by both Cardiology and Neurology. ECG revealed sinus rhythm 64 bpm with prolonged AV Conduction, right bundle-branch block, left anterior hemiblock and subsequent ECG frequent VPBs. His syncopal episodes and paroxysm of light-headedness were concerning for underlying conduction system disease. Pacemaker was recommended, he was consulted by the Electrophysiology team who recommended placement of a pacemaker. Additionally, because of his history of CVA, he was seen and evaluated by Neurology. A head CT was performed and was negative for any acute infarction or hemorrhage. Ventricles and sulci were normal in size and configuration. Neurology recommended an updated carotid ultrasound as one had not been done for several years for comparison, results of which are pending at the time of discharge. It was felt that the patient's symptoms were cardiac in nature and the patient elected to proceed with pacemaker insertion, understanding risks and benefits. There were no intraoperative complications, the patient tolerated the procedure well and was placed on IV antibiotics while in house with a plan for three days oral antibiotics at discharge. His surgical wound remained well approximated, with no signs of erythema, excess warmth, drainage or hematoma. Surgical dressing consisted of gauze and Tegaderm which will remain intact for 72 hours. A chest X-Ray was performed prior to discharge showing good lead placement and no acute process. The device was interrogated and was operating appropriately. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Clindamycin 1% Solution 1 Appl TP DAILY prn 2. Pravastatin 40 mg PO QPM 3. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY 4. Aspirin 325 mg PO DAILY Discharge Medications: 1. Aspirin 325 mg PO DAILY 2. Pravastatin 40 mg PO QPM 3. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY 4. Clindamycin 1% Solution 1 Appl TP DAILY prn 5. Cephalexin 500 mg PO Q6H Duration: 2 Days Discharge Disposition: Home Discharge Diagnosis: syncope, right bundle branch block, left anterior fascicular block s/p insertion of pacemaker Discharge Condition: Stable Discharge Instructions: It was a pleasure caring for you at ___. You were admitted after passing out and having episodes of light headedness and was found to have an abnormal heart rhythm. A pacemaker was placed and you will need to take antibiotics for two days after the procedure and come back to have the pacer checked in the device clinic in one week. Please see d/c instructions for activity precautions for the next 6 weeks. A neurologist evaluated you in the emergency room and did not feel that you had a stroke. The head CT scan was unchanged and the carotid ultrasound results are currently pending. Your symptoms were cardiogenic in nature and a pacemaker was successfully inserted. Ensure you follow up with your PCP and stroke provider on a regular basis as scheduled. Followup Instructions: ___
19799440-DS-9
19,799,440
20,039,952
DS
9
2141-02-08 00:00:00
2141-02-08 15:06:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Abdominal pain x 1 week Major Surgical or Invasive Procedure: none History of Present Illness: ___ woman with hypertension and asthma and one prior episode of diverticulitis in ___ who presented with 1 week of lower abdominal pain. She states she was in her usual state of health until ___ when she began to have watery loose stool. This was followed by an episode of sweating and some chills. She did not check her temperature but wonders if she might have had a fever. 2 days later she then began to have crampy lower abdominal pain that became increasingly severe. The pain was the worst in the left and right lower quadrants and was not associated with eating. She then noticed that she was getting constipated and that trying to have a bowel movement was extremely painful. Given that pain was worsening she called her primary care doctor who recommended going to the emergency room for evaluation. She denies any sick contacts, endorses nausea but no vomiting. Of note she had one serious episode of diverticulitis in ___ when they thought she might need surgical intervention. She was admitted to the hospital at that time and had several days of IV antibiotics and eventually improved without surgery. She states she had a colonoscopy in ___ that was per report normal. Past Medical History: - Hypertension - Asthma - Obesity Social History: ___ Family History: Aunt with colon cancer at age ___. Father's PMH is unknown, her mother has HTN and high cholesterol. Siblings have no significant medical problems. No family history of strokes or MIs. Physical Exam: Admission Exam VS: ___ Temp: 98.0 PO BP: 133/89 HR: 65 RR: 20 O2 sat: 94% O2 delivery: 2L NC General Appearance: pleasant, comfortable, no acute distress Eyes: PERLL, EOMI, no conjuctival injection, anicteric ENT: no sinus tenderness, MMM, oropharynx without exudate or lesions Respiratory: CTA b/l with good air movement throughout Cardiovascular: RR, S1 and S2 wnl, no murmurs, rubs or gallops Gastrointestinal: nd, +b/s, soft, tender in the right and left lower quadrants no rebound no guarding extremities: no cyanosis, clubbing or edema Skin: warm, no rashes/no jaundice/no skin ulcerations noted Neurological: Alert, oriented to self, time, date, reason for hospitalization. Cn II-XII intact. ___ strength throughout. Psychiatric: pleasant, appropriate affect GU: no catheter in place Pertinent Results: Admission Labs ___ 10:35AM BLOOD WBC-7.1 RBC-4.99 Hgb-15.4 Hct-48.6* MCV-97 MCH-30.9 MCHC-31.7* RDW-14.6 RDWSD-52.3* Plt ___ ___ 10:35AM BLOOD Glucose-85 UreaN-15 Creat-0.6 Na-142 K-4.2 Cl-101 HCO3-26 AnGap-15 ___ 10:35AM BLOOD ALT-27 AST-23 AlkPhos-65 TotBili-0.4 ___ 10:35AM BLOOD Albumin-4.2 CT A/P 1. Subtle stranding adjacent to a sigmoid diverticulum, suggestive of mild uncomplicated sigmoid diverticulitis. 2. Interval decrease in size of 2 left adnexal cysts, measuring up to 2.5 cm on current exam, previously measuring up to 3.1 cm. Discharge Labs: Brief Hospital Course: ___ woman with hypertension and asthma and one prior episode of diverticulitis in ___ presents with 1 week of lower abdominal pain found to have diverticulitis. . Acute problems: #Diverticulitis Uncomplicated diverticulitis based on CT A/P. This was treated with oxycodone and cipro/flagyl. #Oxygen requirement Noted to be placed on 2 L of oxygen from the emergency room breathing comfortably, likely due to splinting in the setting of severe abdominal pain. Oxygen requirement resolved the next day #Asthma We continued home albuterol #Hypertension We continued home lisinopril and amlodipine Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO DAILY 2. amLODIPine 5 mg PO DAILY 3. Ibuprofen 400 mg PO Q8H:PRN Pain - Mild 4. albuterol sulfate 90 mcg/actuation inhalation Q4H:PRN wheezing Discharge Disposition: Home Discharge Diagnosis: Diverticulitis Discharge Condition: Stable Discharge Instructions: You were admitted to the hospital with diverticulitis. We treated you with pain and nausea medications and started you on two antibiotics called cipro and flagyl which we would like you to take after leaving the hospital. Followup Instructions: ___
19799506-DS-9
19,799,506
26,501,243
DS
9
2132-12-10 00:00:00
2132-12-11 17:11:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Motor vehicle collision Major Surgical or Invasive Procedure: None History of Present Illness: ___ M status post motor vehicle collision, restrained driver, + head strike, no LOC. Complained of nausea, vomiting, neck pain and spine tenderness on arrival. GCS 15. Past Medical History: Platelet disorder Social History: ___ Family History: Non contributory Physical Exam: Gen: VS: T:96.8 HR: 78 BP: 114/98 RR:17 Sat: 98% on room air HEENT: PEERL. Neck: supple. MIld tenderndess on cervical spine. Cardiac: RRR, normal S1,S2 Respiratory: clear Abdomen: NT, ND. Extremities: DP++ b/l. No edema Pertinent Results: ___ 05:15PM COMMENTS-GREEN TOP ___ 05:15PM GLUCOSE-83 LACTATE-1.0 NA+-141 K+-3.9 CL--100 TCO2-26 ___ 05:06PM UREA N-11 CREAT-1.0 ___ 05:06PM estGFR-Using this ___ 05:06PM ALT(SGPT)-15 AST(SGOT)-22 ALK PHOS-107 TOT BILI-1.0 ___ 05:06PM LIPASE-226* ___ 05:06PM LIPASE-226* ___ 05:06PM ALBUMIN-5.5* ___ 05:06PM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 05:06PM WBC-10.4# RBC-4.81 HGB-15.6 HCT-43.9 MCV-91 MCH-32.4* MCHC-35.4* RDW-12.6 ___ 05:06PM PLT COUNT-137* ___ 05:06PM ___ PTT-34.6 ___ ___ 05:06PM ___ ___ ___ ___ ___ Radiology Report MR CERVICAL SPINE W/O CONTRAST Study Date of ___ 10:25 AM ___ CC6A ___ 10:25 AM MR CERVICAL SPINE W/O CONTRAST Clip # ___ Reason: Please r/o ligamentous injuries UNDERLYING MEDICAL CONDITION: ___ h/o platelet d/o s/p MVC, restrained driver, + head strike, - LOC, c/o nausea, neck pain, T-spine pain. Imaging normal, lipase elevated (226). REASON FOR THIS EXAMINATION: Please r/o ligamentous injuries CONTRAINDICATIONS FOR IV CONTRAST: None. Final Report EXAMINATION: MRI OF THE CERVICAL SPINE INDICATION: ___ h/o platelet d/o s/p MVC, restrained driver, + head strike, - LOC, c/o nausea, neck pain, T-spine pain. Imaging normal, lipase elevated (226). // Please r/o ligamentous injuries TECHNIQUE: T1, T2 and inversion recovery sagittal and gradient sequence T2 axial images of cervical spine obtained. COMPARISON: CT of ___. FINDINGS: There is no evidence of acute bony or ligamentous injury identified. No evidence of ligamentous disruption seen. No evidence of spinal cord compression or intraspinal hematoma. No abnormal signal seen within the spinal cord. Mild degenerative disc disease is seen from C3-4 through the C5-6 levels. Linear hyperintensity adjacent to the left upper esophagus appears to be slightly prominent lymphatic duct, an incidental finding. IMPRESSION: Mild degenerative changes. No evidence of bony or ligamentous injury EXAMINATION: CT HEAD W/O CONTRAST INDICATION: ___ headache, nausea, vomiting after motor vehicle collision TECHNIQUE: Routine unenhanced head CT was performed and viewed in brain, intermediate and bone windows. Coronal and sagittal reformats were also performed. DOSE: DLP: 891.93 mGy-cm CTDI: 48.28 mGy COMPARISON: None. FINDINGS: There is no acute intracranial hemorrhage,acute infarction, mass or midline shift. There is no hydrocephalus. Visualized paranasal sinuses and mastoid air cells are clear. There is no fracture. EXAMINATION: CT C-SPINE W/O CONTRAST INDICATION: ___ post motor vehicle collision. TECHNIQUE: Contiguous axial images were obtained. Sagittal and coronal reformatted images were generated. No contrast was administered. CTDIvol: 768.18 mGy DLP: 36.85 mGy-cm COMPARISON: None FINDINGS: Alignment of the cervical vertebral bodies is normal without subluxation. No fractures are identified. There is no evidence of spinal canal or neural foraminal narrowing. No prevertebral soft tissue swelling is present. The visualized soft tissues are unremarkable. Visualized lung apices are clear. IMPRESSION: No acute fracture or traumatic malalignment. INDICATION: ___ with nausea and vomiting after motor vehicle collision TECHNIQUE: MDCT axial images were acquired through abdomen and pelvis following intravenous contrast administration with split bolus technique. Coronal and sagittal reformations were performed and submitted to PACS for review. No oral contrast was administered. DOSE: DLP: 1043.56 mGy-cm (abdomen and pelvis. COMPARISON: None. FINDINGS: CHEST: The thyroid is unremarkable. Prominent thymic tissue is noted. The heart and great vessels are unremarkable. There is no mediastinal, hilar, axillary, or supraclavicular lymphadenopathy. The central airways remain patent. There is no pulmonary parenchymal abnormality. Mild bibasilar atelectasis is present. There is no pleural effusion or pneumothorax. ABDOMEN: HEPATOBILIARY: The liver demonstrates homogenous attenuation throughout. There is no evidence of focal lesions. There is no evidence of intrahepatic or extrahepatic biliary dilatation. The gallbladder is within normal limits, without stones or gallbladder wall thickening. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions or pancreatic ductal dilatation. There is no peripancreatic stranding. SPLEEN: The spleen shows normal size and attenuation throughout, without evidence of focal lesions. ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: The kidneys are of normal and symmetric size with normal nephrogram. There is no evidence of stones, focal renal lesions or hydronephrosis. There are no urothelial lesions in the kidneys or ureters. There is no perinephric abnormality. GASTROINTESTINAL: Small bowel loops demonstrate normal caliber, wall thickness and enhancement throughout. Colon and rectum are within normal limits. Appendix contains air, has normal caliber without evidence of fat stranding. RETROPERITONEUM: There is no evidence of retroperitoneal and mesenteric lymphadenopathy. VASCULAR: There is no abdominal aortic aneurysm. There is no calcium burden in the abdominal aorta and great abdominal arteries. PELVIS: The urinary bladder and distal ureters are unremarkable. There is no evidence of pelvic or inguinal lymphadenopathy. There is no free fluid in the pelvis. REPRODUCTIVE ORGANS: Reproductive organs are within normal limits BONES AND SOFT TISSUES: There is no evidence of worrisome lesions. Abdominal and pelvic wall is within normal limits. IMPRESSION: No evidence of acute abnormality in the chest, abdomen, or pelvis. The study and the report were reviewed by the staff radiologist. Brief Hospital Course: The patient presented to Emergency Department on ___ after being on a motor vehicle collision. He was evaluated by the Acute Care Service on arrival. Primary and secondary survey did not reveal any acute life threating lesion. Given complains of headache, nausea, vomiting and spine tenderness, the patient underwent CT head/spine and torso which demonstrated no acute fractures or organ lesions. Due to persistent pain on his cervical spine he underwent a MRI to rule out ligamentous injuries, which were none. His c-collar was cleared without any complication. Tertiary survey was completed with no new lesions. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. GI/GU/FEN: The diet was advanced sequentially to a Regular diet, which was well tolerated. Patient's intake and output were closely monitored ID: The patient's fever curves were closely watched for signs of infection, of which there were none. HEME: The patient's blood counts were closely watched for signs of bleeding, of which there were none. Prophylaxis: The patient received subcutaneous heparin and ___ dyne boots were used during this stay and was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. The patient was tolerating a diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan Medications on Admission: 1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB/wheezing Discharge Medications: 1. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN migraine RX *butalbital-acetaminophen-caff 50 mg-325 mg-40 mg 1 capsule(s) by mouth Q6-8H Disp #*30 Capsule Refills:*0 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB/wheezing 3. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*20 Capsule Refills:*0 4. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain RX *hydromorphone [Dilaudid] 2 mg 1 tablet(s) by mouth every four (4) hours Disp #*30 Tablet Refills:*0 5. Fluconazole 100 mg PO Q24H RX *fluconazole [Diflucan] 100 mg 1 tablet(s) by mouth daily Disp #*16 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Motor vehicle collision Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Followup Instructions: ___
19799964-DS-18
19,799,964
21,550,227
DS
18
2144-04-22 00:00:00
2144-04-23 12:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: ___ Major Surgical or Invasive Procedure: ___ EGD History of Present Illness: Mr. ___ is a ___ with hx of systolic heart failure (last EF 45-50% from ___, low of 20% in the past, ICD in place), CAD s/p DES to LAD ___, EtOH abuse, obesity, afib on warfarin, HTN, HLD, RCC s/p cryoablation gallstones, initially presented to ___ on ___ for melena. Notably, pt was just discharged on ___ after admission for cholangitis s/p ERCP and stent revision. Pt was in ___ for planned cardiac cath on ___ (DES x2 placed to mid-LAD and started clopidogrel) when he was found to be jaundiced. ERCP revealed distal CBD stricture as well as gastritis/duodenitis, and a plastic stent was placed. Viral hepatitis work-up and autoimmune labs were negative, as were smooth muscle Ab, AMA, ___, and IgG subclasses. Biliary stent was removed and replaced ___ at ___, with second stent removed on ___ ___ at ___. He was again admitted to ___ on ___ after presenting w/ jaundice and dark urine. Further workup included CT abd/pelvis noted "New intrahepatic and extrahepatic biliary ductal dilatation as compared to ___.. Possible filling defect common duct. Several small, new low attenuation lesions with the liver, very concerning for metastatic disease. Abnormal appearing gallbladder demonstrating new areas of enhancement, with possible associated cystic enhancing mass." Case was reviewed with ERCP at ___, and decision was made to transfer to ___ given concern for new malignancy, antiplatelet therapy, and medical complexity.At time of arrival to ___, pt reported that he was informed that there may be an infection in the gallbladder. He denied abdominal pain, SOB, chest pain, and noted continued dark urine and lighter colored stools. He underwent ERCP on ___ w/ stent placement notable for copious pus. He was then placed on a 2 week course of cipro/flagyl (day 1 = ___ and discharged on ___. Later in the afternoon of ___, pt said he had a "darker" brown stool but didn't think much of it. Earlier today, he noticed his stool had become dark and tarry. He also said after getting up to leave the bathroom that he felt a little lightheaded but denied any syncope or fall. Also denies any abdominal pain, n/v or prior history of GI bleed. He went to ___ this morning and was found to have H/H 10.2/30.4, INR 1.5, and ___ 17.7. He was hypotensive and was given 2 Units of PRBC and 10mg Vit K. BP improved w/ pRBCs. He was transferred to ___ for further evaluation of his GIB. In the ED, vitals were as follows: Temp: 97.5 HR: 80 BP: 95/54 Resp: 18 O(2)Sat: 100 Normal DRE revealed melena. Started on protonix drip and labs drawn. Notable for H/H 10.8/31.6, bicarb 21, BUN 32, and Cr 1.5. GI was consulted. On arrival to the MICU, he is hemodynamically stable w/ HR in ___ and BP of 100s/50s. He denies any abdominal pain or n/v and is AAOx3. Denies any prior hx of GIB. Review of systems: Negative other than above. Past Medical History: CAD s/p DES to the LAD ___ sCHF, most recent EF 45-50% (s/p ICD for prior EF of 20%) Alcohol abuse Atrial fibrillation on Coumadin (no h/o CVA) CKD stage III (found in d/c summary from ___ HTN Hyperlipidemia RCC s/p ablation - around ___ h/o gallstones s/p left knee arthoscopy Social History: ___ Family History: Per OMR, confirmed with patient: Father died from lung CA (heavy smoker), mother died from endocarditis. Physical Exam: ADMISSION EXAM: ================= Vitals: T 97.3, HR 92, BP 114/61, RR 15, SaO2 99% RA GENERAL: NAD, mildly jaundiced HEENT: Scleral icterus, clear oropharynx, PERRL LUNGS: CTAB CV: RRR, no murmur ABD: Obese, soft, NTND EXT: Warm, well-perfused, 2+ peripheral pulses NEURO: A&O x3 DISCHARGE EXAM: ================= Pertinent Results: ADMISSION LABS: ================= ___ 02:00PM BLOOD WBC-14.1* RBC-3.37* Hgb-10.8* Hct-31.6* MCV-94 MCH-32.0 MCHC-34.2 RDW-17.8* RDWSD-58.4* Plt ___ ___ 02:00PM BLOOD Neuts-78* Bands-2 Lymphs-8* Monos-9 Eos-1 Baso-1 ___ Metas-1* Myelos-0 AbsNeut-11.28* AbsLymp-1.13* AbsMono-1.27* AbsEos-0.14 AbsBaso-0.14* ___ 07:20PM BLOOD ___ PTT-33.0 ___ ___ 02:00PM BLOOD Glucose-123* UreaN-32* Creat-1.5* Na-134 K-4.3 Cl-97 HCO3-21* AnGap-20 ___ 02:00PM BLOOD ALT-100* AST-105* AlkPhos-516* TotBili-5.2* DISCHARGE LABS: ================= IMAGING: ========= None Brief Hospital Course: ___ with h/o CAD s/p ___, EtOH abuse, biliary strictures s/p ERCP x 3 with stents and recent cholangitis on cipro/flagyl, now with melena x 1 day on ___ with ICU stay with resolving Hgb/SBP without intervention tx to floors given further workup of possible GI bleeding and biliary involvement. #GI Bleeding: Unclear etiology, possible small bowel vs colon. Now with EGD showing normal gastric/duodenal studies with mild bleeding from the ampulla. Low concern for varices, ___ tears, or ulcers given EGD. Less likely very lower GI bleed given melena without hematochezia. Pt was continued on protonix BID (initially protonix drip). Pt's Upper GI study showed mild oozing at ampulla which could be probable source of melena. ERCP on ___ involved a sphincterotomy (in the setting of continued Plavix/aspirin intake), lithotripsy of cystic duct obstructing stone, and removal of prior stent. #Liver lesions: Concerning for mets vs related to cholangitis on prior CT image. Pt needs to be ruled out for colon cancer in setting of this GIB, some weight loss but possible related to stopping etOH. Last colonoscopy per patient was ___ years ago which was notable for benign polyps. Pt had a triple-phase CT image study (given that his ICD made him ineligible for MR studies) which showed resolution of the previously seen liver lesions and interval development of another lesion, suggesting possible infectious etiology (see below). Pt also had stable LFTs at time of discharge and will require a colonoscopy outpatient. #Cholangitis: Pt had a recent admission for cholangitis diagnosed by pus on ERCp. Pt never endorsed fevers chills, abdominal pain, negative ___. Pt was continued on cipro/flagyl and will continue these medications through ___. Repeat CT scan on ___ showed possible gallbladder perforation with very small adjacent fluid collection. Patient appeared well clinically and was tolerating PO. Surgery was consulted and felt he should have repeat CT imaging in several weeks and if the fluid collection is walled off, he should have percutaneous cholecystostomy to drain it. #Afib with RVR and aberrancy. CHADsVasc is 3. CHF + HTN + Age Pt conintued on home on digoxin, Metoprolol; Plavix and aspirin. No warfarin in the setting of GI bleeding while hospitalized but pt can continue this after discharge. It was deemed not necessary to bridge the pt whiel inpatient. #CAD s/p DES: Pt with known history. Pt will continue aspirin, Plavix outpatient. Pt will restart home warfarin dose outpatient. TRANSITIONAL ============= - Pt should continue cipro/flagyl through ___ - Pt will need a colonoscopy outpatient. - Pt will restart home warfarin starting ___. - Pt requires surgery followup on ___ and interval CT imaging for management of gallbladder perforation and fluid collection. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Clopidogrel 75 mg PO DAILY 3. Digoxin 0.125 mg PO DAILY 4. Furosemide 40 mg PO DAILY 5. Spironolactone 25 mg PO DAILY 6. Warfarin 5 mg PO 4X/WEEK (___) 7. Warfarin 2.5 mg PO 3X/WEEK (___) 8. Lisinopril 5 mg PO DAILY 9. Metoprolol Succinate XL 200 mg PO DAILY 10. Ciprofloxacin HCl 500 mg PO Q12H 11. MetroNIDAZOLE 500 mg PO Q8H Discharge Medications: 1. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 2. Senna 8.6 mg PO BID:PRN constipation RX *sennosides [senna] 8.6 mg 1 tab by mouth twice a day Disp #*60 Tablet Refills:*0 3. Aspirin 81 mg PO DAILY 4. Ciprofloxacin HCl 500 mg PO Q12H 5. Clopidogrel 75 mg PO DAILY 6. Digoxin 0.125 mg PO DAILY 7. Furosemide 40 mg PO DAILY 8. Lisinopril 5 mg PO DAILY 9. Metoprolol Succinate XL 200 mg PO DAILY 10. MetroNIDAZOLE 500 mg PO Q8H 11. Spironolactone 25 mg PO DAILY 12. Warfarin 5 mg PO 4X/WEEK (___) 13. Warfarin 2.5 mg PO 3X/WEEK (___) 14.Outpatient Lab Work Please check CBC on ___ ICD 10: ___.1 Results should be faxed to: ___. ___ ___ Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: cystic duct obstruction (probable Mirizzi's syndrome) SECONDARY DIAGNOSES: liver lesions cholangitis Atrial fibrillation with RVR and aberrancy coronary artery diseases s/p drug-eluting stent Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, You were admitted for your black stools and biliary duct obstruction. With a scope we were able to remove the stent in the biliary tract and open the sphincter, dissolving the stone obstructing the tract. After your procedure, you were stable with no signs of gastrointestinal bleeding. We found a possible hole in your gallbladder wall with some surrounding pus, so you will need to see our surgeons on ___ to have another CT scan and discuss whether you need a procedure to drain the pus. Please restart your warfarin on ___. It was a pleasure taking care of you. Your ___ Team Followup Instructions: ___
19800188-DS-28
19,800,188
23,723,446
DS
28
2133-04-21 00:00:00
2133-04-21 23:47:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: lisinopril / Bactrim / Keflex Attending: ___. Chief Complaint: weakness, muscle aches, gait instability Major Surgical or Invasive Procedure: none History of Present Illness: HISTORY OF PRESENT ILLNESS: ___ female with IV heroine use, endocarditis, hepatitis C, recent admission for ___ Syndrome presenting with weakness and unsteady gait. Pt herself is unable to give detailed history. She states that she has been falling at home and feeling shaky on her feet. She reports having used crack cocaine and IV heroine yesterday. Denies LOC or head trauma. Per ED report, pt was sent in by son who was concerned that she has been weak and unable to walk. She was seen by her PCP ___ for low grade temps (99-100), tachycardia, DOE and crackles at bases of lungs. PCP was concerned about infectious process and ordered CXR and ___ (given prior hx of endocarditis) but pt did not undergo these studies. . Pt had recent complicated hospital admission ___. She had previously been on methadone for her hx of IV heroine use but used IV heroine prior to her 75th birthday and developed cellulitis at site of injection at RUE. She was seen at the ED and prescribed bactrim and keflex and subsequently developed a desquamating rash consistent with ___. She was followed by dermatology service and provided with supportive care including IV hydration and wound care. Her cellulitis was treated with vancomycin. She developed abdominal pain and was noted to have elevated lipase 2795; MRI abdomen was consistent with chronic pancreatitis and she was also treated supportively. Hospital course was further complicated by acute kidney injury (baseline Cr 1.0 rising to 1.6) for which she was seen by renal team who found no significant findings on urine sediment and advised supportive care. She was discharged to rehab for further care. At rehab, A1c was 6.4 and she was started on Januvia and Lantus which her PCP subsequently discontinued. . In the ED, initial VS: 95.8 116 134/76 16 96%RA. Labs significant for K 3.2, Mg 1.5, Phos 1.8; serum tox negative. She received 40meq potassium chloride po and 1 packet neutra-phos prior to transfer. . REVIEW OF SYSTEMS: Reports shortness of breath Denies fever, chills, headache, vision changes, rhinorrhea, congestion, sore throat, cough, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. . Past Medical History: MEDICAL & SURGICAL HISTORY: - Eosinophilia - Followed by primary care physician. In ___, had chest CT which showed "centrilobular nodules and ___ nodular appearance in both lungs favor a bronchiolitis, infectious and/or inflammatory in nature." Per PCP notes, patient is supposed to have a repeat CT chest to follow-up. SPEP and UPEP also to be sent. - Hepatitis C - Distant history of lumbar osteomyelitis - Polysubstance abuse, previously on methadone - Anxiety - Depression - Hypertension - History of endocarditis - Chronic bronchitis - ___ - Chronic pancreatitis Social History: ___ Family History: Noncontributory Physical Exam: Admission PHYSICAL EXAM: VS - 97.8 152/98 93 18 100%RA GENERAL - Mildly fatigued but answering questions appropriately, NAD HEENT - PERRL, EOMI, sclerae anicteric, dry MM, OP clear NECK - Supple, no thyromegaly, no JVD HEART - PMI non-displaced, RRR, nl S1-S2, no MRG LUNGS - bibasilar crackles, good air movement, mildly tachypneic, no accessory muscle use ABDOMEN - NABS, soft/NT/ND, no masses or HSM EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses, no lumbar spine tenderness SKIN - LUE with chronic scar tissue from previous surgery LYMPH - no cervical LAD NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout DISCHARGE PHYSICAL EXAM VS: 98.0, BP 117/74, HR 86, RR 20, sat 97% on RA GEN: A & O X3, NAD HEENT: PERRL, MMM, OP clear, conjunctiva non-injected NECK: supple, JVP flat, no LAD HEART: RRR, good S1, S2, no m/r/g LUNG: CTA ___ ABD: soft, NT/ND, no HSM, +BS EXT: Tender on palpation over right shoulder, limited ROM, tender on palpation over bilateral thigh Pertinent Results: ___ 08:54PM TYPE-ART TEMP-36.8 PO2-76* PCO2-57* PH-7.31* TOTAL CO2-30 BASE XS-0 INTUBATED-NOT INTUBA COMMENTS-O2 DELIVER ___ 06:29PM PO2-88 PCO2-58* PH-7.32* TOTAL CO2-31* BASE XS-1 ___ 06:15PM GLUCOSE-111* UREA N-12 CREAT-1.1 SODIUM-144 POTASSIUM-3.2* CHLORIDE-110* TOTAL CO2-26 ANION GAP-11 ___ 06:15PM estGFR-Using this ___ 06:15PM CALCIUM-8.6 PHOSPHATE-1.8* MAGNESIUM-1.5* ___ 06:15PM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 06:15PM WBC-7.6 RBC-3.35* HGB-10.5* HCT-31.2* MCV-93 MCH-31.2 MCHC-33.5 RDW-14.2 ___ 06:15PM NEUTS-76.5* LYMPHS-17.3* MONOS-3.1 EOS-2.7 BASOS-0.4 ___ 06:15PM PLT COUNT-258 ___ 06:15PM ___ PTT-29.0 ___ ___ 05:55AM BLOOD WBC-5.3 RBC-3.43* Hgb-10.9* Hct-32.4* MCV-94 MCH-31.7 MCHC-33.6 RDW-14.2 Plt ___ ___ 05:15PM BLOOD ESR-37* ___ 05:15PM BLOOD CRP-1.8 ___ 10:00AM BLOOD Calcium-9.0 Phos-3.0 Mg-2.1 ___ 10:00AM BLOOD CK(CPK)-414* ___ 05:29AM URINE Color-Straw Appear-Clear Sp ___ ___ 05:29AM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-SM ___ 05:29AM URINE RBC-0 WBC-6* Bacteri-FEW Yeast-NONE ___ Urine culture mixed flora ___ BLood cultures x 2 - no growth to date ___ RadiologyCHEST (PA & LAT) FINDINGS: PA and lateral views of the chest are compared to previous exam from ___. Left-sided PICC is no longer seen. Lungs are essentially clear noting minimal left basilar opacity compatible with atelectasis on the frontal view. Costophrenic angles are sharp. Cardiomediastinal silhouette is normal, as are the osseous and soft tissue structures. IMPRESSION: No acute cardiopulmonary process. ___ CardiovascularECHO The left atrium is normal in size. Left ventricular wall thicknesses are normal. The left ventricular cavity size is normal. Overall left ventricular systolic function is low normal (LVEF 50%). Right ventricular chamber size and free wall motion are normal. There are focal calcifications in the aortic arch. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Mild to moderate (___) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. No definite vegetations seen but CANNOT be excluded on ther basis of this technically suboptimal study. IMPRESSION: Suboptimal image quality. Consider TEE if the clinical suspicion for endocarditis is high Brief Hospital Course: ___ female with IV heroin use, endocarditis, hepatitis C, recent admission for ___ Syndrome presenting with unsteady gait and delirium. # gait instability: Ms. ___ likely has a multifactorial gait disorder. With further history she reports feeling unsteady upon standing up and then requires a moment to level out before she feels comfortable on her feet again suggesting there is an orthostatic componenet to her unsteadiness. She has LLE weakness that she reports she has had since her endocarditis/osteomyelitis which likely also contributes to her unsteadiness. Suspect that her gait instability was due to a combination of dehydration and electrolyte changes from her diarrhea (see below), baseline weakness, and pharmacological effects of mixing heroin and cocaine with her prescription medications, including quetiapine and citalopram. Pt had a negative infectious workup including chest XR and ___, and was treated with IV fluids and repleted for magnesium and phosphate. Her quetiapine and citalopram were held the evening of admission but restarted w/out issue the following day. She has responded well to her supportive treatment and was seen twice by ___, who felt she was safe to go home. # mental status changes: Pt was reported altered in the ED. Suspect this was due to crack cocaine and heroin effect synergizing w/ quetiapine and citalopram. Could also have been exacerbated by Pt's electrolyte abnormalities (see above). Pt improved w/ electrolyte repleting and IV fluids. Social work was consulted to help w/ Pt's continued substance abuse. Pt was back to baseline prior to discharge. # Bilateral thign pain: Likely related with cocaine use, no evidence of compartment syndrome. CK elevated at 414 from baseline of ___, but improving. Renal function normal. ___ felt Pt was ready to go home after two sessions as inpatient. # Low grade fevers: It seems unlikely Ms. ___ currently has an underlying infectious process. She has been afebrile with a normal white count since entering the hospital. UA was unremarkable, blood and urine cultures are pending. However, given her history of IV drug use, low grade fevers, and concern of PCP, ___, which was not an optimal study but showed no evidence of endocarditis. Pt's ESR is at baseline in ___ and CRP normal at 1.7. Blood cultures showed no growth to date. # Diarrhea: Pt complained of occasional watery diarrhea for the past 2 months, seems to be worse with milk products. Have counseled Pt to avoid milk products for the next ___ weeks and monitor her BMs. If diarrhea continues, would consider further workup. # HTN: continued home dilt # ?Diabetes: Ms. ___ blood glucose was normal during hospitalization. # Depression: restarted home citalopram and quetiapine after return to baseline mental status # HCV: Currently normal LFT's. # anemia: chronic, at baseline. Transitional issues: -drug abuse counseling / prevention -follow up blood culture final results -consider lactose breath testing or further workup of diarrhea if symptoms continue Medications on Admission: 1. brimonidine 0.15 % Drops Sig: One (1) Drop Ophthalmic BID (2 times a day): apply to both eyes. 2. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. diltiazem HCl 180 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day. 4. insulin glargine 100 unit/mL Solution Sig: Ten (10) units Subcutaneous at bedtime: 10 units or as directed at 9pm daily. 5. omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. 6. promethazine 12.5 mg Tablet Sig: One (1) Tablet PO at bedtime as needed for insomnia. 7. quetiapine 200 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO QHS (once a day (at bedtime)). 8. timolol maleate 0.5 % Drops Sig: One (1) Drop Ophthalmic BID (2 times a day). Discharge Medications: 1. brimonidine 0.15 % Drops Sig: One (1) Drop Ophthalmic BID (2 times a day): apply to both eyes. 2. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. diltiazem HCl 180 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day. 4. insulin glargine 100 unit/mL Solution Sig: Ten (10) units Subcutaneous at bedtime: 10 units or as directed at 9pm daily. 5. omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. 6. promethazine 12.5 mg Tablet Sig: One (1) Tablet PO at bedtime as needed for insomnia. 7. quetiapine 200 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO QHS (once a day (at bedtime)). 8. timolol maleate 0.5 % Drops Sig: One (1) Drop Ophthalmic BID (2 times a day). Discharge Disposition: Home With Service Facility: ___ Discharge ___: Primary diagnosis: dehydration heroin and cocaine intoxication Secondary diagnoses: - Eosinophilia - Hepatitis C - Distant history of lumbar osteomyelitis - Polysubstance abuse, previously on methadone - Anxiety - Depression - Hypertension - History of endocarditis - Chronic bronchitis - history ___ - Chronic pancreatitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Ms. ___, You came to the hospital because you were unsteady on your feet and felt weak. You recently had some cocaine and heroin and also had some diarrhea. We feel that the most likely explanation of your symptoms is a combination of dehydration and electrolyte abnormalities in your blood caused by your diarrhea, and an interaction between the heroin, cocaine, and your prescription medications. Your symptoms resolved on their own after we gave you IV fluids and replaced some of your blood salts. You were seen by our physical therapists, who felt that you were safe to go home. You also had an ultrasound of your heart (echocardiogram), which your primary care physician, ___. ___ you needed to rule out an infection of your heart valves given your recent low fevers. Your heart study did not show any sign of infection. You were also seen by our social workers to help you enroll in programs to stop your drug use. From your description of your symptoms, your diarrhea may be related to lactose intolerance. Please avoid milk and diary products for the next ___ weeks and monitor your bowel movements. Please let Dr. ___ if you continue to have diarrhea. We also found that there was evidence of mild muscle damage which likely happened in the setting of cocaine use and may explain your thigh pain. After going home, please make sure that you are well hydrated. We have not made any changes to your medications. Please continue to take them as previously prescribed. Followup Instructions: ___
19800206-DS-16
19,800,206
23,637,191
DS
16
2166-07-11 00:00:00
2166-07-13 21:19:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Presyncope Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ woman with a history of right cerebellar hemangioblastoma s/p resection in ___, hypercholesterolemia, prior Lyme infection, and treatment 2 months ago for presumed (not serologic) anaplasmosis. She was recently admitted for myalgias, transaminitis, and atrial tachycardia and represented with presyncope tonight. Patient was discharged on ___ after presenting with myalgias, transaminitis, and atrial tachycardia. Myalgias and transaminitis were thought to be due to her statin, which was stopped. She was also noted to have ectopic atrial tacyhcardia, which was asymptomatic and felt to be unrelated to presenting symptoms. She was seen by EP, who advised Holter monitor with outpatient follow-up. Since discharge, she reports myalgias have come and gone. They might be somewhat better than before hospitalization, but are still bothersome. She has had ongoing bifrontal HA, which has been present and unchanged since mid ___. She had one episode of swelling of her L middle finger, associated with a "nodule" that resolved spontaneously. She has had some intermittent pain in R elbow but no other joint pain. Of note, patient was treated for presumptive anaplasmosis with a 3-week course of doxycycline in ___. PCP reports that ___ Lyme IgM returned positive, suggesting recent infection. Ehrlichiosis titers negative, babesosis titers indeterminate. On the evening of presentation, patient was doing some tasks around the house around 9:30 pm when she began to feel lightheaded, as if she was going to faint. She called for her son-in-law. She also felt warm, nauseous, had darkening of her vision. She denies palpiatations, CP, SOB, fall, LOC, or headstrike. She has not had recent fevers, chills, GI upset, or other symptoms. In the ED initial vitals were: 99.1 117 ___ 100% room air. EKG showed ectopic atrial tachycardia @ 115. Labs showed unremarkable CBC and chem-10, BNP 42, trop negative x 1, negative UA. Patient was given full dose aspirin and 1L NS. Vitals prior to transfer were: 110 104/71 19 98% RA. On the floor, patient feels well but is concerned about what heart rhythm she may have been in at the time of her presyncope. She has not had recent known tick bites or rashes. Review of Systems: (+) per HPI (-) fever, chills, night sweats, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: - two prior episodes of lyme infection, one with erythema migrans - hypercholesterolemia - right cerebellar hemangioblastoma s/p resection in ___ Social History: ___ Family History: breast cancer in sister, no family hx autoimmune, rheumatologic disease. Mother had hyperthyroidism Physical Exam: Admission Exam: Vitals 98.3 106/71 116 96 RA GENERAL: Well-appearing, NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, good dentition NECK: nontender supple neck, no LAD, no JVD CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing or edema. No swelling, erythema, induration, or other deformity of L middle finger. L elbow is mildly warm but non-tender and patient ranges it passively with no pain. PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact SKIN: warm and well perfused, no excoriations or lesions, no rashes Discharge Exam: Vitals 98.3 106/71 116 96 RA Telemetry: ST, HR 105-112 GENERAL: Well-appearing, NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, good dentition NECK: nontender, able to touch chin to chest put complains of stiffness, however she has full ROM. no LAD, no JVD CARDIAC: Tachycardic, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing or edema. No swelling, erythema, induration. PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: Admission Labs: ___ 12:15AM PLT COUNT-188 ___ 12:15AM NEUTS-65.6 ___ MONOS-4.4 EOS-2.6 BASOS-1.0 ___ 12:15AM WBC-10.0# RBC-4.91 HGB-14.5 HCT-42.2 MCV-86 MCH-29.4 MCHC-34.3 RDW-13.5 ___ 12:15AM CALCIUM-8.4 PHOSPHATE-3.3 MAGNESIUM-2.1 ___ 12:15AM proBNP-42 ___ 12:15AM cTropnT-<0.01 ___ 12:15AM ALT(SGPT)-96* AST(SGOT)-63* ALK PHOS-114* TOT BILI-0.3 ___ 12:15AM estGFR-Using this ___ 12:15AM GLUCOSE-144* UREA N-18 CREAT-0.8 SODIUM-136 POTASSIUM-4.1 CHLORIDE-97 TOTAL CO2-28 ANION GAP-15 ___ 01:20AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 01:20AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 01:20AM URINE GR HOLD-HOLD ___ 01:20AM URINE UHOLD-HOLD ___ 04:48AM PLT COUNT-171 ___ 04:48AM WBC-6.9 RBC-4.41 HGB-13.2 HCT-38.2 MCV-87 MCH-29.8 MCHC-34.4 RDW-14.0 ___ 04:48AM WBC-6.9 RBC-4.41 HGB-13.2 HCT-38.2 MCV-87 MCH-29.8 MCHC-34.4 RDW-14.0 ___ 04:48AM IgG-648* IgM-195 ___ 04:48AM ALT(SGPT)-78* AST(SGOT)-48* ALK PHOS-96 TOT BILI-0.3 ___ 04:48AM ALT(SGPT)-78* AST(SGOT)-48* ALK PHOS-96 TOT BILI-0.3 ___ 04:48AM GLUCOSE-119* UREA N-14 CREAT-0.7 SODIUM-139 POTASSIUM-4.1 CHLORIDE-106 TOTAL CO2-26 ANION GAP-11 ECGStudy Date of ___ 11:47:34 ___ Ectopic atrial rhythm. Compared to the previous tracing of ___ no change. Portable TTE (Complete) Done ___ The left atrium is normal in size. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF = 60%). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. There is mild posterior leaflet mitral valve prolapse. Mild (1+) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. Compared with the prior study (images reviewed) of ___, the findings are similar. CHEST (PA & LAT)Study Date of ___ IMPRESSION: No acute cardiopulmonary process. ABDOMEN US (COMPLETE STUDY)Study Date of ___ IMPRESSION: Normal study. Brief Hospital Course: Ms. ___ is a ___ woman with a history of cerebellar hemangioblastoma s/p resection, anxiety, concern for ___ illness with +Lyme IgM ___ and recent admission for myalgias and transaminitis, attributed to her statin. She was also found to have an asymptomatic ectopic atrial tachycardia. She was placed on a Holter monitor on ___. The evening after the placement of the Holter monitor, she presented with presyncope. # Presyncope: On admission the patient was monitored with continuous telemetry and her Holter monitor was interrogated. She was found to have paroxysmal supraventricular tachycardia that was most likely atrial tachycardia with rates that were mostly under 100. There were no alarming events during her episode of presyncope. Review of her EKGs did not show any prolonged PR interval. She had an echochardiogram which was normal. Her associated symptoms were most closely consisted with vasovagal syncope. She remained hemodynamically stable with heart rates in the low 100s during hospitalization. # Myalgias: The patient was admitted with complaints of myalgias. On her previous admission she was found to have a transaminitis which was attributed to her statin. During this admission her ALT/AST were 78 and 48, decreased since ___. Because of her mild transaminitis she had an abdominal ultrasound which was normal. ___ and anti-sooth antibody labs were drawn and were pending at time of discharge. # Depression: The patient was continued on home citalopram. TRANSITIONAL ISSUES -Follow up with PCP within one week -Follow up with cardiology on ___ -Statin was held during hospitalization due to myalgias; consider working up myalgias in outpatient setting -Will need to follow up on ___ and Anti-smooth antibody labs Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO EVERY OTHER DAY 2. Calcium Carbonate 600 mg PO DAILY 3. Citalopram 20 mg PO DAILY 4. Multivitamins 1 TAB PO DAILY Discharge Medications: 1. Aspirin 81 mg PO EVERY OTHER DAY 2. Calcium Carbonate 600 mg PO DAILY 3. Citalopram 20 mg PO DAILY 4. Multivitamins 1 TAB PO DAILY 5. Ibuprofen 400 mg PO Q8H:PRN pain Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: Presyncope Secondary diagnoses: History of Lyme's infection Hypercholesterolemia Right cerebellar hemangioblastoma s/p resection in ___ Depression Anxiety Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the ___ because you almost lost consciousness. There were concerns that you were having an abnormal heart rhythm. Your heart monitor was evaluated, and it was determined that you were not having a worrisome heart rhythm that caused your symptoms. You need to follow-up with your PCP, ___ further management. It was a pleasure caring for you, and we are glad that you have started to feel better. Take care! Your ___ Team Followup Instructions: ___
19800320-DS-9
19,800,320
27,810,286
DS
9
2185-05-09 00:00:00
2185-05-10 19:45:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: hyperglycemia Major Surgical or Invasive Procedure: None History of Present Illness: ___ with PMH of dementia, diabetes (on insulin with prior hospitalizations for DKA), CKD, HTN, HLD presents with hyperglycemia discovered today by ___. Pt reports forgetting to take his insulin. He does not know how many doses he missed. Today, his ___ came to check his sugars and vitals, and he was found to be hyperglycemic to 600s. She told him to go to the ED. Of note, he lives alone and has ___ services ___ times per week. He reports feeling no symptoms, including weakness and dizziness which he normally gets with hyperglycmia/hypoglycemia. Pt denies all pain, denies excessive urination, denies exesive thirst, denies n/v/d, denies fever or chills. Pt is oriented per baseline, transported to BID w/o incident. Per ___ notes, his BG has been poorly controlled lately at home. ___ reports sugars in 300s-500s. Pt forgets to take insulin and forgets to take sugars. He does not comply with diabetic diet. In the ED, initial vital signs were T 97.9 P 63 BP 119/60 R 17 O2 sat 100% on RA. Labs were notable for BG 715, K of 7.1. Patient was given 1L LR, 1L NS, 10 units regular insulin, insulin drip was initiated at 8 units per hour. His repeat labs showed BG 364 and K 4.9. Insulin drip was d/c'd. He received his ___ dose of SQ insulin. Vitals on Transfer were 97.9, 62, 18, 100% RA. On the floor, the pt continues to deny any cp, sob, dizziness, lightheadedness, n/v/d. Does endorse some constipation. No abd pain. He notes numbness in his hands and feet. ROS: (+) as per HPI (-) polyuria, polydipsia, HA, vision changes. Past Medical History: Type 2 DM for ___ years- Insulin dependent. Last HbA1c is 8.5% in ___. Hypertension Hyperlipidemia CKD Stage 3 Diabetic nephropathy. Hypothyroidism Dementia Social History: ___ Family History: father died of lung CA, denies known DM or CAD Physical Exam: Admission physical exam: Vitals- 97.7, 144/66, 67, 18, 100RA General- Alert, oriented x2, no acute distress HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, motor function grossly normal Skin - onychomycosis Discharge physical exam: VS - 98.3, 119/55, 70, 18, 100RA General- Alert, oriented x2, no acute distress HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, motor function grossly normal Skin - onychomycosis Pertinent Results: Admission labs: ___ 11:35AM BLOOD WBC-5.1 RBC-4.35* Hgb-13.0* Hct-39.5* MCV-91 MCH-30.0 MCHC-33.0 RDW-13.0 Plt ___ ___ 11:35AM BLOOD Glucose-715* UreaN-74* Creat-3.8* Na-124* K-7.1* Cl-91* HCO3-20* AnGap-20 ___ 08:25AM BLOOD Calcium-9.4 Phos-4.2 Mg-2.2 ___ 11:48AM BLOOD Lactate-1.3 K-6.7* ___ 04:24PM BLOOD K-4.9 Pertinent labs: ___ HgbA1c 17.1 Discharge labs: ___ 07:45AM BLOOD WBC-6.0 RBC-3.74* Hgb-11.5* Hct-33.5* MCV-90 MCH-30.7 MCHC-34.2 RDW-13.6 Plt ___ ___ 07:45AM BLOOD Glucose-103* UreaN-73* Creat-3.4* Na-137 K-4.6 Cl-109* HCO3-18* AnGap-15 Pertinent micro: ___ 2:22 am URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: <10,000 organisms/ml. Blood cultures pending X2 Brief Hospital Course: ___ with PMH of poorly controoled DM2, diabetic neuropathy/nephropathy/retinopathy, HTN, HLD, dementia presents with hyperglycemia in the setting of poor home insulin regimen compliance. #Hyperglycemia: Likely due to poor compliance with home diabetes regimen, which can be attributed to pt's memory loss. He came in with BG 715, Na of 125, K of 7.1, Cr of 3.8, HCO3 of 20, lactate 1.3, and negative urine ketones. All labs improved with administration of insulin and IVF. Not consistent with DKA. Off insulin drip and put on home regimen with sliding scale. FSBG were in the 100s-300s from that point on. We consulted ___, who felt that he was on an appropriate basal insulin regimen given his baseline of sugars in the 300s-500s. The pt has been admitted multiple times, including an ICU stay, for this issue. He reports simply forgetting to take the insulin and denies having an aversion to taking. An attempt was made to send the pt to an assisted living facility or nursing home, however he was very resistant. Despite his memory loss, he was felt to have capacity. We were unable to contact his HCP, his daughter, who may have provided more insight into the issue. We tried to set him up with the PACE program, which provides nursing home-level care from home, but were told this has to be done as an outpatient. It was felt that the pt would be safe to leave the hospital and follow up with his PCP at ___ in 2 days to then be set up with PACE. He was given his evening dose of insulin and sent home to have a nurse visit him in the morning. We recommend occupational therapy for the pt to assist him in ways to remember taking his medicines. ___ on CKD: Fluid losses due to dehydration vs worsening of present CKD. CKD Stage 4 - Diabetic nephropathy. Not on HD. Baseline Cr about 2.8. Cr improved slightly from admission but remained somewhat elevated above baseline, even with 3L IVF. He had good urine output with no signs of retention. We did not feel further workup was necessary as an inpatient. The pt will follow with ___ and his PCP for further ___. Once his Cr stabilizes, we recommend adding on an ___ to his regimen. #Hyponatremia: Dehydration plus uncorrected for hyperglycemia. Improved with IVF. Hypertension: Continued home metoprolol and lisinopril. CAD prevention with daily ___. T2DM: Poorly controlled. BG has been 300s-500s at home per prior notes. Last A1c 17.2 in ___. Management as above. Continued gabapentin for diabetic neuropathy. Hyperlipidemia: Continued home statin. Hypothyroidism: Last TSH wnl. Continued home levothyroxine. Dementia: Etiology ___. Possibly early onset Alzheimer's vs vascular dementia, although pt has no known hx of stroke. Chronic decline per ___ notes. He remained at baseline throughout his stay. CAD: On Plavix for NSTEMI at outside hospital. Glaucoma: Continued dorzolamide/timolol eye drops. Vit D deficiency: Continued home supplement. Transitional Issues: #Pending blood cultures #Outpatient OT to help with medication training #Add ___ to diabetes regimen #Dementia workup Medications on Admission: Unable to obtain information regarding preadmission medication at this time. Information was obtained from ___. 1. AndroGel *NF* (testosterone) 1 %(50 mg/5 gram) Transdermal daily 2. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 3. Humalog ___ 40 Units Breakfast Humalog ___ 40 Units Bedtime 4. Lovastatin *NF* 80 mg ORAL DAILY 5. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 6. Levothyroxine Sodium 75 mcg PO DAILY 7. Docusate Sodium 100 mg PO BID 8. Senna 1 TAB PO BID:PRN constipation hold for loose stool 9. Aspirin 81 mg PO DAILY 10. Gabapentin 300 mg PO BID 11. Metoprolol Succinate XL 100 mg PO DAILY 12. Clopidogrel 75 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Clopidogrel 75 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 5. Gabapentin 300 mg PO BID 6. Humalog ___ 45 Units Breakfast Humalog ___ 40 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 7. Levothyroxine Sodium 75 mcg PO DAILY 8. Senna 1 TAB PO BID:PRN constipation hold for loose stool 9. Vitamin D 50,000 UNIT PO 1X/WEEK (___) 10. AndroGel *NF* (testosterone) 1 %(50 mg/5 gram) Transdermal daily 11. Lovastatin *NF* 80 mg ORAL DAILY 12. Metoprolol Succinate XL 100 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary diagnoses: 1. Hyperglycemia 2. Type 2 diabetes mellitus 3. Chronic kidney disease Secondary diagnoses: 1. Hypertension 2. Hypercholesterolemia Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to ___ for high blood sugars and abnormal potassium and sodium levels. You were given IV fluids and insulin, and your blood sugars came down. We now feel it is safe for you to leave the hospital. We did not make any changes to your medications. PLEASE REMEMBER TO TAKE YOUR INSULIN EVERY DAY IN THE MORNING AND AT NIGHT. Please follow up with your PCP at the appointment made below. A visiting nurse ___ come to see you tomorrow morning to help you with your medications. Followup Instructions: ___
19800337-DS-3
19,800,337
21,535,326
DS
3
2168-09-23 00:00:00
2168-10-03 13:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: OTOLARYNGOLOGY Allergies: Penicillins / Levofloxacin Attending: ___. Chief Complaint: R Neck swelling/tenderness/redness, pain with swallowing Major Surgical or Invasive Procedure: ___ Right neck lymph node excisional biopsy. History of Present Illness: The patient is a ___ yo F who underwent LN excision on the right level II with Dr. ___ 2 days ago. She was doing well at home but over the past 24hrs has developed worsening dysphagia and erythema of the neck. She presented to ___ this AM for evaluation. Past Medical History: hx of pneumonia Social History: ___ Family History: Her mother had colon cancer, and her daughter had a brain tumor. There is also a history of hearing loss, and migraines. Physical Exam: V: 98 76 133/76 16 96% Gen: NAD, lying comfortably in bed HEENT: EOM intact, PERRLA, b/l auricles without inflammation or lesions. Neck: R sided erythema superior and inferior to incision extends to submentum. Tender to palpation. No crepitus, no drainage from incision site, with full ROM. ___: RRR no murmors on exam RESP: CTAB Neuro: CN VII, XI, XII intact FOE: Right pyriform/lateral pharyngeal wall with mild but improved edema and includes the lateral pharyngeal wall. The posterior cricoid has minimal edema, right AE fold is still mildly edematous, with no obstructive of the glottic introitus. The cords are bilaterally visualized and mobile. Pertinent Results: ___ 01:09PM BLOOD WBC-8.8 RBC-4.60 Hgb-13.1 Hct-38.7 MCV-84 MCH-28.4 MCHC-33.8 RDW-13.9 Plt ___ Brief Hospital Course: This is a ___ yo F who underwent right level II lymph node dissection on ___. She was doing well at home but two days later she developed worsening dysphagia and erythema of the neck. She presented to ___ after 24 hours of these symptoms (morning of ___ for evaluation. She was readmitted that day for IV antibiotics. She was started on Levo/clinda but was switched to cipro/clinda due to what appeared to be an allergic rash to the Levofloxacin. A CT scan of her neck revealed Post-surgical changes right upper neck with foci of air and fat stranding most pronounced between the sternocleidomastoid muscle and the submandibular gland and extending medially to the parapharyngeal space with mild narrowing of the hypopharyngeal airways. There appeared to be no vascular injury and no abscess formation, and no evidence of a prevertebral or retropharyngeal abscess. She remained afebrile and her condition improved on IV antibiotics over the next three days, with reduction of aryepiglottic fold edema on FOE exam and improvement of her R neck swelling/erythema. She was discharged on po Bactrim and Kelex on ___ in stable condition, and a follow up Dr. ___ was planned for the next week. Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN pain 2. OxycoDONE Liquid ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg/5 mL ___ ml by mouth every four hours Disp #*250 Milliliter Refills:*0 3. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 10 Days Take one tablet twice a day for 10 days 4. Cephalexin 500 mg PO Q12H Duration: 10 Days Take one tablet twice a day for 10 days. Discharge Disposition: Home Discharge Diagnosis: -R Neck cellulitis -R Neck hematoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: -Continue to slowly increase po intake as tolerated -Please take Bactrim and Keflex daily as prescribed for ten days. -No heavy lifting or strenuous activity for at least one week -Return to the clinic for follow up with Dr. ___ in ___ days Followup Instructions: ___
19800649-DS-2
19,800,649
25,623,386
DS
2
2175-07-09 00:00:00
2175-07-09 16:09:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Iodine Attending: ___. Chief Complaint: Skin lesions, fever Major Surgical or Invasive Procedure: None History of Present Illness: ___ with h/o bipolar disorder, CKD, neurogenic bladder, HTN who presents with several months of skin lesions. Patient reports that approximately 3 months ago, he first noticed a multiple isolated lesions on his legs, arms, and trunk that he thought were bedbug bites. These were pruritic and became even more itchy when scratched. He denies exposure to sick contacts, outdoors, new detergents. He went to his dermatologist who took a biopsy and diagnosed with him contact dermatitis. He was referred to an allergist, but was unable to be tesed ___ active rash. His dermatologist prescribed steroids which helped the pruritus but caused him to break out into boils. His steroids were discontinued, and he was instructed to soak in the bath, and use warm towel compresses to try to express the fluids from the boils. He says that he was able to express very little purulent material. He went to his dermatologist again on ___, who swabbed the lesions for culture, and prescribed dicloxacillin. Patient did not improve on this over the next few days, and reported chills and a fever of 102.6F (tympanic) today. The final culture for the swab returned today, growing MRSA, and the patient was contacted by his dermatologist who, in the context of high fever, referred him to the ED for further evaluation and management. On arrival to the ED, initial vitals were: 99 126 142/64 18 95% RA. Labs notable for WBC 16.6 w/ L shift and Cr 1.7 (baseline). Blood and urine Cx drawn and given Vanc 1g IV x1. VS at transfer: 98.4 100 126/75 18 95% RA. Currently, patient is comfortable. Reports mild pruritus of the lesions, but otherwise denies chills, lightheadedness, dizziness, chest pain, joint pain. ROS is positive for new cough, SOB, dysuria with increased urinary frequency (patient has been self-catheterizing for ___ years for neurogenic bladder--negative uro workup), hard stools in the setting of discontinuing laxatives for ~week. ROS: per HPI, otherwise for headache, vision changes, sinus congestion, sore throat, abdominal pain, n/v/d, BRBPR, melena, hematochezia, hematuria Past Medical History: ? SLEEP APNEA ANAL PRURITUS BACK PAIN ___ ESOPHAGUS BIPOLAR AFFECTIVE DISORDER BLADDER DISORDER BPH CHEST PAIN HERNIATED CERVICAL DISC HYPERCHOLESTEROLEMIA HYPERHOMOCYSTEINEMIA HYPERTENSION INTERNAL HEMORRHOIDS MENISCUS TEAR, RIGHT NEVUS, ATYPICAL OSTEOARTHRITIS PAIN IN JOINT PSYCHOSIS RECTAL PAIN RENAL INSUFFICIENCY SCIATICA UTI URINARY RETENTION Social History: ___ Family History: Father died of liver or kidney disease at ___. Maternal uncle with prostate CA. ?CAD, CVA hx in family. No known autoimmune disease; no Chrohn's, no h/o of allergies/eczema or skin conditions in family. Sister has "blood disease" Physical Exam: EXAM ON ADMISSION: VS - 99.1 114/76 98 18 97% RA General: well-appearing Caucasian gentleman, reclining comfortably in bed HEENT: NCAT, MMM, eyes equal and reactive to light; no lesions of mucosal membranes Neck: supple; no cervical LAD; posterior neck/nape of neck erythematous; no lesions CV: RRR, ___ holosystolic murmur loudest at apex, no gallops/rubs; no JVD Lungs: CTAB; no rhonchi/crackles; skin findings on back as mentioned below Abdomen: soft, NTND; skin findings as mentioned below GU: deferred Ext: nonedematous, WWP, sensation intact; 2+ pulses throughout; skin findings as below Neuro: AOx3, grossly intact with no focal abnormalities Skin: scattered hemangiomas and few scattered, non-pruritic, blanching, indurated, erythematous, painless papular lesions of back, on L buttock, bilateral arms, RLQ of abdomen; multiple indurated, some crusted/scabbed/excoriated coalescing papules of anterior shin and medial thighs bilaterally; dorsal aspect of feet bilaterally with excoriated and crusted herpetiform/eczematous papules EXAM ON DISCHARGE: General: well-appearing Caucasian gentleman, reclining comfortably in bed HEENT: NCAT, MMM, eyes equal and reactive to light; no lesions of mucosal membranes Neck: supple; no cervical LAD CV: RRR, ___ holosystolic murmur loudest at apex, no gallops/rubs; no JVD Lungs: CTAB; no rhonchi/crackles; skin findings on back as mentioned below Abdomen: soft, NTND; skin findings as mentioned below GU: deferred Ext: nonedematous, WWP, sensation intact; 2+ pulses throughout; skin findings as below Neuro: AOx3, grossly intact with no focal abnormalities Skin: scattered hemangiomas; few scattered, scabs with small amounts of serous drainage on very mildly erythematous base at sites of previously indurated and erythematous lesions; lichenified skin over dorsal aspect of feet and ankles Pertinent Results: ___ 01:22PM BLOOD WBC-16.6*# RBC-3.83* Hgb-11.8* Hct-35.0* MCV-91 MCH-30.9 MCHC-33.8 RDW-11.9 Plt ___ ___ 01:22PM BLOOD Neuts-89.8* Lymphs-5.0* Monos-3.9 Eos-0.9 Baso-0.4 ___ 06:00AM BLOOD WBC-8.1 RBC-3.60* Hgb-11.5* Hct-33.4* MCV-93 MCH-31.9 MCHC-34.4 RDW-12.2 Plt ___ ___ 01:22PM BLOOD Glucose-118* UreaN-47* Creat-1.7* Na-137 K-4.0 Cl-101 HCO3-23 AnGap-17 ___ 07:17AM BLOOD Glucose-101* UreaN-39* Creat-1.5* Na-144 K-5.0 Cl-107 HCO3-26 AnGap-16 ___ 06:00AM BLOOD Glucose-95 UreaN-42* Creat-1.8* Na-141 K-4.2 Cl-105 HCO3-27 AnGap-13 ___ 06:55AM BLOOD HIV Ab-NEGATIVE CXR ___: Questionable infectious process in the lungs. Given the patient's history, followup of the patient in four weeks after completion of antibiotic therapy is required. If finding is persistent, assessment with chest CT might be considered to exclude other potential etiologies for the lung abnormalities. Brief Hospital Course: ___ with BPD, CKD, neurogenic bladder, HTN, and recent allergic dermatitis presenting with fever and worsening skin lesions despite antibiotics. # Skin lesions/fever: Patient with history of chronically dry skin presenting with multiple MRSA+ abscesses over bialteral legs, arms, and back. Patient was afebrile during course of hospitalization and blood and urine cultures were not positive for infection. Patient came in to the BI on dicloxacillin, which had been prescribed by his dermatologist. Dicloxacillin was discontinued and patient was given IV vancomycin x48 hours with great improvement of skin lesions. For his pruritus, patient was given sarna lotion and diphenhydramine with moderate effect. His dermatologist was contacted and recommended bleach baths 3x/week and mupirocin. Dermatology scheduled follow-up visit with patient. Patient received an HIV test ___ concern for immunocompromise in the setting of diffuse involvement. One day prior to discharge, patient was transitioned to PO doxycycline (versus Bactrim, given CKD). Patient tolerated this well, and was discharged on a 14 day course of doxycycline. # Dysuria: Patient has a ___ year history of neurogenic bladder which has been worked up extensively in the past, per the patient. Also documented history of BPH. Patient has been self-cathing for the past ___ years and reports occasional UTIs. On admission, patient reported recent dysuria and increased frequency. As patient had a CC of fever, UA and UCx were obtained. Both were negative. Patient continued to self-cath during hospitalization without event/complaint. # cough, SOB: Patient has extensive smoking history and may have mild COPD or other lung disease. CXR was obtained and was questionable for infectious process in the lungs; however, patient improved subjectively without intervention. No oxygen requirement during hospitalization. However, given abnormalities on CXR, it was recommended that patient have repeat CXR in 4 weeks. # CKD: On admission, patient's creatinine elevated to 1.8. He was slightly tachycardic with increased BUN (although this appeared to be the patient's baseline). Possibly volume down in setting of decreased PO and increased urinary frequency. BUN/creat > 20. Patient given 1L NS for possible prerenal etiology. Creatinine trended down to 1.5. One day prior to discharge, patient again with creatinine of 1.8 and was again given 1L NS. Given patient's CKD, he was written for doxycycline versus bactrim for continued treatment of his MRSA skin infection. Medications, otherwise, were all renally dosed. # Bipolar disorder: Continued home meds. # Hemorrhoids: Continued home bowel regimen in addition to senna, colace. # HTN: Continued home meds. TRANSITIONAL ISSUES: # abnormal CXR: Radiology suggested that patient, given h/o smoking and COPD, should receive repeat CXR in 4 weeks. If CXR findings persistent, assessment with CT recommended. # Continued bactroban and bleach baths given extent of MRSA infection Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO DAILY 2. Carbamazepine (Extended-Release) 500 mg PO HS 3. BuPROPion (Sustained Release) 200 mg PO QAM 4. QUEtiapine Fumarate 300 mg PO QPM 5. RISperidone 6 mg PO DAILY 6. Ketoconazole 2% 1 Appl TP BID 7. Lorazepam 0.5 mg PO HS 8. guar gum *NF* 1 gram Oral QHS 9. Polyethylene Glycol 17 g PO DAILY 10. Simvastatin 40 mg PO DAILY 11. DiCLOXacillin 500 mg PO Q6H 12. Omeprazole 40 mg PO BID 13. Aspirin 81 mg PO DAILY 14. Hydrochlorothiazide 12.5 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Ketoconazole 2% 1 Appl TP BID 3. Lisinopril 20 mg PO DAILY 4. Lorazepam 0.5 mg PO HS 5. Omeprazole 40 mg PO BID 6. Polyethylene Glycol 17 g PO DAILY 7. QUEtiapine Fumarate 300 mg PO QPM 8. RISperidone 6 mg PO DAILY 9. Simvastatin 40 mg PO DAILY 10. BuPROPion (Sustained Release) 200 mg PO QAM 11. Carbamazepine (Extended-Release) 500 mg PO HS 12. Hydrochlorothiazide 12.5 mg PO DAILY 13. guar gum *NF* 1 gram Oral QHS 14. Mupirocin Nasal Ointment 2% 1 Appl NU BID Duration: 12 Days RX *mupirocin calcium [Bactroban Nasal] 2 % 1 application NU twice a day Disp #*1 Tube Refills:*0 15. Sarna Lotion 1 Appl TP TID:PRN itching RX *camphor-menthol [Sarna Anti-Itch] 0.5 %-0.5 % Apply lotion to skin three times a day Disp #*1 Bottle Refills:*0 16. Doxycycline Hyclate 100 mg PO Q12H Duration: 11 Days RX *doxycycline hyclate 100 mg 1 capsule(s) by mouth twice a day Disp #*21 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: MRSA cellulitis/abscesses Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to the ___ for skin infection. You required intravenous antibiotics for several days during your hospitalization. After we saw that your skin was getting better, we switched you to oral antibiotics. You should continue taking these oral antibiotics after discharge. It is very important you finish the entire course of your antibiotics, even if you feel you do not need them anymore. Please continue taking your other medications, as they are written below. While you were here, we spoke to your dermatologist about your skin condition. She recommended doing the following once you are home, in addition to taking your antibiotics: SWIMMING POOL BATHS: Mix ___ cup Clorox bleach in a bathtub full of warm water. Soak for 10 minutes. Do this at least three times a week. Please follow up with your dermatologist after discharge. It was a pleasure caring for you while you were here. We wish you a speedy recovery! Followup Instructions: ___
19800781-DS-10
19,800,781
28,847,173
DS
10
2152-07-28 00:00:00
2152-07-31 16:56:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Uremia Major Surgical or Invasive Procedure: Coronary Catherization (DES placed to L Cx) Hemodialysis History of Present Illness: Mr ___ is a ___ year old male with a history of diabetes, ESRD who presents with worsening fatigue, nausea, and LLQ abdominal pain. His fatigue has been present for a year or so, most significantly progressing over the past few weeks at which point he has developed daily nausea which is not associated with vomiting. He additionally describes developing LLQ pain at this point, which is intermittent though he can identify no specific trigger and he does not describe colic type symptoms. At its worst the pain is ___ and is completely absent at other times. The pain does not radiate to the groin, but at times is associated with back pain. He denies any hematuria or changes in urination. He denies any bruising or easy bleeding. He denies any chest pain, sob, or orthopnea. Of note, he had a RUE AVF placed in ___ in anticipation of HD, and is reportedly mature. HD was initially being delayed but given new symptoms and discussion with Renal team, patient agreed to initiate HD this admission. Additonally, he has a history of a silent inferior MI, with an EF of 34% and denies any chest pain or shortness of breath currently. In the ED, initial vitals: 97.7 84 156/84 14 100% on RA Labs were notable for: Trop-T: 0.16, proBNP: 7251, Wbc: 7.4, Hgb:11.1 Plt: 223, na: 140, Cl: 109, BuN: 66, Glu: 147, K: 4.8 Bic: 21 Cre: 5.1. He had a UA w/ 600 prot 150 glu 7wbc and few bact He had an EKG which showed sinus narrow intervals, no peaked Ts, no ischemia. CT showed no acute process to explain abdominal pain On arrival to the floor, pt reports no acute symptoms except for his stable ___ LLQ pain. He remained hypertensive to the 180s, did not respond to 10mg IV hydralazine and was restarted on home antihtn as well as 50q6h of po hydralazine. Past Medical History: DM2 with retinopathy, neuropathy, autonomic neuropathy and nephropathy CKD IV/V ___ biopsy proven diabetic nephropathy with nephrotic range proteinuria PVD s/p bilateral bypass surgeries HLD HTN Colon Ca s/p partial colectomy ___ CAD , s/p silent inferior MI Social History: ___ Family History: History of DM on both sides of family, denies any history of CHF or heart attacks Physical Exam: Admission Physical ===================== Vitals- 98.4 181/78 84 18 97% on RA General- Alert, oriented, no acute distress HEENT- Sclerae anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- CTAB no wheezes, rales, rhonchi CV- RRR, Nl S1, S2, No MRG Abdomen- soft,bowel sounds present, mildly tender to deep palpation in LLQ, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis, trace edema Neuro- CNs2-12 intact, motor function grossly normal Discharge Physical ===================== Vitals- 98.4 110s-140s/50s-70s ___ 18 98% General- Alert, oriented, nad HEENT- Sclerae anicteric, MMM, oropharynx clear Neck- supple, no LAD Lungs- CTAB no wheezes, rales, rhonchi CV- RRR, Nl S1, S2 no murmurs rubs gallops Abdomen- soft,bowel sounds present no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis Neuro- CNs2-12 intact, full strength and sensation to light touch/pain bilaterally Pertinent Results: Admission Labs ===================== ___ 08:30AM BLOOD WBC-7.4 RBC-3.80* Hgb-11.1* Hct-32.5* MCV-86 MCH-29.2 MCHC-34.2 RDW-13.2 Plt ___ ___ 08:30AM BLOOD Neuts-68.2 Lymphs-17.7* Monos-10.2 Eos-3.1 Baso-0.7 ___ 08:30AM BLOOD ___ PTT-33.2 ___ ___ 08:30AM BLOOD Glucose-147* UreaN-66* Creat-5.1* Na-140 K-4.8 Cl-109* HCO3-21* ___ 08:30AM BLOOD cTropnT-0.16* proBNP-7251* ___ 08:30AM BLOOD Calcium-8.7 Phos-4.0 Mg-1.8 Discharge Labs ==================== ___ 06:00AM BLOOD WBC-6.2 RBC-3.55* Hgb-10.7* Hct-30.5* MCV-86 MCH-30.0 MCHC-34.9 RDW-13.7 Plt ___ ___ 05:00AM BLOOD Glucose-100 UreaN-29* Creat-5.9* Na-137 K-3.9 Cl-98 HCO3-31 AnGap-12 Pertinent Labs ==================== ___ 01:10PM BLOOD PTH-118* ___ 01:10PM BLOOD 25VitD-18* ___ 01:10PM BLOOD calTIBC-252* Ferritn-103 TRF-194* ___ 06:10AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE HBcAb-NEGATIVE ___ 06:10AM BLOOD HCV Ab-NEGATIVE ___ 08:30AM BLOOD cTropnT-0.16* proBNP-___* ___ 06:10AM BLOOD cTropnT-0.14* ___ 05:05AM BLOOD cTropnT-0.13* Imaging Results ==================== Cardiac Echo ___ IMPRESSION: Mild symmetric LVH with normal biventricular regional/global systolic function. The patient has a mildly dilated ascending aorta. Based on ___ ACCF/AHA Thoracic Aortic Guidelines, if not previously known or a change, a follow-up echocardiogram is suggested in ___ year; if previously known and stable, a follow-up echocardiogram is suggested in ___ years. Compared with the report of the prior study (images unavailable for review) of ___, I did not appreciate the regional wall motion abnormalities noted on the prior study today. 2D strain shows normal intrinsic myocardial contractility in the basal inferior wall CT Head wo contrast ___ IMPRESSION: 1 cm hypodensity within the left globus pallidus is worrisome for a large subacute lacunar infarct or edema surrounding a lesion. Recommend dedicated MR for further evaluation. MRI/MRA (Time of Flight) head/neck IMPRESSION: 1. Study is mildly degraded by motion, and examination of bilateral common carotid and vertebral artery origins limited secondary to motion artifact. 2. Within limits of examination, no definite dissection or significant occlusion of head or neck MRA. 3. 7 mm left insula subacute infarct. 4. Additional curvilinear region of restricted diffusion in left temporal lobe may represent acute infarct, or may be artifactual in nature. Recommend clinical correlation and attention on followup imaging. Brief Hospital Course: ___ year old male with a history of CKD secondary to DM and past silent inferior MI who presented with worsening uremic symptoms and abdominal pain admitted for initiation of HD. Additionally, he underwent cardiac catheterization with a DES placed to the left circumflex, complicated by embolism in L MCA territory without persistent neurologic sequelae. #ESRD: Patient w/ ESRD s/p fistula placement presented with progressing symptoms of uremia. His dialysis proceeded successfully, with one session delayed for AM nausea which responded well to metoclopramide. PPD was placed and negative, he was started on nephrocaps, and he was transitioned to an outpatient TTS schedule. HBV unexposed -HBV immunization as outpatient #Type II NSTEMI: Patient w/ elevated troponin to 0.16 -> 0.14 on follow up. No evidence of acute ischemic change on ekg, BNP of 7251. History of past silent inferior MI. Most likely a combination of demand ischemia in setting of HTN as well as renal failure and impaired clearance. However, given his risk factors and history of CAD he was started on a heparin drip and was catheterized with a drug eluting stent placed to the left circumflex, a procedure which had been planned before surgery but delayed until HD initiation given contrast load. Home beta blockade was continued, see afterload management below. He was discharged on aspirin and plavix for minimum of 6 months. His discharge metoprolol dose was Metoprolol Succinate 25mg daily and atorvastatin 80mg He should not stop these medications until talking to his cardiologist. #Embolic Ischemic Stroke: Immediately post catheterization, he experienced transient word finding difficulties which fully resolved within minutes. The next morning headache and nausea prompted a head ct which was negative for acute bleed, but subtle findings prompted an MRI which was most consistent with recent embolic activity in the Left insula and temporal lobe. He had no focal findings beyond his baseline neuropathy and no lateralizing signs. -No further follow up necessary #HTN: On 75mg irbesartan at home, was initially covered with 25mg losartan but remained hypertensive to the 180s and hydralazine was added. He became symptomatically orthostatic, likely secondary to his autonomic neuropathy, and when his hydralazine was held he became hypertensive to the 200s after catheterization and briefly required a nitroprusside drip. He was discharged on 150mg irbesartan without any hydralazine. -Antihypertensive titration # DM: Used 60 u detemir + aspart sliding scale at home. Last A1c 7.7 in ___. Past complications include retinopathy, neuropathy, autonomic neuropathy and nephropathy. He was initially treated with 60 Lantus BID and sliding scale, with the lantus downtitrated secondary to low glucose levels. He is discharged on 40 u detemir BID plus the sliding scale, with instructions to adjust with his outpatient providers if coverage is insufficient. -Follow up sugars and adjust detemir accordingly #GERD: Patient reports worsening over past few months of substernal chest pain. Brief episodes ~5 seconds of squeezing pain associated with gasping hiccup. Increased cough over same period. Denies dysphagia, possible but less likely to be DES. -8 weeks of high dose ppi, to be followed up as outpatient -transition to 40mg pantoprazole bid, given omeprazole interaction with clopidogrel. #Cardiac echo: normal EF with no wall motion abnormalities, as well as mild symmetric left ventricular hypertrophy. Echo with mildly dilated ascending aorta, seen in ___ as well. -Recommend follow up echo in ___ year # Anemia: Normocytic, and stable at hgb ___, adequate per renal. Likely secondary to deficiency of renal epo production. Recent baseline ___ -EPO or iron as per his outpatient renal team #LLQ Pain: Presented with intermittent LLQ pain, with no reliable pattern. CT negative for acute processes, stones, signs of diverticulitis or other acute process. Resolved without intervention. Transitional Issues ======================== -Intermittently hypertensive and orthostatic, will discharge with 150mg irbesartan qd, please follow up and adjust medications -DES of Lcx on ___, will need minimum 6 months dual antiplatelet therapy. -Trialing 8 week course of high dose ppi (40 mg bid pantoprazole), followup to assess effect -periods of hyperglycemia with in house conversion of detemir to lantus. Will discharge with 40 U Detemir BID from 60 U BID, follow up to assess sugars and possible need to change when on home diet -5s run of narrow complex tachycardia, continue on home beta blocker -If palpitations from tachycardia persist, increase metoprolol to 50mg -___ outpatient Dialysis schedule -Echo with mildly dilated ascending aorta, seen in ___ as well. Recommend follow up echo in ___ year -Negative hepatitis B serology, will need outpatient vaccination Code status: Full Proxy: ___, Relationship: fiancee, Phone number: ___ Patient Contact Number: ___ Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Atorvastatin 80 mg PO QPM 2. Omeprazole 20 mg PO DAILY 3. irbesartan 75 mg oral DAILY 4. Metoprolol Succinate XL 25 mg PO DAILY 5. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain 6. Desipramine 10 mg PO DAILY 7. Levemir (insulin detemir) 60 U subcutaneous BID 8. NovoLOG FLEXPEN (insulin aspart) 100 unit/mL subcutaneous TID W/MEALS 9. Aspirin 81 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Desipramine 10 mg PO DAILY 4. Metoprolol Succinate XL 25 mg PO DAILY 5. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain 6. Clopidogrel 75 mg PO DAILY RX *clopidogrel 75 mg 1 tablet(s) by mouth per day Disp #*30 Tablet Refills:*0 7. Nephrocaps 1 CAP PO DAILY RX *B complex with C#20-folic acid [Nephrocaps] 1 mg 1 capsule(s) by mouth per day Disp #*30 Capsule Refills:*0 8. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth Twice per day Disp #*20 Tablet Refills:*0 9. NovoLOG FLEXPEN (insulin aspart) 100 unit/mL subcutaneous TID W/MEALS 10. sevelamer CARBONATE 800 mg PO TID W/MEALS RX *sevelamer carbonate [Renvela] 800 mg 1 tablet(s) by mouth three times per day Disp #*30 Tablet Refills:*0 11. irbesartan 150 mg oral DAILY RX *irbesartan 150 mg 1 tablet(s) by mouth daily Disp #*15 Tablet Refills:*0 12. Levemir (insulin detemir) 40 U subcutaneous BID 13. Metoclopramide 5 mg PO BID:PRN Nausea Duration: 10 Days RX *metoclopramide HCl [Reglan] 5 mg 1 tablet by mouth twice daily as needed for nausea Disp #*20 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary Diagnoses ==================== End Stage Renal Disease, w/ hemodialysis initiation NSTEMI II Cornary Artery Disease Hypertensive Urgency Embolic Ischemic Stroke Diabetes Secondary Diagnoses ==================== GERD Hyperlipidemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. You were admitted for initiation of dialysis after your symptoms from your kidney disease worsened. You had 3 sessions of dialysis that well. While, here you had chest pain that was concerning for blockages to the vessels of your heart. You had a catheterization where they placed a stent to open a coronary artery. You had some confusion afterwards, and we got imaging of your brain which showed 3 small lesions in the left side of your brain which were likely due to your catheterization procedure, and you are neurologically back to normal with no residual deficits. We also made some changes to your blood pressure and diabetes management. We would like you to increase your irbesartan to 150mg per day from 75, and to follow up with your primary care doctor. Your sugars also ran lower while you were here. We would like you to decrease your levemir to 40 U twice a day from 60. If your glucose is greater than 200 for a day, you can increase your levemir by 5 units. Please call you doctor if it is persistently less than 100 or more than 300. Please call a doctor if you experience shortness of breath, chest pain, confusion, change in vision, weakness numbness or tingling, fevers >101, or for any symptoms that concern you. Thanks, Your ___ Care team Followup Instructions: ___
19800909-DS-7
19,800,909
21,685,167
DS
7
2155-11-19 00:00:00
2155-11-19 13:40:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain and vomiting Major Surgical or Invasive Procedure: Exploratory laparatomy, excision of hernia sac, explant of mesh, primary closure. History of Present Illness: Ms. ___ is a pleasant ___ woman who underwent a laparoscopic incisional hernia repair with mesh on ___ and presented to the ED earlier this evening with a chief complaint of increasing abdominal pain and emesis. Patient reports she had been recovering well until this morning, at which point she noticed increasing pain in the region of her ventral hernia repair and subsequently had several episodes of emesis. Last BM was this morning, no flatus or BM since that time. No fevers or chills. Reports that the pain is dull, constant, with radiation to the sides of her abdomen. No urinary symptoms. Past Medical History: PMH: ventral/incisional hernia, obesity, L ovarian cyst PSH: L salpingo-oophorectomy (robotic), ventral hernia repair with mesh (laparoscopic) Social History: ___ Family History: Mother with breast cancer diagnosed in ___. Father with SLE. Physical Exam: Discharge exam: Gen: NAD N: AAOx3 CV: RRR no M/G/R P: CTAB no W/R/R GI: obese, S/ND appropriately tender, incisions intact Ext: no C/C/E TLD: none Pertinent Results: ___ 05:20PM WBC-20.2*# RBC-5.51* HGB-14.8 HCT-44.8 MCV-81* MCH-26.9 MCHC-33.0 RDW-12.7 RDWSD-37.4 ___ 05:20PM LIPASE-22 ___ 05:20PM ALT(SGPT)-21 AST(SGOT)-15 ALK PHOS-81 TOT BILI-0.2 ___ 05:20PM GLUCOSE-130* UREA N-17 CREAT-0.7 SODIUM-138 POTASSIUM-3.9 CHLORIDE-100 TOTAL CO2-26 ANION GAP-16 ___ 05:20PM ___ PTT-36.3 ___ ___ 05:20PM PLT COUNT-352 ___: CT Abdomen and pelvis with contrast: IMPRESSION: Incarceration of small bowel loops within the ventral hernia sac, with adjacent stranding and free fluid extending to the liver and spleen. There is mild prominence of the small bowel, measuring up to 3.1 cm. No evidence of pneumatosis, or intraperitoneal free air. Brief Hospital Course: ___ was admitted from the ___ ED on ___ for exploratory lapratomy for her incarcerated verntral hernia seen on CT. For more details of her operation, see operative report. The patient was taken from the OR to the PACU in stable condition with foley, NG tube, and ___ drain in place. The patient was then taken from the PACU to the surgical floor in stable condition. POD#1 the patient's Foley catheter was removed and she voided freely. She was maintained NPO and on IV fluids with an NGT in place. On POD#4 the NG tube output had decreased, and the patient tolerated a clamp trial well. The NG tube was removed and the patient was started on sips and oral pain medications. On POD#5 the patient's diet was advanced to a regular diet. The JP output continued to decrease and cleared up, so the JP drain was removed on POD6. The patient was discharged home on POD#6, and was ambulating independently, voiding without difficulty and tolerating oral diet and pain medications. All of her questions were answered. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Fluticasone Propionate NASAL 2 SPRY NU Frequency is Unknown 2. Acetaminophen Dose is Unknown PO Q6H:PRN pain Discharge Medications: 1. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every 4 hours Disp #*50 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID constipation take for as long as you take Oxycodone. RX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily Disp #*30 Capsule Refills:*0 3. Acetaminophen 1000 mg PO Q6H:PRN pain 4. Fluticasone Propionate NASAL 2 SPRY NU DAILY 5. Senna 8.6 mg PO BID:PRN constipation RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*40 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Incarcerated ventral hernia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Do not lift anything heavier than 10 lbs until after you see your surgeon. You may shower, but do not submerge your wound. Please call your doctor or nurse practitioner if you experience the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain is not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. General Discharge Instructions: Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. Incision Care: *Please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *Avoid swimming and baths until your follow-up appointment. *You may shower, and wash surgical incisions with a mild soap and warm water. Gently pat the area dry. *If you have staples, they will be removed at your follow-up appointment. *If you have steri-strips, they will fall off on their own. Please remove any remaining strips ___ days after surgery. Followup Instructions: ___
19801123-DS-2
19,801,123
25,167,545
DS
2
2188-02-25 00:00:00
2188-02-25 22:11:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: arm pain Major Surgical or Invasive Procedure: None History of Present Illness: HOSPITALIST ADMISSION NOTE PCP: Name: ___ MD Email: ___ - HAS ONLY SEEN PATIENT ONCE ___ YEAR AGO Ms. ___ is a ___ yo F with h/o opioid dependence/IVDU previously on suboxone, anxiety, back pain, G6 P1 and 15 weeks pregnant, who presents with acute L arm pain and redness. The patient states she last injected heroin yesterday, and reports using clean needles that she licks. She states she subsequently developed L arm pain and redness near the site of injection. She also reports full body aches, fever, chills, sweats, anxiety, and joint pains currently, all consistent with opioid withdrawal. She is also complaining of significant pain to LUE. "Tylenol is not going to be enough!" She reports using about ~0.5g daily of heroin. She desires sobriety and is amenable to rehab. She reports that she had one ob/gyn visit since becoming pregnant. She is not taking prenatal vitamins. In ED, bedside US did not demonstrate fluid collection in arm. She was started on Vancomycin. She otherwise denies CP, SOB, cough, dyusuria, joint swelling. 10 point review of systems reviewed, all others negative except as listed above Past Medical History: ? HCV Opioid dependence with IVDU, previously on suboxone and methadone Migraines Back pain Social History: ___ Family History: Her mother died of stroke at age of ___. Her father has a history of hypertension. Paternal grandmother, history of diabetes. No history of cancer in the family. Physical Exam: VS:98.7 PO 102 / 66 100 18 99 RA GEN: lying in bed, very uncomfortable generally HEENT: NC/AT, ears intact, MM dry, OP clear, anicteric sclera, PERRL NECK: supple no LAD CV: Regular, tachy, in NAD PULM: CTAB no wheezes or crackles GI: soft. mild TTP at flanks, no rebound or guarding +BS EXT: Mild soft tissue swelling medial LUE with assoc erythema and significant tenderness to erythema. Induration noted no clear area of fluctuance. Injection site noted is non-tender DERM: skin as above, no rashes or lesions noted otherwise NEURO: no focal deficits DC EXAM: VS: 98.4 PO 99 / 63 84 18 100 RA GEN: lying in bed, mild discomfort in NAD HEENT: NC/AT, ears intact, MMM, OP clear, anicteric sclera, PERRL NECK: supple no LAD CV: Regular, tachy, faint ___ SEM noted and stable PULM: CTAB no wheezes or crackles GI: soft. NT/ND, no rebound or guarding +BS EXT: soft tissue swelling medial LUE with assoc erythema and significant tenderness to erythema. The erythema has extended beyond the marked boundaries. Induration noted no clear area of fluctuance. There is a palpable painful cord running along the medial aspect of her forearm. Injection site noted is non-tender DERM: skin as above, no rashes or lesions noted otherwise NEURO: no focal deficits Pertinent Results: INITIAL LABS: ___ 09:30AM URINE HOURS-RANDOM ___ 09:30AM URINE UCG-POSITIVE ___ 09:30AM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 09:30AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-150 KETONE-TR BILIRUBIN-NEG UROBILNGN-2* PH-7.0 LEUK-NEG ___ 09:30AM URINE RBC-1 WBC-1 BACTERIA-FEW YEAST-NONE EPI-5 ___ 09:30AM URINE MUCOUS-RARE ___ 09:00AM URINE HOURS-RANDOM ___ 07:48AM GLUCOSE-149* UREA N-7 CREAT-0.5 SODIUM-135 POTASSIUM-3.0* CHLORIDE-102 TOTAL CO2-18* ANION GAP-18 ___ 07:48AM estGFR-Using this ___ 07:48AM ___ ___ 07:48AM WBC-12.6*# RBC-3.26* HGB-9.9* HCT-30.2* MCV-93 MCH-30.4 MCHC-32.8 RDW-15.5 RDWSD-51.8* ___ 07:48AM NEUTS-86.2* LYMPHS-7.3* MONOS-5.6 EOS-0.1* BASOS-0.1 IM ___ AbsNeut-10.82*# AbsLymp-0.92* AbsMono-0.70 AbsEos-0.01* AbsBaso-0.01 ___ 07:48AM PLT COUNT-158 ___ 07:48AM ___ PTT-31.1 ___ ___ 06:52AM LACTATE-1.4 US: IMPRESSION: 1. Single, live intrauterine pregnancy. Gestational age by ultrasound is 15 weeks and 3 days. ___ 6:40 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: BETA STREPTOCOCCUS GROUP A. FINAL SENSITIVITIES. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ BETA STREPTOCOCCUS GROUP A | CEFTRIAXONE-----------<=0.12 S CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.12 S PENICILLIN G----------<=0.06 S VANCOMYCIN------------ <=0.5 S Anaerobic Bottle Gram Stain (Final ___: Reported to and read back by ___, ___, ON ___ AT 20:15 . GRAM POSITIVE COCCI IN PAIRS AND CHAINS. Aerobic Bottle Gram Stain (Final ___: GRAM POSITIVE COCCI IN PAIRS AND CHAINS. ULTRASOUND ___ FINDINGS: There is normal flow with respiratory variation in the bilateral subclavian vein. The left internal jugular and axillary veins are patent, show normal color flow and compressibility. The left brachial vein contains partially occlusive thrombus throughout. The left basilic and left cephalic vein demonstrate near occlusive thrombus. No fluid collection is identified. IMPRESSION: 1. Partially occlusive deep vein thrombosis of the brachial veins. 2. Near occlusive thrombus in the left basilic and left cephalic vein, superficial vessels. 3. No fluid collection identified. ___ ECHO: The left atrium is normal in size. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. There is a probable vegetation on the aortic valve. There is no aortic valve stenosis. The mitral valve leaflets are structurally normal. No mass or vegetation is seen on the mitral valve. Mild (1+) mitral regurgitation is seen. The tricuspid valve leaflets are mildly thickened. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: 1) Possible aortic valve endocarditis (0.3 x 0.3 echo-dense undulating structure likely attached to RCC). However, image quality not adequate to be certain. Alternatively could be beam widening artifiact. 2) Moderate pulmonary systolic arterial hypertension. LV diastolic dysfunction could not be assess however the pulmonary acceleration time appears short with possibly mid-systolic notching suggesting tentatively that the PASP is elevated due to elevated pulmonary vascular resistance (~ ___ ___. DC LABS: ___ 06:50AM BLOOD WBC-6.6 RBC-2.77* Hgb-8.3* Hct-25.6* MCV-92 MCH-30.0 MCHC-32.4 RDW-16.4* RDWSD-55.8* Plt ___ ___ 06:50AM BLOOD Glucose-87 UreaN-4* Creat-0.5 Na-138 K-3.8 Cl-106 HCO3-21* AnGap-15 ___ 06:50AM BLOOD ALT-88* AST-79* AlkPhos-103 TotBili-0.4 ___ 06:50AM BLOOD Calcium-8.7 Phos-2.8 Mg-1.6 ___ 06:50AM BLOOD HBsAg-Negative HBcAb-Negative ___ 06:50AM BLOOD HIV Ab-Negative Brief Hospital Course: Ms. ___ is a ___ yo F with h/o opioid dependence and IVDU with recent use, 15 weeks pregnant, who presents with L arm redness and swelling c/w cellulitis in the setting of recent injection drug use in the area, found to have GPC bloodstream infection and LUE DVT. Acute Group A Strep bloodstream infection: LUE cellulitis with septic thrombophlebitis: Possible acute aortic valve endocarditis Source of BSI is LUE cellulitis caused by injection use in that arm. US negative for abscess, though exam has a superficial thrombophlebitis. The erythema has extended beyond the initial boundaries, which could be due to her DVT. She is on appropriate antibiotic therapy based on culture data so for now will monitor. There is no sign for septic joint currently based on exam. Her echo was reviewed and findings raised concern for AV endocarditis/vegetation. She currently has no signs/symptoms of CHF - ID consulted: recommending CTX 2g IV q24, day 1 = ___. ___ weeks of treatment recommended - SHE WILL REQUIRE TEE TO EVALUATE FOR AV ENDOCARDITIS. - Monitor LUE for extension of erythema swelling. Could consider re-imaging if continues to worsen. - Pain control with PO and IV Morphine as below. Hypotension: Hypotension on the night of admission since stabilized. Likely multifactorial to include clonidine use for withdrawal symptoms the first nite, and infection with volume depletion. BP improved with IVF. Normal lactate re-assuring. - Clonidine stopped - Monitor BP. DC BP 110s/80s Acute LUE DVT: Found on US. Likely provoked in setting of IVDU and cellulitis. Her pregnancy state is also contributing. This is likely contributing to her worsening LUE swelling - Elevation, warm packs - Lovenox 1mg/kg q12 startged: 50mg SC q12 - In discussion with ___, recommend continuing therapy for 6 months and/or 6 weeks after delivery of her baby Opioid dependence with IVDU and withdrawal: Has had periods of sobriety with medication maintenance: suboxone and methadone in the past. She came in with mild-mod withdrawal, but became hypotensive with clonidine. Given her ongoing pain, she was initiated on PO and IV Morphine which would alleviate her withdrawal symptoms. Please see below for dosing. SW met with the patient and she expressed desire to stop IV heroin. Pregnancy: US reviewed. ___ consulted here. Started prenatal vitamins. HIV and HBV negative. GC/Chlamydia negative. - RPR, rubella, varicella, PENDING ON TRANSFER HCV: HCV serology negative last year. This is reported and will need confirmation Medications on Admission: The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: MEDICATION LIST ON TRANSFER 1. Acetaminophen 500 mg PO Q6H:PRN Pain - Moderate 2. CefTRIAXone 2 gm IV Q 24H 3. Enoxaparin Sodium 50 mg SC Q12H Start: Today - ___, First Dose: Next Routine Administration Time 4. Morphine Sulfate ___ ___ mg PO Q4H:PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity 5. Morphine Sulfate ___ mg IV Q4H:PRN BREAKTHROUGH PAIN 6. Nicotine Patch 21 mg TD DAILY 7. Prenatal Vitamins 1 TAB PO DAILY 8. Promethazine 25 mg PO Q6H:PRN nausea Discharge Disposition: Extended Care Discharge Diagnosis: Group B strep acute bloodstream infection/sepsis Left upper extremity cellulitis Left upper extremity DVT with superficial thrombophlebitis Opioid dependence/IV heroin use Chronic HCV Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted for left arm pain, redness, and swelling and diagnosed with infection (cellulitis), and blood clot in your arm. Your infection also extended to your bloodstream which is a serious infection. You will need a course of antibiotics to be determined and close follow up with infectious disease. You were also diagnosed with a blood clot and will need to continue your Lovenox blood thinner treatment. You will be transferred to ___ for ongoing care of the issues above Followup Instructions: ___
19801386-DS-17
19,801,386
28,249,572
DS
17
2176-07-25 00:00:00
2176-07-25 14:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Amoxicillin Attending: ___. Chief Complaint: odynophagia Major Surgical or Invasive Procedure: upper endoscopy History of Present Illness: Mr. ___ is a ___ year old gentleman with a long history of ___ disease on Humira (last administration ___ presenting with odynophagia, dysphagia, anorexia, vomiting, sputum production for ___ weeks after an admission in ___ for reported Viral meningitis. Unclear if he received antibiotics on that admission, but likely given that he underwent LP and CSF culture. He reports intermittent nausea/vomiting, dry heaving, mouth dryness, early satiety, anorexia, weight loss, variable ostomy output, dark urine, poor PO intake that has been worsening in the last ___ weeks. He also vomits up recently ingested, undigested food and liquids. He also reports some congestion and cough without wheeze, worse in the morning. Denies abdominal pain, mostly central chest pain during eating. He has had oral and esophageal thrush treated with fluconazole in the past. He contacted his PCP/GI Dr. ___ recommended presenting to the ER for further evaluation. . . ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, cough, shortness of breath, chest pain, abdominal pain, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. All other ROS negative. Past Medical History: ___ disease dx ___, s/p total colectomy ___, with enterocutaneous fistula, perianal fistulas. Now treated with remicaid: last infusion ___ -___ inflammation/absesses/ECF treated with Remicaid/Antibiotics (ECF now closed), s/p parastomal hernia repair w/ mesh ___ - s/p open ccy complicated by small bowel injury (primary repair) - s/p appendectomy in ___ - History of acute renal failure -___ disease dx ___, s/p total colectomy ___, with enterocutaneous fistula, perianal fistulas. Now treated with remicaid: last infusion ___ -___ inflammation/absesses/ECF treated with Remicaid/Antibiotics (ECF now closed), s/p parastomal hernia repair w/ mesh ___ - s/p open ccy complicated by small bowel injury (primary repair) - s/p appendectomy in ___ - History of acute renal failure - Chronic pain from a peripheral tendonopathy Social History: ___ Family History: Father - ___, Father's Sister with ___ Physical Exam: VS: 97.3 116/48 71 19 100%RA GENERAL: Well-appearing thin man in NAD, comfortable, appropriate. HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MM dry, OP with streaks of white but no clear thrush NECK: Supple, no thyromegaly, no JVD, no carotid bruits. HEART: RRR, no MRG, nl S1-S2. LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored. ABDOMEN: Soft/NT/ND, multiple fistulas appearing to be healing, wounds clean, dressed and dry. Ostomy im place. EXTREMITIES: WWP, no c/c/e, 2+ peripheral pulses. SKIN: No rashes or lesions. LYMPH: No cervical LAD. NEURO: Awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout Pertinent Results: ___ 11:05PM BLOOD WBC-12.9* RBC-4.30* Hgb-12.7* Hct-36.6* MCV-85 MCH-29.6 MCHC-34.8 RDW-14.8 Plt ___ ___ 05:18AM BLOOD WBC-7.7 RBC-3.40* Hgb-10.3* Hct-29.1* MCV-86 MCH-30.3 MCHC-35.5* RDW-15.1 Plt ___ ___ 11:05PM BLOOD Neuts-80.2* Lymphs-14.8* Monos-3.2 Eos-1.6 Baso-0.2 ___ 11:05PM BLOOD Glucose-107* UreaN-46* Creat-3.8*# Na-134 K-3.7 Cl-104 HCO3-18* AnGap-16 ___ 06:01AM BLOOD Glucose-75 UreaN-30* Creat-1.7* Na-140 K-3.4 Cl-108 HCO3-26 AnGap-9 ___ 11:05PM BLOOD Albumin-4.1 Calcium-10.9* Phos-3.4# Mg-1.2* ___ 06:01AM BLOOD Calcium-9.3 Phos-3.0 Mg-1.8 ___ 06:25AM BLOOD 25VitD-25* ___ 1:30 pm TISSUE ESOPHOGUS. VIRAL CULTURE: R/O CYTOMEGALOVIRUS (Preliminary): No Cytomegalovirus (CMV) isolated. CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Preliminary): ___ 11:27 am URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. CXR IMPRESSION: No radiographic evidence for acute cardiopulmonary process. The study and the report were reviewed by the staff radiologist. EGD Findings: Esophagus: Mucosa: Diffuse candidiasis was seen in the whole Esophagus. Cold forceps biopsies were performed for histology at the upper third of the esophagus. Cold forceps biopsies were performed for histology at the middle third of the esophagus. Cold forceps biopsies were performed for histology at the lower third of the esophagus. Cold forceps biopsies were performed for histology at the esophagus for CMV. Stomach: Normal stomach. Duodenum: Normal duodenum. Impression: Esophageal candidiasis (biopsy, biopsy, biopsy, biopsy) Otherwise normal EGD to third part of the duodenum Brief Hospital Course: ___ with ___ on Humira and metronidazole, h/o candidiasis, p/w odynophagia, dysphagia, and weight loss. # Odynophagia/dysphagia: Symptoms and EGD consistent with candidal esophagitis. Patient's symptoms improved quickly after starting fluconazole. He was discharged on fluconazole for two weeks with GI and ID follow up. # Severe malnutrition/weight loss: TPN was initiated on ___. He was discharged on TPN via PICC. # ___ disease: last dose of Humira was on ___ (prior to admission). Held metronidazole. Humira and metronidazole were restarted on discharge. # Acute kidney disease and Chronic Kidney Disease: Elevated Cr on admission, UNa<10, suggesting volume depletion. Per patient, his Creatinine always increases substantially when he is volume depleted, and later improves. He said that he has been evaluated by Nephrology in the past and told that his kidneys are normal. His creatitine improved to his recent baseline 1.7 with hydration. # Hypercalcemia: Resolved with hydration. # Chronic pain with anxiety: continued Methadone & oxycodone at home dosing. Medications on Admission: adalimumab [Humira Pen] 40 mg/0.8 mL Q14 days, last dose ___ methadone 50mg PO QAM & Q1200; 40mg PO Q1700. oxycodone 5 mg PO PRN pain Flagyl 500 mg PO BID (longstanding med) Prevacid 24Hr 20mg PO BID Probiotic -- Unknown Strength cyanocobalamin (vitamin B-12) 1,000 mcg/mL INJ Qmonth (last dose weeks prior to admission) Multivitamin PO Daily Discharge Medications: 1. methadone 10 mg Tablet Sig: Five (5) Tablet PO QAM (once a day (in the morning)). 2. methadone 10 mg Tablet Sig: Five (5) Tablet PO Q1200 (). 3. methadone 10 mg Tablet Sig: Four (4) Tablet PO Q1700 (). 4. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for Pain, . 5. fluconazole 200 mg Tablet Sig: One (1) Tablet PO once a day for 11 days. Disp:*11 Tablet(s)* Refills:*0* 6. Prevacid 30 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO twice a day. 7. cyanocobalamin (vitamin B-12) 1,000 mcg/mL Solution Sig: One (1) Injection once a month. 8. Probiotic Oral 9. multivitamin Oral 10. adalimumab 40 mg/0.8 mL Pen Injector Kit Sig: One (1) Subcutaneous q14days. 11. Flagyl 500 mg Tablet Sig: One (1) Tablet PO twice a day. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: -___ esophagitis -Weight loss and severe malnutrition -___ disease -Leukocytosis -Acute renal failure -Metabolic acidosis -Hypercalcemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted because of pain with swallowing. You underwent an endoscopy, which showed esophagitis, likely due to ___ (YEAST), which you have had before after being on antibiotics. You were started on an anti-fungal medication called fluconazole, and you noticed immediate improvement in your pain. You were started on TPN for nutrition. Initially the TPN will cycle for 16 hours, but your infusion company will be able to lower this slowly from 16 to 12 to 10 over the next week. Medications changes: You are being discharged with a prescription for fluconazole. You will complete a 2 week course of this. Followup Instructions: ___
19801386-DS-18
19,801,386
27,835,893
DS
18
2176-10-24 00:00:00
2176-10-26 15:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Amoxicillin Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ y/o M with ___ disease complicated by enterocutaneous fistulas (on Humira) and traumatic MVC ultimately requiring end ileostomy who presented with acute onset abdominal pain. Per the patient he noted a new buldge in his lower abdomen that was firm to the touch and extremely painful. Also reports increased drainage from previous fistulas. Reports no recent change in ostomy output. Denies N/V. Is being weaned off TPN; currently gets TPN every other day. Reports subjective fevers last night; no documented fevers. He took an extra 500mg flagyl tablet and a few tablets of advil. He called his gastroenterologist regarding the symptoms and was advised to present to ED. In the ED, initial VS: 98.5 95 132/89 18 100%. CT abdomen showed enlarged size of previously known fistula at midline. No abscesses were seen by study was limited by lack of iv contrast. He was seen by colorectal surgery who recommended admission to medicine for GI consult and continued antibiotics. He was given vancomycin 1g IV, zosyn 4.5g IV, flagyl 500mg IV, morphine 5mg IV, and methadone 40mg po (home dose) prior to transfer to floor. Admission Vitals: Temp: 98 °F (36.7 °C), Pulse: 89, RR: 17, BP: 115/81, O2Sat: 99%, O2Flow: ra, Pain: 5. Overnight the patient did well. Reports that pain is reasonably well controlled. Afebrile. Past Medical History: - ___ disease dx ___ s/p enterocutaneous fistula, perianal fistulas. remicaid: last infusion ___ - MVC in the late ___ after which he required multiple bowel surgies and eventuall colectomy and ileostomy -___ inflammation/absesses/ECF treated with Remicaid/Antibiotics (ECF now closed), s/p parastomal hernia repair w/ mesh ___ - s/p open ccy complicated by small bowel injury (primary repair) - s/p appendectomy in ___ - Chronic pain from a peripheral tendonopathy Social History: ___ Family History: Father - ___ Aunt - ___ Physical Exam: On Admission: VS - 98.6 ___ 18 97%RA GENERAL - Thin male, no acute distress, pleasant and cooperative HEENT - PERRL, EOMI, sclerae anicteric, MMM, OP clear NECK - Supple, no thyromegaly, no JVD HEART - PMI non-displaced, RRR, nl S1-S2, no MRG LUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use ABDOMEN - Ostomy at LLQ, several enterocutaneous fistulas at midline with serosanguinous/purulent drainage, exquisite tenderness to palpation medial to ostomy site where there is a new bulge, diffuse erythema along midline of abdomen to suprapubic region EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses NEURO - awake, A&Ox3, CNs II-XII grossly intact On Discharge: Vitals - 98.3 110/60 72 16 99%RA GENERAL - Thin male, no acute distress, pleasant and cooperative HEENT - PERRL, EOMI, sclerae anicteric, MMM, OP clear NECK - Supple, no thyromegaly, no JVD HEART - PMI non-displaced, RRR, nl S1-S2, no MRG LUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use ABDOMEN - Overall appearance of fistulas and surrounding cellulitis is greatly improved EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses NEURO - awake, A&Ox3, CNs II-XII grossly intact Pertinent Results: On Admission: ___ 07:20PM BLOOD WBC-10.7 RBC-3.72* Hgb-11.3* Hct-33.8* MCV-91 MCH-30.4 MCHC-33.5 RDW-12.9 Plt ___ ___ 07:20PM BLOOD Neuts-70.3* ___ Monos-5.1 Eos-2.1 Baso-0.2 ___ 07:20PM BLOOD ___ PTT-42.3* ___ ___ 07:40AM BLOOD ESR-121* ___ 07:20PM BLOOD Glucose-99 UreaN-36* Creat-1.9* Na-136 K-4.6 Cl-102 HCO3-23 AnGap-16 ___ 07:40AM BLOOD ALT-14 AST-19 LD(LDH)-89* AlkPhos-107 TotBili-0.1 ___ 07:20PM BLOOD Calcium-9.4 Phos-4.3 Mg-2.0 ___ 06:27AM BLOOD Ferritn-573* ___ 07:40AM BLOOD CRP-10.9* On Discharge: ___ 08:00AM BLOOD WBC-9.0 RBC-3.89* Hgb-11.8* Hct-36.9* MCV-95 MCH-30.3 MCHC-31.9 RDW-13.0 Plt ___ ___ 08:00AM BLOOD Glucose-82 UreaN-21* Creat-2.0* Na-139 K-3.8 Cl-104 HCO3-24 AnGap-15 ___ 08:00AM BLOOD Calcium-9.2 Phos-3.9 Mg-1.8 Microbiology: BACILLUS SPECIES; NOT ANTHRACIS | CLINDAMYCIN----------- 0.5 S GENTAMICIN------------ <=2 S LEVOFLOXACIN----------<=0.25 S VANCOMYCIN------------ <=1 S Studies: CT Abdomen - IMPRESSION: 1. Previously on the MRI from ___ seen midline enterocutaneous fistulous tract (slightly inferior and to the right relative to the ileostomy bag) has slightly increased in diameter. There is no definite evidence of abscess formation. However, evaluation is limited without intravenous contrast. MRI/MRE with contrast could be considered for further assessment if required. 2. Complex subcutaneous fistulous formation in the right lower quadrant anterior abdominal wall is similar compared to the MRI from ___, allowing for the noncontrast CT technique. 3. Left lower quadrant ileostomy appears intact without change or evidence of abscess formation. 4. Unchanged small bowel containing right lower quadrant anterior abdominal wall hernia and fat-containing left mid epigastric paramedian abdominal wall hernia. 5. Bilateral pulmonary nodules are new since ___ and may be infectious or inflammatory in nature, particularly if the patient is on TNF inhibitor treatment; follow-up CT is recommended in 3 months after appropriate treatment for presumed infection. UE US - IMPRESSION: No drainable fluid collection at the right elbow. ECHO - The left atrium is normal in size. Left ventricular wall thicknesses are normal. The left ventricular cavity size is normal. Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Overall left ventricular systolic function is low normal (LVEF 50%). Right ventricular chamber size and free wall motion are normal. The aortic root is mildly dilated at the sinus level. The ascending aorta is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Trivial mitral regurgitation is seen. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. Brief Hospital Course: Mr. ___ is a ___ male with ___ disease complicated by enterocutaneous fistulas s/p end ileostomy on humira who presented with acute onset abdominal pain related to a new entero-cutaneous fistula. Found to have bacillus bacteremia. # Abdominal pain/Fistula: The patient has a history of multiple fistulas related to ___ disease. Presented to the ED in the setting of abdominal pain and a CT scan revealed a progression of known fistulas. The patient had last taken Humira on the day prior to admission and takes it once every other week. He was started on vancomycin and zosyn in the ED. Continued on flagyl. Admitted to the medicine floor. On the floor the patient was seen by GI and colorectal surgery. He was not a surgical candidate. Placed on octreotide although this made him vomit and the medication was stopped. Pain was controlled with home methadone and oxycodone regimen. The patient's ___ pain and erythema greatly improved on antibiotics. As discussed below, the ___ hospital course was complicated by a bacillus bacteremia. Once this bacteremia cleared he was given an additional 40mg of humira and his dosing was increased to weekly for 1 month. A PICC line was placed for TPN and the patient was instructed to remain on clears only. Flagyl was discontinued but the patient remained on vancomycin (2 weeks)/zosyn (10 days). He was discharged with plans for close outpatient follow-up. # Bacteremia - The patient's blood culture drawn in the ED grew ___ bottles with bacillus species. The patient was maintained on vancomycin and zosyn. Infectious disease was consulted who recommended removal of the PICC line (suspected source), holding of TPN and echocardiogram. The TTE was unremarkable and a TEE was not pursued. Patient remained HD stable. Surveillance blood cultures were taken and remained negative. A PICC line was replaced. The patient was discharged with plans to complete a total 2 week course of vancomycin and 10 days of zosyn. # Chronic kidney disease: Baseline Cr 1.7 to 2.0. Cr remained near baseline throughout the patient's stay. Nephrotoxins were avoided where able. # Candidal esophagitis: The patient has a history of candidal infections when on broad spectrum antibiotics. In the hospital he was placed on fluconazole prophylactically # Transitional Issues: - F/u CT scan for pulm nodule 3 months - Continue humira weekly for 1 month then return to every-other-week dosing Medications on Admission: 1. methadone 10 mg Tablet Sig: Five (5) Tablet PO QAM (once a day (in the morning)). 2. methadone 10 mg Tablet Sig: Five (5) Tablet PO Q1200 (). 3. methadone 10 mg Tablet Sig: Four (4) Tablet PO Q1700 (). 4. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for Pain, . 5. Prevacid 30 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO twice a day. 6. cyanocobalamin (vitamin B-12) 1,000 mcg/mL Solution Sig: One (1) Injection once a month. 7. Probiotic Oral 8. multivitamin Oral 9. adalimumab 40 mg/0.8 mL Pen Injector Kit Sig: One (1) Subcutaneous q14days. 10. Flagyl 500 mg Tablet Sig: One (1) Tablet PO twice a day. Discharge Medications: 1. methadone 10 mg Tablet Sig: Five (5) Tablet PO QAM (once a day (in the morning)). 2. methadone 10 mg Tablet Sig: Five (5) Tablet PO DAILY (Daily). 3. methadone 10 mg Tablet Sig: Four (4) Tablet PO DAILY (Daily). 4. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. hydromorphone 2 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for Pain. 6. fluconazole 100 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours): Please continue until 7 days after the completion of your antibiotic course. Disp:*30 Tablet(s)* Refills:*0* 7. oxycodone 5 mg Capsule Sig: One (1) Capsule PO every ___ hours as needed for pain. 8. Prevacid 30 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO twice a day. 9. Vitamin B-12 1,000 mcg/mL Solution Sig: One (1) Injection once a month. 10. Humira 40 mg/0.8 mL Kit Sig: One (1) Subcutaneous once a week: Please continue once weekly for the next 4 weeks then space dosing to every other week. . 11. vancomycin in D5W 1 gram/200 mL Piggyback Sig: One (1) Intravenous Q 24H (Every 24 Hours) for 11 days. Disp:*11 Doses* Refills:*0* 12. piperacillin-tazobactam-dextrs 4.5 gram/100 mL Piggyback Sig: 4.5 gram/100ml Piggyback Intravenous Q8H (every 8 hours) for 6 days. Disp:*18 Doses* Refills:*0* 13. Zofran 8 mg Tablet Sig: One (1) Tablet PO three times a day as needed for nausea. Disp:*30 Tablet(s)* Refills:*0* 14. Outpatient Lab Work Vancomycin Level: Please draw 30min before starting vancomycin dose on ___. Please also check Chem 7, CBC with differential with this blood draw. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Bacillus cereus bacteremia Enter-cutaneous fistula ___ disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: It was a pleasure taking care of you at ___! You were admitted due to an infection in your blood and a new fistula from your Crohns. In the hospital you were treated with high dose antibiotics and your condition greatly improved. You were also given an extra dose of Humira and discharged on an increased Humira regimen. You will be discharged with plans to complete a course of antibiotics and follow-up closely with your gastroenterologist. See below for changes made to your home medication regimen: 1) Please CONTINUE Zosyn 4.5g intra-venously every ___ hours and continue for 6 additional days to complete a ___) Please CONTINUE Vancomycin 1,000mg every 24 hours for 11 additional days to complete a ___) Please INCREASE your Humira dosing to 40mg weekly for the next month then return to your every-other week schedule as directed by your gastroenterologist. 4) Please START Zofran 8mg every 8 hours as needed for nausea 5) Please STOP Flagyl (metronidazole) 6) Please STOP your probiotic See below for instructions regarding follow-up care: Followup Instructions: ___
19801386-DS-23
19,801,386
25,838,528
DS
23
2181-05-26 00:00:00
2181-05-26 19:50:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Amoxicillin Attending: ___ Chief Complaint: dehydration Major Surgical or Invasive Procedure: Central Tunneled Line Placement ___ History of Present Illness: Patient is a ___ with a complex PMHx including ___ disease short bowel syndrome secondary to mesh erosion from surgery for MCV, CKD (Cr ___ in ___, s/p removal of Hickman and abscess I&D in ___, chronic pain on methadone, recently left AMA from ___ when admitted with renal failure (underwent renal biopsy c/b hematoma), and Stenotrophomonas bacteremia, now presenting with concern for persistent dehydration. To briefly summary his ___ course, patient was admitted ___ with R sided flank pain, found to have acute on chronic renal failure (Cr 8.2) and Stenotrophamonas bacteremia. Patient was seen by renal while inpatient and underwent renal biopsy. There was concern that his renal failure may have been worsened by NSAID and/or anabolic steroid use. CT and renal ultrasound showed2mm non-obstructing, right sided stone and absence of hydronephrosis. Biopsy showed collapsing glomerulopathy, IgA nephropathy and focal global and segmental glomerulosclerosis. Biopsy showed combination of lesions that were most likely related to three different and potentially independent disease processes: collapsing glomerulopathy, IgA nephropathy, and severe vascular sclerosis. He was started on sevelamer during hospitalization. In terms of his bacteremia, source was though to be his port, given that he gives himself TPN and LR at home. ___ removed his port on ___ and ID recommended that he remain line-free for at least one 1 week. He was initially started on ceftazidime then switched to levofloxacin based on sensitivities. TTE was negative for vegetations. Per discharge summary, patient was discharged on IV levofloxacin for 14 day course (last day ___. However, patient states that he was discharged without any antibiotics. He was also found to have anemia consistent with Fe deficiency. U/S after renal biopsy showed stable hematoma. He received 2U PRBCs on ___. H/H could not be reliably trended due to patient's refusal to have blood draws. He was also hypertensive to 200s requiring IV labetalol. He was not discharged on anti-HTN. Care was difficult has patient refused blood draws, frequently left floor with abusive outbursts towards staff, delaying treatment such as blood transufions. He left AMA on ___. He was seen by psych, ID, renal, and colorectal surgery while admitted. In the ED, initial vitals: 98.3 ___ 18 100% RA - Labs notable for: WBC 16.8 (10.5 on discharge from ___), Hgb 9.6, Cr 10.0 - Patient given: 1L LR Foley placement was attempted however patient was unable to tolerate. - Vitals prior to transfer: 98.2 100 130/90 20 100% RA On arrival to the floor, pt reports that he feels like he was getting dehydrated. he states that he feels "tired and lethargic", exhausted. Just "feels like I'm dehydrated". No confusion, n/v, CP, fevers/chills, abdominal pain. No cough. No dysuria. He notes that the output from his ostomy is slightly looser than usual. He does note a different taste in his mouth than usual. He states that he left AMA because he was "losing faith" in their care and was hearing different things from different teams. He denies being discharged on any antibiotics. He was not discharged with any IV access. He states that he got dehydrated because he didn't have any access. He has not noticed any changes in his urination. Has noticed some decreased UOP, which he attributes to being dehydrated. He was "heavy" in to Advil (15 per day), last before ___ hospitalization. He was using these in attempt to wean methadone. He states that he uses anabolic steroids, 200mg per week, injected. He does this because of short gut syndrome - to help retain fluids. Past Medical History: ___ disease: Dx ___, s/p total colectomy w ileostomy ___ c/b enterocutaneous fistula, perianal fistulas #short bowel syndrome #HTN #chronic pain - states due to nerve damage in extremities (from flagyl use and h/o surgeries) #h/o abscess #vit B12 deficiency #GERD #s/p appendectomy #s/p open cholecystectomy c/b small bowel injury #hip replacement #multiple abdominal surgeries Social History: ___ Family History: Father- ___ Brother- ?___ vs. IBS Aunt and 2 cousins also w ___ Physical Exam: ============== ADMISSION EXAM ============== Vitals: 98.8 131/83 102 19 97 RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, neck supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Chest: dressing over prior port site c/d/I without any surrounding erythema or skin changes. Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding. Multiple scars from prior abdominal surgeries. Ostomy in place. Ext: Warm, well perfused, no cyanosis or edema Skin: Without rashes or lesions Neuro: A&Ox3. Grossly intact. =============== DISCHARGE EXAM =============== Vitals: 97.9 163/83 73 18 98% RA General: Alert, oriented, no acute distress, very muscular HEENT: Sclera anicteric, MMM, oropharynx clear, neck supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Heart: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Chest: central line in place without erythema or discharge. Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding. Multiple scars from prior abdominal surgeries. Ostomy in place. Ext: Warm, well perfused, no cyanosis or edema. Skin: Without rashes or lesions Neuro: A&Ox3. Grossly intact. Pertinent Results: ================ ADMISSION LABS ================ ___ 08:50PM BLOOD WBC-16.8*# RBC-3.87* Hgb-9.6* Hct-30.9* MCV-80*# MCH-24.8*# MCHC-31.1* RDW-21.0* RDWSD-60.4* Plt ___ ___ 06:37AM BLOOD ___ PTT-30.4 ___ ___ 08:50PM BLOOD Glucose-105* UreaN-57* Creat-10.0*# Na-134 K-4.8 Cl-93* HCO3-18* AnGap-28* ___ 08:50PM BLOOD Albumin-2.9* Calcium-8.1* Phos-6.6* Mg-1.6 Iron-37* ___ 08:50PM BLOOD calTIBC-352 Ferritn-110 TRF-271 ================ DISCHARGE LABS ================ ___ 07:19AM BLOOD WBC-6.7 RBC-2.99* Hgb-7.4* Hct-24.7* MCV-83 MCH-24.7* MCHC-30.0* RDW-19.9* RDWSD-60.4* Plt ___ ___ 10:46AM BLOOD ___ PTT-34.8 ___ ___ 07:19AM BLOOD Glucose-95 UreaN-50* Creat-8.6* Na-143 K-3.7 Cl-109* HCO3-20* AnGap-18 ___ 07:19AM BLOOD Calcium-8.6 Phos-4.9* Mg-2.0 ========== IMAGING ========== - RUQ US ___: 1. No hydronephrosis seen in either kidney. 2. Two small simple left renal cysts. 3. Perinephric fluid collection around the right kidney, with internal echogenicity, consistent with known history of hematoma after recent kidney biopsy at outside hospital, as detailed in OMR. - UPPER EXTREMITY VEIN MAPPING ___: On the right, the cephalic vein measures 0.1-0.2 cm. The basilic vein measures 0.1-0.2 cm. Of note, the proximal aspect of the right cephalic vein is very thick-walled likely due to prior thrombus. The brachial artery measures 0.___rtery measures 0.2 cm. On the left, cephalic vein ranges from 0.1-0.3 cm. The distal-most aspect of the cephalic vein on the left appears to be clotted. The the basilic vein measures 0.1-0.2 cm. The brachial artery measures 0.___rtery measures 0.3 cm. - TUNNELED LINE PLACEMENT ___: Successful placement of a double-lumen ___ tunneled line via the right internal jugular venous approach. The tip of the catheter terminates in the right atrium. The catheter is ready for use. ======== MICRO ======== ___: NO GROWTH TO DATE Brief Hospital Course: ___ year old male with PMHx of short gut syndrome on chronic TPN, ___ disease, CKD (unclear etiology), recent hospitalization for renal failure and Stenotrophamonas bacteremia, now presenting with fatigue and concern for dehydration, found to have renal failure and leukocytosis. ============== ACUTE ISSUES ============== # Acute renal failure on CKD: Patient with known CKD of unclear etiology. Review of OMR and ___ hospital show that he has had multiple episodes of ___. He was recently admitted to ___ where he underwent a renal biopsy which revealed multiple pathologies (collapsing glomerulopathy, IgA nephropathy, and severe vascular sclerosis). In terms of collapsing glomerulopathy, can be associated with infections such as HIV, however his HIV ab is negative. Can also be related to anabolic steroids, which he uses. Vascular sclerosis can be secondary to HTN, however path report states that primary causes are more likely. Primary forms of vascular/endotherlial injury include pro-coagulant state, autoimmune d/o, drug-induced, paraproteinemia. This acute episode is likely related to recent dehydration and lack of TPN (as his central line was removed during OSH hospitalization due to bacteremia), as his Cr started to improve with aggressive hydration and resumption of TPN. # HTN: Patient without a diagnosis of HTN, but with BPs ranging from 130s-170s/60s-90s. He was started on amlodipine while in the hospital which was uptitrated to 10 mg prior to discharge. # Recent Stenotrophamonas bacteremia: Patient presented with WBC 16.8 from ~10.5 at discharge from ___. No fevers or no localizing symptoms. His central line, through which he was receiving TPN for short gut syndrome) was removed during his ___ hospitalization. He was not discharged on antibiotics (per DC summary, were planning on discharging on levofloxacin 500mg Iq48h but patient left AMA and did not receive antibiotic script). He was restarted on levofloxacin PO renally dosed 250 mg q48h to complete previously prescribed course. Leukocytosis resolved prior to discharge and blood cultures without any growth x 4 days. # Anemia: Stable. Patient with a history of anemia. Iron: 37, Ferritin: 110, likely a combination of iron deficiency and chronic disease/renal failure. Trended down slightly with administration of IVF (likely a component of dilution) and he remained stable while in the hospital. # Short gut syndrome: Patient is chronically on TPN, however has not been on this due to lack of access (port dc'ed due to bacteremia as above). He underwent vein mapping to determine which side to replace his TPN line and which side to save for potential dialysis in the future. He was restarted on TPN prior to discharge through newly placed tunneled line. ============== CHRONIC ISSUES ============== # Chronic pain: Continued home methadone and oxycodone. ==================== TRANSITIONAL ISSUES ==================== * Renal [] repeat BMP ___ sent to PCP [] Patient needs outpatient renal follow up [] Patient needs outpatient renal transplant follow up in the event he will require renal transplant in the future * HTN [] f/u BPs, Started on amlodipine for HTN * Anemia: [] repeat CBC ___ sent to PCP *ID [] bcx final result pending on discharge *OTHER: # CODE STATUS: Full Code # CONTACT: roommate/girlfriend ___ ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. sevelamer CARBONATE 800 mg PO TID W/MEALS 2. Cyanocobalamin 1000 mcg IM/SC MONTHLY 3. Methadone 50 mg PO DAILY 4. Omeprazole 20 mg PO BID 5. OxyCODONE (Immediate Release) 30 mg PO Q6H:PRN Pain - Moderate 6. TPN Electrolytes (sodium-pot-mag-Ca-chlor-acetat) unknown injection 6X/WEEK 7. LOPERamide 2 mg PO QID Discharge Medications: 1. amLODIPine 10 mg PO DAILY RX *amlodipine 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 2. Levofloxacin 250 mg PO Q48H RX *levofloxacin 250 mg 1 tablet(s) by mouth q48 hours Disp #*2 Tablet Refills:*0 3. Cyanocobalamin 1000 mcg IM/SC MONTHLY 4. LOPERamide 2 mg PO QID 5. Methadone 50 mg PO DAILY 6. Omeprazole 20 mg PO BID 7. OxyCODONE (Immediate Release) 30 mg PO Q6H:PRN Pain - Moderate 8. sevelamer CARBONATE 800 mg PO TID W/MEALS 9.Outpatient Lab Work Lab: BMP, CBC ICD10: N17.9 Send to: Dr. ___ ___ number: ___ Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Discharge Worksheet-Discharge ___ ___., MD on ___ @ 1245 Primary Diagnosis: Acute Kidney Injury Secondary Diagnosis: Chronic Kidney Disease Short Gut Syndrome ___ Disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, You were hospitalized because you were feeling dehydrated. While you were here, you were found to have severe kidney injury. We believe this kidney injury is related to chronic kidney problems which were exacerbated by dehydration. We recommend that you stop taking steroids and testosterone because these can worsen your kidney injury and lead to dialysis. While you were in the hospital, you had a central line placed and were restarted on TPN. Your kidney function started to improve with intravenous fluids and TPN. While you were here, you were also restarted on antibiotics which you should continue to take for 5 more days. Please follow up with the kidney doctors and your ___ PCP. It was a pleasure meeting and taking care of you while you were in the hospital. - Your ___ Team Followup Instructions: ___
19801386-DS-24
19,801,386
26,091,160
DS
24
2181-06-18 00:00:00
2181-06-18 16:49:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Amoxicillin Attending: ___. Chief Complaint: weakness Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ man with HTN, ___ disease s/p colectomy now with short gut syndrome on chronic TPN, CKD, with recent admissions for acute on chronic kidney failure and Stenotrophamonas bacteremia, who presents with increase in Cr. To briefly summarize his course, pt was admitted to ___ ___ with R sided flank pain, found to have acute on chronic renal failure (Cr 8.2) and Stenotrophamonas bacteremia. Renal failure likely precipitated by combination of NSAID and steroid abuse. Renal bx showed 3 different and potentially independent disease processes: collapsing glomerulopathy, IgA nephropathy, and severe vascular sclerosis. Bacteremia was thought ___ to port which pt uses to give himself TPN and LR at home. Port was removed and pt was given IV abx (initially ceftazidime, then levofloxacin intended for 14 day course) but left AMA on ___. Pt next admitted to BI ___ with c/f persistent dehydration and acute on chronic renal failure thought to be ___ to lack of dehydration and lack of TPN as central line was not replaced. Cr improved with aggressive hydration and resumption of TPN. Pt was restarted on PO levofloxacin to complete prior intended course for Stenotrophamonas bacteremia. Pt has since been home and continuing on his TPN therapy. He denies any redness around the catheter site or difficulty with feeds. Notes a recent change in feeding regimen after changing doctors at the ___. Used to be on 3000 mg total (60 dextrose, 125 AA, 30 lipids every other day), now changed to 2500 mg total (60 dextrose, 105 AA, ___ lipids every other day). Over the last 48 hours pt noticed feeling of warmth, chills, and a "buzzing in his head". Also noticed tremulousness in hands. Two days prior to admission he was visited by staff from ___ ___, who deliver TPN and obtain labs from him weekly. The next day they informed him that his labs were abnormal (in particular Cr elevated) and advised that he come to the ED. On review of systems pt has also had "chest congestion worse on the R" for ___ days and a cough for the last week productive of white sputum. He has not noticed any change in his urine output. Has not had any chest pain, shortness of breath, or headache. In the ED, initial VS were 98.6 94 166/92 16 97% RA Exam notable for no redness at central catheter insertion site or around colostomy bag. Labs/imaging showed - CBC with Hgb/HCT 9.4/31.1 - BMP with Cr of 10.0 (pt with Cr 1.6-1.7 in ___, no other recordings until ___ when Cr has been 8.6-10), BUN 90.0, K 2.79, HCO3 50, Cl 80. - Divalents with Phos 4.6 - VBG with pH 7.54, pCO2 68, HCO3 60. - U/A with >600 protein, small blood, few bacteria - CXR showed no acute cardiopulmonary process. Received IV potassium repletion and 1 L NS. Transfer VS were 98.3 ___ 98% RA Decision was made to admit to medicine for further management. On arrival to the floor, patient is in no acute distress. He confirms the above history. Past Medical History: -___ disease: Dx ___, s/p total colectomy w ileostomy ___ c/b enterocutaneous fistula, perianal fistulas -short bowel syndrome -HTN -steroid use -chronic pain - states due to nerve damage in extremities (from flagyl use and h/o surgeries) -h/o abscess -vit B12 deficiency -GERD -s/p appendectomy -s/p open cholecystectomy c/b small bowel injury -hip replacement -multiple abdominal surgeries Social History: ___ Family History: Father- ___ Brother- ?___ vs. IBS Aunt and 2 cousins also w ___ Physical Exam: ============= ADMISSION ============= VS: 98.3 ___ 98% RA GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, dentures in place NECK: nontender supple neck HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes/rales/rhonchi, no dullness to percussion, breathing comfortably without use of accessory muscles ABDOMEN: ostomy bag in LLQ dry and intact, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis or edema, moving all 4 extremities with purpose, clubbing PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII grossly intact, significant asterixis in b/l UE and ___ SKIN: warm and well perfused, no excoriations or lesions, no rashes ============= DISCHARGE ============= VS: 98.4 157/78 77 20 98% RA GENERAL: walking in the halls HEENT: anicteric sclera, pink conjunctiva, moist mucous membranes, dentures in place, round face NECK: nontender supple neck, central line in place without discharge or surrounding erythema HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes/rales/rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: ostomy site in LLQ c/d/i, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis or edema, moving all 4 extremities with purpose, no edema PULSES: 2+ DP pulses bilaterally NEURO: no asterixis SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: =============== ADMISSION LABS =============== ___ 03:00PM BLOOD WBC-7.1 RBC-3.60* Hgb-9.4*# Hct-31.1*# MCV-86 MCH-26.1 MCHC-30.2* RDW-17.9* RDWSD-56.8* Plt ___ ___ 03:00PM BLOOD Neuts-77.2* Lymphs-13.3* Monos-8.5 Eos-0.4* Baso-0.3 Im ___ AbsNeut-5.47 AbsLymp-0.94* AbsMono-0.60 AbsEos-0.03* AbsBaso-0.02 ___ 03:00PM BLOOD Glucose-125* UreaN-90* Creat-10.0*# Na-141 K-2.9* Cl-80* HCO3-50* AnGap-14 ___ 03:00PM BLOOD ALT-18 AST-42* AlkPhos-66 TotBili-0.5 ___ 03:00PM BLOOD Albumin-2.8* Calcium-9.1 Phos-4.6* Mg-2.0 ___ 03:00PM BLOOD Albumin-2.8* Calcium-9.1 Phos-4.6* Mg-2.0 ___ 05:40PM BLOOD ___ pO2-42* pCO2-68* pH-7.54* calTCO2-60* Base XS-29 ___ 05:40PM BLOOD freeCa-1.02* ============ IMAGING ============ -___ CXR: No acute cardiopulmonary process. -___ Renal US: 1. Minimal prominence of the left renal collecting system is noted without hydronephrosis. 2. Unchanged right perinephric fluid collection consistent with known perinephric hematoma following outside hospital kidney biopsy. ================ DISCHARGE LABS ================ ___ 05:00AM BLOOD WBC-9.1 RBC-2.87* Hgb-7.5* Hct-25.5* MCV-89 MCH-26.1 MCHC-29.4* RDW-16.5* RDWSD-53.5* Plt ___ ___ 05:00AM BLOOD Glucose-68* UreaN-74* Creat-11.3* Na-138 K-5.1 Cl-100 HCO3-21* AnGap-22* ___ 05:00AM BLOOD Calcium-11.3* Phos-3.0 Mg-2.6 ___ 07:41AM BLOOD Type-MIX Temp-36.9 pO2-155* pCO2-48* pH-7.35 calTCO2-28 Base XS-0 Intubat-NOT INTUBA Comment-GREEN TOP ___ 07:41AM BLOOD freeCa-1.45* Brief Hospital Course: Mr. ___ is a ___ man with HTN, ___ disease s/p colectomy now with short gut syndrome on chronic TPN, CKD, with recent admissions for acute on chronic kidney failure and Stenotrophamonas bacteremia (completed course of antibiotics), who is now presenting with metabolic alkalosis. ============= ACUTE ISSUES ============= # Metabolic alkalosis with compensation from respiratory acidosis: Admission labs significant for HCO3 50 and pH 7.54 with PCO2 68 representing respiratory compensation. Metabolic alkalosis is likely related to exogenous bicarb administration from the large amount of acetate that patient was receiving in his TPN. Could had also had some degree of contraction alkalosis, although no increase in stool output from ostomy. Resolved completely with discontinuation of acetate from TPN and fluid resuscitation. Due to patient's baseline acidemia from renal failure, he was restarted on acetate in his TPN but at a much lower dose (90 meq per bag). # Hypokalemia/Hypocalcemia: Metabolic derangements secondary to metabolic alkalosis (see above). Improved with supplementation and resolution of metabolic alkalosis. ================ CHRONIC ISSUES ================ # Anemia: Available records document slow drop in Hgb since ___. Likely a combination of iron deficiency and chronic disease/renal failure. # Chronic renal failure: Patient with known CKD with renal biopsy showing multiple pathologies - collapsing glomerulopathy, IgA nephropathy, and severe vascular sclerosis. Previous baseline ___, most recently ___. No indication for urgent hemodialysis initiation at this time and will follow up with renal as an outpatient. # Short gut syndrome: Patient with central line for chronic TPN. Patient arranged to see Dr. ___ as an outpatient who will manage his TPN. ==================== TRANSITIONAL ISSUES ==================== [] Patient will have labs checked on ___ and ___, then weekly, results to be sent to Dr. ___ be managing his TPN), PCP, and ___ doctor [] Patient should follow up with Dr. ___ will manage his TPN going forward [] Patient should follow up with nephrology as an outpatient Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. LOPERamide 2 mg PO QID 2. Methadone 50 mg PO DAILY 3. Omeprazole 20 mg PO BID 4. OxyCODONE (Immediate Release) 30 mg PO Q6H:PRN Pain - Moderate 5. sevelamer CARBONATE 800 mg PO TID W/MEALS 6. amLODIPine 10 mg PO DAILY 7. Cyanocobalamin 1000 mcg IM/SC MONTHLY Discharge Medications: 1. amLODIPine 10 mg PO DAILY 2. Cyanocobalamin 1000 mcg IM/SC MONTHLY 3. LOPERamide 2 mg PO QID 4. Methadone 50 mg PO DAILY 5. Omeprazole 20 mg PO BID 6. OxyCODONE (Immediate Release) 30 mg PO Q6H:PRN Pain - Moderate 7.Outpatient Lab Work Lab: Chem-10 ICD-10: N18.9 Send results to: Dr. ___: ___ AND Dr. ___ ___ AND Dr. ___ ___ Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis: Metabolic Alkalosis Compensatory Respiratory Acidosis Hypokalemia Hypocalcemia Secondary Diagnosis: Chronic Kidney Disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, You were admitted to the hospital because you were feeling tired. You were found to have many abnormalities in your blood work which can cause fatigue and weakness. We believe that these abnormalities are related to an ingredient in your TPN. We changed the TPN formulation and your blood work and symptoms improved dramatically. Please get your labs checked on ___ and ___, then weekly. The results will be sent to your primary care doctor and your kidney doctor. Please follow up at the appointment scheduled with your primary care provider (see below). You will hear from the kidney doctors about ___ follow up appointment within the next ___ days. You will also hear from Dr. ___ office to schedule an appointment, this is a surgeon who will help manage your TPN after you go home. It was a pleasure taking care of you while you were in the hospital. -Your ___ Team Followup Instructions: ___
19801515-DS-18
19,801,515
26,150,573
DS
18
2151-10-14 00:00:00
2151-10-15 21:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___. Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: VATS, pericardial window ___ History of Present Illness: ___ yo M with no PMHx who presents as transfer from ___ with SOB found to have a pericardial effusion. He complains of 5 days of worsening SOB and chest tightness. He also endorses lightheadedness, generalized malaise, poor PO intake, subjective fevers and fatigue over the same time course. He denies preceding viral illness. He does endorse a new rash on both forearms. On arrival to ___, he was noted to have RUE swelling. CTA Chest was done showing no evidence of PE but did show a pericardial effusion so he was transferred to ___ for further management. In the ED, - Initial vitals were: afebrile, HR 106, BP 128/80, RR 18, 97% RA - Exam notable for: right upper extremity with edema. 2+ radial pulse. Pulsus 12. - Labs notable for: At ___: ___ 18.3, K 3.3, Cr 1.4, D-Dimer 704, trop<0.01 At ___ 16.3, k 3.7, Cr 1.3, INR 1.4, Lactate 1.3 - Studies notable for: bedside TTE with RV diastolic collapse with increased transmitral respiratory inflow variation consistent with likely early tamponade physiology. However, TTE limited by poor subcostal views making definitive echo diagnosis of tamponade difficult. At most at 1cm anteriorly. - Patient was given: 500 cc IVF bolus On arrival to the CCU, patient confirms the above history. Past Medical History: None Social History: ___ Family History: Father with diabetes Physical Exam: ADMISSION PHYSICAL EXAMINATION: =============================== VS: Reviewed in MetaVision GENERAL: Well developed, well nourished in NAD. Oriented x3. Mood, affect appropriate. HEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. NECK: Supple. No JVD CARDIAC: Normal rate, regular rhythm. No murmurs, rubs, or gallops. No friction rub. LUNGS: No chest wall deformities or tenderness. Respiration is unlabored with no accessory muscle use. No adventitious breath sounds. ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly or splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. SKIN: Diffuse macular rash on bilateral forearms. No pruritic. PULSES: Distal pulses palpable and symmetric. NEURO: CNII-XII grossly intact. No focal deficits. Moving all 4 extremities with purpose. Pertinent Results: ADMISSION LABS =============== ___ 04:30AM BLOOD WBC-16.3* RBC-4.69 Hgb-14.4 Hct-41.6 MCV-89 MCH-30.7 MCHC-34.6 RDW-12.8 RDWSD-41.5 Plt ___ ___ 04:30AM BLOOD Neuts-59 Lymphs-12* Monos-1* Eos-28* Baso-0 AbsNeut-9.62* AbsLymp-1.96 AbsMono-0.16* AbsEos-4.56* AbsBaso-0.00* ___ 04:30AM BLOOD Polychr-1+* ___ 04:30AM BLOOD ___ PTT-32.7 ___ ___ 04:30AM BLOOD Plt Smr-NORMAL Plt ___ ___ 04:30AM BLOOD Glucose-106* UreaN-10 Creat-1.3* Na-136 K-3.7 Cl-102 HCO3-20* AnGap-14 ___ 04:30AM BLOOD ALT-14 AST-11 AlkPhos-116 TotBili-0.5 ___ 01:41PM BLOOD Calcium-8.8 Phos-2.2* Mg-1.9 ___ 10:29AM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG ___ 04:30AM BLOOD ___ CRP-47.9* ___ 01:41PM BLOOD CMV IgG-POS* EBV IgG-POS* EBNA-POS* EBV IgM-NEG EBVI-Results in ___ 10:29AM BLOOD HIV Ab-NEG ___ 10:29AM BLOOD HCV Ab-NEG ___ 04:46AM BLOOD Lactate-1.3 IMAGING ========= UPPER EXTREMITY VENOUS DOPPLERS ___ No evidence of deep vein thrombosis in the bilateral upper extremity veins TTE ___ #1 CONCLUSION: The left atrium is normal in size. The right atrial pressure could not be estimated. There is mild symmetric left ventricular hypertrophy with a normal cavity size. There is normal regional and global left ventricular systolic function. The visually estimated left ventricular ejection fraction is 65%. Left ventricular cardiac index is normal (>2.5 L/min/m2). There is no resting left ventricular outflow tract gradient. No ventricular septal defect is seen. Normal right ventricular cavity size with normal free wall motion. There is a normal descending aorta diameter. The aortic valve leaflets (3) appear structurally normal. There is no aortic valve stenosis. There is no aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is trivial mitral regurgitation. The pulmonic valve leaflets are normal. There is physiologic tricuspid regurgitation. The pulmonary artery systolic pressure could not be estimated. There is a large circumferential pericardial effusion. There is increased respiratory variation in transmitral inflow c/w increased pericardial pressure/ tamponade physiology. There is early right ventricular diastolic collapse consistent with early tamponade physiology. IMPRESSION: Focused study. Large (max 2.3 cm, located adjacent to the mid-anterolateral wall) circumferential pericardial effusion with increased respiratory variation in transmitral inflow and right ventricular outflow tract invagination in early diastole consistent with increased pericardial pressure/tamponade physiology. Mild symmetric left ventricular hypertrophy with normal cavity size and biventricular systolic function. TTE ___ #2 CONCLUSION: The left atrium is normal in size. There is mild symmetric left ventricular hypertrophy with a normal cavity size. There is normal regional and global left ventricular systolic function. Left ventricular cardiac index is normal (>2.5 L/min/m2). There is no resting left ventricular outflow tract gradient. No ventricular septal defect is seen. Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. There is a normal descending aorta diameter. The aortic valve leaflets (3) appear structurally normal. There is no aortic valve stenosis. There is no aortic regurgitation. The mitral valve leaflets appear structurally normal. There is trivial mitral regurgitation. The pulmonic valve leaflets are normal. The tricuspid valve leaflets appear structurally normal. There is trivial tricuspid regurgitation. The estimated pulmonary artery systolic pressure is normal. There is a moderate to large circumferential pericardial effusion. There is increased respiratory variation in transmitral/transtricuspid inflow but no right atrial/right ventricular diastolic collapse. IMPRESSION: Moderate to large pericardial effusion as described above with increased respiratory variation in transtricuspid inflow but no overt right atrial or right ventricular diastolic collapse. Compared with the prior TTE (images reviewed) of ___ , subcostal views do not demonstrate clear evidence of right ventricular diastolic collapse (previously not well seen). TTE ___ The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with a normal cavity size. Overall left ventricular systolic function is normal. The visually estimated left ventricular ejection fraction is >=60%. Normal right ventricular cavity size with normal free wall motion. The aortic valve leaflets (?#) appear structurally normal. The mitral valve leaflets appear structurally normal. There is a moderate circumferential pericardial effusion, most prominent inferor and lateral to the left ventricle with minimal (<1 cm) anterior to the right ventricle and right atrium. There is no respiratory eccentuation of of transmitral flow. There is right ventricular diastolic collapse c/w increased pericardial pressure/tamponade physiology. IMPRESSION: Moderate circumferential pericardial effusion most prominent inferior and lateral to the left ventricle with echocardiographic evidence for increased pericardial pressure/tamponade physiology. Mild symmetric left ventricular hypertrophy with normal biventricular cavity sizes and global biventricular systolic function. Compared with the prior TTE (images reviewed) of ___, the findings are similar. TTE ___ The left atrium is normal in size. The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with a normal cavity size. There is suboptimal image quality to assess regional left ventricular function. Overall left ventricular systolic function is normal. The visually estimated left ventricular ejection fraction is >=55%. Normal right ventricular cavity size with normal free wall motion. The aortic sinus is mildly dilated. There is a normal descending aorta diameter. The aortic valve is not well seen. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. The pulmonic valve leaflets are normal. The tricuspid valve leaflets appear structurally normal. There is trivial tricuspid regurgitation. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: No pericardial effusion present. Mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function. Normal estimated pulmonary artery systolic pressure. Compared with the prior TTE ___ , there has been interval resolution of pericardial tamponade. CT ABD & PELVIS WITH CONTRAST Study Date of ___ 5:57 ___ FINDINGS: LOWER CHEST: There is a small left pleural effusion with overlying compressive atelectasis. There is trace right basilar atelectasis. The previously seen large pericardial effusion is largerly resolved. ABDOMEN: HEPATOBILIARY: The liver demonstrates homogenous attenuation throughout. There is no evidence of focal lesions. There is no evidence of intrahepatic or extrahepatic biliary dilatation. The gallbladder is within normal limits. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions or pancreatic ductal dilatation. There is no peripancreatic stranding. SPLEEN: The spleen shows normal size and attenuation throughout, without evidence of focal lesions. ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: The kidneys are of normal and symmetric size with normal nephrogram. There is a 1.4 cm cyst in the lower pole of the left kidney. There is no evidence of hydronephrosis. There is no perinephric abnormality. GASTROINTESTINAL: The stomach is unremarkable. Small bowel loops demonstrate normal caliber, wall thickness, and enhancement throughout. The colon and rectum are within normal limits. The appendix is normal. PELVIS: The urinary bladder is decompressed. The distal ureters are unremarkable. There is no free fluid in the pelvis. REPRODUCTIVE ORGANS: The visualized reproductive organs are unremarkable. LYMPH NODES: There is no retroperitoneal or mesenteric lymphadenopathy. There is no pelvic or inguinal lymphadenopathy. VASCULAR: There is no abdominal aortic aneurysm. No atherosclerotic disease is noted. BONES: There is no evidence of worrisome osseous lesions or acute fracture. SOFT TISSUES: The abdominal and pelvic wall is within normal limits. IMPRESSION: 1. No evidence of mass or lymphadenopathy in the abdomen and pelvis. 2. Small left pleural effusion and bibasilar atelectasis. DUPLEX DOP ABD/PEL LIMITED Study Date of ___ 1:30 ___ FINDINGS: Liver: The visualized hepatic parenchyma is within normal limits. Doppler evaluation: Right, middle and left hepatic veins are patent, with appropriate waveforms. Visualized IVC is patent with normal Doppler waveform. IMPRESSION: Patent hepatic veins. Pathology =========== #####################Pathology Examination Name ___ Age Sex Pathology # ___ MRN# ___ ___ ___ Male ___ Report to: ___. ___ ___ by: ___. ___ SPECIMEN SUBMITTED: Immunophenotyping: peripheral blood Procedure date Tissue received Report Date Diagnosed by ___ ___. ___ Previous biopsies: ___ PERICARDIUM, BIOPSY OR TISSUE FLOW CYTOMETRY IMMUNOPHENOTYPING The following tests (antibodies) were performed: Kappa, Lambda, ___ ___ antigens 2, 3, 4, 5, 7, 8, 10, 11c, 13, 14, 16, 19, 20, 23, 33, 34, 38, 45, 56, 64 and 117. RESULTS: 10-color analysis with CD45 vs. side-scatter gating is used to evaluate for leukemia/lymphoma. Approximately 90.5% of total acquired events are evaluable non-debris events. The viability of the analyzed non-debris events, done by 7-AAD is 90.0%. CD45-bright, low side-scatter gated lymphocytes comprise 6.1% of total analyzed events. B cells comprise 5.5% of lymphoid gated events, are polyclonal and do not co-express aberrant antigens. T cells comprise 79.0% of lymphoid gated events and express mature lineage antigens (CD3, CD5, CD2 and CD7). A minor subset of T cells (mix of CD4 positive and CD8 positive T cells) shows dim/variable loss of CD7 (non-specific finding). T cells have a CD4:CD8 ratio of 1.3 (usual range in blood 0.7-3.0). CD56 positive, CD3 negative natural killer cells represent 12.8% of gated lymphocytes and are normal in number (usual range in blood ___. They co-express CD2, CD7 and CD8 (subset). No abnormal events are identified in the “blast gate”. INTERPRETATION: Non-specific T cell predominant lymphoid profile; diagnostic immunophenotypic features of involvement by leukemia/lymphoma are not seen in this specimen. Correlation with clinical and other ancillary findings is recommended. Flow cytometry immunophenotyping may not detect all abnormal populations due to topography, sampling or artifacts of sample preparation. Note: The Technical component of this test was completed at ___, ___ / ___ # ___. The Professional component of this test was completed at ___ ___, Pathology, ___, ___. This test was developed and its performance characteristics determined by NeoGenomics Laboratories. It has not been cleared or approved by the ___. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of ___ (___) as qualified to perform high complexity clinical testing. #########################CYTOGENETICS REPORT - Revised Clinical: eosinophilia ___: peripheral blood CYTOGENETIC DIAGNOSIS: Cell culture for chromosome analysis in progress. See FISH results below. FISH: NEGATIVE for REARRANGEMENT of PDGFRA, PDGFRB and FGFR1. No evidence of interphase peripheral blood cells with rearrangement of the PDGFRA, PDGFRB and FGFR1 genes. Uncultured cells for fluorescence in situ hybridization (FISH) analysis with the ___ Molecular 4q12 tri-color rearrangement break apart probe set: SpectrumGreen directly labeled probe for the ___ gene centromeric to the 5' end of the FIP1L1 gene on ___, SpectrumOrange directly labeled probe for the LNX gene telomeric to the 3' end of FIP1L1, and SpectrumAqua directly labeled probe for the KIT gene and the telomeric 3' end of the PDGFRA gene. This probe combination detects the cytogenetically cryptic FIP1LI/PDGFRA gene rearrangement associated with chronic eosinophilic leukemia, as well as other rearrangements of PDGFRA. FINDINGS: A total of 200 interphase nuclei were examined with the 4q12 tri-color break apart probe set and fluorescence microscopy. 200 cells (100%) had the normal 2 green-red-aqua fusion signals. 0 cells (0%) had 1 green-red-aqua fusion signal and 1 green-aqua signal. 0 cells (0%) had 1 green-red-aqua fusion signal, 1 green-red ___ ___ Department of Pathology Patient: ___ Page 2 of 3 signal and 1 aqua signal. Normal cut-off values for this probe set include: 91% for the normal 2 green-red-aqua fusion signal pattern, 1% for a 1 green-red-aqua fusion and 1 green-aqua fusion pattern, and 7% for a 1 green-red-aqua fusion, 1 green-red fusion and 1 aqua signal pattern. nuc ish(___,LNX,3'PDGFRA/KIT)x2[200] A second hybridization was performed with the ___ PDGFRB dual color break apart probe set: ___ (red) directly labeled probe for a DNA sequence centromeric to the 3' end of the PDGFRB gene on ___ and ___ (green) directly labeled probe for a DNA sequence telomeric to the 5' end of the PDGFRB gene. This probe combination detects rearrangements of the PDGFRB gene which can be seen in some myeloproliferative disorders, often with eosinophilia. FINDINGS: A total of 200 interphase nuclei were examined with the PDGFRB break apart probe set and fluorescence microscopy. 200 cells (100%) had ___ yellow (red-green fusion) signals. 0 cells (0%) had ___ yellow (red-green fusion) signal, 1 red signal and 1 green signal. Normal cut-off values for this probe set include: 92% for a normal ___ yellow (red-green fusion) signal pattern and 2.5% for a ___ yellow (red-green fusion), 1 red and 1 green signal pattern. nuc ish(PDGFRBx2)[200] A third hybridization was performed with the Cytocell FGFR1 tri-color break apart probe set: Red fluorophore directly labeled probe for a DNA sequence centromeric to the 3' end of the FGFR1 gene on 8p11.2, green fluorophore directly labeled probe for a DNA sequence telomeric to the 5' end of the FGFR1 gene, and blue fluorophore directly labeled probe for the centromeric region of chromosome 8. This probe combination detects rearrangements of the FGFR1 gene associated with the 8p11 myeloproliferative syndrome and some lymphoid neoplasms. Amplification of FGFR1, seen in some solid tumors, can also be detected. FINDINGS: A total of 200 interphase nuclei were examined with the FGFR1 tri-color break apart probe set and fluorescence microscopy. 200 cells (100%) had the normal 2 red-green fusion signals and 2 aqua signals. 0 cells (0%) had 1 green-red fusion signal, 1 red signal, 1 green signal and 2 aqua signals. Normal cut-off values for this probe set include: 95% for the normal 2 red-green fusion and 2 aqua signal pattern and 2% for a 1 red-green, 1 red, 1 green and 2 aqua pattern. nuc ish(FGFR1,8cen)x2[200] This test was developed and its performance characteristics determined by ___. It has not been cleared or approved by the ___ Food and Drug Administration (FDA). The FDA does not require this test to go through premarket FDA review. This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. 2) FISH: NEGATIVE for JAK2 REARRANGEMENT. No evidence of interphase peripheral blood cells with rearrangement of the JAK2 gene. This FISH assay does not test for the JAK2 V617F mutation that requires molecular analysis for detection. Uncultured cells for fluorescence in situ hybridization (FISH) analysis with the ___ JAK2 dual color break apart probe set: PlatinumBright___ (red) directly labeled probe for a DNA sequence telomeric to the 5' end of the JAK2 gene on ___ and PlatinumBright495 (green) directly labeled probe for a DNA sequence centromeric to the 3' end of the JAK2 gene. This probe combination detects rearrangements of the JAK2 gene which can be seen in myeloproliferative neoplasms. FINDINGS: A total of 200 interphase nuclei were examined with the JAK2 break apart probe set and fluorescence microscopy. 200 cells (100%) had ___ yellow (red-green fusion) signals. 0 cells (0%) had ___ yellow (red-green fusion) signal, 1 red signal and 1 green signal. Normal cut-off values for this probe set include: 96% for a normal ___ yellow (red-green fusion) signal pattern and 2% for a ___ yellow (red-green fusion), 1 red and 1 green signal pattern. nuc ish(JAK2x2)[200] This test was developed and its performance characteristics determined by ___ Laboratory. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA does not require this test to go through premarket FDA review. This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. ___ ___ Procedure date Tissue received Report Date Diagnosed by ___ ___. ___ Previous biopsies: ___ BLOOD, NEOPLASTIC ___ Immunophenotyping: peripheral blood ___ PERICARDIUM, BIOPSY OR TISSUE INTERPRETATION: Non-specific T cell predominant lymphoid profile; diagnostic immunophenotypic features of involvement by leukemia/lymphoma are not seen in this specimen. Correlation with clinical, morphologic (see separate pathology report ___ and other ancillary findings is recommended. Flow cytometry immunophenotyping may not detect all abnormal populations due to topography, sampling or artifacts of sample preparation. SPECIMEN: BONE MARROW ASPIRATE AND CORE BIOPSY DIAGNOSIS: MILDLY HYPERCELLULAR BONE MARROW FOR AGE WITH MATURING TRILINEAGE HEMATOPOIESIS, MARKED EOSINOPHILIA AND NO MORPHOLOGIC EVIDENCE OF LEUKEMIA/LYMPHOMA OR A MAST CELL DISORDER; SEE NOTE The aspirate smears and core biopsy show numerous eosinophils and eosinophil precursors with normal granulation. A discrete abnormal blast or lymphoid infiltrate is not identified nor is an abnormal mast cell population seen. Corresponding flow cytometry revealed no diagnostic immunophenotypic features of involvement by leukemia/lymphoma (see separate report ___ for full results). Cytogenetics work-up revealed a normal male karyotype and no evidence of rearrangement of the PDGFRA, PDGFRB and FGFR1 genes by ___ (see separate reports ___ and ___). T cell receptor gamma gene rearrangement PCR performed at ___ was positive indicating the presence of clonal T cell population (see OMR for full results). Diagnostic morphologic features of involvement by a lymphoid or mast cell disorder are not seen. The failure to demonstrate a clonal chromosomal abnormality argues against a myeloid neoplasm. A myeloid sequencing panel is pending. The TCR PCR result raises the possibility of the lymphoid variant of hypereosinophilic syndrome. However, a discrete abnormal T cell population was not demonstrated by flow cytometry. If all secondary causes for eosinophilia are excluded, an idiopathic hypereosinophilic syndrome should be entertained. Correlation with all available clinical, laboratory and other ancillary findings is recommended for further characterization. CLINICAL HISTORY: Hypereosinophilia CYTOGENETICS PROCEDURE: Unstimulated and 3 day DSP30/IL2-stimulated cultures for Giemsa-banded chromosome analysis. FINDINGS: An apparently normal 46,XY male chromosome complement was observed in 20 mitotic cells examined in detail. Chromosome band resolution was 400. A karyogram was prepared on 4 cells. Discharge Labs ================== ___ 05:06AM BLOOD WBC-9.8 RBC-3.70* Hgb-11.3* Hct-34.8* MCV-94 MCH-30.5 MCHC-32.5 RDW-14.0 RDWSD-47.9* Plt ___ ___ 05:06AM BLOOD Neuts-64.0 ___ Monos-11.6 Eos-1.1 Baso-0.2 Im ___ AbsNeut-6.28* AbsLymp-2.13 AbsMono-1.14* AbsEos-0.11 AbsBaso-0.02 ___ 05:06AM BLOOD Glucose-143* UreaN-17 Creat-1.0 Na-141 K-4.7 Cl-105 HCO3-26 AnGap-10 ___ 05:06AM BLOOD ALT-220* AST-39 AlkPhos-130 TotBili-0.2 Brief Hospital Course: Mr. ___ is a ___ yo M with no PMHx who presents as transfer from ___ with SOB found to have a pericardial effusion concerning for tamponade physiology s/p pericardial window on ___. Further workup remarkable for profound eosinophilia, with evidence of end organ damage (pericarditis, Transaminitis), meeting criteria for hypereosinophilic syndrome. Etiology of his eosinophilia unclear at the time of discharge, see below. TI ------- [] Discharged on high dose prednisone, ensure patient is taking his ppx meds (PPI, Bactrim, vitD, Calcium) [] Patient does not have a PCP, he was given instructions to set up with a PCP. Confirm that he has done this, if so, please ensure PCP gets ___ copy of his discharge summary [] Patient has expressed symptoms of anhedonia, isolation prior to admission, started on fluoxetine 20, consider uptitrating [] F/u lab work ___ ___ 9 [] Recommend repeat CXR within 6 weeks of discharge for interval change in pleural effusion s/p pericardial window [] Removal of sutures from left chest tube site at next appointment ACUTE ISSUES: ============= # Hypereosinophilic Syndrome (HES) Admission labs/diff w/ eosinophil count of 5k which uptrended to 19k prior to initiation of prednisone. He was also found w/ eos in his pericardial fluid and biopsy, meeting criteria for end organ damage, meeting criteria for Hypereosinophilic Syndrome. Briefly, to delineate between a primary process (heme malignancy) vs a secondary process (parasite/allergy etc) an IgE was sent which returned wnl, thus making the diagnosis of secondary eosinophilia less likely. This raised concern for a myeloid lineage neoplasia such as CEL, or a Tcell leukemia producing IL-5, however cytology performed on peripheral blood is negative for PDGFRA, PDGFRB, FGFR1, and JAK2. Furthermore, the bone marrow biopsy revealed no e/o leukemia or lymphoma. Flow cytometry also failed to reveal a clonal population of Tcells. One result that did return positive was the TC receptor rearrangement. This is associated with T-cell leukemia, but is non-specific. At the time of discharge, etiology remains unknown. A summary of the pertinent laboratory/imaging findings is copied below for completeness. When the pericardial fluid showed eosinophilia, and the diagnosis of HES was made, the patient was started on 1mg/kg of prednisone daily with downtrended to <1.5k at the time of discharge. We subsequently started the patient on Vit D, Calcium, ppi, and Bactrim. ============================ Serum IgE: normal ___: negative ANCA: negative VitB12: 461 RheuFac: <10 CT A/P: no adenopathy or splenomegaly Peripheral blood cytogenetics negative for JAK2 and PDGFRA Tryptase: normal T-cell rearrangement PCR: positive Flow cytometry: negative for clonal population of lymphocytes Bone marrow aspirate and biopsy: MILDLY HYPERCELLULAR BONE MARROW FOR AGE WITH MATURING TRILINEAGE HEMATOPOIESIS, MARKED EOSINOPHILIA AND NO MORPHOLOGIC EVIDENCE OF LEUKEMIA/LYMPHOMA OR A MAST CELL DISORDER. ================================ # Pericardial Effusion complicated by tamponade # VATS w/ pericardial window Patient presented with new pericardial effusion noted on CTA, elevated pulsus, and TTE finding of increased transmitral respiratory inflow variation consistent with early tamponade physiology. Given the anatomic location of the effusion, he required VATS and window as opposed to subxyphoidal drain. Etiology of his pericarditis originally presumed viral, however path results showed numerous eosinophils, leading us to believe that his pericarditis was a manifestation of end organ damage from eosinophilia. He was started on colchicine, but discontinued this given that we started the patient on prednisone for HES as below. # Right upper extremity swelling # B/l UE pruritic rash Unclear etiology of swelling. Dopplers negative. Improved with prednisone.Patient first noticed the rash just prior to admission. The rash was mildly itchy and it was accompanied with bilateral arm swelling. He last used an antibiotic back in ___ and ___ to treat an abscess in his left axilla. Derm was consulted, did not recommend biopsy. Rash improved with steroids. # ___, resolved Unknown baseline. Most likely pre-renal ___ hypovolemia in the setting of acute illness with poor PO intake. Resolved following IVF. #CODE: Full (presumed) #CONTACT: None listed Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ibuprofen 800 mg PO DAILY:PRN Pain - Mild Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild Reason for PRN duplicate override: Alternating agents for similar severity RX *acetaminophen 500 mg ___ tablet(s) by mouth every eight (8) hours Disp #*120 Tablet Refills:*0 2. Calcium Carbonate 500 mg PO BID RX *calcium carbonate [Antacid Calcium] 215 mg calcium (500 mg) 2 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 3. FLUoxetine 20 mg PO DAILY RX *fluoxetine 20 mg 1 capsule(s) by mouth once a day Disp #*30 Capsule Refills:*0 4. Lidocaine 5% Patch 1 PTCH TD QAM RX *lidocaine 5 % apply once daily to shoulder once a day Disp #*30 Patch Refills:*0 5. Omeprazole 20 mg PO DAILY RX *omeprazole 20 mg 1 capsule(s) by mouth once a day Disp #*30 Capsule Refills:*0 6. PredniSONE 100 mg PO DAILY RX *prednisone 50 mg 2 tablet(s) by mouth once a day Disp #*60 Tablet Refills:*0 7. Sulfameth/Trimethoprim SS 1 TAB PO DAILY RX *sulfamethoxazole-trimethoprim 400 mg-80 mg 1 tab-cap by mouth once a day Disp #*30 Tablet Refills:*0 8. Vitamin D 1000 UNIT PO DAILY RX *ergocalciferol (vitamin D2) 2,000 unit 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary Pericarditis Tamponade Hypereosinophilic syndrome hepatitis acute kidney injury Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, WHY WERE YOU ADMITTED TO THE HOSPITAL? -You came to the hospital because you had fluid buildup around your heart. WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL? -The Thoracic Surgery doctors removed ___ around your heart through surgery. -You are found to have an injury to your kidneys. We gave you IV fluids and this resolved. -Our rheumatology and hematology doctors saw ___ for rash on your arms, muscle pain, and an increase in your white blood cell count. -We found that your eosinophil levels were dangerously high, which caused injury to your heart (pericardium) and your liver. -We performed a bone marrow biopsy and a variety of genetic studies on your bone marrow to identify the etiology of your eosinophilia (high eosinophil count) -We started you on high dose steroid medications to lower your eosinophil count WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Do not take any more NSAID medications while on prednisone - Take all of your medications as prescribed (listed below) - Follow up with your doctors as listed below . - Please see below for more information on your hospitalization. It was a pleasure taking part in your care here at ___! We wish you all the best! - Your ___ Care Team Followup Instructions: ___
19801566-DS-7
19,801,566
22,118,192
DS
7
2133-10-25 00:00:00
2133-10-25 17:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: AMS, Dyspnea Major Surgical or Invasive Procedure: G TUBE REPLACEMENT ___ History of Present Illness: Mr. ___ is a ___ gentleman with advanced ALS (chronically on BiPAP 24 hours/day), CAD s/p CABG & BMS, NIDDM who presents with ___ days of chest pain, dyspnea, diaphoresis, and altered mental status. History was primarily obtained from patient's two sons and daughter due to patient's limited ability to communicate. Patient's family reports that he has had a gradual decline in both physical mobility and respiratory status over past 6 months, requiring increasing levels of BiPAP support. They report an acute change over the past ___ days. They report he has been working slightly harder to breathe and has been slightly more confused compared to baseline. Per family, he's had urinary tract infections in the past with similar presentations. Mr. ___ has not had any fevers, increased sputum production, vomiting, or diarrhea. In the ED, initial vitals were T98 HR93 BP111/90 RR20 98% on BiPAP. Exam notable for lethargy, confusion, abdominal tenderness, and increased work of breathing. Labs were notable for WBC 7.5, Hg 14.6, troponin of 0.27 < - 0.19, lactate 2.1 <- 3.2, Cr 0.3, Na 138, K 4.0, proBNP of 148, and D-dimer of 701. VBG was 7.44/41/63/29. UA was notable for 19 WBC and moderate bacteria with nitrite positivity. The patient underwent CT A/P which was notable for diffuse bladder wall thickening concerning for active cystitis, but otherwise no acute process. CXR demonstrated low lung volumes with no concern for focal consolidation. He was given 1g CFTX, 1L NS, 10mg oxycodone 10mg, 1g Tylenol, aspirin, and started on a heparin gtt. In the setting of troponinemia, Cardiology was consulted and recommended medical management and treating underlying demand. While in the ED, DNR/DNI status was confirmed with the patient, but given requirement for BiPAP he was admitted to the ICU for further management. On arrival to the MICU, patient denies ongoing shortness of breath or chest pain. He does complain of increased secretions and requests suctioning. Daughter reports he appears somewhat more uncomfortable than his baseline, but he appears to be back at his baseline level of alertness and interactivity. Past Medical History: ALS, complicated by: - Chronic respiratory failure requiring 24-hour BiPAP at home - Neurogenic bladder requiring straight cath ___ times daily - Dysphagia requiring G-tube - Chronic pain and dyspnea on standing morphine CAD s/p CABG (3v LIMA to LAD, SVG to L PDA), PCI OM1 with BMS ___ DM2 on glimepiride HTN Social History: ___ Family History: Mother - DM Physical ___: ADMISSION EXAM: =============== VITALS: Afebrile SBP 200s HR ___ RR ___ SpO2 high ___ on BiPAP GENERAL: Thin man lying flat with BiPAP on, appears uncomfortable but not in distress HEENT: No icterus or injection. EOMI. NECK: No meningismus. JVP not elevated CARDIAC: Tachycardic, regular, no m/r/g LUNG: Exam limited by BiPAP sounds. No clear crackles or wheezes. ABDOMEN: Soft, mild diffuse tenderness, no rebound or guarding. Hypoactive BS. G-tube with visible yeast or bacterial colonies; exit site clean, no erythema, warmth, tenderness, or prurulence. EXTREMITIES: Warm, no edema. NEURO: Alert, tracks with eyes, reacts to voice and commands, able to communicate by tracing letters with left index finger. Marked diffuse muscular weakness and atrophy. DISCHARGE EXAM: ================= VITALS: Afebrile. HR ___. SBP 130s-170s. RR ___ on BiPAP, SpO2 96-98% GENERAL: Thin man lying flat with BiPAP, appears comfortable. CV: RRR, no m/r/g RESP: Non-labored breathing on BiPAP ABD: Soft, NDNT. G-tube CDI. EXT: Warm, atrophied, trace edema. NEURO: Alert, tracks with eyes, able to communicate by head nod and tracing letter with left index finger. Marked diffuse weakness and atrophy. Pertinent Results: ADMISSION LABS: ================ ___ 09:50PM BLOOD WBC-9.0 RBC-5.48 Hgb-14.4 Hct-45.2 MCV-83 MCH-26.3 MCHC-31.9* RDW-15.2 RDWSD-45.4 Plt ___ ___ 09:50PM BLOOD Neuts-69.5 Lymphs-17.2* Monos-7.0 Eos-5.5 Baso-0.4 Im ___ AbsNeut-6.22* AbsLymp-1.54 AbsMono-0.63 AbsEos-0.49 AbsBaso-0.04 ___ 09:50PM BLOOD ___ PTT-29.5 ___ ___ 09:50PM BLOOD Glucose-262* UreaN-23* Creat-0.4* Na-135 K-4.0 Cl-95* HCO3-25 AnGap-19 ___ 09:50PM BLOOD ALT-35 AST-41* AlkPhos-171* TotBili-0.2 ___ 09:50PM BLOOD Lipase-21 ___ 09:50PM BLOOD cTropnT-0.19* ___ 09:50PM BLOOD Albumin-3.7 Calcium-9.5 Phos-3.9 Mg-2.2 ___ 08:37AM BLOOD D-Dimer-701* ___ 09:50PM BLOOD ___ pO2-63* pCO2-41 pH-7.44 calTCO2-29 Base XS-3 DISCHARGE LABS: ================ ___ 03:10AM BLOOD WBC-8.6 RBC-4.96 Hgb-13.0* Hct-41.4 MCV-84 MCH-26.2 MCHC-31.4* RDW-15.1 RDWSD-45.9 Plt ___ ___ 03:10AM BLOOD Glucose-289* UreaN-15 Creat-0.3* Na-130* K-4.3 Cl-95* HCO3-23 AnGap-16 MICRO: ======== URINE CULTURE (Final ___: KLEBSIELLA PNEUMONIAE. >100,000 CFU/mL. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ KLEBSIELLA PNEUMONIAE | AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S IMAGING/STUDIES: ================= ___ CT A/P: 1. Diffuse bladder wall thickening is not fully explained by the degree of underdistention. Although some of this may relate to chronic outflow obstruction the setting of a mildly enlarged prostate gland, findingsraise concern for cystitis. Correlate with urinalysis. Normal CT appearance enhancement of the kidneys. Otherwise, no acute process identified within the abdomen or pelvis. 2. Patchy, regional areas of hypoenhancing hepatic parenchyma are favored to represent areas of hepatic steatosis. 3. Severe coronary artery calcification. Bibasilar atelectasis. Other incidental findings, as above. ECG ___ Sinus rhythm. Lateral T wave inversions that are non-specific. Compared to tracing #2 frequent atrial premature contractions have resolved. Lateral T wave inversions persist without significant change. Clinical correlation is suggested. ___ TTE: Left ventricular wall thickness, cavity size, and global systolic function are normal (LVEF = 70%). Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Right ventricular chamber size and free wall motion are normal. The aortic arch is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. ___ LOWER EXTREMITY ULTRASOUND: No evidence of deep venous thrombosis in the right or left lower extremity veins. ___ G-TUBE REPLACEMENT Successful exchange of a Ponsky gastric tube for a new 20 ___ mic gastric tube. The tube is ready to use. Brief Hospital Course: ___ with advanced ALS (on BiPAP at home), CAD s/p CABG, who presented with several days of increased work of breathing, chest pain, and altered mental status and was found to have an NSTEMI and UTI. He remained hemodynamically stable but was admitted to the ICU due to need for BiPAP. ================================ ACTIVE ISSUES ================================ #NSTEMI Patient with known CAD s/p CABG and BMS, presenting with chest pain, diaphoresis, tachycardia, and dyspnea concerning for ACS vs. demand ischemia in setting of UTI, hypoxemia, and hypertension. Troponin/CK-MB peaked at 0.35/13. Serial ECGs showed non-specific but dynamic changes c/f active ischemia. TTE was suboptimal quality but found no preserved EF 70% and no clear focal wall motion abnormality or other pathology. Cardiology was consulted and recommended medical management since invasive procedures were not within goals of care per family. He was treated with heparin gtt x 48 hours, aspirin, atorvastatin 80mg, metoprolol, nitroglycerin gtt (later transitioned to isorbide monotritate), and home losartan. Symptoms and BP control improved and patient was discharged at baseline. #HTN Patient was normotensive in ED but had persistently elevated SBP to 180s-200s on admission to FICU, likely due to missed meds in ED but possibly due to inactivation of home metoprolol XL and nitrate by crushing for administration through G-tube. He was initially stabilized with nitroglycerin gtt, later transitioned to isorbide mononitrate, metoprolol tartrate, and previous losartan 25 mg daily. #ACUTE ON CHRONIC RESPIRATORY FAILURE Patient on continuous BiPAP at home for chronic respiratory muscle weakness ___ ALS. He presented with several days of worsened dyspnea, likely multifactorial -- NSTEMI, possible pulmonary edema ___ HTN, increased CO2 production ___ UTI. CT found significant basilar atelectasis but no pneumonia or effusions. NSTEMI raised concern for PE given immobility, but bilateral ___ dopplers were negative for DVT and work of breathing improved quickly by increasing tidal volume on BiPAP. #COMPLICATED UTI Patient presented with AMS similar to prior UTIs. CT abdomen/pelvis found bladder wall thickening consistent with cystitis but no evidence for upper tract infection. Urine culture grew pan-sensitive Klebsiella. He remained hemodynamically stable with no evidence for sepsis. He was treated initially with ceftriaxone, later narrowed to PO Bactrim for 7-day ___. #DIABETES MELLITUS, TYPE 2, c/b #HYPERGLYCEMIA Patient was markedly hyperglycemic on admission but had no ketonuria to suggest DKA/HHS. He was started on new insulin regimen this admission, continued at discharge. #ADVANCED ALS Family reported progressive decline in mobility and respiratory function over 6 months prior to admission requiring ___ home care by family. Code status remained DNR/DNI and efforts were made to maximize patient's comfort, as well as to connect his family with home services. Palliative Care was additionally consulted and recommended initiation of fentanyl patch and NSAID as well as up-titration of morphine for patient's chronic pain and dyspnea, and provided contacts for outpatient services. #NEUROGENIC BLADDER Continued home straight cath regimen q4-6h and prn #CHRONIC DYSPHAGIA G-tube was replaced by ___ without complication and home tube feeds were continued. =========================== TRANSITIONAL ISSUES: =========================== # New medications: Glargine 10u qHS; Humalog 5 qAC; metop tartrate 25 BID (XL not compatible with G-tube); isorbide mononitrate BID (ER not compatible with G-tube); increased losartan from 25 to 50 mg daily; liquid morphine; fentanyl patch. # Bactrim DS x 7 days for complicated UTI (last dose ___ # Stopped meds: bisoprolol; metoprolol XL; isorbide mononitrate ER # Continue to monitor BG and adjust diabetes regimen as indicated. # Continue to monitor BP, consider increasing doses. # Family would like to reestablish Neurology f/u with Dr. ___. # Encourage family to call ___ Care clinic for assistance with symptom management and home care resources. # Healthcare Proxy: Dr. ___ (son) ___ # Code Status: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO/NG DAILY 2. bisoprolol fumarate 2.5 mg oral DAILY 3. OxyCODONE (Immediate Release) 10 mg PO Q6H 4. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 5. Ranitidine 150 mg PO BID 6. Losartan Potassium 25 mg PO DAILY 7. glimepiride 1 mg oral BID 8. Glycopyrrolate 1 mg PO/NG BID 9. Lactulose 30 mL PO DAILY:PRN constipation 10. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB Discharge Medications: 1. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*3 2. Fentanyl Patch 25 mcg/h TD Q72H RX *fentanyl 25 mcg/hour Place on skin with fatty tissue beneath (e.g. thigh). Change every 72 hours. change every 72 hours Disp #*30 Patch Refills:*0 3. Glargine 12 Units Bedtime Humalog 5 Units Breakfast Humalog 5 Units Lunch Humalog 5 Units Dinner Insulin SC Sliding Scale using HUM Insulin RX *insulin glargine [Lantus] 100 unit/mL AS DIR 12 Units before BED; Disp #*3 Vial Refills:*0 RX *insulin lispro [Humalog] 100 unit/mL AS DIR 5 units with meals Disp #*10 Vial Refills:*3 4. Metoprolol Tartrate 25 mg PO BID RX *metoprolol tartrate 25 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*3 5. OxycoDONE Liquid 10 mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg/5 mL 10 mg by mouth every 4 hours as needed Refills:*0 6. Sulfameth/Trimethoprim DS 1 TAB PO BID RX *sulfamethoxazole-trimethoprim 200 mg-40 mg/5 mL 20 ml G-tube twice a day Refills:*0 7. Isosorbide Mononitrate 30 mg PO BID RX *isosorbide mononitrate 10 mg 3 tablet(s) G-tube twice a day Disp #*90 Tablet Refills:*3 8. Losartan Potassium 50 mg PO DAILY RX *losartan 50 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*3 9. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB 10. Aspirin 81 mg PO DAILY 11. Glycopyrrolate 1 mg PO BID 12. Lactulose 30 mL PO DAILY:PRN constipation 13. Ranitidine 150 mg PO BID Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES: ======================= Non-ST elevation myocardial infarction Acute on chronic hypercarbic respiratory failure Amyotrophic lateral sclerosis Bibasilar atelectasis Hypertension Complicated lower urinary tract infection SECONDARY DIAGNOSES ========================== Type 2 diabetes mellitus with hyperglycemia Chronic dysphagia status post gastric tube placement Neurogenic bladder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Lethargic but arousable. Activity Status: Bedbound. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. Why you were admitted: - shortness of breath - small heart attack (NSTEMI) - urinary tract infection What we did while you were here: - You were admitted to the ICU for close monitoring and treatment. - We adjusted your breathing machine (BiPAP) and your breathing improved. - Our Cardiology specialists evaluated you, and we treated your heart attack with medicines. Your chest pain and blood pressure got better. - We gave you antibiotics for your urinary infection. - We replaced your feeding tube. - We adjusted your pain medications. Instruction for when you leave the hospital: - Follow up with your Primary Care and Neurology doctors. - We made some changes to your medications. Please review the detailed instructions in this packet. - Finish the whole course of antibiotics (Bactrim) for your urinary infection. - If you have chest pain or shortness of breath, check your heart rate, blood pressure, and oxygen level. If these are normal, you can try nitroglycerin (up to 3 tabs). - Don't hesitate to call your doctor or return to the ER if you have any recurrence of symptoms. We wish you all the best. Sincerely, Your ___ Care Team Followup Instructions: ___
19801812-DS-10
19,801,812
27,130,921
DS
10
2163-09-23 00:00:00
2163-09-23 16:36:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: amoxicillin / Penicillins / Adderall Attending: ___ Chief Complaint: gluteal spasms, lower extremity parasthesias Major Surgical or Invasive Procedure: Lumbar puncture, ___ guided History of Present Illness: The patient is a ___ with hx of L4-5 disc bulge, low back pain, and sciatica here with ___ months of progressive primarily sensory symptoms. Pt reports that several years ago, he had relatively sudden onset low back pain and sciatica (radiating down both legs) found to have L4-L5 disc bulge. The pain was severe to the point where it would prevent walking. He had severe/significant symptoms for 6 months and then this improved and he only has residual low back pain from this - no radicular symptoms. He denied any sensory symptoms at this time. Over the last ___ months, he has felt progressive onset of the following symptoms - he cannot remember the exact order in which they occurred. He has had pulling/pressure around his waist as if he is wearing a belt, right around the area where one would lie - at his hips. He also endorsed decreased sensation to light touch "from his hips down" involving both his legs equally. He particularly notes decreased sensation around his groin and buttocks bilaterally to the point where he feels that when he is voiding urine and stool, the sensation is abnormal/different in that he cannot feel the urine or stool and instead feels a "pressure". He denies any urinary retention or incontinence, though he does feel like there may be some rectal leaking. He has also noted erectile dysfunction in addition to feeling his gluteal muscles are spasming. He also feels increased pain in his back when sitting up - relieved with lying flat. He also feels that his left leg/buttock is weaker compared to the right which he especially notices when he bends over - feeling that he needs to hold onto something to stabilize himself. Finally, he has also noticed tingling in both feet left more than right and his left whole hand that has been intermittent. On neurologic review of systems, the patient denies headache, lightheadedness. Denies difficulty with producing or comprehending speech. Denies loss of vision, blurred vision, diplopia, vertigo, tinnitus, hearing difficulty, dysarthria, or dysphagia. Denies bowel or bladder incontinence or retention. Denies difficulty with gait. On general review of systems, denies any recent illness, +tick bite ___ years ago but was treated and denies any tick exposure since then. Pt denies recent fever or chills. Denies cough, runny nose, sore throat, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash - has small ecchymosis under right armpit from "fight" that has not resolved. Pt is not a vegan and eats meat. Past Medical History: L knee surgery - meniscal tear Recent car accident 6 months ago - s/p recent Nasal septum surgery Social History: ___ Family History: No family history of autoimmune or neurologic disease. Physical Exam: ADMISSION PHYSICAL EXAM Vitals: 97.8F, HR 126---->98--->30s to ___, BP 112/68, RR 17, 96% on RA, Glu 113 General: Somnolent from ativan, cooperative, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: Supple. No nuchal rigidity Extremities: No ___ edema. Skin: Small ecchymosis under R armpit noted. No rashes noted. Neurologic: -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Attentive, able to name ___ backward slowly. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. There was no evidence of apraxia or neglect. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2mm and brisk. EOMI several beats of end gaze nystagmus b/l. VFF to confrontation. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 5 5 5 5 5 4+ R 5 ___ ___ 5 5 5 5 5 4+ Rectal tone per ED is decreased. -Sensory: Decreased light touch entire left leg and palm of left hand. Pt endorses decreased sensation in anterior groin as well to light touch. Decreased pinprick over right buttock around S3 and medially to perianal area which is S5, and left top of buttock around S3. Cold sensation intact in ___ and ___. Big toe joint proprioception intact at toes. Vibration at toes is >20 sec b/l. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 3 1 R 2 2 2 3 1 Plantar response was flexor bilaterally. No spasticity. No ankle clonus. b/l crossed adductors. +pectoral jerk on the L -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF or HKS bilaterally. -Gait: Good initiation. Narrow-based, normal stride and arm swing. Able to walk in tandem without difficulty. Romberg absent. Endorses feeling that his left leg is weaker on gait. DISCHARGE PHYSICAL EXAM: Gen: awake, alert, young man, anxious appearing HEENT: normocephalic, dried blood in nasal mucosa (per patient and wife, sequel of septoplasty earlier this week) CV: warm, well perfused Abdomen: soft, nontender Extremities: no edema Neurologic -Mental status: awake, alert, oriented to self, place, ___ and situation. Speech is fluent with no dysarthria. Easily maintains attention to examiner. Registers and recalls ___ objects at 5 minutes. -CN: Gaze conjugate, EOMI with no nystagmus, ___ 3>2, face symmetric, tongue midline, shoulder shrug intact bilaterally -Motor: normal bulk and tone. No tremor or asterixis. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 5 5 5 5 5 4+ R 5 ___ ___ 5 5 5 5 5 5 - Sensory: decreased sensation to light touch and pinprick in left lateral leg and patchy areas of anterior foot. No deficits to temperature throughout this area. Otherwise, normal sensation to light touch and pinprick in bilateral ___ and lower extremity. Notably, buttocks and groin area was specifically tested. Great toe joint proprioception intact at toes. Vibration at toes is >20 sec b/l. No extinction to DSS. - Coordination: No intention tremor, No dysmetria on FNF bilaterally. -Gait: Good initiation. Narrow-based, normal stride and arm swing. Able to walk in tandem without difficulty. Pertinent Results: ___ 06:15AM BLOOD WBC-4.2 RBC-5.25 Hgb-15.2 Hct-47.7 MCV-91 MCH-29.0 MCHC-31.9* RDW-12.1 RDWSD-40.0 Plt ___ ___ 09:45PM BLOOD Neuts-44.0 ___ Monos-12.1 Eos-2.1 Baso-0.9 Im ___ AbsNeut-2.88 AbsLymp-2.66 AbsMono-0.79 AbsEos-0.14 AbsBaso-0.06 ___ 06:15AM BLOOD Plt ___ ___ 06:15AM BLOOD Glucose-92 UreaN-19 Creat-0.8 Na-139 K-4.5 Cl-102 HCO3-27 AnGap-15 ___ 06:15AM BLOOD Calcium-9.6 Phos-3.7 Mg-2.0 Cholest-134 ___ 06:15AM BLOOD Triglyc-91 HDL-43 CHOL/HD-3.1 LDLcalc-73 ___ 09:45PM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG Brief Hospital Course: #Gluteal spasms and Parasthesias Patient presented with ___ months of intermittent gluteal spasms and parasthesias in bilateral ___ (L1 to S5 region), L>R, associated with erectile dysfunction and subjective changes in bowel sensation. Exam was notable for significant anxiety, decreased light touch and pinprick in bilateral ___, moreso below the knees, and decreased rectal tone in ED. MRI spine with and without contrast was notable for L5-S1 disk herniation with no other findings, including no cord signal. Patient underwent LP attempt at bedside which was not successful (limited attempts due to patient anxiety). This was therefore completed with ___ under fluoroscopy on ___. Initial studies from the LP were unremarkable, with notably viral culture, ACE, cytology pending at time of discharge. Given relatively unremarkable exam and benign MRI, etiology was thought to be sequela from disk herniation vs sacroradiculitis vs infectious radiculopathy. TRANSITIONAL ISSUES: - Follow up with Neurology clinic in ___ weeks. Appointment made for ___. - When seen in follow up, check cytology, ACE, viral cultures - Patient and mother educated in detail about warning signs, notably saddle anesthesia, bowel/bladder incontinence, and muscle weakness. Educated about when to return to the ED. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. clarithromycin 250 mg oral BID 2. Oxymetazoline 1 SPRY NU BID:PRN nasal congestion Discharge Medications: 1. clarithromycin 250 mg oral BID 2. Oxymetazoline 1 SPRY NU BID:PRN nasal congestion Discharge Disposition: Home Discharge Diagnosis: Lumbar disk herniation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital with sensory changes on your legs, bowels and toes. On exam, you had signs and symptoms consistent with a disc herniation. To further evaluate your symptoms, we sent you for an MRI of your spine, which revealed an L5-S1 disk herniation, however no other concerning signs. You also had a lumbar puncture (spinal tap) which did not show any significant abnormalities on initial results. Moving forward, it will be important that you follow up with a Neurologist in ___ weeks to follow up on the rest of your CSF results. It was a pleasure taking care of you. Sincerely, Your ___ care team Followup Instructions: ___
19802150-DS-10
19,802,150
23,094,572
DS
10
2153-08-22 00:00:00
2153-08-22 17:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: cefepime / azithromycin Attending: ___. Chief Complaint: Mid-back pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ yo F w/ h/o Ph+ ALL s/p induction tx w/ dasatinib and high-dose steroids diagnosed, relapse ___ tx w/ hyper-CVAD ___ part A, ___ part B), ponatinib ___, decreased from 45mg to 30mg given grade 4 hematologic toxicity), and rituximab and IT methotrexate (___) p/w back pain. Pt recently admitted for CN VII palsy ___ thought to be secondary to leptomeningeal involvement and was tx w/ steroids, intrathecal methotrexate, and was continued on her oral ponatinib 30mg. CSF studies and head MRI did not show definitive evidence of new CNS disease, however she was treated as such. She was also seen by opthalmology on that admission. Pt reports that since late morning she has had mid back pain which has been progressive. She denies any trauma. Pain started suddenly while cooking, is crampy in nature, and ___ at its worst. She tried taking oxycodone without relief. Denies muscle weakness or lower extremity numbness, bowel incontinence or urinary retention. She has not had a bowel movement today. She denies fevers but is experiencing sweats. Denies nausea, vomiting or shaking chills. Denies dysuria or increased urinary frequency. In the ED, VS: 71 140/100 18 100% ra. On exam, strength & sensation were intact, she had no vertebral tenderness, + mild paravertebral tenderness thoracic spine, normal rectal tone and perirectal sensation intact. She received morphine, dilaudid, and acyclovir. She had a CXR and plain film of the spine. She was ordered for MRI T/L spine and CTU. On arrival to the floor, she c/o ___ back pain. ROS: Otherwise negative. Past Medical History: PAST ONCOLOGIC HISTORY: # ALL diagnosed ___ ___ - Noted to have a white count of ~ 75K with immature lymphocytosis and platelet of ~ 45K at routine examination ___ - PB immunophenotyping consistent with B cell Acute Lymphoblastic Lymphoma, CD 10 positive; peripheral blood cytogenetics positive for t(9;22)(q34;q11.2) ___ - Initiated on Dasatinib and prednisone (___ R et al Blood ___ 118:___) - Initial hospital course complicated by mild DIC with diffuse alveolar hemorrhage, and a diffuse skin rash. The latter was likely an allergic reaction to cefepime or bactrim. During this period dasatinib was held for 3 days. ___ - IT Mtx; csf clear ___ - Discharged ___ - Admitted for acute viral syndrome ___: found to have WBC 70(56% blasts), admitted to start Hyper-CVAD. treated for possible heel cellulitis ___ (initially vanc/ampicillin, then vanc alone) ___: day 1 cycle 1 hyper-CVAD part A. course complicated by mucositis ___: day 1 cycle 1 hyper-CVAD part B ___: Rituximab and IT Methotrexate ___: Rituximab ___: Admitted for R facial droop, on ponatinib 30mg daily, received IT methotrexate, CSF studies inconclusive. PAST MEDICAL/SURGICAL HISTORY: - Hyperlipidemia Social History: ___ Family History: Father - stomach CA. Mother - esophageal CA Sister - throat CA Children and grandchildren healthy, though daughter with resolved gestational diabetes. No history of stroke, MI. No hematologic malignancies reported. Physical Exam: ADMISSION 148/82, 90, 16, 100% RA Gen: in pain HEENT: OP clear, mmm, sclera anicteric Neck: no jvd CV: rr, no murmurs Pulm: ctab Abd: soft, nt/nd Ext: wwp Neuro: A&Ox3, anxious, strength intact, down going toes, sensation to LT intact, no spinal tenderness. DISCHARGE T 97.9, BP 150/74, HR 60, RR 20, O2 96/RA GENERAL - ___ yo F who appears comfortable, appropriate and in NAD HEENT - Pupils equal and reactive 3 to 2mm, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no lymphadenopathy LUNGS - clear to ausculatation bilaterally, moving air well and symmetrically, resp unlabored, no accessory muscle use HEART - PMI non-displaced, RRR, S1-S2 clear and of good quality without murmurs, rubs or gallops. Port over right chest without erythema or edema. ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs). bilateral heels with large blisters which are non-painful and with no surrounding erythema or induration NEURO - awake, A&Ox3, no sensory deficits on face, other CNs II-XII intact, muscle strength ___ throughout. Decreased sensation to light tough at fingertips. Otherwise grossly intact throughout. Pertinent Results: ADMISSION ___ 11:30PM PLT SMR-VERY LOW PLT COUNT-44* ___ 11:30PM HYPOCHROM-2+ ANISOCYT-1+ POIKILOCY-1+ MACROCYT-OCCASIONAL MICROCYT-OCCASIONAL POLYCHROM-OCCASIONAL OVALOCYT-OCCASIONAL SCHISTOCY-OCCASIONAL BURR-OCCASIONAL ___ 11:30PM NEUTS-56 BANDS-10* LYMPHS-13* MONOS-5 EOS-0 BASOS-0 ATYPS-2* ___ MYELOS-1* NUC RBCS-1* OTHER-13* ___ 11:30PM WBC-9.8# RBC-2.79* HGB-9.2* HCT-26.9* MCV-97 MCH-33.0* MCHC-34.1 RDW-21.8* ___ 11:30PM ALBUMIN-4.2 CALCIUM-9.3 PHOSPHATE-5.3*# MAGNESIUM-2.0 ___ 11:30PM ALT(SGPT)-191* AST(SGOT)-66* ALK PHOS-117* TOT BILI-0.5 ___ 11:30PM GLUCOSE-129* UREA N-23* CREAT-0.6 SODIUM-138 POTASSIUM-4.2 CHLORIDE-103 TOTAL CO2-22 ANION GAP-17 ___ 11:36PM LACTATE-1.4 ___ 11:36PM ___ COMMENTS-GREEN TOP ___ 02:00AM URINE MUCOUS-RARE ___ 02:00AM URINE RBC-2 WBC-7* BACTERIA-FEW YEAST-NONE EPI-0 ___ 02:00AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-MOD ___ 02:00AM URINE COLOR-Straw APPEAR-Clear SP ___ CSF: ___ FISH: analysis with the ABL1/BCR probe set was attempted, however, no cells were observed on the 2 slides received. Therefore, the FISH analysis could not be performed. IMMUNOPHENOTYPING: Non-diagnostic study. Cell marker analysis was attempted, but was nondiagnostic in this case due to insufficient numbers of cells. While definitive diagnostic immunophenotypic features of involvement by leukemia are not seen in specimen, correlation with clinical findings and morphology is recommended: Concurrent cytospin reveals occasional atypical lymphoid cells, raising the suspicion for involvement by ALL. MRI Head: ___ 1. No acute intracranial abnormality, and no significant change since the study obtained roughly 18 hours earlier. 2. No pathologic focus of enhancement; specifically, there is no abnormal sulcal FLAIR-hyperintensity or enhancement to suggest subarachnoid space involvement by ALL. 3. Heterogeneous regional bone marrow signal, which may reflect either infiltration by known ALL, response to systemic therapy, or both. Echo ___: The left atrium is mildly dilated. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF 70-75%). Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Dynamic global and regional biventricular systolic function, most consistent with a high-catecholamine state. Mild mitral regurgitation. CTA CHEST ___: 1. Wedge-shaped consolidation in the right lower lobe compatible with atelectasis. 2. No evidence of pulmonary embolism or acute aortic syndrome. MRI T/L-SPINE ___: Somewhat limited evaluation due to motion. No evidence for discitis, osteomyelitis, abscess or hematoma. Mild degenerative changes as detailed above. L/T-SPINE FILM ___: 1. No evidence of compression fracture. 2. Moderate-to-severe S-shaped scoliosis. Bone Marrow: ___ KARYOTYPE: 46,XX,T(9;22)(Q34;Q11.2)[18]/46,XX[2] INTERPRETATION: Of 20 cells studied, 18 had a t(9;22)(q34;q11.2) consistent with relapse of ALL. DISCHARGE ___ 05:26AM BLOOD WBC-1.7* RBC-2.80* Hgb-9.2* Hct-25.6* MCV-92 MCH-32.7* MCHC-35.8* RDW-20.6* Plt Ct-66* ___ 05:26AM BLOOD Neuts-34* Bands-0 Lymphs-44* Monos-4 Eos-2 Baso-0 Atyps-5* Metas-1* Myelos-0 Blasts-10* NRBC-5* ___ 05:26AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ Macrocy-2+ Microcy-NORMAL Polychr-NORMAL Ovalocy-OCCASIONAL MacroOv-1+ ___ 05:26AM BLOOD Plt Ct-66* ___ 05:26AM BLOOD Glucose-150* UreaN-17 Creat-0.5 Na-137 K-3.9 Cl-102 HCO3-28 AnGap-11 ___ 05:26AM BLOOD ALT-104* AST-31 LD(LDH)-1477* AlkPhos-256* TotBili-0.6 ___ 05:26AM BLOOD Albumin-3.5 Calcium-8.5 Phos-4.0 Mg-2.1 UricAcd-1.9* ___ 08:11AM BLOOD BCR/ABL GENE REARRANGEMENT, QUANTITATIVE PCR, CELL-BASED-PND ___ 10:20AM BLOOD ASPERGILLUS GALACTOMANNAN ANTIGEN-Test ___ 10:20AM BLOOD B-GLUCAN-Test Brief Hospital Course: ___ yo F w/ h/o Ph+ ALL w/ relapse ___ tx w/ hyper-CVAD, ponatinib, and rituximab and IT methotrexate, w/ recent admission for facial droop and concern for leptomeningeal spread now p/w back pain. # Back pain: Likely secondary to ALL progression. Her pain was mostly paraspinal, however given leptomeningeal involvement on last admission, there was concern for possible spinal involvement as well. No evidence of cauda equina syndrome on exam. Review of CSF studies - cx, HSV pcr, cryptococcal ag were non-revealing. CTA chest did not show evidence of PE, and MRI T and L spine did not show evidence of obvious spinal disease. The pathology report as paucicellular, atypical lymphoid cells, though FISH unable to be performed. She was treated with IV dexamethasone 20mg daily, and was transitioned to oral dexamethasone 20mg daily. She also received oxycontin 10mg twice daily, lidoderm patch, and dilaudid prn. She also received valium for pain related to muscle spasms. # ALL W/ CNS involvement: She has refractory disease despite receiving IT methotrexate, steroids, and ponatinib on last admission. Her LDH and blast count was markedly elevated on admission, and given her refractory disease, she was made DNR/DNI after a family meeting on ___ with Dr. ___. Her pain improved with stress dose steroids (dexamethasone 20mg IV daily) as well as ponatinib 30mg, and her LDH and blast count also improved. She was continued on acyclovir and started on bactrim prophlaxis. She received one blood and two platelet transfusions during this admission. She was discharged to home with bridge to hospice, and will follow up with Dr. ___ after discharge. # Anemia, thrombocytopenia: She received one blood and two platelet transfusions during this admission. Discussions were held regarding the benefit of transfusions, and it was agreed that transfusions should continue as long as she feels benefit. # Hypertension: She had hypertensive urgency during this admission with SBP 180-190s, especially when on high dose steroids. She was started on amlodipine 5mg at night, and her blood pressure improved. TRANSITIONAL: # Mrs. ___ has progressive ALL refractory to ponatinib treatment. She improved with dexamethasone 20mg IV daily, which was transitioned to 20mg oral daily at discharge. She was started on oxycontin 10mg BID, lidoderm patch, and dilaudid ___ Q4H prn breakthrough pain. Please follow up on her symptoms, and adjust these medications as appropriate. She was continued on ponatinib 30mg daily. # She has elected to go home with hospice for the time being so that she may return to see Dr. ___ in clinic and receive transfusion treatments as needed. Please revisit her need for inpatient hospice care, and offer this service if appropriate. # Please check her CBC, and offer transfusions as appropriate. She received 1 pRBC and 2 platelet transfusions during this hospitalization. # She was started on amlodipine 5mg QHS because she had hypertensive urgency (SBP 180-190s), likely a result of stress dose steroids. Please follow up on her blood pressure, and adjust this medication as appropriate (taper if steroids are tapered). # Contact: ___ (husband) ___ # CODE: DNR/DNI but not CMO, discharged with bridge to hospice Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q8H 2. Atovaquone Suspension 1500 mg PO DAILY 3. ponatinib *NF* 30 mg Oral daily 4. Potassium Chloride 20 mEq PO DAILY 5. Ranitidine 150 mg PO DAILY 6. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 7. PredniSONE 40 mg PO DAILY 8. OxycoDONE (Immediate Release) 2.5 mg PO Q6H:PRN pain 9. Lidocaine-Prilocaine 1 Appl TP ASDIR Discharge Medications: 1. Acyclovir 400 mg PO Q8H 2. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 3. Atovaquone Suspension 1500 mg PO DAILY 4. Lidocaine-Prilocaine 1 Appl TP ASDIR 5. ponatinib *NF* 30 mg Oral daily 6. Dexamethasone 20 mg PO DAILY RX *dexamethasone 4 mg 5 tablet(s) by mouth daily Disp #*50 Tablet Refills:*1 7. Diazepam 2 mg PO Q6H pain, anxiety, sleep RX *diazepam 2 mg 1 tablet(s) by mouth every 6 hrs Disp #*15 Tablet Refills:*1 8. HYDROmorphone (Dilaudid) 4 mg PO Q4H pain Use this medication only if you have pain that is not controlled with oxycontin and lidoderm patch RX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth every 4 hours Disp #*20 Tablet Refills:*1 9. Lidocaine 5% Patch 2 PTCH TD DAILY RX *lidocaine [Lidoderm] 5 % (700 mg/patch) Apply ___ patches daily Disp #*20 Each Refills:*1 10. Oxycodone SR (OxyconTIN) 10 mg PO Q12H Take every 12 hours whether you have pain or not. RX *oxycodone [OxyContin] 10 mg 1 tablet(s) by mouth every 12 hours Disp #*30 Tablet Refills:*1 11. Docusate Sodium 100 mg PO BID constipation This is for constipation that may be caused by narcotics RX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily Disp #*30 Capsule Refills:*1 12. Senna 1 TAB PO BID:PRN constipation This is for constipation that may be caused by narcotics RX *sennosides [senna] 8.6 mg 1 tab by mouth twice daily Disp #*30 Capsule Refills:*1 13. Sulfameth/Trimethoprim SS 1 TAB PO DAILY This medication helps prevent infections while you are on high dose steroids RX *sulfamethoxazole-trimethoprim [Bactrim] 400 mg-80 mg 1 tablet(s) by mouth daily Disp #*15 Tablet Refills:*1 14. Potassium Chloride 20 mEq PO DAILY 15. Ranitidine 150 mg PO DAILY 16. Amlodipine 5 mg PO HS RX *amlodipine 5 mg 1 tablet(s) by mouth every evening Disp #*30 Tablet Refills:*1 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: - Acute Lymphoblastic Leukemia Secondary: - Back pain - Anemia - Thrombocytopenia (low platelet count) Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, ___ was a pleasure taking care of you at the ___. You were admitted for back pain, and were found to have progression of your leukemia. You were treated with high dose steroids (dexamethasone), as well as pain medications, and your pain improved. We had extensive discussion about your refractory and progressive leukemia, and reached the conclusion that you wanted to go home with ___ to hospice. You will return to clinic to follow up with Dr. ___ as needed. You were started on a number of medications to treat your pain, including dexamethasone 20mg daily, oxycontin 10mg twice daily, and lidoderm patch daily as needed. You may use valium (diazepam) 2mg if you have pain from muscle spasms, or anxiety or difficulty sleeping. You should use dilaudid ___ only if you have pain despite these other medications. You were started on amlodipine 5mg every evening for high blood pressure. Followup Instructions: ___
19802201-DS-11
19,802,201
27,711,305
DS
11
2154-09-28 00:00:00
2154-09-28 14:55:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Abdominal Pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ with 5 day history of diffuse, intermittent abdominal pain. First noticed it on ___. Continued to come and go throughout the week. Pain is diffuse, but worst in the lower quadrants. Denies nausea/vomiting. Does endorse chills, but no objective fever. Has been able to eat throughout this week, but has less appetite than usual. Denies changes in his stools or bloody stools. Has never had abdominal pain like this before. Past Medical History: Possible HNPCC (patient not aware, but per GI note, family history suspicious for HNPCC per father before he passed away), h/o arm lipomas Social History: ___ Family History: per note from gastroenterologist, possible family history of HNPCC, but patient not aware of this. Does endorse multiple family members have had colon cancer. Physical Exam: Physical Exam On Admission: Vitals: 99.0, HR 75, BP 103/62, RR 18, 99% RA GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Soft, distended, tender to palpation diffusely, worst in LLQ, no rebound or guarding, Ext: No ___ edema, ___ warm and well perfused Physical Exam On Discharge: Vitals: GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Soft, non-distended, mildly improved tenderness to palpation Ext: No ___ edema, ___ warm and well perfused Pertinent Results: ___ 10:25PM BLOOD WBC-11.0* RBC-4.04* Hgb-13.1* Hct-39.2* MCV-97 MCH-32.4* MCHC-33.4 RDW-13.4 RDWSD-48.1* Plt ___ ___ 07:55AM BLOOD WBC-11.9* RBC-4.06* Hgb-13.0* Hct-39.6* MCV-98 MCH-32.0 MCHC-32.8 RDW-13.0 RDWSD-46.8* Plt ___ ___ 05:00AM BLOOD WBC-10.7* RBC-3.65* Hgb-11.8* Hct-35.9* MCV-98 MCH-32.3* MCHC-32.9 RDW-12.7 RDWSD-45.8 Plt ___ ___ 06:20AM BLOOD WBC-10.5* RBC-3.84* Hgb-12.4* Hct-37.1* MCV-97 MCH-32.3* MCHC-33.4 RDW-12.7 RDWSD-45.1 Plt ___ ___ 10:25PM BLOOD Glucose-105* UreaN-12 Creat-0.9 Na-134 K-6.6* Cl-103 HCO3-21* AnGap-17 ___ 07:55AM BLOOD Glucose-92 UreaN-13 Creat-0.9 Na-138 K-4.0 Cl-104 HCO3-21* AnGap-17 ___ 05:00AM BLOOD Glucose-76 UreaN-12 Creat-0.9 Na-136 K-3.7 Cl-101 HCO3-22 AnGap-17 IMAGING: --------- IMPRESSION: New opacities in both lower lobes may be reflective of pneumonia/atelectasis. Small bilateral pleural effusions. Brief Hospital Course: Mr. ___ was admitted to the hospital for treatment of perforated diverticulitis. He was placed on IV Antibiotics (Ciprofloxacin and Flagyl) and kept NPO with IVF. His pain improved on HD1 and on HD2 he was started on a regular diet and tolerated well and passed flatus. On HD3 he is tolerating a regular diet, states improved abdominal pain and was switched to PO antibiotics. During the hospital course, it was noted he had persistent oxygen requirement up to 3L where he is asymptomatic. He was weaned off O2 prior to discharge, maintaining a saturation in the 90's. He is to follow up with his PCP ___ 1 week of discharge to for check up of his oxygen saturation. He is ready for discharge on HD3. At the time of discharge he is afebrile, VS stable, tolerating a regular diet and is to be discharged on high fiber diet and continue 2 week PO antibiotic course with ciprofloxacin and flagyl. He is ambulating independently, pain well controlled. He is scheduled to follow up with ___ clinic in 2 weeks. Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. Ciprofloxacin HCl 500 mg PO Q12H NO strenuous exercise while taking this medication RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*27 Tablet Refills:*0 3. MetroNIDAZOLE 500 mg PO TID do NOT drink alcohol while taking this medication RX *metronidazole 500 mg 1 tablet(s) by mouth three times a day Disp #*41 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Perforated Diverticulitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. You were admitted to the hospital due to perforated diverticulitis. You were treated with IV antibiotics and bowel rest and you have recovered well. You are now ready to continue your recovery at home and will be discharged on a course of oral antibiotics. Please schedule an outpatient colonoscopy for 6 weeks from discharge. Please follow the instructions below to ensure a safe recovery: Your oxygen level was low upon this admission and required O2. At the time of discharge you were off oxygen. Please follow up with your primary care within 1 week of discharge for check up of your oxygen status. Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Followup Instructions: ___
19802210-DS-8
19,802,210
20,378,488
DS
8
2182-12-29 00:00:00
2182-12-29 16:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) / NSAIDS Attending: ___. Chief Complaint: ___ ADMISSION NOTE time pt seen & examined: 7:15pm CC: abdominal pain, F/C PCP: ___ ___ Surgical or Invasive Procedure: ERCP with stent placement History of Present Illness: Mr. ___ is an ___ year old male with a history of afib on warfarin (TIA, CHADS of 3), colon CA s/p resection and ostomy, who presented to the ED with RUQ abd pain. Over the past 3 days he developed right flank pain that radiated to the mid back and through the back to his abdomen. This evolved over the past three days into RUQ. He has also had fever to 101.2 and rigors over the past two nights. He has had intermittent RUQ pain over the past several months, each episode resolving spontaneously. He has been lightheaded with abdominal distension - to the point that his ostomy bag came off. He feels lightheaded and very weak, though lightheadedness has been chronic for years. Urine was very dark yesterday, and he increased his intake to four 8 oz glasses of water overnight. Ostomy output also been decreased. No appetite for the past day, unsure if he lost weight. Also with exertional SOB last few mos, worse in last few days, no associated CP. He presented to ___ ___ today, and he was referred to ED for further evaluation. In the ED, vital signs were 98.5 82 131/71 18 97% on RA. Initial labs notable for WBC 32.8 (95.5% N), Hct 36.9, INR 4.8, PTT 46.8, ALT 226, AST 234, Alk Phos 705, Tbili 5.8, lactate 2.3. He was started empirically on Unasyn, and ACS was consulted. He was given 2U FFP and went for ERCP, which showed: "Moderate amount of pus was draining from the ampulla. Cannulation of the biliary duct was successful and deep after a guidewire was placed. Contrast medium was injected resulting in partial opacification due to cholangitis. Scout film was normal. The CBD was 12 mm in diameter. Large amount of debris and 12 mm impacted stone in the distal CBD consistent with a large ___ shaped stone were identified. Cystic duct was patrially opacified and the gallbladder was not seen. The left and right hepatic ducts were normal. IHD were not opacified due to cholangitis. A sphincterotomy was NOT performed due to INR of > 5, therefore no stones were removed. A 7cm by ___ biliary stent was placed successfully traversing the impacted stone to ensure drainage of bile and resolution of cholangitis." In the ERCP suite, pt reports feeling much better and denies any abdominal pain, N/V, F/C. He denies current SOB but confirms he has had intermittent exertional SOB. No cough or other URI sx, no myalgias. ROS otherwise negative. Past Medical History: -rectal cancer s/p resection & end colostomy, chemotherapy ___ -asbestosis -atrial fibrillation -hyperlipidemia -TIA -macular degeneration -remote duodenal ulcer, evaluated at ___, resolved without tx -osteoarthritis -anxiety -___ esophagus (___) -Meniere's disease -Pseudogout Social History: ___ Family History: Father - COPD Physical ___: VS: afeb 134/74 ___ 98% 2L GEN: NAD, well-appearing EYES: conjunctiva clear, icteric ENT: dry mucous membranes NECK: supple CV: irreg irreg s1s2 soft II/VI SEM PULM: CTA, decreased BS GI: decreased BS, mildly distended, soft, nontender, ostomy in place with opaque bag EXT: warm, no edema SKIN: no rashes, icteric NEURO: alert, oriented x 3, answers ? appropriately, follows commands PSYCH: appropriate ACCESS: PIV FOLEY: none Pertinent Results: Admission Labs: ___ 10:15AM BLOOD WBC-32.8*# RBC-4.12* Hgb-11.9* Hct-36.9* MCV-90 MCH-28.8 MCHC-32.2 RDW-16.8* Plt ___ ___ 10:15AM BLOOD Neuts-95.5* Lymphs-1.4* Monos-2.8 Eos-0.1 Baso-0.2 ___ 10:15AM BLOOD ___ PTT-46.8* ___ ___ 10:15AM BLOOD Glucose-160* UreaN-11 Creat-0.8 Na-135 K-3.7 Cl-96 HCO3-25 AnGap-18 ___ 10:15AM BLOOD ALT-226* AST-243* AlkPhos-705* TotBili-5.8* ___ 10:25AM BLOOD Lactate-2.3* ___ 10:15 am BLOOD CULTURE Blood Culture, Routine (Preliminary): GRAM NEGATIVE ROD(S). Anaerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). Ultrasound: **Wet Read** Distended gallbladder with wall edema and small amount of pericholecystic fluid as well as stones and sludge seen concerning for acute cholecystitis. The common bile duct is prominent but no choledocholithiasis is identified. CXR: (prelim report) Extensive bilateral pleural plaques suggest prior asbestos exposure and partially obscure the lung fields making it difficult to accurately discern whether there is underlying new underlying opacities, though no definite new focal consolidation. Blunting of the right costophrenic angle may be due to a small pleural effusion. Brief Hospital Course: ___ year old male with a history of rectal cancer s/p resection and colostomy, a-fib on warfarin, and anxiety who presents with biliary sepsis secondary to acute cholecystitis/cholangitis complicated by supratherapeutic INR. # ESBL E. Coli sepsis: # Cholangitis: He presented with abdominal pain and fever and was found to have obstructive jaundice and ESBL E. coli bacteremia. Met ___ SIRS criteria with WBC of 32.8, fever to 101.2 at home, and tachycardia (100s) while on rate controlling agents. ERCP showed bile duct stone. He underwent ERCP with placement of a plastic stent around the stone to facilitate drainage. A sphincterotomy was not performed due to supratherapeutic INR. His symptoms improved following the prodedure. His liver function tests are improving but not yet normalized. He was initially treated with Unasyn but after blood cultures returned growing ESBL E.coli this was changed to meropenem (___) with plan to complete a 14 day course (ending ___. He was evaluated by surgery with recommendation for interval cholecystectomy in the next several weeks. He will follow up with surgery to schedule cholecystectomy. Ideally the day prior he would undergo repeat ERCP for stent removal, sphincterotomy, stone removal with possible mechanical lithotripsy vs. Spy ___. He will need to go off coumadin in the days preceding this procedure in order to let INR drift down to a safe value to perform invasive procedures. # Atrial fibrillation: He was continued on rate control. He has a CHADS2 score of at least 3, on warfarin with supratherapeutic INR on admission likely due to acute illness and liver injury. His INR trended down and his coumadin was restarted at home dose of 3mg daily. Would recommend monitiring INR closely while on antibiotics. # hyperlipidemia: holding statin in setting of hepatic inflammation # depression/anxiety: continue outpatient sertraline, alprazolam & clonazepam Medications on Admission: alprazolam 0.25 mg tablet twice a day as needed for anxiety brimonidine [Alphagan P] Dosage uncertain clonazepam 0.5 mg tablet half tablet by mouth twice a day as needed for anxiety fluticasone 50 mcg/actuation nasal spray,suspension 1 puff NAS twice a day (Not Taking as Prescribed) omeprazole 20 mg capsule,delayed release 1 capsule,delayed ___ by mouth qam pravastatin 20 mg tablet 1 Tablet(s) by mouth once a day in the evening sertraline 25 mg tablet one tablet by mouth twice a day tramadol 50 mg tablet ___ Tablet(s) by mouth every four (4) - six (6) hours as needed for pain verapamil ER 180 mg 24 hr capsule,extended release 1 capsule,ext rel. pellets 24 hr(s) by mouth qd for heart rate warfarin 2 mg tablet Take up to 2 (two) tablets by mouth once a day or as directed by ___ clinic acetaminophen 500 mg tablet 1 tablet by mouth three times a day as needed for pain aspirin 81 mg tablet,delayed release 1 Tablet(s) by mouth daily multivitamin tablet 1 tablet by mouth qam Discharge Medications: 1. ertapenem 1 gram injection daily contine through ___ RX *ertapenem [Invanz] 1 gram 1 gram daily Disp #*10 Vial Refills:*0 2. Sodium Chloride 0.9% Flush 10 mL IV DAILY and PRN, line flush RX *sodium chloride 0.9 % 0.9 % 10 mL IV daily Disp #*10 Syringe Refills:*0 3. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line flush RX *heparin lock flush (porcine) [heparin lock flush] 10 unit/mL 2 mL IV daily Disp #*10 Syringe Refills:*0 4. Pravastatin 20 mg PO HS 5. Aspirin 81 mg PO DAILY 6. Warfarin 3 mg PO HS 7. Verapamil SR 180 mg PO DAILY 8. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain 9. Acetaminophen 500 mg PO TID:PRN pain 10. ALPRAZolam 0.25 mg PO BID:PRN anxiety 11. ClonazePAM 0.25 mg PO BID:PRN anxiety 12. Multivitamins 1 TAB PO DAILY 13. Omeprazole 20 mg PO DAILY 14. Sertraline 25 mg PO BID Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Cholangitis sepsis E. coli bacteremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: It was a pleasure to participate in your care. You were admitted with abdominal pain and fever and were found to have a gallstone causing obstruction in your bile duct system. This caused an infection (cholangitis) and spread of bacteria to your blood stream (sepsis). You had a procedure (ERCP) to place a stent across the stone and relieve the obstruction. You were treated with antibiotics and will continue this through ___. You were seen by the surgery team. The plan is for you to return to the hospital in several weeks to have the stone removed by the ERCP doctors and to have the surgeon's remove your gallbladder. Followup Instructions: ___
19802296-DS-14
19,802,296
23,683,536
DS
14
2176-09-29 00:00:00
2176-10-01 20:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Allergies/ADRs on File Attending: ___. Chief Complaint: small bowel obstruction Major Surgical or Invasive Procedure: none History of Present Illness: ___ is a ___ y o M w/ hx of lap gastric band ___ yrs ago at ___ who is ___'ed from OSH for c/f SBO and presenting w/ ~1 day hx of acute onset diarrhea, abd pain, distension and dry heaving. He notes the diarrhea to be primarily watery brown with some solid material, having ~1 BM per hour. After the diarrhea started he had rapid abd distension and started dry heaving as well. He presented to OSH for these sx and an NG was placed w/ relief. A CT was done showing c/f SBO and was transferred here to the ED. In the ED his labs were notable for WBC 20, Cr 1.2, and lactate 2.2. A KUB showed an NG coiled in the esophagus and was thus readjusted, w/ repeat KUB showing tip placement in the stomach. He currently feels much better, with no pain, and mild distension. He continues to pass gas and have BMs. He endorsed some sweats, and denies f/c, recent illness, sick contacts. ROS is o/w negative except as noted above. Past Medical History: PMHx/PSHx: lap gastric band ___ yrs ago as noted above Social History: ___ Family History: non-contributory Physical Exam: Discharge physical exam: VS: 99.0 126/82 71 18 98Ra Gen: NAD CV: normal S1, S2, no murmur Pulm: non-labored breathing, no resp distress Abd: soft, non- distended, non-tender Pertinent Results: ___ 02:30AM PLT COUNT-341 ___ 02:30AM NEUTS-89.0* LYMPHS-4.4* MONOS-5.3 EOS-0.0* BASOS-0.3 IM ___ AbsNeut-18.56* AbsLymp-0.91* AbsMono-1.10* AbsEos-0.00* AbsBaso-0.07 ___ 02:30AM WBC-20.8* RBC-5.54 HGB-17.0 HCT-49.1 MCV-89 MCH-30.7 MCHC-34.6 RDW-12.4 RDWSD-40.1 ___ 02:30AM estGFR-Using this ___ 02:30AM GLUCOSE-152* UREA N-26* CREAT-1.2 SODIUM-136 POTASSIUM-5.2* CHLORIDE-102 TOTAL CO2-20* ANION GAP-19 ___ 02:48AM LACTATE-2.2* K+-5.0 ___ 02:48AM ___ COMMENTS-GREEN TOP ___ 01:32PM PLT COUNT-257 ___ 01:32PM WBC-12.3* RBC-4.47* HGB-14.1 HCT-39.9* MCV-89 MCH-31.5 MCHC-35.3 RDW-12.5 RDWSD-40.6 ___ 01:32PM CALCIUM-8.3* PHOSPHATE-2.9 MAGNESIUM-1.7 ___ 01:32PM estGFR-Using this ___ 01:32PM GLUCOSE-91 UREA N-20 CREAT-1.0 SODIUM-140 POTASSIUM-4.3 CHLORIDE-109* TOTAL CO2-20* ANION GAP-15 ___ 01:36PM LACTATE-1.1 ___ 01:36PM ___ COMMENTS-GREEN TOP Brief Hospital Course: The patient transferred form OSH to the ED on ___ after being diagnosed with SBO. He has been evaluated in the ED and admitted to the regular floor for conservative management of SBO. Neurology: The patient was alert and oriented throughout hospitalization; Pain was very well controlled. The patient was then transitioned to oral pain medication once tolerating a regular diet. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. GI/GU/FEN: The patient was initially kept NPO with NGT in place. Eventually, NGT taken off once he started passing gas and moving his bowel. Diet has advance to clears and subsequently, the patient was advanced to regular diet which the patient was tolerating on day of discharge. ID: The patient's fever curves were closely watched for signs of infection, of which there were none. HEME: The patient's blood counts were closely watched for signs of bleeding, of which there were none. Prophylaxis: The patient received subcutaneous heparin and ___ dyne boots were used during this stay and was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Discharge Disposition: Home Discharge Diagnosis: Small bowel obstruction Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital for a small bowel obstruction. You were given bowel rest and intravenous fluids and a nasogastric tube was placed in your stomach to decompress your bowels. Your obstruction has subsequently resolved after conservative management. You have tolerated a regular diet, are passing gas and your pain is controlled with pain medications by mouth. You may return home to finish your recovery. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! Followup Instructions: ___
19802326-DS-9
19,802,326
21,368,813
DS
9
2191-03-03 00:00:00
2191-03-03 16:07:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / Erythromycin Base / tamsulosin Attending: ___. Chief Complaint: Altered Mental Status Major Surgical or Invasive Procedure: None. History of Present Illness: Mr. ___ is a ___ y/o male with HCV cirrhosis followed by ___ liver clinic, afib, COPD, chronic pain and bipolar disorder who presented with confusion. According to the patient's wife, he was ___ admitted to ___ for 4 days for confusion and was found to have a UTI. He was discharged on ___ to his home and was doing relatively well. Overnight his wife found him in the bathroom holding on to the wall and not responding to her. He retunred to ___ where he was noted to have an ammonia level was 53 and a creatinine of 1.8. His wife called Dr. ___ and he was referred to ___. According to his wife, he was discharged on antibiotics however they were unable to fill the script. He was also taking lactulose but was not having bowel movements. She states that he was not having any fevers, vomiting, abdominal pain, diarrhea or rashes. Of note, patient has had multiple admissions to ___ ___ for encephalopathy. It appears that there are multiple etiologies for his decline in mental status. In the ED, initial vs were: 97 40 ___ 97% RA. Patient reportedly had SBP's in the 70's which came up with stimulation to 85. He was given 25g of albumin and 1L of NS. Vitals upon transfer 98.8 50 irreg 107/38 13 100% RA. They checked his abdomen with ultrasound for fluid but there was not enough for tap. On arrival to the ICU, patient was lethargic and unable to follow commands. He was noted ot have a blood pressure of 106/51. Review of systems: (+) Per HPI (-) unable to obtain from patient Past Medical History: # Chronic hepatitis C infection -- Genotype 2 -- Pegylated interferon/ribivarin started ___ -- Discontinued after 8 weeks of planned ___ week course -- Admission on ___ for possible interferon induced psychosis --HCV VIRAL LOAD (Final ___: 15,600,000 IU/mL # Atrial fibrillation -- Previously on Coumadin -- No Coumadin since ___hronic obstructive pulmonary disease # Chronic musculoskeletal pain of unknown etiology # Status post cholecystectomy # History of substance abuse # Possible myelodysplasia on recent bone marrow biopsy # Bipolar disorder # History of peptic ulcer disease # Left lung empyema in ___ # Pilonidal cyst removal in ___ Social History: ___ Family History: No family history of liver disease. Father died from MI at age ___. Physical Exam: ADMISSION EXAM: VS: 98.2 °F HR: 60 BP: 105/51 RR: 15 SpO2: 100% ___: patient was lethargic but in NAD, not following commands HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Irregular, S1/S2 appreciated no m/r/g Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema DISCHARGE EXAM: VS: 98.3 ___ 18 100%RA ___: Disheveled appearing, attentive HEART: Irregular, normal rate, S1/S2 heard. No murmurs/gallops/rubs. LUNGS: CTAB no crackles or wheezes, non labored ABDOMEN: Soft, nondistended non-tender to palpation. No guarding or rebound EXT: no edema b/l SKIN: dry, coccyx wound bandaged NEURO: no asterix Pertinent Results: ADMISSION LABS: ___ 06:57PM BLOOD WBC-10.4 RBC-3.13* Hgb-9.8* Hct-30.5* MCV-98 MCH-31.2 MCHC-32.0 RDW-15.2 Plt ___ ___ 06:57PM BLOOD Neuts-69.9 ___ Monos-5.6 Eos-1.9 Baso-0.6 ___ 06:57PM BLOOD ___ PTT-30.8 ___ ___ 06:57PM BLOOD Glucose-103* UreaN-28* Creat-1.5* Na-144 K-4.0 Cl-120* HCO3-23 AnGap-5* ___ 06:57PM BLOOD ALT-16 AST-38 AlkPhos-74 TotBili-0.2 ___ 06:57PM BLOOD Lipase-58 ___ 06:57PM BLOOD Albumin-3.5 Calcium-9.5 Phos-3.1 Mg-1.9 ___ 06:57PM BLOOD Ammonia-52 ___ 06:57PM BLOOD Lithium-0.4* ___ 06:57PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 07:04PM BLOOD Lactate-0.7 PERTINENT LABS: ___ 06:10AM BLOOD PTH-23 ___ 06:10AM BLOOD 25VitD-28* ___ 06:10AM BLOOD CRP-80.8* ___ 04:45PM BLOOD b2micro-17.8* ___ 06:10AM BLOOD PEP-ABNORMAL B IgG-1550 IgA-180 IgM-111 IFE-MONOCLONAL ___ 06:00AM BLOOD Lithium-0.6 ___ 05:45AM BLOOD Lithium-0.5 ___ 06:57PM BLOOD Lithium-0.4* ___ 11:10PM BLOOD Lactate-1.2 ___ 06:42AM BLOOD freeCa-1.35* ___ 08:01AM BLOOD freeCa-1.51* ___ 01:53PM BLOOD freeCa-1.54* DISCHARGE LABS: ___ 06:30AM BLOOD WBC-19.5* RBC-2.97* Hgb-9.4* Hct-30.5* MCV-103* MCH-31.6 MCHC-30.7* RDW-16.2* Plt ___ ___ 06:30AM BLOOD ___ PTT-27.7 ___ ___ 06:30AM BLOOD Glucose-88 UreaN-42* Creat-1.9* Na-141 K-4.3 Cl-114* HCO3-18* AnGap-13 ___ 06:30AM BLOOD ALT-20 AST-21 AlkPhos-72 TotBili-0.3 ___ 06:30AM BLOOD Calcium-10.1 Phos-3.1 Mg-2.6 IMAGING: ___ CXR: Mild bibasilar atelectasis. ___ Abdominal U/S: 1. No focal liver lesion and no ascites. 2. Patent hepatic vasculature. 3. Minimal central biliary ductal dilatation with dilated common hepatic duct (1.2cm), the etiology of which is unapparent. The pancreatic duct is also noted to be mildly dilated (0.4cm). An MRCP could further characterize. 4. Splenomegaly. 5. Simple bilateral renal cysts. ___ CXR: There is unchanged evidence of mild-to-moderate pulmonary edema. An area of atelectasis at the right lung base is slightly more extensive than before. A linear lucency along the left chest wall corresponds to a skinfold. Moderate cardiomegaly and tortuosity of the thoracic aorta. No new parenchymal opacities. No larger pleural effusions. ___ Sacral x-ray: No radiographic evidence of osteomyelitis. However, MRI is more sensitive. ___: MRI pelvis: No definitive evidence of osteomyelitis on this extremely suboptimal examination which was terminated prematurely. Followup MR examination with sedation or CT examination of the pelvis would provide further imaging evaluation if clinically warranted. ___ Skeletal survey: 1. Tiny 5-mm lucency in the right humeral head which is equivocal for small myelomatous deposits. There is slight mottling throughout the calvarium and the pelvis and the right humerus. 2. Enchondroma within the left proximal humeral shaft. 3. Intact hardware, bilateral proximal femurs. 4. Degenerative changes of bilateral knees, predominantly involving the medial compartment. 5. DISH involving the thoracic spine. 6. Degenerative changes of the thoracic and lumbar spines. Brief Hospital Course: ___ gentleman with HCV cirrhosis, afib, COPD, chronic pain and bipolar disorder who presented with confusion, due to hepatic encephalopathy. Course complicated by ___, due to ATN, and leukocytosis of unclear etiology but possibly due to MGUS vs myelodysplastic disorder. # Encephalopathy: Patient has a history of encephalopathy however not ever attributed to hepatic encephalopathy. His wife noted that when he develops an infection, his ammonia level goes up and he becomes confused. She also noted that when he is not consistent with his lactulose he becomes confused. Patient did not have BM x2 days prior to admission. CT head at ___ negative for acute process. During this hospital stay the patient's mental status/solmnolence improved with lactulose. Methadone, ativan and seroquel initially held in the MICU, but restarted once the patient was transfered to the floor. On the floor the patient's mental status was stable on lactulose until the morning of the ___ the patient was found to be minimally responsive. Additionally, he developed a new O2 requirement, was diaphoretic on exam, and had elevated HR's to 150s. Given the patient's change in mental status he was given naloxone. EKG showed afib with RVR, so he was given IV metoprolol. Given his acute decompensation the patient was transfered back to the MICU for further managment. In the MICU the patient was found to have a retrocardiac opacity on CXR and with rising leukocytosis and for this reason was started on vanc + cefepime for possible HCAP vs. aspiration. Oxygen was weaned. An NGT was placed and lactulose given Q 2 hours until the patient had a large amount of stool output. His mental status cleared and patient was noted to be breathing well on RA. He was transferred back to the floor on ___. On the floor lactulose was continued and was titrated down to ___ bowel movements per day and the patient's mental status returned to his baseline. He should be continued on the lactulose at least TID -- if the patient fails to have ___ bowel movements per day, an extra dose of lactulose should be given. # Monoclonal gammopathy, likely MGUS: The patient has a history of myelodysplasia. Due to hypercalcemia he had a SPEP and UPEP sent. His SPEP was notable for a monoclonal spike. The UPEP and skeletal survey were equivocal. Heme/Onc was consulted and believes this is most likely MGUS, rather than multiple myeloma. He will need Heme/Onc follow up as a patient within in the next few weeks to clarify his diagnosis. [ ] f/u ___ 16:45 FREE KAPPA AND LAMBDA, WITH K/L RATIO Results light chains which is Pending # Leukocytosis: Patient was started on vanco/cefepime empirically at time of transfer to MICU on ___. Subsequent infectious work up was negative including CXR, UA & urine cultures, blood cultures and MRI to r/o osteomyelitis. He was empirically broaded to daptomycin and cefepime based on ID's recommendations on ___. LDH was not elevated and differential was not suggestive of blast crisis. After 8 days of antibiotics ID consults recommended stopping all antibiotics as there was no clear source of infection identified. In the following days he continued to have a leukocytosis (WBC ___ but was afebrile and had no focal complaints. Given no clear source of infection it was thought that the leukocytosis was due to primary marrow problem given concern for myedysplasia. The patient will be seen by Heme/Onc as an outpatient to ensure MGUS/Leukocytosis follow up. # Acute Renal Failure: Patient was noted to have a creatinine of 1.8 at the OSH and 1.5 at ___. Based on the BUN creatining ratio, is likely a prerenal etiology. HRS was unlikely based on high urine Na. Cr trended upward and on ___ on the day the patient was transfered back to the MICU a renal consult was called. Renal Consult found that the etiology of his renal failure was most likely due to ATN. Although HRS was less likley the patient was given a 2 day albumin challenge and his creatinine did not improve. Creat increased on ___ -- given concurrent increase in BUN and large volume dirrhea this may have been prerenal again. Urine lytes rechecked on ___ showed FeNa of 2.06% c/w intristic renal process. Renal consult on ___ believe worsening ___ is still due to ATN with some component of dehydration/prerenal azotemia. In the days prior to discharge the patient's creatinine was downtrending/stable from 1.9-2.2. # Hypotension: Patient reportedly had pressures in the 70's while in the ED when he was admitted. Patient recieved 25g of albumin and 1L of NS with good response. Unclear etiology of hypotension but infection is of concern based on hitory. U/A was notably within normal limits making UTI unlikely despite being recently treated. Received one dose cefepime, then abx discontinued after mental status improved (see above). Patient did not require pressor support at any time during his stay in the ICU. On the floor all blood pressures were stable. # Cirrhosis: Patient has a history of cirrhosis secondary to HCV. Based on his labs synthetic function appears to be maintained with a normal albumin and near normal INR. # Bipolar Disorder: Patient has a significant history of bipolar disorder which appears to be controlled on his current regimen. Continued home dose 300mg qHS. Continued lexapro. # Chronic Pain: Patient has a history of chronic pain and is on methadone for pain relief. On a specific regimen. Initially held methadone which he gets QID 15mg in the morning, afternoon, evening and 25mg at night, then restarted once the patient was transfered to the floor on ___. Methadone was held upon acute mental status change on transfer to the MICU. However, was restarted the next day at a lower dose of 15 mg TID to prevent withdrawl. # Atrial Fibrillation: Patient is rate controlled. Not being anticoagulated due to risk of falls. Initially held metoprolol due to hypotension, then given IV metoprolol on ___ for RVR. On transfer to the MICU initially he was started on diltiazem, however this was discontinued prior to transfer to the floor given rate control and soft SBPs. # Sacral decubitus ulcer: The patient was seen by Wound Care who made recommendations for dressing changes. Given a new leukocytosis on which developed on ___ (while the patient was on antibiotics for presumed aspiration PNA) and with all other infectious work up being negative there was concern for osteomyelitis. On ___ he had a xray of sacrum which was difficult to interpret given degenerative changes seen on imaging. Subsequent MRI was not suggestive of osteomyelitis. In the days prior to discharge the wound seemed to be improving. Daily wound care will need to be continued while the patient is at rehab. TRANSITIONAL ISSUES: #Patient will need Heme/Onc follow up as an outpatient for MGUS vs multiple myeloma. #Patient will need Chem 10 labs checked the week of ___ to ensure that creatinine is downtrending and bicarbonate is stable, if the bicarbonate level is normal sodium bicarbonate supplement can be discontinued. #PENDING RESULTS: f/u ___ FREE KAPPA AND LAMBDA, WITH K/L RATIO Results light chains which is pending at the time of discharge Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Finasteride 10 mg PO DAILY 2. Lactulose 30 mL PO TID 3. Allopurinol ___ mg PO DAILY 4. Lithium Carbonate 300 mg PO QHS 5. Lidocaine 5% Patch ___ PTCH TD DAILY:PRN Pain 6. Quetiapine Fumarate 50 mg PO QHS 7. Lorazepam 0.5-1 mg PO Q8H:PRN Anxiety 8. Methadone 30 mg PO QAM 9. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 10. Naproxen 500 mg PO DAILY 11. Omeprazole 20 mg PO DAILY 12. Aspirin 81 mg PO DAILY 13. Escitalopram Oxalate 10 mg PO QHS 14. Rifaximin 550 mg PO BID 15. Methadone 20 mg PO BID at 12pm and 4pm 16. Methadone 35 mg PO QPM Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Escitalopram Oxalate 10 mg PO QHS 3. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 4. Lactulose 30 mL PO TID 5. Lidocaine 5% Patch ___ PTCH TD DAILY:PRN Pain 6. Lithium Carbonate 300 mg PO QHS 7. Methadone 15 mg PO QID 8. Quetiapine Fumarate 50 mg PO QHS 9. Rifaximin 550 mg PO BID 10. Collagenase Ointment 1 Appl TP DAILY 11. Metoprolol Tartrate 25 mg PO BID 12. Sodium Bicarbonate 1300 mg PO QID 13. Vitamin D 800 UNIT PO DAILY 14. Finasteride 10 mg PO DAILY 15. Lorazepam 0.5-1 mg PO Q8H:PRN Anxiety 16. Omeprazole 20 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Hepatic encephalopathy Acute on chronic renal failure MGUS vs multiple myeloma Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: It was a pleasure to participate in your care at ___. You came to the hospital because of increased confusion. We gave you lactulose and your confusion improved. We were concerned that you had an infection so you were given antibiotics. You were seen by the Infectious Disease team who believes that you were not infected, so your antibiotics were stopped. You were seen by the Renal team because your kidney function was poor during this hospital stay. You were seen by the Oncology team due to your abnormal labs -- you will need to be seen by the Oncology team after you leave the hospital for further management. Please keep all follow up appointments. Please take all medications as prescribed. Followup Instructions: ___
19802576-DS-11
19,802,576
21,256,497
DS
11
2193-03-21 00:00:00
2193-03-21 16:19:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / strawberry / shellfish derived Attending: ___. Chief Complaint: mouth pain, poor po intake Major Surgical or Invasive Procedure: none History of Present Illness: Ms. ___ is a ___ personal care assistant with a ___ pertinent for anxiety/depression, fibroids, anemia, asthma, allergic rhinitis, and tobacco-marijuana smoking (20+ years, often 10 blunts daily) who presents with several weeks of worsening oral pain leading to poor oral intake and dehydration who was sent from her PCP's office ___ for further evaluation of these issues. Patient presented to primary care clinician at ___ on ___ with concern for sore throat that made swallowing painful. She had been taking acetaminophen without relief. Initial concern was for pharyngitis and throat cultures were sent but negative. Because of lack of relief of her symptoms, she went to ___ and they gave her ibuprofen and vicious lidocaine, and did blood work, and sent her home from the ED. Patient again presented to ___ ___ and reported continued severe pain that was making it difficulty to eat. She also reported that ___ had contacted her to let her know her lab work showed she was positive for HSV (later confirmed: HSV1 and HSV IgG positivity, Monospot negative). She reported she was taking acetaminophen and even took some oxycodone left over from a prior surgery that partially helped. She was still eating and drinking little, had minimal urine output, and was feeling weak. In the clinic she was noted to have BP 78/52 (lying) with HR of 127. Given the persistent difficulty with oral intake and low blood pressure she was sent to the ___ ED for further evaluation. Arriving at the ED she was noted to be afebrile with normal vitals including low-normal BP (about 100/70). Exam was notable for a large lesion in the mid-soft palate. Labs were notable for Cr 1.4 (improved to 1 with fluids) and low potassium and magnesium for which she got repletion. CMV serologies were sent. She was started on acyclovir 250mg IV q8 and got several doses. She was given several liters of IVF. She received medications for her pain including magic mouth wash, cepacol lozenges, and acetaminophen. Initially NPO, she by midday ___ she was feeling better and switched from NPO to regular diet, which she tolerated well. ___ was consulted and evaluated her mouth lesion and initial assessment was suspicion for tumor or malignancy and very low suspicion for infectious process. ___ requested maxillary facial CT with contrast and planned to likely pursue setting up outpatient follow-up when they would perform a biopsy. ROS: Pertinent positives and negatives as noted in the HPI. All other systems were reviewed and are negative. Negative or CP, SOB, fevers/chills, vomiting, diarrhea, abdominal pain. Past Medical History: PAST PSYCHIATRIC HISTORY: -Sx/Dx: bipolar disorder, PTSD . PAST MEDICAL HISTORY: ALLERGIC RHINITIS ASTHMA HEMORRHOIDS TOBACCO ABUSE ECZEMATOUS DERMATITIS HEARING LOSS ANEMIA DYSMENORRHEA FIBROIDS CANNABINOID HYPEREMESIS SYMDROME PCP: ___, NP at ___ Social History: SUBSTANCE ABUSE HISTORY: Tobacco: remote history, denies current use EtOH: denies Marijuana: reports ___ blunts daily on weekdays and more on weekend days. Other substances: denies . FORENSIC HISTORY: ___ SOCIAL HISTORY: ___ Family History: FAMILY PSYCHIATRIC HISTORY: Per chart review, grandmother has bipolar disorder and that there is substance use and depression in other family members. Physical Exam: VITALS: Afebrile and vital signs stable T 98.3, BP 99/65, HR 85, RR 18, O2 sat 100% on RA. GENERAL: Anxious thing woman in hospital bed, in no apparent distress EYES: PERRL. EOMI. Anicteric sclerae. ENT: Ears and nose without visible erythema, masses, or trauma. No mucosal lesions noted. Eroding lesion of the soft palate observed, about midline, without bleeding. No cervical lymphadenopathy or gland tenderness noted. CV: Regular rate and rhythm. Normal S1 S2, no S3, no S4. No murmur. No JVD. PULM: Breathing comfortably on room air. Lungs clear to auscultation. No wheezes or crackles. Good air movement bilaterally. GI: Bowel sounds present. Abdomen non-distended, soft, non-tender to palpation. GU: No suprapubic fullness or tenderness to palpation. EXTR: No lower extremity edema. Distal extremity pulses palpable throughout. SKIN: No rashes or scars noted. NEURO: Alert. Oriented to person/place/time/situation. Face symmetric. Gaze conjugate with EOMI. Speech fluent. Moves all limbs spontaneously. No tremors or other involuntary movements observed. PSYCH: Anxious but pleasant, cooperative. Follows commands, answer questions appropriately. Appropriate affect. Pertinent Results: ___ 04:55AM BLOOD WBC-6.3 RBC-3.88* Hgb-9.9* Hct-30.5* MCV-79* MCH-25.5* MCHC-32.5 RDW-16.5* RDWSD-47.7* Plt ___ ___ 01:31PM BLOOD WBC-7.6 RBC-5.32* Hgb-13.6 Hct-42.1 MCV-79* MCH-25.6* MCHC-32.3 RDW-17.5* RDWSD-46.3 Plt ___ ___ 01:31PM BLOOD Neuts-56.9 ___ Monos-14.2* Eos-0.7* Baso-0.5 Im ___ AbsNeut-4.33 AbsLymp-2.08 AbsMono-1.08* AbsEos-0.05 AbsBaso-0.04 ___ 04:55AM BLOOD ___ ___ 01:31PM BLOOD Plt ___ ___ 04:55AM BLOOD Glucose-93 UreaN-10 Creat-0.7 Na-135 K-3.2* Cl-91* HCO3-32 AnGap-12 ___ 10:00PM BLOOD Glucose-110* UreaN-13 Creat-0.8 Na-136 K-3.4* Cl-92* HCO3-35* AnGap-9* ___ 02:58PM BLOOD ALT-9 AST-18 AlkPhos-61 TotBili-0.4 ___ 04:55AM BLOOD Calcium-8.8 Phos-2.2* Mg-2.4 ___ 04:55AM BLOOD Trep Ab-PND ___ 02:58PM BLOOD CMV IgG-PND CMV IgM-PND CMVI-PND ___ 10:00PM BLOOD HIV Ab-NEG ___ 01:40PM BLOOD Lactate-1.9 ___ 01:31PM BLOOD HERPES SIMPLEX VIRUS 1 AND 2 ANTIBODY IGM-PND ___ 02:58PM BLOOD HERPES SIMPLEX VIRUS 1 AND 2 ANTIBODY IGM-PND ___ 8:00 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: < 10,000 CFU/mL. EXAMINATION: CT NECK W/CONTRAST (EG:PAROTIDS) Q22 CT INDICATION: ___ year old woman with oral ulcer, c/f malignancy, unable to tolerate MRI// ?malignancy TECHNIQUE: MDCT acquired helical axial images were obtained from the thoracic inlet through the skull base. Coronal and sagittal multiplanar reformats were then produced and reviewed. DOSE: Acquisition sequence: 1) Spiral Acquisition 3.7 s, 24.2 cm; CTDIvol = 8.1 mGy (Body) DLP = 191.8 mGy-cm. 2) Spiral Acquisition 3.7 s, 24.2 cm; CTDIvol = 23.1 mGy (Body) DLP = 543.5 mGy-cm. Total DLP (Body) = 735 mGy-cm. COMPARISON: MRI nasopharynx dated ___. FINDINGS: Imaging was initially attempted with intravenous contrast material. However, due to technical error, the contrast was not administered in the appropriate amount or at the appropriate time of the study. The study is limited in the absence of intravenous contrast. Dental amalgam artifact further limits evaluation of the oral cavity. Aero digestive tract: 3.6 cm x 2.9 cm x 1.1 cm soft palate soft tissue fullness is better assessed on MRI ___.. No bone destruction. No other abnormalities. No evidence of perineural tumor. Neck lymph nodes: There are multiple bilateral scattered subcentimeter level I-VI cervical lymph nodes, not pathologically enlarged based on CT size criteria. There is no retropharyngeal adenopathy. Extra nodal tumor spread: There are no findings suggestive of extra nodal extension. Deep neck muscles, masticator space: There is no muscle invasion. Bones, skull base: There is no bone involvement. There are no findings suggestive of perineural tumor extension. Jugular foramen, carotid canal, pterygopalatine fossa, infraorbital foramen, other skull base foramina are not involved. Vessels: There is no vascular invasion. Brachial Plexus: There is no brachial plexus contact or invasion. Thyroid, salivary glands: There is no mass. Other findings: There are no lung nodules. IMPRESSION: 1. Technical failure of IV contrast administration. Essentially noncontrast scan. 2. Stable appearance of the hard/soft palate soft tissue abnormality. 3. No definite adenopathy. EXAMINATION: MRI NASOPHARYNX W/O CONTRAST INDICATION: ___ year old woman with oral leision// Oral lesion, rule out malignancy TECHNIQUE: Study is limited due to patient inability to complete the exam. Sagittal T1 imaging of the brain was obtained. Axial T1 and T2 fat sat of the nasopharynx were obtained. Coronal STIR and T1 fat-sat precontrast of the nasopharynx were obtained. After which, the patient was unable to complete exam. FINDINGS: Limited study due to patient inability to complete the exam. No post-contrast imaging was obtained. Lobulated T2 hyperintense submucosal lesions are seen involving the midline hard palate. The lesion appears confined to the hard palate without soft palate involvement. Otherwise, the visualized aerodigestive tract is unremarkable. There is no lymphadenopathy. The parotid and submandibular glands carotid remarkable. The visualized brain and orbits are unremarkable. The mastoid air cells are clear. IMPRESSION: 1. Limited study due to patient inability to complete the exam. No postcontrast imaging was obtained. 2. Lobulated mucosal lesions involving the midline hard palate, differential considerations include necrotizing sialometaplasia. Direct visualization is recommended. 3. No lymphadenopathy. 4. 5-mm descent of the cerebellar tonsils likely secondary to tonsillar ectopia. Brief Hospital Course: Ms. ___ is a ___ personal care assistant with a PMH including anxiety/depression and tobacco-marijuana smoking (20+ years, often 10 blunts daily) who presents with several weeks of worsening oral pain leading to poor oral intake and dehydration who was sent from her PCP's office ___ for further evaluation of these issues. Admitted for management of painful soft palate lesion likely contributing to poor po intake as well as ___ and hypokalemia. # Soft palate lesion Per ___ Consult service, "Given that she reports having it for several weeks, it would be unlikely to be infectious or developmental in nature. Given the bilateral nature of it, trauma seems less likely, though necrotizing sialometaplasia is in the differential. Systemic conditions with oral manifestations, such as granulomatosis with polyangiiitis, SLE, immunocompromised state, Behcet's disease, or syphilis may also be in the differential. It is somewhat concerning for benign or malignant tumor of the minor salivary glands, and as a result, biopsy and imaging would be indicated." She received CT of the area as well as an MRI, though the latter was not completely diagnostic secondary to motion artifact. In my discussion with ___ they think that the relatively rapid onset was consistent with reactive injury. She will follow-up in clinic on ___. She was given Tylenol, Lidocaine, and Tramadol for pain. She understands that the pain will not go away completely, but the medicine will allow her to have acceptable oral intake. # Recent poor po intake Although history suggested throat issues, assessment since arriving at ___ suggests that the oral lesion is the cause of her pain and difficulty eating. Now that she's gotten pain treatment she is eating well without obvious swallowing issues. Low suspicion for infection at this point. CMV esophagitis would be unusual in an immunocompetent individual and wouldn't explain oral lesion so there was no need for acyclovir. Her HIV was negative. Final tests for different infections were pending at the time of discharge, but she can follow up with her PCP to go over results. # Hypokalemia Presumably related to recent poor oral intake. She received oral supplementation of this and phosphorous, and was encouraged to have high potassium foods on discharge with recheck with her PCP next week. # s/p ___ due to dehydration Initial Cr 1.4 with elevated BUN. S/p fluids, now normalized to 0.7. She was able to eat all of her breakfast and lunch without any difficulty prior to discharge. #Anxiety - she was upset and also tearful with many aspects of her hospital stay. She was given Klonopin 0.5 and Xanax 0.5 in order to go through with the CT scan. I was very firm that these were intended for one-time uses, and not intended to be continued on an outpatient basis. Pending Results at discharge that PCP ___ need to follow: Labs ___ 14:58 CMV IgG Ab ___ 14:58 CMV IgM Ab ___ 04:55 Treponema pallidum (Syphilis) Antibodies Send Outs ___ 14:58 HERPES SIMPLEX VIRUS 1 AND 2 ANTIBODY IGM ___ 13:31 HERPES SIMPLEX VIRUS 1 AND 2 ANTIBODY IGM Microbiology ___ 18:04 THROAT CULTURE VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS I spent > 30 min in discharge planning and coordination of care. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen w/Codeine 1 TAB PO Q4H:PRN throat pain 2. ProAir HFA (albuterol sulfate) 2 puffs inhalation Q4H:PRN wheezes 3. Fluticasone Propionate NASAL ___ SPRY NU DAILY 4. Fluticasone Propionate 110mcg 2 PUFF IH BID 5. norgestimate-ethinyl estradiol 0.18/0.215/0.25 mg-35 mcg (28) oral 1 tablet daily 6. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 7. Docusate Sodium 100 mg PO BID 8. Ferrous Sulfate 325 mg PO BID 9. Senna 17.2 mg PO BID 10. Albuterol Inhaler ___ PUFF IH Q6H:PRN shortness of breath/wheezing Discharge Medications: 1. Lidocaine Viscous 2% 15 mL PO TID RX *lidocaine HCl [Lidocaine Viscous] 2 % 10 ml three times a day Refills:*2 2. Polyethylene Glycol 17 g PO TID:PRN Constipation - First Line RX *polyethylene glycol 3350 17 gram 1 packet(s) by mouth twice a day Disp #*30 Packet Refills:*0 3. TraMADol 50 mg PO TID:PRN Pain - Moderate RX *tramadol 50 mg 1 tablet(s) by mouth three times a day Disp #*12 Tablet Refills:*0 4. Acetaminophen w/Codeine 1 TAB PO Q4H:PRN throat pain 5. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 6. Albuterol Inhaler ___ PUFF IH Q6H:PRN shortness of breath/wheezing 7. Docusate Sodium 100 mg PO BID 8. Ferrous Sulfate 325 mg PO BID 9. Fluticasone Propionate 110mcg 2 PUFF IH BID 10. Fluticasone Propionate NASAL ___ SPRY NU DAILY 11. norgestimate-ethinyl estradiol 0.18/0.215/0.25 mg-35 mcg (28) oral 1 tablet daily 12. ProAir HFA (albuterol sulfate) 2 puffs inhalation Q4H:PRN wheezes 13. Senna 17.2 mg PO BID Discharge Disposition: Home Discharge Diagnosis: Soft palate mass Acute Kidney injury Hypokalemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital both to understand the reason there is a mass on the roof of your mouth, and to give medicine to make it more comfortable. You had scans that will help the oral surgeons determine what next steps you will need in order to get a diagnosis, which may include a biopsy in the future. You will continue to experience some mouth swelling and soreness, which is normal, but the medicines should make it easier. As long as you are able to eat some food and drink fluids, there is no need to come to the hospital. If you have concerns, we encourage you to check with your primary care providers as the first step. We wish you the best in your recovery, Your ___ team Followup Instructions: ___
19802576-DS-6
19,802,576
22,187,976
DS
6
2186-05-11 00:00:00
2186-05-20 23:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins Attending: ___. Chief Complaint: n/v since ___ Major Surgical or Invasive Procedure: none. History of Present Illness: ___ F with bipolar disorder, anxiety not on medications, on disability for these psychiatric disorders with multiple ED visits for N/V (improved with IVF and no other interventions), vaginitis/UTI, and myriad of other nonspecific joint complaints presents with continued n/v, inability to tolerate PO since ___. Patient was very vague and did not offer any details as to how recent episode started. From what I could gather, patient was otherwise well until ___ or ___ when all of a sudden, patient began to have nausea, vomiting leading to epigastric abdominal discomfort, inability to tolerate PO. Patient came to the ED, was given compazine, IVF, and instructions to ease diet to liquids/popsicles until symptoms improve. Patient reported to PCP that she remembers being in her brother's home on ___ and woke up ___ at a stranger's house. When she woke up, patient noticed a broken front tooth and cuts on her hand. She believes that she was drugged. She states that she drinks regularly on weekends, about ___ drinks/night, and has been smoking marijuana regularly since age ___, last smoked on ___. States that she does not have any drug use or h/o IVDU. Patient states that she does not take any psychiatric drugs nor is she followed by a psychiatrist/psychologist b/c she does not like how the medications make her feel. Pt has had no hx of any GI bleeding or gastritis in past. In the ED, VS: 98.3 67 113/73 18 98%RA. Patient was given 2L NS, PO/PR compazine and IV ativan without immediate resolution of sx. KUB without obstruction/free air. Patient was then admitted to medicine for further evaluation. Upon arrival, VSS and patient feels much better, without n/v. Patient also describes passing gas and occasionally having diarrhea, a couple of BM/day. No fevers/chills, weight loss. Abdominal pain c/w strain from mult emesis. Patient denies any blood in vomit, says that she's not sure if it has been liquid, food, or bilious. Patiet with weakness and malaise. Currently on period. No cough, SOB, CP, wheeze. Past Medical History: bipolar disorder asthma UTI ___ vaginitis Neck spasm N/V with no etiology found in past Social History: ___ Family History: Father passed away of cancer, unsure what kind or at what age. Mother currently alive, in good health. Physical Exam: Physical Exam on Admission: VS: 98.0 74 126/81 18 100% NAD, A+Ox3, annoyed at having to answer questions, under bed covers, feeling cold. No obvious signs of trauma except L front tooth broke in half Neck: supple w/o LAD Chest: clear w/o wheeze Cardiac: RRR, normal S1/S2 abdomen: soft, NT/ND, slight epigastric tenderness on palp. Skin: clear w/o rash Physical Exam on Discharge: NAD, A+Ox3 Neck: supple w/o LAD Chest: clear w/o wheeze Cardiac: RRR, normal S1/S2 abdomen: soft, NT/ND Skin: clear w/o rash Pertinent Results: Labs on Admission: ___ 08:57AM BLOOD WBC-6.8 RBC-4.00* Hgb-11.8* Hct-35.7* MCV-89 MCH-29.6 MCHC-33.1 RDW-12.4 Plt ___ ___ 08:57AM BLOOD Glucose-107* UreaN-7 Creat-0.7 Na-143 K-3.2* Cl-104 HCO3-25 AnGap-17 ___ 08:57AM BLOOD ALT-14 AST-15 LD(LDH)-170 AlkPhos-46 TotBili-0.6 ___ 08:57AM BLOOD Neuts-69.8 ___ Monos-4.9 Eos-1.5 Baso-0.4 ___ 08:57AM BLOOD Lipase-15 ___ 08:57AM BLOOD Albumin-4.7 ___ 05:03PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 10:00AM URINE Color-Yellow Appear-Hazy Sp ___ ___ 10:00AM URINE Blood-MOD Nitrite-NEG Protein-TR Glucose-NEG Ketone-40 Bilirub-NEG Urobiln-4* pH-8.0 Leuks-NEG ___ 10:00AM URINE RBC-102* WBC-2 Bacteri-MOD Yeast-NONE Epi-3 ___ 10:00AM URINE AmorphX-OCC ___ 10:00AM URINE Mucous-MANY ___ 10:00AM URINE UCG-NEGATIVE Labs on Discharge: ___ 07:30AM BLOOD WBC-6.0 RBC-3.26* Hgb-9.8* Hct-29.5* MCV-91 MCH-30.1 MCHC-33.2 RDW-12.7 Plt ___ ___ 07:30AM BLOOD Glucose-72 UreaN-5* Creat-0.7 Na-142 K-3.3 Cl-108 HCO3-23 AnGap-14 ___ 07:30AM BLOOD Calcium-8.5 Phos-3.3 Mg-1.9 Micro: None Imaging: KUB 1. Paucity of bowel gas, but no definite signs of obstruction. 2. No evidence of free air. Brief Hospital Course: ___ F with bipolar disorder/anxiety not on medications, on disability for these psychiatric disorders with multiple ED visits for N/V (improved with IVF and no other interventions), vaginitis/UTI, and myriad of other nonspecific joint complaints presents with continued n/v likely ___ cyclic vomiting syndrome, perhaps induced by regular marjiuana usage. # N/V: Patient has repeated ED visits for similar complaint, which generally resolves with IVF and anti-emetics. Patient had recent ETOH/marjiuana usage and symptoms subsided by the time the patient arrived the floor. Likely ___ EtOH, marijuana, or other drug ingestion. Other ddx include gastritis, GERD, or PUD. Patient was given zofran as needed, as well as intravenous fluids initially. LFTs WNL as was KUB. We explained to the patient that we think this may be cyclic vomiting ___ marjiuana usage and advised for her to stop. Should her symptoms continue, patient may need an EGD as outpatient to f/u for gastritis/PUD. Medications on Admission: ALBUTEROL NEBULIZER EVERY 4 TO 6 HOURS AS NEEDED FOR ASTHMA ALBUTEROL SULFATE 2 (Two) puff(s)q ___ h prn FLUTICASONE 50 mcg 2 puff daily IBUPROFEN - 600 mg q 8 h prn fever or pain TRIAMCINOLONE affected areas BID MINERAL OIL BID Discharge Medications: 1. fluticasone 50 mcg/actuation Spray, Suspension Sig: One (1) Spray Nasal DAILY (Daily). 2. albuterol sulfate 90 mcg/actuation HFA Aerosol Inhaler Sig: ___ puffs Inhalation every ___ hours as needed for shortness of breath or wheezing. 3. triamcinolone acetonide 0.025 % Ointment Sig: One (1) Appl Topical twice a day. 4. ZOFRAN ODT 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO every eight (8) hours as needed for nausea for 5 days. Disp:*15 Tablet, Rapid Dissolve(s)* Refills:*0* Discharge Disposition: Home Discharge Diagnosis: cyclic vomiting syndrome, likely ___ marijuana use . UTI, vaginitis neck spasm non-specific joint pain bipolar disorder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted for nausea and vomiting, likely secondary to a phenomenon called cyclic vomiting from chronic marijuana use. You were treated with medications to help curb your nausea but in order to prevent this from happening in the future, you will need to stop using marijuana. Please follow up with your PCP, ___. We have sent you home with zofran, for you to take as needed for nausea. Followup Instructions: ___
19802576-DS-7
19,802,576
28,362,473
DS
7
2188-08-05 00:00:00
2188-08-05 18:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins Attending: ___. Chief Complaint: Cannabinoid Hyperemesis Syndrome Post-Operative Nausea and Vomiting Major Surgical or Invasive Procedure: None History of Present Illness: ___ s/p hemorrhoid surgery presents with persistent nausea, vomiting and abdominal pain. Patient said she had her surgery 2 days ago by Dr. ___ at ___ and developed nausea and vomiting immediately following surgery. Reports that she developed periumbilical abdominal pain soon after. Some lower abdominal pain. Says she actually does not have pain at the site itself. No fevers or chills. No urinary symptoms. Passing gas. Has had multiple bowel movements, but denies diarrhea. First bowel movement had some bright red blood coating it, subsequent bowel movements were brown. She is currently having her period. Denies any urinary symptoms. She denies having any prior issues with nausea/vomiting in the past, although on review of records, she was hospitalized with similar symptoms in ___ and had multiple ED visits for similar symptoms prior to that time. On this occasion, she reports that symptoms improved transiently with hot showers. Tried mylanta and procholperazine from her PCP at home without relief. In the ED, initial vitals were ___ pain, T 98.5, HR 60, BP 113/67, RR 16, SaO2 100% on RA. Labs notable for Was given ondansetron 4mg x3, APAP 500mg, lorazepam 2mg, metoclopramide 10mg, and a scopolamine patch. ED felt that, as patient was unable to tolerate any PO and immediately vomits, she was not safe to go home; colorectal surgery team was FYI’d and patient was admitted to general medicine. On the floor, patient complaining of nausea and abdominal discomfort, requesting to take a hot shower. Review of systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies diarrhea, constipation. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Past Medical History: Cannabinoid Hyperemesis Syndrome Prolapsing bleeding internal anal hemorrhoids status-post operative hemorrhoidectomy and elastic band ligation Mood Disorder (records mention Bipolar Disorder, Depression, Anxiety, and/or Agoraphobia) Nausea/Vomiting with no clear past etiology Allergic Rhinitis Asthma Multiparity (>5 pregnancies) Current 0.5 Pack/Day Smoker Eczematous Dermatitis Iron Deficiency Anemia Urinary Tract Infection Vulvovaginal Candidiasis Neck Spasm Social History: ___ Family History: Significant for breast cancer ___ yo sister with invasive ductal carcinoma), unknown malignancy in father. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: 99.7, 120/58, 56, 20, 99%/RA General: Alert, oriented, appears anxious and uncomfortable HEENT/NECK: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple CV: mild bradycardia, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-distended, mild diffuse tenderness to deep palpation without rebound/guarding, normal BS Rectal: external suture noted, no surrounding swelling/erythema, no visible drainage or bleeding Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, strength and sensation grossly intact DISCHARGE PHYSICAL EXAM: Vitals: 99.5, 48-57, 122-135/62-81, 18, 100% on RA General: Alert, oriented, fatigued, easily and without pain flexing abdomen HEENT/NECK: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple CV: Mild bradycardia, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-distended, mild tenderness in epigastrium, no guarding/rebound, normal BS Rectal: external suture noted, no surrounding swelling/erythema, no visible drainage or bleeding Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, strength and sensation grossly intact Pertinent Results: ___ 10:00AM BLOOD WBC-11.4* RBC-3.68* Hgb-11.1* Hct-33.2* MCV-90 MCH-30.3 MCHC-33.5 RDW-14.3 Plt ___ ___ 10:00AM BLOOD Neuts-80.6* Lymphs-12.6* Monos-6.1 Eos-0.6 Baso-0.1 ___ 10:00AM BLOOD ___ PTT-24.4* ___ ___ 10:00AM BLOOD Glucose-135* UreaN-15 Creat-0.7 Na-142 K-3.3 Cl-98 HCO3-26 AnGap-21* ___ 05:40AM BLOOD Glucose-117* UreaN-8 Creat-0.7 Na-141 K-2.8* Cl-100 HCO3-30 AnGap-14 ___ 10:00AM BLOOD ALT-21 AST-23 AlkPhos-45 TotBili-0.5 ___ 10:00AM BLOOD Lipase-14 ___ 10:00AM BLOOD Albumin-5.1 ___ 10:07AM BLOOD Lactate-2.8* ___ 06:27AM BLOOD Lactate-1.3 ___ 11:25AM URINE Blood-TR Nitrite-NEG Protein-300 Glucose-NEG Ketone-150 Bilirub-NEG Urobiln-2* pH-8.5* Leuks-NEG ___ 11:25AM URINE RBC-23* WBC-2 Bacteri-NONE Yeast-NONE Epi-1 ___ 11:25AM URINE UCG-NEGATIVE AXR ___ = No evidence of obstruction noting limited evaluation due to paucity of bowel gas. EKG ___ = HR 48, sinus, QTc 457, no electrolyte disturbance changes HEMORRHOID SURGERY OPERATIVE NOTE ___ = DATE OF OPERATION: ___ PREOPERATIVE DIAGNOSIS: Prolapsing bleeding internal anal hemorrhoids. POSTOPERATIVE DIAGNOSIS: Prolapsing bleeding internal anal hemorrhoids. NAME OF PROCEDURE: ___ hemorrhoidectomy and elastic band ligation. SURGEON: Dr. ___. ANESTHESIA: Local with sedation. INDICATIONS: The patient is a ___ female who had previously been treated conservatively with elastic band ligation for her internal hemorrhoids without success. She understands the risks and benefits of the procedure and agrees to proceed. DESCRIPTION OF PROCEDURE: The patient is brought to the operating room and Properly identified as the patient. Placed on the operating room table in the prone position after obtaining adequate sedation. She was placed in the jackknife position and her buttocks were tapped apart. Skin overlying the perianal region was prepped with Betadine solution and draped sterilely after an appropriate surgical timeout. Bilateral anal nerve block was created with a combination of Marcaine and lidocaine bicarbonate and epinephrine. Following this using a Sawyer anal retractor the left lateral hemorrhoid column was identified. A ligating stitch of ___ Vicryl was placed proximally at the pedicle of the hemorrhoid and after this was tied and tightened the hemorrhoid was excised from distal to proximal by removing the external and internal hemorrhoids in a column. Hemostasis was obtained and the incisions then closed in a continuous running locked fashion out to the dentate line and then in a nonlocked fashion out to the distal aspect. Again hemostasis was assured. Attention was turned to the right anterior position. A significantly enlarged hemorrhoid was similarly identified in this location. A ligating figure-of-eight stitch was placed in the proximal aspect of the hemorrhoid column and the hemorrhoid was excised from distal to proximally and amputated, sent off as a separate specimen. Again hemostasis was assured with direct pressure and the incision was closed in a continuous running locked fashion. Completing this attention was turned to the right posterior position. The internal hemorrhoid in this location was only slightly enlarged or modestly enlarged. The external hemorrhoid was not _____ there was no evidence of bleeding and so we opted for elastic band ligation in this location. Completing this a dry bulky dressing was placed externally. The patient was rotated back in a supine position and sent to recovery stable And extubated. All needle, sponge and instrument counts are correct. Estimated blood loss was less than 10 mL. Drains were none. Specimens were left lateral and right anterior hemorrhoid separately to pathology. I was present, scrubbed and performed the entire procedure. DISCHARGE LABS ___ 03:40PM BLOOD Na-139 K-3.5 Cl-102 Brief Hospital Course: ___, a ___ yo F PMHx chronic daily marijuana use and hemorrhoids s/p hemorrhoidectomy ___ presents with persistent nausea/vomiting with abdominal pain and inability to tolerate PO and refractory to numerous anti-emetics. On ___ AM, she was able to tolerate clears diet and crackers and was willing to go home. # Cannabinoid Hyperemesis Syndrome / PONV: Persistent post-operative nausea with inability to take PO. Has elevated lactate with leukocytosis and ketonuria but has normal BMP/LFTs/Lipase/hCG/AXR. Most likely post-op nausea and vomiting given time course, although marijuana-induced hyperemesis also in ddx given daily marijuana use and relief with hot showers. Patient previously had recurrent episodes of nausea and vomiting attributed to cyclic vomiting vs marijuana hyperemesis. Also with significant psychiatric history, which may be contributing to symptoms. eosinophilic esophagitis also a possibility given hx of ectopy but less likely. EKG in AM showed bradycardia to 48, sinus, QTc 457. She was initially treated with ondansetron, prochlorperazine, and lorazepam IV along with scopolamine patch and famotidine for symptomatic relief. She went home with PO/PR anti-emetics and instructions to avoid marijuana as it was causing her nausea/vomiting. # Hypokalemia: K 2.8 on AM labs from 3.3 in ED, likely related to repeated emesis. She was given several IV K+ repletions as part of maintenance IV fluids and as an initial bolus. Final K+ was 3.5 on discharge. # Bradycardia: HR ___ without clear lightheadedness, dizziness, pre-syncope, or chest pain. Possibly constitutional (otherwise healthy patient) and parasympathetic tone from repeated Valsalva maneuvers. She remained hemodynamically stable in sinus throughout her hospital stay. # Abdominal Pain: Epigastric likely related to vomiting, improved with PR acetaminophen and famotidine. Patient requested avoidance of opioids as this may increase her nausea. Substantially improved on discharge. # Status-Post Hemorrhoidectomy ___: Post-operative nausea/vomiting was at least a component but hard to define feature of her presentation. She was continued on a Senna/Docusate bowel regimen to avoid constipation. # Mood Disorder: Variable but stable history of depression, anxiety and agorophobia continued on home olanzapine 10mg qHS. # Atopy: Chronic stable issues, but eosinophilic esophagitis is a potential cause of nausea/vomiting in this patient (less likely with prompt improvement). Continued on home albuterol inhaler, fluticasone nasal spray # Iron-Deficiency Anemia: Patient has had chronic issues with anemia, attributed to bleeding from her hemorrhoids. Home ferrous sulfate held during hospital stay given risk of constipation but restarted on discharge. # Code Status: Full Code, no health care proxy documented. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN dyspnea, wheeze 2. Clobetasol Propionate 0.05% Cream 1 Appl TP BID:PRN itch 3. Fluticasone Propionate NASAL 1 SPRY NU BID 4. Fluticasone Propionate 110mcg 2 PUFF IH BID 5. Hydrocortisone Acetate Suppository 1 SUPP PR QHS:PRN hemorrhoids 6. Ibuprofen 800 mg PO Q8H:PRN pain 7. OLANZapine 10 mg PO HS 8. Prochlorperazine 10 mg PO Q6H:PRN nausea 9. Docusate Sodium 100 mg PO BID 10. loratadine-pseudoephedrine ___ mg oral daily 11. Mineral Oil ___ mL PO BID:PRN affected area Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN dyspnea, wheeze 2. Docusate Sodium 100 mg PO BID 3. Fluticasone Propionate 110mcg 2 PUFF IH BID 4. Fluticasone Propionate NASAL 1 SPRY NU BID 5. OLANZapine 10 mg PO HS 6. Clobetasol Propionate 0.05% Cream 1 Appl TP BID:PRN itch 7. Hydrocortisone Acetate Suppository 1 SUPP PR QHS:PRN hemorrhoids 8. Ibuprofen 800 mg PO Q8H:PRN pain 9. loratadine-pseudoephedrine ___ mg oral daily 10. Mineral Oil ___ mL PO BID:PRN affected area 11. Famotidine 20 mg PO BID:PRN Abdominal Pain RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*0 12. Prochlorperazine 10 mg PO Q6H:PRN nausea 13. Ondansetron 4 mg PO Q8H:PRN nausea, vomiting RX *ondansetron 4 mg 1 tablet(s) by mouth every eight (8) hours Disp #*12 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Cannabinoid Hyperemesis Syndrome / Post-Operative Nausea and Vomiting Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure to take care of you at ___ ___. You were admitted because you were having nausea/vomiting and couldn't eat anything. We gave you fluids, made sure your electrolytes stay normal, and discharged you once you were eating some food. Best of luck to you in your future health. Please stop consuming marijuana, as we think this is contributing to your nausea. Please take all medications as prescribed, attend all physician appointments as directed, and call a physician with any questions or concerns. Followup Instructions: ___
19803372-DS-20
19,803,372
22,190,767
DS
20
2128-11-25 00:00:00
2128-11-25 16:18:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: thrombocytopenia, headache Major Surgical or Invasive Procedure: None History of Present Illness: ___ y.o female with h.o ITP? who had recent bruising and presented to ___ and she has been having platelet transfusions reportedly almost every other day. She first received IVIG ___ and ___ and was on prednisone starting at 40mg then up to 60mg then down to 10mg per day with plans to stop in 2 days. Pt also reportedly started promacta yesterday. Per report she last saw Dr. ___ ___ and was still having bruising, petechiae and epistaxis. Last plt transfusion ___. Of note, She drinks about ___ beers/day, quit about 24 hours ago since she read about an interaction between promacta and alcohol. Today she continues to have a headache ___ pressure on the top of her head that has been off/on for 1 month and relieved by Tylenol. She denies any paresthesias, weakness, n/v, neck stiffness, visual changes. No change in the character of her headaches. She was given romiplostim in clinic before transfer to the ED. . 10 pt ROS reviewed and otherwise negative for CP, sob, st, cough, palpitations, abdominal pain, nausea, vomiting, diarrhea, constipation, melena, brbpr, dysuria, joint pain. +spontaneous bruising and occasional epistaxis. Past Medical History: thrombocytopenia, ITP? ETOH misuse has had elevated BP lately to ___, no diagnosis of HTN PAST SURGICAL HISTORY: Ovarian cystectomy about ___ years ago tonsillectomy Social History: ___ Family History: Mom is ___ healthy. Dad died MI age ___. One sister died of lung cancer age ___, another sister had laryngeal cancer age ___, brother had a MI age ___. Sister with diabetes. Has 4 boys age ___, ___, ___ all healthy. Physical Exam: GEN: well appearing, NAD vitals:T 98.5 BP 123/60 HR 92 RR 16 sat 98% on RA HEENT: ncat eomi anicteric MMM neck: supple chest: b/l ae no w/c/r heart: s1s2 rr no m/r/g abd: +bs, soft, NT, ND, no guarding or rebound ext: no c/c/e 2+pulses neuro: face symmetric, speech fluent psych: calm, cooperative skin: various ecchymoses on the b/l flanks/sides of ribs, L.arm, legs Discharge PE: T 97.7 HR 79 BP 167/63 RR 16 100% RA Gen: NAD, resting comfortably Lung: CTA B CV: RRR Abd: Nabs, soft Ext NO edema skin: old echymosses, no petechia Pertinent Results: ___ 05:30PM URINE ___ ___ 05:30PM URINE ___ ___ 05:30PM URINE ___ SP ___ ___ 05:30PM URINE ___ ___ ___ ___ 05:30PM URINE ___ ___ ___ 11:35AM ALT(SGPT)-126* AST(SGOT)-47* ALK ___ TOT ___ ___ 11:35AM ___ ___ 11:35AM ___ ___ 11:35AM HIV ___ ___ 11:35AM ___ ___ ___ 11:35AM ___ ___ ___ ___ 11:35AM ___ ___ 11:35AM ___ ___ ___ 11:35AM PLT ___ PLT ___ ___ 11:35AM ___ ___ ___ 10:45AM ___ ___ 10:45AM UREA ___ ___ TOTAL ___ ANION ___ ___ 10:45AM ___ this ___ 10:45AM ___ .___ 06:35AM BLOOD ___ ___ Plt ___ ___ 07:10AM BLOOD ___ ___ Plt ___ ___ 11:35AM BLOOD HCV ___ Head CT: 1. No acute intracranial abnormality. 2. Several subcortical areas of ___ matter hypodensity may reflect sequela of chronic microvascular disease. However, these appears somewhat focal and are more extensive than typical for a patient of this age. Further evaluation with MRI is recommended non urgently. RECOMMENDATION(S): Nonurgent brain MR. ___ PYLORI ANTIBODY TEST (Final ___: POSITIVE BY EIA. (Reference ___. ___ VIRUS ___ AB (Final ___: POSITIVE BY EIA. ___ VIRUS EBNA IgG AB (Final ___: POSITIVE BY EIA. ___ VIRUS ___ AB (Final ___: NEGATIVE <1:10 BY IFA. INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION. In most populations, 90% of adults have been infected at sometime with EBV and will have measurable VCA IgG and EBNA antibodies. Antibodies to EBNA develop ___ weeks after primary infection and remain present for life. Presence of VCA IgM antibodies indicates recent primary infection. Brief Hospital Course: ___ y.o woman with h.o thrombocytopenia s/p steroids, IVIG and plt transfusions, ETOH use who presents with thrombocytopenia and headache. . #thrombocytopenia, refractory with recent steroids, IVIG, romiplostim and plt tranfusions. DDx includes ITP, liver disease/splenomegaly. Reportedly flow at ___ did not show a clonal disorder. She was seen by hematology service who felt that she had ITP; she received two doses of IVIG and also was started on IV dexamethasone. She needs PJP prophylaxis as well as calcium and vitamin D. She did not have any signs of bleeding during her hospitalization. She required premedication with pepcid, benedryl and tylenol when getting IVIG. Discharged on prednisone 60 mg daily with close ___. #Transaminitis. Mild and downtrending. Could be due to alcohol use. Hepatitis serologies showed she was hepatitis C negative and had previously been exposed to hepatitis B and had cleared it. #Tobacco/alcohol use: Patient endorsed drinking six drinks a night so that she could fall asleep. She works ___ at her job and ___ works as primary caretaker of her blind ___ y/o mom with whom she lives. She feels very unhappy with this arrangement, and feels she does the bulk of the care taking because she happens to live with her mother. She spoke with SW. She did not have any signs of alcohol withdrawal. She would benefit greatly from outpatient counseling. Counselled on the importance of alcohol cessation. . ___ CT showing no acute abnormalities. Radiology suggests ___ MRI head for further evaluation of multiple areas of ___ matter hypodensities. . ___ diet . Medications on Admission: The Preadmission Medication list is accurate and complete. 1. PredniSONE 10 mg PO DAILY 2. Promacta (eltrombopag) unknown oral unknown Discharge Medications: 1. PredniSONE 60 mg PO DAILY RX *prednisone 20 mg 3 tablet(s) by mouth once a day Disp #*90 Tablet Refills:*0 2. Calcium 600 + D(3) (calcium ___ D3) 600 mg calcium- 200 unit oral DAILY RX *calcium ___ D3 600 mg calcium (1,500 mg)-200 unit 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 3. Sulfameth/Trimethoprim DS 1 TAB PO DAILY RX ___ [Bactrim DS] 800 ___ mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: 1. ITP 2. Alcohol use Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted because your platelets are low due to having ITP. You were treated by Dr ___ the rest of his hematology team and they advised that you have steroids as well as two doses of IVIG. You should be on calcium and vitamin D to strengthen your bones while on steroids. You met with your social worker to discuss your long term stressors and alcohol use. Please completely avoid alcohol use. Please discuss this further with your PCP - with therapy and medication you will feel much better emotionally. Followup Instructions: ___
19803391-DS-3
19,803,391
25,447,793
DS
3
2195-10-19 00:00:00
2195-10-20 13:05:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Tegaderm / adhesive Attending: ___. Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ man with recurrent metastatic anal cancer in the setting of HIV status post definitive chemoradiotherapy with ___ and mitomycin C with recurrent disease, status post eight cycles of cisplatin and ___ therapy with subsequent ___ disease progression along with ___ evidence of further progression, now status post two cycles of palliative carboplatin with further ___ evidence of disease progression. Patient reported 2 weeks of exertional dyspnea and some chest discomfort. CTA chest ordered on the day of admission in clinic ruled out PE but showed pericardial effusion and interstitial findings suspicious for lymphangitic spread. So the patient was referred to the ED. He denied any recent fevers, nausea, diarrhea, dysuria, or rashes. He did have a cold with some nasal and sinus congestion a couple of weeks ago but this has improved. He had an occasional nonproductive cough that has been going on for months and is unchanged. Past Medical History: PAST ONCOLOGIC HISTORY Anal cancer stage III (T3N2M0) with progressive metastatic disease - ___: anal pap revealed HGSIL - ___: anal pap showed LGSIL - ___: Dr. ___ a nodular lesion on anoscopy. She was able to appreciate regional lymphadenopathy on exam. - ___: MRI of the pelvis showed a large enhancing anal mass measuring up to 3.6 cm in craniocaudal dimension. Pathological right external iliac and right inguinal nodes and a single left inguinal lymph node were enlarged. This was consistant with a T2N3 tumor. That same day, the patient underwent a needle biopsy of the right inguinal node. This showed invasive squamous cell carcinoma that was focally keratinizing and moderately differentiated. - ___ CT of the abdomen and pelvis again showed the right inguinal and external iliac adenopathy as well as a borderline enlarged left inguinal node. There were small number of mildly prominent nodes noted along the retroperitoneum. The chest CT showed three small lung nodules measuring ___ mm. - ___ Started concurrent XRT and ___ - ___ Cycle 2, day 1 of ___ (mitomycin held secondary to counts). - ___ Completion of radiation therapy. - ___ CT torso showed mixed response to treatment with new ___ and paracaval nodes as well as more prominent left pelvic side wall nodes. The right external iliac nodes are decreased in size. - ___ C1D1 Cisplatin 75 mg/m2 D1 + ___ 1000 mg/m2 ___ - ___ C2D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 ___, reduced for mucositis in C1 - ___ C3D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 ___ - ___ CT torso showed decreased size of ___ hypodensity posterior to anus. Stable or decreased size of multiple lymph nodes, including right inguinal, left pelvic wall, aortocaval, and periaortic nodes. - ___ PET showed numerous FDG avid lymph nodes along the retroperitoneum, mediastinum, bilateral pulmonary hilae and the left supraclavicular region are concerning for metastatic disease. Some of these nodes show disproprotionate FDG uptake in relation with their size, suggestive of similar biological root of the increased metabolic activity. Diffuse increased FDG avidity throughout the esophagus is compatible with esophagitis. Although a focal region of relatively higher tracer uptake in the distal esophagus may be related to the same inflammatory process, a neoplasm cannot be excluded. FDG avidity in the lower rectum/anal region may be physiologic although it could be related to disease recurrence. - ___ C4D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 ___ - ___ C5D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 ___ - ___ C6D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 ___ - ___ C7D1 Cisplatin 75 mg/m2 D1 + ___ 500 mg/m2 ___ - ___ C8D1 Cisplatin 75 mg/m2 D1 + ___ 500 mg/m2 ___ - ___ PET CT showed increasing mediastinal and retroperitoneal lymphadenopathy compatible with disease progression. - ___ Lung biopsy revealed metastatic SCC. SNaPShot testing showed a mutation in PI3KCA. - ___ Referred for clinical trial of a PI3KCA active small molecule at ___ - ___ - Dr. ___ - pt would potentially be a good candidate for CLR457 though would need some adjustments of HIV medications for interactions and uncertain about slot availability, will look into this - ___ PET CT showed progressive disease. - ___ Labs showed new ___, Renal consulted who felt this is due to ARVs - ___ Carboplatin 5 x AUC - ___ Carboplatin 5 x AUC - ___ - held C3D1 carboplatin due to significant fatigue along with UTI PAST MEDICAL HISTORY: - HIV - CKD - Renal cysts - Nephrolithiasis, - Hyperlipidemia. Social History: ___ Family History: His brother and paternal grandmother both had kidney stones. Physical Exam: PHYSICAL EXAMINATION ON ADMISSION: ================================== VS: T 98.2 BP 148/84 HR 101 RR 21 O2 97%RA GENERAL: NAD HEENT: EOMI, Neck Supple, MMM CARDIAC: RRR LUNG: CTA ABD: Nondistended, nontender. EXT: No edema. NEURO: Alert and oriented, no focal deficits. PHYSICAL EXAMINATION ON ADMISSION: ================================== VS: T 98.5 BP 130/76 HR 92 RR 18 O2 97%RA GENERAL: NAD HEENT: EOMI, Neck Supple, MMM CARDIAC: RRR LUNG: Scant anterior wheezes, clear posteriorly ABD: ___. EXT: No edema. NEURO: Alert and oriented, no focal deficits. Pertinent Results: LABS ON ADMISSION: ================== ___ 10:30AM BLOOD ___ ___ Plt ___ ___ 10:30AM BLOOD ___ ___ 10:30AM BLOOD Plt ___ ___ 10:30AM BLOOD ___ ___ 10:30AM BLOOD ___ ___ 09:00PM BLOOD cTropnT-<0.01 ___ 06:17AM BLOOD cTropnT-<0.01 ___ 10:30AM BLOOD ___ LABS ON DISCHARGE: ================== ___ 05:07AM BLOOD ___ ___ Plt ___ ___ 05:07AM BLOOD ___ ___ Im ___ ___ ___ 05:07AM BLOOD Plt ___ ___ 05:07AM BLOOD ___ ___ ___ 05:07AM BLOOD ___ IAMGING: ======== ___ CTA CHEST 1. No evidence of pulmonary embolism or aortic abnormality. 2. Interval progression of disease with new pulmonary nodules and increase in size of prior pulmonary nodules involving all lobes. New lymphangitic carcinomatosis, particularly in the right lower lobe. Interval worsening of mediastinal and hilar lymphadenopathy. 3. Increased multifocal areas of bronchial wall thickening, with some areas of ___ opacities, concerning for superimposed infection. 4. New small simple pericardial effusion. Brief Hospital Course: ___ man with recurrent metastatic anal cancer in the setting of HIV who presented with several weeks of progressive exertional chest pain and dyspnea on exertion, found to have progressive metastatic pulmonary disease including increasing nodules and lymphangitic carcinomatosis and new small pericardial effusion. # Exertional chest pain: Patient presented with several weeks of shortness of breath. CTA was negative for PE and notable for markedly worsened pulmonary disease and new lymphangitic carcinomatosis. CTA was notable for small pericardial effusion, but TTE was within normal limits. Troponins were negative. He was started on levofloxacin (Day ___ for empiric treatment of infection. Symptoms were thought to be likely secondary to progressive metastatic disease in the lungs. He was started on prednisone 60 mg on ___, with course to be determined by Dr. ___. # Progressive, recurrent, metastatic anal cancer with progressive disease: Patient was noted to have increased disease on PET from ___. CTA was notable for markedly worsened pulmonary disease and new lymphangitic carcinomatosis, particularly in the right lower lobe. # Renal insufficiency: Patient has a stable CKD with Cr of 1.7. We monitored creatinine, and it remained stable. # HIV: We continued home ART. ***TRANSITIONAL ISSUES:*** - Continue levofloxacin for a total of 7 days (Day ___ last ___ - Patient was started on prednisone 60 mg with course to be determined by Dr. ___ - ___ short duration of steroids, was not provided with PCP ppx - ___ up appointment with primary oncologist pending at discharge #CODE STATUS: Full #CONTACT: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN Shortness of Breath 2. Darunavir 800 mg PO DAILY 3. Doxazosin 4 mg PO HS 4. Dolutegravir 50 mg PO DAILY 5. LaMIVudine 300 mg PO DAILY 6. RiTONAvir 100 mg PO DAILY 7. Multivitamins 1 TAB PO DAILY 8. Fish Oil (Omega 3) Dose is Unknown PO Frequency is Unknown 9. Vitamin D Dose is Unknown PO DAILY Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN Shortness of Breath 2. Darunavir 800 mg PO DAILY 3. Dolutegravir 50 mg PO DAILY 4. Doxazosin 4 mg PO HS 5. LaMIVudine 300 mg PO DAILY 6. Multivitamins 1 TAB PO DAILY 7. RiTONAvir 100 mg PO DAILY 8. Levofloxacin 750 mg PO DAILY RX *levofloxacin [Levaquin] 750 mg 1 tablet(s) by mouth once a day Disp #*5 Tablet Refills:*0 9. PredniSONE 60 mg PO DAILY RX *prednisone 20 mg 3 tablet(s) by mouth once a day Disp #*12 Tablet Refills:*0 RX *prednisone 20 mg 3 tablet(s) by mouth daily Disp #*21 Tablet Refills:*0 10. Fish Oil (Omega 3) Unkown mg PO DAILY 11. Vitamin D Dose is Unknown PO DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: Lymphangitic carcinomatosis Pneumonia SECONDARY DIAGNOSES: Metastatic anal cancer Chronic kidney disease HIV infection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. You came to the hospital because you were experiencing shortness of breath on exertion. CT chest did not show any infection or clots, but it was notable for progression of the cancer in the lungs. We treated you with antibiotics for a possible infection, and also started you on steroids (prednisone) to treat the inflammation in the lungs. Please continue taking the steroids until instructed otherwise by Dr. ___. Take your antibiotics for a total of 7 days, with the final day being ___. Make sure to take all your medications on time and follow up with your doctors as ___. Best regards, -Your ___ team Followup Instructions: ___
19803391-DS-4
19,803,391
20,484,183
DS
4
2196-01-15 00:00:00
2196-01-15 13:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Tegaderm / adhesive Attending: ___. Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: ___ man with metastatic anal cancer in the setting of HIV status with progression of disease despite both definitive and palliative chemotherapy now with PE and lymphangitis carcinomatosis and pulmonary mets on 2L home O2) i.s.o. HIV currently on home hospice (MOLST states DNR/DNI, OK to transfer to hospital) who presents with acute on chronic dyspnea on exertion. He has been short of breath for some time but it worsened in the last week. He also has severe chest tightness and a strong sense of air hunger. He has lost at most 10 lbs and is able to eat well. He denies fevers, chills or significant cough. He had an episode of brown urine that has since resolved. He is currently on anticoagulation with enoxaparin. Reports that he was going down the stairs when he started feeling more short of breath. He took CombiVent x2 and PO morphine x1 from his ___ increased his oxygen to 4L, and was brought in. He denies chest pain, fevers, chills, nausea, vomiting or diarrhea. Endorses R leg swelling, but this is improved from prior. He denies constipation or dysuria. ED Course: - Vitals: T 98.4F P ___ BP 121/86 RR 20 O2 99% 4L O2 - EKG: sinus tachycardia, normal axis - Exam: On 4L O2, end-expiratory wheezes b/l, no crackles, RRR, abd soft, no peripheral edema Labs were notable for: Cr = 1.7 - stable since ___. Pt hydrated for CTA Imaging included: CTA Significant interval increase in the size and number of metastatic lesions within the pulmonary parenchyma as well as bilateral juxta hilar masses. The juxta hilar masses result in compression of bilateral bronchovascular structures, without definite distinct filling defect seen to suggest the presence of acute pulmonary embolism. Past Medical History: PAST ONCOLOGIC HISTORY Anal cancer stage III (T3N2M0) with progressive metastatic disease - ___: anal pap revealed HGSIL - ___: anal pap showed LGSIL - ___: Dr. ___ a nodular lesion on anoscopy. She was able to appreciate regional lymphadenopathy on exam. - ___: MRI of the pelvis showed a large enhancing anal mass measuring up to 3.6 cm in craniocaudal dimension. Pathological right external iliac and right inguinal nodes and a single left inguinal lymph node were enlarged. This was consistant with a T2N3 tumor. That same day, the patient underwent a needle biopsy of the right inguinal node. This showed invasive squamous cell carcinoma that was focally keratinizing and moderately differentiated. - ___ CT of the abdomen and pelvis again showed the right inguinal and external iliac adenopathy as well as a borderline enlarged left inguinal node. There were small number of mildly prominent nodes noted along the retroperitoneum. The chest CT showed three small lung nodules measuring 2-3 mm. - ___ Started concurrent XRT and ___ - ___ Cycle 2, day 1 of ___ (mitomycin held secondary to counts). - ___ Completion of radiation therapy. - ___ CT torso showed mixed response to treatment with new para-aortic and paracaval nodes as well as more prominent left pelvic side wall nodes. The right external iliac nodes are decreased in size. - ___ C1D1 Cisplatin 75 mg/m2 D1 + ___ 1000 mg/m2 D1-4 - ___ C2D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 D1-4, reduced for mucositis in ___ - ___ C3D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 D1-4 - ___ CT torso showed decreased size of ill-defined hypodensity posterior to anus. Stable or decreased size of multiple lymph nodes, including right inguinal, left pelvic wall, aortocaval, and periaortic nodes. - ___ PET showed numerous FDG avid lymph nodes along the retroperitoneum, mediastinum, bilateral pulmonary hilae and the left supraclavicular region are concerning for metastatic disease. Some of these nodes show disproprotionate FDG uptake in relation with their size, suggestive of similar biological root of the increased metabolic activity. Diffuse increased FDG avidity throughout the esophagus is compatible with esophagitis. Although a focal region of relatively higher tracer uptake in the distal esophagus may be related to the same inflammatory process, a neoplasm cannot be excluded. FDG avidity in the lower rectum/anal region may be physiologic although it could be related to disease recurrence. - ___ C4D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 D1-___ C5D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 D1-___ C6D1 Cisplatin 75 mg/m2 D1 + ___ 750 mg/m2 D1-___ - ___ C7D1 Cisplatin 75 mg/m2 D1 + ___ 500 mg/m2 D1-___ - ___ C8D1 Cisplatin 75 mg/m2 D1 + ___ 500 mg/m2 D1-___ - ___ PET CT showed increasing mediastinal and retroperitoneal lymphadenopathy compatible with disease progression. - ___ Lung biopsy revealed metastatic SCC. SNaPShot testing showed a mutation in PI3KCA. - ___ Referred for clinical trial of a PI3KCA active small molecule at ___ - ___ - Dr. ___ - pt would potentially be a good candidate for CLR457 though would need some adjustments of HIV medications for interactions and uncertain about slot availability, will look into this - ___ PET CT showed progressive disease. - ___ Labs showed new ___, Renal consulted who felt this is due to ARVs - ___ Carboplatin 5 x AUC - ___ Carboplatin 5 x AUC - ___ - held C3D1 carboplatin due to significant fatigue along with UTI PAST MEDICAL HISTORY: - HIV - CKD - Renal cysts - Nephrolithiasis, - Hyperlipidemia. Social History: ___ Family History: His brother and paternal grandmother both had kidney stones. Physical Exam: VS: VSS, satting well on 4L NC GENERAL: Pleasant male, visibly dyspneic, taking deep breaths, HEENT: No scleral icterus CARDIAC: Tachy, Regular rate no murmurs, rubs, or gallops LUNG: Appears in respiratory distress. Diffuse wheezes throughout. ABD: Normal bowel sounds, soft, nontender, nondistended, no hepatomegaly, no splenomegaly EXT: Warm, well perfused, no lower extremity edema PULSES:2+ ___ pulses b/l NEURO: Alert, oriented, CN II-XII intact, motor and sensory function grossly intact SKIN: No significant rashes Pertinent Results: ___ 05:32AM BLOOD WBC-6.9 RBC-3.91* Hgb-12.1* Hct-37.8* MCV-97 MCH-30.9 MCHC-32.0 RDW-13.7 RDWSD-48.7* Plt ___ ___ 05:32AM BLOOD WBC-6.9 RBC-3.91* Hgb-12.1* Hct-37.8* MCV-97 MCH-30.9 MCHC-32.0 RDW-13.7 RDWSD-48.7* Plt ___ ___ 05:32AM BLOOD Glucose-92 UreaN-30* Creat-1.5* Na-141 K-4.3 Cl-102 HCO3-30 AnGap-13 Brief Hospital Course: The patient is a ___ year old male with metastatic anal cancer progressing despite palliative and definitive therapy now on hospice who presents with acute on chronic dyspnea. # DYSPNEA - Ddx includes CHF/ACS/PE/increasing pulmonary tumor burden and lymphangetic spread, COPD exacerbation, treated with five day course of Prednisone, held off on diuresis given hypovolemia to euvolemia. Palliative care evaluated patient and changed morphine to oxycodone for dyspnea given poor renal function - Held Lasix on discharge. Please continue to reassess at ___ facility. HIV On HAART: - Continued home meds HLD: - Stopped Lipitor POSSIBLE REFLUX ESOPHAGITIS - Started acid suppression PE: continue lovenox. Adjusted dose based on renal function BPH: continued tamsulosin PPX: MVT/Fish oil/vitamin D/Stool softener CONSTIPATION: Added Senna, Colace, Miralax, and Bisacodyl suppository PRN for opioid-induced constipation CODE: DNR/DNI but would like to return to the hospital, agrees to non-invasive ventilation if needed Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Atorvastatin 10 mg PO QPM 2. Furosemide 40 mg PO DAILY 3. Tamsulosin 0.4 mg PO QHS 4. Dolutegravir 50 mg PO DAILY 5. Darunavir 800 mg PO DAILY 6. RiTONAvir 100 mg PO DAILY 7. LaMIVudine 300 mg PO DAILY 8. LORazepam 0.5 mg PO QHS 9. Enoxaparin Sodium 120 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 10. Multivitamins 1 TAB PO DAILY 11. Fish Oil (Omega 3) 1000 mg PO BID 12. Vitamin D 1000 UNIT PO DAILY 13. Albuterol Inhaler 2 PUFF IH Q4H:PRN sob 14. Docusate Sodium 100 mg PO BID Discharge Medications: 1. Darunavir 800 mg PO DAILY 2. Docusate Sodium 100 mg PO BID 3. Dolutegravir 50 mg PO DAILY 4. Enoxaparin Sodium 80 mg SC Q12H Start: Today - ___, First Dose: Next Routine Administration Time 5. LaMIVudine 300 mg PO DAILY 6. LORazepam 0.5 mg PO QHS 7. Multivitamins 1 TAB PO DAILY 8. RiTONAvir 100 mg PO DAILY 9. Tamsulosin 0.4 mg PO QHS 10. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN Bronchospasm 11. HYDROmorphone (Dilaudid) 0.5-1 mg IV Q2H:PRN Severe dyspnea 12. Ipratropium-Albuterol Neb 1 NEB NEB Q6H 13. Ondansetron 8 mg PO Q8H:PRN nausea 14. OxycoDONE (Concentrated Oral Soln) ___ mg PO Q2H:PRN dyspnea 15. OxycoDONE (Concentrated Oral Soln) 15 mg PO Q6H 16. Polyethylene Glycol 17 g PO DAILY 17. PredniSONE 60 mg PO DAILY Duration: 1 Day 18. Ranitidine 75 mg PO BID:PRN heartburn 19. Senna 8.6 mg PO BID 20. Fish Oil (Omega 3) 1000 mg PO BID 21. Vitamin D 1000 UNIT PO DAILY 22. Bisacodyl ___ID:PRN constipation Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Metastatic anal cancer PE and lymphangitis carcinomatosis and pulmonary metastatic disease Discharge Condition: Activity Status: Ambulatory - Independent. Level of Consciousness: Alert and interactive. Mental Status: Clear and coherent. Discharge Instructions: You presented to the hospital with shortness of breath, though to be due to a combination of your cancer as well as COPD exacerbation. Followup Instructions: ___
19803635-DS-12
19,803,635
29,863,370
DS
12
2154-03-17 00:00:00
2154-03-17 15:02:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: "I couldn't feel my hand" Major Surgical or Invasive Procedure: None History of Present Illness: History of Present Illness: ___ is an ___ year-old ___ woman with poorly-controlled hypertension and untreated hyperlipidemia who was BIBA late this morning many hours after she awakened earlier (around 4am) with new neurologic symptoms. She was in her USOH yesterday, and neither ill nor taking any new medications in the recent past. This morning, she awoke around 4am and says "I couldn't feel my hand." Also, she noticed "my tongue was not normal" -- clarified to mean it felt "big" and "wrong." She was slurring her words slightly. Her right hand seemed weak and less coordinated. She did not alert anyone to these symptoms; she says she did not want to bother her children that early in the morning. She did not eat breakfast, but denies feeling ill. She took her normal dose of verapamil (120 ext rel), and found her BP afterwards to be elevated at 200/100, so she took an additional verapamil 80mg as instructed by her physician; yesterday, she did not measure her BP, but says it is usually 140-160/50-60. She called her son at work to tell him she thought she had a stroke. He and her daughter talked her into calling an ambulance. EMS brought her to our ED, where she arrived hypertensive with exam as below. Initial ED impression was ataxic-hemiparesis (they thought the RUE was ataxic). NCHCT and Neurology consult were ordered in addition to routine lab studies. Review of Systems: On neuro ROS, the pt denies headache, change in vision, diplopia, dysphagia, odynophagia, lightheadedness, vertigo, tinnitus or change in hearing. Denies difficulties producing or comprehending language or reading. No numbness or tingling currently. No leg symptoms sensory or motor. No bowel or bladder incontinence or retention. Denies difficulty with gait or balance, but thinks she is walking slower today than usual. On general review of systems, the pt denies recent fever or chills. No night sweats or recent weight loss or gain. Denies cough, shortness of breath. Denies chest pain or tightness. No current or recent palpitations, but she has experienced palpitations in the past (denies afib or Coumadin use in the past). Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: Past Medical History: 1. Denies any history of stroke, MI, or other vascular disease 2. Denies any neurologic history 3. hypertension (variable on CCB + PRN-CCB + low-dose ACE) 4. hyperlipidemia, unmedicated (LDL 139 in ___ previously as high as 200 in ___ 5. iron-deficiency anemia, on FeSO4 6. mild, chronic LBP 7. mild anxiety 8. h/o vertigo Tx with PRN meclizine Social History: ___ Family History: noncontributory at this time Physical Exam: Exam on admission: General Physical Examination: Vital signs: HR ___ and regular on monitor BP 180/74 --> ranging 118 to 180 systolic here RR ___, SaO2 99% RA General: Very short, friendly ___ woman speaking reasonably good ___, with son/daughter there to help translate occasional words. Awake, cooperative, NAD. HEENT: Normocephalic and atraumatic. Receding hairline. No scleral icterus. Mucous membranes are moist. No lesions noted in oropharynx. Neck: Supple. No LAD. No carotid bruits. Pulmonary: Lungs CTA. Non-labored breathing. Cardiac: RRR, systolic ___ murmur rad to carotids. Abdomen: Soft, non-tender, and non-distended, + normoactive bowel sounds. Extremities: Warm and well-perfused, no clubbing, cyanosis, or edema. 2+ radial, DP pulses bilaterally. Skin: no gross rashes or lesions noted. ***************** Neurologic examination: Mental Status: Awake and alert; MSE is grossly normal to conversation. Further, she is oriented to ___, no, ___. She relates her medical history without difficulty. She is attentive and follows commands quickly and reliably. Speech was mildly dysarthric. Language is fluent with intact repetition and comprehension, normal prosody, and normal affect. Appears happy. There were no paraphasic errors. Able to read ___ without difficulty. Naming is intact to all NIHSS objects, in ___ (initially cactus was "plant," but on prompting, she remembered "cactus;" initially glove was "hand," but again, correct on prompting). Memory - registers 3 objects and recalls ___ at 10 minutes. Good knowledge of recent and current events, including ___ v. ___ POTUS race; ___ VPs. Calculation intact - seven quarters in $1.75. No e/o L/R confusion, apraxia, or neglect. -Cranial Nerves: II: PERRL, 3.5 to 2mm and brisk. Visual fields are FTC. No papilledema or hemorrhages on fundoscopic examination. III, IV, VI: EOMs full and conjugate; no nystagmus. No saccadic intrusion during smooth pursuits. Normal saccades. V: Facial sensation intact and subjectively symmetric to light touch and pinprick V1-V2-V3. VII: Prominently flattened Right nasolabial fold. Lag and incomplete elevation of the right cheek with smile. Brow elevation is symmetric. Eye closure is strong and symmetric. VIII: Hearing intact and subjectively equal to bed-scratch. IX, X: Palate elevates symmetrically with phonation. She pronounces all consonant sounds ___, ga, ba/pa, ta, ca"), but lingual (___) and labial ("ba/pa") sounds are slightly slurred. XI: ___ equal strength in trapezii bilaterally. XII: Tongue protrusion is midline. -Motor: Right hand/forearm cups and pronates slightly (does not drift down). No asterixis. No tremor. Normal muscle bulk and tone except in the Right hand/fingers, which are slightly hypotonic at rest. Delt Bic Tri WE FF FE IO | IP Q Ham TA ___ L 4+ ___ ___ 5 5 5 5 5 5 R 4+ 5 4+ 5 4+ 4 4+ 5- 5 5 5 5 5 -Sensory: No gross deficits to light touch or pinprickin any extremity. Joint position sense is excellent in both thumbs and both great toes. Eyes-closed Finger-to-nose testing revealed no gross proprioceptive deficit (did not miss nose). - Cortical sensory testing: No agraphesthesia in either palm. No astereoagnosia in the Right hand. No extinction to DSS. -Reflexes (left; right): symmetric Biceps (++;++) Triceps (++;++) Brachioradialis (++;++) Quadriceps / patellar (++;++) ___ / achilles (0/+;0/+) Plantar response was flexor on the left and mute-to-flexor on the right. -Coordination: Finger-nose-finger testing and heel-knee-shin testing with no dysmetria or intention tremor. Mirroring arm behavior was normal, with minimal-to-no overshoot. Moderate slowing of Right hand/finger movements. -Gait: Stands without difficulty. Slightly stooped. Slightly wide base, slightly slow, but smooth and well-coordinated gait. Turns normally. Able to walk on heels, toes. Cannot tandem. Romber absent (excellent balance with eyes open and closed). Exam on discharge: T 98.2 BP 158/65 HR 65 RR 18 O2sat 97%RA Gen: NAD, comfortable CV: carotids with brisk upstroke, ___ SEM loudest at RUSB that becomes louder with standing, ___ SRM at apex MS: alert & fully oriented, conversing appropriately with intact speech production, comprehension, prosody and articulation CN: EOM intact, smile symmetric Motor: the previously observed deficits on pronator drift, RAM and finger tapping are essentially no longer noticeable Pertinent Results: ___ 01:20PM ___ PTT-30.3 ___ CT head ___: FINDINGS: There is focal hypodensity identified in the white matter of the precentral gyrus on the left, which could potentially explain right upper extremity weakness. Scattered periventricular and subcortical white matter hypodensities are also seen, non-specific, but commonly due to chronic small vessel disease. The ventricles and sulci are symmetric and unremarkable, appropriate for patient's age. There is no acute intra-axial or extra-axial hemorrhage, mass, midline shift, or territorial infarct. Basilar cisterns are patent. Included portion of the orbits is symmetric and unremarkable. Included paranasal sinuses and mastoids are clear. Skull and extracranial soft tissues are unremarkable. IMPRESSION: Focal hypodensity in the precentral gyrus on the left in a location that could explain patient's upper extremity and facial symptoms. MRI may offer additional detail regarding acuity or other findings to suggest acute stroke. Scattered periventricular white matter hypodensities, non-specific but often due to chronic small vessel disease. MRI brain, MRA head & neck ___: FINDINGS: There is slow diffusion along the left precentral gyrus in the motor area compatible with acute or subacute ischemia. There is corresponding increased T2 and increased FLAIR signal in this region. There is no evidence of acute hemorrhage. Small focus of susceptibility artifact in the left parietal lobe may reflect area of prior hemorrhage or a small cavernoma or may reflect a calcification seen on the prior head CT. A small focus of susceptibility artifact in the right frontal lobe may also reflect prior hemorrhage, cavernoma, or mineralization. Additional similar findings in the pons have the same diagnostic possibilities. Elsewhere, there are scattered foci of increased FLAIR signal in the periventricular and deep white matter bilaterally, likely reflecting sequela of chronic small vessel ischemia. The ventricles, sulci, and subarachnoid spaces are globally prominent, likely reflecting age-related volume loss. Chiari I malformation incidentally noted. Visualized paranasal sinuses, mastoids, and orbits are unremarkable. HEAD MRA FINDINGS: The vertebral and basilar arteries and the posterior circulation are normal without evidence of stenosis, dissection, or aneurysm. The posterior cerebral arteries are normal bilaterally. The bilateral middle cerebral and anterior cerebral arteries are normal in course and caliber without evidence of stenosis, dissection or of aneurysm. There is no occlusion in the middle cerebral arteries bilaterally. NECK MRA FINDINGS: There is a normal three-vessel aortic arch. The origins of the great vessels are unremarkable. Origins of the vertebral arteries are normal. The bilateral vertebral arteries are normal in course and caliber without evidence of stenosis, dissection, or occlusion. The bilateral carotid arteries are normal in appearance without evidence of stenosis, dissection, or occlusion. The images are slightly limited by motion artifact. The distal left internal carotid artery measures 4 mm and the distal right internal carotid artery measures 3 mm. IMPRESSION: 1. Slow diffusion in the left motor area along the central sulcus involving the precentral gyrus. This is compatible with acute/subacute ischemia and corresponds to the area of concern identified on CT. 2. No stenosis or occlusion involving the head or neck vasculature. 3. Chiari I malformation incidentally noted. TTE ___: Echocardiographic Measurements Results Measurements Normal Range Left Atrium - Long Axis Dimension: *4.3 cm <= 4.0 cm Left Ventricle - Septal Wall Thickness: *1.5 cm 0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness: *1.6 cm 0.6 - 1.1 cm Left Ventricle - Diastolic Dimension: 3.6 cm <= 5.6 cm Left Ventricle - Ejection Fraction: >= 75% >= 55% Left Ventricle - Peak Resting LVOT gradient: *140 mm Hg <= 10 mm Hg Left Ventricle - Lateral Peak E': *0.04 m/s > 0.08 m/s Left Ventricle - Septal Peak E': *0.04 m/s > 0.08 m/s Left Ventricle - Ratio E/E': *28 < 15 Aorta - Sinus Level: 3.0 cm <= 3.6 cm Aorta - Ascending: 3.4 cm <= 3.4 cm Mitral Valve - E Wave: 1.1 m/sec Mitral Valve - A Wave: 1.4 m/sec Mitral Valve - E/A ratio: 0.79 Mitral Valve - E Wave deceleration time: *129 ms 140-250 ms TR Gradient (+ RA = PASP): *48 mm Hg <= 25 mm Hg Findings This study was compared to the prior study of ___. LEFT ATRIUM: Mild ___. Mass in the body of the ___. LEFT VENTRICLE: Moderate symmetric LVH. Normal LV cavity size. Normal regional LV systolic function. Hyperdynamic LVEF >75%. TDI E/e' >15, suggesting PCWP>18mmHg. Severe resting LVOT gradient. RIGHT VENTRICLE: Normal RV chamber size and free wall motion. AORTA: Normal aortic diameter at the sinus level. Normal ascending aorta diameter. Complex (>4mm) atheroma in the ascending aorta. AORTIC VALVE: Mildly thickened aortic valve leaflets (3). Cannot exclude AS. No AR. MITRAL VALVE: Mildly thickened mitral valve leaflets. Moderate mitral annular calcification. ___ of mitral valve leaflets. Physiologic MR ___ normal limits). Trivial MR. ___ to moderate (___) MR. ___ VALVE: Normal tricuspid valve leaflets. Mild [1+] TR. Moderate PA systolic hypertension. PULMONIC VALVE/PULMONARY ARTERY: Normal pulmonic valve leaflet. No PS. Physiologic PR. PERICARDIUM: Very small pericardial effusion. Effusion circumferential. GENERAL COMMENTS: Echocardiographic results were reviewed by telephone with the houseofficer caring for the patient. Conclusions The left atrium is mildly dilated. A small, highly mobile mass (0.6 x .05 cm) is seen in the body of the left atrium and appears to be attached to the mitral annular calcification, c/w friable MAC vs. thrombus vs. tumor. This is best seen in the parasternal views but also seen in the apical views. There is moderate symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Regional left ventricular wall motion is normal. Left ventricular systolic function is hyperdynamic (EF>75%). Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). There is a severe resting left ventricular outflow tract obstruction. Right ventricular chamber size and free wall motion are normal. There are complex (>4mm) atheroma in the ascending aorta. The aortic valve leaflets (3) are mildly thickened. The study is inadequate to exclude significant aortic valve stenosis. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is systolic anterior motion of the mitral valve leaflets. Physiologic mitral regurgitation is seen (within normal limits). Trivial mitral regurgitation is seen. Mild to moderate (___) mitral regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is a very small pericardial effusion. The effusion appears circumferential. IMPRESSION: Small, mobile mass consistent with tumor, thrombus vs. less likely vegetation in the body of left atrium which appears to be attached to the mitral annular calcification. Moderate symmetric left ventricular hypertrophy with valvular systolic anterior motion of the mitral valve and severe outflow tract gradient at rest. Hyperdynamic left ventricular systolic function. At least moderate pulmonary hypertension. No intracardiac shunt identfied. Compared with the prior study (images reviewed) of ___, resting outflow tract gradient has increased. The mobile mass is new. There is more mitral regurgitation. Pulmonary hypertension is now present. Brief Hospital Course: ASSESSMENT: ___ yo. WF w/ poorly controlled HTN and untreated dyslipidemia, with complaints of new right hand deficits, facial droop, mild dysarthria. MRI demonstrates the clinically suspected stroke in the left-mid precentral gyrus. Her deficits on exam were lower facial weakness (UMN), mild dysarthria, and mild clumsiness and slowing of FFM as well as orbiting deficit, and these have improved and are barely noticeable now. TTE demonstrated HOCM, MAC, a small mobile mass (differential thrombus vs tumor), and new pulmonary hypertension. In light of these TTE findings, have started warfarin, and pt will be discharged on 5 mg daily. She has been set up for outpt ATC f/u. Ms. ___ was maintained on continuous cardiac telemetery. During this admission she had one episode 20-beat of asymptomatic monomorphic VTach and other shorter runs. Pt has HOCM and is thus predisposed to cardiac arrhythmias. This was discussed with cardiology, no further recs. Ms. ___ blood pressure was difficult to control during this admission. She had a predictable am spike in SBP to approx. 200 with good control afterwards on a regimen of metoprolol 12.5 mg q6h and amlodipine 5 mg daily. Per cardiology recommendations, pt will be discharged on metoprolol succinate 100 mg qhs and amlodipine 5 mg daily. She was also started on atorvastatin 40 mg daily in light of LDL 134 (previously untreated dyslipidemia) Medications on Admission: Medications: 1. verapamil 120 ER qAM 2. verapamil additional 80mg if BP > 140/90 (says ~1-2/mo.) 3. lisinopril 2.5mg daily 4. lorazepam 0.25-0.5mg PRN for anxiety (says ___ 5. lidocaine patch PRN for LBP (says not used recently) 6. FeSO4 325mg daily 7. meclizine 12.5-25mg PRN for vertigo (says not used in 6mos) Discharge Medications: 1. Lorazepam 0.25 mg PO Q12H:PRN anxiety home dose is 0.25-0.5mg PRN for anxiety 2. Warfarin 5 mg PO DAILY16 RX *warfarin 1 mg three and half tablet(s) by mouth every day Disp #*120 Tablet Refills:*2 RX *warfarin [Coumadin] 5 mg 1 tablet(s) by mouth daily Disp #*14 Tablet Refills:*0 3. Ferrous Sulfate 325 mg PO DAILY 4. Lidocaine 5% Patch 1 PTCH TD DAILY:PRN low back pain 5. Meclizine 12.5-25 mg PO Q8H:PRN vertigo 6. Outpatient Lab Work Please check INR on ___ and send the result to ___ ___ clinic at ___. ICD-9: 434.9 7. Amlodipine 5 mg PO DAILY RX *amlodipine 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 8. Atorvastatin 40 mg PO DAILY stroke secondary prophylaxis RX *atorvastatin 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 9. Metoprolol Succinate XL 100 mg PO HS RX *metoprolol succinate 100 mg 1 tablet(s) by mouth every evening Disp #*30 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis: Stroke, intracardiac mass, likely cardiac thrombus Secondary Diagnosis: Hypertrophic obstructive cardiomyopathy, hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___ was a pleasure to take care of you at ___ ___. You were admitted with symptoms of weakness and clumsiness in your right hand, a facial droop, and difficulty pronouncing words. Based on this history and your neurological exam, we obtained an MRI of your brain, which confirmed that you had a stroke. We obtained an echo (ultrasound) of your heart to look for a possible cause of a stroke. This showed a mass in your heart. This is likely a blood clot but it is possible that it is a tumor in your heart. Because of this, we started you on a blood thinner medication called warfarin (Coumadin). You will need to take this medication every day, and have blood levels checked on a number called INR. We have arranged follow-up in the ___ clinic for you. You will need to have another echo in one month to assess what has happened to the blood clot. Over the course of this hospitalization your weakness and other difficulties improved. We expect your deficits from your stroke to continue to improve over the next months. The echo of your heart also showed that you have a condition called HOCM (hypertrophic obstructive cardiomyopathy). This means that there is an obstruction to the blood flow out of the heart. I believe your cardiologist was already aware of this. Because the outflow tract gradient was high, and because your blood pressure was high during this hospitalization, we made some changes to your blood pressure medications, and we will discharge you on metoprolol 100 mg every evening and amlodipine 5 mg daily. This plan was discussed with your cardiologist, Dr. ___. Please monitor your blood pressure at home and call your primary care physician if it is higher than 160. Your visiting nurse ___ also check your blood pressure. These CHANGES were made to your medications: NEW MEDICATIONS: - pravastatin 40 mg daily for high cholesterol - metoprolol succinate 100 mg every evening for high blood pressure - amlodipine 5 mg daily for high blood pressure - warfarin (coumadin) 5 mg daily as a "blood thinner". It is important that you get your blood checked by visiting nurses and to adjust this medication depending on your INR level. CHANGES in MEDICATIONS: - verapamil was STOPPED - STOP taking verapamil as needed. If your blood pressure is high at home, please call your primary care physician or your cardiologist, Dr. ___. Followup Instructions: ___
19803858-DS-9
19,803,858
24,662,172
DS
9
2116-07-20 00:00:00
2116-07-20 15:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest Pain Major Surgical or Invasive Procedure: Cardiac Cath History of Present Illness: ___ with no PMH presents with acute chest pain, code STEMI activated, found to have clean coronaries. He was in usual state of health until this morning, he suddenly developed acute onset chest pain after taking some Mucinex for sore throat. Pain continued unchanged in substernal chest area, associated with nausea and vomiting. He was seen in Urgent Care at ___ ___. There was concern for symptomatic bradycardia with HR 48, and he was sent to ___ ED. In the ED initial vitals were: 99.7 60 ___ 100% RA. Labs notable for normal CBC, ___, troponin. Lactate 3.7. CXR clear. EKG was concerning for ST elevations vs ___ elevations in V3. No prior EKG in ___ or Atrius system. Code STEMI was activated. He was given morphine 5mg IV, aspirin 324mg PO, lorazepam 0.5mg IV. He was taken to cath lab which showed normal coronaries, right radial access. On the floor, he has no complaints. His symptoms have resolved and he is watching football. Recent URI several weeks ago. No recent long travel or sick contacts. ROS: Positive for cough, sore throat, chest pain, recent chills, nausea, vomiting. No dyspnea at rest or with exertion or inspiration, abdominal pain, diarrhea, constipation, dysuria, frequency, palpitations, presyncope, syncope. Past Medical History: None Social History: ___ Family History: FAMILY HISTORY: Grandmother with diabetes. No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION PHYSICAL EXAM VS: T99.0 114/59 80 18 100RA GEN: Young adult male sitting comfortable, no distress HEENT: Sclera anicteric, MMM, no neck adenopathy HEART: RRR, normal S1 S2, no murmurs, no rubs, CP not reproducible to palpation LUNGS: Clear, no wheezes or rales ABD: Soft, NT ND, normal BS EXT: No ___ edema. 2+ pulses. Right radial access with TR band. DISCHARGE PHYSICAL EXAM VS: T98.8 ___ 18 100RA GEN: Young adult male lying comfortable, NAD HEENT: Sclera anicteric, MMM, no neck adenopathy, no JVP HEART: RRR, normal S1 S2, no murmurs, no rubs, CP not reproducible to palpation LUNGS: Clear, no wheezes or rales ABD: Soft, NT ND, normal BS EXT: No ___ edema. 2+ pulses. Right radial access with TR band. Non tender to palpation. No hematoma Pertinent Results: ADMISSION LABS ___ 05:51PM ___ ___ ___ 05:51PM ___ ___ IM ___ ___ ___ 05:51PM cTropnT-<0.01 ___ 05:51PM ALT(SGPT)-26 AST(SGOT)-36 ALK ___ TOT ___ ___ 05:51PM ___ UREA ___ ___ TOTAL ___ ANION ___ ___ 06:06PM ___ ___ 11:38PM ___ DISCHARGE LABS ___ 07:20AM BLOOD ___ ___ Plt ___ ___ 07:20AM BLOOD Plt ___ ___ 07:20AM BLOOD ___ ___ ___ 07:20AM BLOOD ___ RESULTS Cardiac Catheritization ___ -Dominance: R LMCA is normal LAD is normal Circumflex is normal RCA is normal Impression Normal coronary arteries Normal LVEDP and cineangiography Brief Hospital Course: ___ with no PMH presents with acute chest pain, code STEMI activated, found to have clean coronaries. # Chest Pain and EKG Changes. Chest pain on admission was relieved with morphine. EKG showed potential STE in leads V2/V3, which appears likely to be ___ elevation or normal changes in the heart of a young healthy athlete. Cardiac Cath was performed which showed normal coronary arteries. He was not started on any new medications. Potassium and Magnesium were repleted. He was sent home with follow up in primary care. # Lactate elevation. Lactate was elevated to 3.7 on admission and trended down to 1.2 after 1L NS. ***Transitional Issues*** PCP - ___ repeat CBC at follow up to trend Hgb given mild anemia post catheterization. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: None Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis Atypical Chest Pain Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, It was a pleasure taking care of you during your hospitalization at ___. Briefly, you were hospitalized with chest pain and concern that you were having a heart attack. Your EKG showed some concerning findings so you underwent a cardiac catheterization. This test looked at the blood vessels that supply blood to the heart muscle. This test was normal. It was determined that you did *not* have a heart attack. Please follow up with your primary care provider as listed below. We wish you the best, Your ___ Treatment Team Followup Instructions: ___
19804034-DS-17
19,804,034
20,803,534
DS
17
2177-10-27 00:00:00
2177-10-27 15:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Bile Duct Obstruction due to Pancreatic mass Major Surgical or Invasive Procedure: EUS with FNA ___ ERCP with sphincterotomy ___ History of Present Illness: ___ year old Female transferred from ___ after presenting there with abdominal pain and jaundice. SHe notes for about a week prior to admission she noted white stools. she notes some nausea and vomiting, and dark urine. At ___ ___ she had a CT of the abdomen which noted a pancreatic head mass and labs AST 57, AST 174, LIP 473. INR was 1 and WBC of 9.3. She is transferred for ERCP evaluation and HBP surgical consultation. She notes her pain was in a band like patter around the epigastric region around to the back. In the ___ ED her initial vitals were 98.1, 104/52, 20, 97%. She was given IV Fluids with 80meq potassium along with 2g of magnesium IV. She was noted with elevated anion gap which was assumed to be starvation ketosis. Of note she had an elevated HCG on ED labs, although per report has no uterus. She notes an 8lb weight loss. Past Medical History: Type 2 Diabetes Cholecystectomy TAHBSO Social History: ___ Family History: Mother: DM, ___, Cholelithiasis Father: ___ in one eye Identical Twin sister: ___ Cancer Physical Exam: ADMISSION PHYSICAL EXAM: VSS: 98.1, 105/79, 89, 18, 97% GEN: NAD, Jaundice Pain: ___ Eyes: Icteric, EOMI Mouth: Dry MM, sublingual icterus, - OP Lesions PUL: CTA B/L COR: RRR, S1/S2, - MRG ABD: NT/ND, +BS, - CVAT EXT: - CCE NEURO: CAOx3, Non-Focal DISCHARGE PHYSICAL EXAM: VITALS: 98.1PO 151 / 73 79 18 99 RA GENERAL: laying in bed, in NAD EYES: + scleral icterus, no conjunctival injection ENT: MMM, clear OP, normal hearing NECK: Supple, no appreciable LAD RESP: CTA b/l, no w/r/r, non-labored breathing CV: RRR, no m/r/g GI: Soft, TTP in mid-epigastrum, ND, normoactive BS GU: no foley EXT: wwp, no edema SKIN: jaundiced, no rashes NEURO: AOx3, moving all extremities purposefully PSYCH: normal mood and affect Pertinent Results: ADMISSION LABS: =============== ___ 10:10AM BLOOD WBC-8.4 RBC-4.51 Hgb-12.3 Hct-37.4 MCV-83 MCH-27.3 MCHC-32.9 RDW-14.1 RDWSD-42.9 Plt ___ ___ 10:10AM BLOOD Neuts-69.8 ___ Monos-8.1 Eos-0.5* Baso-1.2* Im ___ AbsNeut-5.85 AbsLymp-1.65 AbsMono-0.68 AbsEos-0.04 AbsBaso-0.10* ___ 10:24AM BLOOD ___ PTT-29.2 ___ ___ 02:20PM BLOOD Glucose-214* UreaN-9 Creat-0.4 Na-141 K-3.5 Cl-101 HCO3-20* AnGap-20* ___ 10:10AM BLOOD Glucose-233* UreaN-9 Creat-0.4 Na-140 K-3.6 Cl-100 HCO3-19* AnGap-21* ___ 10:10AM BLOOD ALT-338* AST-192* AlkPhos-461* TotBili-7.2* DirBili-5.3* IndBili-1.9 ___ 10:10AM BLOOD Lipase-90* ___ 02:20PM BLOOD Calcium-9.2 Phos-3.2 Mg-1.6 ___ 10:10AM BLOOD Albumin-3.7 Calcium-9.3 Phos-3.3 Mg-1.5* ___ 02:33PM BLOOD ___ pO2-44* pCO2-38 pH-7.38 calTCO2-23 Base XS--1 Intubat-NOT INTUBA Comment-PERIPHERAL ___ 02:33PM BLOOD Lactate-1.1 ___ 10:29AM BLOOD Lactate-1.2 DISCHARGE LABS: =============== ___ 07:35AM BLOOD WBC-8.7 RBC-4.13 Hgb-11.4 Hct-34.7 MCV-84 MCH-27.6 MCHC-32.9 RDW-14.6 RDWSD-44.2 Plt ___ ___ 07:35AM BLOOD Glucose-211* UreaN-8 Creat-0.5 Na-137 K-4.5 Cl-97 HCO3-19* AnGap-21* ___ 07:35AM BLOOD Glucose-211* UreaN-8 Creat-0.5 Na-137 K-4.5 Cl-97 HCO3-19* AnGap-21* ___ 07:35AM BLOOD ALT-259* AST-85* AlkPhos-416* TotBili-6.6* ___ 07:35AM BLOOD Albumin-3.5 Calcium-9.0 Mg-1.6 IMAGING: ======== CTA pancreatic protocol ___: Improved biliary obstruction post CBD stent. Redemonstration of pancreatic malignancy with vascular involvement, retroperitoneal adenopathy and findings concerning for hepatic metastatic disease. Mild proximal colitis and pneumatosis in the splenic flexure. PROCEDURES: ========== EUS with FNA ___: EUS was performed using a linear echoendoscope at ___ MHz frequency: The head and uncinate pancreas were imaged from the duodenal bulb and the second / third duodenum. The body and tail [partially] were imaged from the gastric body and fundus. •Mass: A 2.6cm X 3.1cm ill-defined mass was noted in the head of the pancreas. The mass was hypoechoic and heterogenous in echotexture. The borders of the mass were irregular and poorly defined. The mass was closely related to the portal vein. However, there was no evidence of portal vein invasion seen on EUS. The mass encroached the CBD and the proximal CBD was dilated at 9mm in diameter. •FNB was performed of the mass. Color doppler was used to determine an avascular path for needle biopsy. A 22-gauge SharkCore needle with a stylet was used to perform biopsy. Three needle passes were made into the mass. •Bile duct: The bile duct was imaged at the level of the porta-hepatis, head of the pancreas and ampulla. The CBD was dilated at 9mm in diameter. •A lymph node was noted in the porta-hepatis. The lymph node was hypoechoic and homogenous in echotexture. The borders were well-defined. No central intra-nodal vessels were seen. ERCP with Spincterotomy ___: The scout film showed surgical clips in the RUQ. The major papilla was normal. •The PD was cannulated using a Rx sphincterotome preloaded with 0.035in guidewire. Partial opacification showed normal PD. Multiple trials to cannulate the CBD were unsuccessful. •The decision was made to place a PD stent to help with biliary cannulation. A ___ x 3cm plastic PD stent was successfully placed in the PD. •The CBD was then successfully cannulated using a Rx sphincterotome preloaded with 0.035in guidewire. •Contrast injection revealed a 2cm mid-CBD stricture. •A biliary sphincterotomy was successfully performed at the 12 o'clock position. There was no post-sphincterotomy bleeding. •Multiple brushings were obtained from the CBD stricture and sent for cytology. •A ___ x 7cm plastic CBD stent was successfully placed in the CBD. •There was excellent contrast and bile drainage at the end of the procedure. •The PD stent was successfully removed at the end of the procedure using a snare. Brief Hospital Course: ___ F with history of DM2, prior cholecystectomy p/w epigastric pain, jaundice, found to have new pancreatic mass. # Obstructive Jaundice # Pancreatic Mass Pt had CT a/p done prior to admission showing new pancreatic head mass. Underwent EUS with FNA today, appearance c/f likely adenocarcinoma. Biopsy result pending. Pt also underwent ERCP with sphincterotomy which she tolerated well. Diet was advanced to regular which pt was tolerating on day of discharge and LFT's downtrended post-procedure. She was treated with Cirpo x5 days post-procedure. She also underwent CTA pancreatic protocol which showed known pancreatic mass with likely vascular invasion and liver mets. Her case will be discussed in multidisciplinary meeting and pt will be called with f/u appointment. # Type 2 Diabetes Held metformin and glipizide while inpatient and placed on ISS. Pt will continue to hold metformin post-discharge until 48 hours after CTA. Billing: greater than 30 minutes spent on discharge counseling and coordination of care Medications on Admission: The Preadmission Medication list is accurate and complete. 1. GlipiZIDE 5 mg PO BID 2. MetFORMIN (Glucophage) 500 mg PO BID 3. biotin 10 mg oral DAILY 4. Cetirizine 10 mg PO DAILY Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth twice a day Disp #*8 Tablet Refills:*0 2. biotin 10 mg oral DAILY 3. Cetirizine 10 mg PO DAILY 4. GlipiZIDE 5 mg PO BID 5. HELD- MetFORMIN (Glucophage) 500 mg PO BID This medication was held. Do not restart MetFORMIN (Glucophage) until 48 hours after your CT scan, and then resume as normal Discharge Disposition: Home Discharge Diagnosis: Pancreatic mass Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You came in with abdominal pain and jaundice. We found that you have a new pancreatic mass on CT scan. This was biopsied and you had a procedure called an ERCP to stent the duct open. You tolerated this procedure well. The multidisciplinary team of liver specialists, surgeons, and oncologist will meet later today to discuss your imaging and pathology. You will get called with a follow-up appointment. Followup Instructions: ___
19804510-DS-15
19,804,510
20,907,769
DS
15
2157-11-22 00:00:00
2157-11-24 20:39:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins / amoxicillin Attending: ___. Chief Complaint: flank pain Major Surgical or Invasive Procedure: None. History of Present Illness: Mr. ___ is a ___ male with no significant past medical history who presents with flank pain and hematuria. The patient was seen at ___ yesterday after experiencing 6 days of flank pain with hematuria. A CT scan without contrast there showed 1 mm non-obstructing stone. He was sent home to follow up with urology. The patient saw urology (Dr. ___ at ___ in ___ this morning in the office, who told him he did not think the stone was contributing to his pain and hematuria. He had a prostate exam and the urologist didn't think prostatitis was ongoing to explain the pain otherwise. He was prescribed Bactrim. Urology had plan to consult nephrology and do a cystoscopy in a few weeks if his symptoms persisted. Here, CTU imaging shows mild hydronephrosis of the left kidney with mild surrounding perinephric stranding and delayed excretion consistent with obstruction of uncertain etiology. However, punctate densities within the left kidney may represent tiny stones. Additional density within the left collecting system as well as at the left ureteral vesicular junction may represent areas of blood clotting, which is likely the etiology of patient's obstruction. At this time, the patient describes persistent 'twisting' constant nonradiating flank pain in the left side, although yesterday it did radiate halfway to the midabdomen. He has some nausea still. No fever. He reports continued blood clots in his urine this morning. No dysuria. He does note a traumatic injury to left kidney at age ___ causing significant hematuria and hospitalization at ___. ED: given dilaudid, NS, Zofran, CTX, morphine, reglan Past Medical History: Migraines Traumatic injury to left kidney at age ___ causing significant hematuria and hospitalization at ___. Social History: ___ Family History: Mother and uncle had kidney stones. Provoked trauma related DVT in mother. DVT in father for unknown etiology Physical Exam: ADMISSION EXAM: VITALS: Afebrile and vital signs stable (see eFlowsheet) GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate CV: Heart regular, no murmur RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. There is +CVAT to left flank. GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs PSYCH: pleasant, appropriate affect NEUROLOGIC: MENTATION: alert and cooperative. Oriented to person and place and time. . . DISCHARGE EXAM: Gen: comfortable sitting up in bed HEENT: anicteric sclera, EOMI, pupils 4 mm b/l, OP clear Neck: no LAD Cards: RR, no m/r/g Chest: CTAB, normal WOB Abd: soft, not tender to palpation, not distended, BS+ GU: no CVA tenderness today b/l Ext: no peripheral edema, 2+ distal pulses Skin: pale, warm, not diaphoretic Neuro: AAOx3, clear speech Psych: calm, cooperative Pertinent Results: ADMISSION LABS: ================== . ___ 12:30AM BLOOD WBC-14.0* RBC-3.88* Hgb-12.2* Hct-35.4* MCV-91 MCH-31.4 MCHC-34.5 RDW-11.9 RDWSD-39.3 Plt ___ ___ 12:30AM BLOOD ___ PTT-26.8 ___ ___ 12:30AM BLOOD Glucose-98 UreaN-13 Creat-1.2 Na-141 K-3.9 Cl-106 HCO3-20* AnGap-15 ___ 06:40AM BLOOD ALT-10 AST-16 AlkPhos-53 TotBili-0.7 . . NOTABLE LABS DURING HOSPITALIZATION: =================== . ___ 06:29AM BLOOD ___ ___ 06:55AM BLOOD calTIBC-209* Ferritn-243 TRF-161* ___ 06:55AM BLOOD Ret Aut-1.4 Abs Ret-0.05 ___ 06:55AM BLOOD TSH-2.0 ___ 06:29AM BLOOD Triglyc-77 HDL-40* CHOL/HD-2.7 LDLcalc-51 . ___ 11:28AM URINE Color-Straw Appear-Clear Sp ___ ___ 11:28AM URINE Blood-LG* Nitrite-NEG Protein-TR* Glucose-NEG Ketone-10* Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG ___ 11:28AM URINE RBC-88* WBC-2 Bacteri-NONE Yeast-NONE Epi-0 ___ 11:28AM URINE Hours-RANDOM Creat-34 TotProt-25 Prot/Cr-0.7* . . MICRO: ================== -___ UCx: no growth (final) -___ BCx: NGTD -___ BCx: NGTD -___ UCx: no growth (final) . . IMAGING: ================== -___ Renal u/s IMPRESSION: 1. Possible 6 mm left superior renal calculus. Mild left hydronephrosis. 2. Decompressed urinary bladder, limiting its evaluation -___ CTU abd/pelvis IMPRESSION: New mild left hydronephrosis with delayed nephrogram consistent with left renal obstruction, likely secondary to blood clots within the left renal pelvis and at the left ureterovesical junction. No urolithiasis demonstrated. . . DISCHARGE LABS: ================== ___ 06:55AM BLOOD WBC-4.8 RBC-3.68* Hgb-11.2* Hct-32.8* MCV-89 MCH-30.4 MCHC-34.1 RDW-11.7 RDWSD-37.5 Plt ___ ___ 06:55AM BLOOD ___ PTT-27.2 ___ ___ 06:55AM BLOOD Glucose-83 UreaN-4* Creat-0.6 Na-144 K-3.5 Cl-105 HCO3-26 AnGap-13 ___ 06:55AM BLOOD Albumin-3.5 Calcium-8.6 Phos-3.2 Mg-1.8 Iron-60 ___ 06:55AM BLOOD ALT-7 AST-8 AlkPhos-44 TotBili-0.5 Brief Hospital Course: # Gross Hematuria # Severe intermittent left flank pain # Left hydronephrosis: due to obstructing blood clots # Left nephrolithiasis *Treated with aggressive IVF and pain control w/ IV morphine PRN. Renal consulted, no concerning findings on urine microscopy, and urine Pr/Cr not consistent with nephrotic syndrome. Urology consulted, advised continued aggressive hydration and initiation of tamsulosin. Flank pain has nearly resolved, with no significant episodes of pain, only some mild discomfort with movement. Gross hematuria has resolved, still has some sediment in otherwise clear urine output. Ultimately the etiology of the hematuria is not definitive, possibly due to nephrolithiasis in setting of chronic aspirin use (Excedrin migraine). *Discharged on tamsulosin (Flomax) to continue until left flank pain has completely resolved. *Advised maintaining good oral hydration (2 L per day oral fluids) per Urology recs. *Advised patient to avoid aspirin (a component of Excedrin) and all NSAIDs at least until he has follow-up lab testing with his PCP. []Please refer for Urology ___ for hematuria []Please refer for Nephrology ___ for recurrent kidney stones and 24-hour urine testing for "litholink" # ___ due to obstruction +/- intravenous contrast: resolved (Cr 1.2 at admission, down to 0.6 on day of discharge) # Anemia: normocytic, likely from acute blood loss, iron studies not suggestive of iron deficiency, but retic ct. inappropriately low. []Please repeat CBC at upcoming PCP ___ visit to ensure improving. # Coagulopathy: mild (INR 1.3), s/p vitamin K 10 mg IV on ___, INR 1.2 on ___. []Please repeat coags at upcoming PCP ___ visit to ensure normalized. # ? of UTI: was initiated on abx prior to transfer to ___ ED and continued initially. Ultimately the ___ UCx (obtained prior to abx) was no growth (final), and both UCx obtained here at ___ were no growth (final), so empiric abx (ceftriaxone) were discontinued. . . . Time in care: [x] Greater than 30 minutes in discharge-related activities today. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Excedrin Extra Strength (aspirin-acetaminophen-caffeine) 250-250-65 mg oral DAILY:PRN Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Moderate 2. Tamsulosin 0.4 mg PO DAILY Stop taking this medication once you have had no flank pain for 48 hours. RX *tamsulosin 0.4 mg 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*1 3. Excedrin Extra Strength (aspirin-acetaminophen-caffeine) 250-250-65 mg oral DAILY:PRN Discharge Disposition: Home Discharge Diagnosis: # Gross Hematuria # Left hydronephrosis: due to obstructing blood clots # ___ due to obstruction +/- intravenous contrast: resolved # Left nephrolithiasis # Anemia # Coagulopathy Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ___, You were admitted to the hospital with worsening left flank pain and blood in your urine ("hematuria"). Based on the imaging studies, we think that you had a kidney stone that *may* have been the cause of bleeding from the left kidney or collecting ducts. The blood that accumulated in your left kidney collecting ducts caused intermittent obstruction that cause your severe episodes of left flank pain. This ultimately resolved with administration of lots of IV fluids and initiation of tamsulosin ("Flomax"). For your hematuria and recurrent left-sided kidney stones, we recommend that you see a Urologist in clinic for further evaluation. In the meanwhile, please continue to drink plenty of fluids (goal of 2 L of fluid intake per day, primarily water or other non-sweetened, non-carbonated beverages). Our Urology team instructed that you should continue taking the tamsulosin (Flomax) until you are having absolutely no more flank pain, at which time you can stop taking it. You were also found to have a slight elevation in your INR, a measure of your body's ability to clot blood. We gave you a dose of intravenous vitamin K and your INR went from 1.3 on ___ to 1.2 on ___. A normal INR is 0.9-1.1. We would ask that you have your primary care physician, ___ your INR when you see him in clinic. If it remains elevated, it may warrant additional work-up with a hematologist (blood specialist). You were also found to have anemia. We suspect that this was likely the result of the blood loss you suffered as a result from hematuria. Your blood counts have been stable for several days, so we do not think you are losing significant amounts of blood any longer. As with your INR, we would ask that your primary care physician, ___ your blood counts when you see him in clinic to ensure that your anemia is improving/resolving. If it is not improving, it would definitely warrant additional work-up with a hematologist. It was a pleasure caring for you and we wish you all the best. Sincerely, The ___ Medicine Team Followup Instructions: ___
19804556-DS-10
19,804,556
24,275,260
DS
10
2175-01-14 00:00:00
2175-01-14 16:23:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: ___ Attending: ___. Chief Complaint: RUE pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ is a ___ yo woman with metastatic lung adenocarcinoma (mets to bone, soft tissue), s/p RT to lower T ___, scapula, R buttock, on ___ (last given ___, who presented after PET scan today demonstrated near total destruction of C6-C7 and weeks of worsening R arm paresthesia and neuropathic pain. Mrs. ___ called her oncologist 4 days prior to admission complaining of weeks of R arm neuropathic pain that was severe and acutely worsening. She described waking up with R arm burning pain and "pins and needles" sensation over the dorsum of her thumb. She states the pain is worst at night and improves with ambulation and gentle exercise. Given the nature of her pain, she was advised to increase her nightly gabapentin dose from 600 mg to 900 mg and continue to monitor her symptoms. Initially she reported that this pain seemed similar to pain she had had ___ years ago in the setting of spinal stenosis, but on interview today she says this pain feels different in its severity and location. Today, Mrs ___ presented for routine f/u PET scan and was called into ED after it demonstrated near total destruction of C6-C7. She was advised to obtain stat MRI C ___ and neurosurgical evaluation especially in light of her R arm symptoms. She denied any preceding trauma or falls. No headache, visual changes, nausea, vomiting. No confusion. No bowel or bladder incontinence. No lower extremity numbness/tingling. She has had some bilateral lower extremity weakness that has been improving with home ___. In the ED: 98.2 F | 96 | 140/78 | 18 | 98% RA. An MRI total ___ was obtained. The C6 metastatic lesion (4.2 x 2.5 x 4.6 cm) was noted to involve the entire vertebra but not compromising the cord. However, a T11 lesion (3.3 x 2.3 x 5.4 cm) had significantly increased from prior imaging ___ and now showed extension into the epidural space with severe compression of the spinal cord without definite cord signal abnormality. Additional ___ mets were noted at C5, C7, T1, T12. Neurosurgery was consulted. They did not find any neurologic deficits on exam to correlate with the T11 finding. Therefore, she was recommended for high dose steroids, continued observation, continued chemoRT, and outpatient follow up. She received 10 mg IV dexamethasone prior to transfer to the floor. Past Medical History: CERVICAL RADICULITIS DEPRESSION HYPERPROLACTINEMIA OSTEOPENIA ASTHMA LUNG MASS LEFT SHOULDER MASS Social History: ___ Family History: Mother with melanoma, RA. Maternal aunt with lung cancer. Otherwise no malignancy history in the family Physical Exam: ADMISSION PHYSICAL EXAM ======================= VITALS: T 98.9 F | 148/82 | 90 | 96% RA General: Tired appearing, pleasant, older Caucasian woman resting in bed in no acute distress Neuro: - Cranial nerves: PERRL, EOMI, Facial sensation equal bilaterally, resists eye opening ___, hearing intact to finger rub b/l, palate elevates symmetrically, tongue midline, shoulder shrug ___ - Motor: ___ deltoid, bicep, tricep, handgrip bilaterally ___ hip flexion, knee extension, plantar and dorsiflexion 4+/5 knee flexion bilaterally - Sensation intact to light touch and pinprick over UE and ___ including the dorsum of right thumb - Alert and oriented, provides clear and cogent hx HEENT: Sclera anicteric. oropharynx clear, MMM. Hard C collar in place Cardiovascular: RRR no murmurs Chest/Pulmonary: Clear to auscultation bilaterally Back: Tenderness to palpation over the T11 area. Tender, tight trapezius muscles on the right Abdomen: Soft, nontender, nondistended. normal bowel sounds Extr/MSK: No peripheral edema, WWP Skin: Hyperpigmented post radiation changes over the left scapula and T11 area Access: PIV DISCHARGE PHYSICAL EXAM ======================== VS: ___ 0416 Temp: 98.4 PO BP: 130/72 HR: 70 RR: 18 O2 sat: 98% O2 delivery: RA General: Pleasant, older Caucasian woman resting in bed in no acute distress Neuro: - Cranial nerves: CN II-XII grossly intact - Motor: ___ deltoid, bicep, tricep, handgrip bilaterally ___ hip flexion, knee extension, plantar and dorsiflexion 4+/5 knee flexion bilaterally - Mildly decreased sensation over the R dorsal thumb (long-standing); otherwise intact to light touch in upper extremities - Alert and oriented, provides clear and cogent hx HEENT: Sclera anicteric. oropharynx clear, MMM. Hard C collar in place Cardiovascular: RRR, nl s1/s2, no murmurs, rubs, gallops Chest/Pulmonary: Clear to auscultation bilaterally, no wheezes, rales, or rhonchi Back: Tenderness to palpation over the T11 area. Tender, tight trapezius muscles on the right. Abdomen: Soft, nontender, nondistended. normal bowel sounds Extr/MSK: No peripheral edema, WWP Skin: Hyper-pigmented post radiation changes over the left scapula and T11 area Access: PIV Pertinent Results: ADMISSION LABS ============== ___ 01:00PM BLOOD WBC-1.6* RBC-2.78* Hgb-9.3* Hct-27.6* MCV-99* MCH-33.5* MCHC-33.7 RDW-14.3 RDWSD-50.5* Plt Ct-55* ___ 01:00PM BLOOD Neuts-43.2 ___ Monos-12.9 Eos-0.0* Baso-0.0 AbsNeut-0.67* AbsLymp-0.68* AbsMono-0.20 AbsEos-0.00* AbsBaso-0.00* ___ 04:35PM BLOOD ___ PTT-29.9 ___ ___ 01:00PM BLOOD Glucose-134* UreaN-9 Creat-0.6 Na-139 K-5.7* Cl-102 HCO3-27 AnGap-10 ___ 07:00AM BLOOD Calcium-8.8 Phos-3.5 Mg-1.7 ___ 04:17PM BLOOD K-5.4* ___ 05:04PM BLOOD K-3.7 DISCHARGE LABS ============== ___ 06:27AM BLOOD WBC-2.1* RBC-2.44* Hgb-8.1* Hct-24.8* MCV-102* MCH-33.2* MCHC-32.7 RDW-15.0 RDWSD-52.1* Plt ___ ___ 07:50AM BLOOD Neuts-60.7 ___ Monos-7.4 Eos-0.0* Baso-0.0 AbsNeut-0.99* AbsLymp-0.52* AbsMono-0.12* AbsEos-0.00* AbsBaso-0.00* ___ 07:50AM BLOOD Glucose-96 UreaN-13 Creat-0.6 Na-143 K-4.5 Cl-104 HCO3-26 AnGap-13 ___ 07:50AM BLOOD Calcium-8.8 Phos-3.3 Mg-2.2 IMAGING ======= MRI Cervical, Thoracic ___ 1. Enhancing soft tissue mass centered at C6 with a prevertebral soft tissue component measuring 4.2 x 2.5 x 4.6 cm and a tiny intratumoral necrotic component in the left posterolateral vertebral body, consistent with metastasis. At the level of C6, moderate to severe spinal canal stenosis is seen with possible subtle increased T2/stir signal abnormality of the cord which may be secondary to artifact however cord edema cannot be excluded at this level. 2. Additional tumoral involvement is seen involving C5 and C7 vertebral bodies as well as spinous processes of C5 and C6. 3. Additional metastatic involvement is seen involving the T1 vertebral body with anterior wedging of T1 consistent with metastases and an associated pathologic compression fracture. 4. 3.3 x 2.3 x 5.4 cm enhancing mass centered at the left T11 spinous process, lamina and pedicle consistent with metastasis extending into the epidural space causing severe compression of the spinal cord at the same level with subtle increased cord signal abnormality concerning for cord edema, worse compared to PET-CT from ___. 5. There is additional tumoral involvement of the spinous process and left pedicle of T12. 6. 3.5 x 3.2 cm left lower lobe enhancing mass. Small left pleural effusion with atelectasis. 7. Additional mild degenerative changes as described in the body of the report. Brief Hospital Course: ___ with metastatic lung adenocarcinoma (mets to bone, soft tissue), s/p radiation therapy to lower T ___, scapula, R buttock, on ___ (last given ___, who presented after PET scan on admission demonstrated near total destruction of C6-C7 and MRI ___ showed new large C6 and previously known T11 lesion with weeks of worsening R arm neuropathic pain. She was started on radiation therapy for C6 lesion. #Spinal metastases Patient had an old T11 metastatic lesion with recent PET scan showing extension into epidural space, severe compression of spinal cord, but no definite cord signal abnormality. Also noted new C6 metastatic lesion with PET scan showing destruction of C6-C7 vertebral bodies and MRI on admission showing replacement of vertebra w/ metastatic lesion, no evidence of associated cord compromise. On stat evaluation by neurosurgery for T11 lesion, they noted there were no neurologic findings to accord with the radiographic images. They recommended outpatient follow up with them, starting steroids, staying in a hard C-collar. Additional spinal mets were noted at T1 and associated pathologic fractures at C5, C7. Following admission, dexamethasone was changed from 4mg Q6h to 4mg BID. The patient was continued on omeprazole 20mg daily. She received radiation therapy for the C6 lesion per radiation oncology. Palliative care was consulted to help with pain control. Pain control was achieved with: standing Tylenol ___ q6h, ibuprofen 600 BID, Flexeril 10 mg BID, oxycontin ___ from home dose), PRN oxycodone and 0.5-1 mg IV dilaudid q6 prn for breakthrough pain. # Right arm paresthesia, neuropathic pain No high grade neural foraminal stenosis seen on MRI. No clear impingement on cord seen on MRI. Given significant cervical metastatic burden and tight tender trapezius on exam, suspect peripheral nerve impingement from muscular tightness causing intermittent pain and paresthesia. Continued gabapentin at ___ and started flexeril at 10 mg BID. # Metastatic lung adenocarcinoma Metastatic disease to ___, R buttock. She is s/p palliative RT to scapula, ___, R buttock. She was due for next cycle of ___ ___, but will likely have to push back next cycle per primary oncologist as currently receiving steroids. # Pancytopenia Platelets noted to be lower than prior; leukopenia and anemia similar to prior. Believed to be likely chemotherapy induced. Continued home folic acid # Opiate induced constipation: Continued senna 2 tabs BID, Colace 1 tab BID, plus Miralax and Milk of magnesia PRN TRANSITIONAL ISSUES []Follow up: Heme-onc with ___ Center []Will need to continue wearing C-collar for 4 weeks until follow up at ___ []Will require further radiation therapy for C6 spinal lesion per RT []Continue Dexamethasone at 4mg BID to be tapered by oncologist at next appointment []With improving pancytopenia on discharge, will need follow up CBC []Required several doses of dilaudid while inpatient, will need to follow up pain control (discharged with oxycodone) []Patient is at risk of malnutrition, will need to continue to encourage PO intake and supplement as needed []Will benefit from ongoing physical therapy Emergency Contact: husband ___. Home- ___. Cell- ___ Code Status: Full presumed This patient was prescribed, or continued on, an opioid pain medication at the time of discharge (please see the attached medication list for details). As part of our safe opioid prescribing process, all patients are provided with an opioid risks and treatment resource education sheet and encouraged to discuss this therapy with their outpatient providers to determine if opioid pain medication is still indicated. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 2. Dexamethasone 2 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. FoLIC Acid 1 mg PO DAILY 5. Gabapentin 600 mg PO TID 6. Omeprazole 20 mg PO DAILY 7. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 8. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Moderate 9. Polyethylene Glycol 17 g PO DAILY:PRN constipation 10. Senna 17.2 mg PO BID 11. OxyCODONE SR (OxyconTIN) 20 mg PO BID 12. OxyCODONE SR (OxyconTIN) 40 mg PO QHS 13. Milk of Magnesia 30 mL PO DAILY:PRN constipation 14. Prochlorperazine 10 mg PO Q6H:PRN nausea/vomiting Discharge Medications: 1. Cyclobenzaprine 10 mg PO BID RX *cyclobenzaprine 10 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*0 2. Ibuprofen 600 mg PO Q8H:PRN Pain - Mild 3. Dexamethasone 4 mg PO BID RX *dexamethasone [Decadron] 4 mg 1 tablet(s) by mouth twice a day Disp #*40 Tablet Refills:*0 4. OxyCODONE SR (OxyconTIN) 50 mg PO QHS RX *oxycodone [OxyContin] 10 mg 1 tablet(s) by mouth every night Disp #*30 Tablet Refills:*2 5. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 6. Docusate Sodium 100 mg PO BID 7. FoLIC Acid 1 mg PO DAILY 8. Gabapentin 600 mg PO TID 9. Milk of Magnesia 30 mL PO DAILY:PRN constipation 10. Omeprazole 20 mg PO DAILY 11. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 12. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Moderate 13. OxyCODONE SR (OxyconTIN) 20 mg PO BID 14. Polyethylene Glycol 17 g PO DAILY:PRN constipation 15. Prochlorperazine 10 mg PO Q6H:PRN nausea/vomiting 16. Senna 17.2 mg PO BID Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS metastatic lung adenocarcinoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You came to the hospital because you were having severe right arm pain. WHAT HAPPENED TO ME IN THE HOSPITAL? - An MRI showed new lesions in your ___ and one ___ fracture which could explain your arm pain - You were started on radiation therapy for the ___ - You received several doses of dilaudid and your pain improved a bit with radiation WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - Please return to the hospital if you experience any new or worsening right arm pain, back pain, numbness or tingling in your arms or legs or loss of sensation. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19804575-DS-10
19,804,575
24,769,885
DS
10
2143-11-30 00:00:00
2143-11-30 18:06:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / ___ Attending: ___. Chief Complaint: Shortness Of Breath Major Surgical or Invasive Procedure: none History of Present Illness: ___ with PMH pulmonary fibrosis, bronchial hyperresponsiveness, atrial fibrillation, CAD s/p MI, CKD, and DM who presents with progressively worsening shortness of breath for the past two weeks. Although he has had exertional dyspnea for a few years now (related to his pulmonary fibrosis), he has noticed marked SOB beyond his baseline and experiences wheezing. He describes a cough productive of scant white phlegm, rhinorrhea, and generalized fatigue. No fevers/chills, myalgias, n/v, diarrhea, chest pain. No orthopnea or swelling of extremities. He has a positive sick contact: his wife had cough and runny nose for the past week. She is now better. Of note, he is followed by pulmonology and his PFTs in ___ were with normal FVC, FEV1, and ratio. In the ED, initial vs were: T97.2 HR59 BP128/55 R20 O2Sat 99%. Labs were remarkable for WBC 5.4, anemia with hematocrit 37.5% (baseline 35-37%), creatinine of 2.3 (baseline 2.0-2.2), INR of 2.2 (on warfarin). Significant wheezing was noted on exam. Patient was given prednisone 60mg, azithromycin 500mg, and albuterol/ipratropium nebs. A CXR was without infiltrate, and EKG was consistent with priors. On arrival to the floor, his initial vitals were 97.8 148/62 58 97RA. He continues to complain of shortness of breath and cough. No additional complaints. His daughter is also present. REVIEW OF SYSTEMS: Denies fever, chills, night sweats, headache, vision changes, sore throat, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. All other 10-system review negative in detail. Past Medical History: 1. Coronary artery disease - MI at ___ old, first patient at ___ to receive TPA. 2. Chronic systolic heart failure EF ___ 3. Atrial fibrillation on coumadin - patient had been on amiodarone, but began to show early pulmonary fibrosis and this was stopped. Also s/p 2 cardioversions. 4. Hyperlipidemia 5. Diabetes mellitus II since ___ 6. Chronic renal failure - recent basline of 1.9 to 2.0 7. Retinopathy 8. Glaucoma 9. Status post Billroth II for bleeding gastric ulcer- > ___ years ago 10. Colonic polyps 11. Claudication 12. Osteoarthritis 13. Gout 14. polymyalgia rheumatica 15. Seasonal allergies 16. Right eye blindness since birth with right ptosis 17. Probable fibrotic NSIP, prior amiodarone use 18. Bronchial hyperresponsiveness Social History: ___ Family History: Postive family history for diabetes and heart disease; sister with colon cancer, another sister with lung cancer. Physical Exam: ADMISSION PHYSICAL EXAM: VS 97.8 148/62 58 97RA. GEN Alert, oriented, no acute distress HEENT NCAT MMM EOMI, OP clear NECK supple, no JVD, no LAD PULM Decreased aeration at bases. Diffuse wheezing and rhonci. No rales. CV: irregular rhythm at rate of 60, normal S1/S2, no mrg ABD soft NT ND normoactive bowel sounds, no r/g EXT WWP 2+ pulses palpable bilaterally, trace lower ext edema NEURO: right eyelid drooped, he is blind out of this eye since birth. Otherwise, CNs2-12 intact, motor function grossly normal SKIN no ulcers or lesions DISCHARGE PHYSICAL EXAM: VS 98 120/50 66 20 98 GEN Alert, oriented, no acute distress HEENT NCAT MMM EOMI, OP clear NECK supple, no JVD, no LAD PULM: Pt able to speak in full sentences without SOB. End expiratory wheezing throughout. Good aeration. No rales. CV: irregular rhythm at rate of 60, normal S1/S2, no mrg ABD soft NT ND normoactive bowel sounds, no r/g EXT WWP 2+ pulses palpable bilaterally, trace lower ext edema NEURO: right eyelid drooped with clouding of right lens, he is blind out of this eye since birth. Otherwise, CNs2-12 intact, motor function grossly normal Pertinent Results: ADMISSION LABS: ___ 12:33PM BLOOD WBC-5.4 RBC-3.88* Hgb-11.5* Hct-37.5* MCV-97 MCH-29.8 MCHC-30.7* RDW-15.5 Plt ___ ___ 12:33PM BLOOD Neuts-63.7 ___ Monos-9.5 Eos-2.8 Baso-0.6 ___ 12:33PM BLOOD ___ PTT-44.1* ___ ___ 12:33PM BLOOD Glucose-140* UreaN-53* Creat-2.3* Na-140 K-5.0 Cl-105 HCO3-22 AnGap-18 ___ 02:52AM BLOOD Calcium-8.4 Phos-2.4* Mg-2.2 INTERIM LABS: ___ Cr 2.8 DISCHARGE LABS: ___ 07:35AM BLOOD WBC-15.3*# RBC-3.53* Hgb-10.4* Hct-33.6* MCV-95 MCH-29.5 MCHC-30.9* RDW-16.1* Plt ___ ___ 07:35AM BLOOD ___ PTT-45.7* ___ ___ 07:35AM BLOOD Glucose-182* UreaN-103* Creat-2.4* Na-130* K-4.7 Cl-98 HCO3-20* AnGap-17 ___ 07:35AM BLOOD Calcium-8.7 Phos-4.3# Mg-2.2 ======================== MICROBIOLOGY: ___ 12:33 pm BLOOD CULTURE: no growth in 48 hours ___ 5:30 pm Influenza A/B by ___: Negative for Influenza A and B. ___ 6:34 pm URINE NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. ======================== ECG ___ Atrial fibrillation with a controlled ventricular response rate of 58 beats per minute. Premature ventricular complexes. Right bundle-branch block with left anterior fascicular block. Anteroseptal myocardial infarction of indeterminate age. Non-specific ST segment changes in the high lateral leads. Compared to the previous tracing of ___ the ventricular ectopy is new. ======================== CXR ___: No acute cardiopulmonary process. Prominence of interstitial markings is unchanged from prior study. Brief Hospital Course: ___ year-old male with PMH pulmonary fibrosis, bronchial hyperresponsiveness, atrial fibrillation, CAD s/p MI, CKD, and DM who presents with worsening shortness of breath, cough, and wheezing for two weeks. Active Issues: # Acute Bronchitis: His clinical presentation of cough, diffuse inspiratory/expiratory wheezing and subjective dyspnea was most consistent with acute viral bronchitis complicated by reactive airway disease. He remained hemodynamically stable, without evidence of CHF exacerbation and did not require supplemental oxygen. Of note, CXR was without infiltrate or pulmonary edema. DFA flu swab and urinary legionella were negative. He was treated with four day course of duonebs, azithromycin, and prednisone 60mg and his lung exam and symptoms improved greatly. He was discharged home with an additional day of prednisone 40mg. Importantly, discharge examination was notable for end expiratory wheezing, although ambultory sats WNL. # ARF on CKD: His baseline Cr is ___, but there was elevation to 2.8 during his stay likely prerenal in nature. His lisinopril was held for 2 days and his creatinine started to trend down back to his baseline. # Supratherapeutic INR: He remained on his home regimen until his Coumadin rose to 3.2 on ___ and 3.9 on ___. Coumadin held ___ and ___. Discharge instructions to hold coumadin night of ___ and restart at home dose on ___ with INR check on ___ and further titration by HCA ACMS. #Hyperglycemia/DM: In setting of prednisone and infection, he initially had poorly controlled glucose during this admission to 400s. He continued his home NPH 48units and was supplemented with HSSI with good effect. No change to his insulin regimen was made on discharge as he was discharged with only one more day of prednisone 40mg. Chronic Issues: #Interstitial Lung Disease: likely a product of amiodarone use, followed by ___ clinic. Unclear how much of current presentation is attributed to his fibrosis and ILD. # Afib: CHADS II score of 3, rate well controlled without medications, anticoagulated on warfain. Supratherapeutic INR discussed above. #CAD/CHF: stable, he continued Imdur, ASA, Lasix, Lisinopril (held briefly in the setting of rising creatinine) #HLD: stable, continued simvastatin #BPH: stable, continued tamsulosin #Gout: stable, continued allopurinol #Allergic rhinitis: stable, continued fluticasone and fexofenadine TRANSITIONAL ISSUES: #Full Code #Discharge examination with faint end expiratory wheezing, however ambulatory sats WNL. #Follow-up with PCP and ___ within 2 weeks. #Will need creatinine follow-up at PCP ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB, wheeze 4. Calcitriol 0.25 mcg PO EVERY OTHER DAY 5. Fluticasone Propionate 110mcg 2 PUFF IH BID 6. Fluticasone Propionate NASAL 1 SPRY NU BID 7. Furosemide 40 mg PO DAILY hold for SBP<100 8. NPH 48 Units Breakfast 9. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY hold for SBP<100 10. Lisinopril 20 mg PO DAILY hold for SBP<100 11. Loratadine *NF* 10 mg Oral daily 12. Ranitidine 150 mg PO DAILY 13. Simvastatin 20 mg PO DAILY 14. Tamsulosin 0.4 mg PO HS hold for SBP<100 15. Warfarin 2 mg PO DAILY16 16. Multivitamins 1 TAB PO DAILY 17. Fish Oil (Omega 3) 1000 mg PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Fish Oil (Omega 3) 1000 mg PO DAILY 4. Furosemide 40 mg PO DAILY hold for SBP<100 5. Calcitriol 0.25 mcg PO EVERY OTHER DAY 6. Fluticasone Propionate NASAL 1 SPRY NU BID 7. Lisinopril 20 mg PO DAILY hold for SBP<100 8. Fluticasone Propionate 110mcg 2 PUFF IH BID 9. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB, wheeze RX *albuterol sulfate 90 mcg ___ puffs inhaled every ___ hours Disp #*1 Inhaler Refills:*2 10. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY hold for SBP<100 11. Loratadine *NF* 10 mg Oral daily 12. Multivitamins 1 TAB PO DAILY 13. Ranitidine 150 mg PO DAILY 14. Simvastatin 20 mg PO DAILY 15. Tamsulosin 0.4 mg PO HS hold for SBP<100 16. NPH 48 Units Breakfast 17. PredniSONE 40 mg PO DAILY RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*2 Tablet Refills:*0 18. Warfarin 2 mg PO DAILY16 Start ___ Discharge Disposition: Home Discharge Diagnosis: Acute bronchitis Reactive airway disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you while you were admitted to ___. You were admitted with cough and shortness of breath and we found you to have acute bronchitis and reactive airways. You were treated with nebulizer breathing treatments, antibiotics, and oral prednisone which you tolerated well. When you return home, you will take 40mg of prednisone tomorrow morning. That will complete your course of prednisone for this acute bronchitis. You should continue all your medications as prescribed. Please use your albuterol inhaler as needed for continued shortness of breath. Please take 2mg coumadin on ___, 2mg on ___ and call ___ clinic on ___ with home INR. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
19804575-DS-11
19,804,575
26,628,850
DS
11
2144-02-07 00:00:00
2144-02-11 19:38:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Amiodarone / Avandia Attending: ___. Chief Complaint: Pleuritic chest pain, shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ year old man with pulmonary fibrosis (from amiodarone and asbestos), bronchial hyperresponsiveness, atrial fibrillation (on coumadin), CAD s/p MI, CKD, and DM presenting to the emergency department with worsening shortness of breath. In ___, he was seen by his outpatient cardiologist who noted low blood pressure, so his lasix dose was decreased from 40 mg to 20 mg daily. Over the next two months, his weight increased from 210 lbs to 216 lbs and he noted increasing shortness of breath. He was seen in clinic on ___ and CXR at that time was notable for stable interstitial disease and volume overload. He has noted no change in his baseline cough and it has remained minimally productive of clear sputum. His daughter ___ nurse) increased his lasix back to 40 mg daily and his weight over the next two days decreased to 213 lbs. On ___ ___, he woke with sharp, pleuritic chest pain on his left side, so he went to ___ for evaluation. They were concerned for pneumonia in the ED based on chest pain, dyspnea, and CXR with possible infiltrate, so he was started on ceftriaxone and azithromycin and sent him to the ___ for further care. On arrival to the ED, initial VS were 99.3 70 177/79 22 100% 4L NC. Labs were notable for proBNP of 2581, Creatinine of 2.0 (baseline 2.0-2.3), hyperkalemia to 6.1 (hemolyzed), Lactate:1.8, WBC count of 13.7 (85.2% PMNs). Given continued concern for pneumonia, he was also given a dose of Zosyn. Chest x-ray was stable from the study on ___ showing pulmonary edema and stable interstitial lung disease. He was also wheezy and given his underlying bronchial hyperresponsiveness, he was given solumedrol 125 mg IV x 1 and started on nebulizer treatments, before being sent to the floor for further management. Transfer VS were 98.3 68 122/47 20 96%. On arrival to the floor, patient reports improved dyspnea following steroids and nebulizers. He reports cough as above that is improved from his baseline and resolution of the pleuritic chest pain felt earlier in the day. He denies chest pain or pressure and notes that the pain today was not similar to his prior MI. REVIEW OF SYSTEMS: Denies fever, chills, headache, rhinorrhea, congestion, sore throat, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. All other 10-system review negative in detail. Past Medical History: 1. Coronary artery disease - MI many years ago, first patient at ___ to receive TPA 2. Chronic systolic heart failure EF ___ 3. Atrial fibrillation on coumadin - patient had been on amiodarone, but began to show early pulmonary fibrosis and this was stopped. Also s/p 2 cardioversions 4. Hyperlipidemia 5. Diabetes mellitus II since ___ 6. Chronic renal failure - recent basline of 1.9 to 2.0 7. Retinopathy 8. Glaucoma 9. Status post Billroth II for bleeding gastric ulcer- > ___ years ago 10. Colonic polyps 11. Claudication 12. Osteoarthritis 13. Gout 14. polymyalgia rheumatica 15. Seasonal allergies 16. Right eye blindness since birth with right ptosis 17. Probable fibrotic NSIP, prior amiodarone use 18. Bronchial hyperresponsiveness Social History: ___ Family History: Postive family history for diabetes and heart disease; sister with colon cancer, another sister with lung cancer. Physical Exam: ADMISSION PHYSICAL EXAM: VS - 98.0 141/61 77 18 98% 2___ GEN - Alert, oriented, no acute distress HEENT - NCAT, MMM, EOMI, ambliopic right eye, sclera anicteric, OC/OP clear NECK - supple, difficult to assess JVP PULM - Bibasilar rales, diffuse wheezes, good air movement CV - Irregularly irregular, normal rate, S1/S2, no m/r/g ABD - Soft, NT/ND, normoactive bowel sounds, no guarding or rebound, remote midline scar EXT - WWP, 1+ pitting edema, right leg more swollen than left (stable per patient and daughter) 2+ pulses palpable bilaterally NEURO - CN II-XII intact (with the exception of ambliopic right eye), motor function grossly normal SKIN - no ulcers or lesions DISCHARGE PHYSICAL EXAM: VS - 98.1/98.1 140/60 70 18 96% 2___ GEN - Alert, oriented, no acute distress HEENT - NCAT, MMM, EOMI, ambliopic right eye, sclera anicteric, OC/OP clear NECK - supple, difficult to assess JVP PULM - Bibasilar rales, diffuse wheezes, good air movement CV - Irregular rhythm, normal rate, normal S1/S2, no m/r/g ABD - Soft, NT/ND, normoactive bowel sounds, no guarding or rebound, remote, well-healed midline scar EXT - WWP, 1+ pitting edema, right leg more swollen than left (stable per patient and daughter) 2+ pulses palpable bilaterally NEURO - CN II-XII intact (with the exception of ambliopic right eye), motor function grossly normal SKIN - no ulcers or lesions Pertinent Results: Admission labs: ___ 03:30PM BLOOD WBC-13.7* RBC-3.91* Hgb-11.1* Hct-37.2* MCV-95 MCH-28.5 MCHC-29.9* RDW-16.7* Plt ___ ___ 03:30PM BLOOD Neuts-85.2* Lymphs-5.6* Monos-8.1 Eos-0.6 Baso-0.5 ___ 03:30PM BLOOD Glucose-182* UreaN-49* Creat-2.0* Na-137 K-6.1* Cl-104 HCO3-18* AnGap-21* ___ 03:30PM BLOOD Lactate-1.8 Notable labs: ___ 03:30PM BLOOD cTropnT-0.03* proBNP-2581* ___ 12:31AM BLOOD CK-MB-3 cTropnT-0.03* ___ 07:20AM BLOOD CK-MB-3 cTropnT-0.03* Discharge labs: ___ 07:20AM BLOOD WBC-8.2 RBC-3.60* Hgb-10.2* Hct-33.1* MCV-92 MCH-28.3 MCHC-30.7* RDW-16.9* Plt ___ ___ 07:20AM BLOOD ___ PTT-49.1* ___ ___ 07:20AM BLOOD Glucose-293* UreaN-56* Creat-2.1* Na-137 K-4.3 Cl-102 HCO3-24 AnGap-15 ___ 07:20AM BLOOD Calcium-8.3* Phos-3.1 Mg-2.1 Micro: ___ Urine culture: negative (final) Studies: ___ CXR: PA and lateral views of the chest demonstrates stable cardiomegaly. Fibrotic changes particullary at the periphery of the lung parenchyma are stable. There is no evidence of pleural effusion. No focal consolidations worrisome for pneumonia. moderate tortuosity of the thoracic aorta IMPRESSION: Fibrotic changes of the lungs with cardiomegaly, stable from 2 days prior. ___ CXR: As compared to the previous radiograph, the fibrotic changes of the lung parenchyma has moderately increased. In addition, there is a minimal prominence of the vascular structures. Given the increased size of the cardiac silhouette, a combination of progressive fibrosis and mild fluid overload is likely. However, neither the frontal nor the lateral radiographs show evidence of pleural effusion. Moderate tortuosity of the thoracic aorta. Brief Hospital Course: ___ year old man with pulmonary fibrosis (from amiodarone and asbestos), bronchial hyperresponsiveness, atrial fibrillation (on coumadin), CAD s/p MI, CKD, and DM presenting to the emergency department with worsening shortness of breath with signs of decompensated heart failure. # Acute on chronic decompensated systolic heart failure: Patient with EF of ___ on TTE in ___. His lasix dose was recently decreased from 40 mg to 20 mg daily which was associated with 6 lb weight gain and increasing shortness of breath. CXR on ___ with volume overload and stable on ___ (day of admission). He has responded well to increasing lasix back to 40 mg daily at home and weight was down to 213 lbs (target 210 lbs). Patient was started on ceftriaxone/azithromycin at OSH and received a dose of Zosyn on arrival to ___ ED given concern for pneumonia, but given lack of new cough, fever or consolidation on CXR, antibiotics were discontinued on arrival to the floor. He has responded well to IV lasix and his pleuritic chest pain resolved prior to discharge. His lung exam was notable for prominent wheezing, likely from bronchial hyperresponsiveness triggered by pulmonary edema, which responded well to standing nebulizers. His weight on discharge was 211. # Interstitial Lung Disease: Likely a product of amiodarone use and asbestos exposure as a ___. He is followed by ___ ___. While much of current presentation of dyspnea is attributed to his pulmonary edema in the setting of decompensated heart failure (above), his fibrosis and ILD is certainly playing a role in the form of bronchial hyperresponsiveness. He is diffusely wheezy on exam and has responded well to steroids in the ED and standing nebulizers on the floor. He was seen by pulmonary who agreed that his symptoms are most likely related to pulmonary edema. If his wheezing persists, they recommended uptitrating Advair to four puffs twice a day and using a spacer to maximize efficiency of inhaler. # Microscopic hematuria: Unclear etiology. Patient reports no trauma or recent foley catheter use. He is asymptomatic. This should be evaluated further in the outpatient setting with urology follow up. # CKD: His baseline Cr is 2.0-2.3 and he is currently within that range. Likely related to diabetes. # Type 2 diabetes: He was continued on NPH 42 units QAM, and was started on a humalog insulin sliding scale. His glucose was poorly controlled on this regimen given solumedrol dosed in the ED. His family was somewhat reluctant to change current regimen to a more standard basal/bolus (glargine/humalog) regimen as it would require many injections per day. They were encouraged to follow up with endocrinology to pursue alternative options. # Afib: CHADS2 score of 3, rate well controlled without medications, anticoagulated on warfain 2 mg daily and in therapeutic range at 2.2 on admission. # CAD: Stable. Continued Imdur, ASA, Lasix, Lisinopril. # HLD: Stable. Continued simvastatin. # BPH: Stable. Continued tamsulosin. # Gout: Stable. Continued allopurinol. # Allergic rhinitis: stable, continued fluticasone and fexofenadine. # Transitional issues: - Code status: Full (confirmed ___ - Target weight: 210 lbs; discharge weight 211 lbs - If any rebound in wheezing post-discahrge on reasonable lasix dosage, would consider increase in flovent dose first, as well as maximizing spacer usage to increase effectiveness of inhlaer medications. - He should follow-up with Drs. ___ next month or earlier if needed. - Would consider endocrinology follow up to address insulin regimen if family is willing as NPH once daily dosing is not ideal. - Patient noted to have microscopic hematuria on admission. No evidence of trauma or recent foley catheter use. Patient should be referred to urology for further workup if this persists. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Fish Oil (Omega 3) 1000 mg PO DAILY 4. Furosemide 40 mg PO DAILY hold for SBP<100 5. Calcitriol 0.25 mcg PO EVERY OTHER DAY 6. Fluticasone Propionate NASAL 1 SPRY NU BID 7. Lisinopril 10 mg PO DAILY hold for SBP<100 8. Fluticasone Propionate 110mcg 2 PUFF IH BID 9. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB, wheeze 10. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY hold for SBP<100 11. Loratadine *NF* 10 mg Oral daily 12. Multivitamins 1 TAB PO DAILY 13. Ranitidine 150 mg PO DAILY 14. Simvastatin 20 mg PO DAILY 15. Tamsulosin 0.4 mg PO HS hold for SBP<100 16. NPH 42 Units Breakfast 17. Warfarin 2 mg PO DAILY16 Start ___ Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB, wheeze 2. Allopurinol ___ mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Calcitriol 0.25 mcg PO EVERY OTHER DAY 5. Fish Oil (Omega 3) 1000 mg PO DAILY 6. Fluticasone Propionate 110mcg 2 PUFF IH BID 7. Fluticasone Propionate NASAL 1 SPRY NU BID 8. NPH 42 Units Breakfast 9. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 10. Lisinopril 10 mg PO DAILY 11. Loratadine *NF* 10 mg Oral daily 12. Multivitamins 1 TAB PO DAILY 13. Ranitidine 150 mg PO DAILY 14. Simvastatin 20 mg PO DAILY 15. Tamsulosin 0.4 mg PO HS 16. Warfarin 2 mg PO DAILY16 17. Furosemide 40 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary diagnoses: - Acute on chronic decompensated systolic heart failure - Bronchial hyperresponsiveness - Pulmonary fibrosis Secondary diagnoses: - Coronary artery disease - Atrial fibrillation on coumadin - Diabetes mellitus II - Chronic renal failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Ambulatory sat 92-94% on room air. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at the ___. You were first seen at ___ where they were concerned about pneumonia based on your chest x-ray. When you arrived at the ___, you chest x-ray was actually similar to a prior x-ray which did not show pneumonia, so we discontinued your antibiotics. We think your symptoms are related to the extra fluid on your lungs from decreasing your water pill (Lasix). You received one dose of steroids in the ED and we gave you nebulizer treatments and additional lasix which helped with your breathing. You were seen by the lung doctors who recommended that you increase your fluticasone to 4 puffs twice a day if you continue to have wheezing. You should also use the spacer to make sure the medication distributes properly in your lungs. Also, make sure you rinse out your mouth after use. Your blood sugars were high in the hospital because you received a dose of steroids in the ED. You should resume your normal insulin regimen on discharge. Please weigh yourself daily. If your weight increases by more than 3 lbs please call your doctor. Your lasix dose may need to be increased. Followup Instructions: ___
19804575-DS-9
19,804,575
26,266,749
DS
9
2143-08-06 00:00:00
2143-08-08 21:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Amiodarone / Avandia Attending: ___. Chief Complaint: lower extremity worse Major Surgical or Invasive Procedure: None History of Present Illness: ___ with Afib and CAD p/w bilateral ___ rash x 2 weeks. Reports that the rash started on the dorsum of the feet, has slowly been creeping upward. He reports the rash is pruritic. Mild bilateral symmetric swelling that is worse at night but has improved since admission. He has not missed any doses of Lasix, reports no change in diet, the only change in activity is that he has been staying inside more over the past week due to the humidity's affect on his interstitial lung disease. He reports mild shortness of breath that is baseline for him and only occurs with activity. Recent PFTs are stable. He denies fever, chills, headache or neckpain. He has not used new soaps or detergents. He has not had exposure to bug bites or new animals or plants. . Initial VS in the ED: 97 66 156/72 16 98% Exam notable for bilateral erythematous rash with areas of significant confluence and palpable purpura as well as small pustules. . Labs notable for supratheraputic INR of 4.5, Hct of 37 c/w baseline, Cr of 2.0 lower than baseline 2.4. . Patient was given a chest x-ray which showed a small right pleural effusion without focal consolidation. Bilateral ___ US was performed, showing no DVT bilaterally. VS prior to transfer: 98.7 °F (Oral), Pulse: 53, RR: 16, BP: 150/59, O2Sat: 100, O2Flow: (Room Air) Past Medical History: 1. Coronary artery disease - patient states he had an MI ___ years ago and was the first patient at ___ to receive TPA. 2. Chronic systolic heart failure 3. Atrial fibrillation on coumadin - patient had been on amiodarone, but began to show early pulmonary fibrosis and this was stopped. Also s/p 2 cardioversions. 4. Hyperlipidemia 5. Diabetes mellitus II since ___ 6. Chronic renal failure - recent basline of 1.9 to 2.0 7. Retinopathy 8. Glaucoma 9. Status post Billroth II for bleeding gastric ulcer- > ___ years ago 10. Colonic polyps 11. Claudication 12. Nocturnal leg cramps 13. Osteoarthritis 15. Gout Social History: ___ Family History: Postive family history for diabetes and heart disease; sister with colon cancer, another sister with lung cancer. Physical Exam: Admission Physical Exam: Vitals: T:97.0 BP:150/80 P:64 R:18 O2: General: Alert, oriented x3, no acute distress HEENT: Sclera anicteric, MMM, oropharynx ___. Mucous membranes normal. Neck: supple, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis 2+ edema Neuro: CNII-XII intact. EOMI intact. Str 5 in all extremities. Skin: Dorsum of foot and anterior leg- nonblanching confluent purpura and brown hyperpigmentation with scattered scabs and scaling around the ankles. Scattered pustules are present on the leg and up the thigh. Forearms- diffuse petechiae along the anterior forearm and stable brusing of the posterior forearm consistent with Warfarin use. Discharge Physical Exam: General: Alert, oriented x3, no acute distress HEENT: Sclera anicteric, MMM, oropharynx ___. Mucous membranes normal. Neck: supple, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact. EOMI intact. Str 5 in all extremities. Skin: Dorsum of foot and anterior leg- nonblanching confluent purpura and brown hyperpigmentation with scattered scabs and scaling around the ankles. Erythema and edema improved. Scattered pustules are present on the leg and up the thigh. Forearms- diffuse erythematous macules along the anterior forearm and stable brusing of the posterior forearm consistent with Warfarin use. Pertinent Results: Admission Labs ___ 10:05AM BLOOD WBC-7.8 RBC-3.98* Hgb-12.0* Hct-37.6* MCV-94 MCH-30.1 MCHC-31.9 RDW-16.4* Plt ___ ___ 10:05AM BLOOD Neuts-70.7* Lymphs-13.8* Monos-8.7 Eos-6.4* Baso-0.4 ___ 10:05AM BLOOD Plt ___ ___ 11:58AM BLOOD ___ PTT-63.1* ___ ___ 10:05AM BLOOD Glucose-123* UreaN-56* Creat-2.0* Na-141 K-5.0 Cl-108 HCO3-26 AnGap-12 ___ 10:05AM BLOOD CRP-17.7* ___ 03:28PM BLOOD ___ * Titer-1:80 Discharge Labs: ___ 07:55AM BLOOD WBC-7.7 RBC-4.04* Hgb-12.0* Hct-38.3* MCV-95 MCH-29.8 MCHC-31.4 RDW-16.3* Plt ___ ___ 07:55AM BLOOD Plt ___ ___ 07:55AM BLOOD ___ PTT-57.2* ___ ___ 07:55AM BLOOD Glucose-180* UreaN-55* Creat-2.0* Na-141 K-5.3* Cl-105 HCO3-28 AnGap-13 ___ 07:55AM BLOOD Calcium-8.3* Phos-3.6 Mg-2.0 IMAGING: BILAT LOWER EXT VEINS Study Date of ___ 10:02 AM FINDINGS: Gray-scale and Doppler images of the right and left common femoral, both superficial femoral, popliteal, and proximal calf veins were obtained. There is wall-to-wall flow with normal response to compression and augmentation in all visible veins. IMPRESSION: No DVT in either lower extremity. CHEST (PA & LAT) Study Date of ___ 10:49 AM FINDINGS: PA and lateral chest radiographs were obtained. Lung volumes are slightly low. There is increased interstitial markings, similar to the prior study from ___. There is no focal consolidation, large pleural effusion, or pneumothorax. Mild cardiomegaly is unchanged. Brief Hospital Course: Assessment and Plan: This is a ___ with Afib and CAD p/w worsening leg swelling and bilateral ___ rash x 2 weeks. # Acute on chronic venous stasis dermatitis - The patient was admitted initially with a bilateral worsening lower extremity rash. The rash appeared as a macular nonblanching erythema superimposed upon chronic stasis dermatitis changes in the setting of an increase in lower extremity edema. Bilateral lower extremity ultrasound revealed no DVT. His leg edema resolved with IV diuresis. He was started on triamcinolone topical cream and his lower extremities were wrapped to help to mobilize fluid. The patient clinically improved and he was discharged home with ___ services and close follow up with his PCP. # Folliculitis - Patient also noted to have a superimposed folliculitis of his bilateral lower extremities. He was started on Keflex and discharged home with plans to complete at 7 day course. # Lower extremity edema - ___ be related to acute on chronic CHF exacerbated vs venous stasis. There was no evidence of DVT. He was given 1 dose of IV lasix with improvement in his lower extremity swelling. He was discharge with plans to resume his home lasix dosing. # Hx of CAD - continued ASA, statin, imdur. # Atrial fibrillation - INR supratherapeutic on admission. His warfarin was held on ___ and ___. He was discharged with instructions to have his INR checked on ___ and discuss ongoing dosing of his warfarin with the ___ clinic. # Interstitial lung disease - continued fluticasone and albuterol prn # CKD - stable # DM - continued home insulin regimen with a sliding scale while in house. Blood sugars remained well controlled. # Gout - continued allopurinol # BPH - continued tamsulosin # GERD - continued ranitidine TRANSITIONAL ISSUES - Patient will need close monitoring of his INR and adjustment of his warfarin dosing as hew as supratherapeutic during admission. He should have his next INR drawn on ___ - Patient should follow up with his PCP to assess for improvement of his lower extremity infection after he completes a course of Keflex and topical steroid cream. - blood cultures pending at time of discharge - Patient full code during admission Medications on Admission: Preadmission medications listed are correct and complete. Information was obtained from PatientFamily/Caregiver. 1. Allopurinol ___ mg PO DAILY 2. Calcitriol 0.25 mcg PO DAILY 3. Fluticasone Propionate NASAL 1 SPRY NU BID 4. Fluticasone Propionate 110mcg 2 PUFF IH BID 5. Furosemide 40 mg PO DAILY hold for SBP<100 6. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY hold for SBP<100 7. Lisinopril 20 mg PO DAILY hold for SBP<100 8. Ranitidine 150 mg PO BID 9. Simvastatin 20 mg PO DAILY 10. Tamsulosin 0.4 mg PO HS hold for SBP<100 11. Warfarin 2 mg PO DAILY16 12. Aspirin 81 mg PO DAILY 13. Loratadine *NF* 10 mg Oral daily 14. NPH 48 Units Breakfast 15. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB, wheeze Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB, wheeze 4. Calcitriol 0.25 mcg PO EVERY OTHER DAY 5. Fluticasone Propionate 110mcg 2 PUFF IH BID 6. Fluticasone Propionate NASAL 1 SPRY NU BID 7. Furosemide 40 mg PO DAILY hold for SBP<100 8. NPH 48 Units Breakfast 9. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY hold for SBP<100 10. Lisinopril 20 mg PO DAILY hold for SBP<100 11. Loratadine *NF* 10 mg Oral daily 12. Ranitidine 150 mg PO DAILY 13. Simvastatin 20 mg PO DAILY 14. Tamsulosin 0.4 mg PO HS hold for SBP<100 15. Cephalexin 500 mg PO Q8H please get blood cultures first RX *cephalexin 500 mg 1 capsule(s) by mouth Q8 hours Disp #*21 Capsule Refills:*0 16. Triamcinolone Acetonide 0.025% Cream 1 Appl TP BID apply to forearm rash and lower leg rash RX *triamcinolone acetonide 0.025 % apply to affected area twice daily Disp #*60 Gram Refills:*1 17. Warfarin 2 mg PO DAILY16 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis: folliculitis Secondary Diagnosis: chronic systolic heart failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you while you were admitted to ___. You were admitted because you were found to have increased lower extremity swelling and a rash. This was likely related to venous stasis, lower extremity swelling, and a superimposed infection called folliculitis. You were started on a topical steroid cream, antibiotics, and given some intravenous lasix with improvement in your symptoms. Also your coumadin dose was held given that your INR was elevated. The following changes have been made to your medication regimen: Please START taking - keflex ___ mg every 8 hours for 7 days (last day ___ - triamcinolone cream 0.25 % twice daily Please CHANGE - ranitidine to once daily (dosed for your renal function) Your INR was high (4.5). We held your coumadin on ___. Please HOLD your warfarin dose on ___ as your INR is still high (4.2). Please have your INR checked on ___ and discuss with your providers what dose of coumadin you should take. Please take the rest of your medications as prescribed and follow up with your doctors as ___. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
19805439-DS-3
19,805,439
24,908,577
DS
3
2118-09-09 00:00:00
2118-09-09 09:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: Penicillins / latex / adhesive Attending: ___. Chief Complaint: neck pain Major Surgical or Invasive Procedure: 1. Anterior cervical diskectomy and interbody arthrodesis C5-C6. 2. Interbody reconstruction with biomechanical device C5- C6. 3. Anterior plate instrumentation C5, C6. 4. Autograft, same incision. History of Present Illness: ___ known cervial disk herniation having progressive bilateral UE weakness over the last 1.5 week. Acutely worsened ___ days ago with severe neck pain and R shoulder pain. Had an outpatient MRI yesterday which showed disc narrowing at C5-C6, no cord signal abnormality. Due to pain, patient presented to ___ ___ today and sent here for spine eval. Denies urinary/bowel incontinence, ___ symptoms. Of note pateint was seen by Dr. ___ ___ - He noted a previous large C5-C6 disk herniation. At the time she had no emergent signs requiring surgical intervention. No signs of myelopathy.Her chief complaint is neck pain. Many symptoms have been present for a long period of time. It was unclear to him whether surgical intervention would help her with her primary complaint. Past Medical History: bronchial asthma, panic disorder, depression, bipolar and ADD. Social History: She is single with the domestic partner. She smokes one pack per day for ___ years. Physical Exam: Admission PE 98.6 76 116/65 18 100% RA RUE Motor ___ C5 Deltoid ___ C6 Wrist Extension ___ C7 Triceps ___ C8 Finger Flexion ___ T1 Finger Abduction SILT C5-T1 ___ negative LUE Motor ___ C5 Deltoid ___ C6 Wrist Extension ___ C7 Triceps ___ C8 Finger Flexion ___ T1 Finger Abduction SILT C5-T1 ___ negative RLE Motor ___ L2 Hip flexion/adduction ___ L3 Knee Extension ___ L4 Tib Ant ___ L5 ___ ___ S1 ___ ___ S2 Toe Flexion SILT L2-S2 Babinski down going Clonus no beats LLE Motor ___ L2 Hip flexion/adduction ___ L3 Knee Extension ___ L4 Tib Ant ___ L5 ___ ___ S1 ___ ___ S2 Toe Flexion SILT L2-S2 Babinski down going Clonus no beats Discharge Physical Exam: General:Well appearing sitting up in bed, some discomfort to surgical site, pleasant CV:RRR Resp:CTAB ABd:soft,ntnd,+bs's Extremities:wwp,2+distal pulses ___ LUE: throughout, RUE: 4+/5 Grip, ___ Del/EF/EE/WF/WE/IO +SILT BUE's Pertinent Results: ___ 04:45AM BLOOD WBC-14.2* RBC-4.01 Hgb-12.9 Hct-37.8 MCV-94 MCH-32.2* MCHC-34.1 RDW-11.8 RDWSD-40.9 Plt ___ ___ 03:55PM BLOOD Neuts-60.8 ___ Monos-5.8 Eos-3.0 Baso-0.4 Im ___ AbsNeut-7.78* AbsLymp-3.81* AbsMono-0.74 AbsEos-0.39 AbsBaso-0.05 ___ 04:45AM BLOOD Plt ___ ___ 04:45AM BLOOD Glucose-87 UreaN-7 Creat-0.6 Na-138 K-4.1 Cl-104 HCO3-25 AnGap-13 Brief Hospital Course: Patient was admitted to the ___ Spine Surgery Service and taken to the Operating Room for the above procedure. Refer to the dictated operative note for further details. The surgery was without complication and the patient was transferred to the PACU in a stable condition. TEDs/pnemoboots were used for postoperative DVT prophylaxis. Intravenous antibiotics were continued for 24hrs postop per standard protocol. Initial postop pain was controlled with oral pain medication. Diet was advanced as tolerated. The patient was transitioned to oral pain medication when tolerating PO diet. The patient was voiding independently. The patient was ambulating independently. Hospital course was otherwise unremarkable. On the day of discharge the patient was afebrile with stable vital signs, comfortable on oral pain control and tolerating a regular diet. Medications on Admission: Prilosec 40 mg capsule,delayed release oral 1 capsule,delayed ___ Twice Daily ___ ___ 16:04) Ativan 1 mg tablet oral 1 tablet(s) Three times daily, as needed ___ ___ 16:05) tramadol 50 mg tablet oral 2 tablet(s) Three times daily ___ ___ 16:05) Zoloft 100 mg tablet oral 2 tablet(s) Once Daily ___ ___ 16:05) Adderall 30 mg tablet oral 1 tablet(s) Once Daily at noon ___ ___ 16:06) Adderall XR 30 mg capsule,extended release oral 1 capsule,extended release 24hr(s) Twice Daily (AM and ___ ___ ___ 16:06) Discharge Medications: 1. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN headache 2. HYDROmorphone (Dilaudid) 6 mg PO Q4H:PRN pain please do not operate heavy machinery,drink alcohol or drive RX *hydromorphone [Dilaudid] 4 mg 1.5 tablet(s) by mouth every four (4) hours Disp #*80 Tablet Refills:*0 3. Sertraline 50 mg PO DAILY 4. Tizanidine 4 mg PO TID 5. Diazepam 5 mg PO Q6H:PRN pain or spasm may cause drowsiness RX *diazepam 5 mg 1 tablet(s) by mouth every six (6) hours Disp #*50 Tablet Refills:*0 6. Docusate Sodium 100 mg PO BID constipation please take while on pain medication RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: 1. Herniated nucleus pulposus C5-C6. 2. Spinal cord compression. 3. Nerve root compression. 4. Right arm pain with weakness. Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ACDF: You have undergone the following operation: Anterior Cervical Decompression and Fusion Immediately after the operation: • Activity: You should not lift anything greater than 10 lbs for 2 weeks. You will be more comfortable if you do not sit in a car or chair for more than ~45 minutes without getting up and walking around. • Rehabilitation/ Physical Therapy: ___ times a day you should go for a walk for ___ minutes as part of your recovery. You can walk as much as you can tolerate. • Swallowing: Difficulty swallowing is not uncommon after this type of surgery. This should resolve over time. Please take small bites and eat slowly. Removing the collar while eating can be helpful – however, please limit your movement of your neck if you remove your collar while eating. • Cervical Collar / Neck Brace: You have been given a soft collar for comfort. You may remove the collar to take a shower or eat. Limit your motion of your neck while the collar is off. You should wear the collar when walking, especially in public • Wound Care: Remove the dressing in 2 days. If the incision is draining cover it with a new sterile dressing. If it is dry then you can leave the incision open to the air. Once the incision is completely dry (usually ___ days after the operation) you may take a shower. Do not soak the incision in a bath or pool. If the incision starts draining at anytime after surgery, do not get the incision wet. Call the office at that time. If you have an incision on your hip please follow the same instructions in terms of wound care. • You should resume taking your normal home medications. • You have also been given Additional Medications to control your pain. Please allow 72 hours for refill of narcotic prescriptions, so plan ahead. You can either have them mailed to your home or pick them up at the clinic located on ___. We are not allowed to call in narcotic (oxycontin, oxycodone, percocet) prescriptions to the pharmacy. In addition, we are only allowed to write for pain medications for 90 days from the date of surgery. • Follow up: Please Call the office and make an appointment for 2 weeks after the day of your operation if this has not been done already. At the 2-week visit we will check your incision, take baseline x rays and answer any questions. We will then see you at 6 weeks from the day of the operation. At that time we will most likely obtain Flexion/Extension X-rays and often able to place you in a soft collar which you will wean out of over 1 week. Please call the office if you have a fever>101.5 degrees Fahrenheit, drainage from your wound, or have any questions. Followup Instructions: ___
19805513-DS-8
19,805,513
23,086,985
DS
8
2132-05-05 00:00:00
2132-06-17 09:28:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: LLQ abd pain, distention, N/V Major Surgical or Invasive Procedure: Colonoscopy with colonic stent placement History of Present Illness: 35 previously healthy woman who presents with LLQ of about 2 months duration which has slowly increased over that time. More recently, she became increasingly distended and for the past week has not been able to pass stool or flatus. She saw her PCP who treated her for constipation, and last night she tried Miralax and Milk of Magnesia resulting in a small bowel movement this morning, which contained a small amount of blood. She reports she also has been having difficulty keeping food down and experiencing intermittent nausea for the past week, with vomiting about once a day for the past 3 days. In addition she complains of epigastric burning pain, which she says has worsened since she started taking Ibuprofen for her abdominal pain. She denies any sick contacts or foods different from baseline. She denies fevers/chills, chest pain, or shortness of breath. She denies changes in urinary habits. Past Medical History: PMH: Does have a reported history of anorexia nervosa PSH: None Social History: ___ Family History: Non contributory Physical Exam: NAD, A&Ox3 RRR, no m/r/g CTAB abd soft, mild left side TTP, improved from admission MAE, no edema Pertinent Results: ___ 02:30PM URINE MUCOUS-MANY ___ 02:30PM URINE RBC-2 WBC-1 BACTERIA-NONE YEAST-NONE EPI-1 ___ 02:30PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-100 GLUCOSE-NEG KETONE-150 BILIRUBIN-NEG UROBILNGN-2* PH-6.5 LEUK-NEG ___ 02:30PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 02:30PM URINE GR HOLD-HOLD ___ 02:30PM URINE UCG-NEGATIVE ___ 02:30PM URINE HOURS-RANDOM ___ 02:30PM URINE HOURS-RANDOM ___ 02:55PM PLT COUNT-347 ___ 02:55PM NEUTS-90.7* LYMPHS-5.9* MONOS-3.0 EOS-0.2 BASOS-0.1 ___ 02:55PM WBC-10.1# RBC-4.41 HGB-12.4 HCT-36.9 MCV-84 MCH-28.1# MCHC-33.6 RDW-15.7* ___ 02:55PM ALBUMIN-4.3 CALCIUM-9.1 PHOSPHATE-2.1* MAGNESIUM-2.4 ___ 02:55PM LIPASE-33 ___ 02:55PM ALT(SGPT)-17 AST(SGOT)-26 ALK PHOS-67 TOT BILI-0.4 ___ 02:55PM estGFR-Using this ___ 02:55PM GLUCOSE-103* UREA N-17 CREAT-0.5 SODIUM-140 POTASSIUM-3.6 CHLORIDE-98 TOTAL CO2-26 ANION GAP-20 CT abd/pelvis: LOWER CHEST: There is mild bibasilar dependent atelectasis. The included portions of the heart and pericardium are unremarkable. There is no pleural effusion. LIVER: There is mild periportal edema. The liver enhances homogeneously, with no focal lesions or intrahepatic biliary duct dilatation. The gallbladder is unremarkable and the portal vein is patent. PANCREAS: The pancreas does not demonstrate focal lesions or peripancreatic stranding or fluid collection. SPLEEN The spleen is homogeneous and normal in size. ADRENALS: The adrenal glands are unremarkable. KIDNEYS: The kidneys do not show solid or cystic lesions and demonstrate symmetric nephrograms and excretion of contrast. No pelvicaliceal dilatation or perinephric abnormalities are present. GI TRACT: Enteric contrast is seen to the level of the proximal small bowel. The stomach is distended. There is diffuse fluid distension of small bowel measuring up to at most 3.7cm and large bowel up to 6.2 cm in the transverse colon. The cecum is very mildly dilated up to 8.4 cm. There is wall thickening and edema with mucosal hyper-enhancement involving the distal transverse colon to the level of the splenic flexure. In the distal descending colon, there appears to be a transition point with more colonic wall thickening and hyper-enhancement distal to this point (601b:17). The sigmoid colon and rectum are collapsed. The appendix is visualized and normal. VASCULAR: The aorta is normal in caliber without aneurysmal dilatation. The origins of the celiac axis, SMA, bilateral renal arteries, and ___ appear patent. RETROPERITONEUM AND ABDOMEN: There is no retroperitoneal or mesenteric lymph node enlargement. There is a small to moderate amount of ascites. No abdominal wall hernia or free air is identified. PELVIC CT: The urinary bladder and distal ureters are unremarkable. No pelvic wall or inguinal lymph node enlargement is seen. There is a small amount of pelvic free fluid. The uterus and bilateral adnexa are unremarkable. OSSEOUS STRUCTURES: No blastic or lytic lesions suspicious for malignancy is present. The bones appear probably demineralized. IMPRESSION: 1. Multifocal areas of colonic wall thickening and mucosal hyper-enhancement involving the distal transverse colon and descending colon are likely infectious or inflammatory in etiology. The presence of small to moderate amount of ascites may favor an infectious process somewhat. The transverse colon is dilated up to 6.2 cm and developing toxic megacolon cannot be excluded. 2. Diffuse distension of fluid filled loops of small and large bowel with a transition point in the descending colon secondary to the infectious or inflammatory process could indicate an ileus versus obstruction of large bowel associated with inflammatory narrowing. Peritonitis can also explain diffuse bowel dilatation, but there is collapse of sigmoid and rectum beyond the second segment of marked inflammatory change along the colon. 3. Suspicion for bony demineralization. DEXA scan is recommended for further evaluation. CT chest: There is no concerning consolidation or lung nodules. There is mild bibasilar atelectasis and small nonhemorrhagic pleural effusions. There is no pneumothorax. The airways are patent to the segmental level. The thyroid is normal. Supraclavicular, axillary, mediastinal and hilar lymph nodes are not enlarged. Aorta and pulmonary arteries are normal size. There are no filling defects in the pulmonary arteries concerning for pulmonary emboli. Cardiac configuration is normal and there is no appreciable coronary calcification. Relative osteopenia is again noted. This study is not designed to evaluate the upper abdominal contents. Colonic wall thickening and ascites are better characterized on the prior CT abdomen and pelvis of ___. IMPRESSION: Small non-hemorrhagic pleural effusions. No evidence of intrathoracic malignancy. Colonoscopy: A ulcerated circumferential 5 cm mass of malignant appearance was found in the sigmoid colon / descending colon. The mass caused a complete obstruction. The scope could not traverse the lesion. Cold forceps biopsies were performed for histology. Brief Hospital Course: Mrs. ___ was admitted to ___ for abdominal pain, nausea and vomiting. She had these symptoms for 2 months which had been worsening. A CT scan showed a possible mass in the transverse to descending colon. She was taken by GI for colonoscopy. At that time they placed a stent, which relieved her symptoms. She was eventually started on a regular diet, which she tolerated without difficulty. Her pain resolved and at the time of discharge she was doing well. She Will follow up at ___ for elective colectomy. Medications on Admission: none Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg 1 tablet(s) by mouth every 4 hours Disp #*30 Tablet Refills:*0 3. Docusate Sodium 100 mg PO BID Continue to take while taking narcotic medication RX *docusate sodium 100 mg 1 capsule(s) by mouth Twice a day Disp #*50 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Left Colon mass Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital for a bowel obstruction. You were given bowel rest and intravenous fluids, a nasogastric tube was placed in your stomach to decompress your bowels, and GI placed a colonic stent. Your obstruction has subsequently resolved after placement of the stent. Samples from your colon were taken and this tissue has been sent to the pathology department for analysis. You will receive these pathology results at your follow-up appointment. If there is an urgent need for the surgeon to contact you regarding these results they will contact you before this time. You have tolerated a regular diet, are passing gas and your pain is controlled with pain medications by mouth. You may return home to finish your recovery. Please monitor your bowel function closely. You may or may not have had a bowel movement prior to your discharge which is acceptable, however it is important that you have a bowel movement in the next ___ days. If you are taking narcotic pain medications there is a risk that you will have some constipation. Please take an over the counter stool softener such as Colace, and if the symptoms do not improve call the office. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! Followup Instructions: ___
19805532-DS-2
19,805,532
23,283,321
DS
2
2182-04-12 00:00:00
2182-04-12 18:20:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: COPD exacerbation Major Surgical or Invasive Procedure: None History of Present Illness: ___ M w hx asthma (since childhood), multiple environmental allergies, COPD, and current smoker, presented with 2 days of productive cough and increased shortness of breath. Has long hx of hospitalizations for COPD, one requiring intubation ___ years ago, most recently in ___. Just moved to ___ from ___. Started having a cold w rhinorrhea and sneezing several days ago, which is how his exacerbations usually being. Describes green sputum and one episode of post-tussive emesis (non-bloody). He is on several inhaled maintenance medications for his COPD. He denies fevers, chills, chest pain, abdominal pain, dysuria, frequency, extremity weakness or paresthesia, recent travel, hemoptysis, nausea, or diarrhea. His pulmonologist is Dr. ___ in ___ (___) and he requests she be contacted in the morning. Peak flows post duonebs were 125 in AM, 150 in ___. In the ED, initial vitals: T 97.1 HR 112 BP 116/80 RR 18 97%RA - Exam notable for: -No increased work of breathing -Vital signs stable, afebrile, normal SPO2 -Breath sounds severely decreased in all lung fields, scattered expiratory wheezes, no focal consolidation -No JVD, peripheral edema or signs of heart failure - Labs notable for: lactate 1.4 --> 3.6 --> 3.4, WBC 14.8, HGB 13.0, gluc 124, BMP wnl, trop neg x2, flu negative - Imaging notable for: CXR w hyperexpanded lungs otherwise WNL - Pt given: pred, azithro, montelukast ___ 05:16 PO PredniSONE 60 mg ___ 05:17 IH Albuterol 0.083% Neb Soln 1 NEB ___ 05:17 IH Ipratropium Bromide Neb 1 NEB ___ 05:55 IH Albuterol 0.083% Neb Soln 1 NEB ___ 05:55 IH Ipratropium Bromide Neb 1 NEB ___ 06:31 IH Albuterol 0.083% Neb Soln 1 NEB ___ 06:31 IH Ipratropium Bromide Neb 1 NEB ___ 06:50 PO Azithromycin 500 mg ___ 12:19 IH Ipratropium Bromide Neb 1 NEB ___ 12:19 IH Albuterol 0.083% Neb Soln 1 NEB ___ 12:19 PO/NG Montelukast 10 mg ___ 17:40 IH Ipratropium Bromide Neb 1 NEB ___ 17:40 IH Albuterol 0.083% Neb Soln 1 NEB - Vitals prior to transfer: HR 101 BP 123/75 RR 22 100% RA Upon arrival to the floor, the patient reports the above history. He has been smoking on and off since age ___, recently quit but then started smoking again. REVIEW OF SYSTEMS: As above. Past Medical History: - Asthma - COPD - Seasonal allergies - Osteoarthritis Social History: ___ Family History: Non-contributory Physical Exam: ADMISSION PHYSICAL EXAM ======================= VITALS: Temp: 99.2 PO BP: 130/77 HR: 101 RR: 18 O2 sat: 95% RA GENERAL: well developed, well nourished, frequent coughing fits HEENT: sclera anicteric, MMM CARDIAC: regular rate and rhythm, no murmurs, rubs, or gallops LUNGS: poor air movement throughout w wheezing and rhonchi, slightly inc WOB on RA ABDOMEN: soft, non-tender, non-distended, bowel sounds present, no rebound or guarding GU: No foley EXTREMITIES: warm, well perfused, no cyanosis or edema NEURO: AOx3, face symmetric, moving all extremities w purpose and against gravity DISCHARGE PHYSICAL EXAM ======================= Pertinent Results: ADMISSION LABS ============== ___ 07:35AM BLOOD WBC-14.8* RBC-4.42* Hgb-13.0* Hct-40.2 MCV-91 MCH-29.4 MCHC-32.3 RDW-14.5 RDWSD-48.2* Plt ___ ___ 07:35AM BLOOD Neuts-79.9* Lymphs-11.1* Monos-5.7 Eos-2.3 Baso-0.4 Im ___ AbsNeut-11.79* AbsLymp-1.64 AbsMono-0.84* AbsEos-0.34 AbsBaso-0.06 ___ 07:35AM BLOOD Glucose-124* UreaN-15 Creat-0.9 Na-141 K-4.1 Cl-106 HCO3-21* AnGap-14 ___ 07:35AM BLOOD cTropnT-<0.01 ___ 08:35PM BLOOD cTropnT-<0.01 ___ 10:43AM BLOOD ___ pO2-71* pCO2-43 pH-7.39 calTCO2-27 Base XS-0 ___ 07:46AM BLOOD Lactate-1.4 IMAGING ======= CXR (___) ---------- IMPRESSION: 1. No definite pneumonia. 2. The lungs are hyperexpanded, compatible with provided history of COPD. DISCHARGE LABS ============== Brief Hospital Course: SUMMARY ======= ___ yo M with hx of COPD, asthma, seasonal allergies, current smoker who presented to ED with increased sputum production, worsening cough, rhinorrhea with concern for COPD exacerbation likely precipitated by viral URI. ACTIVE ISSUES ============= #COPD Exacerbation #Asthma Patient presented with increased sputum production and worsening cough consistent with COPD exacerbation in the setting of several days of rhinorrhea, cough, occasional fevers/chills at home, which was thought to be a viral URI. Flu PCR was negative, and CXR was clear. Patient had a mild leukocytosis to 14.8. He was given prednisone 60 mg and azithromycin 250 mg in the ED (___) as well as duonebs q6h and ipratropium q2h PRN for a planned 5-day course of both prednisone 40 mg and azithromycin 250 mg. Patient remained on room air during his hospital stay with goal oxygen saturation of 88-92%, and he remained above goal on room air during his hospitalization. His home montelukast was continued. #Abnormal EKG Patient found to have incomplete RBBB on EKG; unsure if this is a new finding as did not have patient's baseline EKG's since he just moved to ___. A new RBBB in the setting of COPD could indicate developing right heart strain; as patient was euvolemic on presentation and remained euvolemic as well as normal cardiac exam, no urgent need for echocardiogram, and it was decided to defer echo for the patient to receive as an outpatient. #Smoking cessation Patient in contemplative stage. He has tried Chantix in the past which has worked for him, but he has said that his insurance didn't cover it which is why he stopped. #Elevated lactate Thought to be ___ albuterol use as patient was not septic. Initial lactate 3.6 after nebulizer in ED, repeat 3.4, and not trended as it was downtrending. CHRONIC ISSUES ============== #Seasonal allergies -Patient's home montelu___ was continued. TRANSITIONAL ISSUES =================== [ ]Smoking cessation - as patient in contemplative stage, please continue to support him and provide resources as needed [ ]Abnormal EKG - please help patient coordinate getting an echocardiogram done to assess for right heart strain or other reasons for incomplete RBBB CORE MEASURES ============= Contact: None Code: Full (confirmed) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing 2. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation BID 3. Montelukast 10 mg PO DAILY 4. Ipratropium-Albuterol Neb 1 NEB NEB ASDIR Discharge Medications: 1. Azithromycin 250 mg PO DAILY Duration: 1 Dose Start on ___ RX *azithromycin 250 mg 1 tablet(s) by mouth Once a day Disp #*1 Tablet Refills:*0 2. Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN intense coughing RX *codeine-guaifenesin 10 mg-100 mg/5 mL 5 mL by mouth As needed for cough at bedtime Refills:*0 3. PredniSONE 40 mg PO DAILY Duration: 1 Dose Start on ___ RX *prednisone 20 mg 2 tablet(s) by mouth Once a day Disp #*2 Tablet Refills:*0 4. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing 5. Ipratropium-Albuterol Neb 1 NEB NEB ASDIR RX *ipratropium-albuterol 0.5 mg-3 mg (2.5 mg base)/3 mL 1 ampule neb Every 6 hours as needed Disp #*56 Ampule Refills:*0 6. Montelukast 10 mg PO DAILY 7. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation BID Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS ================= COPD Exacerbation SECONDARY DIAGNOSES =================== Asthma Seasonal allergies Upper respiratory viral infection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you. WHY WAS I ADMITTED TO THE HOSPITAL? You were admitted to the hospital because of a flare-up of your COPD. We think it was due to a viral infection of your respiratory system. WHAT WAS DONE WHILE I WAS HERE? We gave you steroids, various forms of nebulizers, antibiotics, and cough medicine to help calm your lungs down. WHAT DO I NEED TO DO ONCE I LEAVE THE HOSPITAL? -Continue taking the antibiotic and steroid for one more day (your last day will be ___. -Continue using the duonebs treatment every 6 hours until you are back at your baseline breathing status. -Continue using your home medications as previously directed. -Please continue to think about quitting smoking, as it will greatly help your breathing; you can speak with your primary doctor about quitting strategies when you are ready. -Please follow-up with your primary doctor within 1 week of leaving the hospital. Be well, Your ___ Care Team Followup Instructions: ___
19805562-DS-21
19,805,562
29,834,353
DS
21
2160-03-13 00:00:00
2160-03-28 12:53:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: left calf wound, cellulitis Major Surgical or Invasive Procedure: ___: PROCEDURE: 1. Split-thickness skin graft 10 x 15 cm from left thigh to left calf. 2. Placement of 10 x 15 cm VAC sponge. ___: Excisional debridement of left leg, skin, fat, fascia, and drainage of hematoma with placement of a VAC dressing 20 x 10 cm. ___: PROCEDURE: 1. Split-thickness skin graft 10 x 15 cm from left thigh to left calf. 2. Placement of 10 x 15 cm VAC sponge. History of Present Illness: Mr. ___ is a ___ year old gentleman who presents 9 days after falling off his tractor and being struck on his LLE. He sustained a 4in x 6in soft tissue injury for which he initially presented to an OSH ED. Notably plain films at the time of the original injury were reportedly negative for fracture or bony involvement. He had been receiving wound care as an outpatient with superficial debridement, bacitracin and gauze dressings but the leg had continued to swell and the skin overlying the wound turned black. He was advised to present to ___ by his PCP with concern for compartment syndrome. On exam the lateral aspect of his left calf has a necrotic eschar overlaying a tense fluid pocket, likely hematoma. The entire left calf is erythematous with scattered ecchymosis, although the patient endorses much of this is chronic changes following a total hip replacement in ___. There is notably a well-demarcated rind of blanching erythema directly around the edges of the wound. Sensation, motor and pulses are all intact and the limb compartments are soft and mildly tender. Past Medical History: PAST MEDICAL HISTORY: Chronic anemia secondary to a bleeding "GI plexus" OSA Afib on Coumadin CHF, reportedly normal TTE HTN OA HLD MVA with head injury ___ Vitamin D deficiency Chronic bronchitis Diaphragmatic hernia PAST SURGICAL HISTORY: L total hip replacement ___ Retinal repair Social History: ___ Family History: noncontributory Physical Exam: Admission PHYSICAL EXAMINATION: VSS: 98.4 100 138/96 20 100%RA GEN: No acute distress, well-nourished, appropriately groomed. NEURO: Alert and oriented to time, person and place. CN II-XII grossly intact. Sensation to pressure and fine touch intact and symmetric bilaterally HEENT: Pupils equal, round, reactive to light and accommodating; sclerae anicteric. No nystagmus or ptosis. Oropharynx moist and pink. Nose and ears atraumatic CV: Irregularly irregular rhythm, no murmurs, rubs or gallops, 2+ peripheral pulses symmetrically RESP: Clear to auscultation bilaterally, no wheezes, rales or crackles GI: Abdomen obese and soft, non-tender and non-distended. No hepatosplenomegaly. Abdomen dull to percussion. Bowel sounds normoactive. Rectal exam deferred LYPMH: No cervical, axillary or inguinal lymphadenopathy GU: Deferred MSK: The lateral aspect of his left calf has a necrotic eschar overlaying a tense fluid pocket. The entire left calf is erythematous with scattered chronic ecchymoses. There is a well-demarcated rind of blanching erythema directly around the edges of the wound. Sensation, motor and pulses are all intact and the limb compartments are soft and mildly tender. Discharge Physical Exam: VS: VSS afebrile GEN: AA&O x 3, NAD, calm, cooperative. HEENT: (-)LAD, mucous membranes moist, trachea midline, EOMI, PERRL. CHEST: Clear to auscultation bilaterally, (-) cyanosis. ABDOMEN: (+) BS x 4 quadrants, soft, nontender to palpation EXTREMITIES: left thigh skin graft donor site: dressed with xeroform, no erythema. left calf wound with skin graft taking well to wound bed, dressed with adaptic and kerlix. Pertinent Results: ___ 10:50AM BLOOD WBC-6.3 RBC-4.06* Hgb-11.1* Hct-36.7* MCV-90 MCH-27.3 MCHC-30.2* RDW-17.8* RDWSD-59.4* Plt ___ ___ 08:03AM BLOOD WBC-6.5 RBC-4.04* Hgb-11.1* Hct-36.5* MCV-90 MCH-27.5 MCHC-30.4* RDW-17.7* RDWSD-58.8* Plt ___ ___ 06:55AM BLOOD WBC-5.8 RBC-3.91* Hgb-10.5* Hct-35.6* MCV-91 MCH-26.9 MCHC-29.5* RDW-17.9* RDWSD-58.9* Plt ___ ___ 09:30AM BLOOD WBC-6.3 RBC-4.05* Hgb-10.9* Hct-36.6* MCV-90 MCH-26.9 MCHC-29.8* RDW-17.8* RDWSD-59.0* Plt ___ ___ 06:31AM BLOOD WBC-5.7 RBC-3.97* Hgb-10.7* Hct-35.6* MCV-90 MCH-27.0 MCHC-30.1* RDW-17.7* RDWSD-59.2* Plt ___ ___ 06:28AM BLOOD ___ ___ 07:10AM BLOOD ___ ___ 10:50AM BLOOD ___ ___ 10:50AM BLOOD Glucose-149* UreaN-12 Creat-0.8 Na-144 K-3.4 Cl-105 HCO3-27 AnGap-15 ___ 08:03AM BLOOD Glucose-102* UreaN-9 Creat-0.7 Na-145 K-3.6 Cl-108 HCO3-28 AnGap-13 ___ 06:55AM BLOOD Glucose-93 UreaN-11 Creat-0.7 Na-141 K-3.7 Cl-104 HCO3-26 AnGap-15 ___ 09:30AM BLOOD Glucose-170* UreaN-13 Creat-0.8 Na-140 K-3.7 Cl-102 HCO3-27 AnGap-15 IMAGING ========================================== left ankle/tib-fib XR: 1. No fracture is identified. 2. Plantar subluxation of the navicular may be a chronic process. Degenerative changes are noted in the knee and ankle joints. 3. Soft tissue hematoma in the left lateral calf. PATHOLOGIC DIAGNOSIS: Eschar, left calf, excisional debridement: Extensively necrotic skin and fibroadipose with acute inflammation, abscess formation and hematoma. Brief Hospital Course: ___ year old male on Coumadin admitted to the General Surgery service for management of a left calf soft tissue hematoma with associated cellulitis. The patient was hemodynamically stable. He received antibiotics with some benefit but the area continued to be exquisitely tender and clearly needed drainage and debridement. The patient was therefore consented and taken to the operating room for excisional debridement of left leg, skin, fat, fascia, and drainage of hematoma with placement of a VAC dressing which went well without complication (reader referred to the Operative Note for details). After a brief, uneventful stay in the PACU, the patient arrived on the floor tolerating a regular diet and on oral pain medicine and on antibiotics. The patient was hemodynamically stable. POD2 the VAC dressing was taken down and the wound bed appeared very healthy and well granulated, with very little residual circumferential skin necrosis. It was felt that the patient was appropriate for placement of a split-thickness skin graft to definitively close the wound. Antibiotics were discontinued at this time due to resolution of cellulitis, normal labs and the patient had been afebrile. On ___ the patient was taken to the operating room and underwent split-thickness skin graft from left thigh to left calf with placement VAC sponge which went well without complication (reader referred to the Operative Note for details). Coumadin was re-started post-op. On POD5 the VAC was removed from the skin graft site. The wound was taking to the graft and it appeared healthy. At the time of discharge on POD5, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home with ___ services for wound care. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. .. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 40 mg PO DAILY 2. Fish Oil (Omega 3) 1000 mg PO DAILY 3. Atenolol 50 mg PO DAILY 4. Diltiazem Extended-Release 300 mg PO DAILY 5. Warfarin 7.5 mg PO 3X/WEEK (___) 6. Pravastatin 40 mg PO QPM 7. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 8. Furosemide 40 mg PO DAILY 9. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 10. flaxseed oil 1,000 mg oral DAILY 11. Potassium Chloride 10 mEq PO BID 12. Ascorbic Acid ___ mg PO DAILY 13. Vitamin D 5000 UNIT PO DAILY 14. melatonin 10 mg oral QHS:PRN insomnia 15. Warfarin 5 mg PO 4X/WEEK (___) Discharge Medications: 1. Acetaminophen 650 mg PO TID RX *acetaminophen 325 mg 2 tablet(s) by mouth three times a day Disp #*40 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*20 Capsule Refills:*0 3. Senna 8.6 mg PO BID:PRN constipation 4. TraMADol 50 mg PO Q8H:PRN Pain - Moderate RX *tramadol 50 mg 1 tablet(s) by mouth every eight (8) hours Disp #*25 Tablet Refills:*0 5. Ascorbic Acid ___ mg PO DAILY 6. Atenolol 50 mg PO DAILY 7. Diltiazem Extended-Release 300 mg PO DAILY 8. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 9. Fish Oil (Omega 3) 1000 mg PO DAILY 10. flaxseed oil 1,000 mg oral DAILY 11. Furosemide 40 mg PO DAILY 12. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 13. Lisinopril 40 mg PO DAILY 14. melatonin 10 mg oral QHS:PRN insomnia 15. Potassium Chloride 10 mEq PO BID Hold for K > 16. Pravastatin 40 mg PO QPM 17. Vitamin D 5000 UNIT PO DAILY 18. Warfarin 5 mg PO 4X/WEEK (___) 19. Warfarin 7.5 mg PO 3X/WEEK (___) Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Soft tissue crush injury / infected hematoma to the left calf Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You presented to ___ with a traumatic soft tissue injury to your left calf. The site was incised and drained of an old hematoma in the OR. The cellulitis resolved and the wound bed was amenable to a skin graft, so the decision was made to take you back to the OR for a skin graft. You tolerated this procedure well. The VAC dressing has been removed and the wound looks healthy. The dressing over the left thigh graft donor site should remain in place until it peels up on its own; you may trim the edges. You are medically cleared to be discharged home to continue your recovery. You will be set up with a visiting nurse for wound care. Please note the following discharge instructions: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Incision Care: *Please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *Avoid swimming and baths until your follow-up appointment. *You may shower, but DO NOT get graft sites wet. Wrap them up in plastic before showering. Followup Instructions: ___
19805768-DS-12
19,805,768
29,559,147
DS
12
2161-05-19 00:00:00
2161-05-21 17:16:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: exertional dyspnea, cough Major Surgical or Invasive Procedure: None History of Present Illness: ___ male with PMHx notable for hypertension and GERD presenting to the ED for cough and dyspnea x3 weeks. Reports most concerning symptom is significant resting dyspnea. Initially began 3 weeks ago with a hacking, nonproductive cough without any associated chest pain. Gradually progressed to the point where he can no longer walk across the room without feeling severely short of breath. He denies any orthopnea/PND, night sweats, chills, hemoptysis, chest pain, or palpitations. History notable for 10 lb weight loss over the last ___ weeks which he attributes to significantly decreased appetite. This has improved over past several days. Reports remote volunteer work in homeless shelter but otherwise has no significant history of occupational or other exposures. Initially presented to his PCP 1 week ago and received fluticasone inhaler without improvement. Seen again by PCP 1 day ago where he was diagnosed with PNA by CXR. Started on azithromycin. Over past 24h symptoms have not significantly worsened. Presented today because he is worried that he was not getting better. Review of systems further negative for headache, abdominal pain, nausea, vomiting, or dysuria. ED course notable for 97.8 96 117/75 22 94% NC. Labs notable for WBC 8.0, BNP 249, trop negative. EKG with sinus tachycardia. CXR with right greater than left-sided reticulonodular opacities without significant change from prior. Started on IV azithromycin. Past Medical History: hypertension GERD hx H. pylori infection iron deficiency anemia macular degeneration renal mass prostatic cyst depression cholecystectomy colonic polyps Social History: ___ Family History: Colon cancer in father, HTN and depression in mother, and ___ disease in living brother. Physical Exam: ADMISSION PHYSICAL EXAM: ========================== Vitals: T 98.8 BP 131/83 HR 85 RR 20 O2Sat 92% 3L NC GENERAL: Elderly appearing man in no acute distress. HEENT: AT/NC, PERRL, anicteric sclera, MMM NECK: supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs LUNGS: On 3L O2 NC. Diffuse crackles b/l, more prominent on R. Breathing without use of accessory muscles ABDOMEN: nondistended, nontender in all quadrants EXTREMITIES: no cyanosis, clubbing, trace edema to midway up shins. NEURO: A&Ox3, moving all 4 extremities with purpose DISCHARGE PHYSICAL EXAM ============================== PHYSICAL EXAM: Vitals: 97.6 102/68 82 18 93% RA (sitting, 92-93% while ambulating on RA GENERAL: Elderly appearing man in no acute distress. HEENT: AT/NC, PERRL, anicteric sclera, MMM NECK: supple, no LAD HEART: RRR, S1/S2, no murmurs LUNGS: Diffuse crackles b/l, R > L. Decreased breath sounds at bases b/l. No egophany. Breathing without use of accessory muscles ABDOMEN: nondistended, nontender in all quadrants, large midline scar (old) EXTREMITIES: no cyanosis, clubbing, trace edema to midway up shins. NEURO: alert and orietend , moving all 4 extremities with purpose Pertinent Results: ADMISSION LABS ======================= ___ 08:30PM URINE COLOR-Yellow APPEAR-Hazy* SP ___ ___ 08:30PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR* GLUCOSE-NEG KETONE-TR* BILIRUBIN-NEG UROBILNGN-2* PH-7.0 LEUK-LG* ___ 08:30PM URINE RBC-3* WBC-25* BACTERIA-FEW* YEAST-NONE EPI-0 TRANS EPI-<1 ___ 08:30PM URINE AMORPH-RARE* ___ 08:30PM URINE MUCOUS-RARE* ___ 04:19PM K+-4.2 ___ 03:50PM URINE COLOR-Yellow APPEAR-Hazy* SP ___ ___ 03:50PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-100* GLUCOSE-NEG KETONE-40* BILIRUBIN-NEG UROBILNGN-2* PH-7.0 LEUK-LG* ___ 03:50PM URINE RBC-2 WBC-63* BACTERIA-FEW* YEAST-NONE EPI-<1 ___ 03:50PM URINE MUCOUS-OCC* ___ 02:53PM GLUCOSE-91 UREA N-25* CREAT-1.0 SODIUM-139 POTASSIUM-6.8* CHLORIDE-94* TOTAL CO2-29 ANION GAP-16 ___ 02:53PM cTropnT-<0.01 ___ 02:53PM proBNP-249 ___ 02:53PM WBC-8.0 RBC-4.32* HGB-12.7* HCT-38.1* MCV-88 MCH-29.4 MCHC-33.3 RDW-14.0 RDWSD-45.6 ___ 02:53PM NEUTS-77.6* LYMPHS-14.4* MONOS-6.4 EOS-0.4* BASOS-0.4 IM ___ AbsNeut-6.20* AbsLymp-1.15* AbsMono-0.51 AbsEos-0.03* AbsBaso-0.03 ___ 02:53PM PLT COUNT-519* ___ 12:30PM GLUCOSE-108* ___ 12:30PM UREA N-30* CREAT-1.2 SODIUM-142 POTASSIUM-4.4 ___ 12:30PM estGFR-Using this ___ 12:30PM WBC-11.8* RBC-4.74 HGB-14.0 HCT-42.0 MCV-89 MCH-29.5 MCHC-33.3 RDW-13.9 RDWSD-44.7 ___ 12:30PM NEUTS-83.0* LYMPHS-8.5* MONOS-7.0 EOS-0.2* BASOS-0.5 IM ___ AbsNeut-9.78* AbsLymp-1.00* AbsMono-0.83* AbsEos-0.02* AbsBaso-0.06 ___ 12:30PM PLT COUNT-568*# PERTINENT LABS ======================= ___ 12:30PM BLOOD WBC-11.8* RBC-4.74 Hgb-14.0 Hct-42.0 MCV-89 MCH-29.5 MCHC-33.3 RDW-13.9 RDWSD-44.7 Plt ___ ___ 07:10AM BLOOD WBC-7.5 RBC-4.41* Hgb-12.9* Hct-39.8* MCV-90 MCH-29.3 MCHC-32.4 RDW-14.6 RDWSD-47.9* Plt ___ MICROBIOLOGY ======================= ___ 12:00 am SPUTUM Source: Expectorated. **FINAL REPORT ___ GRAM STAIN (Final ___: ___ PMNs and >10 epithelial cells/100X field. Gram stain indicates extensive contamination with upper respiratory secretions. Bacterial culture results are invalid. PLEASE SUBMIT ANOTHER SPECIMEN. RESPIRATORY CULTURE (Final ___: TEST CANCELLED, PATIENT CREDITED. UA === Urine Specimen Type RANDOM W Urine Color Yellow YELLOW N/A W Urine Appearance Clear CLEAR N/A W Specific Gravity 1.025 1.001 - 1.035 W DIPSTICK URINALYSIS Blood NEG NEG N/A W Nitrite NEG NEG N/A W Protein NEG NEG mg/dL W Glucose NEG NEG mg/dL W Ketone NEG NEG mg/dL W Bilirubin NEG NEG N/A W Urobilinogen 0.2 0.2 - 1 mg/dL W pH 6.0 5 - 8 units W Leukocytes SM* NEG N/A W MICROSCOPIC URINE EXAMINATION RBC 8* 0 - 2 #/hpf W WBC 15* 0 - 5 #/hpf W Bacteria NONE NONE /hpf W Yeast NONE NONE /hpf W Epithelial Cells 0 #/hpf W OTHER URINE FINDINGS Urine Mucous FEW* NONE /hpf W IMAGING ===================== ___ Chest CT IMPRESSION: ___ nodular opacities diffusely in the right lung and at the left lung base compatible with multifocal infectious process with both typical and atypical organisms.. ___ (PA & LAT) IMPRESSION: Stable findings of reticular nodular opacities mostly in the right lung which remain concerning for infection. ___ (PA & LAT) IMPRESSION: New diffuse reticulonodular opacities, most prominent in the right lung. Differential considerations may include acute viral infection, disseminated tuberculosis, sarcoid, or disseminated carcinoma. Recommend clinical correlation. DISCHARGE LABS ============================ ___ 07:10AM BLOOD WBC-7.5 RBC-4.41* Hgb-12.9* Hct-39.8* MCV-90 MCH-29.3 MCHC-32.4 RDW-14.6 RDWSD-47.9* Plt ___ ___ 07:10AM BLOOD Plt ___ ___ 07:25AM BLOOD Glucose-91 UreaN-24* Creat-0.9 Na-142 K-4.9 Cl-103 HCO3-23 AnGap-16 ___ 07:25AM BLOOD Calcium-9.0 Phos-3.3 Mg-1.8 ___ 05:15PM BLOOD D-Dimer-___* Brief Hospital Course: ___ male with PMHx notable for hypertension and GERD admitted for cough, dyspnea x3 weeks with new O2 requirement. Pt got a CXR and CT that showed Tree and ___ opacities. Pulmonology was consulted and they decided that the most likely diagnosis is pneumonia due to aspiration due to hx of GERD. They discussed lifestyle modifications with him (small meals, not eating before bed, raising head of bed). Patient got azithromycin and ceftriaxone in the hospital, discharged on levofloxacin for at total of 7 days of antibiotics. He initially required 3L of O2 by nasal cannula but on discharge spo2 was 92-93% at rest and while ambulating on RA without symptoms of dyspnea. We continued to treat his hypertension and GERD with his home medications. Of note, patient also appeared to have a UTI on admission based on results of his UA which showed leuk esterase, WBCs, bacteria, and RBCs (however was asx and culture was negative). The UA improved over the course of the hospitalization but we recommend repeating another UA in several weeks to see if there is continued inflammation. ACUTE ISSUES: ============= #Pneumonia Per pulm patient most likely has aspiration pneumonia ___ to GERD. They recommend that he continue is 7 day treatment for CAP. Legionella negative. Was continued on CTX and azithromycin. He was ambulating well prior to discharge and maintaining saturations > 89%. #Weight loss 10lb weight loss confirmed in OMR since ___. Notes decreased PO intake due to loss of appetite. However, in context of ongoing cough and CXR findings, can also consider TB, malignancy, or other systemic processes. Reassuring that he denies any other constitutional symptoms such as fevers, nightsweats. No lymphadenopathy appreciated. LDH elevated at 271. Most likely ___ to pneumonia. Recommend it is followed up and if weight loss continues then undergo further workup in outpatient setting. #Proteinuria/bacteruria Patient had +leuk, protein, bacteria, and WBCs in urine at time of admission. Culture was negative but if sample was from after patient received ceftriaxone then we would expect a negative culture. Repeat UA showed small leuk esterase, 15 WBCs, and 8 RBCS which is significantly better than his prior UA. Presuming pt had a UTI that is improving with ceftriaxone. If he has another UTI should have urologic work up. CHRONIC ISSUES: =============== #hypertension: Continued home Hydrochlorothiazide 25 mg PO/NG DAILY and home Lisinopril 10 mg PO/NG DAILY #gastroesophageal reflux disease: Continued Omeprazole 40 mg PO DAILY and increased to BID per pulm recs. Continued home ranitidine. Was given GERD lifestyle precautions: elevate the ___, at least ___ hours after last meal before sleep, avoid EtOH and caffeine #allergic rhinitis: continued fluticasone Transitional Issues: ==================== -New medications: Levofloxacin 500 mg qd (to complete 7 day course for community acquired pneumonia on ___ -Changed medications: Omeprazole was increased from 40 mg qd to BID -Imaging: Please repeat chest CT in 12 weeks to see if tree and ___ opacities have resolved. -GERD: Please decrease omeprazole to qd after a month (he has a history of osteopenia). Consider GI referral or surgical referral for further management. -Labs: Repeat UA to evaluate for inflammation and microscopic hematuria. -Code status: Full code -Emergency contact: ___ ___ (do not contact unless emergency) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN nasal allergies 2. Hydrochlorothiazide 25 mg PO DAILY 3. Lisinopril 10 mg PO DAILY 4. Omeprazole 40 mg PO DAILY 5. Urocit-K 10 (potassium citrate) 10 mEq (1,080 mg) oral TID 6. Ranitidine 300 mg PO QHS 7. Aspirin 81 mg PO DAILY 8. PreserVision AREDS 2 (vit C,E-Zn-coppr-lutein-zeaxan) 250-200-40-1 mg-unit-mg-mg oral BID Discharge Medications: 1. Levofloxacin 500 mg PO Q24H RX *levofloxacin 500 mg 1 tablet(s) by mouth daily Disp #*3 Tablet Refills:*0 2. Omeprazole 40 mg PO DAILY RX *omeprazole 40 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 3. Aspirin 81 mg PO DAILY 4. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN nasal allergies 5. Hydrochlorothiazide 25 mg PO DAILY 6. Lisinopril 10 mg PO DAILY 7. PreserVision AREDS 2 (vit C,E-Zn-coppr-lutein-zeaxan) 250-200-40-1 mg-unit-mg-mg oral BID 8. Ranitidine 300 mg PO QHS 9. Urocit-K 10 (potassium citrate) 10 mEq (1,080 mg) oral TID Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary diagnosis: ================== Aspiration pneumonitis Community acquired pneumonia Secondary diagnosis: ==================== Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. Please see below for information on your time in the hospital. WHY WAS I IN THE HOSPITAL? You were in the hospital with pneumonia (an infection in your lungs) most likely due to your acid reflux. WHAT HAPPENED IN THE HOSPITAL? We started you on antibiotics to help treat the pneumonia as well as gave you oxygen since testing showed that the level of oxygen in your blood was low. You had a CT and the lung doctors saw ___ and recommended lifestyle management as it was consistent with gastroesophageal reflux disease. WHAT SHOULD I DO WHEN I GO HOME? Continue to take your antibiotics and omeprazole as prescribed (the frequency of omeprazole was changed). Please do not eat large meals prior to lying down and instead, eat small meals and remain upright for several hours prior to lying down. Try as much as you can to avoid foods and drinks that increase reflux symptoms (spicy foods, chocolate, and coffee). Follow up with your primary care doctor ___ below, the soonest appointment was with a resident working with Dr. ___. We wish you the best! -Your Care Team at ___ Followup Instructions: ___
19805768-DS-13
19,805,768
29,914,724
DS
13
2161-05-22 00:00:00
2161-05-22 20:58:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Dyspnea, tachycardia Major Surgical or Invasive Procedure: None History of Present Illness: ___ w/ PMHx notable for HTN and GERD presents with dyspnea and tachycardia after recent admission (discharged ___ for PNA. Patient reports history of poor appetite and cough for about one month. He was then admitted to ___ and treated with levaquin/azithro for what was presumed to be an aspiration PNA from GERD. Patient reports that at the time of discharge he was still having some significant DOE. He said he returned home and continued to have dyspnea even with the slightest activity. He said he feels fine at rest though "even going to the fridge makes me short of breath." He otherwise says he has been feeling somewhat better as his cough has been improving quite a bit but is still having less PO intake than is normal for him due to decreased appetite (at baseline he says if you put two cheeseburgers in front of him he would make them disappear immediately). Denies fevers, chills, CP, palpitations, n/v/d, constipation, calf pain, or dizziness/LH. In the ED, initial VS were: 97.6 104 110/66 20 94% 2L NC Labs showed: BUN 33, plt 513, BNP 73, lactate 1.3 UA: Trace protein, 40 ketones, few bacteria Imaging showed: CXR: Improving ill-defined opacities within the lungs bilaterally, more pronounced in the lung bases and on the right, likely reflective of resolving aspiration pneumonia. CTA Chest: 1. Re-demonstration of ___ nodular opacities diffusely in the right lung and at the left lung base with smaller regions of focal consolidations along the right lung fissures in base suggestive of an ongoing infectious process not significantly changed from study of ___. 2. No evidence of pulmonary embolism or aortic abnormality. Patient received: Levofloxacin 750 mg IV, 1L NS On arrival to the floor, patient reports feeling somewhat anxious as to the prospect that he will not get back to the baseline level of health that he enjoyed prior to his original hospitalization for PNA. He otherwise is feeling better and has been able to get down some diet ginger ale. REVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as per HPI Past Medical History: hypertension GERD hx H. pylori infection iron deficiency anemia macular degeneration renal mass prostatic cyst depression cholecystectomy colonic polyps Social History: ___ Family History: Colon cancer in father, HTN and depression in mother, and ___ disease in living brother. Physical Exam: ADMISSION PHYSICAL EXAM: ====================== VS: 98.4 99/68 83 18 94% RA GENERAL: Pleasant gentleman sitting comfortably in bed HEENT: NCAT, MMM NECK: Neck veins flat sitting upright HEART: RRR, no m/r/g LUNGS: Faint bibasilar crackles ABDOMEN: Soft, NT/ND, BS+ EXTREMITIES: WWP, no c/c/e PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: ======================= Vitals: 97.8 115/75 79 18 95% 2L General: alert, oriented, no acute distress HEENT: sclera anicteric, MMM, oropharynx clear Lungs: mild rhonchi with inspiration with somewhat reduced air movement but significantly improved from prior hospitalization CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, no rebound tenderness or guarding GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNs2-12 intact, motor function grossly normal Pertinent Results: ADMISSION LABS: ============== ___ 03:10PM BLOOD WBC-7.7 RBC-5.03 Hgb-14.7 Hct-44.5 MCV-89 MCH-29.2 MCHC-33.0 RDW-14.3 RDWSD-45.9 Plt ___ ___ 03:10PM BLOOD Neuts-73.2* ___ Monos-6.5 Eos-0.3* Baso-0.5 Im ___ AbsNeut-5.60 AbsLymp-1.46 AbsMono-0.50 AbsEos-0.02* AbsBaso-0.04 ___ 03:10PM BLOOD Glucose-72 UreaN-33* Creat-1.2 Na-138 K-4.5 Cl-95* HCO3-24 AnGap-19* ___ 03:10PM BLOOD proBNP-73 ___ 07:45AM BLOOD Calcium-9.0 Phos-3.5 Mg-1.8 ___ 03:11PM BLOOD Lactate-1.3 ___ 03:10PM URINE Color-Yellow Appear-Clear Sp ___ ___ 03:10PM URINE Blood-NEG Nitrite-NEG Protein-TR* Glucose-NEG Ketone-40* Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG ___ 03:10PM URINE RBC-1 WBC-4 Bacteri-FEW* Yeast-NONE Epi-0 ___ 03:10PM URINE CastHy-11* MICRO LABS: ========== ___ CULTUREBlood Culture, Routine-PENDINGEMERGENCY WARD NO GROWTH TO DATE ___ CULTUREBlood Culture, Routine-PENDINGEMERGENCY WARD NO GROWTH TO DATE ___ CULTURE-PENDINGEMERGENCY WARD NO GROWTH TO DATE IMAGES: ======= CXR (___): Improving ill-defined opacities within the lungs bilaterally, more pronounced in the lung bases and on the right, likely reflective of resolving aspiration pneumonia. CTA (___): 1. Re-demonstration of ___ nodular opacities diffusely in the right lung and at the left lung base with smaller regions of focal consolidations in the right lung suggestive of an ongoing infectious process not significantly changed from study of ___. 2. No evidence of pulmonary embolism or aortic abnormality. DISCHARGE LABS: ============== ___ 07:45AM BLOOD WBC-5.5 RBC-4.33* Hgb-12.7* Hct-38.2* MCV-88 MCH-29.3 MCHC-33.2 RDW-14.3 RDWSD-45.9 Plt ___ ___ 07:45AM BLOOD Glucose-79 UreaN-31* Creat-1.0 Na-139 K-4.1 Cl-98 HCO3-23 AnGap-18* Brief Hospital Course: ___ recently admitted for aspiration pneumonitis/aspiration pneumonia thought to be ___ to GERD with PMHx notable for hypertension and GERD who was sent to the ED by his PCP because of continuing SOB and tachycardia. In the Ed patient got one dose of levaquin and IL of NS. He had a CXR that showed improvement of prior pneumonia. CTA showed no pulmonary emboli and tree and ___ opacities and consolidations consistent with his prior scans. Patients vitals have been within normal limits on the floor but was mildly orthostatic by elevated HR which was though to be ___ dehydration. Patient got more fluids and the tachycardia resolved and orthostatics negative. He has no fevers, chills, sputum production, or cough, and his WBC is normal. He does not de-sat on room air with ambulation and he walked down the hall without difficulty. Shortness of breath thought to be ___ resolving pneumonia and de-conditioning. Sent home on no new medications but with a prescription for pulmonary ___ to help with re-conditioning. #Dyspnea: Patient was seen by pulmonology on last admission and CT showed tree and ___ opacities which they thought were likely aspiration pneumonitis/aspiration pneumonia ___ to GERD. Since his d/c he has had continuing SOB with activity but his cough is improving. He went to his PCP ___ ___ and he was mildly tachycardia and she thought he was dehydrated. She sent him to the ED for fluids. His CXR looked improved. He got 1L NS and a dose of levaquin. In the ED given his tachycardia and SOB they got a CTA which did not show a PE and showed similar tree and ___ pattern and opacities consistent with PNA. Pt is very anxious that he is dying (especially when the possibility of a PE was brought up). His continuing SOB is most likely ___ to his pneumonia/pneumonitis as well as continuing anxiety. Given that his pneumonia appears to be improving and he completed a course, they were discontinued. He had normal ambulatory sats and was not orthostatic upon discharge. #Anxiety: Patient is very anxious that he will never return to his baseline. I believe this anxiety is contributing to his SOB. Pt reports he has long hx of depression (both circumstantial and genetic) and has never been treated effectively with an antidepressant. We discussed starting an SSRI for anxiety which he is not interested in at the current time but he will think about it. #Tachycardia: Most likely secondary to hypovolemia (initially) and de-conditioning. His vitals and HR improved with IVF. He was given a prescription to pulmonary rehab prior to discharge. #Elevated Cr: SG 1.025, hyaline casts, ketonuria, protein. Mild ___ probably secondary to poor PO intake and dehydration. Cr 1.2 --> 1.0. Improved with IVF. #Hypertension: Continued home medications #Gastroesophageal reflux disease: Continued omeprazole 40 mg BID (from last admission) and home ranitidine. Encouraged continued lifestyle changes to mitigate GERD/reflux impact on lungs per previous Pulmonary consult recommendations. #hx allergic rhinitis: continued home fluticasone Transitional Issues: ==================== -New medications: No new medications were started this admission. -Imaging: Please repeat chest CT in 12 weeks to see if tree and ___ opacities have resolved. -He was given a prescription to pulmonary ___ upon discharge. -GERD: Please decrease omeprazole to qd after a month (he has a history of osteopenia). Consider GI referral or surgical referral for further management. -Labs: Repeat UA to evaluate for inflammation and microscopic hematuria. -Code status: Full code -Emergency contact: ___ ___ (do not contact unless emergency) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Hydrochlorothiazide 25 mg PO DAILY 3. Lisinopril 10 mg PO DAILY 4. Omeprazole 40 mg PO BID 5. PreserVision AREDS 2 (vit C,E-Zn-coppr-lutein-zeaxan) 250-200-40-1 mg-unit-mg-mg oral BID 6. Urocit-K 10 (potassium citrate) 10 mEq (1,080 mg) oral TID Discharge Medications: 1. Omeprazole 40 mg PO BID 2. Aspirin 81 mg PO DAILY 3. Hydrochlorothiazide 25 mg PO DAILY 4. Lisinopril 10 mg PO DAILY 5. PreserVision AREDS 2 (vit C,E-Zn-coppr-lutein-zeaxan) 250-200-40-1 mg-unit-mg-mg oral BID 6. Urocit-K 10 (potassium citrate) 10 mEq (1,080 mg) oral TID Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis Aspiration Pneumonia Dehydration Secondary Diagnosis Gastroesophageal reflux disease HYPERTENSION Discharge Condition: Discharge condition: stable Mental Status: A&O x3 Ambulatory status: ambulatory Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. Please see below for information on your time in the hospital. WHY WAS I IN THE HOSPITAL? You were in the hospital because you were dehydrated and you were having difficulty breathing in the setting of a resolving pneumonia. WHAT HAPPENED IN THE HOSPITAL? We gave you 1 dose of antibiotics in the emergency room, we gave you fluids to help with your dehydration, and you got a chest xray and cat scan of your lungs. WHAT SHOULD I DO WHEN I GO HOME? You should continue to eat and drink when you are hungry and thirsty. You should go to pulmonary rehab (see below). You should follow up with your primary care doctor in 11 weeks for a cat scan of your chest to make sure your pneumonia has fully resolved. We wish you the best! -Your Care Team at ___ Followup Instructions: ___
19805942-DS-16
19,805,942
25,649,665
DS
16
2120-10-12 00:00:00
2120-10-15 21:38:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: indomethacin / meglumine Attending: ___. Chief Complaint: palpitations Major Surgical or Invasive Procedure: DC cardioversion ___ History of Present Illness: Ms. ___ is a ___ year-old lady with a PMH of hyperlipidemia, rheumatic mitral valve disease with mild-moderate mitral stenosis and mild mitral regurgitation, and prior PVCs, who presented with persistent palpitations, found to be in atrial fibrillation with RVR. Past Holter in ___ showed frequent premature ventricular beats and two short runs of SVT. As she was mostly asymptomatic in the past, she was not started on a beta blocker. Four days prior to this admission, she began to experience palpiations, accompanied by intermittent periods of chest pressure, shortness of breath (as if "the air gets blocked and she is starving for air") and dizziness when going from sitting to standing. She is comfortable sleeping on her stomach. She denies having any syncope, chest pain, lower extremity edema, PND, fevers, chills, nausea, vomiting, diarrhea, constipation, dysuria or hematuria. At her outpatient cardiologist's office, EKG showed afib/flutter at ___hanges. In the ED, initial vitals were: HR 160, RR 18; 30 minutes later they were: 135 122/88 16 94%. EKG showed afib/flutter with RVR at 168 bpm, with ST elevations in aVR and V1, and ST depressions in I, V4-V6. Labs were unremarkable, with troponin-T < 0.01. Portable chest x-ray showed: mildly enlarged heart with streaky opacities in the left midlung and right lung base suggestive of atelectasis, evidence of mild fluid overload. UA/UCx and BCx were not sent. Patient was given metoprolol tartrate 5 mg IV x2, and placed on diltiazem and heparin IV drips. She was discussed with ___ attending Dr. ___ recommended admission to ___ floor. Vital signs prior to admission were: 98 124 ___ 16 98%. On arrival to the floor, patient was comfortable, but continued to experience sensation of heart palpitations. She denied any shortness of breath, chest pain/pressure or dizziness on arrival. On review of systems, she denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. She denies recent fevers, chills or rigors. he denies exertional buttock or calf pain. All of the other review of systems were negative. Cardiac review of systems is notable for absence of dyspnea on exertion, paroxysmal nocturnal dyspnea, ankle edema, or syncope. Past Medical History: 1. CARDIAC RISK FACTORS: -Diabetes, +Dyslipidemia, -Hypertension 2. CARDIAC HISTORY: -Rheumatic MV disease with mild-mod mitral stenosis and mild mitral regurgitation, echo ___ -PVCs 3. OTHER PAST MEDICAL HISTORY: - hearing loss - colonic polyp - H/O: hysterectomy - Pseudophakia - s/p cataract surgery ___ Social History: ___ Family History: Mother with DM, HTN, heart disease (pt thinks secondary to Avandia). Father with "valve problem" in his ___, where it "would not shut" all the way. Grandparents lived into their ___. Physical Exam: ADMISSION PHYSICAL EXAMINATION: VS: T 98.3 113/56 133 18 94RA GENERAL: WDWN female in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVP of 10 cm at 45 degrees. CARDIAC: PMI located in ___ intercostal space, midclavicular line. Irregularly irregular, tachycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. + bibasilar crackles, no wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+ Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+ DISCHARGE PHYSICAL EXAMINATION: VS: Tm 98.3 85-115/52-66 ___ 93-100% 68.8 from 70.2kg yesterday I: 750 O: 1350 GENERAL: WDWN female in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with no JVP elevation CARDIAC: PMI located in ___ intercostal space, midclavicular line. Irregularly irregular, tachycardic, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. + bibasilar crackles, no wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. 2+ radial, dp, pt pulses Pertinent Results: LABS ___ 11:42PM PTT-70.1* ___ 09:03PM CK(CPK)-35 ___ 09:03PM CK-MB-2 cTropnT-<0.01 ___ 09:03PM TSH-4.3* ___ 01:40PM GLUCOSE-111* UREA N-11 CREAT-0.8 SODIUM-143 POTASSIUM-5.1 CHLORIDE-108 TOTAL CO2-24 ANION GAP-16 ___ 01:40PM cTropnT-<0.01 ___ 01:40PM WBC-8.8 RBC-4.49 HGB-13.5 HCT-40.8 MCV-91 MCH-30.2 MCHC-33.2 RDW-12.6 ___ 01:40PM NEUTS-70.8* ___ MONOS-4.8 EOS-0.3 BASOS-0.2 ___ 01:40PM PLT COUNT-263 ___ 01:40PM ___ PTT-28.0 ___ ___ 06:03AM BLOOD ___ PTT-35.7 ___ ___ 06:03AM BLOOD Glucose-90 UreaN-11 Creat-0.8 Na-141 K-3.9 Cl-107 HCO3-26 AnGap-12 ___ 06:03AM BLOOD Calcium-8.7 Phos-4.4 Mg-1.9 ___ 06:40AM BLOOD Triglyc-121 HDL-39 CHOL/HD-4.7 LDLcalc-120 IMAGING/STUDIES: ECG ___ Atrial fibrillation with slowing of the ventricular response as compared with previous tracing of ___. The ischemic appearing ST-T wave changes are less prominent but persist in leads I, aVL and V4-V6. Clinical correlation is suggested. TRACING #2 TEE ___ No spontaneous echo contrast or thrombus is seen in the body of the left atrium or left atrial appendage. Mild spontaneous echo contrast is seen in the body of the right atrium. Mild spontaneous echo contrast is seen in the right atrial appendage. Right atrial appendage ejection velocity is good (>20 cm/s). No thrombus is seen in the right atrial appendage The aortic valve leaflets (3) are mildly thickened. Trace aortic regurgitation is seen arising from the aortic root in between the left and noncoronary cusps. The mitral valve leaflets are moderately thickened. The mitral valve shows characteristic rheumatic deformity. There is moderate valvular mitral stenosis (area 1.0-1.5cm2). Moderate (2+) mitral regurgitation is seen. IMPRESSION: SEC seen in the right atrium and right atrial appendage with no atrial clot identified. Rheumatic mitral valvular disease with moderate mitral stenosis and moderate mitral regurgitation. CXR ___ 1. Findings which may suggest slight vascular congestion. 2. Streaky multifocal opacities in the lower lungs, suggestive of chronic carring, although acuity is difficult to judge without prior comparisons. Correlation with prior radiographs may be helpful if available. Otherwise, depending on the level of clinical concern for subtle early pneumonia, short-term follow-up radiographs, preferably with PA and lateral technique, if possible, could be considered. Brief Hospital Course: Ms. ___ is a ___ year-old lady with a PMH of hyperlipidemia, rheumatic mitral valve disease with mild-moderate mitral stenosis and mild mitral regurgitation and prior PVCs, who presented with persistent palpitations and was found to be in atrial fibrillation with RVR s/p DCCV. # New atrial fibrillation/flutter: Unclear trigger, no signs of infection or ischemia, two sets of troponin negative, TSH only mildly elevated at 4.3. Time course was also unclear, although patient reported palpitations over the preceding 2 weeks. She was started on heparin and diltiazem drips in ED. Rate control was achieved, warfarin started, diltiazem drip discontinued overnight in favor of PO metoprolol due to asymptomatic SBP ___. Underwent TEE on ___ which showed no evidence of intra-atrial thrombus and subsequent DC cardioversion resulted in successful conversion to normal sinus rhythm. Switched from heparin gtt to lovenox as bridge to warfarin. INR subtherapeutic at 1.6 morning of discharge. . # Acute pulmonary edema: Presented with bibasilar crackles and evidence of vascular congestion on CXR in the setting of afib with RVR 120s-150s. Pt briefly required supplemental oxygen, but was weaned to room air after diuresis with PO lasix and return to NSR. . # TRANSITIONAL ISSUES: - Anticoagulation: Initiated on warfarin this admission, pt to follow up at ___ in ___ for INR check on ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 162 mg PO DAILY 2. Fish Oil (Omega 3) 1000 mg PO DAILY 3. MSM *NF* (methylsulfonylmethane) 1,000 mg Oral daily Discharge Medications: 1. Enoxaparin Sodium 70 mg SC BID RX *enoxaparin 80 mg/0.8 mL 70 mg(s) SC Twice a day Disp #*14 Syringe Refills:*0 2. Aspirin 162 mg PO DAILY 3. Fish Oil (Omega 3) 1000 mg PO DAILY 4. Warfarin 5 mg PO DAILY16 RX *warfarin 1 mg 5 tablet(s) by mouth daily Disp #*150 Tablet Refills:*0 5. MSM *NF* (methylsulfonylmethane) 1,000 mg Oral daily 6. Metoprolol Succinate XL 75 mg PO DAILY RX *metoprolol succinate 25 mg 3 tablet(s) by mouth daily Disp #*90 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: Atrial fibrillation with rapid ventricular response SECONDARY DIAGNOSES: Rheumatic mitral valve disease with stenosis and regurgitation Hyperlipidemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at ___. You were admitted to the hospital for an abnormal heart rhythm called atrial fibrillation. You had a procedure called cardioversion that returned your heart to a normal rhythm and rate. You will need to take a blood thinner from now on to reduce your risk of stroke. You will need to continue injecting lovenox until instructed to stop by the ___ clinic. The ___ clinic will also monitor your labs and help you with your warfarin dosing. Please note the following changes to your medications: START taking: 1. warfarin 2. metoprolol Please see below for your follow-up appointments. Wishing you all the best! Followup Instructions: ___
19805942-DS-17
19,805,942
23,444,000
DS
17
2121-04-27 00:00:00
2121-04-28 15:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: indomethacin / meglumine Attending: ___. Chief Complaint: afib with RVR Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ female with a history of rheumatic mitral valve disease (with MS and MR) and paroxysmal atrial fibrillation (s/p DCCV ___ who presents for recurrent afib with RVR. The patient's first episode of atrial fibrillation was in ___ of this year and she was successfully treated with a TEE cardioversion and started on Coumadin and metoprolol. She has not had any (known) recurrences of afib until today. The patient was in her usual state of health until this morning when she was eating breakfast when she began to feel dizzy, nauseous, weak and a little bit short of breath. She could feel that her heartbeat racing. She presented to her cardiologist Dr. ___ ___ performed an EKG in clinic which demonstrated atrial fibrillation with rapid ventricular response in the 120s. Dr. ___ referred her to the Emergency Room. In the ED, initial vitals were 0 97.9 52 129/74 16 96%. EKG showed sinus bradycardia @ 49 bpm, incomplete RBBB with TWI in V1-V3 (stable from prior EKGs). She was then admitted to the cardiology service for further management. On arrival to the floor, her VS were T 98 HR 51 BP 151/86 RR20 100% on RA. She feels well at the moment and denies any complaints. On review of systems, she denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. She denies recent fevers, chills or rigors. She denies exertional buttock or calf pain. All of the other review of systems were negative. Cardiac review of systems is notable for absence of chest pain, paroxysmal nocturnal dyspnea, orthopnea, syncope or presyncope. She reports some ankle edema that has resolved. Past Medical History: 1. CARDIAC RISK FACTORS: -Diabetes, +Dyslipidemia, -Hypertension 2. CARDIAC HISTORY: -Rheumatic MV disease with mild-mod mitral stenosis and mild mitral regurgitation, echo ___ -Atrial Fibrillation (s/p DCCV ___ -PVCs 3. OTHER PAST MEDICAL HISTORY: - hearing loss - colonic polyp - H/O: hysterectomy - Pseudophakia - s/p cataract surgery ___ Social History: ___ Family History: Mother with DM, HTN, heart disease (pt thinks secondary to Avandia). Father with "valve problem" in his ___, where it "would not shut" all the way. Grandparents lived into their ___. Physical Exam: Admission Physical Exam: VS: T 98 BP 151/86 HR 51 RR 20 100% on RA Wt: 69.3 kg General: NAD, comfortable, pleasant HEENT: NCAT, PERRL, EOMI Neck: supple, no JVD CV: bradycardic rhythm, no m/r/g Lungs: CTAB, no w/r/r Abdomen: soft, NT/ND, BS+ Ext: WWP, no c/c/e, 2+ distal pulses bilaterally Neuro: moving all extremities grossly Discharge Physical Exam: VS: 97.7 46 119/74 18 96% RA Wt: 69kg IOs 8hr: 400/BRP IOs 24hr: 720/250 General: NAD, comfortable, pleasant HEENT: NCAT, PERRL, EOMI Neck: supple, no JVD CV: bradycardic rhythm, no m/r/g Lungs: CTAB, no w/r/r Abdomen: soft, NT/ND, BS+ Ext: WWP, no c/c/e, 2+ distal pulses bilaterally Neuro: moving all extremities grossly Pertinent Results: Admission Labs: ___ 03:25PM BLOOD WBC-5.0 RBC-4.56 Hgb-13.6 Hct-39.6 MCV-87 MCH-29.8 MCHC-34.4 RDW-12.7 Plt ___ ___ 03:25PM BLOOD Neuts-48.7* Lymphs-44.3* Monos-5.7 Eos-0.7 Baso-0.7 ___ 03:25PM BLOOD ___ PTT-58.2* ___ ___ 03:25PM BLOOD Glucose-90 UreaN-10 Creat-0.8 Na-140 K-4.0 Cl-106 HCO3-28 AnGap-10 ___ 03:25PM BLOOD GreenHd-HOLD Discharge Labs: ___ 05:00AM BLOOD WBC-5.4 RBC-4.44 Hgb-13.7 Hct-38.7 MCV-87 MCH-30.9 MCHC-35.4* RDW-12.7 Plt ___ ___ 05:00AM BLOOD Plt ___ ___ 05:00AM BLOOD ___ PTT-44.7* ___ ___ 05:00AM BLOOD Glucose-87 UreaN-20 Creat-0.8 Na-142 K-4.0 Cl-106 HCO3-28 AnGap-12 ___ 05:00AM BLOOD Calcium-8.8 Phos-4.7* Mg-2.1 Imaging: Echo ___ EXERCISE ECG AND HEMODYNAMIC DATA: Utilizing the standard ___ protocol the patient was exercised for 7:24 minutes, achieving a maximum heart rate of 152 bpm , which is 97% of predicted maximal heart rate. The target heart rate was 85% of age predicted maximal heart rate and was acheived during the test. The peak BP was 152/92 mmHG with a rate pressure product of 23,100. The tested was stopped due to general fatigue and foot fatigue. The patient had no symptoms during the test. The patient had no chest pain. There were normal blood pressure and heart rate responses to stress. In response to stress, the ECG showed no ST-T wave changes (see exercise report for details). POST STRESS IMAGING: Post exercise imaging was obtained at rates between 138 bpm and 111 bpm. All exercise images, including continuous capture, were reviewed. After exercise, echo images demonstrated appropriate augmentation of all left ventricular segments with systolic decrease in LV cavity size. Post exercise stress images show hyperdynamic global LV systolic function. CONCLUSIONS 1. The left atrial volume is severely increased. 2. The aortic valve is trileaflet and is mildly thickened. There is trace-to-mild aortic regurgitation. There is no evidence of aortic stenosis. 3. The mitral valve leaflets are thickened, with tethering of the leaflet tips, dense focal calcification at the tip of the anterior mitral leafletand adjoining chordate, and diastolic doming of the anterior leaflet, consistent with rheumatic mitral valve disease. Mild mitral regurgitation is present. The peak transvalvular velocity is 1.5 m/sec, with peak/mean gradients of 9 / 4 mm Hg. The Mitral valve area by PHT is 1.3 cm2. The Mtiral valve area by panimetry is 1.7 cm2. 4. Tricuspid valve appears structurally and functionally normal. Trace regurgitation is seen. Normal PA systolic pressure, estimated at 23 mmHg above RA pressure. 5. Ventricular chamber sizes, wall thicknesses, and resting contraction are normal. 6. No prior report available for comparison. 7. No 2D echocardiographic evidence of inducible ischemia at the level of stress achieved. Rest images show evidence of rheumatic valvular disease. Message sent to Dr. ___. TEE ___ IMPRESSION: SEC seen in the right atrium and right atrial appendage with no atrial clot identified. Rheumatic mitral valvular disease with moderate mitral stenosis and moderate mitral regurgitation EKG ___ (Intern Read): Sinus bradycardia at 49. Left atial enlargement. Incomplete RBBB with TWI in V1-V3 (stable from previous EKGs). CXR ___ FRONTAL AND LATERAL VIEWS OF THE CHEST: The heart size remains mildly enlarged. The previously seen pulmonary edema has entirely resolved. There is no pleural effusion, pneumothorax or focal airspace consolidation. The mediastinal and hilar structures are unremarkable. Brief Hospital Course: Ms. ___ is a ___ female with a history of rheumatic mitral valve disease (with MS and MR) and paroxysmal atrial fibrillation (s/p DCCV ___ who presents for recurrent afib with RVR. ACTIVE ISSUES: # Paroxysmal Atrial Fibrillation: The patient had symptomatic afib with RVR at her Cardiologist's office prior to admission, but she had spontaneously converted back into sinus rhythm by the time she arrived in the ER. There is no evidence in her history to suggest an illness that might have triggered her to go back into afib. She appears clinically euvolemic without evidence of heart failure. She was seen by EP, who recommended decreasing her Metoprolol Succinate from 50 to 25mg daily and then adding Metoprolol Tartrate 25mg PRN rapid heart beat. #Supra-therapeutic INR INR 4.5 on admission. Coumadin was held. She was discharged on 3mg daily with INR follow-up. TRANSITIONAL ISSUES: []Patient discharged on 3mg Coumadin. Needs INR check on ___ at her ___. # CODE: Full Code # EMERGENCY CONTACT: ___ (daughter) - ___, ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 162 mg PO DAILY 2. Warfarin 4 mg PO DAYS (___) 3. Metoprolol Succinate XL 50 mg PO DAILY 4. Warfarin 2.5 mg PO DAYS (WE,TH,FR) 5. Fish Oil (Omega 3) 1000 mg PO BID 6. MSM (methylsulfonylmethane) 1,000 mg Oral daily Discharge Medications: 1. Aspirin 162 mg PO DAILY 2. Fish Oil (Omega 3) 1000 mg PO BID 3. MSM (methylsulfonylmethane) 1,000 mg Oral daily 4. Warfarin 3 mg PO DAILY16 RX *warfarin [Coumadin] 1 mg 3 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Outpatient Lab Work Patient will need INR drawn on ___ at her ___ ___. Results should be faxed to ___. 6. Metoprolol Succinate XL 25 mg PO DAILY 7. Metoprolol Tartrate 25 mg PO DAILY:PRN rapid heart beat RX *metoprolol tartrate 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Atrial Fibrillation Rheumatic Heart Disease Mitral Stenosis Mitral Regurgitation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, It was a pleasure taking care of you at ___. You were admitted because you had a rapid heart rate and you were seen by your cardiologist. You did not have a rapid heart rate and were asymptomatic in the hospital. You were also seen by the electrophysiology (EP) doctors who recommended ___ your Long-acting Metoprolol Succinate (Toprol XL) from 50mg to 25mg daily. If you have symptoms of a rapid heart beat, then you should take 1 dose of short acting Metoprolol (Metoprolol Tartrate). We held your Coumadin since your INR was elevated. You should take 3mg Coumadin over the weekend and have your INR checked at ___ Anticoagulation Program on ___. Followup Instructions: ___
19805942-DS-18
19,805,942
25,183,245
DS
18
2125-05-10 00:00:00
2125-05-10 21:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: indomethacin / meglumine Attending: ___ Chief Complaint: Palpitations Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ year-old female with a past medical history of rheumatic heart disease with moderate mitral regurgitation and mild mitral stenosis, paroxysmal atrial fibrillation, and hyperlipidemia. Initially diagnosed with AF w/ RVR in ___ s/p TEE DCCV. The patient has had longstanding paroxysmal atrial fibrillation and cardioverts on her own. She had an episode of palpitations in ___ which lasted for approximately 3 hours but terminated just prior to her presentation to the ED. Earlier this year she reported an increase in palpitations. In ___ patient was prescribed flecainide 50mg BID per EP but never started taking it. Since ___ night she had experienced palpitations with a sense of intermittent chest discomfort described as a sharp sensation and intermittent mild shortness of breath along with a mild headache. Palpitations have been constant since that time. Took flecainide yesterday x2 (has not been taking but was prescribed in ___ by Dr. ___, this is the first time she has ever taken it) reports that did not help palpitations. Took other meds as scheduled including metoprolol and warfarin. Symptoms have persisted and she had seen her primary cardiologist this AM, noted her to be in atrial fibrillation with increased ventricular rates and low normal blood pressure along with her symptoms as described above. Given her continuing symptoms, along with atrial fibrillation with increased ventricular rates, the decision was made to pursue cardioversion by the emergency room staff on an urgent basis. She denies any chest pain, shortness of breath, orthopnea, PND, ___ edema, or claudication. [x] cardioversion: 100J, one shock. 10mg etomidate, no complications. Post-cardioversion EKG: NSR @ 55, STD in V1-2 CWP In the ED, initial vitals were 98.7 145 117/83 22 98% RA EKG showed af w/ RVR, and stable t wave inversions in v1,v2,v3 HR @140. Vitals on transfer: 97.3 69 109/49 24 97% RA. Labs notable for 3.3, K 4.2 Patient was given: ___ 12:59 IV Metoprolol Tartrate 5 mg ___ 12:59 PO Metoprolol Tartrate 25 mg ___ 14:38 IV Prochlorperazine 10 mg Atrius cardiology consulted. REVIEW OF SYSTEMS: Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, syncope, or presyncope. Past Medical History: 1. CARDIAC RISK FACTORS: -Diabetes, +Dyslipidemia, -Hypertension 2. CARDIAC HISTORY: -Rheumatic MV disease with mild-mod mitral stenosis and mild mitral regurgitation, echo ___ -Atrial Fibrillation (s/p DCCV ___ -PVCs 3. OTHER PAST MEDICAL HISTORY: - hearing loss - colonic polyp - H/O: hysterectomy - Pseudophakia - s/p cataract surgery ___ Social History: ___ Family History: Mother with DM, HTN, heart disease (pt thinks secondary to Avandia). Father with "valve problem" in his ___, where it "would not shut" all the way. Grandparents lived into their ___. Physical Exam: ADMISSION PHYSICAL ================== VS: 97.4PO, 125 / 66, R Lying 61 16 99 RA GENERAL: NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVD at 5-6cm CARDIAC: PMI located in ___ intercostal space, midclavicular line. RRR, normal S1, S2. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. No femoral bruits. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric DISCHARGE ========== VS: 97.9 PO 101 / 67 R Lying 61 20 91 RA GENERAL: NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVD at 5-6cm CARDIAC: PMI located in ___ intercostal space, midclavicular line. RRR, normal S1, S2. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. No femoral bruits. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric Pertinent Results: ADMISSION LABS ============ ___ 12:45PM BLOOD WBC-7.6 RBC-4.72 Hgb-14.1 Hct-42.4 MCV-90 MCH-29.9 MCHC-33.3 RDW-12.6 RDWSD-41.6 Plt ___ ___ 12:45PM BLOOD Neuts-50.1 ___ Monos-7.8 Eos-0.7* Baso-0.3 Im ___ AbsNeut-3.82# AbsLymp-3.10 AbsMono-0.59 AbsEos-0.05 AbsBaso-0.02 ___ 12:45PM BLOOD Glucose-97 UreaN-13 Creat-0.9 Na-135 K-6.5* Cl-98 HCO3-25 AnGap-12 ___ 12:45PM BLOOD CK(CPK)-69 ___ 12:45PM BLOOD CK-MB-1 cTropnT-<0.01 ___ 12:45PM BLOOD Calcium-8.6 Phos-3.9 Mg-2.0 ___ 12:45PM BLOOD TSH-3.2 ___ 12:45PM BLOOD Free T4-1.4 DISCHARGE LABS ============== ___ 06:40AM BLOOD WBC-5.1 RBC-4.09 Hgb-12.1 Hct-36.7 MCV-90 MCH-29.6 MCHC-33.0 RDW-12.5 RDWSD-40.9 Plt ___ ___ 06:40AM BLOOD Glucose-94 UreaN-14 Creat-0.8 Na-142 K-5.3* Cl-105 HCO3-26 AnGap-11 ___ 06:40AM BLOOD Calcium-9.0 Phos-4.3 Mg-2.1 MICRO ===== UCx NGTD IMAGING ======= CXR ___ No acute pathology Brief Hospital Course: Ms. ___ is a ___ year-old female with a past medical history of rheumatic heart disease with moderate mitral regurgitation and mild mitral stenosis, paroxysmal atrial fibrillation, hyperlipidemia, AF w/ RVR in ___ s/p TEE DCCV on metop presenting with palpitations. #Afib with RVR: Symptoms of palpitations, intermittent chest discomfort, mild shortness of breath started ___. Patient went to outpatient cardiologist, was found to be in atrial fibrillation with increased ventricular rate, normal-low blood pressure, therapeutic INR. Patient was sent to ED for better control. In ED, patient was cardioverted at 100J, one shock followed by 10mg etomidate, no complications. She was admitted for observation. EP team consulted for further management and recommended flecainide only after CAD/structural heart disease ruled out properly. Patient wanted to continue the conversation with her cardiologist and PCP as outpatient before committing herself to further imaging or procedures. No medication changes on discharge. Of note, patient was prescribed flecainide by ___ clinic in ___ but never took this medication. Patient should be continued on Coumadin since DOACs not well studied in patients with more than mild MS. - continued metoprolol 25mg XL daily today, continued on Coumadin, daily dose is 2 mg on ___ 3 mg all other days #Rheumatic heart disease: Mild mitral regurgitation at rest, mild to moderate mitral stenosis in the setting of rheumatic heart disease seen on Echo in ___. Likely has resulted in her afib given the atrial strain associated with prolonged mitral stenosis/regurg. No evidence of volume overload. #Dyslipidemia: Continued pravastatin 10 mg tablet daily #Osteoporosis: Continued home vitamin D TRANSITIONAL ISSUE ================= [ ] Will be started on an anti-arhythmic medication as an outpatient. CAD must be ruled out prior to starting flecainide. #CODE STATUS: Full (presumed) #CONTACT: Name of health care proxy: ___ Phone number: ___ Comments: Pt would like her ___ to be contacted in emergency ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 25 mg PO DAILY 2. Pravastatin 10 mg PO QPM ___ MD to order daily dose PO DAILY16 4. Vitamin D 1000 UNIT PO DAILY Discharge Medications: 1. Metoprolol Succinate XL 25 mg PO DAILY 2. Pravastatin 10 mg PO QPM 3. Vitamin D 1000 UNIT PO DAILY 4. ___ MD to order daily dose PO DAILY16 ___ - 2mg ___- 3mg Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis ================= Atrial fibrillation with rapid ventricular response Atrial fibrillation Secondary diagnosis =================== Rheumatic heart disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you here at ___. What happened while you were in the hospital? - You presented to the emergency department with worsening palpitations. - In the emergency department you were found to have atrial fibrillation with rapid ventricular response, or AF with RVR. This is when your heart starts to be irregularly and very fast. You were given medication to control your heart rate and you were also cardioverted. Your rhythm returned to normal after the cardioversion. - The electrophysiology (EP) team was consulted to help guide further management. They recommended starting the medication Flecainide. Prior to doing this, it is important to rule out any coronary artery disease or heart disease or else it can be dangerous to take Flecainide. Further management regarding your heart rate will be done as an outpatient. What to do on discharge? - Continue to take all your medications as prescribed except flecainide. Do not take this medication until you meet with your cardiologist. Your cardiologist may refer you to an EP doctor. - If you experience any chest pain, palpitations, lightheadedness, please return to the emergency department. - Please follow up with your cardiologist and primary care doctor. We are happy to see you feeling better. Sincerely, Your ___ team Followup Instructions: ___
19806522-DS-17
19,806,522
20,606,850
DS
17
2155-02-20 00:00:00
2155-02-20 21:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Fall, Seizure, Acute Renal Failure Major Surgical or Invasive Procedure: None. History of Present Illness: ___ year old Male who presents from nursing home after unwitnessed fall. The patient had been in his ususal state of health and mental status, when the nurse heard him fall, and discovered the patient on the floor of his room with a right sided head laceration. By report he had no loss of bowel or bladded continence, and while his hands and mouth were twitching, his mental status was at baseline. The patient was tachycardic in the 120s and hypertensive to the 180s. Oxygen was given to the patient, although he was not hypoxemic. There was no prodrome prior to the fall, and he did not note anything wrong prior to the event, although he is poorly oriented and limited in his verbal expression. On arrival to the ___ ED, he was noted with his baseline mental status, answering simple questions with "I'm Fine" and responding to name only. He was noted in acute renal failure. Head, Neck, Chest and abdominal CTs were obtained, which demonstrated severe bullous emphysema, a thyroid nodule and a left adrenal nodule. While in the ED he experienced a witnessed tonic/clonic seizure, although had no post-ictal state that could be noted (although with his limited baseline, this may have been masked). There was concern from the ED staff, that he aspirated during the event. Overnight he was given 500cc of IVF for probably hypovolemia. He reports today that he is OK and denies any problems. Past Medical History: Schizophrenia HTN (Baseline BPs in the 120s-130s/60s-70s) Enucleated L eye Positive PPD Type 2 DM Social History: ___ Family History: Unable to obtain Physical Exam: Admission: Vitals: 100.7 131/44 110 18 98% RA ___ 146 General: Alert, oriented x1, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI in R eye,L eye socket closed, difficult to assess pupillary response in R given cataract Neck: supple, JVP not elevated, no LAD or bruits CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi but difficult to auscultate Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: no foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, brisk cap refill Neuro: Oriented to person and that he is in a hospital. CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred. Skin: 6 cm laceration on R scalp, crusted blood noted, closed with staples. Discharge: Vitals: 98 141/55 66 18 99% RA General: Alert, oriented x1, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI in R eye, L eye socket closed Neck: supple, JVP not elevated CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: no foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, brisk cap refill Neuro: Oriented to person. Able identify and distinguish between 2 and 3 fingers. Skin: 6 cm laceration on R scalp, crusted blood noted, closed with staples, healing well. Pertinent Results: ___ 06:25AM BLOOD WBC-8.4 RBC-3.52* Hgb-10.7* Hct-31.7* MCV-90 MCH-30.5 MCHC-33.8 RDW-12.7 Plt ___ ___ 10:55AM BLOOD WBC-9.1 RBC-4.12* Hgb-12.4* Hct-38.0* MCV-92 MCH-30.2 MCHC-32.8 RDW-13.0 Plt ___ ___ 10:55AM BLOOD Neuts-66.8 ___ Monos-4.5 Eos-1.7 Baso-0.7 ___ 06:25AM BLOOD Glucose-69* UreaN-17 Creat-1.1 Na-139 K-3.3 Cl-100 HCO3-27 AnGap-15 ___ 10:55AM BLOOD Glucose-208* UreaN-23* Creat-1.4* Na-135 K-4.0 Cl-96 HCO3-22 AnGap-21* ___ 06:25AM BLOOD CK(CPK)-224 ___ 07:20PM BLOOD CK(CPK)-123 ___ 10:55AM BLOOD ALT-12 CK(CPK)-58 AlkPhos-69 TotBili-0.3 ___ 06:25AM BLOOD CK-MB-3 cTropnT-<0.01 ___ 07:20PM BLOOD CK-MB-3 cTropnT-<0.01 ___ 10:55AM BLOOD cTropnT-<0.01 ___ 10:55AM BLOOD CK-MB-2 ___ 06:25AM BLOOD Albumin-3.6 Calcium-8.7 Phos-2.5* Mg-1.8 ___ 12:04PM URINE Color-Yellow Appear-Clear Sp ___ ___ 12:04PM URINE Blood-LG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG ___ 12:04PM URINE RBC-54* WBC-2 Bacteri-NONE Yeast-NONE Epi-0 ___ 12:04PM URINE Mucous-RARE ___ 06:07PM URINE Hours-RANDOM Creat-41 Na-71 K-55 Cl-101 ___ 12:04 pm URINE URINE CULTURE: Neg ___ 10:55 am BLOOD CULTURE Source: Venipuncture #1. Blood Culture, Routine (Pending): CT HEAD W/O CONTRAST Study Date of ___ 11:03 AM IMPRESSION: No evidence of acute intracranial process. CT C-SPINE W/O CONTRAST Study Date of ___ 11:05 AM IMPRESSION: 1. No evidence of acute cervical spinal fracture or malalignment. 2. Large right apical bleb. Left apical blebs and scarring. CT ABD & PELVIS WITH CONTRAST Study Date of ___ 12:28 ___ IMPRESSION: 1. No acute process. 2. Severe emphysema with large right apical bullae. 3. Atherosclerotic disease of the aorta without evidence of aneurysm. Severe calcification at the origin of the left renal artery and bilateral external iliac arteries likely causing flow limiting stenosis but not well assessed on this non-angiographic study. 4. Nodular hyperplasia of the left adrenal gland. CHEST (PORTABLE AP) Study Date of ___ 5:26 ___ FINDINGS: Biapical bullous emphysema is present with adjacent scarring. Lungs are otherwise clear. Heart size, mediastinal and hilar contours are normal. EKG ___: Sinus rhythm. Right bundle-branch block. J point elevation in the anterolateral leads which may be due to early repolarization but cannot exclude ischemic process. Clinical correlation is suggested. Compared to tracing #1 ST segment elevation appears more prominent and the heart rate is slower. Discharge: ___ 06:10AM BLOOD WBC-7.8 RBC-3.69* Hgb-11.5* Hct-33.7* MCV-91 MCH-31.3 MCHC-34.3 RDW-12.8 Plt ___ ___ 06:10AM BLOOD Glucose-96 UreaN-12 Creat-1.1 Na-141 K-3.9 Cl-104 HCO3-29 AnGap-12 ___ 06:10AM BLOOD Calcium-9.3 Phos-2.9 Mg-1.9 ___ 06:05AM BLOOD TSH-1.5 Brief Hospital Course: This is an ___ yo M w/ a history of DMII, hypertension, and schizophrenia who presented from a nursing home with an unwitnessed fall and subsequent self-limited convulsive episode in the ED, with possible aspiration, admitted for monitoring and syncope work-up. # Syncope vs. mechanical fall: Unclear circumstances of what occurred. Per discussion w/ nurse from nursing home, sounds like it could have been either a mechanical fall, syncope, or a seizure (event in ED appears to have been a true self-limited seizure episode). There was low concern for a primary cardiac cause for the syncope: EKG consistent with RBB, no evidence of other blocks on telemetry and no other significant arrythmias seen. No evidence of significant structural heart disease on exam. Troponins were negative. Neurocardiogenic causes are possible but impossible to disentangle given absence of history. Orthostatis is possible but he was hypertensive during the event. Later in the admission,he technically met criteria for orthostatics by HR and answered "yes" to dizziness but the meaning of his answers have been difficult to asses (A+0x1 at baseline) and his BP did not drop significantly, so overall low concern for orthostasis. No bruits on exam to suggest a carotid etiology. A primary seizure event is possible, though myoclonic movements can be seen in syncope - seizure event in ED was most likely post-traumatic per neurology (see below). It is also quite likely that this was simply a mechanical fall (he has fallen before). His hydration status was maintained, monitored on telemetry. He was kept on fall precautions. Attempts were made to acquire medical records from his PCP but were unsuccessful. If he has not had an echocardiogram, TTE as an outpatient would complete the workup but likely to be low-yield. He should be assessed carefully by ___ at rehab for ambulation safety. Given that he has only one eye, with a cataract and DM, he should be referred back to his ophthalmologist for a vision exam as declining vision could contribute to falls. At discharge he still had staples in place. # Seizure in the ED: Self-limited, ~60 sec. He was seen by neurology who felt this was likely to be post-traumatic in origin. No known seizure disorder or obvious etiologies on initialy work-up. CT head was negative. EEG with frontal and temporal slowing (possibly indicating dementia) preliminarily but final read pending at discharge. B12/RPR/TSH were sent for a dementia workup He was maintained on seizure and aspiration precautions, and started on a one week course of prophylactic Keppra 500 mg BID (day 1 = ___. He will followup with neurology in clinic. # Dementia: Per discussion with nurse from nursing home, his current mental status (communicative, answers questions with answers of uncertain meaningfulness, A+Ox1) appears to be at his baseline. Soft two point restraints initially were used for safety and fall prevention while in bed but he was able to sit in a chair in the work area under observation. He was given one dose of 2.5 mg Zyprexa overnight when he continued to try to get out of bed. # Possible aspiration event: Occured during seizure in the ED. Was never hypoxic on the floor, and CXR had no evidence of pneumonitis. He was given a diet as recommended by speech and swallow and maintained on aspiration precautions. # Acute Renal Failure: Cr 1.4 on admission. Likely pre-renal as it resolved with hydration. # Type 2 Diabetes controlled with Complications: Not on insulin. Unclear if hypoglycemia could have contributed to presentation (on glipizide, sugars not checked at the time) but sugars during admission were well-controlled. A1c within normal limits. His home diabetes meds were held on admission and he was maintained on an insulin sliding scale. He was given a diabetic diet and his home meds were restarted at discharge. He should have yearly followup with a podiatrist (corns seen on his feet) and ophthalmologist. # Benign Hypertension: Appears well-controlled for the most part at baseline. Hypertensive to 180/80 during initial event. His home antihypertensives were held while admitted as he was normotensive. They were restarted at discharge. # Schizophrenia: Not on any anti-psychotic medication at baseline. He got one dose of zyprexa as above. No changes were made. # COPD: Looks like severe emphysema with prominent apical blebs/bullae but no known history of lung disease. It may not be necessary to refer him to pulmonology as he is apparently asymptomatic and oxygenates well on room air. A referral to pulmonary would be indicated if he were to become symptomatic. #Peripheral Vascular Disease: "Severe calcification at the origin of the left renal artery and bilateral external liac arteries likely causing flow limiting stenosis but not well assessed on this non-angiographic study, as well as nodular hyperplasia of the left adrenal gland". He does not have any obvious manifestations of peripheral vascular disease. If he were to develop any, appropriate followup would be indicated. His unilateral renal artery stenosis could be contributing to his hypertension so could consider referral for further workup if thought to be appropriate. This is not a contraindication to ACE-I therapy. The adrenal finding is likely not clinically significant. He does not have any evidence of adrenal hyperplasia. It could be followed up if clinically concerned. Transitional issues: - He should follow up with neurology in clinic. - He is being discharged on 1 week of Keppra 500 mg BID, day 1 = ___ (last day ___ - If he were to become symptomatic from a pulmonary perspective, he should be referred to pulmonology - If he has not had a echocardiogram recently, consider getting a TTE to complete syncope workup, though unlikely to be high yield given absence of sigmata of structural heart disease or CHF - He should be evaluated by ___ at rehab for ambulatory safety and need for any assist devices - The final read of his EEG was pending at discharge and should be followed up - B12/RPR were pending at discharge and should be followed up - He should be reminded to rise slowly from sitting and should stay hydrated (goal 2L fluids daily) - Staples should be removed from scalp sometime between ___ - His incidental findings on CT (L renal artery stenosis, bilateral iliac stenosis, and severe radiographic emphysema) should be followed up as clinically indicated Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Bacitracin Ophthalmic Oint 1 Appl LEFT EYE DAILY 2. Triamterene-Hydrochlorothiazide 1 CAP PO DAILY 3. Potassium Chloride 20 mEq PO DAILY 4. Docusate Sodium 200 mg PO DAILY 5. Lisinopril 2.5 mg PO DAILY 6. GlipiZIDE 10 mg PO BID 7. MetFORMIN (Glucophage) 500 mg PO BID 8. Guaifenesin 15 mL PO Q4H:PRN cough 9. Acetaminophen 325 mg PO Q4H:PRN pain 10. calamine *NF* per rectum Miscellaneous prn itching hemorrhoids Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary diagnoses: Fall Seizure Secondary diagnoses: Diabetes Hypertension Schizophrenia Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___: It was a pleasure caring for you at ___. You were admitted after falling at your nursing home. We are still unsure why you fell but do not think it was related to your heart. One possibility is that you got dizzy when standing up: You should remain hydrated and rise slowly from sitting. Another possibility is that your vision has been worsening: we want you to see your ophthalmologist and have your vision rechecked. You also had a seizure in the emergency room. We think this was a result of hitting your head after falling. We are discharging you with a medication called Keppra, which you should take for 5 more days. We also want you to followup with the neurology specialists in their clinic. The staples in your scalp should be removed sometime between ___ Please take all of your medications as prescribed. Followup Instructions: ___
19806781-DS-15
19,806,781
22,246,486
DS
15
2116-01-30 00:00:00
2116-02-01 08:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Levaquin / Vancomycin / Sulfa (Sulfonamide Antibiotics) / Shellfish Derived / Iodine-Iodine Containing / Prochlorperazine Maleate / Cartia XT / Cipro / Seroquel / clonazepam / Reglan Attending: ___. Chief Complaint: Tachycardia, n/v, epigastric pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ F with HTN, HL and well controllled asthma who presents with 10 days of sinus tachycardia, nausea/vomiting, and epigastric pain. A week ago she went to an OSH with sinus tachycardia and hypokalemia (2.5 per patient). They repleted her potassium and discharged her. She followed up with her PCP and stopped her HCTZ, adderall, and claritin. She scheduled a stress test for today. However, walking to the stress test she got tachycardic to the 160s was sent to the ED. In the ED, initial VS were: T 98.7 HR 142 BP 131/87 RR18 O2 sat95%. She appeared tremulous, agitated, diaphoretic and warm. There was no thyromegaly or nodules on thyroid exam. She had no proptosis, lid lag, rales, peripheral edema or JVD. A CXR did not show any evidence of an acute process. She received 2 L of NS in the ED and Propranolol 10 mg PO. She c/o anxiety, palpitations, heat-intolerance, eye discomfort, hand tremors, join aches, depressed mood, epigastric pain, and swelling for 2 weeks. She reports a 15 lb weight loss in a month. She has also noticed an erythematous and pruritc rash over her chest and back of her arms for the last month (including when she was on claritin). Denies recent albuterol use, fever, chills, AMS, diarrhea, abdominal pain, neck pain, voice changes or dysphagia. Denies history of neck radiation. Labs were notable for TSH of <0.2 and free T4 of 2.4. Tox screen was negative. On arrival to the MICU, the patient was alert, oriented, and in no acute distress. Her HR was in the ___ s/p 10 mg of propranolol. Review of systems: (+) Per HPI (-) Denies fever, chills, or night sweats. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath, or wheezing. Denies chest pain, chest pressure or weakness. Denies constipation. Denies dysuria, frequency, or urgency. Denies arthralgias or myalgias. Denies rashes or skin changes. Past Medical History: Cervical Cancer s/p hysterectomy HYPERLIPIDEMIA HYPERTENSION DEPRESSION Asthma- well controlled DEGENERATIVE DISC DISEASE s/p surgery CRUSH INJURY RIGHT FOOT NARCOTIC CONTRACT IN CHART H/O ACUTE RENAL FAILURE H/O RETINAL DETACHMENT *S/P APPENDECTOMY *S/P ___ FUNDOPLICATION *S/P TONSILLECTOMY & ADENOIDECTOMY Social History: ___ Family History: Sister- hypothyroidism Physical ___: Physical Exam on Admission: Vitals: T98.6, HR106, BP133/74, RR26, O2sat: 99% General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL. mild proptosis R>L. No lid lag. No enlarged thyroid, non tender, no palpable nodules. Neck: supple, JVP not elevated, no LAD. ___ erythematous rash across chest and back of arms. CV: Tachycardic, regular rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly. Surgical scars. GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. Right foot with surgical scars. Neuro: CNII-XII intact. Mildy hypereflexive in upper extremities. Physical Exam on Discharge: Vitals: T:98.6 HR:106 BP125/71, RR22 O2sat:94%RA Exam otherwise unchanged from admission Pertinent Results: Lab results on admission: ___ 06:00PM BLOOD WBC-6.2 RBC-4.19* Hgb-12.9 Hct-37.6 MCV-90 MCH-30.7 MCHC-34.2 RDW-12.8 Plt ___ ___ 06:00PM BLOOD Neuts-75.0* Lymphs-12.3* Monos-9.2 Eos-3.1 Baso-0.5 ___ 06:00PM BLOOD ___ PTT-28.3 ___ ___ 02:15PM BLOOD Na-141 K-4.2 Cl-103 ___ 06:00PM BLOOD Glucose-104* UreaN-14 Creat-0.6 Na-138 K-3.5 Cl-105 HCO3-20* AnGap-17 ___ 06:00PM BLOOD ALT-35 AST-26 AlkPhos-51 TotBili-0.2 ___ 02:15PM BLOOD Mg-2.3 ___ 06:00PM BLOOD Albumin-4.4 ___ 04:21AM BLOOD Calcium-8.8 Phos-3.5 Mg-2.2 ___ 02:15PM BLOOD TSH-<0.02* ___ 02:15PM BLOOD Free T4-2.4* Lab Results on Discharge: ___ 04:21AM BLOOD WBC-4.2 RBC-3.64* Hgb-11.3* Hct-32.4* MCV-89 MCH-31.1 MCHC-34.9 RDW-13.0 Plt ___ ___ 04:21AM BLOOD Plt ___ ___ 04:21AM BLOOD Glucose-95 UreaN-12 Creat-0.5 Na-140 K-3.5 Cl-110* HCO3-24 AnGap-10 ___ 04:21AM BLOOD CK(CPK)-54 ___ 11:15AM BLOOD T4-11.8 T3-179 ___ 06:00PM BLOOD Anti-Tg-PND Thyrogl-PND antiTPO-PND ___ 06:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG Imaging: CXR ___: No evidence of acute disease. Moderate hiatal hernia. Thyroid Scan Technetium ___: Globally decreased tracer uptake in the thyroid gland compatible with sub-acute thyroiditis. Brief Hospital Course: ___ yo woman who presented with tachycardia, agitation, and n/v in the setting of a decreased TSH and elevated free T4 c/w thyrotoxicosis and hyperthyroidism. ACUTE CARE # Tachycardia/Hyperthyroidism: Her decreased TSH (<0.2) and increased free T4 (2.4) suggest a hyperthyroid state. Endocrinology had a low suspicion for thyroid storm given her history and physical exam with no overt signs of heart failure at this point. The most likely etiology of her hyperthyroidism is thyroiditis given findings of uptake scan. The patient was started on Propanolol 10mg q6h PRN heart rate. The patient's thyroid antibodies were pending at time of discharge. The patient will have repeat thyroid function tests in one week to monitor her course, and she should have follow up regarding her thyroid function, ideally with endocrinology or with her PCP. There is no indication for treatment with PTU in the setting of thyroiditis. CHRONIC CARE # Hypokalemia: Reports taking Potassium chloride 10 mEq as an outpatient before this past month of symptoms. At the OSH she was reported to be hypokalemic. On admission her potassium was 4.2. She has been taking KCl since she presented to the OSH one week ago. Possibly secondary to increased catecholamines from the thyroid storm leading to intracellular shift of postassium. ___ also be exacerbated by hydrochlorothiazide and salmeterol. # Nausea: Presented witn nausea and vomiting. Cont home Zofran PRN nausea # Asthma: Well controlled. She was asked to hold this medication at time of discharge due to hypokalemia, tachycardia. She may continue the fluticasone. # Hypertension: Not hypertensive on admission. As patient is starting propanolol, asked her to stop her hydrochlorothiazide but to continue Benicar. As well, the patient reports hypokalemia, which is likely exacerbated in the setting of hydrochlorothiazide. # Hyperlipidemia: Hold resuvastatin for now # Depression: Has been on buproprion for years with good results but reports that her mood has been down over the last few weeks since she has been feeling fatigued. Continue home Buproprion HCl XL 300 mg daily # Neuropathic pain: After her accident ___ years ago she has had difficulty with neuropathic pain in her back and legs. Continue home gabapentin and cymbalta. Has not been taking hydrocodone- acetaminophen for the last few weeks. # GERD: s/p ___ fundoplication. Continue home omeprazole ISSUES OF TRANSITIONS IN CARE # Code: Full (confirmed) # Contacts: Husband ___ ___, daughter ___ ___ ___. # ___ Studies: thyroid antibodies # Issues to discuss at follow up: - improvement in thyroid function tests - use of propanolol. Address restarting hydrochlorothiazide. - Hypokalemia: asked patient to avoid using salmeterol, hydrochlorothiazide. Medications on Admission: Preadmission medications listed are correct and complete. Information was obtained from PatientwebOMR. 1. Ondansetron 4 mg PO BID:PRN nausea 2. Epinephrine 1:1000 0.3 mg IM ONCE:PRN anaphylaxis 3. olmesartan *NF* 20 mg Oral daily 4. Amphetamine Salt Combo *NF* (amphetamine-dextroamphetamine) 20 mg Oral BID 1 tablet in AM, 1 table at noon 5. Amphetamine Salt Combo *NF* (amphetamine-dextroamphetamine) 10 mg Oral DAILY In ___ 6. Gabapentin 100 mg PO TID 7. Duloxetine 20 mg PO DAILY 8. Lorazepam 1 mg PO HS at bedtime 9. Rosuvastatin Calcium 40 mg PO DAILY 10. Fluticasone Propionate 110mcg 2 PUFF IH DAILY 11. Hydrocodone-Acetaminophen (5mg-500mg) 1 TAB PO Q6H:PRN pain 12. Omeprazole 20 mg PO DAILY with breakfast 13. Potassium Chloride 10 mEq PO DAILY Duration: 24 Hours 14. BuPROPion 300 mg PO DAILY 15. Hydrochlorothiazide 12.5 mg PO DAILY 16. Salmeterol Xinafoate Diskus (50 mcg) 1 INH IH Q12H Discharge Medications: 1. Outpatient Lab Work Please have your TSH, Free T4 checked on ___. Please have the results faxed to Dr ___, ___ and to Dr. ___ at ___. 2. BuPROPion 300 mg PO DAILY 3. Duloxetine 20 mg PO DAILY 4. Fluticasone Propionate 110mcg 2 PUFF IH DAILY 5. Gabapentin 100 mg PO TID 6. Lorazepam 1 mg PO HS 7. Omeprazole 20 mg PO DAILY with breakfast 8. Ondansetron 4 mg PO BID:PRN nausea 9. Epinephrine 1:1000 0.3 mg IM ONCE:PRN anaphylaxis 10. Hydrocodone-Acetaminophen (5mg-500mg) 1 TAB PO Q6H:PRN pain 11. olmesartan *NF* 20 mg Oral daily 12. Potassium Chloride 10 mEq PO DAILY Duration: 24 Hours 13. Rosuvastatin Calcium 40 mg PO DAILY 14. Salmeterol Xinafoate Diskus (50 mcg) 1 INH IH Q12H 15. Propranolol 10 mg PO Q6H RX *propranolol 10 mg 1 tablet(s) by mouth every six (6) hours Disp #*60 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: primary diagnosis: thyroiditis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, ___ was a pleasure taking care of you at the ___ ___. As you know, you were admitted for symptoms of thyroiditis. You were seen by the endocrinologists, who have advised you to use Propanolol for rapid heart rate, to keep your heart rate between 80-100. Stop hydrochlorothiazide. Otherwise, you can continue your other medications as you are. Followup Instructions: ___
19806999-DS-17
19,806,999
24,906,420
DS
17
2159-06-26 00:00:00
2159-06-26 15:50:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Dizziness, headache, numbness/tingling on the right Major Surgical or Invasive Procedure: None History of Present Illness: This is a ___ right handed woman with hypertension who presents to the ED with the above symptoms; she provides her own history. She reports that for the past month now, she has been experiencing intermittent ___ times/week) headaches described as starting on the back of her neck, and extending forward to the right side of her head. She notes tight neck muscles and a "pulling sensation" and her headaches are described as a constant pressure. Tylenol at night may sometimes take the edge off. These have been getting slightly more frequent, but she hadn't sought medical attention for the same. Yesterday evening, she went to the movie theater and noticed that her arm went quite heavy. She did not notice any clumsiness or weakness; she could text and use her hands to eat. At that time, she noticed the relatively acute onset of 1) numbness and tingling over the right hemibody (including trunk) as well as 2) "dizziness", which she clarifies as a sensation of something "rushing to my head" when she got up from a seated position. These two sensations continued to persist overnight and till this morning. She had some difficulty sleeping last night. On review of systems, she denies any difficulty with the left leg or arm. She has not fallen or had any clumsiness with her lower extremities. No episodes of loss of consciousness, double vision, dysphagia, vomitting, nausea, chest pain, congestion or drooling. Past Medical History: past medical history includes a recent cholecysectomy for gallstones. She was seen by cardiology a decade ago for palpitations and suspected premature beats. She has never been diagnosed with a stroke or heart attack. Social History: ___ Family History: Family history is negative for significant neurological illness. Physical Exam: V/s were 98.1F, HR 64, BP 175/112, RR 18, 100%. She is pleasant and cooperative and appeared to be in no distress. Her neck muscles were tight (trapezius and splenius) and were tender to palpation. Neck excursion was limited. Bending her neck to her left exacerbated her symptoms. Chest examination revealed clear lung sounds and a relatively slow heart rate without murmurs. Pulses were symmetric. Belly was obese but soft and nontender. Lower extremities were without edema. There were a few scattered tattoos. Neurologically, she was awake, alert and oriented x 3. She could recall ___ backwards and had no paraphasic errors. Speech was clear. She had difficulty with doing simple calculations (# quarters in $1.75). Pupils were round, equal and reactive to light (___) with full visual fields to confrontation. Eye movements were full to confrontation. Face was symmetric without ptosis or droop. Facial sensation testing revealed diminished (~50%) pinprick sensation and cold sensation over the right face (extending to the scalp) that split down the midline. Face position sense was preserved. Vibration over the left forehead was sensed stronger than vibration over the right forehead. Tongue was strong and midline. Bilateral SCMs and traps were ___. Motor examination identified a positive ___ sign on the right. Tone and bulk were normal. Major muscle groups were tested at ___, including brachioradialis, infraspinatus, supraspinatus and intrinsic muscles of the hand. Reflexes were symmetric and 2+ in the upper extremities and 1+ in the lower extremities with downgoing toes bilaterally. Sensory examination once again identified diminished pinprick over the right hemibody that split sharply down the midline. Vibration sense and joint position sense were normal at both great toes and symmetric. No R/L confusion, no extinction. Finger-nose testing was without dysmetria. Gait and tandem gait were normal, and Romberg was negative. Pertinent Results: ___ 10:21AM GLUCOSE-103* UREA N-12 CREAT-0.8 SODIUM-142 POTASSIUM-4.5 CHLORIDE-107 TOTAL CO2-22 ANION GAP-18 ___ 10:21AM estGFR-Using this ___ 10:21AM WBC-7.1 RBC-5.11 HGB-14.2# HCT-41.6 MCV-81* MCH-27.7# MCHC-34.1# RDW-14.4 ___ 10:21AM PLT COUNT-205 ___: identified no acute lesions or hypodensities MRI/MRA head and neck No acute infarct or intracranial hemorrhage. Nonspecific white matter abnormalities, of uncertain clinical significance, could be sequelae of chronic small vessel ischemic disease but some what atypical give her age. Also, on the differential would be headaches, vasculitis, demyelinating disease and lyme disease. No significant stenosis on the head and neck MRA. Brief Hospital Course: ___ woman with hypertension presents with one month of intermittent headaches followed by ~ 1 day of right hemibody numbness that splits down the midline with + ___ on the right. CT head unremarkable. MRI/MRA head and neck showed no acute infarct or intracranial hemorrhage. There was no significant stenosis on the head and neck MRA. Based on her history, exam and imaging, it is highly unlikely that patient had a stroke. Seizure is highly unlikely as her sensory symptoms persisted for days without spreading or other symptoms suggestive of seizures. Complex migraine is considered but there is no clear relationship between the onset of her sensory symptoms and her headaches. We have given patient aspirin 81mg daily while she was in the hospital but given that she did not have a stroke, she will not have to continue with the aspirin. Her fasting lipid is still pending at this time. Her a1c is 5.9. She was continued to half dose of her home atenolol initially when stroke was still considered a possible etiology. She was discharged on her home does of atenolol. For her chronic daily headaches, she was prescribed nortriptyline 10mg qhs as a trial. We have set up a follow up appointment for her to follow up with her PCP. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atenolol 50 mg PO DAILY 2. Losartan Potassium 100 mg PO DAILY 3. Calcium Carbonate Dose is Unknown PO DAILY 4. Fish Oil (Omega 3) 1000 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY Discharge Medications: 1. Atenolol 50 mg PO DAILY 2. Calcium Carbonate 1000 mg PO DAILY 3. Fish Oil (Omega 3) 1000 mg PO DAILY 4. Losartan Potassium 100 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. Nortriptyline 10 mg PO HS RX *nortriptyline 10 mg 1 by mouth at bedtime Disp #*30 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Tension/cerevicogemic headaches Subjective right hemibody altertation in skin sensations of undetermined etiology Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Neuro exam: Non focal. Decreased sensation to pinprick and temperature on the right hemibody. Discharge Instructions: Dear Ms ___, It was a pleasure taking care you. You were here because of headaches and abnormal sensation on the right side of the body. You have got CT scan and MRI of your head which did not show any stroke. We do not think that your symptoms are related to a stroke. For your headache, we have prescribed nortriptyline to be taken everyday at bedtime. Please follow up with your PCP as scheduled. Medication changes: - We ADDED NORTRIPTYLINE 10mg qhs to be taken every day at bedtime to treat your headaches. Please continue to take the rest of your home medications as previously prescribed. Please call your doctor or go to the emergency room if experience any of the danger signs listed below. Followup Instructions: ___
19807025-DS-5
19,807,025
21,434,336
DS
5
2117-10-30 00:00:00
2117-10-30 14:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Heroin overdose Major Surgical or Invasive Procedure: Intubation ___ History of Present Illness: The patient is a ___ with history of substance abuse, presenting from OSH with heroin overdose. The patient was found by his fiance unresponsive and blue at 10pm, last seen normal at 8:30pm. Initially found by EMS to have an oxygen sat of 66% on room air. He was given naltrexone 2mg IV x 2 with improvement in his mental status. He was brought to ___ where he was noted to be dyspneic. He was intubated for combativeness and hypoxia. A head, neck and chest CT were performed. Reportedly, the patient had a fever for the last two days. He was given piperacillin-tazobactam, levofloxacin, and vancomycin. CT head, C-spine, and chest was unremarkable. In the ED, initial vital signs were 103.4 hr 97 120/68 rr 16 100% on vent (A/C Vt 500 rate 14 Fi02 100 ___. Labs demonstrated mild leukocytosis to 11.5k with left shift, unremarkable chem-7, serum tox screen was negative. Urine tox screen significant for opiates, cocaine, and methadone. UA was unremarkable. Lactate 1.1. Patient was given tylenol and maintained on propofol and fentanyl gtt. On arrival to the MICU, initial vital signs were 113 129/82 21 94%/intubated, patient is intubated and somewhat agitated. Past Medical History: PTSD Opiate Abuse Social History: ___ Family History: Non-contributory. Physical Exam: ADMISSION: General- intubated, sedated, not responding to sternal rub HEENT- pupils 2mm and minimally reactive Neck- supple CV- RRR, no m/r/g Lungs- coarse breath sounds anteriorly Abdomen- soft, nontender GU- foley in place Ext- WWP no c/c/e Neuro- unresponsive to commands Pertinent Results: ADMISSION: ___ 04:45AM BLOOD WBC-11.5* RBC-4.57* Hgb-14.5 Hct-41.4 MCV-91 MCH-31.9 MCHC-35.1* RDW-11.9 Plt ___ ___ 04:45AM BLOOD Neuts-86.8* Lymphs-6.8* Monos-5.3 Eos-0.7 Baso-0.3 ___ 04:45AM BLOOD ___ PTT-26.9 ___ ___ 04:45AM BLOOD Glucose-101* UreaN-16 Creat-1.2 Na-133 K-4.6 Cl-96 HCO3-26 AnGap-16 ___ 04:45AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG DISCHARGE: ___ 04:55AM BLOOD WBC-5.8 RBC-4.45* Hgb-13.9* Hct-40.1 MCV-90 MCH-31.4 MCHC-34.8 RDW-11.9 Plt ___ ___ 04:55AM BLOOD Glucose-113* UreaN-9 Creat-1.0 Na-135 K-4.3 Cl-99 HCO3-29 AnGap-11 ___ 04:55AM BLOOD Calcium-8.8 Phos-2.6* Mg-1.9 ECHOCARDIOGRAM (___) The left atrium is normal in size. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. No masses or vegetations are seen on the aortic valve. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. No mass or vegetation is seen on the mitral valve. The estimated pulmonary artery systolic pressure is normal. No vegetation/mass is seen on the pulmonic valve. There is no pericardial effusion. CTA CHEST (___) No evidence of pulmonary embolism. Findings compatible with extensive bilateral aspiration pneumonia. MRI C-SPINE (___) In comparison with the prior cervical spine CT examination dated ___, again a calcific lesion is noted inferior to the level of C1, consistent with the provided diagnosis of longus coli calcific tendinitis, associated with small amount of retropharyngeal fluid with no evidence of narrowing of the airway. There is no evidence of abnormal enhancement to suggest leptomeningeal disease, there is no evidence of a large abscess formation, no drainable fluid collections are identified. Brief Hospital Course: ___ with history of substance abuse, presenting from OSH with heroin overdose. # Respiratory failure: Secondary to heroin overdose with component of noncardiogenic pulmonary edema. Received naloxone in the field with improvement in symptoms. Patient was easily extubated after arrival. He was persisently hypoxemic after extubation which was thought to be secondary to aspiration pneumonitis found on CT. There was no evidence of pulmonary embolism. # Fevers: Patient reporting history of ___ days fevers prior to presentation, found to have mild neutrophilic leukocytosis. Was given vancomycin/piperacillin-tazobactam/levofloxacin at OSH. An echocardiogram was performed to evaluate for endocarditis given drug use history, though no vegetations were identified on TTE. Blood cultures have remained negative. Other possible foci included an effusion identified on OSH CT C-SPINE. An MRI was performed to evaluate for abscess; this was not evident on imaging. Patient was discharged on short course of amoxicillin-clavulanate for aspiration pneumonitis/pneumonia. # Heroin overdose: Patient with history of polysubstance abuse. During hospitalization, patient required clonidine, lorazepam, and hydromorphone to prevent agitation. Patient was unwilling to wait for social work evaluation. Patient left against medical advise after demonstrating understanding of risks of leaving hospital prior to complete evaluation. He was provided with course of amoxicillin-clavulanate as above. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Prazosin 1 mg PO QHS 2. Fluoxetine 60 mg PO DAILY 3. ClonazePAM 2 mg PO DAILY:PRN anxiety Discharge Medications: 1. ClonazePAM 2 mg PO DAILY:PRN anxiety 2. Fluoxetine 60 mg PO DAILY 3. Prazosin 1 mg PO QHS 4. Amoxicillin-Clavulanic Acid ___ mg PO Q12H Duration: 5 Days RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*10 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary: heroin overdose aspiration pneumonia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to ___ for difficulty breathing due to a heroin overdose. You were on a breathing machine for a short amount of time. You were also having fevers and were found to have a pneumonia. You need to complete a course of antibiotics for this. You should see your primary care doctor within ___ days of leaving the hospital to discuss how you are doing. You should avoid using heroin and other illicit drugs, please discuss with your primary care doctor ___ referral to a suboxone provider. Given the fact that you were receiving sedating medications, you were advised to remain in your room for a loved one to pick you up, but you insisted on leaving by yourself. You therefore signed yourself out against medical advice despite the risk of harm to yourself in leaving on your own. Followup Instructions: ___
19807183-DS-14
19,807,183
23,147,327
DS
14
2154-10-04 00:00:00
2154-10-05 10:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Codeine Attending: ___. Chief Complaint: Nasal Pain, with swelling of nasal bridge Major Surgical or Invasive Procedure: None History of Present Illness: This is a ___ with history of migraines, asthma, and depression who presents with nasal pain. Patient reports that she was in her USOH until ___ when she developed nasal and facial congestion. She initially thought her symptoms were related to a URI however her symptoms gradually worsened and she stated having worsening facial and teeth pain with associated neck pain. She also had chills and subjective fevers. Given her symptoms she presented to her PCP 1 day prior to admission who felt patient had a sinus infection. Patient was given Augmentin. On day of admission, she had worsening facial and nasal pain and represented to her PCP's office. Given worsening symptoms, she was referred to the ED for further evaluation. In the ED, initial VS were: 98.9 72 141/84 16. Evaluation revealed soft tissue swelling on right nare without e/o abscess on CT. I+D was attempted and approximately 2cc of pus was expressed. Patient received morphine, dilaudid, zofran, vanc and unasyn. Patient was then admitted for further management. VS prior to transfer were 99.0 82 129/88 16 93%. On arrival to the floor, patient complains of continued nasal pain with associated neck pain and photophobia (only in right eye). Denied teeth swelling or abscess. Denied SOB, chest pain, dysphagia or odynophagia. Past Medical History: - Migraines - Asthma - Depression - Patient reported prior leg/foot soft tissue infection requiring debridement Social History: ___ Family History: Patient reports recurrent skin infections in several family members Physical Exam: ADMISSION EXAM: VS: 98.0 BP 132/85 80 18 98% RA GENERAL: uncomfortable appearing, NAD, holding right eye shut HEENT: NCAT, EOMI however reporting pain on eye movements, sclera anicteric, no conjunctivitis, significant erythema and edema of nose, right > left, edema of right nare with bogginess of right turbinate, tenderness over right frontal and maxillary sinuses, OP clear, uvula midline NECK - supple, no thyromegaly, no JVD, no carotid bruits, full ROM. tenderness over right side of neck, +submandibular LAD LUNGS - course breath sounds throughout HEART - PMI non-displaced, RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) SKIN - no rashes or lesions LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, DTRs 2+ and symmetric, cerebellar exam intact, steady gait DISCHARGE EXAM: VS:98 132/85 80 18 97%RA GENERAL: comfortable appearing, NAD HEENT: NCAT, EOMI, sclera anicteric, no conjunctivitis, erythema and edema of nose greatly improved, but still slightly red, well within outlined margins, mild tenderness over right frontal and maxillary sinuses, OP clear, uvula midline NECK - supple, no thyromegaly, no JVD, no carotid bruits, full ROM. tenderness over right side of neck, +submandibular LAD LUNGS - expiratory wheezing over b/l lower lung fields HEART - PMI non-displaced, RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) SKIN - no rashes or lesions LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout Pertinent Results: ___ 05:55PM WBC-9.5 RBC-3.93* HGB-12.5 HCT-37.2 MCV-95 MCH-31.7 MCHC-33.5 RDW-13.8 ___ 05:55PM NEUTS-74.4* ___ MONOS-4.3 EOS-1.2 BASOS-0.4 ___ 05:55PM PLT COUNT-263 ___ 05:55PM GLUCOSE-92 UREA N-5* CREAT-0.5 SODIUM-140 POTASSIUM-3.4 CHLORIDE-105 TOTAL CO2-24 ANION GAP-14 ___ 06:03PM LACTATE-1.___: CT NECK WITH INTRAVENOUS CONTRAST: There is soft tissue swelling along the anterior aspect of the right nostril measuring up to 14 mm on axial projection. Findings correspond with physical exam finding of focal abscess at this site. No rim-enhancing drainable fluid collection is identified at this site. There is no extension into the adjacent facial soft tissues or deep structures of the neck. The globes are symmetric. There is no periorbital cellulitis or abscess. CT appearance of the extraocular muscles and optic nerves appears normal. The salivary glands appear normal. No cervical lymphadenopathy is identified. Views of the aerodigestive tract appear within normal limits. There is mild mucosal thickening within the ethmoid air cells. The remainder of the visualized paranasal sinuses and mastoid air cells are well aerated. Limited views of the intracranial structures appear within normal limits. The neck vasculature is grossly patent. The thyroid gland is homogeneous without focal nodule. The imaged lung apices are clear. No cervical spine abnormality is evident. IMPRESSION: 14 mm soft tissue density along the anterior right naris. No CT evidence of drainable fluid collection. No extension to the orbits, face, or deep spaces of the neck. ___. ___ ___. ___ Brief Hospital Course: ___ with history of depression, asthma, and migraines presenting with nasal pain found to have nasal/preseptal cellulitis. ACTIVE ISSUES: # Nasal/preseptal cellulitis: No orbital involvement or evidence of abscess on CT although per ED report, able to drain 2cc pus on I+D that was not sent for culture. Despite lack of evidence for orbital involvement, patient exhibiting symptoms of eye involvement including pain with eye movements. Nasal involvement, zoster ophthalmicus should remain on differential however appears less likely given appearance. She was continued on vancomycin and unasyn. Her exam greatly improved, with no eye pain or involvement and good vision. She had minimal tenderness to palpation and resolving erythema over nose. She was then switched to Bactrim and Augmentin to complete a ___t discharge. # Asthma: She initially had expiratory wheezing on exam, likely related to URI although septic embolic from ENT process is also possibility, but less likely given benign findings on CT and rapid clinical improvement. She was treated with albuterol nebs while inpatient and discharged on her home medications. CHRONIC ISSUES: # Migraines: continued home medications while inpatient. # Depression: continued home medications while inpatient. # FEN: IVFs / replete lytes prn / regular diet # PPX: heparin SQ, bowel regimen # ACCESS: PIV # CODE: full code # DISPO: ___ for now TRANSITIONAL ISSUE: - patients having an ankle abscess drained in the past, may benefit from ID re: colonization? Medications on Admission: Preadmission medications listed are correct and complete. Information was obtained from Patient. 1. Topiramate (Topamax) 100 mg PO HS 2. BuPROPion (Sustained Release) 300 mg PO QAM 3. Fluticasone Propionate NASAL 1 SPRY NU DAILY 4. Sumatriptan Succinate 50 mg PO Frequency is Unknown 5. Clonazepam 1 mg PO QHS 6. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID Discharge Medications: 1. BuPROPion (Sustained Release) 300 mg PO QAM 2. Clonazepam 1 mg PO QHS 3. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 4. Topiramate (Topamax) 100 mg PO HS 5. Amoxicillin-Clavulanic Acid ___ mg PO Q8H RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by mouth Every 8 hours Disp #*25 Tablet Refills:*0 6. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone [Oxecta] 5 mg 1 tablet(s) by mouth every ___ hours Disp #*10 Tablet Refills:*0 7. Sulfameth/Trimethoprim DS 2 TAB PO BID RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 2 tablet(s) by mouth Twice a day Disp #*30 Tablet Refills:*0 8. Fluticasone Propionate NASAL 1 SPRY NU DAILY 9. Sumatriptan Succinate 50 mg PO PRN Migraine Discharge Disposition: Home Discharge Diagnosis: Soft tissue abscess Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, you were admitted to ___ after being transferred from your primary care physician for facial swelling. You had a soft tissue abscess that was drained and you were treated with antibiotics. You will continue on these two antibiotics for a total of 7 days. Please see below for your follow-up appointments. It was a pleasure caring for you and we wish you a speedy recovery! Followup Instructions: ___
19807332-DS-21
19,807,332
22,419,561
DS
21
2181-11-04 00:00:00
2181-11-04 17:40:00
Name: ___ ___ No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Anemia Major Surgical or Invasive Procedure: Bone marrow biopsy (___) History of Present Illness: Mr. ___ is a ___ female with history of recently diagnosed CLL, HIV, diabetes, hyperlipidemia, hypertension, and bipolar disorder who presents with anemia. Patient was told to come to the ED by his PCP for abnormal lab results from 2 days ago. He was told that his hemoglobin was low and may need blood transfusions. He reports that for the past few weeks he has experienced worsening fatigue, weakness, and labored breathing with activity. For the past week he has felt dizzy with sitting and standing. Today he started to experience midline minor chest pressure with activity, non-radiating, and resolved with rest and was associated with palpitations. He denies bruising, melena, and BRBPR. On arrival to the ED, initial vitals were 97.6 79 122/61 18 99% RA. Exam was unremarkable. Labs were notable for CBC 51.8, H/H 5.5/16.8, Plt 73, Na 140, K 4.2, BUN/Cr ___, and negative UA. CXR was negative for pneumonia. No medications given. ___ was consulted who recommended transfusion and admission. Prior to transfer vitals were 97.6 84 120/69 20 100% RA. On arrival to the floor, patient reports feeling tired. He denies pain. He denies fevers/chills, night sweats, headache, vision changes, cough, hemoptysis, abdominal pain, nausea/vomiting, diarrhea, hematemesis, hematochezia/melena, dysuria, hematuria, and new rashes or bruising. Past Medical History: CLL Type II Diabetes Hypertension Hyperlipidemia HIV Bipolar Disorder Social History: ___ Family History: Leukemia in maternal relative. Lung cancer in grandparents who were all smokers. Cousin with leukemia. Physical Exam: ADMISSION PHYSICAL EXAM: ========================= VS: Temp 98.8, BP 114/68, HR 81, RR 18, O2 sat 97% RA. GENERAL: Pleasant man, in no distress, lying in bed comfortably. HEENT: Anicteric, PERLL, OP clear. CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, positive bowel sound. EXT: Warm, well perfused, no lower extremity edema, erythema or tenderness. NEURO: A&Ox3, good attention and linear thought, CN II-XII intact. Strength full throughout. Sensation to light touch intact. SKIN: No significant rashes. DISCHARGE PHYSICAL EXAM: ========================== VS: Temp: 98.9 PO BP: 117/67 HR: 70 RR: 18 O2 sat: 98% RA GENERAL: Pleasant man, in no distress, lying in bed comfortably. HEENT: Anicteric, PERLL, OP without erythema, exudates or ulcers. CARDIAC: RRR with normal s1/s2, no murmurs, rubs or gallops appreciated. LUNG: Normal respiratory effort, CTAB without crackles, wheezes, or rhonchi. ABD: Soft, obese, non-tender, non-distended, normoactive bowel sound. No masses appreciated. EXT: Warm, well perfused, no lower extremity edema, erythema or tenderness. NEURO: A&Ox3, CN II-XII grossly intact. Strength normal throughout. SKIN: Warm, dry. No rashes. Biopsy site without bleeding, ecchymosis or erythema. Pertinent Results: ADMISSION LABS: ================ ___ 11:10PM BLOOD WBC-51.8* RBC-1.71*# Hgb-5.5*# Hct-16.8*# MCV-98 MCH-32.2* MCHC-32.7 RDW-15.2 RDWSD-53.8* Plt Ct-73* ___ 11:10PM BLOOD Neuts-6* Bands-0 Lymphs-91* Monos-1* Eos-0 Baso-1 ___ Myelos-1* AbsNeut-3.11 AbsLymp-47.14* AbsMono-0.52 AbsEos-0.00* AbsBaso-0.52* ___ 11:10PM BLOOD Glucose-139* UreaN-27* Creat-1.0 Na-140 K-4.2 Cl-101 HCO3-26 AnGap-13 ___ 11:10PM BLOOD ALT-18 AST-22 LD(LDH)-294* AlkPhos-85 TotBili-0.2 ___ 11:10PM BLOOD Albumin-4.3 Calcium-8.8 Phos-4.6* Mg-2.2 Iron-175* PERTINENT LABS: ================ ___ 11:10PM BLOOD Ret Aut-0.7 Abs Ret-0.01* ___ 11:10PM BLOOD calTIBC-306 ___ Ferritn-655* TRF-235 DISCHARGE LABS: ================= ___ 06:50AM BLOOD WBC-49.3* RBC-2.59* Hgb-8.1* Hct-24.3* MCV-94 MCH-31.3 MCHC-33.3 RDW-16.3* RDWSD-53.8* Plt Ct-63* ___ 06:50AM BLOOD Neuts-5* Bands-0 Lymphs-91* Monos-4* Eos-0 Baso-0 ___ Myelos-0 AbsNeut-2.47 AbsLymp-44.86* AbsMono-1.97* AbsEos-0.00* AbsBaso-0.00* ___ 06:50AM BLOOD Glucose-124* UreaN-25* Creat-0.9 Na-136 K-4.5 Cl-100 HCO3-25 AnGap-11 ___ 06:50AM BLOOD Calcium-9.0 Phos-4.9* Mg-2.2 PERTINENT IMAGING/PROCEDURES/PATH: ================================== ___ CT Abd/pelvis w/ contrast: Minimally changed abdominopelvic lymphadenopathy with many nodes unchanged and few nodes minimally enlarged. Splenomegaly is slightly increased, measuring 17.7 cm and previously measuring 17.1 cm. ___ CT Chest w/o contrast: Minimally changed supraclavicular, axillary, mediastinal, and hilar lymphadenopathy with many nodes unchanged and few nodes minimally enlarged. ___ Peripheral blood cytogenetics Pending at discharge ___ Bone marrow biopsy Aspirate and immunophenotyping pending at discharge Brief Hospital Course: Mr. ___ is a ___ male with history of recently diagnosed CLL, HIV, DM, HTN, and HLD who presents with anemia. ACUTE MEDICAL CONDITIONS: ========================= # Symptomatic Anemia Presented with several weeks of fatigue, lightheadedness, and dyspnea on exertion found to have new profound anemia with Hgb 5.5. Iron studies were unrevealing and hemolysis labs were negative. There were no signs of bleeding. Reticulocyte count was inappropriately low (absolute 0.01). He described having 4 weeks of URI sxs, prompting concern that the decreased production was due to a viral illness vs more likely, worsened CLL. Both peripheral blood cytogenetics and a bone marrow biopsy were done to differentiate between these two etiologies. Both tests were pending at discharge. He ultimately received 3u pRBC during this admission. H/H were stable at discharge. # CLL # Thrombocytopenia Diagnosed with RAI stage III CLL ___ month prior to admission and had not been on treatment as the patient had been asymptomatic. CBC on admission showed worsening anemia and new thrombocytopenia, consistent with RAI stage IV disease. Repeat CT chest/abd/pelvis showed mildly worsened diffuse lymphadenopathy. Both peripheral blood cytogenetics and bone marrow biopsy were done to evaluate if dropping blood counts were due to CLL vs less likely viral illness. Bone marrow biopsy was limited- core biopsy was attempted but aborted due to pain. Patient will follow up with Dr. ___ on ___ to discuss possible treatment pending results. CHRONIC MEDICAL CONDITIONS: =========================== # Hypertension Presented on atenolol and lisinopril at home. Lisinopril held in the setting of anemia and normotensive pressures. Both restarted at discharge. DISCHARGE LABS: =============== CBC: 49.3/8.___ TRANSITIONAL ISSUES: ===================== [] Follow up cytogenetics and bone marrow biopsy [] Repeat CBC at next appointment to evaluate anemia/thrombocytopenia [] BP stable on monotherapy here; consider stopping amlodipine and continuing lisinopril if BP remains low as an outpatient CODE: Full Code (confirmed) EMERGENCY CONTACT HCP: ___ (partner) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atenolol 12.5 mg PO DAILY 2. Atorvastatin 40 mg PO QPM 3. Atripla (efavirenz-emtricitabin-tenofov) ___ mg oral DAILY 4. Lisinopril 20 mg PO DAILY 5. Testosterone Gel 1% 50 mg TP DAILY 6. Docusate Sodium 100 mg PO BID:PRN constipation 7. MetFORMIN (Glucophage) 500 mg PO BID 8. Aspirin 81 mg PO DAILY 9. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 10. Multivitamins 1 TAB PO DAILY 11. Vitamin D 1000 UNIT PO DAILY 12. Ascorbic Acid ___ mg PO DAILY 13. Cyanocobalamin 250 mcg PO DAILY 14. Fish Oil (Omega 3) 1000 mg PO DAILY Discharge Medications: 1. Ascorbic Acid ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atenolol 12.5 mg PO DAILY 4. Atorvastatin 40 mg PO QPM 5. Atripla (efavirenz-emtricitabin-tenofov) ___ mg oral DAILY 6. Cyanocobalamin 250 mcg PO DAILY 7. Docusate Sodium 100 mg PO BID:PRN constipation 8. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 9. Fish Oil (Omega 3) 1000 mg PO DAILY 10. Lisinopril 20 mg PO DAILY 11. MetFORMIN (Glucophage) 500 mg PO BID 12. Multivitamins 1 TAB PO DAILY 13. Testosterone Gel 1% 50 mg TP DAILY 14. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: #Primary: Anemia #Secondary: Chronic lymphocytic leukemia Hypertension Diabetes mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___! Why you were admitted to the hospital: - You were having fatigue and lightheadedness, then lab work showed that you were anemic (low blood counts) What happened while you were here: - You were given blood to replete your counts and make you feel better - Further tests, including a bone marrow biopsy, were done to further evaluate the cause of the anemia What you should do once you get home: - Continue taking your medications as prescribed and follow up with Dr. ___ at the appointment outlined below. - Please call Dr. ___ your PCP if you begin having fatigue or new symptoms We wish you the best. Sincerely, Your ___ Care Team Followup Instructions: ___
19807332-DS-22
19,807,332
20,520,468
DS
22
2181-11-09 00:00:00
2181-11-11 21:45:00
Name: ___ ___ No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Fever Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ y/o male with a hx of CLL (dx ___, HIV on atriplia, DM, HTN, and HLD who presents with fever and cough. The patient was recently hospitalized at ___ from ___ for symptomatic anemia and thrombocytopenia. Work up was notable for decreased reticulocyte count indicating poor production, concerning for worsening CLL vs viral illness. Peripheral blood flow cytometry and bone marrow biopsy were done; final read still pending. He received 3u pRBC with plan to follow up with Dr. ___ as an outpatient for further management. Since discharge, the patient describes three days of mildly productive cough, rhinorrhea, congestion, postnasal drip, and malaise. He also reports worsening dyspnea on exertion, mild shortness of breath at baseline, and chest pressure with deep breaths. No chest pain or palpitations. He then had a fever to ___ last night, prompting him to come to the ED today. Otherwise, he had two episodes of vomiting (clear liquid, no blood) this morning without any nausea since. Also reports three episodes of loose stools yesterday, no BMs today. No headaches, vision changes, focal weakness, sinus pain, ear pain, sore throat, abdominal pain, rashes or joint pain. In the ED, vitals: Temp 102.8 BP 131/75 HR 127 RR 18 96% on RA Labs: Cr 1.0, WBC 88.6 (94% lymph), H/H 9.___, plts 73, lactate 1.4, trop <0.01, CK 183, influenza negative Imaging: CXR unremarkable Given: Vancomycin, cefepime, acetaminophen and 2L NS Consults: None Past Medical History: PAST ONCOLOGIC HISTORY: - ___ - Seen in ___ clinic for leukocyte-predominant lymphocytosis noted during annual physical exam. Noted to have smudge cells c/w CLL - ___ CT Chest/Abd/pelvis: Multiple pathologically enlarged supraclavicular, subpectoral, axillary, and mediastinal lymph nodes. Extensive retroperitoneal, mesenteric, and pelvic lymphadenopathy. Splenomegaly, up to 15.8 cm. - ___ - Rai stage III CLL. Held treatment as patient remained asymptomatic - ___ - Admitted for symptomatic anemia and new thrombocytopenia. Repeat imaging showed mild interval enlargement of lymph nodes PAST MEDICAL/SURGICAL HISTORY: CLL Type II Diabetes Hypertension Hyperlipidemia HIV Bipolar Disorder Social History: ___ Family History: Leukemia in maternal relative. Lung cancer in grandparents who were all smokers. Cousin with leukemia. Physical Exam: ADMISSION PHYSICAL EXAM: ======================== Vitals: 98.6F BP 156/76 HR 114 RR 18 95% on Ra Gen: WDWN, obese male in NAD. Ill-appearing. HEENT: No conjunctival pallor. No icterus. MMM. OP without erythema, exudates or ulcers. No maxillary or frontal TTP. Nares without significant erythema. EOMI. NECK: Supple LYMPH: No cervical or supraclav LAD. CV: RRR with normal S1 and S2. II/VI SEM over LLSB and apex. No rubs or gallops. LUNGS: Normal respiratory effort. Diffuse rhonchi and expiratory wheezes. No crackles. ABD: Normoactive BS. Soft, obese. Non-tender, non-distended. No masses appreciated. EXT: WWP. No ___ edema or erythema. SKIN: No rashes/lesions, petechiae/purpura ecchymoses. NEURO: A&Ox3. CN II-XII intact. ___ strength throughout. LINES: PIV c/d/I. DISCHARGE PHYSICAL EXAM: ======================== Vitals: Temp: 98.4 PO BP: 100/62 HR: 84 RR: 20 O2 sat: 98% O2 RA Gen: WDWN, obese male in NAD. Lying comfortably in bed. HEENT: No conjunctival pallor. No icterus. MMM. OP without erythema, exudates or ulcers. Nares without significant erythema. NECK: Supple CV: RRR with normal S1 and S2. II/VI SEM over LLSB and apex. No rubs or gallops. LUNGS: Normal respiratory effort. Diffuse expiratory wheezes and scattered rhonchi. No crackles. ABD: Normoactive BS. Soft, obese. Non-tender, non-distended. No masses appreciated. EXT: WWP. No ___ edema or erythema. SKIN: No rashes/lesions, petechiae/purpura ecchymoses. NEURO: A&Ox3. CN II-XII grossly intact. Moves all extremities. LINES: PIV c/d/i. Pertinent Results: ADMISSION LABS: ================ ___ 11:15AM BLOOD WBC-88.6*# RBC-2.98* Hgb-9.4* Hct-28.0* MCV-94 MCH-31.5 MCHC-33.6 RDW-15.3 RDWSD-50.4* Plt Ct-73* ___ 11:15AM BLOOD Neuts-3* Bands-0 Lymphs-94* Monos-2* Eos-0 Baso-0 ___ Metas-1* Myelos-0 AbsNeut-2.66 AbsLymp-83.28* AbsMono-1.77* AbsEos-0.00* AbsBaso-0.00* ___ 11:15AM BLOOD Glucose-163* UreaN-31* Creat-1.0 Na-135 K-4.6 Cl-96 HCO3-22 AnGap-17 ___ 11:15AM BLOOD ALT-25 AST-25 CK(CPK)-183 AlkPhos-106 TotBili-0.4 ___ 11:29AM BLOOD Lactate-1.4 PERTINENT LABS: ================= ___ 11:15AM BLOOD WBC-88.6*# Lymph-94* Abs ___ CD3%-6 Abs CD3-4704* CD4%-3 Abs CD4-2605* CD8%-2 Abs CD8-1780* CD4/CD8-1.46 ___ 11:15AM BLOOD Lipase-21 ___ 11:15AM BLOOD cTropnT-<0.01 ___ 11:15AM BLOOD CK-MB-2 ___ 06:35AM BLOOD Hapto-177 ___ 06:35AM BLOOD IgG-608* IgA-75 IgM-72 ___ 06:35AM BLOOD CMV VL-NOT DETECT ___ 06:35AM BLOOD HBV VL-NOT DETECT HCV VL-NOT DETECT ___ 06:35AM BLOOD HIV1 VL-NOT DETECT ___ 07:50AM BLOOD B-GLUCAN-PND ___ 07:50AM BLOOD MYCOPLASMA PNEUMONIAE ANTIBODIES (IGG, IGM)-PND DISCHARGE LABS: ================ ___ 06:44AM BLOOD WBC-32.3* RBC-2.10* Hgb-6.4* Hct-20.3* MCV-97 MCH-30.5 MCHC-31.5* RDW-15.4 RDWSD-52.4* Plt Ct-49* ___ 06:44AM BLOOD Glucose-136* UreaN-17 Creat-0.8 Na-140 K-3.7 Cl-101 HCO3-26 AnGap-13 ___ 06:44AM BLOOD Calcium-8.5 Phos-4.4 Mg-2.2 PERTINENT MICRO/PATH: ====================== ___ urine legionella: Negative ___ Respiratory viral panel: POSITIVE FOR RESPIRATORY SYNCYTIAL VIRUS (RSV). ___ MRSA screen: Negative ___ 05:47AM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE ___ 02:43PM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE PERTINENT IMAGING: ================== ___ CXR: Low lung volumes. No evidence of focal consolidation or pleural effusion. Brief Hospital Course: Mr. ___ is a ___ y/o male with a hx of CLL (dx ___, HIV on atriplia, DM, HTN, and HLD who presented with fever, cough, and rhinorrhea, diagnosed with viral URI. #Respiratory Syncytial Virus Infection #Viral URI Presented with cough, congestion/postnasal drip, shortness of breath, and malaise. Initially met ___ SIRS criteria (fever, tachycardia) concerning for sepsis. Exam was notable for diffuse wheezes/rhonchi. Work up included: influenza negative, CXR unremarkable, negative urine/blood cultures, and negative urine legionella. He received IVF and was initially treated with vancomycin/cefepime/azithromycin for presumed HCAP; however antibiotics were discontinued after ___ days when his symptoms were felt due to a viral infection. Following discharge, the respiratory panel returned positive for RSV, confirming the above suspicions. HIV/HepB/HepC/CMV/EBV/HSV viral loads, mycoplasma IgG/IgM, and B-glucan were pending at discharge. He will follow up with Dr. ___ further management. #CLL Diagnosed in ___, initially held treatment as patient was asymptomatic. He was recently admitted for new anemia and thrombocytopenia, consistent with RAI stage IV disease. Repeat CTs at that time showed mild disease progression. Bone marrow biopsy with 93% lymphocytes and extensive CLL involvement. Flow cytometry pending at discharge. He will follow up with Dr. ___ on ___ for further discussions and likely initiation of chemotherapy with fludarabine and cyclophosphamide. #Anemia/Thrombocytopenia Admitted ___ for new symptomatic anemia/thrombocytopenia and required 3u pRBC. Work up at that time was notable for reduced reticulocyte count and bone marrow biopsy with extensive CLL, consistent with inadequate production. He required one blood transfusion during this admission, on day of discharge (___). # Hypertension Presented on atenolol and lisinopril at home. Both medications were held in the setting of infection and normal/borderline low blood pressures. TRANSITIONAL ISSUES: ==================== [] Will see Dr. ___ in clinic and likely start chemotherapy on ___ [] Follow up final flow cytometry results [] Follow up CD4 counts, HIV VL, Hep B/C VL, EBV VL, HSV VL, mycoplasma IgG/IgM, and B-glucan [] Atenolol/lisinopril held at discharge. Consider restarting if he becomes hypertensive [] Aspirin held at discharge due to thrombocytopenia # CODE: Full (presumed) # CONTACT: ___ (partner) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. Docusate Sodium 100 mg PO BID:PRN constipation 3. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 4. Multivitamins 1 TAB PO DAILY 5. Testosterone Gel 1% 50 mg TP DAILY 6. Ascorbic Acid ___ mg PO DAILY 7. Aspirin 81 mg PO DAILY 8. Atripla (efavirenz-emtricitabin-tenofov) ___ mg oral DAILY 9. Cyanocobalamin 250 mcg PO DAILY 10. Fish Oil (Omega 3) 1000 mg PO DAILY 11. Lisinopril 20 mg PO DAILY 12. MetFORMIN (Glucophage) 500 mg PO BID 13. Vitamin D 1000 UNIT PO DAILY 14. Atenolol 12.5 mg PO DAILY Discharge Medications: 1. Fluticasone Propionate 110mcg 2 PUFF IH BID Duration: 5 Days 2. Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough RX *codeine-guaifenesin 10 mg-100 mg/5 mL 5 ml by mouth every six hours Disp ___ Milliliter Milliliter Refills:*0 3. Ascorbic Acid ___ mg PO DAILY 4. Atorvastatin 40 mg PO QPM 5. Atripla (efavirenz-emtricitabin-tenofov) ___ mg oral DAILY 6. Cyanocobalamin 250 mcg PO DAILY 7. Docusate Sodium 100 mg PO BID:PRN constipation 8. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 9. Fish Oil (Omega 3) 1000 mg PO DAILY 10. MetFORMIN (Glucophage) 500 mg PO BID 11. Multivitamins 1 TAB PO DAILY 12. Testosterone Gel 1% 50 mg TP DAILY 13. Vitamin D 1000 UNIT PO DAILY 14. HELD- Aspirin 81 mg PO DAILY This medication was held. Do not restart Aspirin until Instructed by your doctor 15. HELD- Atenolol 12.5 mg PO DAILY This medication was held. Do not restart Atenolol until instructed to by your doctor 16. HELD- Lisinopril 20 mg PO DAILY This medication was held. Do not restart Lisinopril until instructed by your doctor Discharge Disposition: Home Discharge Diagnosis: #Primary: Viral upper respiratory tract infection #Secondary: Chronic lymphocytic leukemia Anemia ___ CLL Thrombocytopenia Sepsis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. Why you were admitted to the hospital: - You were having fever, chills, nasal congestion, cough and shortness of breath What happened while you were here: - You were briefly treated with intravenous antibiotics - It was ultimately felt that a viral infection was causing your symptoms - You were given supportive measures like intravenous fluids and cough medications and your symptoms improved - You also received a blood transfusion due to low blood counts from the CLL What you should do once you return home: - Please follow up with Dr. ___ as described below; you have an appointment (time not yet scheduled) on ___. If you do not receive a phone call, please call clinic at ___ to verify your time - You will discuss and possibly start chemotherapy at this visit - Continue taking your medications as prescribed. Do not take atenolol or lisinopril until you follow up with Dr. ___ ___, Your ___ Care Team Followup Instructions: ___
19807987-DS-20
19,807,987
29,913,595
DS
20
2191-08-12 00:00:00
2191-08-12 17:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: amlodipine / pravastatin / Zocor Attending: ___. Chief Complaint: Chest pain Major Surgical or Invasive Procedure: Coronary angiogram ___ History of Present Illness: Mr. ___ is a ___ year-old male with history of hypertension, type 2 diabetes on metformin (A1C from ___ 6.6%), CKD (baseline Cr 1.2-1.4), asthma, former smoker (quit in ___) referred to the ED from his PCP office for ongoing chest pain. Per chart review, patient has a ___ week-history atypical of right-sided chest pain that occurs ___ days per day and occurs at both rest and exertion. Pain is described as achy and radiates to right trapizius region and right arm. Of note, patient had a recent ED visit on ___ with similar complaint. Stress MIBI from ___ with possible reversible, medium size perfusion defect involving the RCA territory. Normal left ventricular cavity size and function. LVEF 68%. Patient was supposed to have coronary angiogram on ___ however, due to continued chest pain was referred to the ED. Patient denies any presyncope symptoms, shortness of breath, PND, orthopnea, lower extremity edema, palpitations or presyncope. He also denies nausea, vomiting, change in bowel habit, fever or weight loss. In the ED: Patient reports right-sided shoulder pain with cervical pain. Initial vital signs were notable for: Temp: 97.6 HR: 74 BP: 138/83 Resp: 18 O2 Sat: 98 RA Labs were notable for: Hb: 11.8 | WBC: 5.3 | Plt: 231 Cr: 1.4 | K: 4.8 | BG: 204 T< 0.01 Patient was seen by Atrius Attending Dr. ___ thought that patient's symptoms might be cardiac in origin based on his prior stress MIBI and recommended urgent coronary angiography. Patient was shifted to cath lab. Studies performed include: =========================== Coronary Angiography - ___, which showed < 50% lesions in all 3 vessels serving the inferior wall. Consults: Cardiology Vitals on transfer: BP : 137/80 mmHg | HR: 67 | RR: 18 | O2 SATS: 97% RA. Upon arrival to the floor, patient confirms HPI. He endorses trapizial discomfort and pain in the cervical spine area. Past Medical History: - HTN: ___ years - DM/Pre-diabetes - Asthma - Obesity - Hypercholesterolemia - Allergic rhinitis - Erectile dysfunction - CKD - Peripheral neuropathy - Colonic polyp Social History: ___ Family History: Congestive heart failure Mother deceased age ___ of chf Myocardial Infarction Mother ___ Onset Mother ___ Mother ___ Sister Physical ___: ADMISSION PHYSICAL EXAM: ========================= VITALS: BP : 137/80 mmHg | HR: 67 | RR: 18 | O2 SATS: 97% RA. GENERAL: Alert and interactive. In no acute distress. HEENT: NCAT. PERRL, EOMI. Sclera anicteric and without injection. MMM. NECK: Thyroid is normal in size and texture, no nodules. No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. No increased work of breathing. BACK: Pain and paravertebral cervical spine tenderness ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial 2+ bilaterally. SKIN: Warm. Cap refill <2s. No rash. NEUROLOGIC: CN2-12 intact. ___ strength throughout. Normal sensation. Gait is normal. AOx3. DISCHARGE PHYSICAL EXAM: ========================= VS: T 97.5, BP 101/65, HR 72, RR 18, O2 97% on RA GEN: Well appearing, NAD CVD: RRR, no m/r/g PULM: CTAB ABD: Soft, non tender, non distended EXT: No tenderness to palpation of R shoulder joint, some reproducible pain w/ neck rotation Pertinent Results: LABS =============== ___ 02:10PM BLOOD WBC-5.3 RBC-3.94* Hgb-11.8* Hct-35.0* MCV-89 MCH-29.9 MCHC-33.7 RDW-11.3 RDWSD-36.6 Plt ___ ___ 02:10PM BLOOD Neuts-50.4 ___ Monos-8.8 Eos-0.4* Baso-0.2 Im ___ AbsNeut-2.69 AbsLymp-2.13 AbsMono-0.47 AbsEos-0.02* AbsBaso-0.01 ___ 02:10PM BLOOD Glucose-204* UreaN-25* Creat-1.4* Na-138 K-4.8 Cl-103 HCO3-23 AnGap-12 ___ 07:01AM BLOOD CK(CPK)-225 ___ 02:10PM BLOOD cTropnT-<0.01 ___ 07:01AM BLOOD CK-MB-1 cTropnT-<0.01 ___ 07:01AM BLOOD Calcium-9.7 Phos-3.8 Mg-1.8 STUDIES/IMAGING ================= ___ Coronary angiogram Moderate severity two vessel coronary coronary artery disease. ___ TTE Mild symmetric left ventricular hypertrophy with normal cavity size and regional/global biventricular systolic function. No valvular pathology or pathologic flow identified. ___ XR Shoulder Three views of the right shoulder are provided. No comparison. Status post shoulder surgery with surgical material and surgical remnants at the middle and lateral aspect of the humeral head. The humeral acromial distance is normal. No luxation. Mild degenerative changes at the level of the humeral glenoid joint. No cortical discontinuity indicative of fracture. ___ XR CSpine Three views of the cervical spine are provided. There is no comparison. Absence of the physiological cervical lordosis. Mild dorsal narrowing of the disc spaces and dorsal and ventral osteophyte formation, mild degenerative changes at the level of the intervertebral joints. No vertebral compression fractures. Brief Hospital Course: TRANSITIONAL ISSUES ===================== [] The patient's pain was felt to be secondary to musculoskeletal etiology in the arm or shoulder. If persistent consider advanced imaging or referral to orthopedics/pain specialist. [] Given findings of non obstructive CAD, recommend aggressive primary prevention strategies, including good control of blood pressure and diabetes. He may also benefit from carvedilol instead of labetolol. [] The patient was found to be slightly anemic with Hbg 10.9. Recommend age appropriate cancer screening and further work up if anemia worsens. SUMMARY ========= Mr. ___ is a ___ year-old male with history of hypertension, type 2 diabetes on metformin (A1C from ___ 6.6%), CKD (baseline Cr 1.2-1.4), asthma, former smoker (quit in ___ who presented with R sided chest and arm pain in the setting of a recent abnormal stress test. ACTIVE ISSUES =============== # Chest and shoulder pain # Stable coronary artery disease Given a recent stress test on ___ revealing for a possible reversible medium sized perfusion defect in the RCA territory, the patient's presenting symptoms of chest and arm pain were concerning for acute coronary syndrome, although troponins were negative and EKG was non specific. He underwent urgent cardiac catheterization which was revealing for non obstructive coronary artery disease, with no more than 60% stenosis in all 3 major vessels. An echo was done which showed normal global and regional systolic function. The patient continued to have arm, shoulder, and upper chest pain however, so xrays of the cervical spine and shoulder joint were obtained which showed mild degenerative changes in the spine and glenohumoral joint. Given his prior shoulder surgery and chronic back and joint pain, it was felt that the patient's symptoms were secondary to musculoskeletal etiology, which was likely aggravated recently when moving heavy boxes. The patient was given a lidocaine patch and pain medications. CHRONIC ISSUES ================ # Hyperlipidemia The patient was continued on home atorvastatin 80mg daily. # Type 2 Diabetes Mellitus Diabetes seems to be well controlled without retinopathy. A1C from ___ was 6.6. He was continued on metformin 500mg daily. # Hypertension The patient was continued on labetalol 600 mg BID, Torsemide 20mg daily, spironolactone 25mg daily, and lisinopril 20 mg daily. # Anemia of 11.8. It appears to be around his baseline in 12 range. Patient has history of colon polyps. Recommend outpatient with age appropriate screening. # Chronic pain/neuropathy The patient was continued on home gabapentin 300mg TID. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 80 mg PO QPM 2. Spironolactone 25 mg PO DAILY 3. MetFORMIN (Glucophage) 500 mg PO DAILY 4. Lisinopril 20 mg PO DAILY 5. Gabapentin 300 mg PO TID 6. Torsemide 20 mg PO DAILY 7. Sildenafil 20 mg PO ONCE:PRN Erectile dysfunciton 8. Acetaminophen 325 mg PO Q6H:PRN Pain - Mild/Fever 9. Labetalol 600 mg PO BID 10. Vitamin D 1000 UNIT PO DAILY 11. Fluticasone Propionate 110mcg 2 PUFF IH BID 12. Albuterol Inhaler 2 PUFF IH Q6H:PRN Asthma 13. Cyclobenzaprine 5 mg PO TID:PRN Back pain Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Acetaminophen 325 mg PO Q6H:PRN Pain - Mild/Fever 3. Albuterol Inhaler 2 PUFF IH Q6H:PRN Asthma 4. Atorvastatin 80 mg PO QPM 5. Cyclobenzaprine 5 mg PO TID:PRN Back pain 6. Fluticasone Propionate 110mcg 2 PUFF IH BID 7. Gabapentin 300 mg PO TID 8. Labetalol 600 mg PO BID 9. Lisinopril 20 mg PO DAILY 10. MetFORMIN (Glucophage) 500 mg PO DAILY 11. Sildenafil 20 mg PO ONCE:PRN Erectile dysfunciton 12. Spironolactone 25 mg PO DAILY 13. Torsemide 20 mg PO DAILY 14. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: Musculoskeletal arm pain Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. Why were you admitted to the hospital? - You were having right arm and chest pain. What happened while you were in the hospital? - Because you recently had an abnormal stress test, you were taken to have a procedure called a coronary angiogram. This showed mild narrowing of your heart arteries, but there were no major blockages, meaning you did not have a heart attack. - An ultra sound of your heart was done which showed normal heart function. - Your pain was felt to be more likely related to muscle or bone issues. Xrays of your shoulder and neck were done and you were treated with pain medications. What should you do when you go home? - Please take all your medications as prescribed. - Follow up with your primary care doctor as discussed below. We wish you the best! Your ___ Care Team Followup Instructions: ___
19808040-DS-13
19,808,040
26,922,334
DS
13
2143-08-19 00:00:00
2143-08-22 22:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Shortness of Breath/Fatigue Major Surgical or Invasive Procedure: None History of Present Illness: This is a ___ yo M with h/o HTN who was refered to the ED by his PCP ___ 1 month of fatigue and dyspnea. The patient presented to his PCP office today as he has been feeling poorly for over a month. Normally, he is very active, however, he began noticing difficulty completing his workouts 1 month ago. This progressed to increased fatigue with minimal exertion like climbing a flight of stairs. He denies chest pain or discomfort. Over the last few days, the patient has waking up around 5AM with acute shortness of breath. He also has noted a mild sensation of orthopnea. His appetite has been low and he endorses early satiety. He has noted increased abdominal bloating, pressure, and intermittent diarrhea since this time as well. A couple of months ago, the patient had a self-resolving episode of deep cough, fatigue, sore throat, but no rashes or GI symptoms. The patient saw his PCP today and was noted to have sinus tachycardia to 130s, so was refered for evaluation. In the ED, the patient had a CXR with evidence of pulmonary edema. He was peristently tachycardic. Cards was consulted and performed a bedside TTE that showed EF 15%. The patient was given 20mg IV lasix and was admitted for evaluation and treatment of acute systolic heart failure. REVIEW OF SYSTEMS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: Borderline HTN Social History: ___ Family History: Parents are healthy with only hyperlipidemia, but no early CAD or cardiomyopathy. Sister with asthma. Grandmother with "weak heart" and passed away in her ___. Physical Exam: ON ADMISSION VITALS: 98, 125/94, 112, 20, 96% RA GENERAL: NAD HEENT: PERRL, EOMI NECK: JVD elevated to level of mid neck at 60 degrees, when laid flat it increases to level of jaw LUNGS: mild crackles at bases bilaterally HEART: sinus tachycardia, normal S1, S2, +S3, no MRG ABDOMEN: Soft, NT, NABS, no organomegaly EXTREMITIES: Mild 1+ edema ___ NEUROLOGIC: A+OX3 ON DISCHARGE PE Afebrile, BP- 100-113/65, P- 86-93, RR- 18, 100%RA I/O- 700/700 Awake, alert, walking around, NAD HEENT- clear oropharnyx Neck- supple, JVP 9cm Lungs- very mild crackles at bases Heart- S1S2, no S3, no MRG Abd- sot, NT, ND, no hepatomegaly appreciated Extrem- 2+ pulses, 1+ distal pitting edema Pertinent Results: ON ADMISSION ___ 04:46PM GLUCOSE-101* UREA N-11 CREAT-1.2 SODIUM-139 POTASSIUM-4.3 CHLORIDE-105 TOTAL CO2-24 ANION GAP-14 ___ 04:46PM cTropnT-<0.01 proBNP-2992* ___ 04:46PM WBC-6.9 RBC-4.76 HGB-15.7 HCT-45.6 MCV-96 MCH-33.0* MCHC-34.5 RDW-13.4 ___ 04:46PM PLT COUNT-210 ON DISCHARGE ___ 05:50AM BLOOD WBC-7.0 RBC-4.85 Hgb-15.5 Hct-46.0 MCV-95 MCH-32.0 MCHC-33.8 RDW-13.1 Plt ___ ___ 05:50AM BLOOD UreaN-26* Creat-1.1 Na-138 K-4.2 Cl-103 HCO3-26 AnGap-13 ___ 05:50AM BLOOD Mg-2.4 Other Pertinent Results ___ 07:15PM BLOOD calTIBC-358 Ferritn-342 TRF-275 ___ 08:00AM BLOOD TSH-2.0 ___ 05:15PM BLOOD ___ dsDNA-NEGATIVE ___ 05:15PM BLOOD RheuFac-3 ___ 07:15PM BLOOD HIV Ab-NEGATIVE ___ 08:20AM BLOOD CK(CPK)-41* ___ 04:46PM BLOOD ALT-82* AST-31 AlkPhos-63 TotBili-2.1* Images ECG Sinus tachycardia. Marked left atrial abnormality. A-V conduction delay for the rate. Left ventricular hypertrophy with repolarization changes. Poor R wave progression across the precordium, probably related to the left ventricular hypertrophy. No previous tracing available for comparison. Echo ___ The left atrium is mildly dilated. The estimated right atrial pressure is at least 15 mmHg. Left ventricular wall thicknesses are normal. The left ventricular cavity is severely dilated. There is severe global left ventricular hypokinesis (LVEF = ___. A left ventricular mass/thrombus cannot be excluded. Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve leaflets are structurally normal. Moderate (2+) mitral regurgitation is seen. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Dilated left ventricle with severe global systolic dysfunction, most c/w nonischemic cardiomyopathy. Moderate functional mitral regurgitation. Mild pulmonary hypertension. Echo ___ IMPRESSION: Markedly dilated left ventricular cavity with severe global hypokinesis c/w diffuse process (toxin, metabolic, etc. The pattern is less suggestive of multivessel CAD). At least mild-moderate mitral regurgitation. Borderline pulmonary arterial systolic hypertension. Compared with the findings of the prior study (images reviewed) of ___, global left ventricular systolic function is slightly improved and the heart rate is slower. Cardiac MR ___ Brief Hospital Course: ___ year old M with no significant PMHx presents with 3 weeks of worsening shortness of breath and fatigue, found to have severe systolic heart failure. Congestive Heart Failure Echocardiogram revealed EF ___. The patient was initially aggressively diuresed and begun on PO Lisinopril. After he became more euvolemic, beta blocker therapy (metoprolol succinate) was initiated. He was also started on spironolactone. One evening, the patient was triggered for symptomatic hypotension (81/59) but this quickly resolved with 200cc of NS. Afterwards he was started on digoxin therapy as well. The cause of the patient's systolic heart failure is unclear. He does report alcohol use and does note that he had a viral illness that included a sore throat in ___, but a strep test was negative at the time. All other tests for known causes of heart failure were negative including TSH, iron studies, HIV, ___, anti dsDNA, and RF. Repeat echocardiogram showed no evidence of LV thrombus. By discharge, the patient had been diuresed ___ of fluid and was feeling well. He was seen by Social Work to help him cope with his new diagnosis and by nutrition for diet education for heart failure patients. Transitional Issues The patient will be followed closely in the ___ clinic under the guidance of Dr ___ NP ___. The patient had a cardiac MRI done before discharge that has yet to be ___. He has been instructed to weigh himself each morning after voiding and before breakfast. If he gains more than 2 lbs in a day or gains weight for 3 straight days he has been instructed to call Dr ___. He has also been instructed to avoid alcohol and caffeine. He should not be taking any supplements or herbal medications until they are cleared by Dr ___. Medications on Admission: Preadmission medications listed are correct and complete. Information was obtained from PatientFamily/Caregiver. 1. Multivitamins 1 TAB PO DAILY 2. Fish Oil (Omega 3) Dose is Unknown PO DAILY 3. Probiotic *NF* (lactobacillus rhamnosus GG) 10 billion cell Oral Daily Discharge Medications: 1. Digoxin 0.125 mg PO DAILY RX *digoxin 125 mcg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 2. Furosemide 20 mg PO DAILY RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Lisinopril 5 mg PO DAILY RX *lisinopril 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 4. Metoprolol Succinate XL 25 mg PO DAILY Hold for HR<55, SBP<90 RX *metoprolol succinate 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Spironolactone 12.5 mg PO DAILY Hold for SBP<90 RX *spironolactone 25 mg 0.5 (One half) tablet(s) by mouth daily Disp #*15 Tablet Refills:*0 6. Fish Oil (Omega 3) 1000 mg PO DAILY 7. Multivitamins 1 TAB PO DAILY 8. Probiotic *NF* (lactobacillus rhamnosus GG) 10 billion cell Oral Daily Discharge Disposition: Home Discharge Diagnosis: Acute Systolic Congestive Heart Failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You came to the hospital with shortness of breath and fatigue. An ultrasound of your heart showed that you're heart is very weak and you have something called systolic heart failure. We have started you on medications that have been shown to benefit patients with your condition. In addition, we have started a water pill that will help keep fluid out of your lungs and improve your breathing, which can happen with heart failure. It is vital that you take these medications every day - do not stop any of them unless you discuss this with Dr. ___. DO NOT start any new medications, herbs or supplements until you consult with Dr ___. Many of these medications can interact poorly with the medications you are already taking and worsen your heart disease. It is unclear what has caused your heart failure. All of the blood tests that can detect a specific cause have been negative. You did report you had a viral illness several months ago; this can be a cause. In addition, alcohol consumption can cause this as well. You must avoid ALL alcohol on discharge. Also please avoid caffeine intake until you follow up with Dr ___ ___. You will continue to follow-up with the Heart Failure service with Dr ___ NP ___. They will optimize your medications and monitor your heart function. Weigh yourself every morning after voiding, call Dr. ___ ___ if your weight goes up more than 2 lbs in a day, or you notice your weight increases by 3 pounds over 3 consecutive days. It was a pleasure taking care of you, Mr ___. Followup Instructions: ___
19808487-DS-22
19,808,487
29,124,262
DS
22
2162-03-01 00:00:00
2162-03-02 11:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Altered Mental Status, Abnormal Labs. Major Surgical or Invasive Procedure: NONE History of Present Illness: Mr. ___ is a ___ year old male with history of HIV on HAART therapy, Afib, peripheral artery disease, hypertension, and diabetes mellitus type II, presenting for laboratory abnormalities at rehab concerning for acute renal failure. Patient is being admitted to the MICU for further management of his acute renal failure. Patient was recently admitted for 10 day stay, and discharged on ___ (3 days prior to his admission) to rehab. Patient was initially admitted to the vascular surgery service for non-healing right plantar ulcer, and underwent procedure. During his hospital stay, patient underwent cannulation and access of his left common femoral artery and placement of a ___ sheath, catheter placement of right external iliac artery, abdominal aortogram, and right lower extremity angiogram. He also underwent on ___ debridement of his right foot with resection of the remnant ___ metatarsal, vein graft, and full thickeness skin graft of 6x5 cm over the wound. During the procedure, there is no notation of low blood pressure or other hemodynamic instabilities. He underwent an ALT flap to the right foot, FTSG to right dorsal foot surface, and handsewn arterial anastomosis end to end to distal DP. A vein graft required left medial thigh saphenous branch graft and two coupled anastomoses. A dangle protocol was done and tolerated well. During procedure, patient did have a 10 point hematocrit drop and was transfused 1 unit pRBC. Patient also was started on ciprofloxacin for a presumed UTI, and given MSSA and mixed bacterial flora in the OR culture, he was seen by ID and started on cefazolin with OPAT. Patient was also restarted on his pradaxa on POD#4. Patient was discharged to rehab, and patient did not have labs drawn upon discharge for renal function. Patient was discharged on ___, and last electrolytes obtained on ___, which showed discharged CR BUN ___. Patient was at rehab, found to have increasingly altered mental status, and labs initially concerning for elevated BUN / Cr, and therefore was sent to ___ for further evaluation. #In the ED, initial vitals: 97.8 85 93/36 18 99% RA. Patient was then found to be hypotensive to 68/41, and was started on IVF and norepinephrine for hypotension. Patient's initial exam was non-focal, however patient was found to not be following commands. Patient's labs were c/f K 5.2, BUN 113 / 8.1, CK 61, Phosph 8.6, Mag 4.7, Calcium 7.4. INR 13.4, PTT 150. Lactate 2.4. Patient was evaluated by renal, who advised foley catheter placement, urine studies. Patient had initial u/a with RBC, WBC 44, Protein 30, Mod leuk, Large blood. Patient also evaluated by vascular surgery, without acute intervention. Imaging obtained was CT abdomen with mild fullness, mild hydronephrosis of the right renal collecting, atrophic pancreas, no RP hematoma, anasarca, and dilated loops of the proximal small bowel with likely partial or early complete SBO. Patient also had a CT head without abnromalitiy, and CXR obtained, and cultured. Patient was given ___ 17:45 IVF 1000 mL NS ___ 18:28 IV Piperacillin-Tazobactam 4.5 g ___ 18:51 IV DRIP Norepinephrine Started 0.03 mcg/kg/min ___ 19:06 IV Vancomycin 1000 mg ___ 19:06 IV DRIP Norepinephrine Rate Changed to 0.06 mcg/kg/min ___ 19:27 IV Dextrose 50% 25 gm ___ 19:27 IVF 1000 mL NS 1000 mL ___ 19:27 IVF 1000 mL NS 1000 mL ___ 19:27 IVF 1000 mL NS 1000 mL On transfer, vitals were: 66 86/50 17 98% RA On arrival to the MICU, patient was alert and oriented x 2. Patient denied any complaints at this time. He was complaining of some leg pain where a former drain was done. Review of systems: (+) Per HPI Past Medical History: 1. Atrial Fibrillation 2. Aortic Stenosis s/p AVR (bioprosthetic) 3. Hypertension 4. Dyslipidemia 5. IDDM Type II 6. HIV on HAART 7. PCP ___ 8. Chronic Pancreatitis 9. Hepatitis B PSH: 1. AVR ___ Tissue Valve). 2. Left foot podiatric Surgery. Social History: ___ Family History: Mother: passed at age ___, aortic aneurysm Sister: healthy Physical ___: ADMISSION PHYSICAL EXAM: Vitals: T: afebrile BP: 110s/50s P: 80s R: 18 O2: 98% on RA GENERAL: Alert, oriented to self/place/president, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Irregular rhythm, regular rate, no murmurs appreciated ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding EXT: WWP, no peripheral edema, R-sided amputation. DISCHARGE PHYSICAL EXAM Vitals: T: 97.5 BP: 127/54 (127-153/64-95) P: 64 (64-95) R: 20 O2:99RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, PERRL, EOMI, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Irregularly irregular with systolic murmur Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: no clubbing, cyanosis or edema. Pulses not palpable in lower extremities bilaterally. RLE amputation site appears pink and well-perfused; lower right leg shows chronic venous stasis hyperpigmentation. Skin: Left thigh has medial and lateral incision sites covered with bandage. Unstageable pressure ulcer on lower middle back. MSK: Moves all extremities. No paraspinal tenderness. Neuro: Oriented to own name, place, date, birthday, and situation. Diminished sensation on lower right leg compared to left leg. Labs: see below Imaging and studies: see below Pertinent Results: ADMISSION LABS ======================== ___ 05:40PM BLOOD WBC-14.3* RBC-3.06* Hgb-8.6* Hct-27.2* MCV-89 MCH-28.1 MCHC-31.6* RDW-14.8 RDWSD-48.3* Plt ___ ___ 05:40PM BLOOD Neuts-69 Bands-12* Lymphs-11* Monos-5 Eos-3 Baso-0 ___ Myelos-0 AbsNeut-11.58* AbsLymp-1.57 AbsMono-0.72 AbsEos-0.43 AbsBaso-0.00* ___ 05:40PM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ Macrocy-1+ Microcy-1+ Polychr-NORMAL Ovalocy-1+ ___ 06:39PM BLOOD ___ PTT-150* ___ ___ 09:50PM BLOOD ___ Thrombn-150* ___ 05:40PM BLOOD Glucose-62* UreaN-113* Creat-8.1*# Na-132* K-5.2* Cl-93* HCO3-19* AnGap-25* ___ 05:40PM BLOOD ALT-1 AST-25 CK(CPK)-61 AlkPhos-107 TotBili-0.1 ___ 05:40PM BLOOD Albumin-2.8* Calcium-7.4* Phos-8.6*# Mg-4.7* ___ 09:50PM BLOOD calTIBC-208 Ferritn-181 TRF-160* ___ 09:50PM BLOOD CRP-33.4* ___ 09:50PM BLOOD Digoxin-1.3 ___ 05:40PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 06:16PM URINE Color-DKMB Appear-Hazy Sp ___ ___ 06:16PM URINE Blood-LG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-MOD ___ 06:16PM URINE RBC->182* WBC-44* Bacteri-FEW Yeast-NONE Epi-0 SIGNIFICANT LABS ======================== ___ 02:52AM BLOOD ___ PTT-144.6* ___ ___ 05:50AM BLOOD ___ PTT-33.4 ___ ___ 09:50PM BLOOD ___ Thrombn-150* ___ 09:50PM BLOOD Ret Aut-2.63* Abs Ret-0.0800 ___ 05:40PM BLOOD Glucose-62* UreaN-113* Creat-8.1*# Na-132* K-5.2* Cl-93* HCO3-19* AnGap-25* ___ 05:50AM BLOOD Glucose-143* UreaN-16 Creat-1.0 Na-146* K-4.1 Cl-111* HCO3-25 AnGap-14 ___ 02:52AM BLOOD ALT-0 AST-18 LD(LDH)-321* AlkPhos-94 TotBili-0.1 MICROBIOLOGY ======================== __________________________________________________________ ___ 8:37 am SWAB Source: L medial thigh incision. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. WOUND CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Preliminary): NO GROWTH. __________________________________________________________ ___ 9:54 am STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). __________________________________________________________ ___ 10:10 am MRSA SCREEN Source: Nasal swab. **FINAL REPORT ___ MRSA SCREEN (Final ___: No MRSA isolated. __________________________________________________________ ___ 2:52 am BLOOD CULTURE Source: Line-PICC. Blood Culture, Routine (Pending): __________________________________________________________ ___ 10:00 pm MRSA SCREEN Source: Nasal swab. **FINAL REPORT ___ MRSA SCREEN (Final ___: No MRSA isolated. __________________________________________________________ ___ 6:15 pm BLOOD CULTURE Blood Culture, Routine (Pending): __________________________________________________________ ___ 6:16 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. __________________________________________________________ Time Taken Not Noted Log-In Date/Time: ___ 5:42 pm BLOOD CULTURE Blood Culture, Routine (Pending): RADIOLOGY ======================== ___ CXR IMPRESSION: Low lung volumes with probable bibasilar atelectasis. ___ CT ABD PELVIS W/O CON IMPRESSION: 1. Limited evaluation without IV contrast and with the patient's arms down causing significant streak artifact in the upper abdomen. 2. Dilated loops of proximal small bowel with apparent transition zone in the left upper hemipelvis and relatively collapsed loops distally. Gas and stool remains in the colon. Findings may reflect a partial small bowel obstruction. 3. Mild hydronephrosis and proximal hydroureter on the right without evidence of urolithiasis. This could be further evaluated with MRU if clinically indicated. 4. The pancreas is severely atrophic with numerous scattered calcifications compatible with chronic pancreatitis. 5. No retroperitoneal hematoma. The abdominal aorta is normal in caliber with scattered atherosclerosis. 6. Mild anterior height loss of T12, new since at least ___. 7. Trace left pleural effusion. Anasarca. 8. Small fat and fluid containing left inguinal hernia. DISCHARGE LABS ========================= ___ 05:46AM BLOOD WBC-11.2* RBC-2.82* Hgb-7.9* Hct-25.8* MCV-92 MCH-28.0 MCHC-30.6* RDW-15.5 RDWSD-48.7* Plt ___ ___ 05:46AM BLOOD Plt ___ ___ 05:46AM BLOOD Glucose-245* UreaN-11 Creat-0.8 Na-139 K-3.7 Cl-106 HCO3-26 AnGap-11 ___ 05:46AM BLOOD Calcium-7.7* Phos-2.5* Mg-1.6 Brief Hospital Course: In short, Mr. ___ had previously been hospitalized, d/c'd on ___ (admitted to ___ surgery) for a non-healing ulcer. During his stay he received several procedures includign abdominal aortogram and RLE angiogram. He also underwent surgical debridement of his right foot with resection of the ___ metatarsal, vein graft, and full thickness skin graft 6x5 cm over the wound on ___ the procedure was notable for a 10pt Hct drop and was transfused 1 unit pRBC. He was subsequently started on ciprofloxacin for a presumed UTI and cefazolin w/OPAT after MSSA and mixed bacterial flora were seen on OR culture. He was restarted on Pradaxa for A-fib on ___. He was discharged to rehab on ___ (3 days prior to current admission). His last renal function labs taken on ___ showed BUN Cr ___. Three days later in rehab, the patient was found to have altered mental status and labs concerning for elevated BUN/Cr (Cr reportedly 7.5). In the ED he was found to be hypotensive to 68/41 and was started on IVF and norepi. Patient's neuro exam was non-focal but he could not follow commands. Labs c/f K 5.2, BUN 113 / 8.1, CK 61, Phosph 8.6, Mag 4.7, Calcium 7.4. INR 13.4, PTT 150. Lactate 2.4. He was evaluated by renal, and a foley was placed with U/A showing RBC, WBC 44, Protein 30, Mod leuk, Large blood. CT abdomen showed mild fullness, mild hydronephrosis of the right renal collecting, atrophic pancreas, no RP hematoma, anasarca, and dilated loops of the proximal small bowel c/w with likely partial or early complete SBO. Patient was subsequently bolused ___. He was also given IV Zosyn, Vanc, and norepinephrine (0.06). He was transferred to the MICU, where he has been hemodynamically stable and afebrile. His UOP has gradually increased and his Cr has fallen. On ___ his INR was found to be 17 and he was given 10mg vit K. On ___ INR had dropped to 1.6, Cr was down to 2.2 and UA was positive for 18 WBC and >182 RBC. His pradaxa was held given his elevated INR. The etiology of the coagulopathy is unknown, even though pradaxa is renally excreted, it is very strange that it could build up to high enough levels during renal failure to cause such a profound coagulopathy. Having said this, with the patient's normalization of his INR, his pradaxa was restarted on ___. Plastics evaluated his RLE and noted a fluid collection in medial thigh that they opened up today at bedside today and sent for culture. The wound sites showed no signs of infection per their report and antibiotics were stopped on ___. Mr. ___ MICU stay has also been notable for some confusion, loose BM starting on ___ (c.diff negative; tx w/loperamide), and nausea (tx w/Zofran). The patient was also found to be anemic with his baseline Hgb reported to be around 10; his hgb is currently stable at 8.8 today (was 8.6 on admission). Anemia could be multifactorial and related to blood loss possibly related to hematuria in setting of coagulopathy or due to intraoperative blood loss. No evidence of GI bleed, no RP bleed on CT. Furthermore, reticulocyte count on ___ were c/w inadequate Epo response, possibly c/w acute renal failure. Latest serum iron on ___ showed iron of 6 (TIBC low at 208, transferrin low at 160, ferritin WNL) His MCV on transfer was WNL at 93. RBC morphology studies on ___ were WNL. His pradaxa was restarted once his renal function returned to baseline. Since his transfer from the MICU, the patient was never febrile and the wound and other cultures remained negative. # Osteomyelitis. He was continued on cefazolin for osteomyelitis s/p amputation, and will need a 6 week course ___ - ___ (6 weeks therapy)) # ___ retention. Cr normalized to 0.8 on ___. On the day of discharge; voiding trial was attempted, but unsuccessful. He required replacement of his Foley. Finasteride and tamsulosin were restarted. Patient will follow up with urology as outpatient. During this hospitalization, his medications were all renally dosed and then returned to his previous dossing with normalization of the patient's GFR. # Delirium. Mental status returned to baseline since discharge from MICU. # Atrial fibrillation s/p bioprosthetic AVR. Was restarted on home digoxin and diltiazem. Dabigatran was restarted after INR normalized. # Hypertension. Lisinopril and furosemide were held in the setting of hypotension; with a plan to restart as outpatient. #HIV/AIDs on HAART. Hx of PCP ___ was continued on home HAART therapy. TRANSITIONAL ISSUES [] Will require urology follow up for BPH and Foley removal (scheduled) [] Please check weekly CBC w/ diff, BUN, ESR/CRP while on cefazolin [] Please consider restarting lisinopril and furosemide [] Metoprolol succinate was restartd at a lower dose; please uptitrate as needed [] Please follow up with OPAT/ID for continued surveillance of osteomyelitis. Continue cefazolin, planned course: ___ - ___ [] Please uptitrate gabapentin to 600 TID (preadmission dose) for control of pain, slowly as to not cause somnolence. [] Pt's insulin dose was decreased to lantus 15u daily. This may require continued uptitration, goal FSs 150s-200s. Wound care: Site: RLE Patient may 'dangle' the RLE for 30 minutes TID. The dangle periods may be used for bathroom use and getting OOB to chair. Non-weight bear on RLE. Please apply aquaphor ointment to RLE daily (over surgical sites). . Sacral pressure ulcer: after cleansing, cover wound with Mepilex sacrum foam dressing. Change every three days and prn [] CONTACT: ___ at ___; PCP ___ ___ RN ___ ___ proxy is ___ in ___ also his sister [] CODE STATUS: Full Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Abacavir Sulfate 300 mg PO BID 2. Acetaminophen 650 mg PO Q6H 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 20 mg PO QPM 5. CefazoLIN 2 g IV Q8H 6. Creon 12 3 CAP PO TID W/MEALS 7. Dabigatran Etexilate 150 mg PO BID 8. Digoxin 0.25 mg PO DAILY 9. Diltiazem Extended-Release 180 mg PO BID 10. Docusate Sodium 100 mg PO BID 11. Etravirine 200 mg PO BID 12. Furosemide 40 mg PO DAILY 13. Gabapentin 600 mg PO TID 14. LaMIVudine 150 mg PO DAILY 15. Metoprolol Succinate XL 100 mg PO BID 16. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain- moderate 17. Polyethylene Glycol 17 g PO DAILY:PRN constipation 18. Raltegravir 400 mg PO BID 19. Senna 8.6 mg PO BID:PRN constipation 20. Simethicone 40-80 mg PO QID:PRN gas pain 21. Lisinopril 5 mg PO DAILY 22. Glargine 42 Units Breakfast Insulin SC Sliding Scale using UNK Insulin Discharge Medications: 1. Abacavir Sulfate 300 mg PO BID 2. Acetaminophen 650 mg PO Q6H 3. Creon 12 3 CAP PO TID W/MEALS 4. Dabigatran Etexilate 150 mg PO BID 5. Docusate Sodium 100 mg PO BID 6. Etravirine 200 mg PO BID 7. LaMIVudine 150 mg PO DAILY 8. Polyethylene Glycol 17 g PO DAILY:PRN constipation 9. Raltegravir 400 mg PO BID 10. Senna 8.6 mg PO BID:PRN constipation 11. LOPERamide 2 mg PO QID:PRN diarrhea 12. Tamsulosin 0.4 mg PO QHS 13. Aspirin 81 mg PO DAILY 14. Atorvastatin 20 mg PO QPM 15. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain- moderate RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*42 Tablet Refills:*0 16. Simethicone 40-80 mg PO QID:PRN gas pain 17. Insulin SC Sliding Scale Fingerstick QACHS Insulin SC Sliding Scale using HUM Insulin 18. CefazoLIN 2 g IV Q8H ___ - ___ 19. Outpatient Lab Work ICD-10: Acute Osteomyelitis Draw every ___: WEEKLY: CBC with differential, BUN, Cr, ESR/CRP, INR ALL LAB RESULTS SHOULD BE SENT TO: ATTN: ___ CLINIC - FAX: ___ All questions regarding outpatient parenteral antibiotics after discharge should be directed to the ___ R.N.s at ___ or to the on-call ID fellow when the clinic is closed. 20. Metoprolol Succinate XL 100 mg PO DAILY 21. Gabapentin 300 mg PO TID 22. Finasteride 5 mg PO DAILY 23. Digoxin 0.25 mg PO DAILY 24. Diltiazem Extended-Release 180 mg PO BID 25. Lorazepam 0.25 mg PO Q4H:PRN anxiety RX *lorazepam 0.5 mg 0.5 (One half) tablet by mouth every four hours Disp #*42 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis Acute Renal Failure Atrial Fibrilation Altered Mental Status Anemia Secondary Diagnosis HIV/AIDS Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you while in the hospital. You came to the hospital because of confusion. You were found to be in kidney failure. This was attributed to an obstruction, preventing urine from emptying out of your bladder. You required a stay in the ICU to normalize your kidney function. During this time, you were at very high risk of bleed and your blood thinning medication was held. Once your kidney function returned to normal, we restarted your medications. We also started you on a medication to prevent your bladder from becoming obstructed. Your medications and follow up appointments are detailed bellow. We wish you the best! Your ___ care team Followup Instructions: ___
19808744-DS-10
19,808,744
23,495,682
DS
10
2180-11-03 00:00:00
2180-11-23 06:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: back pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ yo F with PMH as noted, with three week h/o low back pain, L leg pain, and one week h/o L ankle pain. Pt previously treated with several day course of oral steroids (pred 40 mg daily) with improvement (completed ___, but since then has been managing conservatively. She has seen ___ but has increased pain with ___. Pain is in left lumbar region with radiation down L leg, burning sensation. Has had increased L ankle pain for the week prior to admission, no trauma. She has been crawling for the three days prior to admission. On the day of admission, alarm went off - she "dragged myself down the stairs" and police arrived. She called her daughter, who brought her to the ED. In the ED, neurosurgery team recommended L-spine MRI and pain control, but patient has pacer. Pt received diazepam 5 mg with improvement, along with acetaminophen 1000 mg. However, she states that the diazepam made her feel unwell, and she would prefer to try flexeril. She is hesitant to take NSAIDS given prior PUD. Her apixaban was dosed at 3:10 pm. She was admitted for further care. On admission, she feels well, with no current pain. She states that her ankle pain is the most severe pain. Past Medical History: Sick sinus s/p pacer Pacer details: Date of Implant: ___ Indication: ___ Device brand/name: ___ Model Number:2240 HTN CHF Gastric ulcer (NSAID related) h/o melanoma Social History: ___ Family History: FAMILY HISTORY: Mom with ulcers. No history of colon or other cancer. Physical Exam: ADMISSION: Physical Exam: afeb 123/74 61 18 95% (RA) GENERAL: NAD Mentation: Alert, speaks in full sentences Eyes: NC/AT Ears/Nose/Mouth/Throat: MMM Neck: Supple Resp: CTA bilat CV: RRR, normal S1S2 GI: Soft, NT/ND, normoactive bowel sounds Skin: No rash Extremities: No edema Neuro: - Mental Status: Alert & oriented x3. Able to relate history without difficulty -Motor: Normal bulk, strength and tone throughout. No abnormal movements noted. Able to sit up without difficulty, can bend L knee to 100 degrees without difficult. LLE ___ strength ___ Spine - nontender L ankle- No ecchymoses; nontender. Can flex/extend without difficulty DISCHARGE: ___ 0815 Temp: 98.2 PO BP: 133/70 HR: 80 RR: 18 O2 sat: 94% O2 delivery: RA GENERAL: NAD Mentation: pleasant woman in NAD at rest in bed. Eyes: NC/AT Ears/Nose/Mouth/Throat: MMM Neck: Supple Resp: CTA bilat CV: RRR, normal S1S2 GI: Soft, NT/ND, normoactive bowel sounds Skin: No rash Extremities: No edema Neuro: no facial droop, ___ strength through b/l ___ including ankle flex/dorisflex, hip flexion, knee extension, gait deferred. + mild lumbar vertebral tenderness, no paraspinal muscle tenderness. Pertinent Results: LABS: ==== ___ 10:50AM BLOOD WBC-12.2* RBC-4.19 Hgb-13.2 Hct-39.0 MCV-93 MCH-31.5 MCHC-33.8 RDW-13.2 RDWSD-45.3 Plt ___ ___ 04:55AM BLOOD WBC-7.2 RBC-3.86* Hgb-12.1 Hct-36.6 MCV-95 MCH-31.3 MCHC-33.1 RDW-13.2 RDWSD-45.6 Plt ___ ___ 10:50AM BLOOD Glucose-119* UreaN-11 Creat-0.7 Na-141 K-4.1 Cl-103 HCO3-25 AnGap-13 IMAGING: ====== ___ CXR IMPRESSION: Pacemaker leads terminate in right atrium and right ventricle. Heart size and mediastinum are stable. Lungs are clear. There is no appreciable pleural effusion. There is no pneumothorax ___ L ankle plain film Impression: No acute fracture or dislocation. Brief Hospital Course: ___ with SSS s/p PPM on apixiban, ___, PUD, and known DJD who presents with acute worsening of low back pain with radiation down the leg. Based on ___ CT, patient with extensive DJD at L4-S1, remains neurologically intact but with worsening pain limiting function. CT noted lateral disc protusion with compression of L5, consistent with patient's distribution of pain. Additionally, CT noted perineural S2 lesion likely cyst but cannot exclude nerve sheath tumor and thus MRI recommended. She was seen by Spine surgery who felt there was no emergent process warranting urgent surgical intervention. Recommended MRI. Due to PPM, clearance was obtained from Cardiology. Unfortunately, unable to get MRI ___. After discussing with patient and family, plan for ongoing conservative management with symptom control, outpatient pain clinic, and outpatient scheduled MRI. Outpatient providers contacted via email to coordinate ongoing care. TRANSITIONAL ISSUES: ================= Recommend MRI to further evaluate perineural S2 lesion, likely cyst but cannot exclude neural sheath tumor. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Apixaban 5 mg PO BID 2. Atorvastatin 20 mg PO QAM 3. Metoprolol Succinate XL 50 mg PO BID 4. Omeprazole 40 mg PO QHS 5. Torsemide 60 mg PO QAM 6. Verapamil SR 240 mg PO QAM Discharge Medications: 1. Acetaminophen 650 mg PO TID 2. Cyclobenzaprine 10 mg PO HS:PRN moderate pain RX *cyclobenzaprine 10 mg 1 tablet(s) by mouth at bedtime Disp #*20 Tablet Refills:*0 3. TraMADol ___ mg PO Q6H:PRN Pain - Severe RX *tramadol 50 mg 0.5 to 1 tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 4. Apixaban 5 mg PO BID 5. Atorvastatin 20 mg PO QAM 6. Metoprolol Succinate XL 50 mg PO BID 7. Omeprazole 40 mg PO QHS 8. Torsemide 60 mg PO QAM 9. Verapamil SR 240 mg PO QAM Discharge Disposition: Home Discharge Diagnosis: # Lumbar radiculopathy Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a privilege to care for you at the ___ ___. You were admitted with back and leg pain that is due to a herniated disc in your spine. You were evaluated by our spine surgeons who luckily feel that there is no emergency requiring surgical intervention. It is very reasonable to try a conservative management approach. This will including giving you medications to treat your symptoms, seeing the Pain doctors on ___, and coordinating an outpatient MRI in case this approach does not work and you need further evaluation by the Spine team. Please only take the flexeril at night as this can make you very sleepy. You are also being provided a prescription for a medication called tramadol that you can take in the daytime for pain, but this sometimes makes people drowsy as well. Please make sure you are very cautious until you know how these medications affect you. Following discharge I will be reaching out to Dr. ___ to coordinate the next steps. Again, it is very important to go to your visit with her on ___ ___s visit the pain clinic visit arranged for ___ as well. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19809002-DS-6
19,809,002
22,341,699
DS
6
2164-02-24 00:00:00
2164-02-27 06:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: ___: Laparoscopic cholecystectomy History of Present Illness: ___ with a history of reflux who presents with RUQ pain which started at 1 am this morning. The pain was sharp and associated with nausea and non-bloody emesis x4. He initially tried tums and went back to sleep but again awoke with severe pain. He has been having issues with constipation for the past several days but did have a small bowel movement this morning. He last ate last night. At the time of my evaluation he says his pain is improved, but is still present. He has no nausea at this time. He has no fevers or chills. Past Medical History: Past Medical History:GERD Past Surgical History:None Social History: ___ Family History: non-contributory Physical Exam: Admission Physical Exam: Vitals: 96.6 69 128/85 18 98RA GEN: A&O, NAD CV: RRR, No M/G/R PULM: non-labored on RA ABD: Soft, mildly distended. Mildly TTP RUQ. Ext: No ___ edema, ___ warm and well perfused Discharge Physical Exam: VS: 98.2, 153/91, 89, 18, 94%RA Gen: A&O x3, lying comfortably in bed CV: HRR Pulm: LS ctab Abd: soft, appropriately TTP around incisions. Lap sites CDI. Ext: WWP no edema Pertinent Results: Laboratory: ___ 05:12AM BLOOD WBC: 11.2* RBC: 4.60 Hgb: 14.3 Hct: 41.2 MCV: 90 MCH: 31.1 MCHC: 34.7 RDW: 11.8 RDWSD: 37.___ ___ 05:12AM BLOOD Glucose: 126* UreaN: 16 Creat: 0.9 Na: 142 K: 4.3 Cl: 105 HCO3: 23 AnGap: 14 ___ 05:12AM BLOOD ALT: 30 AST: 24 AlkPhos: 76 TotBili: 0.3 ___ 05:12AM BLOOD Albumin: 5.2 Calcium: 10.3 Phos: 3.3 Mg: 2.0 Post-Op Labs: ___ 07:10AM BLOOD WBC-11.5* RBC-4.42* Hgb-13.7 Hct-39.9* MCV-90 MCH-31.0 MCHC-34.3 RDW-12.1 RDWSD-39.2 Plt ___ ___ 07:10AM BLOOD Glucose-96 UreaN-10 Creat-0.9 Na-145 K-4.2 Cl-104 HCO3-25 AnGap-16 ___ 07:10AM BLOOD ALT-79* AST-47* AlkPhos-75 TotBili-0.7 ___ 07:10AM BLOOD Calcium-9.7 Phos-4.4 Mg-2.0 Imaging: US: IMPRESSION: Cholelithiasis without evidence of acute cholecystitis. Of note, there is a 1.7 cm stone at the gallbladder neck. Brief Hospital Course: The patient was admitted to the General Surgical Service on ___ for evaluation and treatment of abdominal pain. Admission abdominal ultra-sound revealed cholelithiasis without evidence of acute cholecystitis. The patient underwent laparoscopic cholecystectomy, which went well without complication (reader referred to the Operative Note for details). After a brief, uneventful stay in the PACU, the patient arrived on the floor tolerating liquids, on IV fluids, and oral analgesia for pain control. The patient was hemodynamically stable. Pain was well controlled. POD1, the patient experienced an episode of intense abdominal muscle spasms that were relieved with flexeril and Ativan. Diet was progressively advanced as tolerated to a regular diet with good tolerability. The patient voided without problem. During this hospitalization, the patient ambulated early and frequently, was adherent with respiratory toilet and incentive spirometry, and actively participated in the plan of care. The patient received subcutaneous heparin and venodyne boots were used during this stay. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home without services. The patient and his wife received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: none Discharge Medications: 1. Acetaminophen 1000 mg PO Q6H RX *acetaminophen 500 mg 2 tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 2. Cyclobenzaprine 10 mg PO ONCE Duration: 1 Dose RX *cyclobenzaprine 10 mg 1 tablet(s) by mouth once a day Disp #*1 Tablet Refills:*0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*20 Capsule Refills:*0 4. LORazepam 0.5 mg PO ONCE Duration: 1 Dose RX *lorazepam 0.5 mg 1 tab by mouth once a day Disp #*1 Tablet Refills:*0 5. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*5 Tablet Refills:*0 6. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 17 gram 1 powder(s) by mouth once a day Disp #*14 Packet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Cholelithiasis Biliary colic Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital with biliary colic. You were taken to the operating room and had your gallbladder removed laparoscopically. You tolerated the procedure well and are now being discharged home to continue your recovery with the following instructions. Please follow up in the Acute Care Surgery clinic at the appointment listed below. ACTIVITY: o Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. o You may climb stairs. o You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. o Don't lift more than ___ lbs for 4 weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. o You may start some light exercise when you feel comfortable. o You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: o You may feel weak or "washed out" for a couple of weeks. You might want to nap often. Simple tasks may exhaust you. o You may have a sore throat because of a tube that was in your throat during surgery. o You might have trouble concentrating or difficulty sleeping. You might feel somewhat depressed. o You could have a poor appetite for a while. Food may seem unappealing. o All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: o Tomorrow you may shower and remove the gauzes over your incisions. Under these dressing you have small plastic bandages called steri-strips. Do not remove steri-strips for 2 weeks. (These are the thin paper strips that might be on your incision.) But if they fall off before that that's okay). o Your incisions may be slightly red around the stitches. This is normal. o You may gently wash away dried material around your incision. o Avoid direct sun exposure to the incision area. o Do not use any ointments on the incision unless you were told otherwise. o You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. o You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: o Constipation is a common side effect of narcotic pain medications. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. o If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: o It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as "soreness". o Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. o You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. o Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. o Your pain medicine will work better if you take it before your pain gets too severe. o Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. o If you are experiencing no pain, it is okay to skip a dose of pain medicine. o Remember to use your "cough pillow" for splinting when you cough or when you are doing your deep breathing exercises. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: Take all the medicines you were on before the operation just as you did before, unless you have been told differently. If you have any questions about what medicine to take or not to take, please call your surgeon. Followup Instructions: ___
19809073-DS-21
19,809,073
22,480,977
DS
21
2196-02-18 00:00:00
2196-02-18 16:40:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: fever, respiratory symptoms Major Surgical or Invasive Procedure: None History of Present Illness: ___ M with hx of AML s/p chemo and allo SCT ___ years c/b GVHD of lungs and liver which have resolved with immunosuppresion presents with fever, rash, URI symptoms. Reports that starting two months ago, he has had on and off URI symptoms (chest and nasal congestion). On ___, he was returning home from dinner and felt lightheaded with 'spotted' vision, diaphoresis, and slowly fell to the floor. No trauma and no LOC. He crawled into the house and the symptoms resolved after ___ minutes. No cp, palpitations, confusion, urine/bowel incontinence. Reports feeling dehydrated especially because he played hockey for 90 minutes the night before. His wife took him to ___ where he had an extensive evaluation including CTA, EKG, CXR, heart monitor which were all normal. He was discharged on ___. On ___, he also had chest congestion, nasal congestion, rhinorrhea, mild sore throat and bilateral eye erythema with yellowish discharge. On ___, he developed a cough with productive green phlegm. He also noted a rash on ___ around his bilateral ankle that was non-pruritic and non-tender. Also developed a fever to 102 and went to see his PCP. Patient was started on azithromycin which he took for one days. He called Dr. ___ on ___ regarding his symptoms and was instructed to come in to the ED. In the ED, initial vitals were 97, 124/68, 80, 16, 95% RA. He had a CXR which showed RLL pneumonia and he was started on levofloxacin. He was admitted for further evaluation. This morning, he continues to complain of chest, nasal congestion, productive sputum, and rhinorrhea. No eye pain/pruritus, loss of vision, neck pain, penile discharge, sob, cp. +waking up with his eyes glued shut. +mild sore throat. No recent travel. Two cats at home and no other pets. Does part time writing and works with elementary school children. Up to date with his vaccines post allo SCT. Review of Systems: (+) Per HPI. Denies chills, night sweats, headache, vision changes, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: -AML diagnosed ___ s/p M6-FAB, s/p induction chemotherapy with 3 days of idarubicin and seven days of continuous infusion of ARA-C, then s/p allogeneic transplant from a sibling donor with busulfan and Cytoxan conditioning in ___. His course was complicated by presumed graft versus host disease of the lung and liver, both of which resolved with immune suppression. -AAA, stable at 4.2 cm -attention symptoms -degenerative disk disease -right inguinal hernia -tonsillectomy as a child Social History: ___ Family History: Mother w/blood disease (not cancer) and followed by a hemato___. Also with atrial fibrillation. Father died in a plane crash at age ___. His grandfather died of leukemia in his ___. Physical Exam: ADMISSION PHYSICAL EXAM VITALS - 98.9, 125/81, 80, 17, 94% RA, weight 166.4 lbs General: well appearing male, NAD, pleasant HEENT: PERRL, EOMI, conjunctiva with diffuse erythema and yellow discharge/crusting, no photophobia. Dried mucus noted on nasal passages. OP clear. Mild sinus tenderness R>L. Neck: supple, no LD, no thyromegaly, no meningeal signs Lungs: R basilar crackles, no accessory muscle use, no wheezes/rhonchi CV: RRR, no m/g/r Abdomen: +BS, soft, NT, ND, no hepatomegaly appreciated Ext: wwp, 2+ pedal pulses. Petechial, non-blanchable rash in b/l medial side of ankles with some lesions spreading to the leg/feet. Non-tender to palpation. no c/c/e. Negative kernig and brudzinski. Neuro: A&Ox3, CN II-XII grossly intact DISCHARGE PHYSICAL EXAM VITALS - Tm 98.1, Tc 97.8, 118/84 (118-131/73-84), 68 (66-79), 18, 95-97% RA, weight 166.4 General: well appearing male, NAD, pleasant HEENT: conjunctiva with much improved diffuse erythema without discharge/crusting, no photophobia. OP clear. Mild sinus tenderness R>L Lungs: R basilar crackles stable from yesterday, no accessory muscle use, no wheezes/rhonchi CV: RRR, no m/g/r Abdomen: +BS, soft, NT, ND, no hepatomegaly appreciated Ext: wwp, 2+ pedal pulses. Petechial, non-blanchable rash in b/l medial side of ankles with some spread to mid-leg and b/l feet. Non-tender to palpation. no c/c/e. Neuro: A&Ox3, CN II-XII grossly intact Pertinent Results: ADMISSION LABS ___ 07:20PM BLOOD WBC-12.4*# RBC-4.29* Hgb-15.2 Hct-44.6 MCV-104* MCH-35.4* MCHC-34.1 RDW-12.3 Plt ___ ___ 07:20PM BLOOD Neuts-82.6* Lymphs-9.8* Monos-6.1 Eos-0.3 Baso-1.2 ___ 07:20PM BLOOD Glucose-98 UreaN-21* Creat-1.0 Na-139 K-4.2 Cl-98 HCO3-25 AnGap-20 ___ 06:40AM BLOOD ALT-55* AST-41* AlkPhos-93 TotBili-0.6 ___ 07:20PM BLOOD Calcium-9.8 Phos-3.1 Mg-2.1 ___ 07:34PM BLOOD Lactate-1.1 DISCHARGE LABS ___ 07:20AM BLOOD WBC-6.8 RBC-3.67* Hgb-13.0* Hct-37.6* MCV-102* MCH-35.3* MCHC-34.6 RDW-12.7 Plt ___ ___ 07:20AM BLOOD Neuts-73.9* ___ Monos-5.2 Eos-1.5 Baso-0.7 ___ 07:20AM BLOOD Glucose-101* UreaN-17 Creat-0.9 Na-140 K-4.2 Cl-104 HCO3-28 AnGap-12 ___ 07:20AM BLOOD ALT-58* AST-37 LD(LDH)-135 AlkPhos-89 TotBili-0.5 ___ 07:20AM BLOOD Calcium-9.2 Phos-3.0 Mg-1.9 ___ 07:20AM BLOOD VitB12-1337* Folate-15.6 ___ 06:40AM BLOOD IgG-834 PENDING LABS ___ 07:40AM BLOOD MYCOPLASMA PNEUMONIAE ANTIBODIES (IGG, IGM)-PND ___ 04:45PM BLOOD MYCOPLASMA PNEUMONIAE ANTIBODIES (IGG, IGM)-PND URINE ___ 07:30PM URINE Color-Yellow Appear-Clear Sp ___ ___ 07:30PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 07:30PM URINE RBC-0 WBC-1 Bacteri-FEW Yeast-NONE Epi-0 MICRO ___ 5:12 pm SPUTUM Site: INDUCED Source: Induced. GRAM STAIN (Final ___: >25 PMNs and <10 epithelial cells/100X field. 2+ ___ per 1000X FIELD): MULTIPLE ORGANISMS CONSISTENT WITH OROPHARYNGEAL FLORA. RESPIRATORY CULTURE (Final ___: SPARSE GROWTH Commensal Respiratory Flora. LEGIONELLA CULTURE (Preliminary): NO LEGIONELLA ISOLATED. Immunoflourescent test for Pneumocystis jirovecii (carinii) (Final ___: NEGATIVE for Pneumocystis jirovecii (carinii).. FUNGAL CULTURE (Preliminary): NO FUNGUS ISOLATED. ___ 7:58 pm URINE Site: CLEAN CATCH Source: ___. Legionella Urinary Antigen (Final ___: NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. ___ 4:00 pm THROAT FOR STREP R/O Beta Strep Group A (Final ___: NO BETA STREPTOCOCCUS GROUP A FOUND. ___ 4:45 pm IMMUNOLOGY N. HIV-1 Viral Load/Ultrasensitive (Final ___: HIV-1 RNA is not detected. ___ MONOSPOT (Final ___: NEGATIVE by Latex Agglutination. ___ 2:40 am Rapid Respiratory Viral Screen & Culture Source: Nasopharyngeal swab. **FINAL REPORT ___ Respiratory Viral Culture (Final ___: TEST CANCELLED, PATIENT CREDITED. Inadequate specimen for respiratory viral culture. PLEASE SUBMIT ANOTHER SPECIMEN. Respiratory Viral Antigen Screen (Final ___: Greater than 400 polymorphonuclear leukocytes;. Specimen inadequate for detecting respiratory viral infection by DFA testing. PENDING MICRO ___ 4:00 pm SWAB NEISSERIA GONORRHOEAE (GC), NUCLEIC ACID PROBE, WITH AMPLIFICATION (Pending): Chlamydia trachomatis, Nucleic Acid Probe, with Amplification (Pending): ___ BLOOD CULTURE Blood Culture, Routine-PENDING ___ BLOOD CULTURE Blood Culture, Routine-PENDING IMAGING ___ CXR The lungs are hyperinflated with flattening of the diaphragms suggestive of COPD. Heart size is normal. The aorta remains aneurysmally dilated and tortuous, unchanged. Pulmonary vascularity is not engorged. Ill-defined patchy opacity within the right lower lobe is concerning for pneumonia, and is new compared to the prior exam. Left lung is clear. No pleural effusion or pneumothorax is identified. Posttraumatic changes of the right acromioclavicular joint are re- demonstrated. There are no acute osseous abnormalities. IMPRESSION: Right lower lobe pneumonia. Follow up radiographs after treatment are recommended to ensure resolution of this finding. Brief Hospital Course: ___ M with hx of AML s/p allogeneic stem cell transplant ___ years ago c/b GVHD of liver and lung that resolved with immunosuppresion presents with URI symptoms, fever, rash, and conjunctivitis for 5 days and found to have RLL pneumonia. # RLL pneumonia: most likely CAP as he is not neutropenic and only spent one day at an OSH hospital. O2 saturations are high ___ at RA and remained afebrile throughout his hospitalization. He had mild leukocytosis on admission that resolved by discharge. Legionella antigen negative. Mycoplasma antibodies pending. Treated with levofloxacin for a 7 day course. # Viral syndrome: Likely explains the conjunctivitis, sinusitis, URI symptoms and petechial rash. Per report, he has had multiple viral infections recently. HIV viral load was negative. He had mild transaminases on admission that trended down by discharge. A monospot to test for mononucleosis was negative. Strep test was negative. Urine and blood cultures with no growth to date. A nasopharyngeal viral swab was ordered but was unable to be interpreted. GC/chlamydia swab pending at discharge. # viral conjunctivitis: most likely viral given that is bilateral with no photophobia, pain, pruritus, or visual loss. Improving by discharge. # Petechial rash on b/l lower extremity: likely secondary to viral syndrome. Platelets are normal. GVHD would be less likely given that he is ___ years from his transplant. # presyncope: per patient, workup at OSH (CTA, EKG, heart monitor) was negative. Probably vasovagal in the setting of recent dehydration after playing hockey as patient had prodrome without LOC or cardiac symptoms. Monitored on telemetry without any events. EKG at baseline. # mild anemia: hct dropping from 44.6 on admission to 37.6 at discharge with elevated MCV. LDH is normal and thus unlikely to be hemolysing. Stools were guaic negative. Folate and vitamin B12 were checked and were in appropriate range. CHRONIC # Attention symptoms: reports that he has not taken amphetamine- dextroamphetamine in a couple of weeks. This medication was held during his hospitalization. #AML s/p allogeneic stem cell transplant ___: from a sibling donor. His disease has been in remission. Has follow up with Dr. ___ on ___. TRANSITIONAL ISSUES -discharged with 7 day course of levofloxacin. Please repeat CXR in 2 weeks to ensure resolution of pna -mild anemia with elevated CMV and normal vitB12 and folate, please recheck CBC -please follow up with pending blood cxs, mycoplasma antibodies, GC/chlamydia PCR -has f/u with PCP ___ ___ # CODE: Full # EMERGENCY CONTACT: ___ (wife): ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amphetamine-dextroamphetamine *NF* 5 mg Oral qAM 2. amphetamine-dextroamphetamine *NF* 10 mg Oral noon 3. budesonide *NF* 180 mcg/actuation Inhalation BID 4. Zolpidem Tartrate 10 mg PO HS:PRN insomnia 5. Multivitamins 1 TAB PO DAILY 6. Vitamin D ___ UNIT PO DAILY 7. Fish Oil (Omega 3) 1000 mg PO DAILY Discharge Medications: 1. budesonide *NF* 180 mcg/actuation Inhalation BID 2. Fish Oil (Omega 3) 1000 mg PO DAILY 3. Multivitamins 1 TAB PO DAILY 4. Vitamin D ___ UNIT PO DAILY 5. amphetamine-dextroamphetamine *NF* 5 mg Oral qAM 6. amphetamine-dextroamphetamine *NF* 10 mg ORAL NOON 7. Zolpidem Tartrate 10 mg PO HS:PRN insomnia 8. Levofloxacin 750 mg PO DAILY take for four more days (last day on ___ RX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*4 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: PRIMARY: -community acquired pneumonia -viral illness -presyncope SECONDARY: AML s/p allogeneic SCT Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during your stay at ___ ___. You were admitted to the hospital because of pneumonia and a viral illness. You improved with antibiotics. Please continue to take the antibiotic for 4 more days (last day on ___ and follow up with Dr. ___ Dr. ___. Please make sure you keep yourself hydrated to prevent feeling lightheaded. In addition, you should hold off playing hockey until your symptoms resolve. Followup Instructions: ___
19809088-DS-13
19,809,088
29,454,852
DS
13
2116-07-13 00:00:00
2116-07-13 15:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Penicillins / morphine / Asacol Attending: ___. Chief Complaint: Wound infection s/p ventral hernia repair with mesh 6 months ago Major Surgical or Invasive Procedure: ___: Ultrasound guided drainage of fluid collection in the anterior abdominal wall. 8 ___ catheter was placed to a JP bulb. History of Present Illness: Ms. ___ is a ___ with Past Surgical History notable for total colectomy ___ years ago, with Lysis of Adhesions for small bowel obstruction, 8 months ago, complicated by ventral hernia, repaired with mesh (physio mesh and composite type mesh polypropylene w/Monocryl coating) 6 months ago at ___. Patient reports that has required aspiration and drain placement x4, with most recent drain removed on ___ of last week. On ___ patient spiked fever to 102 and was placed on ciprofloxacin 250mg BID. She has remained afebrile since ___. On ___ patient appreciated erythema and warmth of abdomen as well as swelling around her incision. Describes buring sensation around incision, at worst ___ on pain scale, curently ___. Pain alleviated by lying down, exacerbated by movement. On Review of systems: patient denies changes in bowel movements, nausea, vomiting, shortness of breath chest pain. Past Medical History: Past Medical History: Collagenous colitis s/p total colectomy GERD Post-operative ileus Arthritis Asthma (Improved since quitting smoking) Paroxysmal atrial tachycardia Hypercholesterolemia HTN Past Surgical History: Total colectomy with end ileostomy and subsequent takedown and J-Pouch formation ___ years ago. Laparotomy and lysis of adhesions for small bowel obstruction- ___ Symptomatic incarcerated abdominal incisional hernia repair with physio mesh and composite type mesh polypropylene w/Monocryl coating - ___ Appendectomy (Childhood) Tonsillectomy Adenoidectomy L knee replacement R ACL repair Carpal Tunnel release Social History: ___ Family History: Sister died of lung cancer Physical Exam: Upon Admisson: Vitals: T 97.2, P 83, BP 152/82, RR 18, SpO2 100%RA GENERAL: awake and alert. HEENT: No scleral icterus CV: Regular sinus rhythm. PULM: Clear to auscultation bilterally. ABDOMEN: Midline incision with swelling at distal aspect. Lower abdomen tender to palpation, two drain sites healing DRE: Deferred Extremities: no upper or lower extremity edema. Extremities, warm and well perfused Upon discharge: VITALS: 98.0 84 139/69 20 98RA GENERAL: Awake and alert. HEART: Regular sinus rhythm. LUNGS:no respiratory distress, clear bilaterally. ABDOMEN:soft, NT, ND, midline incision scar, JP in place with serosang output EXTREMITIES: warm well perfused Pertinent Results: ___ 07:20AM BLOOD WBC-7.4 RBC-4.44 Hgb-13.2 Hct-39.2 MCV-88 MCH-29.8 MCHC-33.7 RDW-12.1 Plt ___ ___ 09:35AM BLOOD ___ PTT-30.6 ___ ___ 07:20AM BLOOD Glucose-90 UreaN-5* Creat-0.5 Na-143 K-4.2 Cl-106 HCO3-25 AnGap-16 ___ 07:20AM BLOOD Calcium-9.2 Phos-4.4 Mg-2.0 ___ CT abdomen/pelvis 1. 3.3 x 10.2 x 16.5 cm fluid collection measuring up to 11 Hounsfield units with minimal surrounding stranding in the anterior abdominal wall, concerning for a seroma, however an underlying infectious process/abscess cannot be entirely excluded. 2. Status post colectomy. Multiple dilated loops of small bowel in the right abdomen with no definite transition point identified, could relate to post surgical findings. ___ ___ drain placement An 8 ___ ___ catheter was advanced into the fluid collection under ultrasound guidance. Once adequate positioning was confirmed, the catheter was deployed and the pigtail was formed. 220 cc of serosanguinous fluid was aspirated. 8 cc of fluid was sent for microbiology. The drain was placed to a JP bulb, secured to the skin with a Stat Lock, and sterile dressings were applied. Brief Hospital Course: The patient is a ___ year old female who was admitted to the Acute Care Surgery service with a fluid collection in her abdominal wall. She was made NPO and was continued on a course of ciprofloxacin started by her PCP. On Hospital day 2 she had a JP drain placed under ultrasound by interventional radiology who aspirated 220 cc of serosanguinous fluid. Gram stain and cultures were sent. That evening, she was advanced to a regular diet, which she tolerated well. On Hospital day 3 her antibiotics were changed from ciprofloxacin to oral clindamycin. Her cultures came back showing Staphylococcus aureus coagulase positive. At the time of discharge she was in stable condition. She was advised to follow up with Dr. ___ in the ___ clinic on ___. She was given a prescription for a 14 day course of clindamycin. Medications on Admission: 1. Amitriptyline 50 mg PO HS sleep 2. Bismuth Subsalicylate Chewable 2 TAB PO QID:PRN diarrhea 3. LOPERamide 4 mg PO QID:PRN diarrhea Discharge Medications: 1. Amitriptyline 50 mg PO HS sleep 2. Bismuth Subsalicylate Chewable 2 TAB PO QID:PRN diarrhea 3. Clindamycin 300 mg PO Q6H RX *clindamycin HCl 300 mg 1 capsule(s) by mouth four times a day Disp #*56 Capsule Refills:*0 4. LOPERamide 4 mg PO QID:PRN diarrhea Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Fluid collection in abdominal wall Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the Acute Care Surgery service with a subcutaneous fluid collection. You had a drain placed in ___, and you were started on antibiotics. You are now ready to complete your recovery at home. Please follow the instructions below: -You have one JP drain in place. Continue to empty this drain as taught during your hospital stay. Please record fluid appearance and total output daily. -You are being given a prescription for an antibiotic. Please complete entire 14 day course of this antibiotic. -You may resume all home medications. -You may resume a normal diet as tolerated. -You may resume normal activity as tolerated. You may shower with the JP drain in place. -You have a follow up appointment with Dr. ___ on ___ at 1:45PM. If you need to change this appointment, please call the ACS office at ___. -If you experience severe abdominal pain, fever>101, or anything else that concerns you, please call the ACS office or go the closest emergency room. Followup Instructions: ___
19809088-DS-14
19,809,088
22,119,326
DS
14
2116-09-22 00:00:00
2116-09-27 23:55:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Penicillins / morphine / Asacol Attending: ___. Chief Complaint: Abdominal wound infection Major Surgical or Invasive Procedure: PROCEDURE: 1. Exploratory laparotomy. 2. Excision of ventral hernia mesh. 3. Lysis of adhesions. History of Present Illness: Ms. ___ is a ___ with multiple abdominal surgeries and ventral hernia s/p mesh repair (___) complicated by multiple wound infections, most recently requiring ___ drainage at ___ on ___, now presenting with abdominal wall erythema extending across her incision. Her ___ drain was removed on ___, and she has since been doing well aside from reporting loose stools ___ times daily. Two weeks ago, she noted an approximate quarter size erythematous area to the right of her midline incision about 8cm above her umbilicus. This area remained unchanged over two weeks and she had no associated symptoms. However, on the day of presentation, she reports feeling 'achy' in her abdomen all day with decreased appetite, fatigue, and pain 'around my mesh,' but without nausea, vomiting, fevers, or chills. She reports increased flatus and ongoing loose brown stools. When she arrived home from work, she additionally felt that her abdomen was distended 'as though pregnant.' She noted that the skin on her abdomen was warm and the redness had spread to the left side of her abdomen as well. Given the abdominal distention and worsening erythema having had multiple wound infections in the past, she came into ___ ED for evaluation. Past Medical History: Past Medical History: Collagenous colitis s/p total colectomy GERD Post-operative ileus Arthritis Asthma (Improved since quitting smoking) Paroxysmal atrial tachycardia Hypercholesterolemia HTN Past Surgical History: Total colectomy with end ileostomy and subsequent takedown and J-Pouch formation ___ years ago. Laparotomy and lysis of adhesions for small bowel obstruction- ___ Symptomatic incarcerated abdominal incisional hernia repair with physio mesh and composite type mesh polypropylene w/Monocryl coating - ___ Appendectomy (Childhood) Tonsillectomy Adenoidectomy L knee replacement R ACL repair Carpal Tunnel release Social History: ___ Family History: Sister died of lung cancer Physical Exam: Admission: Vitals: T 97.7 HR 84 BP 124/76 RR 16 O2sat 96%RA GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Large healed midline incision with multiple drain scars. Erythema (blanching) on either side of midline scar about 6cm above umbilicus, warm to touch L>R. Abdomen soft, distended, non-tender, no rebound tenderness or voluntary guarding, normoactive bowel sounds, no palpable masses Ext: No ___ edema, ___ warm and well perfused Discharge: GEN: NAD HEENT: WNL PULM: nonlabored on RA, CTAB CV: RRR, no M/R/G ABD: Soft, appropriately tender, incision C/D/I. JP removal site well healed. EXT: WWP, no edema Pertinent Results: ___ WBC-11.5*# RBC-4.40 Hgb-13.3 Hct-40.1 Plt ___ ___ WBC-11.4* RBC-4.09* Hgb-12.6 Hct-38.0 Plt ___ ___ WBC-9.3 RBC-3.93* Hgb-11.8* Hct-37.0 Plt ___ ___ WBC-8.7 RBC-3.76* Hgb-11.7* Hct-35.4* Plt ___ ___ WBC-7.5 RBC-3.83* Hgb-11.8* Hct-35.2* Plt ___ ___ WBC-9.1 RBC-4.15* Hgb-12.6 Hct-38.5 Plt ___ ___ Glucose-118* UreaN-13 Creat-0.6 Na-142 K-3.9 Cl-104 HCO3-26 ___ Glucose-121* UreaN-7 Creat-0.6 Na-142 K-4.2 Cl-103 HCO3-28 ___ Glucose-153* UreaN-6 Creat-0.6 Na-135 K-4.1 Cl-101 HCO3-27 ___ Glucose-118* UreaN-7 Creat-0.7 Na-137 K-4.6 Cl-102 HCO324 ___ Glucose-112* UreaN-4* Creat-0.6 Na-141 K-4.0 Cl-103 HCO3-32 ___ Glucose-106* UreaN-7 Creat-0.8 Na-140 K-3.9 Cl-102 HCO3-26 TISSUE (Final ___: Oxacillin RESISTANT Staphylococci MUST be reported as also RESISTANT to other penicillins, cephalosporins, carbacephems, carbapenems, and beta-lactamase inhibitor combinations. Rifampin should not be used alone for therapy. This isolate is presumed to be resistant to clindamycin based on the detection of inducible resistance . STAPH AUREUS COAG + | CLINDAMYCIN----------- R ERYTHROMYCIN---------- =>8 R GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- =>8 R OXACILLIN------------- =>4 R RIFAMPIN-------------- <=0.5 S TETRACYCLINE---------- <=1 S TRIMETHOPRIM/SULFA---- <=0.5 S VANCOMYCIN------------ 1 S IMAGING: Abdominal Ultrasound ___: FINDINGS: Focal transverse and sagittal grayscale and color ultrasound images were obtained of the anterior abdominal wall. A thin fluid collection is seen within the mid portion of the anterior abdominal wall, measuring 7.2 cm in width and only 0.6 cm in anteroposterior dimension. There is a trace amount of fluid extending towards the left abdominal wall and anterior to the periumbilical region. CT abd/pelvis ___: IMPRESSION: 1. Status post colectomy with distended segments of small bowel in the right abdomen, similar to ___. No clear transition point is identified and findings are most consistent with dysmotility or functional ileus. 2. Anterior abdominal wall low-density fluid collection has decreased in size since the prior exam but is now thick-walled with mild surrounding soft tissue stranding. Findings may represent a resolving seroma but superinfection cannot be excluded on the basis of imaging. Brief Hospital Course: Patient was admitted to the Acute Care Surgery Service from the Emergency Department. Please refer to the HPI for details of her initialy presentation. An abdominal ultrasound showed thin fluid collection within the mid portion of the anterior abdominal wall, measuring 7.2 cm width and only 0.6 cm in anteroposterior dimension. Given patient's prior extensive infectious history with her hernia mesh, she was started on empiric IV-Vancomycin therapy. She was made NPO with IVFs. A CT scan was obtained which showed anterior abdominal wall low-density fluid collection which has decreased in size since the prior exam but now thick-walled with mild surrounding soft tissue stranding suspicious for an infection. Patient was taken to the operating room by Dr. ___ on ___ and underwent exploratory laparotomy. excision of ventral hernia mesh and lysis of adhesions and primary closure. Two ___ drains were placed in the subcutaneous space to prevent reaccumulation of seroma. The operation was without complications and she tolerated the procedure well. She was extubated immediately postoperatively and was transferred to the floor in a stable condition. Given the extensive amount of lysis of adhesions she underwent, she was kept NPO with a nasogastric tube in place. She was kept on IV-vancomycin. On POD1, the NGT was discontinued. Her foley catheter was removed without difficulty. On POD3, patient's JP drains were removed without event. Her intraoperative cultures speciated as Methicillin resistant Staph aureus with sensitivites shown above. Patient remained NPO with IVFs due to lack of return of bowel function, however she remained without any nausea or significant abdominal distension. On POD 5, patient had return of bowel function with multiple bowel movements. She was advanced to a regular diet without any event. Her IV-vancomycin was changed to Bactrim based on her culture data. By the time of discharge, patient was tolerating a regular diet with normal bladder and bowel function. She remained afebrile with normal vital signs and laboratory values. She was ambulating without difficulty and her incisions were well healing. Patient reported full comfort to continue her recovery at home. She is to follow up with us in ___ clinic as shown in her discharge instructions. Medications on Admission: Lo-Peramide 4mg QAM and 2mg QHS, Peptobismol 3 tablets daily, Vitamin B12 1,000mcg daily, albuterol inhaler prn, Amitriptyline 50mg QHS, Vit D3 1000U daily, Gabapentin 900 mg QHS, Pravastatin 40mg daily, Rabeprazole 20mg QHS, Verapamil 180mg QHS Discharge Medications: 1. Amitriptyline 50 mg PO HS 2. Gabapentin 900 mg PO HS 3. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg 1 tablet(s) by mouth q4hrs prn Disp #*30 Tablet Refills:*0 4. Pravastatin 40 mg PO DAILY 5. Sulfameth/Trimethoprim DS 2 TAB PO BID RX *sulfamethoxazole-trimethoprim [Bactrim DS] 800 mg-160 mg 2 tablet(s) by mouth twice a day Disp #*16 Tablet Refills:*0 6. Verapamil SR 180 mg PO Q24H 7. Acetaminophen 650 mg PO Q6H:PRN fever/headache RX *acetaminophen [8 HOUR PAIN RELIEVER] 650 mg 1 tablet extended release(s) by mouth q6hrs prn Disp #*30 Tablet Refills:*0 8. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*30 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Recurrent infections of abdominal wall mesh Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to ___ with a wound infection and abdominal pain. An ultrasound showed you had a fluid collection around the mesh in your abdomen and an x-ray showed you had a partial small bowel obstruction. The decision was made to take you to the operating room to remove the infected mesh. You had an extensive lysis of adhesions and removal of mesh done on ___. You tolerated the procedure well and post operatively you were kept nothing by mouth with IV fluids and IV antibiotics for several days until you had return of bowel function. You are now tolerating a regular diet and your pain is well controlled with oral pain medicine. You are ready to go home to continue your recovery. You will complete a course of antibiotics by mouth. Please follow up with the ___ clinic at the appointment listed below. Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Incision Care: *Please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *Avoid swimming and baths until your follow-up appointment. *You may shower, and wash surgical incisions with a mild soap and warm water. Gently pat the area dry. *If you have staples, they will be removed at your follow-up appointment. *If you have steri-strips, they will fall off on their own. Please remove any remaining strips ___ days after surgery. Followup Instructions: ___
19809155-DS-2
19,809,155
20,196,399
DS
2
2171-08-15 00:00:00
2171-08-15 10:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: amoxicillin / Iodinated Contrast- Oral and IV Dye / lisinopril Attending: ___. Chief Complaint: acute worsening of chronic low back pain Major Surgical or Invasive Procedure: T10-T12 DECOMPRESSION History of Present Illness: ___ female history of hypertension, depression who presents with acute worsening of chronic low back pain over the last 2 weeks. She also endorses radicular pain down the anterior thighs bilaterally, frequent episodes of urinary incontinence without awareness over the last 3 months, and new complaint of her left knee giving out over the last 2 weeks. She does walk with a walker at baseline for over the past year due to her low back pain. Patient otherwise denies numbness, tingling, weakness, saddle anesthesia, loss of bowel function. Past Medical History: PMH/what PSH: HTN Obesity Depression Anxiety MEDS: Antihypertensives Paxil Bupropion Ativan Social History: Occasional tobacco No active EtOH Daily marijuana Physical Exam: PE: VS ___ 2342 Temp: 97.5 PO BP: 151/82 L Lying HR: 78 RR: 20 O2 sat: 97% O2 delivery: Ra NAD, A&Ox4 nl resp effort RRR incisional vac in place with good suction Sensory: ___ L2 L3 L4 L5 S1 S2 (Groin) (Knee) (Med Calf) (Grt Toe) (Sm Toe) (Post Thigh) R SILT SILT SILT SILT SILT SILT L SILT SILT SILT SILT SILT SILT Motor: ___ Flex(L1) Add(L2) Quad(L3) TA(L4) ___ ___ R 5 5 5 5 5 5 5 L 5 5 5 5 5 5 5 Pertinent Results: ___ 06:47AM BLOOD WBC-16.6* RBC-3.84* Hgb-11.0* Hct-35.7 MCV-93 MCH-28.6 MCHC-30.8* RDW-17.7* RDWSD-59.7* Plt ___ ___ 07:36AM BLOOD WBC-18.3* RBC-4.17 Hgb-12.0 Hct-37.7 MCV-90 MCH-28.8 MCHC-31.8* RDW-17.2* RDWSD-57.4* Plt ___ ___ 02:00AM BLOOD WBC-13.2* RBC-4.44 Hgb-12.7 Hct-39.9 MCV-90 MCH-28.6 MCHC-31.8* RDW-17.2* RDWSD-57.0* Plt ___ ___ 02:00AM BLOOD Neuts-60.6 ___ Monos-7.3 Eos-3.0 Baso-0.5 Im ___ AbsNeut-8.00* AbsLymp-3.73* AbsMono-0.97* AbsEos-0.39 AbsBaso-0.07 ___ 06:47AM BLOOD Plt ___ ___ 07:36AM BLOOD Plt ___ ___ 10:24AM BLOOD ___ PTT-25.6 ___ ___ 02:00AM BLOOD Plt ___ ___ 06:47AM BLOOD Glucose-112* UreaN-12 Creat-0.7 Na-142 K-4.6 Cl-104 HCO3-27 AnGap-11 ___ 07:36AM BLOOD Glucose-119* UreaN-16 Creat-1.2* Na-140 K-4.5 Cl-101 HCO3-26 AnGap-13 ___ 07:36AM BLOOD Calcium-8.8 Phos-3.8 Mg-1.6 Brief Hospital Course: Patient was admitted to the ___ Spine Surgery Service and taken to the Operating Room for the above procedure.Refer to the dictated operative note for further details.The surgery was without complication and the patient was transferred to the PACU in a stable ___ were used for postoperative DVT prophylaxis.Intravenous antibiotics were continued for 24hrs postop per standard protocol.Initial postop pain was controlled with oral and IV pain medication.Diet was advanced as tolerated.Foley was removed on POD#2. Physical therapy and Occupational therapy were consulted for mobilization OOB to ambulate and ADL's.Hospital course was otherwise unremarkable.On the day of discharge the patient was afebrile with stable vital signs, comfortable on oral pain control and tolerating a regular diet. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Gabapentin 1200 mg PO QHS 2. Nabumetone 750 mg PO DAILY 3. ALPRAZolam 1 mg PO DAILY:PRN anxiety, insomnia 4. BuPROPion 100 mg PO DAILY 5. CloNIDine 0.1 mg PO QHS 6. Labetalol 200 mg PO BID 7. PARoxetine 60 mg PO DAILY 8. Prazosin 2 mg PO QHS 9. Sumatriptan Succinate 50 mg PO Q3H:PRN migraine 10. TraZODone 50 mg PO QHS:PRN insomnia 11. Verapamil SR 120 mg PO Q24H 12. Gabapentin 800 mg PO BID Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H 2. Docusate Sodium 100 mg PO BID 3. Heparin 5000 UNIT SC BID prevent blood clots 4. Miconazole Powder 2% 1 Appl TP QID:PRN skin folds 5. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills:*0 6. Senna 8.6 mg PO BID 7. ALPRAZolam 1 mg PO DAILY:PRN anxiety, insomnia 8. BuPROPion 100 mg PO DAILY 9. CloNIDine 0.1 mg PO QHS 10. Gabapentin 800 mg PO BID 11. Gabapentin 1200 mg PO QHS 12. Labetalol 200 mg PO BID 13. Nabumetone 750 mg PO DAILY 14. PARoxetine 60 mg PO DAILY 15. Prazosin 2 mg PO QHS 16. Sumatriptan Succinate 50 mg PO Q3H:PRN migraine 17. TraZODone 50 mg PO QHS:PRN insomnia 18. Verapamil SR 120 mg PO Q24H Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: 1. Thoracic spinal stenosis. 2. Thoracic myelopathy. 3. Lower extremity dysfunction, with bladder dysfunction. Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Thoracic Decompression Without Fusion You have undergone the following operation: Thoracic Decompression Without Fusion Immediately after the operation: • Activity:You should not lift anything greater than 10 lbs for 2 weeks.You will be more comfortable if you do not sit or stand more than~45 minutes without moving around. • Rehabilitation/ Physical ___ times a day you should go for a walk for ___ minutes as part of your recovery.You can walk as much as you can tolerate.Limit any kind of lifting. • Diet:Eat a normal healthy diet.You may have some constipation after surgery.You have been given medication to help with this issue. • Brace:You may have been given a brace.If you have been given a brace, this brace is to be worn when you are walking.You may take it off when sitting in a chair or lying in bed. • Wound Care: Keep the incision covered with a dry dressing on until your follow up appointment. If the incision is draining cover it with a new sterile dressing and keep it covered until your follow up appointment. Do not soak the incision in a bath or pool.If the incision starts draining at anytime after surgery,do not get the incision wet.Cover it with a sterile dressing and call the office. • You should resume taking your normal home medications. • You have also been given Additional Medications to control your pain.Please allow 72 hours for refill of narcotic prescriptions,so please plan ahead.You can either have them mailed to your home or pick them up at the clinic located on ___.We are not allowed to call in or fax narcotic prescriptions(oxycontin,oxycodone,percocet) to your pharmacy.In addition,we are only allowed to write for pain medications for 90 days from the date of surgery. • Follow up: ___ Please Call the office and make an appointment for 2 weeks after the day of your operation if this has not been done already. ___ At the 2-week visit we will check your incision, take baseline X-rays and answer any questions.We may at that time start physical therapy. ___ We will then see you at 6 weeks from the day of the operation and at that time release you to full activity. Please call the office if you have a fever>101.5 degrees Fahrenheit and/or drainage from your wound. Physical Therapy: 1)Weight bearing as tolerated.2)Gait,balance training.3)No lifting >10 lbs.4)No significant bending/twisting. Treatments Frequency: Keep the incision covered with a dry dressing on until your follow up appointment. If the incision is draining cover it with a new sterile dressing and keep it covered until your follow up appointment. Do not soak the incision in a bath or pool.If the incision starts draining at anytime after surgery,do not get the incision wet.Cover it with a sterile dressing and call the office. Followup Instructions: ___
19809180-DS-9
19,809,180
26,556,275
DS
9
2120-04-06 00:00:00
2120-04-07 11:26:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) / iodine / Levaquin Attending: ___. Chief Complaint: throat foreign body Major Surgical or Invasive Procedure: EGD with foreign body removal History of Present Illness: ___ with history of GERD presents to ED with esophageal foreign body. She ate homemade chicken soup ___ but then felt something lodge in esophagus. She went to her PCP ___, had CXR showing no FB, so was given symptomatic treatment with viscous Xylocaine. Then, due to persistence of symptoms, she returned to ___ who ordered CT scan which showed 18 x 16 x 3 mm foreign body in the cervical esophagus. She was then transferred to ___ for further care. Past Medical History: Vit D deficiency Depression GERD Social History: ___ Family History: No FH of GI strictures or autoimmune conditions. Physical Exam: ADMISSION PHYSICAL: VITALS: 98.0 123/73 78 15 100% RA General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: Warm, dry, no rashes or notable lesions. Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally. DISCHARGE PHYSICAL: General: NAD, laying back in bed HEENT: EOMI, AT/NC, no JVD, no tracheal deviation, no LAD Cardiac: RRR, s1+s2 normal, no m/g/r appreciated Lungs: CTAB Abd: +BS, non-tender, non-distended, no organomegaly appreciated Ext: Pulses present, no edema Skin: No lesions identified Neuro: No motor/sensory deficits elicited Pertinent Results: ADMISSION LABS: ___ 05:05PM URINE HOURS-RANDOM ___ 05:05PM URINE UHOLD-HOLD ___ 05:05PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 05:05PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-10* BILIRUBIN-NEG UROBILNGN-8* PH-6.5 LEUK-NEG ___ 04:00PM GLUCOSE-86 UREA N-7 CREAT-0.8 SODIUM-139 POTASSIUM-4.8 CHLORIDE-99 TOTAL CO2-26 ANION GAP-14 ___ 04:00PM estGFR-Using this ___ 04:00PM CALCIUM-9.9 PHOSPHATE-3.6 MAGNESIUM-2.0 ___ 04:00PM WBC-10.7* RBC-4.05 HGB-12.6 HCT-38.3 MCV-95 MCH-31.1 MCHC-32.9 RDW-13.1 RDWSD-45.3 ___ 04:00PM NEUTS-75.4* LYMPHS-15.9* MONOS-7.0 EOS-1.2 BASOS-0.2 IM ___ AbsNeut-8.04* AbsLymp-1.69 AbsMono-0.75 AbsEos-0.13 AbsBaso-0.02 ___ 04:00PM PLT COUNT-297 ___ 04:00PM ___ PTT-33.6 ___ DISCHARGE LABS: ___ 05:37AM BLOOD WBC-9.8 RBC-3.78* Hgb-11.5 Hct-34.9 MCV-92 MCH-30.4 MCHC-33.0 RDW-13.2 RDWSD-44.6 Plt ___ ___ 05:37AM BLOOD Plt ___ ___ 05:37AM BLOOD Glucose-87 UreaN-6 Creat-0.7 Na-141 K-4.0 Cl-102 HCO3-24 AnGap-15 ___ 05:37AM BLOOD Calcium-9.2 Phos-3.6 Mg-1.7 IMAGING: ___ CT Neuro ___ opinion: IMPRESSION: A radiopaque curvilinear structure is lodged in the upper esophagus slightly below the cricopharyngeus, and just above the level of the thoracic inlet, compatible with known foreign body. There is circumferential esophageal wall thickening and inflammatory changes, but no definite perforation or pneumomediastinum. MICRO: ___ Urine Cx: NEG Brief Hospital Course: ___ with history of GERD presents to ED with esophageal foreign body (chicken bone). Following chicken soup ___, she felt something lodge, had CXR ___ showing no FB, given symptomatic treatment with viscous Xylocaine. Persistence of symptoms, prompted CT scan showing 18 x 16 x 3 mm foreign body in the cervical esophagus. Transferred to ___, where she underwent EGD and removal of the bone on ___. They visualized erosive disease to the esophagus, for which she would benefit from 5 days of amoxicillin. She was maintained on her home oral PPI BID. Gastrografin swallow study ___ yielded no leakage. She tolerated soft diet prior to discharge. Remained clinically stable. ACUTE ISSUE: #Foreign body: After eating chicken soup s/p removal via EGD and visualization of erosive damage to esophagus. Gastrograffin study to check for leak was negative. Started on clears diet, and advanced to softs to stay for 5 days prior to regular diet. Continued viscous lidocaine for pain. Transitioning with Amoxicllin for 5 days given esophageal injury. CHRONIC ISSUES: #GERD: continued lansoprazole #Depression: no meds at home #Vit D deficiency: on no meds, outpt issue TRANSITIONAL ISSUES: #Discharged with 5 day course of amoxicillin for infection prophylaxis given esophageal injury #Patient to schedule follow-up in ___ clinic in ___ weeks after discharge. #Soft diet for 5 days before advancing to regular diet; can use viscous lidocaine for ongoing pain #Patient to follow-up with outpatient GI doctor Dr. ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Lidocaine Viscous 2% 15 mL PO TID:PRN sore throat 2. Lansoprazole Oral Disintegrating Tab 30 mg PO BID Discharge Medications: 1. Amoxicillin 500 mg PO Q8H RX *amoxicillin 500 mg 1 capsule(s) by mouth every 8 hours Disp #*15 Capsule Refills:*0 2. Lansoprazole Oral Disintegrating Tab 30 mg PO BID 3. Lidocaine Viscous 2% 15 mL PO TID:PRN sore throat Discharge Disposition: Home Discharge Diagnosis: Food particle esophageal impaction Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at ___ ___. Why was I in the hospital? - You were hospitalized for the removal of a piece of food that was impacted in the tube that connects your mouth to stomach. What was done while I was in the hospital? - Pictures were taken that showed the piece of food stuck. - A camera was inserted to see the piece and remove it. - Pictures were taken to make sure you had no leak after the piece was removed. What should I do when I go home? - It is very important that you take your prescribed medications. - Please go to your scheduled appointment with your primary doctor. - If you have any fevers or chest pain, please tell your primary doctor or go to the emergency room. Best wishes, Your ___ team Followup Instructions: ___
19809456-DS-17
19,809,456
28,298,444
DS
17
2175-10-16 00:00:00
2175-10-16 17:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Celebrex / Norvasc Attending: ___. Chief Complaint: Hypoxia and weakness Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old female with hx. COPD on home ___, pulmonary HTN, hypertrophic obstructive cardiomyopathy, aortic aneurysm s/p repair presenting with c/o weakness. Patient reports fatigue and weakness starting 1 week ago. Says has been going on gradually but worsened over last week. For the last 2 weeks she has increased ___ oxygen use - used to be only at night now pretty much all the time. Has had associated increase in clear sputum production, mostly in the AM. Denies fevers or chills, no sick contacts. No chest pain or palpitations. No weight gain, denies orthopnea or PND. At ___ baseline she could walk to ___ car from ___ house without oxygen, but now is too fatigued to complete even simply activities. In the ED, initial vitals: 98.6 65 147/87 16 81% RA. Labs were notable for a CBC with WBC 3.2, plt 88, nl trop/BNP, chem-7 with Cl 95, Bicarb 44. CXR showed cardiomegaly and no signs of pneumonia. Patient was given duonebs, methylpred 125mg IV, as well as full dose aspirin. Upon arrival to the floor patient says she feels better. Denies dyspnea, wheezing, or chest pain. No other complaints. Past Medical History: 1. Aneurysm of ascending aorta and aortic arch, s/p repair ___ 2. Tortuous dilated thoracic aorta. 3. HOCM - LVOT 10mmHg cath ___ TTE: LVOT 19mmHg, 1+AR, 1+MR 5. L vocal cord dysphagia- ___ 6. Hypertension. 7. Hypercholesterolemia. 8. Diabetes mellitus, type 2. 9. Hypothyroidism. 10. Glaucoma. 11. Osteoarthritis. 12. Osteopenia 13. Status post total abdominal hysterectomy. 14. Status post colonic polypectomy. 15. h/o Left Nasolabial abscess, s/p excision. (___) 16. Status post thoracic aortic stent graft repair for posterior penetrating ulcer. 17. Euthyroid multinodular goiter (left-sided dominant ~3cm solid nodules FNA negative for malignancy). 18. ? h/o asthma 19. ? h/o Tb work-up Social History: ___ Family History: Father, deceased, possibly due to cancer. Mother, deceased, died during childbirth when Ms. ___ was approximately ___ years old. Reports that family members on maternal side have characteristically "died young." Sister with ___, and another sister who died in ___ ___ of cancer, though she does not recall the type. Physical Exam: ADMISSION EXAM Vitals- 98.2 159/57 hr 78 17 96% 2L General- awake, alert, in NAD but mildly tachypneic HEENT- PERRLA, EOMI, OMM no lesions Neck- supple, JVD elevated to manible at 30 degrees Lungs- expiratory wheezing b/l, no crackles CV- RRR, 2+ systolic murmur RUSB Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, strength ___ in UE and ___ b/l DISCHARGE EXAM Vitals- 99 120/51 69 18 96% 2L General- awake, alert, NAD, mildly tachypneic HEENT- PERRLA, EOMI, OMM no lesions Neck- supple, JVD elevated to manible at 30 degrees Lungs- mild expiratory wheezing b/l, no crackles CV- RRR, 2+ systolic murmur RUSB Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- grossly intact Pertinent Results: ___ LABS ___ 06:00PM URINE BLOOD-TR NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.5 LEUK-LG ___ 06:00PM URINE RBC-3* WBC-16* BACTERIA-FEW YEAST-NONE EPI-1 ___ 03:20PM BLOOD WBC-3.2* RBC-4.59 Hgb-12.6 Hct-40.7 MCV-89 MCH-27.5 MCHC-31.0 RDW-16.2* Plt Ct-88* ___ 03:20PM BLOOD Plt Smr-LOW Plt Ct-88* ___ 03:20PM BLOOD Glucose-112* UreaN-14 Creat-0.8 Na-145 K-4.2 Cl-95* HCO3-44* AnGap-10 ___ 03:20PM BLOOD Calcium-9.8 Phos-3.2 Mg-2.0 ___ 03:53PM BLOOD ___ Temp-36.6 pO2-43* pCO2-86* pH-7.37 calTCO2-52* Base XS-19 Intubat-NOT INTUBA ___ 03:53PM BLOOD Lactate-1.3 PERTINENT LABS ___ 03:20PM BLOOD proBNP-554 ___ 03:20PM BLOOD cTropnT-<0.01 DISCHARGE LABS ___ 06:35AM BLOOD WBC-5.3# RBC-4.14* Hgb-11.5* Hct-36.5 MCV-88 MCH-27.7 MCHC-31.4 RDW-16.4* Plt Ct-90* ___ 06:35AM BLOOD Glucose-78 UreaN-13 Creat-0.7 Na-147* K-3.6 Cl-98 HCO3-46* AnGap-7* ___ 06:35AM BLOOD Calcium-9.0 Phos-2.9 Mg-2.0 MICRO NONE REPORTS ___ Imaging CHEST (PORTABLE AP) IMPRESSION: No definite acute cardiopulmonary process. Brief Hospital Course: ___ year old female with hx. COPD on home ___, pulmonary HTN, hypertrophic obstructive cardiomyopathy, aortic aneurysm s/p repair presenting with c/o weakness #Hypoxia: Ms. ___ was hypoxic to low ___ on arrival to ED and mid ___ on home 2L on arrival to floor. Given progressive requirement in home oxygen, likely etiology is acute on chronic COPD. There was low concern for pulmonary embolism given gradual onset and lack of tachycardia or heart failure (normal BNP). She was treated with albulterol and ipratropium nebulizers, prednisone 40mg x5 days (last day ___, and azithromycin x5 days (last day ___. On day of discharge, ___ breathing was subjectively returned to baseline and O2 saturation was mid-90s on home O2 (2L). #Acute on chronic COPD exacerbation: Patient has severe baseline COPD. Given ___ increased O2 requirement and sputum production at time of admission, she was treated for COPD exacerbation as outlined under Hypoxia. Supplemental O2 was continued to reach goal saturation of low to mid-90s. #Fatigue/weakness: Likely etiology of patient's fatigue and weakness is COPD exacerbation. TSH was recently normal in ___ and she had no signs or symptoms of acute coronary syndrome or acute blood loss. She was treated for COPD exacerbation as outlined above. #Alkalosis: Patient's alkalosis is likely chronic in setting of severe COPD. VBG was indicative of CO2 retention (pCO2 86) that is worse than prior. Contraction alkalosis was also considered but was less likely. She was treated for COPD as above. #Pulmonary HTN: Patient had an ECHO in ___ that demonstrated mild-moderate mitral regurgitation, moderate tricuspid regurgitation, and moderate pulmonary arterial systolic HTN. Etiology is likely multifactorail in setting of cardiac and lung disease. Patient had signs of TR on exam (JVP elevated to level of mandible), but no peripheral edema to suggest right sided heart failure. ___ cardiac status was monitored by physical exam. #Aortic aneurysm/ulcer: Patient is s/p ascending aortic replacement and graft stent repair for penetrating ulcer. CXR on admission demonstrated stable cardiomegaly. #Leukopenia, thrombocytopenia: Etiology for these is unclear. She has had thrombocytopenia in the past. This could represent MDS. ___ blood counts were monitored as an inpatient. WBC count normalized from 3.2 to 5.3 on day of discharge and platelet count remained stable in ___. TRANSITIONAL ISSUES # will complete course of antibiotics and prednisone, total 5d each # CODE STATUS: DNR/DNI # CONTACT: ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN dyspnea 2. Amlodipine 5 mg PO DAILY 3. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation BID 4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 5. Vitamin D 50,000 UNIT PO 2X/MONTH 6. HydrALAzine 50 mg PO BID 7. Ipratropium Bromide MDI 2 PUFF IH QID 8. Levothyroxine Sodium 50 mcg PO DAILY 9. Metoprolol Tartrate 50 mg PO BID 10. Pilocarpine 1% 1 DROP BOTH EYES Q8H 11. Travatan Z (travoprost) 0.004 % ophthalmic QHS 12. Aspirin 81 mg PO DAILY Discharge Medications: 1. Amlodipine 5 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 4. HydrALAzine 50 mg PO BID 5. Levothyroxine Sodium 50 mcg PO DAILY 6. Metoprolol Tartrate 50 mg PO BID 7. Pilocarpine 1% 1 DROP BOTH EYES Q8H 8. Azithromycin 250 mg PO Q24H Duration: 4 Doses RX *azithromycin 250 mg 1 tablet(s) by mouth daily Disp #*2 Tablet Refills:*0 9. PredniSONE 40 mg PO DAILY RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*2 Tablet Refills:*0 10. Albuterol Inhaler 2 PUFF IH Q6H:PRN dyspnea 11. Ipratropium Bromide MDI 2 PUFF IH QID 12. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION BID 13. Travatan Z (travoprost) 0.004 % ophthalmic QHS 14. Vitamin D 50,000 UNIT PO 2X/MONTH Discharge Disposition: Home Discharge Diagnosis: Acute on chronic COPD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at ___. You were admitted for shortness of breath and increased oxygen requirement, likely due to COPD exacerbation. You were treated with nebulizers, steroids, and antibiotic medication (azithromycin), supplemental oxygen, and improved. Followup Instructions: ___
19809456-DS-18
19,809,456
20,745,313
DS
18
2175-11-12 00:00:00
2175-11-22 16:55:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Celebrex / Norvasc Attending: ___. Chief Complaint: shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is an ___ with history of COPD on 2L home O2 with recent admit this month, pulmonary hypertension, HOCM, aortic aneurysm, HTN, HLD, MDM, hypothyroidism, OA, ostoepenia and other issues who presents with fatigue and SOB. The patient's symptoms began the day prior to presentation. She noted fatigue > SOB after climbing a flight of stairs at home, which is unusual for her. She denies fever or chills, she denies cough or sputum production. She denies N/V/D, dysuria, abdominal pain, melena or hematochezia. She reports good PO intake. In the ED, initial VS were 98.2 65 169/59 20 87% 2L. Labs were notable for lactate 1.4, normal UA, normal chem panel (other than hemolysed K), normal lfts/cbc. Exam was notable for AOX3, dyspnea on exertion. Imaging was notable for CXR which showed slight opacification in RLL which could not rule out PNA. Received nebs/IV vanco, cefepime, azithro for pneumonia/solumedrol 80 mg. Admitted to medicine for further management. On arrival to the floor, patient reports that she feels at her baseline in terms of her breathing; her main complaint is fatigue with activity. REVIEW OF SYSTEMS: As per HPI Past Medical History: 1. Aneurysm of ascending aorta and aortic arch, s/p repair ___ 2. Tortuous dilated thoracic aorta. 3. HOCM - LVOT 10mmHg cath ___ TTE: LVOT 19mmHg, 1+AR, 1+MR 5. L vocal cord dysphagia- ___ 6. Hypertension. 7. Hypercholesterolemia. 8. Diabetes mellitus, type 2. 9. Hypothyroidism. 10. Glaucoma. 11. Osteoarthritis. 12. Osteopenia 13. Status post total abdominal hysterectomy. 14. Status post colonic polypectomy. 15. h/o Left Nasolabial abscess, s/p excision. (___) 16. Status post thoracic aortic stent graft repair for posterior penetrating ulcer. 17. Euthyroid multinodular goiter (left-sided dominant ~3cm solid nodules FNA negative for malignancy). 18. ? h/o asthma 19. ? h/o Tb work-up Social History: ___ Family History: Father, deceased, possibly due to cancer. Mother, deceased, died during childbirth when Ms. ___ was approximately ___ years old. Reports that family members on maternal side have characteristically "died young." Sister with ___, and another sister who died in her ___ of cancer, though she does not recall the type. Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VS - 99.4 154/66 60 20 95% on 3L NC General: NAD, thin woman, breathing comfortably HEENT: MMM, OP clear Neck: Supple, no JVD CV: RRR, loud III/VI early systolic murmur loudest at apex, loud P2 Lungs: Moderate air movement throughout, prolonged expiratory phase but no wheezing or crackles Abdomen: Soft, NT ND +BS GU: Deferred Ext: 1+ pitting edema to mid-shin on R, none on L Neuro: CN II-XI intact Skin: No rash DISCHARGE PHYSICAL EXAM: ======================== Pertinent Results: ADMISSION LABS: =============== ___ 03:15PM BLOOD WBC-3.9* RBC-4.48 Hgb-12.7 Hct-40.5 MCV-90 MCH-28.4 MCHC-31.4 RDW-16.7* Plt ___ ___ 03:15PM BLOOD Neuts-73* Bands-1 ___ Monos-6 Eos-0 Baso-0 ___ Myelos-0 Other-1* ___ 03:15PM BLOOD Hypochr-NORMAL Anisocy-OCCASIONAL Poiklo-2+ Macrocy-NORMAL Microcy-NORMAL Polychr-OCCASIONAL Target-2+ ___ 03:15PM BLOOD Glucose-121* UreaN-14 Creat-0.6 Na-142 K-5.5* Cl-96 HCO3-37* AnGap-15 ___ 03:15PM BLOOD ALT-19 AST-38 AlkPhos-56 TotBili-0.5 ___ 03:15PM BLOOD Albumin-4.4 ___ 03:18PM BLOOD Lactate-1.4 K-4.7 ___ 03:20PM URINE Color-Straw Appear-Clear Sp ___ ___ 03:20PM URINE Blood-TR Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-8.0 Leuks-NEG ___ 03:20PM URINE RBC-1 WBC-1 Bacteri-NONE Yeast-NONE Epi-<1 ___ 03:20PM URINE Mucous-RARE PERTINENT LABS: =============== ___ 06:12AM BLOOD TSH-0.31 PERTINENT IMAGING: ================== ECG ___: Sinus rhythm. Compared to the previous tracing of ___ no change. Intervals Axes Rate PR QRS QT/QTc P QRS T 61 138 92 396/397 71 72 70 CXR ___: IMPRESSION: Probable mild pulmonary edema with bilateral lower lobe opacities, which could represent an early pneumonia. Small bilateral effusions, right greater than left. Stable cardiomegaly and post-surgical changes in the descending thoracic aorta. RLE US ___: IMPRESSION: No evidence of a DVT in the right lower extremity. PERTINENT MICRO: ================ ___ 3:15 pm BLOOD CULTURE #1 SOURCE:VENIPUNCTURE. **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. DISCHARGE LABS: =============== ___ 06:12AM BLOOD Calcium-8.6 Phos-2.5* Mg-1.9 ___ 06:12AM BLOOD Glucose-70 UreaN-14 Creat-0.6 Na-146* K-4.0 Cl-98 HCO3-44* AnGap-8 ___ 06:12AM BLOOD WBC-4.2 RBC-3.98* Hgb-11.2* Hct-35.4* MCV-89 MCH-28.1 MCHC-31.6 RDW-16.8* Plt ___ Brief Hospital Course: Ms. ___ is an ___ with history of COPD on 2L home O2 (with recent admission ___ for SOB/weakness), pulmonary hypertension, HOCM, aortic aneurysm, HTN, HLD, MDM, hypothyroidism, OA, ostoepenia and other issues who presents with fatigue and SOB. ACTIVE ISSUES: ============== # Fatigue / Shortness of breath: This was felt to be most consistent with her baseline COPD in the setting of running out of her tiotropium inhaler. Deconditioning may also be contributing. Soon after having her medications restarted, the patient reported that her respiratory status currently close to baseline. COPD exacerbation was felt to be unlikely given no cough or fever, PNA also felt unlikely but given comorbidities, recent hospitalization, and worsening hypoxemia in ED, she was briefly on vanc/levofloxacin for HCAP and received 1 dose of Solumedrol in ED. TSH was normal. Antibiotics and steroids were discontinued and she continued to do well. She was discharged home without antibiotics or steroids with instructions to call her PCP if she felt worse. Her prescriptions were renewed. # RLE edema: Per patient, asymmetric RLE edema is a chronic problem for her, but given no Hx of vascular surgery on this leg and asymmetric swelling, ___ was performed to r/o DVT. This was negative. CHRONIC ISSUES: =============== # HOCM: This was not an active issue during this hospitalization. She was continued on her home Metoprolol and Aspirin. # HTN: Continued home Hydralazine, Metoprolol, and Amlodipine. # DM2: The patient is noton oral hypoglycemics or insulin at home. She was maintained on a gentle ISS while in-house. # Hypothyroidism: The patient was continued on her home synthroid. TSH this admisison was 0.3. # Glaucoma: The patietn was continued on her home eye drops. # ?h/o asthma The patient received advair while in-house (symbicort non-formulary) and was continued on albuterol and ipratropium. # CODE: Full (presumed) # EMERGENCY CONTACT HCP: Sister ___ ___ and Brother ___ ___ TRANSITIONAL ISSUES: ==================== - Patient provided with prescriptions for all inhalers to ensure she has access to these meds after discharge. - Patient instructed to call her primary care physician to ___ an appointment to be seen early next week - Patient with asymmetric RLE edema, per patient this is chronic, there was no DVT on ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amlodipine 5 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 4. HydrALAzine 50 mg PO BID 5. Levothyroxine Sodium 50 mcg PO DAILY 6. Metoprolol Tartrate 50 mg PO BID 7. Pilocarpine 1% 1 DROP BOTH EYES Q8H 8. Albuterol Inhaler 2 PUFF IH Q6H:PRN dyspnea 9. Ipratropium Bromide MDI 2 PUFF IH QID 10. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION BID 11. Travatan Z (travoprost) 0.004 % ophthalmic QHS 12. Vitamin D 50,000 UNIT PO 2X/MONTH Discharge Medications: 1. Amlodipine 5 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 4. HydrALAzine 50 mg PO BID 5. Ipratropium Bromide MDI 2 PUFF IH QID RX *ipratropium bromide [Atrovent HFA] 17 mcg/actuation 2 puffs four times a day Disp #*1 Inhaler Refills:*0 6. Levothyroxine Sodium 50 mcg PO DAILY 7. Metoprolol Tartrate 50 mg PO BID 8. Pilocarpine 1% 1 DROP BOTH EYES Q8H 9. Albuterol Inhaler 2 PUFF IH Q6H:PRN dyspnea RX *albuterol sulfate [ProAir HFA] 90 mcg 2 puffs every six (6) hours Disp #*1 Inhaler Refills:*0 10. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION BID RX *budesonide-formoterol [Symbicort] 160 mcg-4.5 mcg/actuation 1 puff twice a day Disp #*1 Inhaler Refills:*0 11. Travatan Z (travoprost) 0.004 % ophthalmic QHS 12. Vitamin D 50,000 UNIT PO 2X/MONTH Discharge Disposition: Home Discharge Diagnosis: Primary: Shortness of breath, fatigue Secondary: Chronic obstructive pulmonary disease, pulmonary hypertension, hypertrophic obstructive cardiomyopathy, Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was our pleasure caring for you at ___ ___. You were admitted to the hospital for shortness of breath and fatigue. We looked for evidence of pneumonia and did not find any. Your breathing and oxygen levels were unchanged from your baseline. It is likely that your shortness of breath and fatigue were related to running out of your Tiotropium inhalers, as well as possibly a viral respiratory illness that resolved on its own. Because of swelling in your R leg, we did an ultrasound to look for a blood clot and did not find any. Because your breathing was at your baseline and you showed no signs of infection, you were discharged home. It is very important that you call your primary care doctor early this week to schedule an appointment to be seen. If you continue to feel poorly when you go home, or if your breathing gets worse, you should call your primary care doctor to receive a prescription for Azithromycin and Prednisone. Thank you for allowing us to participate in your care. Followup Instructions: ___
19809456-DS-20
19,809,456
25,637,611
DS
20
2176-09-05 00:00:00
2176-09-06 09:09:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Celebrex / Norvasc Attending: ___. Chief Complaint: Epistaxis Major Surgical or Invasive Procedure: None History of Present Illness: Primary Care Physician: ___ CHIEF COMPLAINT: Nosebleed HISTORY OF PRESENT ILLNESS: ___ with PMH of COPD (FEV1 43%, 2L home O2), pHTN, HOCM, aortic aneurysm, HTN, HLD, hypothyroidism, OA, and multiple hospitalization for hypercarbic respiratory failure who is presenting with a nosebleed since ___. She reports no real history of nosebleeds and says that it stopped on its own. She is also reports mild difficulty with swallowing and having a globus sensation. With regard to her COPD, she denies any change in breathing or cough and no increased or change in quality in her sputum production. Her PCP noted her to be hypoxic in clinic and increased baseline 2L home O2 to 4L. She denies ___ edema. Vitals in the ED: 99.0 66 185/79 18 94% 4L NC Labs notable for: WBC 3.0, Hgb 12.5, Hct 40.0, Plt 75, HCOe 43, proBNP 437, TnT 0.01, UA with 32 RBC 1 WBC neg ___ and nitrates. VBG notable for pCO2 of 108 but pH was 7.32 with HCO3. Repeat VBG was pCO2 91, pH 7.37. Imaging: CT Head without any intracranial process, but opacity within the right maxillary sinus. Parietal scalp lesion. CXR without opacity or edema. Patient given: Azithromycin 500mg PO and Prednisone 40mg daily and was admitted for possible COPD exacerbation(?). Vitals prior to transfer: 80 164/70 26 97% Nasal Cannula. On the floor, patient is resting comfortably in her bed without any ongoing complaints. Denies any worsening SOB or cough and does not have a current nosebleed. Later in morning, patient felt overall at her baseline and denied swallowing difficulty aside from globus sensation which she pondered but later retracted (“I ___ really have an issue with food”). She had only gotten her blood pressure medications shortly after discussion. Review of Systems: (+) per HPI, epistaxis, possible dysphagia (-) She denies chest pain, fevers, chills, nausea, vomiting and diarrhea. She denies abdominal pain, back pain, bleeding. 9-point ROS otherwise negative. Past Medical History: - Severe COPD with hypercapnia and hypoxemia, on home O2 (possible asthma) - Moderate-to-severe pHTN - HOCM - LVOT 10mmHg cath ___ TTE: LVOT 19mmHg, 1+AR, 1+MR - S/p endovascular repair of ruptured thoracic aorta and status post ascending aortic replacement - Tortuous dilated thoracic aorta. - L vocal cord dysphagia- ___ - Hypertension. - Hypercholesterolemia - Diabetes Mellitus Type II - Hypothyroidism. - Glaucoma. - Osteoarthritis. - Osteopenia - Status post total abdominal hysterectomy. - Status post colonic polypectomy. - h/o Left Nasolabial abscess, s/p excision. (___) - Euthyroid multinodular goiter (left-sided dominant ~3cm solid nodules FNA negative for malignancy). - Possible TB workup Social History: ___ Family History: Father, deceased, possibly due to cancer. Mother, deceased, died during childbirth when Ms. ___ was approximately ___ years old. Reports that family members on maternal side have characteristically "died young." Sister with ___, and another sister who died in her ___ of cancer. Physical Exam: ADMISSION/DISCHARGE PHYSICAL EXAMINATION: VITALS: 98.3, 65-72, ___ (improved to SBP 150s when home antihypertensives administered), 18, 96-100% on ___ Pain/Dyspnea, Ins 180, Outs 530 GENERAL: NAD, pleasant and conversant HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, no active epistaxis or crusted blood NECK: nontender supple neck, no LAD, no JVD CARDIAC: RRR, S1/S2, ___ systolic murmur at RUSB and at apex radiating to the axilla. LUNG: CTAB with prolonged expiratory phase. Minimal rales. Short of breath with speaking. ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 extremities with purpose PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: LABS: ___ 02:11PM BLOOD WBC-3.0* RBC-4.64 Hgb-12.5 Hct-40.0 MCV-86 MCH-27.0 MCHC-31.3 RDW-16.8* Plt Ct-75* ___ 07:52AM BLOOD WBC-4.1 RBC-4.49 Hgb-12.3 Hct-36.5 MCV-81* MCH-27.4 MCHC-33.7 RDW-16.9* Plt Ct-74* ___ 07:52AM BLOOD Neuts-47.8* ___ Monos-9.9 Eos-1.0 Baso-0.5 ___ 02:11PM BLOOD ___ PTT-30.5 ___ ___ 07:52AM BLOOD Ret Aut-0.9* ___ 02:11PM BLOOD Ret Aut-1.0* ___ 02:11PM BLOOD Glucose-103* UreaN-10 Creat-0.6 Na-143 K-4.2 Cl-92* HCO3-43* AnGap-12 ___ 07:52AM BLOOD Glucose-73 UreaN-11 Creat-0.6 Na-144 K-3.9 Cl-94* HCO3-46* AnGap-8 ___ 07:52AM BLOOD ALT-11 AST-14 LD(LDH)-193 AlkPhos-61 TotBili-0.4 ___ 02:11PM BLOOD cTropnT-<0.01 ___ 02:11PM BLOOD proBNP-437 ___ 07:52AM BLOOD Albumin-3.7 Calcium-9.4 Phos-3.7 Mg-1.9 ___ 02:11PM BLOOD TSH-1.2 ___ 03:03PM BLOOD ___ pO2-58* pCO2-108* pH-7.32* calTCO2-58* Base XS-22 ___ 04:10PM BLOOD ___ O2 Flow-1 pO2-57* pCO2-91* pH-7.37 calTCO2-55* Base XS-21 ___ 08:49AM BLOOD ___ pO2-73* pCO2-91* pH-7.38 calTCO2-56* Base XS-23 Comment-GREEN TOP ___ 04:10PM BLOOD Lactate-0.7 ___ 04:10PM BLOOD freeCa-1.19 ___ 02:50PM URINE Blood-SM Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-8.0 Leuks-NEG ___ 02:50PM URINE RBC-32* WBC-1 Bacteri-NONE Yeast-NONE Epi-0 ___ 02:50PM URINE Color-Straw Appear-Clear Sp ___ STUDIES: # Blood Cx: NGTD # Urine Cx: Mixed bacterial flora from GI contamination # CXR (___): The lungs are well-expanded. There is no focal consolidation, pleural effusion or pneumothorax. Again seen is a markedly tortuous dilated aorta with a stent graft unchanged in size and configuration since prior studies. The cardiomediastinal silhouette is unchanged. IMPRESSION: No acute cardiopulmonary process or change from the prior study. # CT HEAD (___): 1. No acute intracranial process. 2. Complete opacification of the right maxillary sinus. 3. Unchanged right parietal scalp lesion, possibly a sebaceous cyst or other benign etiology. # EKG: NSR with LVH and repol abnormality. No concerning ST/TW changes. Brief Hospital Course: ___, an ___ yo F PMHx COPD Gold III on home oxygen and multiple hospitalizations for respiratory failure presented with self-limited epistaxis and concern of fatigue and globus sensation in ___ ED. Patient's dyspnea/cough were unchanged from baseline and hypoxemia/hypercarbia were unchanged from baseline with normal pH and no new symptoms. However patient was noted to have leukopenia/thrombocytopenia that was worst that prior baseline as well as hematuria without evidence of nephrolithiasis. Patient was discharged to outpatient followup as she was feeling at her baseline. # COPD without Exacerbation: Patient with known COPD with Chronic Hypercapnia on Home Oxygen, with GOLD III disease last PFTs ___ with FEV1 43%. Patient has stable symptoms with no change in dyspnea or cough. Patient has elevated pCO2 but normal pH indicated stable compensation. Patient also has normal troponin and BNP. Patient does not meet criteria for active flare and therefore has no indication for antibiotics or systemic corticosteroids. Her SaO2 was at baseline. She was maintained on fluticasone-salmeterol inhaler during her hospitalization due to ___ formulary. # Hypertensive Crisis: Patient with known HTN on 3 antihypertensives was not given any antihypertensive in the ED after presenting with SBP>180 and continued to be >180 on arrival to ___; patient was subsequently given home antihypertensives. Patient denies headache, visual changes, chest pain, change in dyspnea, focal weakness or numbness, and lower extremity swelling. Her SBP improved to 150s when she was given her home amlodipine, metoprolol, and hydralazine. # Leukopenia / Thrombocytopenia: Patient has thrombocytopenia dating back to ___ (maybe worse in setting of mild consumption) and leukopenia intermittently during the same time period with unremarkable differential (not neutropenic). Differential includes poor bone marrow production (possible MDS), hypersplenism (given thrombocytopenia), immune destruction, and acute viral infection (less likely given lack of acute symptoms). Patient reticulocyte count was low but her WBC was low-normal on day of discharge. # Epistaxis: Patient on no anticoagulation aside from aspirin presented with several days of intermittent slow epistaxis versus far less likely hemoptysis with resolved symptoms, normal vitals, stable respiratory status, and stable Hgb. Patient had no remaining evidence of epistaxis on admission and was discharged with saline nasal spray to avoid dry nares predisposing to epistaxis. # Dysphagia: Patient at one point reported a globus sensation without difficulty swallowing food or changes in cough. Speech and Swallow Consult (see ___ Note) was called and had no concerns about her ability to eat/swallow. # Hematuria: No current symptoms of nephrolithiasis or UTI and urine culture showed mixed GI flora. Could consider CT-Abd/Pelvis and cystoscopy as outpatient to evaluate for GU malignancy as indicated. # Hypothyroidism: Continued on home levothyroxine. # Glaucoma: Continued on home eye drops. TRANSITIONAL ISSUES: - Patient noted to have leukopenia (not neutropenic) and thrombocytopenia worse than prior results since ___ without signs of acute etiology (acute viral infection, destructive process, liver disease) and may benefit from any outpatient bone marrow aspiration - Patient noted to have hematuria on admission without pain or urinary symptoms suggestive of nephrolithiasis or infection; patient may benefit form outpatient CT-Abd/Pelvis and cystoscopy to rule out genitourinary tract malignancy - Patient was discharged with saline nasal spray to reduce the risks of further nose bleeding; patient may benefit from humidified home oxygen if there is a recurrent issue - There was initial concern that patient might have difficulty swallowing; Speech & Swallow evaluation did not show any difficulty with swallowing and she requires no modifications/limitations regarding consistency - Consider alterations in antihypertensive regimen given use of medications requiring multiple doses per day (metoprolol tartrate, hydralazine); of note patient was severely hypertensive (SBP>180s) but had no symptoms and blood pressure improved with administration of home medications - Code Status: DNR (new from prior admissions, patient felt that (“when it’s my time it’s my time”), patient was unsure regarding mechanical ventilation and will discuss with healthcare proxy and may be further discussed as an outpatient - Contact: ___ (sister) at ___ - ___: Home without Services Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 3. HydrALAzine 50 mg PO BID 4. Levothyroxine Sodium 50 mcg PO DAILY 5. Metoprolol Tartrate 50 mg PO BID 6. Travatan Z (travoprost) 0.004 % ophthalmic QHS 7. Vitamin D 50,000 UNIT PO 2X/MONTH 8. Amlodipine 5 mg PO DAILY 9. Albuterol Inhaler 2 PUFF IH Q4H:PRN dyspnea 10. Ibuprofen 400 mg PO DAILY 11. Ipratropium Bromide MDI 2 PUFF IH QID 12. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION 2 puffs BID Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN dyspnea 2. Amlodipine 5 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 5. HydrALAzine 50 mg PO BID 6. Ibuprofen 400 mg PO DAILY 7. Ipratropium Bromide MDI 2 PUFF IH QID 8. Levothyroxine Sodium 50 mcg PO DAILY 9. Metoprolol Tartrate 50 mg PO BID 10. Travatan Z (travoprost) 0.004 % ophthalmic QHS 11. Vitamin D 50,000 UNIT PO 2X/MONTH 12. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION 2 PUFFS BID 13. Sodium Chloride Nasal ___ SPRY NU TID:PRN Dry Nose RX *sodium chloride 0.65 % ___ SPRY intranasally three times a day Disp #*1 Spray Refills:*0 Discharge Disposition: Home Discharge Diagnosis: PRIMARY: Epistaxis Concern of Chronic Obstructive Pulmonary Disease Exacerbation Thrombocytopenia Leukopenia Hematuria Hypertensive Crisis Concern of Dysphagia SECONDARY: COPD on Home Oxygen Gold Stage III Hypothyroidism Glaucoma Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure to take care of you at ___ ___. You were admitted to the hospital because you had nose bleeding and doctors were concerned about your breathing. Luckily, you nose bleeding stopped and your breathing and oxygen numbers were very similar to your previous numbers. Best of luck to you in your future health. You were found to have relatively low number of clot-forming cells and infection-fighting cells as well as a small amount of blood in your urine. Your primary care doctor has been informed about these issues and more testing may be done as an outpatient. We gave you a prescription for a nasal spray to reduce the likelihood of future nose bleeds. While in the hospital, you were having thoughts about whether or not you would want a machine to breath for you if you had severe difficulty breathing; continue to think about this topic and talk about it with your healthcare proxy and primary doctor. Please take all medications as prescribed, attend all doctors ___ as ___ (or call to reschedule), and call a doctor if you have any questions or concerns. Sincerely, Your ___ Care Team Followup Instructions: ___
19809456-DS-21
19,809,456
28,140,413
DS
21
2176-11-22 00:00:00
2176-11-23 13:28:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Celebrex / Norvasc Attending: ___. Chief Complaint: altered mental status Reason for MICU transfer: hypercarbia Major Surgical or Invasive Procedure: None History of Present Illness: ___ with PMH of COPD (FEV1 43%, 2L home O2), pHTN, HOCM, aortic aneurysm, HTN, HLD, hypothyroidism, OA, and multiple hospitalization for hypercarbic respiratory failure who is presenting with increased confusion for a couple months, worsening over the last month. Also with generalized weakness. Today, the patient was noted to be dishelved at home, in bed, which is atypical for her. Fall while in the bathroom, unsure of headstrike but head by vanity. No LOC. Forgot to take underwear down, defecated into underwear. Almost fell again. No changes in vision. Per the patient's brother ___, who checked on the patient as recently as yesterday, she has been confused over at least the last month. He and other family members have been concerned she cannot take care of herself at home alone, and they were trying to get her to go to the hospital for this reason. Finally, when the patient's sister ___ went over today, she was unable to get out of bed on her own and fell when they tried to help her up. In the ED, initial vitals: 98.0 84 163/59 16 100% 4LNC. Labs notable for: Na 146, WBC 3.2, Hct 32 (baseline 40), and Plt 83 (at baseline). VBG 7.31/111/39/59. Her recent VBGs showed a normal pH at pCO2s in the ___ in ___. CT head showed no acute process. CT neck with no fx or dislocation. CXR showed blunting of the costophrenic angles vs hyperinflation, otherwise no acute process. The patient became somnolent when placed on high dose nasal cannula. She improved with weaning down to RA/home O2 requirement. Repeat VBG showed ___. UA showed hematuria but neg leuk and nitrites, few bacteria. On arrival to the FICU, The patient is confused. She is not answering questions appropriately. She does not know why she is at the hospital or what happened today. She denies any shortness of breath, cough, fever, urinary symptoms, abdominal pain, or diarrhea. REVIEW OF SYSTEMS: (+) Per HPI. 10 point ROS is otherwise negative. Past Medical History: - Severe COPD with hypercapnia and hypoxemia, on home O2 (possible asthma) - Moderate-to-severe pHTN - HOCM - LVOT 10mmHg cath ___ TTE: LVOT 19mmHg, 1+AR, 1+MR - S/p endovascular repair of ruptured thoracic aorta and status post ascending aortic replacement - Tortuous dilated thoracic aorta. - L vocal cord dysphagia- ___ - Hypertension. - Hypercholesterolemia - Diabetes Mellitus Type II - Hypothyroidism. - Glaucoma. - Osteoarthritis. - Osteopenia - Status post total abdominal hysterectomy. - Status post colonic polypectomy. - h/o Left Nasolabial abscess, s/p excision. (___) - Euthyroid multinodular goiter (left-sided dominant ~3cm solid nodules FNA negative for malignancy). - Possible TB workup Social History: ___ Family History: Father, deceased, possibly due to cancer. Mother, deceased, died during childbirth when Ms. ___ was approximately ___ years old. Reports that family members on maternal side have characteristically "died young." Sister with ___, and another sister who died in her ___ of cancer. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: 98.4, 95, 159/62, 21, 86% on RA GENERAL: Alert, confused, no acute distress HEENT: Sclera anicteric, MM dry, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: diminished breath sounds throughout, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, ___ RUSB systolic ejection murmur ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema SKIN: no lesions rashes or bruising NEURO: CNs grossly intact ___ strength throughout DISCHARGE PHYSICAL EXAM VS: 98.0 79 115/52 12 100%2L GENERAL: AOx3 HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: diminished breath sounds throughout, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, ___ RUSB systolic ejection murmur ABD: soft non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: no edema SKIN: no lesions rashes or bruising NEURO: CNs grossly intact ___ strength throughout Pertinent Results: ADMISSION LABS: ================ ___ 03:35PM BLOOD WBC-3.2* RBC-3.66* Hgb-10.3* Hct-32.2* MCV-88# MCH-28.3 MCHC-32.2 RDW-16.4* Plt Ct-83* ___ 04:08AM BLOOD WBC-4.5 RBC-3.48* Hgb-9.8* Hct-30.4* MCV-87 MCH-28.2 MCHC-32.3 RDW-16.6* Plt Ct-87* ___ 03:35PM BLOOD Neuts-78.4* Lymphs-14.8* Monos-5.5 Eos-0.9 Baso-0.4 ___ 04:08AM BLOOD Neuts-73.4* Lymphs-17.1* Monos-8.1 Eos-1.1 Baso-0.3 ___ 02:47PM BLOOD ___ PTT-27.7 ___ ___ 04:08AM BLOOD ___ PTT-28.7 ___ ___ 03:35PM BLOOD Glucose-113* UreaN-20 Creat-0.5 Na-146* K-4.9 Cl-92* HCO3-45* AnGap-14 ___ 04:08AM BLOOD Glucose-119* UreaN-17 Creat-0.6 Na-146* K-4.1 Cl-92* HCO3-49* AnGap-9 ___ 03:35PM BLOOD ALT-12 AST-16 LD(LDH)-283* CK(CPK)-43 AlkPhos-61 TotBili-0.5 ___ 03:35PM BLOOD proBNP-484 ___ 03:35PM BLOOD cTropnT-<0.01 ___ 04:08AM BLOOD Albumin-4.1 Calcium-8.8 Phos-2.7 Mg-1.8 ___ 03:35PM BLOOD TSH-0.41 ___ 05:36PM BLOOD ___ pO2-39* pCO2-111* pH-7.31* calTCO2-59* Base XS-22 ___ 05:36PM BLOOD K-4.5 ___ 03:47PM BLOOD Lactate-2.0 ___ 07:10PM BLOOD O2 Sat-60 ___ 05:36PM BLOOD O2 Sat-75 ___ 07:10PM URINE Blood-SM Nitrite-NEG Protein-30 Glucose-NEG Ketone-40 Bilirub-NEG Urobiln-2* pH-6.5 Leuks-NEG ___ 07:10PM URINE RBC-12* WBC-1 Bacteri-FEW Yeast-NONE Epi-0 TransE-<1 ___ 07:10PM URINE CastHy-3* DISCHARGE LABS ================= ___ 04:43AM BLOOD WBC-3.3* RBC-3.84* Hgb-10.8* Hct-32.5* MCV-84 MCH-28.0 MCHC-33.2 RDW-16.7* Plt Ct-93* ___ 04:43AM BLOOD Glucose-75 UreaN-25* Creat-0.7 Na-140 K-3.9 Cl-88* HCO3-45* AnGap-11 ___ 04:08AM BLOOD ALT-13 AST-17 LD(LDH)-221 AlkPhos-59 TotBili-0.7 ___ 04:43AM BLOOD Calcium-8.7 Phos-5.2* Mg-2.1 ___ 03:35PM BLOOD TSH-0.41 ___ 05:31AM BLOOD ___ pO2-37* pCO2-112* pH-7.33* calTCO2-62* Base XS-25 MICRO ================= ___ 7:10 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: <10,000 organisms/ml. ___ 3:35 pm BLOOD CULTURE Blood Culture, Routine (Pending): ___ 9:30 pm MRSA SCREEN Source: Nasal swab. **FINAL REPORT ___ MRSA SCREEN (Final ___: No MRSA isolated. IMAGING/REPORTS ================= ___-SPINE W/O CONTRAST There is no acute fracture or traumatic malalignment. There is no prevertebral soft tissue swelling. Multilevel, multifactorial degenerative changes are noted with disc space narrowing, subchondral sclerosis, and marginal osteophyte formation. There is also uncovertebral and facet hypertrophy causing mild bilateral neural foraminal narrowing at C4-C5 and C5-C7. The thyroid gland is massively enlarged with a dominant heterogeneous lesion measuring 3.4 x 3.1 cm in the left lobe. There is no cervical lymphadenopathy. Visualized lung apices are clear. IMPRESSION: 1. No acute fracture or traumatic malalignment. 2. Multilevel, multifactorial degenerative changes as described above. 3. Massively enlarged and heterogeneous thyroid gland for which clinical correlation advised. ___ Imaging CT HEAD W/O CONTRAST There is no evidence of infarction, hemorrhage, edema, or mass. Slightly prominent ventricles and sulci suggest mild age related global atrophy. The basal cisterns appear patent and there is preservation of gray-white matter differentiation. No osseous abnormalities seen. There is near complete opacification of the right maxillary sinus containing inspissated secretions as well as sclerosis of the maxillary wall compatible with chronic sinusitis. The remaining paranasal sinuses, mastoid air cells, and middle ear cavities are clear. The orbits are unremarkable. A well-circumscribed hypodense lesion is seen at the right parietal soft tissues measuring 2.6 x 1.1 cm compatible with a sebaceous cyst. IMPRESSION: 1. No acute intracranial process. 2. Near complete opacification of the right maxillary sinus containing inspissated secretions with sclerosis of the maxillary wall compatible with chronic sinusitis. ___ Imaging CHEST (PA & LAT) FINDINGS: Cardiac and mediastinal silhouettes are stable. Again, the aorta is markedly tortuous, dilated with a stent graft, similar to prior study. Thoracic scoliosis is noted. No new focal consolidation is seen. No pneumothorax is seen. There is slight blunting of the costophrenic angles which may be due to the lungs being hyperinflated, trace pleural effusions not excluded. IMPRESSION: Slight blunting of the posterior costophrenic angles, trace pleural effusions not excluded. Otherwise, no significant interval change from the prior study. Radiology Report CHEST (PORTABLE AP) Study Date of ___ 6:11 ___ As compared to the previous image, the patient has made a stronger inspiratory effort. Unchanged appearance of the cardiac silhouette. Unchanged appearance of the stent graft. No pleural effusions. No pneumonia, no pulmonary edema. Brief Hospital Course: ___ with PMH of COPD (FEV1 43%, 2L home O2), pHTN, HOCM, aortic aneurysm, HTN, HLD, hypothyroidism, OA, and multiple hospitalization for hypercarbic respiratory failure who is presenting with worsening confusion and inability to care for herself at home. # Confusion: Per collateral history, the patient may be gradually declining at home. She has been hospitalized multiple times in the last ___ years. Her CO2 was noted to be at her baseline. There was no evidence of infection on CXR or UA. No acute proess on head imaging in CT and no notable metabolic derangements. Patientlikely has a baseline dementia. No acute confusion state in the FICU. Patient was transferred to the medical floor where she had acute change in her mental status thought to be from hypercarbia. Confusion resolved with BIPAP use and patient was back to her baseline mental status for rest of hospital stay. # Chronic hypercarbic respiratory failure: Severe COPD FEV1 32 and restriction from cardiomegaly and thoracic aortic graft, which is also compressing the airways. On 2L O2 by NC at home. On arrival to the FICU she denied any respiratory symptoms and esd satting well on home O2 requirement of 2L. Despite shallow, frequent breaths, she is relatively stable from prior with no evidence of exacerbation. Neg CXR and no infectious symptoms.Patient was transferred to the floor. On ___ the patient was transferred to the floor with clear mental status and breathing comfortably on intermittent BIPAP. However, during the afternoon, she was found to acutely desaturate to 50% with depressed mental status. Her O2 sats earlier were documented to be 99-100% and she may have hypoventilated ___ this. She did also receive one dose of IV lasix which may have led to a metabolic alkalosis further lessening her respiratory drive. She was placed on BIPAP and transfrerred back to the ICU on ___. ABG without significant change in her baseline PC02. Patient was continued on BIPAP in the ICU and her symptoms improved. She was weaned back to baseline of 2L NC. The patient ___ BIPAP while sleeping as well as intermitently throughout the day. The patients O2 goal should be 89-92%. She was continued on her albuterol, ipratropium and advair. On discharge the patient will be discharged on combivent as this may be easier to use. BiPAP: Settings:Inspiratory pressure (Pressure support) 10 cm/H2O- Expiratory pressure (EPAP Fixed) 5 cm/H2O. IPAP 15 # HTN: Patient was hypertensive to 200s systolic on the floor, her amlodipine and hydralazine doses were increased, continued her metoprolol. # Glaucoma: continued home eye drops. # Hypothyroidism: contiued home levothyroxine. # Communication: no signed HCP on file; Sister ___ ___ and Brother ___ ___ # Code: DNR/DNI confirmed by patient and family member TRANSLATIONAL ISSUES # has been living along, may not be safe will need home evaluation and physical therapy evaluation # patient should use bi-pap at night and while sleeping throughout day. She may intermittently need it throughout the day for desaturations. Patient uses 2L NC throughout the day. - Goal O2 sat 89-92% # Amlodipine and hydralazine doses increased for high blood pressure # consider CT trachea to evaluate compression from aortic graft # oupatient pulmonary rehab # pulmonary follow-up on discharge # would benefit from a MOLST # BiPAP: Settings:Inspiratory pressure (Pressure support) 10 cm/H2O- Expiratory pressure (EPAP Fixed) 5 cm/H2O. IPAP 15 Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q4H:PRN dyspnea 2. Amlodipine 5 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 5. HydrALAzine 50 mg PO BID 6. Ibuprofen 400 mg PO DAILY 7. Ipratropium Bromide MDI 2 PUFF IH QID 8. Levothyroxine Sodium 50 mcg PO DAILY 9. Metoprolol Tartrate 50 mg PO BID 10. Travatan Z (travoprost) 0.004 % ophthalmic QHS 11. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION 2 PUFFS BID 12. Pilocarpine 1% 1 DROP BOTH EYES Q8H Discharge Medications: 1. Ipratropium-Albuterol Inhalation Spray 1 INH IH Q6H:PRN wheezing 2. Amlodipine 10 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 5. HydrALAzine 50 mg PO Q8H 6. Levothyroxine Sodium 50 mcg PO DAILY 7. Metoprolol Tartrate 50 mg PO BID 8. Pilocarpine 1% 1 DROP BOTH EYES Q8H 9. Docusate Sodium 100 mg PO BID 10. Senna 8.6 mg PO BID:PRN constipation 11. Ibuprofen 400 mg PO DAILY 12. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION 2 PUFFS BID 13. Travatan Z (travoprost) 0.004 % ophthalmic QHS Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY: Hypercarbic respiratory failure SECONDARY: Hypothyroidism Glaucoma Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure to take care of you at ___ ___. You were admitted to the hospital because of difficulty breathing. You were treated with medications and your breathing stabilized. You will need to use a breathing machine at night to help you. Best of luck to you in your future health. Please take all medications as prescribed, attend all doctors ___ as ___ (or call to reschedule), and call a doctor if you have any questions or concerns. Sincerely, Your ___ Care Team Followup Instructions: ___
19809503-DS-10
19,809,503
21,064,073
DS
10
2158-02-18 00:00:00
2158-02-18 21:38:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: AVASTIN / Percocet Attending: ___ Chief Complaint: right lower back pain Major Surgical or Invasive Procedure: ___: Epidural catheter placement under fluoroscopy ___: Intrathecal pump placement History of Present Illness: ___ yo F metastatic RCC s/p R nephrectomy (mets to left kidney, liver, and chest wall) most recently s/p RT ___, CKD stage III, h/o uterine cancer, PMR on prednisone taper, s/p colostomy secondary to ruptured diverticulum in ___, and osteoarthritis who is referred from heme/onc office to r/o cord compression. Patient was at heme/onc office today for CT chest w/ contrast to assess for metastatic disease. Recieved IV hydration and PO contrast. Prior to heading to CT scan patient attempted to use commode and was unable to stand up thereafter due to severe worsening of chronic right lower back pain. She did not have any weakness, sensory deficit, or other neurologic deficit associated with the pain at that time. She denies any recent illness or infection, fever, nausea/vomiting, urinary symptoms or bowel (colostomy) dysfunction, saddle anesthesia, weakness, sensory deficit, or other neurologic deficit. She has had subacutely worsening confusion over the past week per her daughter's report. Of note, typically after prepping for a CT scan, the patient has significant ostomy output. However, since admission, she has not had any ostomy output which is concerning. ED Course: Vitals 15:11 Pain ___ 81 138/65 18 94% ra -Multiple doses of morphine 5mg IV and ativan 0.5 mg IV given. -Exam revealed normal sphincter tone, reflexes, and sensation/strength bilaterally both upper/lower extremities -Radiology ordered: 16:28 MR ___ SPINE W/O CONTRAST 16:28 MR THORACIC SPINE W/O CONTRAST Past Medical History: Past Oncologic History: Please see oncology notes in OMR for full details --Renal Cell CA diagnosed in ___. s/p nephrectomy; last cancer-directed therapy (a trial) in ___. recently, she has undergone RT to a bony met that was causing pain. --___ CT TORSO shows progression in L sided lytic lesion in 8th rib with growth of the extrapleural soft tissue --She has been receiving chest cyberknife therapy for chest wall metastases and was undergoing CT chest on the day of admission for concern for new R rib cage met. Chronic medical conditions: 1. Metastatic renal cell cancer as noted above 2. polymyalgia rheumatica on chronic prednisone 3. HTN, stable 4. Heart murmur, stable 5. GERD, stable 6. restless leg syndrome 7. Degenerative joint disease 8. Osteoporosis 9. Hx laparoscopic cholecystectomy ___. Hx motor vehicle accident with submandibular surgery at the age of ___ 11. Hypercholesterolemia 12. Osteoarthritis 13. Depression/anxiety --h/o uterine cancer --? asthma/COPD Social History: ___ Family History: Stroke. Hypertension. Colon cancer (father). Stomach, liver, bone, lung cancer (paternal uncle). Physical Exam: Admission: T99.2, 160/80, 83, 16, 95%RA GEN: NAD, asleep but easily arousable HEENT: PERRL, EOMI, MMM, oropharynx clear, no cervical LAD Resp: inspiratory rhonchi diffuse (ausc anteriorly). CV: RRR with II/VI SEM, nl S1 S2. JVP<7cm ABD: normal bowel sounds, non-tender, not distended, soft. Back: significant TTP right para-spinal area. Unable to assess vertebral tenderness due to patient's drowsiness. EXTR: Warm, well perfused. No edema. 2+ pulses. NEURO: drowsy but able to follow commands (too sleepy to answer questions more than "yes" and "no"), CN ___ grossly intact, motor grossly intact in all four extremities, 2+ reflexes symmetric but brisk. Babinski downgoing. . . Discharge: VS: 97.9 126/45 ___ 16 95/2.5L GEN: NAD, alert and arousable. A&O to her name, being in the hospital and the year (thought it was ___. Knows ___ is the president. HEENT: Slightly moon-shaped facies, dry mucous membranes CV: regular rate and rhythm, no murmurs appreciated PULM: very coarse breath sounds anteriorly, non labored breathing ABD: Obese, soft, no TTP elicitied on palpation, LLQ ostomy with minimal dark brown stool Extremities: no ___ pitting edema, no rash or excoriations NEURO: alert and oriented Pertinent Results: Admission: ====== ___ 06:10PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 06:10PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-SM ___ 06:10PM URINE RBC-2 WBC-4 BACTERIA-FEW YEAST-NONE EPI-<1 ___ 04:09PM GLUCOSE-103* UREA N-22* CREAT-1.3* SODIUM-134 POTASSIUM-5.2* CHLORIDE-100 TOTAL CO2-22 ANION GAP-17 ___ 04:09PM WBC-8.7 RBC-4.58 HGB-13.9 HCT-42.2 MCV-92 MCH-30.4 MCHC-33.0 RDW-14.4 ___ 04:09PM PLT COUNT-187 . Discharge: ====== ___ 08:00AM BLOOD WBC-5.7 RBC-3.45* Hgb-10.6* Hct-31.3* MCV-91 MCH-30.8 MCHC-33.9 RDW-16.1* Plt ___ ___ 08:00AM BLOOD Glucose-78 UreaN-21* Creat-0.9 Na-134 K-4.4 Cl-97 HCO3-26 AnGap-15 ___ 08:00AM BLOOD Calcium-9.9 Phos-3.4 Mg-1.9 . . ==== Studies: ==== * KUB ___: There is residual contrast seen throughout the colon. There is no definite dilated loops of small bowel. There are no signs for free intra-abdominal gas, however, this is a single supine view. Air and stool are seen throughout mostly the transverse colon. There is a paucity of bowel gas within the pelvis. Degenerative changes of the lumbar spine and of the right hip are again noted. * MRI L/T spine ___: IMPRESSION: 1. Large mass involving the right posterior elements of T12 and the adjacent right posterior paravertebral muscles, which extends into the right lateral epidural space, but does not exert mass effect on the thecal sac. The mass also moderately narrows the right T11-12 neural foramen and extends minimally into the superior portion of the right T12-L1 neural foramen. 2. Enlargement of the more medial left eighth rib metastasis compared to ___ torso CT; the more lateral metastasis is not fully imaged. Adjacent pleural effusion or thickening is not fully evaluated. 3. No evidence of additional metastatic disease in the lumbar spine. Multilevel lumbar degenerative disease with slight progression compared to ___ at L2-L3 and L3-4. 4. Markedly distended bladder. Please correlate clinically whether the patient may have urinary retention. * NCHCT ___: IMPRESSION: No intracranial hemorrhage or mass effect. Intracranial metastases are better assessed via MRI. * CT abd/pelvis ___: IMPRESSION: 1. Enlarged 5.1 x 3.7 x 2.7 cm heterogeneously enhancing metastasis along the right costovertebral margin at the thoracolumbar junction with invasion of the posterior elements and new compression deformity of T12. Involvement of the epidural space is better demonstrated on the recent spine MRI. 2. Status post right nephrectomy. 3. Stable 11 mm nodule anterior to the right psoas muscle. 4. Left lower quadrant end colostomy. 5. Stable mild intra and extrahepatic bile duct dilatation. 6. Right inguinal hernia containing nonobstructed small bowel. * CT chest ___: IMPRESSION: 1. New right middle lobe pulmonary metastasis, substantial increase in left lower rib metastasis with local invasion of the pleura and lower lobe, and substantial growth of T12 metastasis involving both posterior elements, erector musculature, vertebral body, and probably vertebral canal. * MRI brain ___: IMPRESSION: 1. No evidence for intracranial metastatic disease. 2. Chronic infarction in the left cerebellar hemisphere, new since ___. *KUB ___: FINDINGS: Supine and left lateral decubitus views of the abdomen demonstrate a combination of gas and stool within non-distended loops of colon, which also contain residual oral contrast. Air-filled non-dilated loops of small bowel are also present as well as a moderately distended, gas-filled stomach. On the lateral decubitus view, air-fluid levels are present in both large and small bowel as well as the stomach. No free intraperitoneal air is evident. *CXR ___: FINDINGS: Left chest wall mass with associated rib destruction, adjacent pleural and parenchymal opacification in the left mid and lower hemithorax is unchanged since recent CT. Small lung nodules are seen to better detail on that study including a dominant right middle lobe nodule measuring about 8 mm. No new areas of consolidation are present to suggest the presence of a pneumonia. Cardiomediastinal contours are unchanged allowing for marked patient rotation and apicolordotic projection. *CXR ___: FINDINGS: As compared to the previous radiograph, there is unchanged evidence of a left chest wall mass, with tips projecting over the left ventral lateral chest wall. Moderate cardiomegaly and tortuosity of the thoracic aorta. No pleural effusions. No pulmonary edema. No evidence of pneumonia. No pneumothorax. *CXR ___: FINDINGS: Cardiomediastinal contours are stable. Large left chest wall mass with rib destruction appears similar compared to the prior radiograph. No definite new areas of consolidation to suggest the presence of pneumonia, but standard PA and lateral chest radiographs would be helpful to more fully evaluate the lung bases which are partially obscured by overlying breast tissue and left chest wall mass. *CT A/P w/o contrast ___: IMPRESSION: No intra-abdominal findings to explain the patient's abdominal pain. Chronic findings include surgically absent right adrenal gland and kidney, bony mets/soft tissue mass along the right costovertebral margins, compression deformity of the T12 vertebral body and a left lower quadrant end colostomy. *CT Chest w/o contrast ___: IMPRESSION: 1. New bilateral ground-glass opacity, lower lobe predominant, with peribronchial infiltration and also evidence of subpleural consolidation in left lower lobes are compatible with miltifocal pneumonia. 2. Middle lobe pulmonary metastasis, and left posterior arch of VIII rib metastasis with pleural invasion are unchanged since ___. *Hip R, 2 view ___: There is no evidence of fracture, dislocation or osteolytic osseous lesions. There are degenerative changes in the joint with decrease in the joint space and a small osteophyte. Surgical clips project in the right pelvis. *Chest XR ___: FINDINGS: The patient is intubated. The tip of the endotracheal tube projects 4.6 cm above the carina. The known left chest wall mass with massive rib destructions has obviously slightly increased in extent and is causing relatively large left pleural effusion with both basal, lateral and apical component. These changes lead to substantial volume loss in the left hemithorax and subsequent shift of the mediastinal structures to the left. Mild hyperexpansion of the right lung. Several of the larger nodules in the right lung, documented on a CT examination from ___, are seen on the chest x-ray. *CXR ___: AP radiograph of the chest demonstrates interval improvement of the left lung aeration with still present left lower lobe atelectasis. The ET tube tip is 6.5 cm above the carina. Left retrocardiac consolidation is consistent with atelectasis. Clips project over the left hemithorax, unchanged. Right lung is overall clear. No pneumothorax is seen. *CXR ___: FINDINGS: Portable semi-upright frontal view of the chest. The endotracheal tube has been removed. The right lung is clear. Left lower lobe atelectasis persists. Left lower pleural mass and lower lobe consolidation appear unchanged. Clips project over the left hemithorax. Left lower rib irregularity is due to known metastatic disease. Normal size heart. No pleural effusion or pneumothorax. IMPRESSION: Unchanged left lower lobe atelectasis and left pleural mass/consolidation better characterized on the prior chest CT. *CXR ___: FINDINGS: In comparison with the study of ___, there is continued opacification involving much of the mid and lower left lung. Findings are again consistent with a combination of pleural mass and lower lung consolidation as seen on the CT examination of ___. The right lung is essentially clear. ___ KUB: Supine views of the abdomen demonstrate no dilated loops of bowel or air-fluid levels to suggest obstruction. There is no evidence of pneumatosis or secondary signs of free air on the supine radiograph. Surgical clips in the upper abdomen are again noted. Visualized right lung base appears clear. Imaged osseous structures are intact. Degenerative joint changes of the lower lumbar spine are evident. Multiple surgical clips are in the pelvis bilaterally. IMPRESSION: No evidence of obstruction. ___ CXR: FINDINGS: AP portable chest x-ray shows stable left base opacification due to a combination of pleural mass and left lower lobe consolidation, unchanged since prior chest x-ray. No new consolidation. Cardiomediastinal silhouette is unchanged. No pneumothorax. IMPRESSION: No changes since prior CXR. The study and the report were reviewed by the staff radiologist. ======= MICROBIOLOGY ------------- ___ 6:03 am URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ___ Urine CX: STAPHYLOCOCCUS, COAGULASE NEGATIVE | GENTAMICIN------------ <=0.5 S LEVOFLOXACIN----------<=0.12 S NITROFURANTOIN-------- <=16 S OXACILLIN-------------<=0.25 S TETRACYCLINE---------- <=1 S VANCOMYCIN------------ 1 S ___ Blood cx x2: NEGATIVE ___ C diff assay - NEGATIVE ___ Urine culture: NEGATIVE ___ Blood cx: NEGATIVE ___ Urine cx: NEGATIVE ___ Urine CX: NEGATIVE ___ Blood CX: NEGATIVE ___ BAL: Commensal respiratory flora ___ SPUTUM: Contaminated ___ Urine cx: NEGATIVE ___ Blood CX x2: **** ___ C diff: NEGATIVE ___ Blood cx x2: **** Brief Hospital Course: Ms. ___ is a ___ yo F w/ metastatic RCC s/p R nephrectomy (mets to left kidney, liver, and chest wall) most recently s/p RT ___, CKD stage III, PMR on prednisone taper, s/p colostomy presenting with acutely worsening right lower back pain, found to have T12 mass compressing epidural space but no cord compression, treated with XRT and aggressive pain control. . # T12 mass/pathologic compression fx: Likely metastatic RCC, explains her severe acute on chronic right sided back pain. No e/o cord compression on imaging or exam. She was started on XRT with radiation oncology, with improvement in her symptoms. She received trials of gabapentin, baclofen, tizanidine without marked symptom improvement. The chronic pain service was involved with her care, directing an epidural catheter placement ___. Infusion of bupivacaine + hydromorphone allowed the patient to have modestly reduced opiate requirement, allowing improved mentation. However, she was still unable to move without severe pain and was not able to sit or stand. Because of perceived modest improvement, an intrathecal pump was placed on ___ under fluoroscopy. This also seemed to afford a reduced opiate requirement with somewhat improved mental status. However, there were again intermittent pain crises. Ultimately, her lack of pain control was attributed to progressive disease, especially given newer symptoms involving not just the thoracic spine but the right hip and leg. She improved with titration of the ITP and IV dilaudid and was discharged to inpatient hospice. . # AMS: Per daughter, pt has been more confused x2 weeks before admission. Acute confusion/somnolence on admission was likely medication related from numerous doses of IV morphine and ativan in the ED, as well as pain. MRI brain w/o CNS disease. She was initially alert and oriented x3 early in this admission with some forgetfulness but appeared to tolerate her opioid regimen. She became more regularly confused and was more reliably oriented only x2 later in her admission, depending on her medications that day. Efforts to control her pain with the intrathecal pump were aimed toward achieving analgesia while also preventing delirium secondary to narcotics. Her steroid dose, initially increased given her T12 fracture and lesion in that area, was tapered later on to avoid any steroid induced mental status changes. She was discharged to inpatient hospice. . # Metastatic renal cell cancer: Has been managed over the last ___ years with palliative XRT - failed VEGF inhibitor systemic therapy in the past. New mets as above, as well as new R lung met and worsening left thoracic chest wall/pleural dx. She was given palliative XRT for T12 spinal met as above. She had previously been made DNR/DNI given physician recommendations to the daughter that resuscitation would likely cause more harm than good and was discharged to inpatient hospice. . # Fevers/Diaphoresis: The patient was persistently diaphoretic and intermittently had fevers during this admission. She was treated for a hospital acquired pneumonia on ___. However, she continued to spike fevers every several days, sometimes without obvious explanation as to the source. Notably, ___ she had a fever to 102 associated with depressed mental status, and there was some concern for meningitis given that she had the intrathecal pump placed 6 days previously. Her mental status improved to a degree and her WBC was normal. Other infectious workup was also normal. It was thought that some of her dysregulated temperature was due to her underlying renal cell cancer. She did continue to spike fevers, and was started on treatment with cefepime and vancomycin for presumed HCAP. She completed the course of antibiotics prior to discharge. . # CKD stage III: Cr 1.2-1.3, around baseline. She had no major nephrologic issues. . # Urinary retention: Foley placed on admission, drained 750 ccs. Likely ___ narcotics. This resolved and the foley was discontinued. However, it had to be replaced because of ongoing retention in the setting of high-dose narcotic use as well as extreme pain associated with getting on the bed pan. . # PMR: PO dexamethasone 4mg qd was started per palliative care recommendations for symptom control. ___ weeks post radiation therapy this was titrated down to her home prednisone dose so as to avoid steroid induced mental status changes. . . TRANSITIONAL ISSUES - Discharged to inpatient hospice - Intrathecal pump: With 1.5mg/day dilaudid and 11.2mg/day bupivicaine. Will alarm around ___. Please contact Dr. ___ ___ at the ___ Pain ___ regarding titration and refill of pump. ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. PredniSONE 8 mg PO DAILY 2. Lorazepam 0.5 mg PO Q6H:PRN anxiety 3. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB 4. Amlodipine 10 mg PO DAILY 5. Fluticasone Propionate 110mcg 2 PUFF IH BID 6. Hydrocodone-Acetaminophen (5mg-500mg) 2 TAB PO Q6H:PRN pain 7. Morphine SR (MS ___ 30 mg PO Q8H 8. Omeprazole 20 mg PO DAILY 9. Acetylcysteine 600 mg Other BID 10. Vitamin D ___ UNIT PO DAILY 11. Loratadine 10 mg PO DAILY 12. Citalopram 20 mg PO DAILY Discharge Medications: 1. Citalopram 20 mg PO DAILY 2. Lorazepam 0.5-1 mg PO Q4H:PRN anxiety 3. PredniSONE 5 mg PO DAILY 4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H 5. Baclofen 10 mg PO TID 6. Docusate Sodium 100 mg PO BID Hold for loose stools 7. Gabapentin 400 mg PO BID 8. Gabapentin 600 mg PO HS 9. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line flush 10. HYDROmorphone (Dilaudid) ___ mg IV Q1H:PRN breakthrough pain 11. Ipratropium Bromide Neb 1 NEB IH Q6H 12. Methadone 5 mg PO TID 13. Pantoprazole 40 mg PO Q24H 14. Senna 1 TAB PO BID 15. Sodium Chloride 0.9% Flush 10 mL IV DAILY and PRN, line flush 16. TraZODone 25 mg PO HS:PRN insomnia 17. Intrathecal pump dilaudid 1.5mg/day and bupivicaine 11.2mg/day in the intrathecal pump Please contact Dr. ___ at the ___ Pain ___ regarding titration and refill of pump. ___ Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary diagnoses: Metastatic renal cell cancer Secondary diagnoses: T12 compression fracture, toxic-metabolic encephalopathy, urinary retention, health care associated pneumonia, CKD, PMR Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Lethargic but arousable. Activity Status: Bedbound. Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you at ___. You were admitted with back pain and found to have a tumor around your spine. This is likely a new metastasis from your renal cell cancer. You were treated with pain medication and radiation therapy. Your pain did not improve much, and seemed to get worse. This required more pain medications which made you confused at times. We decided to try directly infusing pain medication into the spinal area with an epidural catheter (___). Since this seemed to help a bit, we placed a permanent pump that sits in the right side of your abdominal wall to deliver pain medications to the spinal cord. Unfortunately, neither of these interventions reduced your pain to a point where you were able to sit up or stand. Because there were no treatments available for your renal cell cancer, you, your daughter ___, and the medical team caring for you decided that your goals of care should be focused on maximizing your comfort. Eventually, you were discharged to inpatient hospice for continued comfort care. Again, it was our pleasure participating in your care. We wish you the best -- Your ___ Medicine Team Followup Instructions: ___
19810060-DS-12
19,810,060
25,507,058
DS
12
2158-06-01 00:00:00
2158-06-01 12:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Iodinated Contrast Media - IV Dye Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: EUS ERCP with sphincterotomy History of Present Illness: ___ year old female w/PMH of cholecystectomy presenting for RUQ pain radiating to back for several days. She reports she has been having pain for the past few days that began in RUQ and moves towards the back. Yesterday, her pain became more acute after eating chocolate and potato chips. She attempted to vomit the food and she vomited potato chips. She went to ___ to urgent care and was told to come to the ER. She currently feels like something is stuck near her abdomen and is attempting to come up through her lower esophagus. She reports she also had right arm numbness yesterday that resolved in the ER. She denies chest pain or SOB, blurry vision, weakness in ___, difficulty swallowing, dysuria, diarrhea, vaginal discharge. Last BM this morning. GYN: Her LMP was ___, lasts 4 days, irregular, occasional skips months. She has never had a pap smear. She was seen by gynecology on last hospitalization for concern for lower abdominal pain. She has not followed up with gynecology since then. Last sexually active ___ years prior. Past Medical History: ___ Cholecystectomy ___ Social History: ___ Family History: Family History: Mother: ___, 'enlarged heart', Diabetes Grandmother(maternal: ___ Father: healthy Physical ___: Physical Exam on admission: VS: T: 97.7, BP: 105/67, HR: 60, RR: 18, O2: 95% RA General Appearance: pleasant, comfortable, no acute distress Eyes: PERLLA, EOMI, no conjuctival injection, anicteric ENT: no sinus tenderness, MMM, oropharynx without exudate or lesions Respiratory: CTA b/l with good air movement throughout Cardiovascular: NS1/S2, RRR, no bruits Gastrointestinal: TTP RUQ/RLQ/LLQ, TTP over epigastrium, NABS, ND, soft Extremities: no cyanosis, clubbing or edema Skin: warm, no rashes/no jaundice/no skin ulcerations noted Neurological: Alert, oriented to self, time, date, reason for hospitalization. Cn II-XII intact. Sensation in ___ intact. TTP over right lower extremity near ankle (reports prior injury), no swelling/erythema appreciated MSK: ___ strength in ___, +right CVA tenderness Psychiatric: pleasant, appropriate affect Discharge physical exam: Pertinent Results: Admit: Labs ___ 08:25PM ALT(SGPT)-221* AST(SGOT)-447* ALK PHOS-128* TOT BILI-0.9 ___ 08:25PM LIPASE-38 Procedures: # EUS (___): Abnormal mucosa in the stomach. CBD max diameter 5.5 mm. No intrinsic stones or sludge were noted. Small stone in the cystic duct stump with no evidence of obstruction. Otherwise normal eus to third part of the duodenum # ERCP (___): The common bile duct, common hepatic duct, right and left hepatic ducts, biliary radicles and cystic duct were filled with contrast and well visualized. A small filling defect was noted at the level of the mid common bile duct. Sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire. Balloon sweeps reveled small amount of sludge and a small stone. Occlusion cholangiogram showed no evidence of filling defects. # Pelvic U/S (___): Normal Brief Hospital Course: ASSESSMENT & PLAN: ___ h/o CCY ___ admitted with abd pain, transaminitis. s/p EUS, ERCP w/sphincterotomy ___, #Abd pain: Ms. ___ was admitted with abd pain, N/V, elevated LFTs. She had history of chronic cholecystitis in ___ - and the thought was that her symptoms/signs were c/w choledocholithiasis. To work this up, EUS was done - showing small stone in the cystic duct stump - but was otherwise unremarkable. She has an ERCP with sphincterotomy with removal of small stone, sludge. Gradually, her LFT's improved and she had no further abd pain or N/V. Hep, EBV serologies were negative. She understands that she should not take aspirin, Plavix, NSAIDS, Coumadin for 5 days. She should also complete a 5d course of ciprofloxacin post ERCP. Follow-up with Dr. ___ as previously scheduled. #Gyn: RLQ/LLQ pain. Hep C, HIV, urine GC/chlamydia, TVUS were negative. No further pain here. She is recommended to have follow-up outpatient gynecology to establish care and pap smear (can be done at PCP as well). #Bradycardia: TSH wnl, ECG completed . #PPX: Heparin subq q12 #Code Status: FULL CODE # Emergency Contact: Friend: ___: ___ ___ on Admission: Melatonin prn Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H 2. Docusate Sodium 100 mg PO BID constipation Discharge Disposition: Home Discharge Diagnosis: Filling defect note at level of mid common bile duct/sphincterotomy performed, small stone in the cystic duct stump Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: -Please follow-up with hepatology as outpatient -Please follow-up with primary care appointment next week -Please follow-up with gynecology for annual exam/pap smear Followup Instructions: ___
19810411-DS-15
19,810,411
21,922,574
DS
15
2174-09-29 00:00:00
2174-09-29 06:56:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: UROLOGY Allergies: codeine / Demerol Attending: ___ Chief Complaint: Fevers post-TURP Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ yo male with recent TURP and left stent placement on ___ with Dr. ___ presented yesterday with one day of fevers. The pt states that he was doing well post-operatively. He had low-grade fever 5 days ago which resolved. Yesterday, the pt reports a fever to 105. He presented to the ___ Emergency Department with a fever of 102. He was fluid resuscitated, given ceftriaxone and ciprofloxacin, and transferred to the ED at ___. Notably, UA with leuk est, WBCs, and RBCs, negative nitrites, and CBC with WBC 5.4. UCx and BCx's were drawn and he was started on vanc/zosyn. A CT was done that shows normal post-op changes and cystitis. Currently, he is doing well. He complains of mild lower abdominal crampy pain. No nausea. No fevers overnight. HIs foley remains in place. Past Medical History: HTN HLD BPH Social History: ___ Family History: No family history of prostate cancer Physical Exam: Exam on Admission Tmax 99.7, Tc 97.5, HR 52, BP 140/68, RR19, 97% on RA Gen: No acute distress, alert & oriented HEENT: Extraocular movements intact, face symmetric CHEST: Warm and well-perfused BACK: Non-labored breathing, no CVA tenderness bilaterally ABD: Soft, mild tenderness to palpation of lower abdomen, non-distended, no guarding or rebound EXT: Moves all extremities well PSY: Appropriately interactive Pertinent Results: ___ 08:07PM LACTATE-1.2 ___ 07:53PM GLUCOSE-98 UREA N-17 CREAT-1.2 SODIUM-139 POTASSIUM-4.2 CHLORIDE-104 TOTAL CO2-25 ANION GAP-14 ___ 07:53PM WBC-5.4 RBC-4.01* HGB-11.5* HCT-35.5* MCV-89 MCH-28.7 MCHC-32.4 RDW-13.9 RDWSD-45.0 ___ 07:53PM URINE COLOR-Red APPEAR-Hazy SP ___ ___ 07:53PM URINE BLOOD-LG NITRITE-NEG PROTEIN-300 GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-LG ___ 07:53PM URINE RBC->182* WBC->182* BACTERIA-FEW YEAST-NONE EPI-0 ___ 07:53PM URINE MUCOUS-RARE Brief Hospital Course: Pt was admitted to the urology service for management of fevers after one night of observation in the ED. He was started on vancomycin and cefepime. He was hydrated and given a regular diet. He had no fevers while at the hospital. After 24 hours of being afebrile, he was transitioned to PO antibiotics. His BCx was NGTD and UCx from outside hospital and ___ with enterococcus sensitive to ampicillin. He was discharged in stable condition with instructions to return with further fevers and a ten day course of amoxicillin. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. alfuzosin 10 mg oral Q24H 2. Amlodipine 5 mg PO DAILY 3. Finasteride 5 mg PO DAILY 4. Metoprolol Succinate XL 50 mg PO DAILY 5. Omeprazole 40 mg PO DAILY 6. Simvastatin 10 mg PO QPM 7. Aspirin 325 mg PO DAILY 8. Cyanocobalamin Dose is Unknown PO DAILY Discharge Medications: 1. Amlodipine 5 mg PO DAILY 2. Finasteride 5 mg PO DAILY 3. Aspirin 325 mg PO DAILY 4. Metoprolol Succinate XL 50 mg PO DAILY 5. Omeprazole 40 mg PO DAILY 6. Simvastatin 10 mg PO QPM 7. Amoxicillin 500 mg PO Q8H urosepsis RX *amoxicillin 500 mg 1 capsule(s) by mouth every eight hours Disp #*27 Capsule Refills:*0 8. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice daily Disp #*30 Capsule Refills:*0 9. Senna 17.2 mg PO HS RX *sennosides [senna] 8.6 mg 2 tabs by mouth daily Disp #*20 Capsule Refills:*0 10. alfuzosin 10 mg oral Q24H Discharge Disposition: Home Discharge Diagnosis: Urosepsis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: -Resume your pre-admission/home medications EXCEPT as noted. You should ALWAYS call to inform, review and discuss any medication changes and your post-operative course with your primary care doctor. -If prescribed; complete the full course of antibiotics. -You may be discharged home with a medication called PYRIDIUM that will help with the "burning" pain you may experience when voiding. This medication may turn your urine bright orange. -Colace has been prescribed to avoid post surgical constipation and constipation related to narcotic pain medication. Discontinue if loose stool or diarrhea develops. Colace is a stool softener, NOT a laxative - AVOID STRAINING for bowel movements as this may stir up bleeding. -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated -No vigorous physical activity or sports for 4 weeks or until otherwise advised -Do not lift anything heavier than a phone book (10 pounds) or participate in high intensity physical activity for a minimum of four weeks or until you are cleared by your Urologist in follow-up -Tylenol should be your first line pain medication, a narcotic pain medication has been prescribed for breakthrough pain >4. Replace Tylenol with narcotic pain medication. -Max daily Tylenol (acetaminophen) dose is 4 grams from ALL sources, note that narcotic pain medication also contains Tylenol -Do not drive or drink alcohol while taking narcotics and do not operate dangerous machinery. Also, if the Foley catheter and Leg Bag are in place--Do NOT drive (you may be a passenger). WHEN YOU ARE DISCHARGED WITH A FOLEY CATHETER: -Please also reference the nursing handout and instructions on routine care and hygiene -Your Foley should be secured to the catheter secure on your thigh at ALL times until your follow up with the surgeon. -IF YOU HAVE A PRESCRIPTION FOR DITROPAN/OXYBUTININ: YOU MUST STOP at least 24hours before planned foley removal and void trial. -DO NOT have anyone else other than your Surgeon or your surgeon's representative remove your Foley for any reason. -Wear Large Foley bag for majority of time; the leg bag is only for short-term periods for when leaving the house. -Do NOT drive if you have a Foley in place (for your safety) Followup Instructions: ___
19810528-DS-16
19,810,528
21,167,298
DS
16
2175-07-06 00:00:00
2175-07-06 14:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___ Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: =================================================== MEDICINE NIGHTFLOAT ADMISSION NOTE Date of admission: ___ ==================================================== PCP: ___ CC: ___ pain HISTORY OF PRESENT ILLNESS: ___ M PMH Crohn's disease (Dx ___ currently on remicade, ___ s/p ablation ___, with history of multiple prior small bowel obstructions previously requiring ex lap x3, presenting with abdominal pain. Patient had multiple small bowel obstructions and feels the symptomatology is consistent with prior. On ___ patient noted worsening abdominal pain and distention, which has improved somewhat over the past couple days. He noted a subsequent decrease in the size of his BMs; with eventual cessation of BMs 2 days ago and no passing of gas for the past day. He denies nausea, vomiting, fevers, dysuria, hematuria. Denies chest pain, shortness of breath. On a Remicade infusion, last was ___. Reports he is in the hospital every ___ months with an SBO; last ex lap was ___ years ago. Denies any cardiac symptoms since his ___ ablation in ___. In the ED, initial VS were: 96.7 67 129/75 15 99/RA Exam: -Mildly distended abdomen, diffusely tender, worse in epigastric area -Regular rate and rhythm, no murmurs rubs Labs: -Unremarkable chem 7, CBC, LFTs; lactate 1.6; nl coags; unremarkable UA Imaging: -CT A/P: mild/partial SBO. GI consult: recommended IV methylpred and admission to medicine. No NGT placed as pt without significant symptoms. CRS made aware, they will see the patient on the floor if desired by inpatient team. Imaging showed: Patient received: ___ 06:17 IVF NS ___ Started ___ 06:17 IV Morphine Sulfate 4 mg ___ ___ 08:16 IV Ondansetron 4 mg ___ ___ 08:16 IVF NS ___ Started ___ 08:17 IVF NS 1000 mL ___ Stopped (2h ___ ___ 09:11 IVF NS 1000 mL ___ Stopped (___) ___ 09:47 IV HYDROmorphone (Dilaudid) .5 mg ___ ___ 14:29 IV MethylPREDNISolone Sodium Succ 20 mg ___ ___ 14:29 IVF ___ ___ Started ___ 14:42 IV HYDROmorphone (Dilaudid) .5 mg ___ ___ 18:34 IV HYDROmorphone (Dilaudid) .5 mg ___ ___ 20:34 IVF ___ 1000 mL ___ Stopped (6h ___ ___ 22:01 IV HYDROmorphone (Dilaudid) .5 mg ___ Transfer VS were: 97.8 66 ___ On arrival to the floor, patient reports ongoing abdominal pain without passing gas, with pain reasonably well controlled at present. REVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as per HPI Past Medical History: -___ white syndrome with tachycardia had ablation successfully in ___. -appendectomy age ___ -episodic small bowel obstructions s/p ex-lap x3, last ___ -Crohn's disease diagnosed in ___ (colonoscopy ___ showing terminal ileitis confirmed on biopsies) MRI enterography ___ terminal ileitis measuring approximately 6 cm resulting in upstream partial small bowel obstruction. At the age of ___ he had an appendectomy and then since then he's had at least eight admissions for small bowel obstruction. Three times he's had surgery. The last surgical procedure was done ___ years ago and at that time there was no mention made of inflammatory bowel disease. He was admitted to ___ with an acute small bowel obstruction on ___ and released on ___. He underwent tests there which I have copies of that showed on initial CAT scan on ___ small bowel obstruction and then subsequent x-rays including an MRI showed terminal ileitis with 6 cm of inflammation and proximal to this there was some dilatation of the small bowel. -He had negative blood tests for hepatitis B and tuberculosis in ___ Social History: ___ Family History: father died of heart disease. Mother is alive and well. No one in the family has inflammatory bowel disease or other G.I. conditions. Physical Exam: ADMISSION PHYSICAL EXAM: VS: 97.9 120/80 59 16 99 ra GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no LAD, no JVD HEART: RRR, nl S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Firm but not taut, mildly distended, diffusely tender to palpation, faint bowel sounds present. EXTREMITIES: no cyanosis, clubbing, or edema NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: PHYSICAL EXAM: VS: 98.4 132/83 HR66 17 97 Ra GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no LAD, JVP not elevated HEART: RRR, nl S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Non-distended, soft, non-tender, normal bowel sounds EXTREMITIES: no cyanosis, clubbing, or edema NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ADMISSION LABS: WBC 9 (up from 5.4 on ___ Hb stable 12.3 (12.1) BMP wnl ALT 43 (normal AST 36, Alk phoph 62, TBili 0.2, lipase 26) Lactate 1.6, nl coags, U/A bland PENDING: INFLIXIMAB CONCENTRATION AND ANTI-INFLIXIMAB ANTIBODY Results Pending BMP ___ pending Urine culture ___ pending CT scan ___: LOWER CHEST: There is minimal bibasilar atelectasis. There is no evidence of pleural or pericardial effusion. ABDOMEN: HEPATOBILIARY: The liver demonstrates homogenous attenuation throughout. 2 subcentimeter hepatic hypodensities are too small to characterize, however are not significantly changed, likely representing hepatic cysts or biliary hamartomas. There is no evidence of intrahepatic or extrahepatic biliary dilatation. The gallbladder is within normal limits. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions or pancreatic ductal dilatation. There is no peripancreatic stranding. SPLEEN: The spleen shows normal size and attenuation throughout, without evidence of focal lesions. ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: The kidneys are of normal and symmetric size with normal nephrogram. Few tiny a cortical hypodensities in the right kidney are not significantly changed, previously characterized as cysts on MRI. There is no hydronephrosis. There is no perinephric abnormality. GASTROINTESTINAL: The stomach is unremarkable. Again seen is wall thickening and mild mucosal hyper enhancement of the distal/terminal ileum extending to the ileocecal valve (601:32, 2:67). Proximal to this segment of abnormal bowel, there are mildly dilated loops of small bowel measuring up to 3.6 cm, the more proximal of which are more prominent in caliber compared with prior. The colon and rectum are within normal limits. The appendix is not visualized, however there are no secondary signs of acute appendicitis. There is no evidence of free air or free fluid. PELVIS: The urinary bladder and distal ureters are unremarkable. There is no free fluid in the pelvis. REPRODUCTIVE ORGANS: The prostate and seminal vesicles are normal. LYMPH NODES: There is no retroperitoneal or mesenteric lymphadenopathy. There is no pelvic or inguinal lymphadenopathy. VASCULAR: There is no abdominal aortic aneurysm. Mild atherosclerotic disease is noted. BONES: There is no evidence of worrisome osseous lesions or acute fracture. SOFT TISSUES: The abdominal and pelvic wall is within normal limits. IMPRESSION: Partial or mild small-bowel obstruction secondary to an abnormal segment of terminal/distal ileum with mild wall thickening and mild mucosal hyperenhancement, consistent with mild active Crohn's inflammation. Brief Hospital Course: Mr. ___ is a ___ M PMH Crohn's disease (Dx ___ currently on remicade (last infusion ___, ___ s/p ablation ___, with history of multiple prior small bowel obstructions previously requiring ex lap x3, presenting with partial SBO. He was treated conservatively with bowel rest, IV fluids, and Methylpred for his Crohn's. His diet was slowly advanced, and he started having regular bowel movements on ___. At time of discharge, he had no abdominal pain, he was tolerating a regular diet, vitals were stable, and his abdominal exam was benign. He was discharged on Prednisone 60mg daily, and has follow-up with his outpatient gastroenterologist in ___ week. TRANSITIONAL ISSUES: Hb 12.3 Infliximab concentration and anti-infliximab antibody pending - Patient will take Prednisone 60mg daily until he sees Dr. ___ in clinic. Since he was discharged on a short (2 week maximum) course of steroids, he was NOT given PPI, Bactrim, Vitamin d, or Calcium. If prednisone is continued longer term, he will need these medicines. - Follow up with Dr. ___ in 1 week - Contact: ___ ___: Brother Phone: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. InFLIXimab 500 mg IV Q4WEEKS Discharge Medications: 1. PredniSONE 60 mg PO DAILY RX *prednisone 20 mg 3 tablet(s) by mouth daily Disp #*42 Tablet Refills:*0 2. HELD- InFLIXimab 500 mg IV Q4WEEKS This medication was held. Do not restart InFLIXimab until Dr. ___ you to restart it Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS - partial small bowel obstruction SECONDARY DIAGNOSIS - Crohn's disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you. Why was I admitted to the hospital? - You had a partial blockage in your bowels. What happened while I was here? - You got steroids and IV fluids. - Your bowels got better, and you were able to eat food. What should I do when I go home? - Take Prednisone 60mg (3 pills) every day until you see Dr. ___ - ___ up with Dr. ___ in 1 week (see below for appointment) - If you have any abdominal pain, nausea, vomiting, or if you stop having bowel movements, please call Dr. ___ We wish you all the best in the future! Sincerely, Your ___ Care Team Followup Instructions: ___
19810967-DS-5
19,810,967
20,765,560
DS
5
2169-12-19 00:00:00
2169-12-19 18:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: worst headache of life Major Surgical or Invasive Procedure: ___ Angio for AComm aneurysm coiling History of Present Illness: ___ year old male with history of hypertension (med noncompliant) who presents today with sudden onset worst headache of life. He was in class at approximately 10:50am during headache onset; he waited for class to end then presented to the ___ where he was transferred to ___ ED. On eval in the ED, the patient reports headache improved. He has had recent vision changes, difficulty reading. Denies nausea/vomiting. No weakness/paresthesias. Past Medical History: Hernia repair ___ Hypertention (untreated) Social History: Single, lives alone. Originally from ___. Student at ___ - ___ in ___. Former smoker, ___ yrs, quit ___ yrs ago. Denies ETOH/illicits. Tobacco Use: [ ]No [x]Yes [ ]Current Smoker Years: Packs per day: [x]Previous Smoker Years: 5 Packs per day: Recreational Drug use: [x]No [ ]Yes Alcohol Use: [x]No [ ]Yes Family History: Negative for aneurysm/stroke Is there a family history of Aneurysms? [x]No [ ]Yes Physical Exam: ================= ON ADMISSION: ================= Date and Time of evaluation: ___ 16:45 ___ and ___: [x]Grade I: Asymptomatic, mild headache, slight nuchal rigidity [ ]Grade II: Moderate to severe headache, nuchal rigidity, no neurological deficit other than cranial nerve palsy. [ ]Grade III: Drowsiness/Confusion, mild focal neurological deficit. [ ]Grade IV: Stupor, moderate-severe hemiparesis. [ ]Grade V: Coma, decerebrate posturing. Fisher Grade: [ ]1 No hemorrhage evident [x]2 Subarachnoid hemorrhage less than 1mm thick [ ]3 Subarachnoid hemorrhage more than 1mm thick [ ]4 Subarachnoid hemorrhage of any thickness with IVH or parenchymal extension ___ SAH Grading Scale: [x]Grade I: GCS 15, no motor deficit [ ]Grade II: GCS ___, no motor deficit [ ]Grade III: GCS ___, with motor deficit [ ]Grade IV: GCS ___, with or without motor deficit [ ]Grade V: GCS ___, with or without motor deficit ___ Coma Scale: [ ]Intubated [x]Not intubated Eye Opening: [ ]1 Does not open eyes [ ]2 Opens eyes to painful stimuli [ ]3 Opens eyes to voice [x]4 Opens eyes spontaneously Verbal: [ ]1 Makes no sounds [ ]2 Incomprehensible sounds [ ]3 Inappropriate words [ ]4 Confused, disoriented [x]5 Oriented Motor: [ ]1 No movement [ ]2 Extension to painful stimuli (decerebrate response) [ ]3 Abnormal flexion to painful stimuli (decorticate response) [ ___ Flexion/ withdrawal to painful stimuli [ ]5 Localizes to painful stimuli [x]6 Obeys commands _15_ Total ICH Score: GCS [ ]2 GCS ___ [ ]1 GCS ___ [x]0 GCS ___ ICH Volume [ ]1 30 mL or Greater [x]0 Less than 30 mL Intraventricular Hemorrhage [ ]1 Present [x]0 Absent Infratentorial ICH [ ___ Yes [x]0 No Age [ ]1 ___ years old or greater [x]0 Less than ___ years old Total Score: 0 O: T: 97.8 BP: 181/101 HR: 78 R: 19 O2Sats: 100%RA Gen: WD/WN, comfortable, NAD. HEENT: Pupils: PERRL EOMs Full Neck: Supple. Lungs: No resp distress Extrem: Warm and well-perfused. No C/C/E. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Language: Speech fluent with good comprehension. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 4mm to 3mm bilaterally. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to finger rub bilaterally. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift Sensation: Intact to light touch Handedness Left ============= ON DISCHARGE: ============= Opens eyes: [ ]spontaneous [x]to voice [ ]to noxious Orientation: [x]Person [x]Place [x]Time Follows commands: [ ]Simple [x]Complex [ ]None Pupils: PERRL 4-3mm bilaterally EOM: [x]Full [ ]Restricted Face Symmetric: [x]Yes [ ]NoTongue Midline: [x]Yes [ ]No Pronator Drift [ ]Yes [x]No Speech Fluent: [x]Yes [ ]No Comprehension intact [x]Yes [ ]No Motor: TrapDeltoidBicepTricepGrip ___ Left5 5555 IPQuadHamATEHLGast ___ Left5 5 5 5 5 5 [x]Sensation intact to light touch Angio Groin Site: Right groin: [x]Soft, no hematoma [x]Palpable pulses Pertinent Results: Please see OMR for pertinent lab and imaging results. Brief Hospital Course: Mr. ___ presented to ___ ED with worst headache of life. A CTA demonstrated subarachnoid hemorrhage and A-comm aneurysm. #SAH with A-comm aneurysm patient went to angio for coiling of an A-comm aneurysm. The procedure was uncomplicated and he tolerated it well. Please see separately dicatated operative report for complete details of the procedure. He was extubated and transferred to PACU for recovery where he remained neurologically and hemodynamically stable. He was transferred to the surgical ICU for ongoing close neurological monitoring. He was started on nimodipine to prevent vasospasm. He was kept euvolemic with IV fluids running at 100cc/hr. He remained neurologically stable and was called out to the neuro step-down unit. IV fluids were discontinued but was given IVF bolus as needed to maintain euvolemia. Repeat CTA was done on ___ which was negative for vasospasm. #Back pain The patient complained of low back pain, which is likely related to the ___ blood. He was given 6mg IV Dex x1, which helped the pain. He was subsequently started on a 3 day Dex taper. Given his ongoing back pain, patient was given oxycodone and was evaluated by Physical therapy. He was cleared as safe for discharge to home by physical therapy. #Hypertension Patient has baseline hypertension and is prescribed amlodipine which he was non-compliant with prior to his hospitalization. His amlodipine was held while he was on the nimodpine as it is the same class of antihypertensive. He remained normotensive on this regimen and can start his amlodipine when the nimodipine course is complete. The patient was sent with nimodipine that was delivered to his bedside. Medications on Admission: amlodipine (non-compliant) Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever do not exceed 4g in 24h from all sources 2. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation - Second Line 3. Docusate Sodium 100 mg PO BID 4. Milk of Magnesia 30 mL PO Q6H:PRN constipation 5. NiMODipine 60 mg PO Q4H Treatment course 21 days (___) RX *nimodipine 30 mg 2 capsule(s) by mouth every 4 hours Disp #*200 Capsule Refills:*0 6. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate RX *oxycodone [Oxaydo] 5 mg 1 tablet(s) by mouth every 6 hours as needed Disp #*28 Tablet Refills:*0 7. Senna 17.2 mg PO QHS Discharge Disposition: Home Discharge Diagnosis: Subarachnoid hemorrhage ACOMM aneurysm Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Discharge Instructions Aneurysmal Subarachnoid Hemorrhage Procedures: •You had a cerebral angiogram to coil the aneurysm. You may experience some mild tenderness and bruising at the puncture site (groin). Activity •We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. •You make take leisurely walks and slowly increase your activity at your own pace. ___ try to do too much all at once. •You make take a shower. •No driving while taking any narcotic or sedating medication. •If you experienced a seizure while admitted, you must refrain from driving. Medications •Resume your normal medications and begin new medications as directed. •You may be instructed by your doctor to take one ___ a day. If so, do not take any other products that have aspirin in them. If you are unsure of what products contain Aspirin, as your pharmacist or call our office. •Please do NOT take any ADDITIONAL blood thinning medication (Aspirin, Plavix, Coumadin) until cleared by the neurosurgeon. •You have been discharged on a medication called Nimodipine. This medication is used to help prevent cerebral vasospasm (narrowing of blood vessels in the brain). •You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience: •Mild to moderate headaches that last several days to a few weeks. •Difficulty with short term memory. •Fatigue is very normal •Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. When to Call Your Doctor at ___ for: •Severe pain, swelling, redness or drainage from the incision site or puncture site. •Fever greater than 101.5 degrees Fahrenheit •Constipation •Blood in your stool or urine •Nausea and/or vomiting •Extreme sleepiness and not being able to stay awake •Severe headaches not relieved by pain relievers •Seizures •Any new problems with your vision or ability to speak •Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: •Sudden numbness or weakness in the face, arm, or leg •Sudden confusion or trouble speaking or understanding •Sudden trouble walking, dizziness, or loss of balance or coordination •Sudden severe headaches with no known reason Followup Instructions: ___
19811575-DS-21
19,811,575
22,863,261
DS
21
2138-03-08 00:00:00
2138-03-08 15:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: lisinopril Attending: ___. Chief Complaint: Right periprosthetic femur fracture Major Surgical or Invasive Procedure: Right periprosthetic femur open reduction internal fixation History of Present Illness: ___ year-old male with history of IDDM with insulin pump, R THA (___), right acetabular ORIF (___) presents to ___ ED with right hip pain after fall. He reports that he first fell on his right side after running into someone and tripping last week while on a cruise in ___. X-rays on the cruise ship reportedly did not show any evidence of fracture, however he used crutches for the remainder of the trip. Upon flying across the country to return home on ___, he fell again while using the crutches to go up his driveway. This was immediately followed by severe pain in the right hip, prompting his presentation to the ___ and subsequent transfer to ___ for management. He is on ASA 81 daily and took his last dose ___ AM (___). No other anticoagulation. His diabetes is well-controlled with his insulin pump and glucometer, though he does report a recent burn on the bottom of his right foot. Denies hx of peripheral neuropathy. Past Medical History: -HTN -HLD -T2DM complicated by mild retinopathy and peripheral neuropathy on insulin pump -Right acetabulum fracture s/p ORIF (___) Social History: ___ Family History: Father: ___ at age ___ from prostate cancer Mother: ___ emphysema Sister: ___ Physical ___: On discharge: Temp: 98.4 PO BP: 110/55 L Lying HR: 109 RR: 18 O2 sat: 97% O2 delivery: Ra GEN: AOx3 WN, WD in NAD HEENT: NCAT, EOMI, anicteric CV: RRR PULM: unlabored breathing EXT: Right lower extremity: Surgical dressing c/d/i Fires ___ SILT sural, saphenous, superficial peroneal, deep peroneal and tibial distributions digits warm and well perfused Pertinent Results: See OMR for pertinent lab and imaging results. Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a R periprosthetic femur fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for R periprosthetic femur ORIF, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to home with home physical therapy was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is touchdown weightbearing in the right lower extremity extremity, and will be discharged on Lovenox for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 5 mg PO DAILY 2. Atorvastatin 40 mg PO DAILY 3. Hydrochlorothiazide 12.5 mg PO DAILY 4. irbesartan 300 mg oral DAILY 5. MetFORMIN XR (Glucophage XR) 1500 mg PO DAILY 6. Aspirin 81 mg PO DAILY 7. Insulin Pump SC (Self Administering Medication)Insulin Lispro (Humalog) Target glucose: 80-180 Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H 2. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 3. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 4. Enoxaparin Sodium 40 mg SC QPM RX *enoxaparin 40 mg/0.4 mL 40 mg sc qpm Disp #*30 Syringe Refills:*0 5. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate RX *hydromorphone 2 mg ___ tablet(s) by mouth every four (4) hours Disp #*45 Tablet Refills:*0 6. Senna 8.6 mg PO DAILY 7. Insulin Pump SC (Self Administering Medication)Insulin Lispro (Humalog) Target glucose: 80-180 8. amLODIPine 5 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. Atorvastatin 40 mg PO DAILY 11. Hydrochlorothiazide 12.5 mg PO DAILY 12. irbesartan 300 mg oral DAILY 13. MetFORMIN XR (Glucophage XR) 1500 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Periprosthetic femur fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: -Touchdown weightbearing right lower extremity MEDICATIONS: 1) Take Tylenol ___ every 6 hours around the clock. This is an over the counter medication. 2) Add Dilaudid as needed for increased pain. Aim to wean off this medication in 1 week or sooner. This is an example on how to wean down: Take 1 tablet every 3 hours as needed x 1 day, then 1 tablet every 4 hours as needed x 1 day, then 1 tablet every 6 hours as needed x 1 day, then 1 tablet every 8 hours as needed x 2 days, then 1 tablet every 12 hours as needed x 1 day, then 1 tablet every before bedtime as needed x 1 day. Then continue with Tylenol for pain. 3) Do not stop the Tylenol until you are off of the narcotic medication. 4) Per state regulations, we are limited in the amount of narcotics we can prescribe. If you require more, you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5) Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds (senna, colace, miralax) are over the counter and may be obtained at any pharmacy. 6) Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. 7) Please take all medications as prescribed by your physicians at discharge. 8) Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: - Please take Lovenox daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. - If you have a splint in place, splint must be left on until follow up appointment unless otherwise instructed. Do NOT get splint wet. TREATMENT/FREQUENCY: Any staples or superficial sutures you have are to remain in place for at least 2 weeks postoperatively. Incision may be left open to air unless actively draining after POD3. If draining, you may apply a gauze dressing secured with paper tape. You may shower and allow water to run over the wound, but please refrain from bathing for at least 4 weeks postoperatively. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever greater than 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns Physical Therapy: Touchdown weightbearing right lower extremity Treatments Frequency: Site: Right hip Description: Incision dry,healing well. After POD 2: ___ reapply dry dressing daily then open to air when no longer draining. Followup Instructions: ___
19811664-DS-9
19,811,664
27,848,527
DS
9
2136-03-02 00:00:00
2136-03-04 23:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Chest pain, syncope, episodes of apnea Major Surgical or Invasive Procedure: none History of Present Illness: ___ year old ___ speaking woman presents to the ED after a syncopal episode during a exercise stress test. the patient was on the treadmill and after 3 minutes she felt dizzy and her vision became dark. She does not remember the entire event. The staff witnessed the event and layed the patient on the floor. She was in sinus rhythm the entire time and was normotensive. According to her boyfriend she has had multiple episodes of syncope when her heart rate is elevated including walking, sex, climbing stairs. The patient feels light headed prior to passing out. The episodes last a few minutes and she wakes after with a normal mental status. Her boyfriend has witness many events the last ___ months in which she appears limp and becomes apneic lasting between 30 seconds to a few minutes. No tonic-clonic activity. She also has had chest pain for the past few months. The pain is substernal and does not radiate. It is usually is associated with walking or climbing stairs. The pain is relieved with rest. Associated with shorntess of breath. She is also complaining of left temporal headache today. She denies any visual changes. In the ED the patient was hemodynamically stable. She describes chest pain. She was given aspirin, 3 doses of sub-lingual nitro, a GI cocktail, and 4mg IV morphine with some relief. While in the ED the patient was witnessed to have one episode of unresponsiveness with associated apnea on the monitor lasting a few seconds. No tonic-clonic activity. Normal sinus on the monitor with a normal blood pressure. An EEG was performed without any noted abnormality. She had one of her unresponsive episodes while on the EEG and did not demonstrate and pathology. In the ED, initial VS were: 61, 100% on RA, 113/71, 14, afebrile . On arrival to the MICU, the patient is alert and oriented. She describes having substernal chest pain without radiation. She feels tired and a little dizzy. . Review of systems: -Denies any fever or chills, no abd pain, no N/V/D, no rash, no focal neurological symptoms Past Medical History: GERD Social History: ___ Family History: Denies Physical Exam: Vitals: T:98.6 BP:128/75 P:64 R:18 O2: 98% 2L NC General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL; no temporal tenderness Neck: supple, JVP not elevated, CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops; no chest tenderness with palpation Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred, finger-to-nose intact . On discharge stable with no episodes of apnea. Was able to ambulate without difficulty. Pertinent Results: ___ 10:50AM BLOOD WBC-5.8 RBC-4.56 Hgb-11.4* Hct-35.2* MCV-77* MCH-25.0* MCHC-32.4 RDW-14.7 Plt ___ ___ 04:46AM BLOOD WBC-4.8 RBC-4.51 Hgb-11.3* Hct-35.4* MCV-79* MCH-25.1* MCHC-31.9 RDW-15.0 Plt ___ ___ 06:32AM BLOOD WBC-5.4 RBC-4.20 Hgb-10.4* Hct-32.8* MCV-78* MCH-24.7* MCHC-31.6 RDW-14.7 Plt ___ ___ 06:32AM BLOOD ___ ___ 10:50AM BLOOD ESR-13 ___ 06:32AM BLOOD Glucose-94 UreaN-13 Creat-0.8 Na-138 K-4.4 Cl-103 HCO3-28 AnGap-11 ___ 10:50AM BLOOD cTropnT-<0.01 ___ 10:04PM BLOOD cTropnT-<0.01 ___ 04:46AM BLOOD Calcium-9.1 Phos-4.0 Mg-2.3 ___ 10:04PM BLOOD D-Dimer-341 ___ 10:50AM BLOOD TSH-1.7 ___ 10:50AM BLOOD CRP-1.4 . Stress ECHO at rest: The left atrium is normal in size. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). The estimated cardiac index is normal (>=2.5L/min/m2). There is no left ventricular outflow obstruction at rest or with Valsalva. Right ventricular chamber size and free wall motion are normal. There is no aortic valve stenosis. No aortic regurgitation is seen. Physiologic mitral regurgitation is seen (within normal limits). The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. Post exercise images not possible pt collapsed on treadmill at the termination of exercise. Rhythm was sinus tachycardia prior to and post collapse. . CT HEAD: Final Report INDICATION: ___ woman with syncope event, question intracranial process. COMPARISON: None. TECHNIQUE: Contiguous axial imaging was obtained through the brain. No contrast was administered. Coronal and sagittal reformats were completed. FINDINGS: There is no acute intracranial hemorrhage, edema, mass effect, or territorial infarction. The ventricles and sulci are normal in size and configuration. The visualized paranasal sinuses, mastoid air cells and middle ear cavities are clear. Osseous structures are intact. IMPRESSION: No acute intracranial process. The study and the report were reviewed by the staff radiologist. . CXR: EXAM: Chest frontal and lateral views. CLINICAL INFORMATION: ___ female with history of chest pain. COMPARISON: None. FINDINGS: Frontal and lateral views of the chest were obtained. Lungs are clear without focal consolidation. No pleural effusion or pneumothorax is seen. Cardiac and mediastinal silhouettes are unremarkable. IMPRESSION: No acute cardiopulmonary process. Brief Hospital Course: #Chest Pain: Patient has had multiple months of exertional SOB that seem to be more frequent. Was in stress testing today with syncopal episode. She received aspirin in the ED. Has had one negative troponin this morning. She was ruled out for an MI with serial enzymes and had no evidence of disease on an echocardiogram. Her EKG did not demonstrate any changes. #Syncope: Pt had episode of syncope during a stress test. per the history she has been experiencing similar symptoms over the last few months. Does not have associated seizure like activity or post-ictal activity. She had a normal short term EEG while in the ED including one of her episodes. Had a normal resting TTE today prior to stress testing. Normal CT head. She was evaluated by cardiology and neurology, neither of whom could determine a physiologic source for her syncope. She was discharged with neurology followup. - Telemetry #Apnea episodes: Patient seems to have short episodes of unresponsiveness with apnea. Was witnessed today while in the ED. unclear etiology. Does not have any hypoxia during episode. She may benefit from sleep testing as an outpatient. #Temporal headache: No evidence of temporal arteritis at this time. Likely tension headache. No vision changes. Normal CRP and ESR, improved with tylenol. Medications on Admission: None Discharge Medications: None Discharge Disposition: Home Discharge Diagnosis: syncope Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital with falls and blacking out. You were evaluated thoroughly and no clear reason for your symptoms was identified. You do not seem to have seizures or any problems with your heart. We discussed the plan with your primary care physician. Please follow up with your physicians as below. If you have worsening symptoms or fall please contact a physician or come to an emergency room. We have not made any changes to your medications. Followup Instructions: ___
19811688-DS-16
19,811,688
28,400,288
DS
16
2190-05-31 00:00:00
2190-06-01 10:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ M with neurofibromatosis 1 with metastatic nerve sheath tumor who presented to the ED with acute onset chest pain. Patient reports that since discharge last ___ he began having hiccups and heart burn sensation. Reports his oncologist discontinue many of his nausea meds and then started Chlorpromazine, without relief. Subsequently he began experiencing worsening "heart burn" sensation in his mid chest with occasional episodes of sharp, tight, burning sensation in his mid chest which lasts seconds and resolves but recurrs frequently. He reports this is ___ in severity and nothing has bene improving his symptoms. Also reports nausea without emesis. The pain occurs at rest, worst with laying down. Also reports ongoing SOB for the past week. Of note the patient was just discharged from Oncology service last ___ fo an elective chemotherapy admission. Denies leg pain/leg swelling. In ED labs were notable for neutropenia and acute renal failure, vitals notable for tachycardia to 125. He was given 500cc bolus, aspirin, zofran, vanc/cefepime and started on a heparin drip for presumed PE. Unable to obtain CTA due to ___. Patient arrived without an EKG in the chart Past Medical History: Hypothyroidism hypercholesterolemia neurofibromatosis 1 metastatic nerve sheath tumor with pancreatic and lung mets Social History: ___ Family History: Mother - NF, breast ca age ___ Father - unknown ___ GM - kidney failure Maternal Aunt- kidney failure on HD Maternal uncle- kidney cancer Physical Exam: Admission Exam: Vitals: 98.1 116/64 113 20 96%RA Pain Scale: ___ currently General: Patient appears overall well, he is pleasant, appropriate interactive and in NAD. During exam he has constant hiccups and once experienced similar symptoms to previous which occurred after multiple hiccups, this resolved spontaneously. HEENT: Sclera anicteric, MMM Neck: Port-a-cath site left chest appears c/d/i, non-tender Lungs: Clear to auscultation bilaterally, moving air well and symmetrically, no wheezes, rales or rhonchi appreciated CV: Tachycardic rate, regular rhythm, S1 and S2 clear and of good quality, no murmurs, rubs or gallops appreciated Abdomen: soft, non-tender, non-distended, normoactive bowel sounds throughout, no rebound or guarding Ext: Warm, well perfused, full distal pulses, no clubbing, cyanosis or edema Neuro: AOx3 Discharge Exam: 98.5 99.2 110/60 100 18 97%RA Appears well overall, walking around the floors in NAD, hiccuping during exam but improved. NF subcutaneous nodules evidence on face, trunk and extremities Slightly odd affect but appropriate and interactive Lungs clear CV Tachy but regular. Per patient always has tachycardia around 100 Pertinent Results: Admission Labs: ___ 02:00PM BLOOD WBC-1.8*# RBC-4.22* Hgb-11.4* Hct-33.1* MCV-79* MCH-27.1 MCHC-34.6 RDW-15.1 Plt ___ ___ 12:44AM BLOOD WBC-2.3* RBC-3.88* Hgb-10.6* Hct-31.2* MCV-80* MCH-27.2 MCHC-33.9 RDW-15.8* Plt ___ ___ 02:00PM BLOOD Neuts-38.0* Lymphs-46.7* Monos-12.7* Eos-1.6 Baso-0.9 ___ 12:44AM BLOOD Neuts-20* Bands-2 Lymphs-49* Monos-25* Eos-0 Baso-0 Atyps-4* ___ Myelos-0 ___ 02:00PM BLOOD UreaN-26* Creat-1.6* Na-132* K-3.3 Cl-92* HCO3-26 AnGap-17 ___ 12:44AM BLOOD Glucose-133* UreaN-30* Creat-1.7* Na-129* K-3.4 Cl-92* HCO3-24 AnGap-16 ___ 12:44AM BLOOD ___ PTT-26.8 ___ ___ 02:00PM BLOOD ALT-127* AST-55* AlkPhos-111 TotBili-0.3 ___ 12:44AM BLOOD ALT-123* AST-61* AlkPhos-110 TotBili-0.2 Discharge Labs: ___ 06:00AM BLOOD WBC-5.4# RBC-3.28* Hgb-9.1* Hct-26.7* MCV-81* MCH-27.6 MCHC-34.0 RDW-16.4* Plt ___ ___ 06:00AM BLOOD Glucose-89 UreaN-14 Creat-0.9 Na-138 K-3.2* Cl-103 HCO3-24 AnGap-14 ___ 06:00AM BLOOD ALT-69* AST-29 AlkPhos-84 TotBili-0.1 ___ 06:00AM BLOOD Calcium-7.9* Phos-2.9 Mg-2.3 Reports: ___: No evidence of deep venous thrombosis in the bilateral lower extremity veins. CXR PA/LAT (my read): Port in place left chest, pulm vascular congestion but otherwise clear lung fields V/Q scan: No evidence for PE, normal examination Brief Hospital Course: ___ with neurofibromatosis 1 with malignant peripheral nerve sheath tumor of L lower leg in ___ s/p radiation and surgical resection, recently diagnosed new pancreatic mass and lung nodules in ___ s/p biopsy consistent with MPNST now s/p C1 AIM admitted now with chest pain most likely GERD and hiccup related, ruled out PE. # Chest pain: His symptoms were most consistent with a primary GI process such as GERD and esophageal spasm especially since this occurred after significant hiccups. While suspicion was low for a PE the patient was tachcyardic to the 120s with dyspnea and has active malignancy and a recent hospitalization for chemotherapy so V/Q performed (ARF on admission) which ruled out PE. Started on PPI and Maalox with improvement in symptoms. # Hiccups: New onset after chemo administration, continuous and refractory. Attempted Reglan, Lorazepam, Zofran and Thorazine in the outpatient setting without improvement. Started on standing Baclofen inpatient and Thorazine PRN with improvement in symptoms though also with continuing hiccups. Would recommend uptitrating dose of Baclofen if hiccups continue. # Acute Renal Failure: Pre-renal given poor PO intake and ongoing lasix use in a patient who previously did not require diuretics (was started for edema after massive IVF administration with chemo). Treated with IVFs with resolution. Discontinued Furosemide, no indication for ongoing lasix use. # Hyponatremia: Hypovolumic and resolved with IVFs # Neutropenia: Chemo related s/p Neulasta ___ prior to admission, counts recovered as expected. # Malignant peripheral neural sheath tumor: Metastatic s/p resection in ___ currently C1 adriamycin/ifosfamide. Dr ___ was involved during patients admissions Transitional issues: # CONTACT: Mother ___ ___ or ___ # Recommend uptitrating Baclofen if hiccups continue Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO DAILY 2. Levothyroxine Sodium 125 mcg PO DAILY 3. Lisinopril 10 mg PO DAILY 4. Lorazepam 0.5-1 mg PO Q6H:PRN Anxiety 5. Acetaminophen 325-650 mg PO Q6H:PRN pain 6. Bisacodyl 10 mg PO/PR DAILY:PRN constipation 7. Docusate Sodium 100 mg PO BID 8. Polyethylene Glycol 17 g PO DAILY:PRN constipation 9. Prochlorperazine 10 mg PO Q6H:PRN nausea and vomiting 10. Senna 8.6 mg PO BID:PRN constipation 11. Ondansetron ___ mg PO Q8H:PRN nausea 12. Furosemide 40 mg PO DAILY Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN pain 2. Atorvastatin 40 mg PO DAILY 3. Bisacodyl 10 mg PO/PR DAILY:PRN constipation 4. ChlorproMAZINE 25 mg PO TID:PRN Hiccups 5. Docusate Sodium 100 mg PO BID 6. Levothyroxine Sodium 125 mcg PO DAILY 7. Polyethylene Glycol 17 g PO DAILY:PRN constipation 8. Senna 8.6 mg PO BID:PRN constipation 9. Baclofen 10 mg PO TID RX *baclofen 10 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 10. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills:*0 11. Lisinopril 10 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Active: - GERD - Hiccups Chronic: - Malignant peripheral neural sheath tumor s/p resection ___ and C1 adriamycin/ifosfamide Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr ___, It was a pleasure treating you during this hosptialization. You were admitted with chest pain however this seems most consistent with esophageal reflux and heartburn exacerbated by hiccups. Your medications were adjusted to include an acid suppressing agent and medications to reduce your hiccups. You also had some mild renal failure which improved with IV fluids, this occurred because you were dehydrated. It is important you eat and drink plenty of fluids to prevent this from happening, also stop taking Lasix. Followup Instructions: ___
19811704-DS-6
19,811,704
26,196,091
DS
6
2187-01-14 00:00:00
2187-01-14 16:53:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: chest pain Major Surgical or Invasive Procedure: None History of Present Illness: (history derived from OSH notes as pt unable to provide) ___ with h/o dementia, CAD s/p CABG in ___, CHF 35-40%, presents with 2 days of intermittent L anterior CP. Pain started last night, recurred when he awoke today. Recieved sublingual nitro at nursing home. He presented initially to ___, where ther was initial concern for 0.5mm STE's in III, avF, which resolved. Troponin was 0.06 at 2:45pm. He received 3 SLN with good effect, and was started on ASA 325mg, morphine 2mg IV and started on heparin gtt. He was then transferred to ___ ED. In the ED, initial VS were:98.4 78 150/64 16 97% RA. Labs not performed. EKG showed SR 74, RBBB, Inferior Q waves c/w prior. No ST changes. CXR not performed. Pt was seen by cardiology, who recommended admission to ___ for medical mgmt of NSTEMI and possible cath. Pt was given no new medications. On the floor pt's VS were notable for BP of 176/81. He denied CP or SOB. He denied any other kinds of pain. Past Medical History: # CAD s/p MI ___ & CABG (5 vessel)- anatomy unknown # History of GIB ___ erosive gastritis # Depression # Inclusion Body Myositis - presented previously in ___ with weakness and elevated CK - followed by Neuro (Dr. ___ # OSA # BPH Social History: ___ Family History: father died at ___, mother died at ___ of ICH, son has GERD ___ hiatal hernia Physical Exam: Initial Physical Exam: VS: 98.9, 176/81, 77, 18, 97% on RA General- Alert, orientedx2ish (knows month and year and the president, not the date), no acute distress, resting comfortably. HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Mild bibasilar crackles, no wheezes or ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 1+ pulses in the LEs, no clubbing, cyanosis or edema Neuro- CNs2-12 grossly intact, motor function grossly normal Discharge PHysical: VS: 98.6 101-150/51-59 ___ 18 95-98% RA UOP: ___ yesterday Telemetry- No overnight events; Avg HR 50-60s GENERAL: alert, awake, responsive to questions, breathing comfortably completely recumbent on CPAP HEENT: NCAT. PERRLA, EOMI, MMM. Sclera anicteric, no conjunctival pallor. OP clear, trachea midline, no thyromegaly or cervical LAD. NECK: Supple, with JVP of 5 cm without evidence of HJR. Carotids benign bilaterally. CARDIAC: S1/S2 soft ___ early systolic murmur RUSB. PMI non-enlarged, non-displaced. No parasternal or subxiphoid heaves, precordial thrills, or palpable pulsations in the 3LICS. LUNGS: coarse crackles at bilateral bases, clear in upper lung fields ABDOMEN: Soft, NT, ND. BS + X4, No HSM or tenderness. Abd aorta not enlarged by palpation. No abdominal bruits. EXTREMITIES: No CCE or edema. No femoral bruits. L femoral access site unremarkable. SKIN: No concerning lesions. Pertinent Results: ADMISSION LABS: ___ 07:50AM BLOOD WBC-9.7# RBC-4.34* Hgb-13.7*# Hct-39.3*# MCV-91# MCH-31.5# MCHC-34.8 RDW-14.1 Plt ___ ___ 01:50AM BLOOD Glucose-85 UreaN-28* Creat-0.7 Na-146* K-3.7 Cl-107 HCO3-28 AnGap-15 ___ 01:50AM BLOOD Calcium-8.2* Phos-2.3* Mg-1.9 PERTINENT LABS: ___ 03:30PM BLOOD cTropnT-0.07* ___ 01:50AM BLOOD cTropnT-0.07* DISCHARGE LABS: ___ 09:30AM BLOOD WBC-10.1 RBC-3.74* Hgb-12.1* Hct-34.2* MCV-91 MCH-32.2* MCHC-35.3* RDW-14.1 Plt ___ ___ 09:30AM BLOOD Plt ___ ___ 09:30AM BLOOD Glucose-89 UreaN-42* Creat-0.8 Na-144 K-3.8 Cl-109* HCO3-21* AnGap-18 ___ 09:30AM BLOOD ALT-14 AST-22 LD(LDH)-216 AlkPhos-63 TotBili-0.4 ___ 09:30AM BLOOD Lipase-27 ___ 09:30AM BLOOD Calcium-8.1* Phos-2.8 Mg-1.8 Brief Hospital Course: This is a ___ year old man with h/o CAD s/p CABG ___, dementia, inclusion body myositis, remote UGIB who presents with NSTEMI, hospital course c/b likely aspiration pneumonitis. #NSTEMI: patient was poor interventional candidate and so was treated with medical management that included aspirin, metoprolol, no statin due to his myositis. He was given amlodipine for anti-anginal activity. On hospital day 2 he developed recurrent chest pain that was unresponsive to nitroglycerin; this subsequently resolved with morphine and did not recur. He was started on isosorbide mononitrate with good effect. On discharge, he does not complain of chest pain. #aspiration pneumonitis: patient had an aspiration episode in which he had a witnessed regurgitation during sleep ___. The next morning, he was newly hypoxemic, lethargic but arousable. A chest x-ray showed opacities at bilateral bases consistent with aspiration pneumonitis. He was started on empiric vanc/cefepime/flagyl and given IV hydration. Over the next two days he markedly improved and reduced his oxygen requirement. He was transitioned to PO clindamycin for a further 5 days of therapy. #anorexia: patient was noted to have markedly decreased appetite in-house. His home PPI dose was increased and stool softeners given, with some improvement in his symptoms. Recommend continued observation and symptomatic treatment. Transitional issues: -follow-up appetite loss -clindamycin finishes ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Cyanocobalamin 100 mcg PO DAILY 2. Nitroglycerin SL 0.3 mg SL PRN chest pain 3. Vitamin D 50,000 UNIT PO Frequency is Unknown 4. Senna 1 TAB PO HS 5. Polyethylene Glycol 17 g PO DAILY:PRN constipation 6. Acetaminophen 650 mg PO Q6H:PRN pain 7. Calcium Carbonate 1250 mg PO HS 8. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing 9. Omeprazole 20 mg PO DAILY 10. Venlafaxine XR 225 mg PO DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing 3. Calcium Carbonate 1250 mg PO HS 4. Cyanocobalamin 100 mcg PO DAILY 5. Polyethylene Glycol 17 g PO DAILY:PRN constipation 6. Senna 1 TAB PO HS 7. Venlafaxine XR 225 mg PO DAILY 8. Amlodipine 5 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. Clindamycin 300 mg PO Q6H Last day ___. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 12. Lisinopril 5 mg PO DAILY 13. Omeprazole 20 mg PO BID 14. Vitamin D 50,000 UNIT PO Frequency is Unknown 15. Nitroglycerin SL 0.3 mg SL PRN chest pain 16. Metoprolol Succinate XL 25 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Non-ST elevation myocardial infarction Aspiration pneumonitis Angina Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, You were admitted to ___ because of chest pain. After doing some tests, we determined that you were having a small heart attack. We gave you medicines to treat this heart attack and your chest pain improved. You had an episode where you regurgitated and got stomach contents in your lungs. This caused you to be short of breath. We gave you extra oxygen and antibiotics and this improved your breathing markedly. Finish taking the antibiotic, called Clindamycin, on ___. Please call your doctor or visit the emergency room if you feel further chest pain, shortness of breath, dizziness, or swelling in your legs. Followup Instructions: ___
19811865-DS-13
19,811,865
23,872,234
DS
13
2142-12-16 00:00:00
2142-12-17 12:51:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: dacarbazine / metformin Attending: ___. Chief Complaint: fever, hemoptysis, dyspnea Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ yo F with Hodgkin's Lymphoma Stage IIIB (EBV+) on ABVD chemotherapy, s/p bronchoscopy here ___ with transbronchial biopsy complicated by intraalveolar hemorrhage, who presents with fevers, hemoptysis, and left upper back pain. She had an admission ___ ___BUS and fluoroscopic guided transbronchial biopsies in LLL and tracheal biopsies with IP. Biopsies were performed for pulmonary nodules noted on imaging. She had hemorrhage with biopsy, resulting in hypoxia which had resolved by the time of discharge. She was still having hemoptysis at time of discharge. On ___ she received 2 U PRBCs as an outpatient for Hgb 7.5 (which she was discharged from the hospital with). She reports that in the last days she has been experiencing DOE with ADL. She has had a cough since the bronchoscopy, but is bringing up less brown matter than before (seen at bedside, appears to be old blood). No pleuritic chest pain. + pain and she points to the left posterior costal margin; she thinks this started some time after bronchoscopy. + fatigue. Fever to 100.7 today. She has otherwise been eating well. She has intermittent nausea, no vomiting, no diarrhea. No headache, no focal neurologic symptoms. No urinary symptoms. Notes two weeks of calf pain L>R. Went to her PCP and was directed to ED for fever. In the ED, initial VS were: 8 99.6 127 124/74 18 97% RA Labs were notable for: H/H 9.5/28.0 (appropriate bump from recent transfusion), lactate 2.5. Imaging included: CTA Chest which showed no PE, focal consolidation in LLL c/w prior hemorrhage, but unable to r/o infection, and post-surgical seroma. Treatments received: 2L NS, 2g cefepime, 1g vanco, 500mg azithro, 10mg oxy. She was seen by IP who did not feel there was any indication for repeat bronchoscopy and agreed with empiric therapy for HCAP. On arrival to the floor, T 100.6, BP 134/60, HR 119, RR 18, SpO2 97% RA. REVIEW OF SYSTEMS: as above Past Medical History: PAST ONCOLOGIC HISTORY Presented in ___ to her PCP complaining of not feeling well for a couple of months. + fatigue and weight loss In ___, she developed a rash. 2 weeks prior to presenting to her PCP she had had flu-like symptoms. Off and on abdominal pain. Chest CT without contrast showed right axillary and mediastinal adenopathy. The largest mediastinal node measured 1.5 cm in the AP window. There was retroperitoneal and epigastric adenopathy with the largest lymph node in the prepancreatic area measuring 10 mm and she also had multiple lung nodules, all subcentimeter. She underwent a mammogram and ultrasound of the right axilla. The right axillary lymph node was biopsied and was negative for malignant cells. The patient then underwent on ___, an abdomen and pelvis CT with contrast, which demonstrated an enlarged spleen at 14.7 cm. There was moderate upper abdominal retroperitoneal adenopathy, retrogastric, peripancreatic, and paraaortic lymphadenopathy. The largest lymph node was in the left paraaortic area just below the origin of the SMA measuring 1.6 cm in short axis diameter. The patient then underwent a PET CT on ___, which demonstrated multiple enlarged FDG-avid lymph nodes including the right level 5 nodes measuring up to 9 mm with an SUVmax of 5.1, right level 4 lymph node measuring 1.4 cm with an SUVmax of 10.4, and a right supraclavicular lymph node measuring up to 1 cm with an SUVmax of 2.1. Scattered small left cervical lymph nodes were not FDG-avid. There were multiple enlarged FDG-avid axillary nodes including the largest being a 1.8 x 1.2 cm right axillary node with SUVmax 9.4. There were multiple FDG-avid mediastinal, bilateral hilar, and epicardial lymph nodes. There was a right upper paratracheal node measuring 1 cm with an SUVmax of 10.2, a right lower paratracheal node measuring 8 mm, SUVmax of 4.6. There were bilateral hilar nodes with SUVmax of 4.7 on the right and 3.3 on the left, a 1.7 x 0.5 cm right epicardial node with an SUVmax of 4.5. Spleen was enlarged at 15 cm, intensely avid with an SUVmax of 8.8. There was extensive FDG-avid upper abdominal retroperitoneal lymphadenopathy including celiac nodes measuring up to 1.4 cm with an SUVmax of 8.4 and multiple periportal and portacaval lymph nodes up to 4.5 x 2.2 cm with an SUVmax of 6.9. There were multiple retroperitoneal nodes seen such as retrocaval node measuring 1 cm with an SUVmax of 8.7. There were enlarged FDG-avid right common iliac node measured 1 cm with SUVmax 13 and a right external iliac node measuring up to 9 mm with SUVmax 5.2. She underwent a right axillary lymph node biopsy, which was unfortunately also an FNA at ___ on ___. The cytology showed atypical lymphoid proliferation. The pathology revealed focal effacement of the lymph node architecture by a polymorphous infiltrate associated with fibrosis. The morphologic and immunophenotypic findings were suspicious for Hodgkin lymphoma. Bone marrow biopsy done ___ was unremarkable. Excisional biopsy was recommended. Underwent excisional biopsy of right axilla lymph node on ___. Biopsy confirmed diagnosis of Hodgkin's lymphoma, classical nodular sclerosing type. In situ hybridization studies for ___ virus encoded RNA (___) is positive in neoplastic cells ___ cells and their variants). ___- echocardiogram showed EF 55% ___ underwent left sided port placement at ___ which was complicated by left subclavian artery puncture. Procedure was aborted and pt was transported to ___ for vascular repair on evening of ___, admitted to vascular surgery service. ___- underwent successful port placement through ___ ___ the unaffected side ___- spiked fever on ___ and infectious work up was unremarkable. She was transferred to the oncology service. No evidence of infection. ___- PFTs- FEV1 77% (mildly reduced), FVC 80% (borderline normal), ratio normal, diffusing capacity normal adjusted for Hgb ___- given C1 D1 ABVD on ___ afternoon at the following doses: Bleomycin 19 units IV (10 units/m2) Bleomycin - TEST DOSE 1 unit IV DOXOrubicin 48 mg IV (25 mg/m2) VinBLAStine (Velban) 11.5 mg IV (6 mg/m2) Dacarbazine 720 mg IV (375 mg/m2) - had infusion reaction (rigors) x 2 despite infusion reaction treatment with (solumedral, benadryl, tylenol and demerol) so received 60% of the total 720 mg dose. She received on demerol 12.5 mg IV x 2, may benefit from higher dose in future Reaction noted in allergy section of epic. ___- She received 1 unit of blood on ___ prior to discharge. ___- hospitalized for orbital cellulitis- PRESEPTAL CELLULITIS - severe swelling but limited to preseptal space on imaging, no intra-ocular abnormalities on opthal exam in setting of neutropenia will cover broadly, since Staph/Strep most common - was treated with vancomycin and Zosyn for 5 days while in house. Culture data from purulent fluid expressed from infection yielded MSSA. Zosyn was discontinued for just vancomycin while awaiting sensitivities. Antibiotic therapy was narrowed to complete 14 days of dicloxicillin as an outpatient. While inpatient, she developed antibiotic-associated diarrhea, which resolved with stopping Zosyn. She also developed vaginal candidiasis, which was treated with fluconazole 150 mg x1. Ophthalmology followed the patient while in house with daily assessment of IOP & visual acuity. She briefly received latanoprost for elevated IOP in the right eye, which was attributed to artifact/infection, and not glaucoma. This resolved after day 1 of infection/use of latanoprost. Warm compresses and hygiene were use and emphasized. Analgesia with oxycodone. ___- diagnosed with shingles ___- repeat PFTs- unchanged compared to baseline ___- PET after 2 cycles with marked improvement (initial PET done at ___, CD being sent to ___ for comparison) PAST MEDICAL HISTORY: -Herpes Zoster -COPD, not on home O2 -HEADACHE - CLASSICAL MIGRAINE, INTRACTABLE -H/O TOBACCO DEPENDENCE -ADJUSTMENT DISORDER W DEPRESSED MOOD -MENOPAUSE -DM (diabetes mellitus), type 2, uncontrolled -GERD -Vitamin D deficiency -Hyperlipidemia -Nonproliferative diabetic retinopathy of both eyes -Major depression -Anxiety -s/p Left subclavian artery puncture from attempted port placement and repair on ___ Social History: ___ Family History: Father ___ Grandmother dementia, cancer-colon Paternal Aunt ___ Inflammatory Bowel Disease Paternal Uncle Cancer - ___ Sister ___ Disease Physical Exam: ADMISSION EXAM: T 100.6, BP 134/60, HR 119, RR 18, SpO2 97% RA. GENERAL: chronically ill-appearing woman in NAD HEENT: Alopecia, NC/AT, EOMI, PERRL, MMM, poor dentition, CARDIAC: RRR, nl S1 and S2, no murmurs LUNG: decreased breath sounds throughout, very slight rales at the left base ABD: +BS, soft, NT/ND, no r/g EXT: No lower extremity pitting edema, ttp of the left calf PULSES: 2+DP pulses bilaterally NEURO: A&OX3, strength ___ in proximal and distal extremities, sensation grossly intact SKIN: Warm and dry DISCHARGE EXAM: VS T 98 102 18 120/68 97RA GENERAL: chronically ill-appearing woman in NAD HEENT: Alopecia, NC/AT, EOMI, PERRL, MMM, poor dentition, CARDIAC: RRR, nl S1 and S2, no murmurs LUNG: decreased breath sounds throughout, very slight rales at the left base ABD: +BS, soft, NT/ND, no r/g EXT: No lower extremity pitting edema, ttp of the left calf PULSES: 2+DP pulses bilaterally NEURO: A&OX3, strength ___ in proximal and distal extremities, sensation grossly intact SKIN: Warm and dry Pertinent Results: ADMISSION LABS: ___ 12:12PM BLOOD WBC-4.4# RBC-3.25* Hgb-9.5*# Hct-28.0* MCV-86 MCH-29.3 MCHC-34.0 RDW-17.8* Plt ___ ___ 12:12PM BLOOD Neuts-89.3* Lymphs-7.8* Monos-2.0 Eos-0.8 Baso-0.2 ___ 12:12PM BLOOD ___ PTT-26.4 ___ ___ 12:12PM BLOOD Glucose-296* UreaN-7 Creat-0.6 Na-133 K-3.6 Cl-98 HCO3-22 AnGap-17 ___ 01:00PM BLOOD Lactate-2.5* ___ 05:33AM BLOOD ALT-12 AST-15 AlkPhos-113* TotBili-0.7 ___ 02:00PM URINE Color-Straw Appear-Clear Sp ___ ___ 02:00PM URINE Blood-TR Nitrite-NEG Protein-NEG Glucose-300 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG ___ 02:00PM URINE RBC-2 WBC-1 Bacteri-NONE Yeast-NONE Epi-<1 DISCHARGE LABS: ___ 06:00AM BLOOD WBC-1.8* RBC-3.34* Hgb-9.7* Hct-28.2* MCV-84 MCH-29.0 MCHC-34.4 RDW-17.4* Plt ___ ___ 06:00AM BLOOD Glucose-201* UreaN-8 Creat-0.6 Na-139 K-4.3 Cl-105 HCO3-28 AnGap-10 ___ 06:00AM BLOOD Calcium-9.4 Phos-3.2 Mg-2.1 MICROBIOLOGY: ___ BLOOD CULTURE: NO GROWTH ON DISCHARGE ___ URINE CULTURE (Final ___: <10,000 organisms/ml. ___ SPUTUM CULTURE: GRAM STAIN (Final ___: <10 PMNs and >10 epithelial cells/100X field - cancelled STUDIES: ___ CXR: IMPRESSION: Interval improvement of left lung base opacity, possibly representing resolving hemorrhage. Interval improvement and now new opacity due to underlying infection or new hemorrhage, is not excluded. ___ CTA: Final Report EXAMINATION: CTA CHEST IMPRESSION: 1. No pulmonary embolism or acute aortic pathology. 2. Focal consolidation in the left lower lobe may represent resolving post-operative hemorrhage, but superimposed infection should certainly be considered in the appropriate clinical setting. Several other subtle areas of ground-glass opacity as described above may be due to the expiratory phase of the scan versus mild pulmonary edema. 3. Overall stable appearance of right axillary simple fluid collection, which most likely represents a postsurgical seroma. ___ BILATERAL LOWER EXTREMITY DOPPLER ULTRASOUNDS: IMPRESSION: No evidence of deep venous thrombosis in the bilateral lower extremity veins. Brief Hospital Course: ___ with COPD (no home O2), hx of major depression and anxiety and stage IIIB Hodgkin's lymphoma (EBV+) on C4D8 ABVD (her treatment history has been complicated by multiple problems including subclavian injury with initial port placement, preseptal cellulitis, zoster) who presents with fever and left sided back pain after undergoing bronchoscopy and biopsies on ___ which were complicated by bleeding. Imaging with consolidation in LLL which may represent resolving hemorrahge and/or pneumonia. Patient was started on Vancomycin and Cefepime for empiric coverage but narrowed eventually to levofloxacin on discharge for PNA. # Hodgkin's Lymphoma, Stage IVB. On cycle 4 of ABVD. She continued Neupogen 300 mcg SC qod and received last dose on ___, day of discharge. # Community acquired pneumonia: Likely source of her fevers, chest pain. BAL grew S. viridans. Briefly on vanc/cefepime/azithro, but changed to ceftriaxone/azithro on ___ and then to PO levofloxacin to include atypical coverage. Discharged home with total 7 days antibiotics. Blood, urine cultures with no growth. Sputum culture inadequate. # Hemoptysis: Complication of recent bronchoscopy. This improved throughout admission, although she still had scant brown hemoptysis on discharge. # Back Pain: Possibly acute from PNA. She continued home oxycodone and bowel regimen with colace and senna. # Left leg pain: Due to complaints of left leg pain, bilateral ___ dopplers were performed, which revealed no DVT. Pain may be due to neupogen. # DMII: She continued home lantus and ISS. # COPD: She continued atrovent and albuterol nebs PRN dyspnea, cough, wheezing # Post-herpetic neuralgia: She continued gabapentin. Acyclovir was given instead of home prophylactic Valacyclovir, as this is non-formulary. # Migraines: Contined Topamax # HLD: Cont statin. # Hypothyrodisim: Cont Levothyroxine. # Depression: Cont Cymbalta. TRANSITIONAL ISSUES: =============== - Discharged with 3 remaining days of PO levoquin (last day = ___ - Still having left calf pain, however doppler showed no DVT. - Hemoptysis resolving, still with some dime-sized, brown sputum. - Code: Full - Name of health care proxy: ___ Relationship: Son Phone number: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB 2. Duloxetine 60 mg PO DAILY 3. Levothyroxine Sodium 25 mcg PO DAILY 4. Loratadine 10 mg PO DAILY 5. Lorazepam 1 mg PO Q6H:PRN anxiety, nausea 6. Omeprazole 20 mg PO BID 7. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain 8. Pravastatin 40 mg PO QHS 9. Senna 8.6 mg PO BID:PRN constipation 10. Topiramate (Topamax) 25 mg PO QHS 11. Multivitamins W/minerals 1 TAB PO DAILY 12. Ondansetron 8 mg PO Q8H:PRN nausea 13. Polyethylene Glycol 17 g PO DAILY:PRN constipation 14. Prochlorperazine 10 mg PO Q8H:PRN nausea 15. Gabapentin 300 mg PO TID 16. ValACYclovir 1000 mg PO Q8H 17. Glargine 10 Units Bedtime Humalog 4 Units Breakfast Humalog 4 Units Lunch Humalog 4 Units Dinner Insulin SC Sliding Scale using HUM Insulin 18. Filgrastim 300 mcg SC QOD Discharge Medications: 1. Duloxetine 60 mg PO DAILY 2. Filgrastim 300 mcg SC QOD 3. Gabapentin 300 mg PO TID 4. Glargine 10 Units Bedtime Humalog 4 Units Breakfast Humalog 4 Units Lunch Humalog 4 Units Dinner Insulin SC Sliding Scale using HUM Insulin 5. Levothyroxine Sodium 25 mcg PO DAILY 6. Loratadine 10 mg PO DAILY 7. Lorazepam 1 mg PO Q6H:PRN anxiety, nausea 8. Multivitamins W/minerals 1 TAB PO DAILY 9. Omeprazole 20 mg PO BID 10. Ondansetron 8 mg PO Q8H:PRN nausea 11. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain 12. Polyethylene Glycol 17 g PO DAILY:PRN constipation 13. Pravastatin 40 mg PO QHS 14. Prochlorperazine 10 mg PO Q8H:PRN nausea 15. Senna 8.6 mg PO BID:PRN constipation 16. Topiramate (Topamax) 25 mg PO QHS 17. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB 18. ValACYclovir 1000 mg PO Q8H 19. Levofloxacin 750 mg PO DAILY Duration: 3 Days RX *levofloxacin 750 mg 1 tablet(s) by mouth dailyd Disp #*3 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary diagnoses: healthcare-associated pneumonia Secondary diagnoses: hodgkin's lymphoma, type II diabetes mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, It was a pleasure taking care of you at the ___ ___. You were admitted for fevers, shortness of breath and pain in your back. Imaging of your chest showed that you may have a pneumonia that was causing those symptoms. We initially gave you antibiotics through your IV, but then transitioned you to oral antibiotics. We also performed ultrasounds of your legs, which showed no clot. We are discharging you with 3 more doses of antibiotics. Start taking one pill of levofloxacin daily tomorrow. Your last pill will be on ___. Please continue to take all your medications as prescribed and follow-up at the appointments below. On behalf of your ___ team, We wish you all the best Followup Instructions: ___
19812073-DS-15
19,812,073
22,683,833
DS
15
2141-01-06 00:00:00
2141-01-05 15:23:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROSURGERY Allergies: ALL antibiotics except penicillin Attending: ___. Chief Complaint: headaches, interhemispheric SDH s/p fall Major Surgical or Invasive Procedure: none History of Present Illness: This is a ___ year old ___ speaking female with a history of Afib on coumadin, CAD s/p PCI (cordis) to RCA in ___, CHF with EF 30%, presenting s/p mechanical fall (missed a stair). No LOC. Complaning of upper back pain only. No nausea, vomiting, HA, blurred vision Past Medical History: 1. CARDIAC RISK FACTORS: +Diabetes, ?Dyslipidemia, +Hypertension 2. CARDIAC HISTORY: -CABG: none -PERCUTANEOUS CORONARY INTERVENTIONS: PCI (Cordis) to RCA in ___ at ___ -PACING/ICD: none 3. OTHER PAST MEDICAL HISTORY: rapid Atrial fibrillation Systolic heart failure with an EF of 30% and global hypokinesis h/o lower GI bleed (hemorrhoidal) while on pradaxa in the past Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: On Admission: awake, alert, oriented x 3 follows commands throughout PERRL, EOMI, FSTM no drift MAE x ___ sensation intact to light touch At discharge: she is a awake, alert and oriented, PERRLA, EOMi, face symmetrical, no pronator drift, MAE well. Pertinent Results: ___ 10:40PM ___ PTT-37.6* ___ ___ 10:40PM PLT COUNT-242 ___ 10:40PM WBC-16.0*# RBC-4.91 HGB-12.3 HCT-37.6 MCV-77* MCH-25.0* MCHC-32.7 RDW-17.3* ___ 10:40PM GLUCOSE-171* UREA N-16 CREAT-0.9 SODIUM-131* POTASSIUM-4.3 CHLORIDE-93* TOTAL CO2-27 ANION GAP-15 CT head ___ : IMPRESSION: 1. Moderate left parietal subgaleal hematoma. 2. Small 3.5 mm wide and 35 mm long left parafalcine acute subdural hematoma. CT C-spine ___ height of the vertebral bodies of the C-spine is preserved. There is no acute fracture or acute malalignment. There is no prevertebral soft tissue swelling. There is are bridging anterior osteophyte from C3-C6 anteriorly as well as a mild posterior osteophyte formation at C4 and C5, but no significant spinal canal or neural foraminal narrowing. CT T-Spine ___: The height of the vertebral bodies of the thoracic spine is preserved. There is no acute fracture or malalignment. Anterior and lateral (right greater than left) bridging osteophytes are seen throughout the thoracic spine, likely representing DISH. There is no evidence of posterior rib fracture and the partially seen posterior lungs are clear. Visualized soft tissues are unremarkable. CT head ___: 1. Mild interval improvement of the parasagittal subdural hematoma along the anterior falx as well as the left parietal subgaleal hematoma. 2. No new acute hemorrhage, mass effect, or infarction. CXR ___: As compared to the previous radiograph, there is no relevant change. Moderate cardiomegaly without pulmonary edema. No acute findings such as edema or pneumonia. No pleural effusions, no pneumothorax. Brief Hospital Course: Mrs. ___ was admitted to the Neurosurgery service for frequent neuro checks and systolic blood pressure control less than 140. Her Coumadin and Aspirin were held and she was placed on Vitamin K daily x3 days. Her INR of 2.6 was not actively reversed because her hemorrhage was small. On ___ she complained of a feeling in her chest that she described as being short of breath. EKG was stable, Chest Xray was negative for cardiopulmonary process. Repeat Head CT was stable. Initial troponin was mildly elevated at 0.06 and thus medicine consult was initiated. Cardiac enzymes were trended and serial EKGs were obtained. Potassium and Magnesium were repleated. She refused the third set of cardiac enzymes. The medicine service and Dr. ___ that there was no acute cardiac issue. They patient had no other complaints of chest pain on this date, ___. She was seen and evaluated by ___ and OT. They felt that she needed rehab or 24 hour supervision at home. Her son told nursing and case management that he could provide this service and she was discharged home with ___. Medications on Admission: Glipizide 5mg BID Metformin 500mg QAM and 100mg QPM CHLORTHALIDONE - chlorthalidone 25 mg tablet 1 Tablet(s) by mouth once a day DILTIAZEM HCL [DILTIA XT] - (Dose adjustment - no new Rx) - Diltia XT 120 mg capsule, extended release 1 capsule(s) by mouth once a day ESOMEPRAZOLE MAGNESIUM [NEXIUM] - Nexium 40 mg capsule,delayed release 1 Capsule(s) by mouth daily () ISOSORBIDE MONONITRATE - (Prescribed by Other Provider) - isosorbide mononitrate ER 120 mg tablet,extended release 24 hr 1 Tablet(s) by mouth once a day LISINOPRIL - lisinopril 20 mg tablet 1 tablet(s) by mouth once a day METOPROLOL SUCCINATE - metoprolol succinate ER 100 mg tablet,extended release 24 hr 2 Tablet(s) by mouth once a day NITROGLYCERIN [NITROSTAT] - (Prescribed by Other Provider) - Dosage uncertain ROSUVASTATIN [CRESTOR] - Crestor 20 mg tablet 1 Tablet(s) by mouth DAILY (Daily) WARFARIN - warfarin 1 mg tablet 2 Tablet(s) by mouth as directed ASPIRIN [ASPIRIN LOW DOSE] - (Prescribed by Other Provider) - Aspirin Low Dose 81 mg tablet,delayed release 1 tablet po once a day Discharge Medications: 1. Diltiazem Extended-Release 120 mg PO DAILY 2. Lisinopril 20 mg PO DAILY 3. Omeprazole 40 mg PO DAILY 4. Metoprolol Succinate XL 200 mg PO DAILY 5. Acetaminophen 650 mg PO Q6H:PRN headaches 6. Chlorthalidone 25 mg PO DAILY 7. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 8. Rosuvastatin Calcium 20 mg PO DAILY 9. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN headache RX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth Q6hr Disp #*60 Tablet Refills:*0 10. GlipiZIDE 5 mg PO BID 11. MetFORMIN (Glucophage) 500 mg PO BID 12. Nitroglycerin SL 0.3 mg SL PRN chest pain Please give one now Discharge Disposition: Home with Service Discharge Diagnosis: acute parafalcine SDH Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: •Take your pain medicine as prescribed. •Exercise should be limited to walking; no lifting, straining, or excessive bending. •Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication. •Unless directed by your doctor, do not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, or Ibuprofen etc. •Do not restart your Aspirin or Coumadin until you have seen Dr. ___ in Follow up clinic in onem week. •CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING •New onset of tremors or seizures. •Any confusion, lethargy or change in mental status. •Any numbness, tingling, weakness in your extremities. •Pain or headache that is continually increasing, or not relieved by pain medication. •New onset of the loss of function, or decrease of function on one whole side of your body. Followup Instructions: ___
19812073-DS-18
19,812,073
24,222,082
DS
18
2144-03-16 00:00:00
2144-03-28 00:15:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: ALL antibiotics except amoxicillin / lidocaine Attending: ___ Chief Complaint: Chest pain and weight gain Major Surgical or Invasive Procedure: ___ - TTE History of Present Illness: Ms. ___ is a ___ female with history CAD s/p MI and 3 stents, paroxysmal atrial fibrillation on coumadin, chronic venous stasis, previous pericardial effusion, and diastolic dysfunction (last echo ___ 60%EF) who presents with chest pain since 5pm last night. Chest pain initially ___ and persisted until now, currently ___. Additionally when she took her blood pressure last night while having chest pain SBP was in the 200 mmHg. Pain is not obviously positional or pleuritic, however she feels SOB and that she cannot take a deep breath. She noted ___ pound weight gain recently and took an extra torsemide and metolazone yesterday accordingly. Also has minor nonproductive cough, HA and nausea. Denies fever or chills, changes in BM (last yesterday). In the ED initial vitals were: 99.7 70 175/69 20 100% RA. Labs notable for WBC 9.4, H/H 10.3/33.1 (at baseline), Plt 158, INR 3.2, Na 135, K 3.3, BUN/Cr ___ (at baseline), trop 0.01, BNP 3160, lactate 1.4. CXR showed minimal pulmonary vascular congestion and trace pleural effusions. Bedside ultrasound without pericardial effusion. Patient was given Aspirin 324mg PO plus Omeprazole 40 mg, Amiodarone 100 mg, Torsemide 40 mg, Potassium Chloride 40 mEq, and Tylenol ___. Patient refused further potassium and IV lasix. ECG with SR and 1st degree block with rate 70 bpm. Vitals on transfer were 98.3 59 131/62 24 100% NC. On the floor patient states she is not currently having chest pain ___ chest pain and back pain worse when she moves. Past Medical History: - Diabetes - Dyslipidemia - Hypertension - CAD with PCI (Cordis) to RCA in ___ at ___ - Atrial fibrillation on coumadin - Transient systolic heart failure (Tachycardia induced cardiomyopathy) with an EF of 30% which has resolved with noraml EF on most recent TTE. - h/o lower GI bleed (hemorrhoidal) while on pradaxa in the past - ___ in ___ resolution on CT on ___ (EF 30% --> 55%) - CAD, s/p IMI ___ and DES to RCA. - Hx LGIB on dabigatran - Venous stasis Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ON ADMISSION: ================================ PHYSICAL EXAM: VS: T=98.4F BP=132/69 HR=65 RR=22 O2 sat=100% 3L GENERAL: NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVP of 10 cm. CARDIAC: RR, normal S1, S2. No murmurs/rubs/gallops. LUNGS: Mild crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: 2+ pitting edema through thighs bilaterally w/ venostatic changes; skin sloughing on left skin. PULSES: Distal pulses palpable and symmetric ON DISCHARGE: =========================================== PHYSICAL EXAM: VS: T98.2 BP 140/54, HR 61, RR 20, O2 95% on RA GENERAL: NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVP of 10 cm. CARDIAC: RR, normal S1, S2. No murmurs/rubs/gallops. LUNGS: Mild crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: 2+ pitting edema through thighs bilaterally w/ venostatic changes; skin sloughing on left shin. PULSES: Distal pulses palpable and symmetric Pertinent Results: ON ADMISSION: =============================== ___ 04:00PM GLUCOSE-129* UREA N-21* CREAT-1.3* SODIUM-135 POTASSIUM-3.7 CHLORIDE-92* TOTAL CO2-27 ANION GAP-20 ___ 04:00PM CK-MB-2 cTropnT-0.03* ___ 11:25AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-SM ___ 11:25AM URINE RBC-<1 WBC-5 BACTERIA-NONE YEAST-NONE EPI-1 TRANS EPI-<1 ___ 11:25AM URINE HYALINE-4* ___ 08:02AM LACTATE-1.4 ___ 07:50AM GLUCOSE-162* UREA N-18 CREAT-1.3* SODIUM-135 POTASSIUM-3.3 CHLORIDE-93* TOTAL CO2-31 ANION GAP-14 ___ 07:50AM proBNP-3160* ___ 07:50AM CALCIUM-9.6 PHOSPHATE-3.7 MAGNESIUM-1.7 ___ 07:50AM WBC-9.4# RBC-3.83* HGB-10.3* HCT-33.1* MCV-86 MCH-26.9 MCHC-31.1* RDW-16.8* RDWSD-52.2* ___ 07:50AM NEUTS-89.1* LYMPHS-4.3* MONOS-5.4 EOS-0.3* BASOS-0.3 IM ___ AbsNeut-8.39*# AbsLymp-0.41* AbsMono-0.51 AbsEos-0.03* AbsBaso-0.03 ___ 07:50AM PLT COUNT-158 ___ 07:50AM ___ PTT-38.5* ___ ON DISCHARGE: ==================================== ___ 06:40AM BLOOD WBC-5.3 RBC-3.33* Hgb-8.8* Hct-28.4* MCV-85 MCH-26.4 MCHC-31.0* RDW-16.7* RDWSD-52.9* Plt ___ ___ 07:50AM BLOOD Neuts-89.1* Lymphs-4.3* Monos-5.4 Eos-0.3* Baso-0.3 Im ___ AbsNeut-8.39*# AbsLymp-0.41* AbsMono-0.51 AbsEos-0.03* AbsBaso-0.03 ___ 06:40AM BLOOD Plt ___ ___ 06:40AM BLOOD Glucose-104* UreaN-51* Creat-1.7* Na-133 K-4.1 Cl-94* HCO3-29 AnGap-14 ___ 06:30AM BLOOD CK-MB-2 cTropnT-0.03* ___ 06:40AM BLOOD Calcium-9.0 Phos-4.1 Mg-2.1 IMAGING/STUDIES: ===================================== ___ TTE Left Ventricle - Ejection Fraction: 55% to 60% >= 55% The left atrium is moderately dilated. The right atrium is moderately dilated. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with normal cavity size. There is mild regional left ventricular systolic dysfunction with akinesis of the basal inferior wall. The remaining segments contract normally (LVEF = 55-60 %). Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Trivial mitral regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is an anterior space which most likely represents a prominent fat pad. Compared with the prior study (images reviewed) of ___ heart rate is slower. Pulmonary pressures are higher. Other findings are similar. ___ No focal consolidation is seen. There may be very trace pleural effusions. No pneumothorax is seen. The cardiac silhouette is moderately enlarged. There may be minimal pulmonary vascular congestion. Mediastinal contours are unremarkable. Moderate cardiomegaly and possible minimal pulmonary vascular congestion. Possible trace pleural effusions. Brief Hospital Course: Ms. ___ is a ___ female with history CAD s/p Cordis to LAD, paroxysmal atrial fibrillation on Coumadin, chronic venous stasis, previous pericardial effusion, and diastolic dysfunction (last echo ___ 60%EF) with normal ECG, elevated trops with volume overload on exam and pulmonary congestion on CXR. # Chest pain: Patient presented to the ED with chest pain. Cardiac enzymes were negative and EKGs were unchanged. Her chest pain improved with diursesis and she was started on Imdur for relief of chest pain. On discharge she was chest pain free. She was continued on her aspirin and crestor as well as omeprazole. # Decompensated Diastolic Heart Failure: She was disuresed with 60 mg IV Lasix and responded with good urine output net negative 2L and Cr of 1.3-1.4. TTE on ___ demonstrated LVEF 55-60% with mildly elevated left ventricular filling pressures but was otherwise unremarkable. One day prior to discharge, she was started on home dose toresmide 40 mg and Indur 30 mg daily was started to help relieve chest pain. She stated her shortness of breath and chest pain were both improved. She was discharged on amiodarone 100 mg daily, isorbide mononitrate 30 mg daily, labetaolol 100 mg BID and toresmide 40 mg. Her lisinopril wad held at time of discharge as her creatinine increased from 1.4 to 1.7. # Paroxysmal Atrial Fibrillation: Patient was on warfarin for history of paroxysmal atrial fibrillation, 3 mg daily. On admission, her INR was supratherapeutic to 3.9. Her dose was held on ___ INR in AM was 1.9 and she was restarted on 3 mg warfarin daily with INR 2.0 for remainder of the hospitalization. =========================== Transitional Issues: =========================== - Patient had an increased Cr 1.7 on discharge. Held lisinopril 5mg on discharge. Please check electrolytes and renal function on ___ and assess for restarting lisinopril. - Patient had a constant ___ somewhat responsive to SLN. Started 30 mg isosorbide mononitrate 30 mg daily with improvement in chest pain. - Patient in sinus brady to ___ with frequent PACs with SBPs 100-110's. Continued amidarone 100 mg daily/labetalol 100 mg BID. - Discharge weight: 80.1 kg - Code: Full Code - Contact: ___ (son) ___, ___ ___ home care (___): ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amiodarone 100 mg PO DAILY 2. Warfarin 3 mg PO DAILY16 3. Lisinopril 5 mg PO DAILY 4. Labetalol 100 mg PO BID 5. Rosuvastatin Calcium 10 mg PO QPM 6. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 7. Torsemide 40-60 mg PO DAILY 8. Metolazone 2.5 mg PO DAILY:PRN weight gain 9. Aspirin 81 mg PO DAILY 10. Vitamin D 1000 UNIT PO DAILY 11. Acetaminophen 975 mg PO Q8H 12. Omeprazole 40 mg PO BID 13. Senna 17.2 mg PO BID 14. TraMADOL (Ultram) 50 mg PO BID:PRN pain Discharge Medications: 1. Acetaminophen 975 mg PO Q8H 2. Amiodarone 100 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Labetalol 100 mg PO BID 5. Omeprazole 40 mg PO BID 6. Rosuvastatin Calcium 10 mg PO QPM 7. Senna 17.2 mg PO BID 8. Torsemide 40-60 mg PO DAILY 9. TraMADOL (Ultram) 50 mg PO BID:PRN pain 10. Vitamin D 1000 UNIT PO DAILY 11. Warfarin 3 mg PO DAILY16 12. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY RX *isosorbide mononitrate 30 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 13. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 14. Metolazone 2.5 mg PO DAILY:PRN weight gain Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: ACUTE: - HFpEF (LEVF 55-60% on ___ - CAD s/p IMI with PCI (Cordis) to RCA in ___ at ___ - Paroxysmal atrial fibrillation on Coumadin - Pulmonary hypertension CHRONIC: - Dyslipidemia - Hypertension - Diabetes - Arthritis s/p hip replacement Discharge Condition: Activity Status: Ambulatory - Independent. Level of Consciousness: Alert and interactive. Mental Status: Confused - sometimes. Discharge Instructions: Dear Ms. ___, You were admitted to ___ with chest pain and increased weight. We treated you with a high dose of water pill (Lasix) to remove the extra fluid weight. We were concerned about your chest pain. We examined the functioning of your heart by electrocardiogram which showed your heart rate was slow, but there was no evidence of heart attack. We also examined the functioning of your heart with an electrocardiogram, it showed your heart muscle was working the same as before and functioning relatively normally. While in the hospital, we started you on a new medication to help with your chest pain called Imdur (isorbide mononitrate). It is important to go to your appointment on ___ to see if you should continue this medication. Please take your medications as prescribed. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Thank you for allowing us to participate in your care - ___ care team Followup Instructions: ___
19812073-DS-19
19,812,073
20,555,520
DS
19
2147-05-13 00:00:00
2147-05-13 13:23:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: ALL antibiotics except amoxicillin / lidocaine / ACE Inhibitors / lisinopril Attending: ___. Chief Complaint: Cough and Dyspnea Major Surgical or Invasive Procedure: N/A History of Present Illness: ___ ___ speaker w/ HFpEF, CAD s/p stents, afib (on apixaban), HTN, HLD, DM, CKD, who presented to the ED for cough and shortness of breath. Patient was referred in by her ___ after ___ days of worsening cough, dyspnea, myalgia and general malaise. Cough may be worse when supine, she is unsure. It has been non-productive, and she denies hemoptysis. It has limited her mobility, so that her average level of activity around the house has caused her more dyspnea than usual. She denies any sick contacts. She denies fever, rhinorrhea, sore throat. She hasn't been hungry and has been eating less. She is compliant with her medications with the help of her home aide. In the ED: - Initial vital signs were notable for: Temp 98.2, HR 61, BP 190/83, RR 22, SPO2 100% on 4L nasal cannula - Labs were notable for: Cr 1.9, Flu negative, lactate 0.6, proBNP 8196, INR 1.7 - Portable CXR: pulmonary edema, peribronchial cuffing, and no overt pneumonia - Patient was given: IV methylpred 80, duonebs, lasix IV 40, home meds Admitted to medicine for CHF and presumed viral respiratory infection. Past Medical History: - Atrial fibrillation on coumadin - HFpEF - Transient systolic heart failure (Tachycardia induced cardiomyopathy) with an EF of 30% which has resolved with noraml EF on most recent TTE. - CAD (s/p IMI with stent to RCA in ___ at ___) - Diabetes - Dyslipidemia - Hypertension - h/o lower GI bleed (hemorrhoidal) while on pradaxa in the past - Hx LGIB (while on Pradaxa) - Venous stasis Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ========================= ADMISSION PHYSICAL EXAM: ========================= VITALS: ___ 1706 Temp: 97.6 PO BP: 156/76 R Lying HR: 51 RR: 18 O2 sat: 96% O2 delivery: 2 L FSBG: 241 GENERAL: Elderly woman, alert and interactive, well-nourished HEENT: NCAT. PERRL, EOMI. Sclera anicteric and without injection. MMM. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Bilateral rhonci, more prominent at the bases. No wheezing. ABDOMEN: Slightly distended but non-tender EXTREMITIES: bilateral pedal edema, pitting, 1+. Brawny discoloration consistent with venous stasis of legs. NEUROLOGIC: CN2-12 grossly intact. ___ strength throughout. Sensation grossly intact. ======================== Discharge Physical Exam: ======================== PHYSICAL EXAM: ___ 0715 Temp: 98.4 PO BP: 164/84 HR: 75 RR: 18 O2 sat: 94% O2 delivery: Ra FSBG: 111 Wt: 175.71 lb General: Elderly woman in no acute respiratory distress on RA HEENT: NCAT. PERRL, EOMI. Sclera anicteric and without injection. Neck: Supple, no palpable lymphadenopathy. Lungs: Decreased aeration, clear to auscultation bilaterally CV: Audible S1 and S2 with no appreciable m/r/g. Normal rate and rhythm. GI: Soft, non-tender. Ext: 1+lower extremity edema. Brawny discoloration. Neuro: CN ___ intact. Alert, interactive. Moving all 4 extremities with purpose. Pertinent Results: Pertinent Results: ADMISSION LABS ============== ___ 09:25PM PLT COUNT-149* ___ 09:25PM ___ PTT-30.6 ___ ___ 09:25PM NEUTS-77.5* LYMPHS-13.1* MONOS-6.6 EOS-1.8 BASOS-0.5 IM ___ AbsNeut-3.43 AbsLymp-0.58* AbsMono-0.29 AbsEos-0.08 AbsBaso-0.02 ___ 09:25PM WBC-4.4 RBC-3.49* HGB-9.2* HCT-29.4* MCV-84 MCH-26.4 MCHC-31.3* RDW-15.7* RDWSD-47.8* ___ 09:25PM proBNP-8196* ___ 09:25PM cTropnT-<0.01 ___ 09:25PM estGFR-Using this ___ 09:25PM GLUCOSE-136* UREA N-32* CREAT-1.9* SODIUM-132* POTASSIUM-3.5 CHLORIDE-92* TOTAL CO2-26 ANION GAP-14 ___ 09:28PM LACTATE-0.6 ___ 10:24PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 10:24PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 10:24PM URINE UHOLD-HOLD ___ 10:24PM URINE HOURS-RANDOM ___ 11:00PM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE ___ 07:52AM cTropnT-<0.01 ___ 07:52AM GLUCOSE-187* UREA N-29* CREAT-1.9* SODIUM-140 POTASSIUM-3.9 CHLORIDE-100 TOTAL CO2-26 ANION GAP-14 Discharge Labs =============== ___ 06:53AM BLOOD WBC-6.4 RBC-3.90 Hgb-9.9* Hct-33.0* MCV-85 MCH-25.4* MCHC-30.0* RDW-16.1* RDWSD-50.2* Plt ___ ___ 06:53AM BLOOD Plt ___ ___ 06:53AM BLOOD Glucose-96 UreaN-23* Creat-1.4* Na-139 K-4.1 Cl-96 HCO3-29 AnGap-14 ___ 06:53AM BLOOD Calcium-9.1 Phos-2.8 Mg-2.1 Relevant Studies ================= CHEST (AP AND LAT) ___ Moderate to severe cardiac enlargement is unchanged. Mediastinal and hilar contours are similar. Pulmonary vasculature does not appear engorged. Lungs remain hyperinflated. Minimal blunting of the right costophrenic angle appears similar to prior exams, likely chronic pleural thickening. No definite pleural effusion or pneumothorax. Patchy atelectasis is seen in the lung bases without focal consolidation. No acute osseous abnormality. Remote left third rib fracture is present. IMPRESSION: Mild atelectasis in the lung bases. No definite focal consolidation to suggest pneumonia. Brief Hospital Course: ___ ___ speaker w/ HFpEF, CAD, afib (on apixaban), HTN, HLD, DM, CKD, admitted with acute hypoxic respiratory failure secondary to bronchitis (likely viral, but treated with antibiotics out of an abundance of caution), and a CHF exacerbation. # Acute on chronic diastolic heart failure BNP was 8K, compared to baseline of about ___. Patient also appeared volume overloaded with elevated JVP and peripheral edema. She was diuresed with 80mg IV Lasix BID with improvement in her clinical exam, pulmonary symptoms, and her creatinine. Prior to discharge, patient was advised to increase her dose of home Torsemide from 40mg daily to 40mg BID; however, given patient resistance to this dose, a compromise was reached at 60mg daily for torsemide. # Acute Bronchitis/bronchopneumonia, possibly bacterial Lung exam clinically consistent with bronchitis or bronchopneumonia. CXR was nonspecific, but given her hypoxia and cough, we treated empirically for possibility of bacterial bronchitis or CAP. Completed 5-day course of CTX/azithro on ___. # Acute hypoxemic respiratory failure She initially required ___ O2 in the setting of her infection and CHF, but was weaned to room air by time of discharge. # ___ on CKD, likely cardiorenal syndrome Creatinine has been slowly rising over the last few years. At time of admission creatinine was 1.9. Cr improved with diuresis - down to 1.4 on day of discharge, suggestive that 40mg torsemide was likely an inadequate dose for her (see above for torsemide adjustment). Losartan was increased to 100mg for greater BP control without a discernible effect on her creatinine. # Asymptomatic Bradycardia Patient experienced heart rates intermittently in the ___ on ___ - likely a junctional escape rhythm - though she remained asymptomatic. Cardiology was consulted and recommended holding labetalol and diltiazem while continuing the amiodarone to maintain sinus rhythm given her history of Afib. # HTN Home losartan was initially held during early diuresis. However, was restarted once renal function was found to be stable. Patient's diltiazem and labetolol were discontinued (per cards recs) due to junctional bradycardia (40s-50s) noted on first few days of admission. Patient's losartan was increased to 100mg and amlodipine 10mg was added for further BP control. # Anemia Hb has dropped two points since last checked in ___ (11 to 9). Ferritin, Transferrin and TIBC labs were consistent with an anemia of chronic disease. #Insomnia Difficulties with sleep. Started on Ramelteon on ___. Recommended melatonin at time of discharge. CHRONIC ISSUES: =============== # CAD Patient relays that she is s/p multiple cardiac stents. She occasionally has chest pain with exertion. Aspirin and statin were continued. # Atrial fibrillation Was in sinus rhythm at last cardiology visit in ___. Home Amiodarone and Apixaban (reduced dose due to age and Cr) were continued throughout admission. Diltiazem was stopped, as above. Transitional Issues [] DIURETIC DOSE: Increased torsemide from 40mg daily to 60mg daily. This is a lower maintenance dose than we felt was needed (based on her IV Lasix requirements), but it was the highest dose she would consent to try. Please reassess volume exam, weight, creatinine. [] ADHERENCE: If she is back in CHF at the time of her follow up appointment, please probe her on whether she took the higher dose or not. Barriers to diuretic adherence include her concern for possible ___ if she were to be over-diuresed, and a general distrust of most healthcare providers (although she seems to like her PCP and cardiologist). [] HYPERTENSION: Labetalol and Diltiazem discontinued due to bradycardia (HR in ___, Losartan increased to 100mg and Amlodipine started (10mg) - will likely need further titration of antihypertensive regimen as an outpatient. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Torsemide 20 mg PO BID 2. Rosuvastatin Calcium 10 mg PO QPM 3. Amiodarone 100 mg PO DAILY 4. Labetalol 100 mg PO BID 5. Losartan Potassium 50 mg PO DAILY 6. Diltiazem Extended-Release 120 mg PO DAILY 7. Apixaban 2.5 mg PO BID 8. Aspirin 81 mg PO DAILY 9. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 10. Omeprazole 20 mg PO DAILY 11. TraMADol 50 mg PO TID:PRN Pain - Moderate 12. Meclizine 25 mg PO Q12H:PRN nausea Discharge Medications: 1. amLODIPine 10 mg PO DAILY RX *amlodipine 10 mg 1 tablet(s) by mouth Once a day Disp #*30 Tablet Refills:*0 2. Torsemide 60 mg PO DAILY RX *torsemide 20 mg 3 tablet(s) by mouth Once a day Disp #*90 Tablet Refills:*0 3. Losartan Potassium 100 mg PO DAILY RX *losartan 100 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 4. Amiodarone 100 mg PO DAILY 5. Apixaban 2.5 mg PO BID 6. Aspirin 81 mg PO DAILY 7. Meclizine 25 mg PO Q12H:PRN nausea 8. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 9. Omeprazole 20 mg PO DAILY 10. Rosuvastatin Calcium 10 mg PO QPM 11. TraMADol 50 mg PO TID:PRN Pain - Moderate Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Heart Failure Exacerbation Viral Upper Respiratory Infection Bacterial Bronchitis Diabetes Hypertension Bradycardia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You had a bad cough and low oxygen levels - this was likely because you had bronchitis and worsening of your heart failure. WHAT HAPPENED TO ME IN THE HOSPITAL? - You were given a medicine called Furosemide ("Lasix") in order to remove some of the excess fluid that had accumulated in your body. - You were started on antibiotics to help treat the bacterial infection in your lungs that we believe has contributed to your low oxygen level and cough. - You were seen by our physical therapists, who recommended that you get physical therapy at home when you leave the hospital. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. Weigh yourself every morning, call Dr ___ weight goes up more than 3 lbs. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19812212-DS-19
19,812,212
28,972,811
DS
19
2145-07-30 00:00:00
2145-07-31 13:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: vertigo and nausea Major Surgical or Invasive Procedure: N/A History of Present Illness: The patient is a ___ woman with a past medical history significant for AFib on coumadin, PPM, HTN, HLD, uterine CA s/p resection, NIDDM, hypothyroidism presents with sudden onset vertigo, nausea, vomiting. Patient reports that yesterday she was in her usual state of health, other than feeling a slight cold with sniffles she was going to the bathroom around 9 ___, and while she was sitting on the toilet room started spinning around her. She tried to get up, but she was unable to she called her daughter who she lives with. Her daughter called EMS, and EMS brought her to ___. Patient believes that the spinning will be stopped when she got to the hospital. At ___, they performed a head CT which showed an old cerebellar infarct. Patient speech was initially slurred, but reportedly was back to baseline according to the family. She was noted to be mildly hypertensive to 177 systolic. Her ___ stroke scale was 0. She was noted to have very beating nystagmus and mild left-sided ataxia. Her family requested transfer to ___. ___ arriving to the emergency department here, the patient does not endorse room spinning vertigo. Reports overall "unwell" and not like her usual self. On neurologic review of systems, the patient denies headache, or confusion. Denies difficulty with producing or comprehending speech. Denies loss of vision, blurred vision, diplopia, vertigo, tinnitus, hearing difficulty, dysarthria, or dysphagia. Denies focal muscle weakness, numbness, parasthesia. Denies loss of sensation. Denies bowel or bladder incontinence or retention. Denies difficulty with gait. On general review of systems, the pt endorses recent fever or chills. No night sweats or recent weight loss or gain. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: AFib on coumadin PPM HTN HLD Uterine cancer s/p resection NIDDM Hypothyroidism PPM info (___, ___: The patient had a single chamber pacemaker VVI placed by Dr. ___. The patient tolerated the procedure well. She underwent a ___ placement of a generator with a model # ___, serial # ___. The right ventricular lead is Guidant Model # ___, ___ # ___. Social History: ___ Family History: Unknown Physical Exam: ======================== ADMISSION PHYSICAL EXAM: ======================== Vitals: T: afebrile P: 65 R: 18 BP: 145/58 SaO2: 95% on 2L NC General: Awake, cooperative, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: Supple, no carotid bruits appreciated. No nuchal rigidity Pulmonary: Lungs CTA bilaterally without R/R/W Cardiac: RRR, nl. S1S2, no M/R/G noted Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or organomegaly noted. Extremities: No ___ edema. Skin: no rashes or lesions noted. Neurologic: -Mental Status: Alert, slightly sleepy. Oriented x 3. Able to relay recent events, but cannot give specific details. Requires repeated stimulation to attend to examiner. Intact repetition andcomprehension. Normal prosody. There were no paraphasic errors. Pt was able to name both high and low frequency objects. Patient is unable to read, but can accurately describe stroke card and name objects. Speech was slightly dysarthric. Able to follow both midline and appendicular commands. There was no evidence of apraxia or neglect. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2mm and brisk. Fine vertical nystagmus on primary gaze that does not extinguish. Persistent horizontal nystagmus bilaterally that does not extinguish, although patient has a hard time sustaining end gaze. Does not fully bury sclera bilaterally. V: Facial sensation intact to light touch. VII: Slight left NLFF with symmetric activation. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. Was unable to complete head impulse test due to patient cooperation, she couldn't follow command to move her head. No skew. ___ did not reproduce symptoms, although it did not make her feel "good" and patient did have fine nystagmus as she did on primary gaze. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 5 5 5 5 ___ 5 5 5 5 5 5 R 5 5 5 5 5 ___ 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense, proprioception throughout. No extinction to DSS in the upper extremities. Persistently extinguishes to DSS on the right in the lower extremities. -DTRs: Bi Tri ___ Pat Ach L 1 1 1 0 0 R 1 1 1 0 0 Plantar response was flexor bilaterally. -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF bilaterally. When patient sits up, she leans to the left and can momentarily sit up straight but then slumps back to the left. -Gait: Patient extremely fatigued with sitting, and did not feel comfortable attempting to walk. ======================== DISCHARGE PHYSICAL EXAM: ======================== General: Awake, cooperative, NAD HEENT: No scleral icterus noted, MMM Pulmonary: CTAB, no crackles Cardiac: Skin warm, well-perfused Extremities: No peripheral lower extremity edema Neurologic: -Mental Status: Alert and cooperative. Language is fluent with intact comprehension. -Cranial Nerves: EOMI with prominent right-beating nystagmus on right end gaze that extinguishes, subtle left-beating nystagmus on left gaze, and subtle torsional nystagmus on upgaze. Face symmetric at rest. -Motor: No pronator drift bilaterally. Full motor exam deferred. -Coordination: No dysmetria on FNF bilaterally. Mild dysmetria on finger tapping bilaterally. Pertinent Results: ___ 05:32PM LACTATE-3.1* ___ 04:30PM GLUCOSE-107* UREA N-32* CREAT-1.3* SODIUM-139 POTASSIUM-5.1 CHLORIDE-95* TOTAL CO2-23 ANION GAP-21* ___ 04:30PM CALCIUM-9.3 MAGNESIUM-1.6 ___ 06:30AM LACTATE-2.3* K+-5.4* ___ 06:25AM GLUCOSE-137* UREA N-34* CREAT-1.2* SODIUM-136 POTASSIUM-5.7* CHLORIDE-98 TOTAL CO2-21* ANION GAP-17 ___ 06:25AM estGFR-Using this ___ 06:25AM ALT(SGPT)-23 AST(SGOT)-31 ALK PHOS-50 TOT BILI-0.5 ___:25AM LIPASE-39 ___ 06:25AM ALBUMIN-4.2 CALCIUM-8.9 PHOSPHATE-3.7 MAGNESIUM-1.7 CHOLEST-113 ___ 06:25AM TRIGLYCER-110 HDL CHOL-33* CHOL/HDL-3.4 LDL(CALC)-58 ___ 06:25AM TSH-2.5 ___ 06:25AM DIGOXIN-0.5* ___ 06:25AM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG tricyclic-NEG ___ 04:55AM URINE HOURS-RANDOM ___ 04:55AM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG oxycodn-NEG mthdone-NEG ___ 04:55AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 04:55AM URINE BLOOD-NEG NITRITE-POS* PROTEIN-TR* GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 04:55AM URINE RBC-1 WBC-<1 BACTERIA-MANY* YEAST-NONE EPI-0 ___ 04:55AM URINE HYALINE-1* ___ 04:55AM URINE MUCOUS-RARE* ___ 04:22AM %HbA1c-6.2* eAG-131* ___ 04:00AM cTropnT-<0.01 ___ 04:00AM VoidSpec-HEMOLYSIS ___ 04:00AM WBC-10.9* RBC-3.94 HGB-12.0 HCT-38.4 MCV-98 MCH-30.5 MCHC-31.3* RDW-17.3* RDWSD-61.6* ___ 04:00AM NEUTS-78.4* LYMPHS-12.5* MONOS-8.2 EOS-0.1* BASOS-0.3 IM ___ AbsNeut-8.58* AbsLymp-1.37 AbsMono-0.90* AbsEos-0.01* AbsBaso-0.03 ___ 04:00AM PLT COUNT-203 ___ 04:00AM ___ PTT-34.4 ___ ___ 02:44AM LACTATE-2.6* ___ 04:00AM BLOOD Neuts-78.4* Lymphs-12.5* Monos-8.2 Eos-0.1* Baso-0.3 Im ___ AbsNeut-8.58* AbsLymp-1.37 AbsMono-0.90* AbsEos-0.01* AbsBaso-0.03 ___ 04:45AM BLOOD Plt ___ ___ 04:45AM BLOOD ___ PTT-40.9* ___ ___ 04:45AM BLOOD Glucose-96 UreaN-20 Creat-1.1 Na-140 K-4.3 Cl-98 HCO3-27 AnGap-15 ___ 04:45AM BLOOD Calcium-9.1 Phos-3.1 Mg-1.9 URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 CFU/mL. Brief Hospital Course: The patient is a ___ year old woman with history of AFib on Coumadin, permanent pacemaker, diastolic heart failure, diabetes, hypertension, hyperlipidemia, prior cerebellar infarct, endometrial cancer, hypothyroidism, who presents with acute onset of vertigo and nausea on ___. # Neurologic History and examination were somewhat challenging in localizing her symptoms to peripheral or central location. Possibilities included a peripheral vestibulopathy, given the severity of symptoms and rapid resolution, vs. central, such as recrudescence of a chronic cerebellar infarct visualized on head CT, or an acute posterior fossa infarct, although this was felt less likely given that she had presented with a therapeutic INR. Unfortunately, MRI to confirm absence of acute infarct was not possible due to her MRI-incompatible pacemaker. CTA head/neck was negative for vertebrobasilar atherosclerotic disease. She does have several risk factors including DM (A1c of 6.2), hyperlipidemia (LDL 58), and hypertension (initial SBPs in 130-150s range, which then improved to 110-140s). No changes were made to her medication regimen while inpatient; she should continue to follow with PCP and physician at her ___ clinic to optimize her regimen for her cardiovascular risk factors. # CV/Pulm The patient on presentation was slightly dyspneic and had pitting edema in her lower extremities, with evidence of pulmonary edema on CXR and bilateral crackles on pulmonary exam. She was given Lasix 40mg IV x1 with dramatic improvement in her symptoms, and did not have any further desaturations or edema. She reportedly had a history of diastolic heart failure. She did not require any further dosages but will require further follow up and consideration of need for small standing diuretic dose. She was also placed on her home digoxin. In terms of her history of hypertension, patient was placed on her home atorvastatin. She was initially placed on her half dose of metoprolol (25 mg BID) but was transitioned to full dose day of discharge. # Heme The patient's INR upon presentation was within therapeutic range of 2.6, however on HOD 3, it had increased to 3.6, so dose was held x2 days. Her INR on therapeutic on day of discharge at 2.4. # Endo Patient has a history of diabetes. She was placed on an insulin sliding scale throughout admission. Patient also has a history of hypothyroidism. She was continued and discharged on her home levothyroxine dose. # ID Ms. ___ was found to have >100K E. coli on urine culture. However, she did not endorse any symptoms of a UTI (urgency, frequency, pain). Because this is consistent with asymptomatic bacteriuria, she was not placed on antibiotics. Transitional issues: [ ] Obtain INR ___, consider decreasing pt's daily warfarin dosage regimen. [ ] Monitor patient's weight, I/Os, vital signs; start on diuretic as needed for mild diastolic heart failure. [ ] If febrile or complaining of urinary symptoms, considering treating for UTI. E. coli sensitivity data below. [ ] Patient will be scheduled Stroke clinic follow up in ___ months. ESCHERICHIA COLI | AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- =>32 R CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Pravastatin 20 mg PO QPM 2. Digoxin 0.125 mg PO DAILY 3. MetFORMIN (Glucophage) 500 mg PO BID 4. Metoprolol Tartrate 50 mg PO BID 5. Levothyroxine Sodium 100 mcg PO DAILY 6. Allopurinol ___ mg PO DAILY 7. Warfarin 5 mg PO 6X/WEEK (___) 8. Warfarin 2.5 mg PO 1X/WEEK (SA) Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Digoxin 0.125 mg PO DAILY 3. Levothyroxine Sodium 100 mcg PO DAILY 4. MetFORMIN (Glucophage) 500 mg PO BID 5. Metoprolol Tartrate 50 mg PO BID 6. Pravastatin 20 mg PO QPM 7. Warfarin 5 mg PO 6X/WEEK (___) 8. Warfarin 2.5 mg PO 1X/WEEK (SA) Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Acute onset vertigo Possible acute infarct vs. recrudescence of chronic cerebellar infarct Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, You were admitted to the hospital due to symptoms of vertigo, nausea, and vomiting. Fortunately, your symptoms improved rapidly. The cause of your symptoms is not clear. There are a number of possibilities, including a possible problem with your vestibular system (such as in BPPV), or worsening of your previous stroke. Finally, while unlikely because your INR level was on the high side, it is always possible that you had a new small stroke. Unfortunately, because of your pacemaker, we are unable to obtain an MRI to confirm this definitively. You have many risk factors for stroke, including: - Atrial fibrillation - Hypertension - Hypercholesterolemia - Diabetes Your INR level was good on presentation but later became high during the admission at 3.6, so we held your Coumadin dose for a few days, then resumed it when it came back to therapeutic range. This will need to be closely monitored and titrated. In addition, you had evidence of edema (excess water) in your lungs and other tissues, possibly due to heart failure, so we gave you a dose of Lasix (a diuretic medication) to help remove some of the fluid. You ___ need to be on a dose chronically to prevent fluid buildup, so you should follow up with your PCP to continue care for your heart. You should continue all of your other medications as prescribed, and continue following with your PCP to ensure that your diabetes and blood pressure are well managed. It was a pleasure taking care of you. We wish you the best! Sincerely, Your ___ Care Team Followup Instructions: ___
19812383-DS-17
19,812,383
29,497,775
DS
17
2180-07-25 00:00:00
2180-07-25 16:28:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Bactrim / Sulfa (Sulfonamide Antibiotics) / Pollen Extracts Attending: ___. Chief Complaint: constipation Major Surgical or Invasive Procedure: none History of Present Illness: HPI: Pt is an ___ y/o F with PMHx of pancreatic neuroendocrine tumor not currently undergoing treatment, who presented to the ED with constipation. The patient reports chronic problems with constipation, which has been particularly bad for the past 2 days, with no BM during that time. She also endorses anorexia as well as intermittently episodes of dysphagia (recently both to solids and liquids). She also reports chronic RUQ abdominal pain that radiates to the shoulder. Prior to presentation, she attempted to manually disempact herself however was unable to do so successfully. ED Course: Initial VS: 99.0 116 128/72 18 100% Pain ___ Labs significant for WBC 14.0. Lactate 2.3. Mild transaminitis. Imaging: CT with hepatic lesion; no SBO. Meds given: none VS prior to transfer: 98.2 100 119/69 20 97% RA Pain ___ On arrival to the floor, the patient reports feeling better. Per her report, she had a large loose BM after drinking the CT contrast, which helped with her symptoms. She reports a 10 pound weight loss over the past ___s some lightheadedness with walking. ROS: As above. Denies fever, headache, lightheadedness, dizziness, sore throat, sinus congestion, chest pain, heart palpitations, shortness of breath, cough, nausea, vomiting, diarrhea, urinary symptoms, muscle or joint pains, focal numbness or tingling, skin rash. The remainder of the ROS was negative. Past Medical History: ONCOLOGIC HISTORY: - Ms. ___ presented with chronic constipation in ___. CT imaging revealed two suspicious lesions in her liver concerning for metastatic disease which was corroborated by both MRI and PET/CT findings showing similar findings. She underwent an ultrasound-guided biopsy of a liver lesion which showed tumor cells positive for CK-20, negative for CK-7, HePar1, ER, PR, mammoglobin, and GCDFP; immuonphenotypically not characteristic of metastatic breast cancer. - On ___, she underwent surgical resection of segment 8, 6 and 4a, performed by Dr. ___, with pathology revealing metastatic neuroendocrine carcinoma, 4a = 0.5 cm, 6 = 0.6 cm, 8 = 1.6 cm. Staining positive for chromogranin, synaptophysin and CK 20 (focal), negative for ER, mammoglobin, CK 7, GCDFP. - A subsequent CT scan showed a distal pancreatic tumor nodule and she then underwent distal pancreatectomy and splenectomy on ___, performed by Dr. ___. - She had a CT scan performed on ___ that showed two more metastatic sites in her liver. - An image-guided biopsy confirm that these were metastasis, and she had radiofrequency ablation to these on ___. She had a follow up scan on ___ that showed these to be well ablated. - Last seen in ___ clinic in ___. OTHER MEDICAL HISTORY: 1. History of ovarian cyst. 2. Status post appendectomy. 3. Status post cholecystectomy. 4. Breast cancer diagnosed in ___ when she was ___ years old for which she underwent a modified mastectomy and radiation. 5. Metastatic neuroendocrine tumor as above. 6. Carpel tunnel 7. Hemorrhoids Social History: ___ Family History: Her mother had ___ disease at age ___ and died at age ___. Her materal grandmother died of breast cancer. Maternal granfather was a smoker and died of lung cancer. Paternal grandmother died of melanoma. No other family history of malignancy. Physical Exam: Physical Examination: VS: 97.6 137/70 92 14 98%RA GEN: Alert, oriented to name, place and situation. no acute signs of distress. cachectic HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric, MMM. Neck: Supple Lymph nodes: No cervical, supraclavicular or axillary LAD. CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops. RESP: Good air movement bilaterally, no rhonchi or wheezing. ABD: Soft, non-tender, non-distended EXTR: No lower leg edema DERM: No active rash Neuro: muscle strength grossly full and symmetric in all major muscle groups PSYCH: Appropriate and calm. Pertinent Results: ================================== Labs ================================== ___ 10:15PM BLOOD WBC-14.0*# RBC-4.39 Hgb-13.8 Hct-43.1 MCV-98 MCH-31.5 MCHC-32.1 RDW-12.9 Plt ___ ___ 06:30AM BLOOD WBC-10.6 RBC-3.76* Hgb-11.7* Hct-37.1 MCV-99* MCH-31.1 MCHC-31.6 RDW-13.0 Plt ___ ___ 10:15PM BLOOD Glucose-95 UreaN-19 Creat-1.0 Na-140 K-5.7* Cl-103 HCO3-19* AnGap-24* ___ 06:30AM BLOOD Glucose-80 UreaN-18 Creat-0.8 Na-140 K-3.8 Cl-105 HCO3-20* AnGap-19 ___ 10:15PM BLOOD ALT-41* AST-83* AlkPhos-152* TotBili-1.0 ___ 06:30AM BLOOD Calcium-9.9 Phos-3.7 Mg-1.9 ___ 10:15PM BLOOD Albumin-4.4 ___ 10:15PM BLOOD Lactate-2.3* K-4.0 ================================== Radiology ================================== CT a/p FINDINGS: Imaged lung bases demonstrate sub-5-mm pulmonary nodules, which are stable since prior (2:5, 9). No pleural effusion is seen. Visualized distal esophagus is unremarkable. Heart is normal in size without pericardial effusion. There is a large heterogeneous hypoenhancing mass centered in the right hepatic lobe measuring 16.3 x 11 x 12 cm (2:14, 601B:21), which is new since prior exam. There is intrahepatic biliary ductal dilatation in the right hepatic lobe distal to this mass and slight mass effect on the right kidney. The visualized left hepatic lobe demonstrates homogeneous enhancement. The patient is status post partial liver resection and radiofrequency ablation of segments VIII and VI. The portal vein appears patent. Perihepatic fluid collection measures 2.8 x 1.8 cm and is unchanged (2:29). The patient is status post splenectomy and distal pancreatectomy. A 2.3 x 1.1 cm fluid collection, likely lymphocele, within the resection bed is also stable (2:27). Residual pancreas enhances homogeneously without ductal dilatation or peripancreatic fluid collection. The adrenal glands are prominent, unchanged. The kidneys enhance and excrete contrast symmetrically without evidence of hydronephrosis or renal masses. Small and large bowel loops are normal in caliber without evidence of bowel wall thickening or obstruction. There is no free air or free fluid within the abdomen. Intra-abdominal aorta and its branches demonstrate calcified atherosclerotic disease without associated aneurysmal changes. There are multiple mesenteric and retroperitoneal lymph nodes, unchanged. CT OF THE PELVIS: The bladder, distal ureters, and uterus are unremarkable. The rectum is distended with moderate amount of fecal matter, with hyperenhancing mucosa. There is no free air or free fluid within the pelvis. No inguinal or pelvic wall lymphadenopathy is detected. OSSEOUS STRUCTURES: No suspicious lytic or sclerotic bony lesion is seen. IMPRESSION: 1. Large hypoenhancing heterogeneous mass centered in the right hepatic lobe is new since prior exam and most likely represents metastatic disease in this patient with known history of prior metastatic lesions to the liver. There is intrahepatic biliary ductal dilatation distal to this lesion and slight mass effect on the right kidney. 2. Post-surgical changes related to splenectomy, distal pancreatectomy with stable fluid collection, likely lymphocele within the resection bed. 3. Stable pulmonary nodules in the visualized lung bases. Brief Hospital Course: ___ y/o F with PMHx of pancreatic neuroendocrine tumor not currently undergoing treatment, who presented to the ED with constipation. She had a bowel movement after drinking contrast for CT scan. She felt much better afterward. She will begin taking colace and senna twice a day at home. If there is no BM after two days, she will take miralax and then dulcolax. On the CT scan there was a new large 16cm liver lesion which is presumably a new metastasis from her pancreatic neuroendocrine cancer. We discussed possible treatments and she again confirmed that she does not want any cancer directed treatment such as ablation or chemotherapy. She would like to focus on symptomatic care, with the understanding that her cancer will progress and eventually may lead to her death. we discussed that her current symptoms of weight loss and fatigue may be cancer related. She is very interested in establishing care with our palliative care service to help manage these symptoms as well as others as they come up, and eventually being set up with home hospice when needed. She has an appointment in clinic in the coming weeks. She has been having some intermittent trouble with dysphagia, with a feeling that things are getting stuck in her midchest. She has no trouble with food going down the wrong way or cough after eating. I suggested a barium swallow to further evaluate this, which she will set up as an outpatient with her PCP. # Dispo: [x] Discharge documentation reviewed, pt is stable for discharge. [x] Time spent on discharge activity was greater than 30min. [ ] Time spent on discharge activity was less than 30min. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) unknown unknown oral unknown 3. Docusate Sodium 100 mg PO DAILY 4. Polyethylene Glycol 17 g PO DAILY 5. Senna 1 TAB PO DAILY:PRN constipation 6. Vitamin B Complex 1 CAP PO DAILY Discharge Medications: 1. Docusate Sodium 100 mg PO BID 2. Senna 1 TAB PO BID 3. Aspirin 81 mg PO DAILY 4. Polyethylene Glycol 17 g PO DAILY:PRN constipation 5. Bisacodyl 10 mg PO DAILY:PRN constipation 6. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) 0 unknown ORAL Frequency is Unknown 7. Vitamin B Complex 1 CAP PO DAILY Discharge Disposition: Home Discharge Diagnosis: constipation neuroendocrine pancreatic cancer Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___ was a pleasure taking care of you during your stay at ___ ___. You were admitted for constipation and weakness. Your constipation resolved after drinking contrast for a CT scan. You have had weakness and weight loss for the past few months. We suspect this may be related to the onset of symptoms from your cancer, which was found on CT scan to have grown in the liver over the past year. You confirmed that you do not want any treatment directed at this cancer, but would like to focus on treatment to alleviate any symptoms that may come. We have scheduled an appointment with the palliative care clinic to help you in this regard. Followup Instructions: ___